Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
prerank,pulmonary valve development (GO:0003177),-0.7040715656746052,-2.0580221388112285,0.0,0.1923601912079717,0.143,12/18,15.31%,NOTCH2;ROBO1;SMAD6;NOS3;BMP4;BMPR2;SLIT2;JAG1;STRA6;TNFRSF1A;TGFB2;HEY2
prerank,cotranslational protein targeting to membrane (GO:0006613),-0.4633475016447264,-2.0007495607814705,0.0,0.19903164292616726,0.275,49/91,27.56%,RPS14;RPL24;RPL18A;RPS16;RPL38;RPL28;RPS19;RPL37;RPS2;RPL19;RPL5;RPL34;RPS25;RPS15;RPLP1;RPL31;RPL3;SRPRA;RPS6;SRP14;RPS8;RPL11;RPL12;SSR2;RPL7A;SRP68;RPL13;RPS21;RPL35A;RPL26;RPS9;RPL32;RPS29;RPS23;RPLP2;RPL8;SRP72;RPL41;SIL1;RPS17;RPS5;RPS15A;UBA52;RPL37A;SRP19;RPS10;RPL6;RPL9;RPS27
prerank,pulmonary valve morphogenesis (GO:0003184),-0.6762281861650308,-1.9304895394339765,0.0,0.31355823075519085,0.523,10/17,15.31%,NOTCH2;ROBO1;SMAD6;NOS3;BMP4;SLIT2;JAG1;STRA6;TGFB2;HEY2
prerank,protein localization to cell-cell junction (GO:0150105),-0.6975822554725157,-1.9228170115284486,0.002932551319648094,0.25990863985470164,0.556,7/15,11.99%,TJP1;CGNL1;CDH5;TJP2;PAK2;MPP7;ACTG1
prerank,eosinophil migration (GO:0072677),0.8327674557694469,1.9213656481335493,0.0,0.17227969473570065,0.258,3/14,4.10%,LGALS3;CCL11;CCL4
prerank,eosinophil chemotaxis (GO:0048245),0.8327674557694469,1.9213656481335493,0.0,0.17227969473570065,0.258,3/14,4.10%,LGALS3;CCL11;CCL4
prerank,regulation of leukocyte chemotaxis (GO:0002688),-0.6437021481053471,-1.8980397343492128,0.0,0.27530857423753635,0.673,7/18,10.11%,PTN;MTUS1;SLC8B1;LYN;SLIT2;CAMK1D;IL6R
prerank,somite development (GO:0061053),0.8874537117915782,1.8885491256576366,0.0015552099533437014,0.23356686905344287,0.445,7/11,8.63%,PTCH1;MEOX1;MEOX2;SOX11;LOXL3;PPP2R3A;SMO
prerank,vascular process in circulatory system (GO:0003018),-0.736940725426144,-1.8862911529187736,0.0,0.2277824229498195,0.72,6/13,7.87%,ROCK2;ROCK1;NOS3;NPR1;ACE;AGTR1
prerank,regulation of tube diameter (GO:0035296),-0.736940725426144,-1.8862911529187736,0.0,0.2277824229498195,0.72,6/13,7.87%,ROCK2;ROCK1;NOS3;NPR1;ACE;AGTR1
prerank,regulation of trans-synaptic signaling (GO:0099177),0.7192336020085875,1.8857093596005752,0.0,0.18410281104109188,0.459,13/33,10.36%,RELN;CEL;NGF;NRG3;GRIK3;CACNA1A;GRIK5;GRIK2;LRRC4C;GRID2;NLGN1;GRIK1;PXK
prerank,regulation of glucose import (GO:0046324),-0.5590396511960521,-1.874746985718085,0.0,0.23252789009460742,0.771,13/30,9.62%,PRKAG2;OSBPL8;SORBS1;IGF1;OCLN;APPL2;GRB10;CREBL2;PRKCI;INSR;RHOQ;ARPP19;GSK3A
prerank,negative regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902548),0.8476696532708421,1.8606134916736101,0.0,0.2383926308107454,0.63,3/12,3.45%,DCN;ADAMTS12;CADM4
prerank,calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0016339),0.6985415135919639,1.8598279518004055,0.001272264631043257,0.20187770018048956,0.637,9/35,9.72%,DCHS1;CDH19;CDH10;CDH22;PCDHGB4;CDH8;NLGN1;CDH20;CDH7
prerank,positive regulation of SMAD protein signal transduction (GO:0060391),-0.6946710718031264,-1.8401114838605042,0.005917159763313609,0.3072574152435617,0.893,6/13,4.03%,BMP6;DAB2;RBPMS;BMP4;NUP93;TGFBR1
prerank,neuronal action potential (GO:0019228),0.7462006664008175,1.8346865070539815,0.0,0.2747926623515417,0.788,9/22,8.45%,ANK3;KCNA2;SCN7A;SCN2A;KCNA1;SCN5A;SCN3A;KCNMB2;KCNMB3
prerank,spinal cord development (GO:0021510),0.8343658656849218,1.8190211839012183,0.0015151515151515152,0.3187415640698327,0.862,7/12,8.79%,RELN;VIT;GLI2;SOX11;NF1;LOXL3;SOX12
prerank,"positive regulation of synaptic transmission, glutamatergic (GO:0051968)",0.7654237119072703,1.8146202885364713,0.0027472527472527475,0.30295059920843714,0.877,6/18,5.72%,RELN;TSHZ3;CACNG7;NRXN1;CCR2;NLGN1
prerank,regulation of NMDA receptor activity (GO:2000310),0.6745989876511919,1.803165369337685,0.0012690355329949238,0.33326710695931333,0.913,10/32,5.72%,RELN;CRH;GRIA1;EPHB2;GRIA3;CAPN1;GRIN2B;CCR2;DLG2;NLGN1
prerank,regulation of chondrocyte differentiation (GO:0032330),0.734045445677047,1.8021927777802538,0.0,0.30647974215014123,0.916,11/24,10.85%,SOX6;ADAMTS12;EFEMP1;PKDCC;SOX9;MBOAT2;PTHLH;ZBTB16;TRPS1;SOX5;PTPN11
prerank,regulation of T cell activation (GO:0050863),0.6570448679520496,1.8018280740910895,0.003667481662591687,0.2826287802526854,0.918,10/42,9.64%,LGALS3;PRKCQ;PYCARD;PTPN22;FGL1;TNFAIP8L2;CCR2;METTL3;LAX1;IL4I1
prerank,NAD biosynthesis via nicotinamide riboside salvage pathway (GO:0034356),-0.6782265933882332,-1.8006353741526107,0.0,0.4105166623929662,0.957,5/13,7.97%,PTGIS;NAMPT;NAXD;PARP10;PTGS2
prerank,response to sterol (GO:0036314),0.8294839184649626,1.7959017312343135,0.0,0.28679873336091855,0.932,4/11,6.38%,RORA;TGFB1;RORC;TGFBR2
prerank,regulation of lymphocyte proliferation (GO:0050670),0.7767636621787581,1.7882799347808027,0.0014388489208633094,0.30312677781227515,0.959,4/16,4.44%,LGALS3;FGF10;PTPN22;SOX11
prerank,regulation of T cell migration (GO:2000404),0.7473315396142858,1.7835532002831878,0.0027210884353741495,0.3065967303139546,0.968,3/18,1.40%,APOD;CXCL10;PYCARD
prerank,regulation of smooth muscle cell migration (GO:0014910),-0.5822997046129739,-1.7677948198038005,0.010344827586206896,0.520979729629998,0.987,11/20,12.47%,IGF1;NRP1;VTN;IGFBP3;SLIT2;IGFBP5;S100A11;ACE;PDGFRB;SERPINE1;CCN4
prerank,connective tissue development (GO:0061448),0.6627064485728082,1.7661573148420713,0.0,0.369773994653307,0.988,13/35,8.89%,SOX6;SULF1;SOX8;SOX9;PGRMC2;ITGB8;HOXD3;ZBTB16;RORC;CREB3L2;DYRK1B;TRIP11;SOX5
prerank,negative regulation of lymphocyte activation (GO:0051250),0.7161928988232076,1.761616920120591,0.00423728813559322,0.3727191286669549,0.992,8/21,9.64%,LGALS3;PTPN22;FGL1;SOX11;TNFAIP8L2;SAMSN1;LAX1;IL4I1
prerank,modified amino acid transport (GO:0072337),-0.6246066106366386,-1.759904458617138,0.006711409395973154,0.5149063499723983,0.992,5/15,13.58%,SLC16A12;SLC6A13;PDPN;SLC5A6;MGST1
prerank,regulation of platelet-derived growth factor receptor signaling pathway (GO:0010640),0.7976992017644405,1.7563475408608027,0.001519756838905775,0.38123517882690056,0.996,5/12,13.88%,APOD;CBLB;PTPRJ;CBL;SNCA
prerank,regulation of SMAD protein signal transduction (GO:0060390),-0.5807416407184471,-1.7496078048126937,0.003968253968253968,0.5209719540452448,0.994,6/21,4.03%,BMP6;DAB2;RBPMS;BMP4;NUP93;TGFBR1
prerank,blood vessel diameter maintenance (GO:0097746),-0.49105920120007757,-1.7483518533559654,0.009302325581395349,0.49058996742016564,0.994,15/34,22.91%,ROCK2;ROCK1;NOS3;KLF2;NPR1;ACE;AGTR1;ECE1;NOS1;EDNRB;EDN1;GCLC;GPER1;ACE2;AGT
prerank,endochondral bone morphogenesis (GO:0060350),-0.6958281097497332,-1.745966348853277,0.005747126436781609,0.4679652744107612,0.994,6/11,15.98%,COL13A1;BMP4;BMPR2;INPPL1;TMEM119;TRPV4
prerank,smoothened signaling pathway (GO:0007224),0.6639695630744271,1.7404504857378775,0.003875968992248062,0.45016737571805365,0.999,8/32,8.63%,PTCH1;PTCH2;GLI2;DHH;STK36;CC2D2A;GLI1;SMO
prerank,alpha-amino acid catabolic process (GO:1901606),0.682455330570706,1.738555423700951,0.00788436268068331,0.43846871326850867,0.999,8/29,9.64%,AADAT;KYNU;CBS;DAO;SARDH;GOT2;MTRR;IL4I1
prerank,SRP-dependent cotranslational protein targeting to membrane (GO:0006614),-0.4109970494063386,-1.7374931732446692,0.0,0.47673082069605704,0.997,47/87,27.56%,RPS14;RPL24;RPL18A;RPS16;RPL38;RPL28;RPS19;RPL37;RPS2;RPL19;RPL5;RPL34;RPS25;RPS15;RPLP1;RPL31;RPL3;RPS6;SEC61B;SRP14;RPS8;RPL11;RPL12;RPL7A;SRP68;RPL13;RPS21;RPL35A;RPL26;RPS9;RPL32;RPS29;RPS23;RPLP2;RPL8;SRP72;RPL41;RPS17;RPS5;RPS15A;UBA52;RPL37A;SRP19;RPS10;RPL6;RPL9;RPS27
prerank,regulation of homotypic cell-cell adhesion (GO:0034110),0.7948975023121586,1.7355031374548635,0.0031007751937984496,0.43542158941604053,0.999,3/11,1.04%,ANK3;PRKCA;PRKCQ
prerank,lysine catabolic process (GO:0006554),0.8022514599963345,1.730866850013531,0.002936857562408223,0.42462507149690776,0.999,5/12,3.36%,AADAT;GCDH;AASS;SLC25A21;DLST
prerank,lysine metabolic process (GO:0006553),0.8022514599963345,1.730866850013531,0.002936857562408223,0.42462507149690776,0.999,5/12,3.36%,AADAT;GCDH;AASS;SLC25A21;DLST
prerank,negative regulation of vascular endothelial growth factor signaling pathway (GO:1900747),0.8171478060269244,1.7265880649653833,0.001597444089456869,0.4315839598280904,0.999,2/10,3.45%,DCN;CADM4
prerank,pyroptosis (GO:0070269),-0.6155583104881952,-1.7249194174226385,0.0029940119760479044,0.5021248513783063,0.998,10/15,36.49%,CASP4;AIM2;CASP8;GSDMD;GSDME;APIP;ZBP1;CASP1;TREM2;NLRC4
prerank,positive regulation of vascular endothelial growth factor production (GO:0010575),0.693523052942512,1.7234762531373016,0.006756756756756757,0.4330445570533006,0.999,9/24,11.09%,RORA;SULF1;EIF2AK3;TGFB1;NOX1;CYP1B1;BRCA1;HIF1A;IL6ST
prerank,myelination in peripheral nervous system (GO:0022011),0.7839490682733891,1.722165767046857,0.00872093023255814,0.42288521491685016,0.999,4/13,5.07%,LGI4;PRX;NF1;ARHGEF10
prerank,negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642),0.8146795708912498,1.7217523642611607,0.008051529790660225,0.40990377830361635,0.999,3/10,2.79%,APOD;LRP1;PTPN2
prerank,action potential (GO:0001508),0.6245178548933354,1.7213695579412849,0.004807692307692308,0.3977461779822428,0.999,13/44,10.70%,ANK3;GNA14;KCNA2;SCN7A;SCN2A;KCNA1;CHRNA4;SCN5A;KCND2;SCN3A;KCNMB2;KCNMB3;AKAP6
prerank,regulation of ceramide biosynthetic process (GO:2000303),-0.6194729077252034,-1.721367161488209,0.009259259259259259,0.48948688347205127,0.998,8/15,24.24%,PRKCD;SIRT3;RACK1;TNFRSF1A;ORMDL3;SPHK1;ORMDL1;SPHK2
prerank,aortic valve development (GO:0003176),-0.4813426501643467,-1.7173049143185704,0.004545454545454545,0.4825098194431782,0.999,10/34,3.97%,ROBO1;ROCK2;SMAD6;ELN;ROCK1;NOS3;BMP4;BMPR2;SLIT2;TIE1
prerank,cellular response to sterol (GO:0036315),0.7673294308881004,1.7151027549033606,0.0077279752704791345,0.417811124835697,1.0,8/13,16.10%,RORA;PTCH1;GRAMD1A;RORC;SMO;GRAMD1C;GRAMD1B;GPLD1
prerank,aspartate family amino acid catabolic process (GO:0009068),0.723933977488801,1.7116791413664516,0.004092769440654843,0.4223184972540695,1.0,7/19,11.92%,AADAT;GCDH;AASS;SLC25A21;DLST;GOT2;PHYKPL
prerank,regulation of vascular endothelial growth factor production (GO:0010574),0.6827803134211309,1.7090319217210541,0.008032128514056224,0.4227678638865237,1.0,10/26,11.09%,RORA;SULF1;EIF2AK3;TGFB1;CCR2;NOX1;CYP1B1;BRCA1;HIF1A;IL6ST
prerank,sprouting angiogenesis (GO:0002040),-0.4417586681187032,-1.7078226188155716,0.006289308176100629,0.49785708447034294,1.0,18/51,5.90%,ROBO1;NRP1;TEK;CCBE1;VEGFC;ANGPT1;PIK3R3;RSPO3;CDH13;ACVRL1;VEGFD;BMP4;ENG;SLIT2;EPHB4;RNF213;KDR;THBS1
prerank,regulation of ion transmembrane transporter activity (GO:0032412),0.6325125887834542,1.7031399540976107,0.005037783375314861,0.441496878771216,1.0,14/39,17.21%,FXYD3;CHRM3;UTRN;ANK2;WNK3;FGF12;STK39;FXYD6;FXYD1;AHCYL1;TCAF1;NEDD4L;HOMER1;RIPK1
prerank,cartilage development (GO:0051216),0.607244471241957,1.6989114380385801,0.0,0.4501704543539435,1.0,13/49,9.67%,OSR2;SOX6;SULF1;FGF2;SOX9;TGFB1;ITGB8;HOXD3;ZBTB16;CREB3L2;TRIP11;SOX5;AMELX
prerank,neuron migration (GO:0001764),0.6066906703865093,1.6986146002419904,0.0024096385542168677,0.4384914227356018,1.0,19/48,11.86%,RELN;FGF13;ASTN2;MAP1B;NRCAM;VEGFA;SEMA3A;AUTS2;NTRK2;CEP85L;CDKL5;NAV1;DISC1;SDCCAG8;FGFR1;GPM6A;POMGNT2;ADGRL3;CDK5R1
prerank,epithelial structure maintenance (GO:0010669),-0.6642736310782935,-1.6982822046378636,0.011661807580174927,0.5140194704781142,1.0,3/11,8.36%,RBP4;CXADR;STRAP
prerank,positive regulation of chondrocyte differentiation (GO:0032332),0.8077517849752069,1.6972282651824975,0.003048780487804878,0.43376704252782244,1.0,5/10,8.89%,SOX6;PKDCC;SOX9;ZBTB16;SOX5
prerank,myeloid cell development (GO:0061515),-0.5907440068408016,-1.6941677298839821,0.014035087719298246,0.5068787066801755,1.0,5/18,13.20%,FOXP1;KIT;ALAS1;APP;NCKAP1L
prerank,positive regulation of nitric oxide biosynthetic process (GO:0045429),-0.5255353519573379,-1.6920676594577768,0.011811023622047244,0.49508939888435244,1.0,12/25,22.44%,TLR4;INSR;KLF2;PTGS2;KLF4;DDAH2;HSP90AA1;ASS1;EDN1;HSP90AB1;CLU;AKT1
prerank,peripheral nervous system development (GO:0007422),0.6755624676737727,1.6872578305721402,0.010869565217391304,0.4772678377972211,1.0,7/23,11.33%,ERBB3;SOX8;NGF;NF1;PMP22;GDNF;GPC1
prerank,presynapse assembly (GO:0099054),0.7176888453674276,1.686787998016685,0.011747430249632892,0.46705548251082135,1.0,6/16,5.72%,CEL;LRP4;PTEN;IL1RAPL1;WNT5A;NLGN1
prerank,regulation of sodium ion transmembrane transporter activity (GO:2000649),0.6317073262205593,1.6864698563521001,0.0,0.4565932584790933,1.0,10/39,9.57%,FXYD3;WNK2;ANK3;FGF13;UTRN;WNK3;FGF12;FGF14;STK39;FXYD6
prerank,extracellular matrix assembly (GO:0085029),0.6829164836624558,1.6838538039369122,0.0040650406504065045,0.4587938318904193,1.0,8/23,6.82%,NTN4;HAS2;PXDN;TGFB1;GPM6B;TNXB;NTNG2;NTNG1
prerank,negative regulation of T cell activation (GO:0050868),0.6305517273258611,1.6798198126166237,0.006369426751592357,0.47082544585122216,1.0,8/35,9.64%,LGALS3;GLMN;PTPN22;FGL1;TNFAIP8L2;SDC4;LAX1;IL4I1
prerank,diol biosynthetic process (GO:0034312),-0.6004856008766041,-1.678949030273917,0.024691358024691357,0.5270910152632693,1.0,8/15,25.70%,ACER2;SPTLC2;ASAH2;SPR;QDPR;SPHK1;SPHK2;SPTLC1
prerank,acyl-CoA biosynthetic process (GO:0071616),0.7172003768244251,1.6781356653052402,0.015781922525107604,0.4692994458223581,1.0,8/16,11.37%,GCDH;ACACA;ACSS1;SCD5;ACLY;FASN;PPT2;DIP2A
prerank,protein localization to endoplasmic reticulum (GO:0070972),0.7259933275406993,1.6722773492178054,0.011204481792717087,0.49137744598285804,1.0,5/16,10.41%,SEC16B;ANK2;PPP1R15A;GBF1;VAPA
prerank,homocysteine metabolic process (GO:0050667),0.7813226551326087,1.6704669763497433,0.009389671361502348,0.49029739454193794,1.0,5/11,8.74%,CTH;TST;DPEP1;CBS;MTRR
prerank,positive regulation of glucose import (GO:0046326),-0.5468155400718526,-1.666183918354434,0.011235955056179775,0.5612025185346097,1.0,9/21,9.47%,OSBPL8;SORBS1;IGF1;OCLN;CREBL2;PRKCI;INSR;RHOQ;ARPP19
prerank,aortic valve morphogenesis (GO:0003180),-0.4909681257928441,-1.665414943324707,0.018018018018018018,0.5428680007100918,1.0,9/30,3.97%,ROBO1;ROCK2;SMAD6;ELN;ROCK1;NOS3;BMP4;SLIT2;TIE1
prerank,regulation of chemokine (C-X-C motif) ligand 2 production (GO:2000341),-0.639940075776191,-1.6638257206012705,0.017964071856287425,0.5299685935892502,1.0,5/12,13.93%,FOXP1;MAP2K5;TLR4;KLF4;TIRAP
prerank,positive regulation of mononuclear cell migration (GO:0071677),0.6440059669041568,1.6631634080068185,0.005069708491761723,0.5236828917901856,1.0,5/29,7.02%,LGALS3;CXCL10;ANO6;CCR2;PLA2G7
prerank,regulation of smoothened signaling pathway (GO:0008589),0.5785696297337275,1.662898602008134,0.0058823529411764705,0.5135682901271523,1.0,11/50,8.63%,RORA;GPC3;PTCH1;PTCH2;STK36;EVC;GLI1;HHIP;UCHL5;RAB34;SMO
prerank,negative regulation of cell communication (GO:0010648),0.6734947712748266,1.6628704727417365,0.012465373961218837,0.5025925962366306,1.0,6/21,9.75%,UBASH3B;ERBB3;ACVR1;SOCS5;HHIP;PTPN1
prerank,heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0007157),0.6262909613038438,1.6621887346379387,0.004944375772558714,0.49614991411994325,1.0,9/37,8.17%,DCHS1;TENM2;TENM3;IL1RAPL1;GRID2;NLGN1;CADM3;HMCN1;CADM1
prerank,regulation of gene expression by genetic imprinting (GO:0006349),-0.6785039897453493,-1.6601960279107795,0.023054755043227664,0.5269652636931842,1.0,4/10,7.85%,IGF2;PCGF3;PRMT7;PCGF5
prerank,protein trimerization (GO:0070206),0.7450543324273426,1.6584130937631811,0.02346041055718475,0.4964231574256974,1.0,3/14,1.57%,SCARA5;STEAP4;SLC1A5
prerank,protein homotrimerization (GO:0070207),0.7450543324273426,1.6584130937631811,0.02346041055718475,0.4964231574256974,1.0,3/14,1.57%,SCARA5;STEAP4;SLC1A5
prerank,macrophage migration (GO:1905517),0.7504790299327275,1.6578728379521839,0.017964071856287425,0.48962178789591554,1.0,5/13,13.84%,LGALS3;CCR2;TAFA4;CKLF;P2RY12
prerank,stress fiber assembly (GO:0043149),-0.6051173883961013,-1.6574972200047418,0.006802721088435374,0.502768014207348,1.0,7/15,12.86%,SORBS1;PHACTR1;ITGB5;TNFAIP1;RHOA;PDLIM1;FAM171A1
prerank,contractile actin filament bundle assembly (GO:0030038),-0.6051173883961013,-1.6574972200047418,0.006802721088435374,0.502768014207348,1.0,7/15,12.86%,SORBS1;PHACTR1;ITGB5;TNFAIP1;RHOA;PDLIM1;FAM171A1
prerank,artery development (GO:0060840),-0.5444539055149638,-1.6527807443406264,0.007662835249042145,0.5033359245238611,1.0,13/23,12.76%,ROBO1;NRP1;ACVRL1;SMAD7;ENG;BMPR2;TGFBR1;TBX1;EFEMP2;STRA6;HECTD1;PDE2A;SLC2A10
prerank,negative regulation of T cell receptor signaling pathway (GO:0050860),0.7175046508559888,1.6512788923064936,0.008797653958944282,0.5162808098077277,1.0,5/17,10.53%,LGALS3;PTPN22;PTPN2;PRNP;PTPRJ
prerank,endothelial cell differentiation (GO:0045446),-0.6458023733990168,-1.648491928332104,0.013850415512465374,0.5053972147976785,1.0,7/12,12.04%,ACVRL1;BMPR2;TIE1;KDR;KDM6B;JAG1;PROX1
prerank,acylglycerol homeostasis (GO:0055090),0.6846544138099044,1.6481915063497363,0.009589041095890411,0.5244489392859251,1.0,6/20,15.20%,RORA;MLXIPL;IL18;PNPLA8;MTLN;LIPC
prerank,positive regulation of CREB transcription factor activity (GO:0032793),0.6923447393155604,1.6450670745022167,0.0205761316872428,0.5321267332458018,1.0,4/18,3.77%,RELN;VEGFA;CRTC1;RPS6KA4
prerank,positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002824),0.7563509009983537,1.6448313867688928,0.011235955056179775,0.523559404283938,1.0,4/12,12.59%,PRKCQ;CCR2;CARD9;ZBTB1
prerank,muscle organ development (GO:0007517),0.570183749216157,1.6442643349763504,0.0056947608200455585,0.5171637263616841,1.0,14/54,11.39%,LAMA2;SOX6;CXCL10;CHODL;UTRN;SGCD;EGR3;EVC;ITGB1BP2;MKX;SGCE;CHD2;MRAS;EMD
prerank,cytoplasmic translation (GO:0002181),-0.3765285520388246,-1.643990851284366,0.0,0.5077042145948008,1.0,45/91,27.56%,RPS14;GSPT1;RPL24;DRG1;RPL18A;RPS16;RPL38;RPL28;RPS19;RPL37;RPS2;FTSJ1;RPL19;RPL5;RPL34;RPS25;RPS15;RPLP1;RPL31;RPL3;DRG2;RPS6;RPS8;RPL11;RPL12;RPL7A;RPL13;RPS21;RPL35A;RPL26;RPS9;RPL32;RPS29;RPS23;RPL8;RPL41;RPS17;RPS5;RPS15A;UBA52;RPL37A;RPS10;RPL6;RPL9;RPS27
prerank,cellular amino acid catabolic process (GO:0009063),0.5519738960538932,1.6422097605734454,0.0,0.5190623815881448,1.0,35/87,22.76%,AADAT;GCDH;AASS;KYNU;CBS;IVD;SLC25A21;DLST;BCKDHB;MCCC1;DAO;HMGCLL1;SARDH;GOT2;MTRR;MCCC2;IL4I1;HIBADH;PHYKPL;HIBCH;ALDH5A1;GLS2;GLS;DBT;GSTZ1;AUH;AMT;BCKDK;ALDH7A1;ASPA;HYKK;GLUD1;DDAH1;ALDH6A1;CARNS1
prerank,regulation of synapse maturation (GO:0090128),0.7892210451641554,1.639087822870675,0.020440251572327043,0.5278028762697453,1.0,4/10,11.79%,RELN;NRXN1;YWHAZ;ANAPC2
prerank,macrophage chemotaxis (GO:0048246),0.7784086131172094,1.631317490283467,0.0203125,0.5634825676750985,1.0,3/10,9.37%,LGALS3;TAFA4;CKLF
prerank,protein targeting to ER (GO:0045047),-0.37186621697733774,-1.6296921322664213,0.0,0.5524877712117433,1.0,49/99,26.80%,RPS14;RPL24;RPL18A;RPS16;RPL38;RPL28;RPS19;RPL37;SPCS2;RPS2;RPL19;RPL5;RPL34;RPS25;RPS15;RPLP1;RPL31;RPL3;SRPRA;RPS6;SRP14;RPS8;RPL11;RPL12;ZFAND2A;RPL7A;SRP68;RPL13;RPS21;RPL35A;RPL26;RPS9;RPL32;RPS29;RPS23;RPLP2;RPL8;SRP72;RPL41;RPS17;RPS5;RPS15A;UBA52;RPL37A;GET3;SRP19;RPS10;RPL6;RPL9
prerank,regulation of bicellular tight junction assembly (GO:2000810),-0.5517060970915868,-1.6294526253243673,0.033444816053511704,0.53743308912721,1.0,6/19,1.98%,TJP1;ROCK2;PRKCH;ROCK1;CLDN5;OCLN
prerank,negative regulation of signal transduction (GO:0009968),0.5081115881919119,1.6276841651592804,0.0,0.5768502943991844,1.0,37/249,6.20%,APOD;DCN;GPC3;PTCH1;SOSTDC1;BMP5;UBASH3B;ADAMTS12;SULF1;PTCH2;ERBB3;PRKCQ;CREB3L1;TAX1BP3;FGF2;PTEN;RNF157;BCL2;VGLL4;ERBB2;EGFR;LRP1;PTPRT;ACVR1;FRZB;PTPN2;CADM4;IRAK3;TLE1;SOCS5;FBXW7;WIF1;SLC27A4;HHIP;SOCS1;SHISA2;METTL3
prerank,positive regulation of dendrite morphogenesis (GO:0050775),0.6798573735534887,1.626073436119749,0.011034482758620689,0.5767267876152264,1.0,5/19,6.26%,RELN;IL1RAPL1;OBSL1;CDKL5;CDKL3
prerank,organophosphate catabolic process (GO:0046434),0.7419815199463817,1.6250407270232814,0.022727272727272728,0.5730473420524045,1.0,2/11,2.67%,PLBD1;NUDT15
prerank,chondrocyte differentiation (GO:0002062),0.6173216662762607,1.6244581328618182,0.01282051282051282,0.5675095826587786,1.0,9/32,9.67%,OSR2;SOX6;SULF1;SOX9;EIF2AK3;TGFB1;CREB3L2;SOX5;AMELX
prerank,response to cholesterol (GO:0070723),0.6867539534147967,1.6216868909475182,0.01483679525222552,0.5757823170998687,1.0,8/17,16.10%,PTCH1;TGFB1;GRAMD1A;TGFBR2;SMO;GRAMD1C;GRAMD1B;GPLD1
prerank,cellular response to increased oxygen levels (GO:0036295),-0.6470302769072207,-1.6192367565935766,0.020710059171597635,0.5659614874269225,1.0,9/11,31.18%,ATP6V0D1;ATP6AP1;ATP6V0A2;CAV1;TMEM199;FAS;ATP6V1G1;CCDC115;ATP6V1A
prerank,negative regulation of small molecule metabolic process (GO:0062014),-0.5190051203206848,-1.6181407913043246,0.0036496350364963502,0.5555035360848863,1.0,5/20,10.64%,WNT4;CLK2;SIK1;GSK3A;C1QTNF3
prerank,negative regulation of peptide hormone secretion (GO:0090278),0.6816081230081552,1.6162166958580944,0.022130013831258646,0.5992691272240259,1.0,3/18,2.35%,FFAR4;CRH;PRKN
prerank,negative regulation of lipid metabolic process (GO:0045833),0.6441808069393733,1.6150629586790135,0.017857142857142856,0.5966720321706007,1.0,3/22,8.12%,APOD;PDE3B;ASXL3
prerank,axonogenesis (GO:0007409),0.5041313012640792,1.6127097014670768,0.0,0.6015823853694299,1.0,64/237,13.43%,LAMA2;RELN;GFRA1;NTN4;ANK3;PRKCA;DOCK7;LGR6;ENAH;PRKCQ;GLI2;EFNA4;PTEN;SEMA3E;IRS2;EPHB6;GFRA4;SEMA6C;EFNA5;MAP1B;NRCAM;EPHB2;MAPK7;SEMA3A;AUTS2;NRXN1;CTNNA2;WNT5A;SPTBN1;BAIAP2;NTNG2;NTNG1;PPP3CB;S100A6;CNTN6;FYN;GAB2;CNTN2;TNR;DOK6;DOK4;SPG11;DSCAM;DCC;PALLD;PIK3R1;GDNF;KIF5C;USP33;PTPN11;GPC1;MAPK1;OPHN1;EFNB1;PLPPR4;CDK5R1;PTPRA;NRP2;UNC5C;EFNB3;RAB3A;DRD2;SH3KBP1;LYPLA2
prerank,regulation of cartilage development (GO:0061035),0.6812255528414425,1.6087653098352472,0.023578363384188627,0.6168187841371265,1.0,7/18,8.89%,SOX6;SOX9;MBOAT2;PTHLH;ZBTB16;TRPS1;SOX5
prerank,bicellular tight junction assembly (GO:0070830),-0.41591374882432464,-1.6086497575256073,0.0,0.5814989473495622,1.0,12/46,8.89%,AFDN;PARD6G;CDH5;PECAM1;CLDN5;OCLN;ESAM;PRKCI;PARD3;CLDN14;PAK2;MPP7
prerank,myelination (GO:0042552),0.5808680872215258,1.6085910833266504,0.0036407766990291263,0.6088975864361145,1.0,12/46,12.65%,LGI4;MPZ;SCN2A;PLP1;NF1;ARHGEF10;KLK6;EIF2B5;EPB41L3;PMP22;GPC1;MYOC
prerank,regulation of cellular carbohydrate metabolic process (GO:0010675),0.6976389346164042,1.6072698128654535,0.01878612716763006,0.6071927307905678,1.0,4/16,7.17%,RORA;PRKN;RORC;PDK3
prerank,sulfur amino acid catabolic process (GO:0000098),0.7732732351498603,1.6048263902971351,0.020967741935483872,0.6138782592010883,1.0,4/10,8.74%,CTH;TST;CBS;MTRR
prerank,positive regulation of alpha-beta T cell proliferation (GO:0046641),0.7069579818764182,1.6046947650124015,0.026604068857589983,0.6061156767171988,1.0,4/14,7.90%,PTPN22;CCR2;TGFBR2;IL18
prerank,cellular response to ATP (GO:0071318),0.7144568535827759,1.604050746292853,0.020864381520119227,0.6017993009231671,1.0,8/14,21.50%,P2RY2;HSP90B1;P2RY12;P2RY1;SSH1;TAF1;RYR3;P2RX7
prerank,regulation of keratinocyte migration (GO:0051547),0.7453016723282548,1.6038933488288265,0.017080745341614908,0.5945867335600268,1.0,4/12,2.99%,EPB41L4B;FGF10;PTEN;MAP4K4
prerank,positive regulation of sodium ion transport (GO:0010765),0.7215240822340274,1.6019325088874228,0.04327666151468315,0.5984596709022351,1.0,6/12,15.13%,ANK3;WNK3;CNKSR3;SCN5A;AHCYL1;PKP2
prerank,regulation of nervous system development (GO:0051960),0.5982836591590233,1.601628069316226,0.009913258983890954,0.5922046141581481,1.0,3/37,0.75%,LGI4;NKX6-2;DOCK7
prerank,glial cell differentiation (GO:0010001),0.6187990048920478,1.597927097964318,0.0158311345646438,0.6057600942719239,1.0,7/28,7.61%,RELN;ERBB3;SOX8;FGF10;SOX9;SOX11;EIF2B5
prerank,urogenital system development (GO:0001655),0.744875118973856,1.5970672967039956,0.01557632398753894,0.6029820651864829,1.0,3/11,3.35%,OSR2;SOX9;EPHB2
prerank,negative regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043124),0.5995030468953443,1.593790314167017,0.008816120906801008,0.6147773003841521,1.0,13/38,18.57%,RORA;PYCARD;TLE1;OTUD7B;NLRX1;PPM1B;ESR1;RHOH;PER1;RIPK1;OTUD7A;ZMYND11;MAPKBP1
prerank,regulation of stem cell proliferation (GO:0072091),-0.5436721841320044,-1.592015967925603,0.02,0.6367815133585368,1.0,9/17,15.06%,GJA1;FBLN1;KDM1A;ZFP36L1;ACE;AGO3;PTPRC;HMGA2;TERT
prerank,sulfur compound catabolic process (GO:0044273),0.5920793167563149,1.5891069680431755,0.014634146341463415,0.6359376626654912,1.0,8/38,7.19%,DCN;VCAN;CTH;LUM;TST;DPEP1;BCAN;GALNS
prerank,regulation of T cell differentiation (GO:0045580),0.5993414001953619,1.587682307086311,0.017587939698492462,0.6364697181706318,1.0,11/33,17.76%,IL2RA;CBFB;CCR2;METTL3;ZMIZ1;RHOH;ZBTB1;GATA3;RUNX1;ABL1;MDK
prerank,regulation of plasma membrane bounded cell projection organization (GO:0120035),0.6146449083612958,1.5873949420203126,0.019659239842726082,0.6302444855037116,1.0,10/27,6.82%,PTEN;IL1RAPL1;FRMD7;NCS1;PSEN1;CTNNA2;FBXO7;DISC1;NTNG2;NTNG1
prerank,regulation of cholesterol esterification (GO:0010872),-0.6510768959365179,-1.5869668348798336,0.043478260869565216,0.6445734268396601,1.0,6/10,22.91%,AGTR1;ABCG1;STARD4;APOE;LAMTOR1;AGT
prerank,protein localization to cell junction (GO:1902414),-0.5050161165275299,-1.5862839578841592,0.033783783783783786,0.6315369762667471,1.0,6/22,8.23%,TJP1;CGNL1;NLGN2;JAM3;TJP2;PAK2
prerank,actomyosin structure organization (GO:0031032),-0.37302445867253814,-1.5862667643622081,0.0,0.6165533296232387,1.0,15/75,6.22%,TJP1;SORBS1;PHACTR1;ROCK2;FRMD5;TMOD3;PGM5;MYH9;ROCK1;ITGB5;TNFAIP1;EPB41L5;EPB41;CIT;TPM1
prerank,glycosaminoglycan catabolic process (GO:0006027),0.5613730373983647,1.5862652783801718,0.010477299185098952,0.6292087122484856,1.0,21/55,18.20%,DCN;GPC3;HSPG2;VCAN;LUM;FGF2;TGFB1;SDC2;SDC4;BCAN;GALNS;NCAN;GPC1;SDC3;GPC4;IDS;SPAM1;HYAL1;SLC9A1;CSPG4;SGSH
prerank,aggrephagy (GO:0035973),0.6281591501573195,1.5862256339851857,0.02826379542395693,0.621976734637586,1.0,15/27,22.86%,DYNLL1;PRKN;WDFY3;ACBD5;ATG5;DYNC1I1;HDAC6;DYNC1I2;UBB;PARK7;PCNT;WDR81;VIM;UBQLN1;DYNC1H1
prerank,ribosomal small subunit biogenesis (GO:0042274),-0.4354248661329939,-1.5842769420329132,0.01020408163265306,0.6100499571149977,1.0,24/39,30.62%,RPS14;NPM1;RPS16;RPS19;WDR3;RPS25;RPS15;RIOK3;RPS6;EMG1;SURF6;MRPS7;RIOK1;MRPS11;DDX52;RPS17;SNU13;RPS5;TSR3;RIOK2;PWP2;RPS27;NOL11;NOP14
prerank,regulation of cation channel activity (GO:2001257),0.5232350600614024,1.5813435301087237,0.00546448087431694,0.6428833853442659,1.0,18/89,6.55%,RELN;ANK3;CRH;FGF13;ANK2;GRIA1;CACNG7;GRIA3;CAPN1;HPCA;SHISA9;GRIN2B;DLG2;NLGN1;FGF12;JPH3;CACNB4;FGF14
prerank,type I interferon signaling pathway (GO:0060337),-0.43658609230958023,-1.5813251701087236,0.02030456852791878,0.5951676205043563,1.0,18/41,21.83%,SP100;IFIT2;IFI27;IFITM3;IRF2;SAMHD1;IRF1;IFITM2;OAS2;IRF9;STAT2;IFI35;ISG15;IFIT1;BST2;IFNAR1;IFNAR2;RSAD2
prerank,cellular response to type I interferon (GO:0071357),-0.43658609230958023,-1.5813251701087236,0.02030456852791878,0.5951676205043563,1.0,18/41,21.83%,SP100;IFIT2;IFI27;IFITM3;IRF2;SAMHD1;IRF1;IFITM2;OAS2;IRF9;STAT2;IFI35;ISG15;IFIT1;BST2;IFNAR1;IFNAR2;RSAD2
prerank,ERBB2 signaling pathway (GO:0038128),0.6061450346684945,1.5810406989947494,0.017948717948717947,0.636977842496842,1.0,16/31,22.34%,PRKCA;ERBB3;ERBB2;EGFR;ERBIN;BTC;ERBB4;PIK3R1;PTPN18;MYOC;GAB1;HBEGF;GRB2;SOS1;CPNE3;NRG1
prerank,canonical glycolysis (GO:0061621),-0.5011543368474953,-1.577031392982635,0.025454545454545455,0.5871114088314148,1.0,10/24,23.62%,FOXK1;PFKP;PGK1;PGAM1;GPI;PFKM;PFKL;ENO1;GAPDHS;ENO3
prerank,glucose catabolic process to pyruvate (GO:0061718),-0.5011543368474953,-1.577031392982635,0.025454545454545455,0.5871114088314148,1.0,10/24,23.62%,FOXK1;PFKP;PGK1;PGAM1;GPI;PFKM;PFKL;ENO1;GAPDHS;ENO3
prerank,membrane depolarization (GO:0051899),0.6060785888320656,1.5728643598236238,0.022756005056890013,0.6798824953933607,1.0,8/32,6.94%,CACNA1E;SCN7A;SCN2A;CACNA1A;CHRNA4;SCN5A;CACNB4;SCN3A
prerank,cardiac atrium morphogenesis (GO:0003209),-0.5616303844878252,-1.5727480638442626,0.03767123287671233,0.5919523514123927,1.0,7/16,19.45%,NOTCH2;ENG;BMPR2;PROX1;TGFB2;HEY2;ZFPM1
prerank,positive regulation of mitochondrial fission (GO:0090141),0.6498883890300862,1.5726909157222788,0.03954802259887006,0.6732547805222447,1.0,4/18,7.73%,DCN;SPIRE1;PRKN;BNIP3
prerank,positive regulation of ceramide biosynthetic process (GO:2000304),-0.6362319180204314,-1.5724811231479972,0.03234501347708895,0.5692972132860202,1.0,4/10,10.31%,PRKCD;SIRT3;RACK1;TNFRSF1A
prerank,positive regulation of sphingolipid biosynthetic process (GO:0090154),-0.6362319180204314,-1.5724811231479972,0.03234501347708895,0.5692972132860202,1.0,4/10,10.31%,PRKCD;SIRT3;RACK1;TNFRSF1A
prerank,negative regulation of cell-substrate junction organization (GO:0150118),0.6909704535133215,1.5720945405401299,0.020378457059679767,0.6619752246090311,1.0,3/16,1.66%,APOD;DLC1;PTEN
prerank,negative regulation of focal adhesion assembly (GO:0051895),0.6909704535133215,1.5720945405401299,0.020378457059679767,0.6619752246090311,1.0,3/16,1.66%,APOD;DLC1;PTEN
prerank,regulation of neurotransmitter receptor activity (GO:0099601),0.5413688775306974,1.5718031926218896,0.015294117647058824,0.6565073533784537,1.0,11/57,5.72%,RELN;CRH;GRIA1;CACNG7;DLGAP1;GRIA3;CAPN1;SHISA9;GRIN2B;DLG2;NLGN1
prerank,ephrin receptor signaling pathway (GO:0048013),0.5280054528414692,1.5703095584992255,0.005506607929515419,0.6583929947430103,1.0,28/82,14.33%,SIPA1L1;MMP2;DNM1;EFNA4;ARPC1B;EPHB6;EFNA5;EPHB2;ARHGEF28;PSEN1;SDC2;GRIN2B;PAK1;RASA1;CHN1;ITSN1;ANKS1B;FYN;VAV3;NCSTN;PTPN11;EFNB1;CDK5R1;ANKS1A;APH1A;EFNB3;EPHA10;PSEN2
prerank,positive regulation of T-helper 17 type immune response (GO:2000318),0.738607643107015,1.5694136862954429,0.023961661341853034,0.656460960789579,1.0,3/11,13.22%,PRKCQ;CARD9;MALT1
prerank,positive regulation of glucose transmembrane transport (GO:0010828),-0.4807141105071809,-1.568698839318028,0.01652892561983471,0.5731343881304727,1.0,10/26,9.47%,OSBPL8;SORBS1;IGF1;OCLN;CLIP3;CREBL2;PRKCI;INSR;RHOQ;ARPP19
prerank,eye morphogenesis (GO:0048592),0.6547448490041528,1.5685380262542756,0.019858156028368795,0.6547780355989012,1.0,6/19,8.49%,EFEMP1;TENM3;COL5A2;VEGFA;NF1;RARG
prerank,"regulation of synaptic transmission, glutamatergic (GO:0051966)",0.5709883534301333,1.5676061958792924,0.014580801944106925,0.6533157337349006,1.0,13/46,12.69%,RELN;TSHZ3;CACNG7;GRIK3;NRXN1;CCR2;SYT1;NLGN1;GRIK1;GRM5;DGKI;OPHN1;DRD2
prerank,positive regulation of protein tyrosine kinase activity (GO:0061098),0.5687816193413623,1.567306339475761,0.026410564225690276,0.6480947242565127,1.0,11/41,9.79%,RELN;ERBB3;GPRC5B;FBXW7;NCF1;NTRK2;PRNP;FYN;BTC;PTPN1;GRM5
prerank,negative regulation of ERK1 and ERK2 cascade (GO:0070373),0.5642486069485295,1.566091519741098,0.019536019536019536,0.6483913604452347,1.0,12/46,9.88%,WNK2;PTEN;DUSP4;PTPN2;EPHB2;CNKSR3;DUSP6;LMO3;SPRED2;SPRED1;PTPN1;SPRED3
prerank,positive regulation of sodium ion transmembrane transporter activity (GO:2000651),0.7090183634902282,1.5657924672156365,0.021244309559939303,0.6433586174544842,1.0,3/14,3.54%,WNK2;ANK3;WNK3
prerank,skeletal system development (GO:0001501),0.5017800044067765,1.56368289144689,0.003121748178980229,0.6492323807446897,1.0,38/148,12.65%,SOX6;BMP5;SULF1;VCAN;ANKH;GLI2;PKDCC;SOX9;AKAP13;FRZB;PTHLH;EIF2AK3;EVC;SOX11;ITGB8;PAPSS2;EXT1;HHIP;WNT5A;HOXD3;COL9A2;ZBTB16;TRPS1;CREB3L2;BCAN;FGFR1;TRIP11;SOX5;ADAMTS4;BPNT2;SLC10A7;NCAN;MMP16;COL1A2;BMP7;KIAA1217;VKORC1;MYOC
prerank,negative regulation of cytokine production involved in inflammatory response (GO:1900016),0.689911538222385,1.5622864808174148,0.03458646616541353,0.6504834378434289,1.0,2/16,1.40%,APOD;PYCARD
prerank,negative regulation of nucleocytoplasmic transport (GO:0046823),0.6995904517221572,1.5598276229096,0.034482758620689655,0.658311115884183,1.0,2/13,0.83%,APOD;MDFIC
prerank,membrane assembly (GO:0071709),0.5921424550307828,1.5596849799113617,0.026957637997432605,0.6525672171176892,1.0,9/34,8.19%,ANK3;CEL;LRP4;PTEN;IL1RAPL1;NRXN1;SPTBN1;NLGN1;GAK
prerank,positive regulation of calcium ion import (GO:0090280),0.7065066707079293,1.5587252761039414,0.02599388379204893,0.6518279415201961,1.0,1/12,0.37%,LGALS3
prerank,regulation of protein export from nucleus (GO:0046825),-0.49660694255045335,-1.5586907353449064,0.028368794326241134,0.6030393633222786,1.0,6/23,8.21%,SP100;PTPN14;XPO4;IFI27;GSK3B;CAMK1
prerank,negative regulation of viral genome replication (GO:0045071),-0.42639484941940387,-1.5579015782512804,0.011049723756906077,0.594913070354941,1.0,15/40,21.83%,ZC3HAV1;PLSCR1;IFITM3;IFIH1;PARP10;TNIP1;IFITM2;OAS2;PROX1;HMGA2;TASOR;ISG15;IFIT1;BST2;RSAD2
prerank,negative regulation of signaling (GO:0023057),0.6161350191003198,1.5573388797984569,0.03633916554508748,0.6535018460505561,1.0,6/25,9.75%,UBASH3B;ERBB3;ACVR1;SOCS5;HHIP;PTPN1
prerank,regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235),0.6358059721543481,1.5572866223396935,0.038408779149519894,0.6476079475189289,1.0,9/21,18.76%,CREB3L1;PRKN;EIF2AK3;SELENOS;HERPUD1;NCK1;OPA1;BCL2L11;PARK7
prerank,base conversion or substitution editing (GO:0016553),0.7331703649594564,1.5567352818650009,0.0364741641337386,0.6445655080139542,1.0,4/11,13.08%,METTL3;APOBEC1;ADARB2;ADARB1
prerank,acyl-CoA metabolic process (GO:0006637),0.582905379214336,1.5566285860233473,0.024906600249066,0.6390219087754844,1.0,14/35,20.99%,ACACA;DLST;THEM4;OXSM;ACOT11;ACSF2;SUCLA2;ACSL6;HMGCS2;GPAT4;GLYAT;DBI;ACOT8;ACBD6
prerank,smooth muscle contraction (GO:0006939),-0.5762125698409721,-1.5553368701569734,0.046583850931677016,0.5940474755245112,1.0,6/14,14.80%,ROCK2;ROCK1;PIK3C2A;MYLK;MYH11;ACTA2
prerank,interferon-gamma-mediated signaling pathway (GO:0060333),-0.4305141142116817,-1.5550985833569795,0.018867924528301886,0.5841765722696322,1.0,17/45,21.38%,SP100;PRKCD;TRIM25;IRF2;CAMK2G;TRIM5;ICAM1;IRF1;CAMK2A;OAS2;PML;VCAM1;IRF9;TRIM21;TRIM68;MT2A;IFNGR2
prerank,prostanoid biosynthetic process (GO:0046457),-0.5706497303040098,-1.5536821540331174,0.0379746835443038,0.5790462692194549,1.0,5/15,7.97%,PLA2G4A;PTGIS;PTGDS;PTGS1;PTGS2
prerank,modulation of chemical synaptic transmission (GO:0050804),0.5059997896125341,1.553171625768992,0.003188097768331562,0.6533450011307244,1.0,32/107,15.56%,RELN;CEL;CLSTN2;PTEN;NGF;NRG3;GRIK3;DLGAP1;CACNA1A;GRIK5;GRIK2;SLC12A2;LRRC4C;GRID2;SYT1;NLGN1;SLC8A2;GRIK1;USP46;SYN1;NMU;GRM5;MCTP1;PXK;DGKI;RIMS1;OPHN1;DRD2;CLSTN1;ITGB1;HOMER1;STX1B
prerank,negative regulation of cartilage development (GO:0061037),0.7091539567718748,1.5525513477719401,0.03343023255813953,0.6507182265888599,1.0,4/13,3.66%,ADAMTS12;EFEMP1;SOX9;PTHLH
prerank,negative regulation of chondrocyte differentiation (GO:0032331),0.7008380517343642,1.5524740778286445,0.024709302325581394,0.6452796111255459,1.0,4/14,3.66%,ADAMTS12;EFEMP1;SOX9;PTHLH
prerank,indolalkylamine catabolic process (GO:0046218),0.7384748997503534,1.550654754689737,0.04395604395604396,0.6491614715923375,1.0,3/10,9.64%,AADAT;KYNU;IL4I1
prerank,negative regulation of cell projection organization (GO:0031345),0.5600740340331566,1.550186503387139,0.03209876543209877,0.6460608109749428,1.0,20/48,20.13%,PTEN;GORASP1;LPAR1;SEMA3A;PRNP;MT3;GRIN2B;FYN;GAK;BAG5;DCC;HDAC2;FKBP4;MYLIP;STX1B;EFNB2;RTN4RL1;KANK1;DENND5A;PTPRS
prerank,nucleotide biosynthetic process (GO:0009165),-0.5375623069015292,-1.549649904857031,0.04498269896193772,0.5852735845059096,1.0,10/18,22.58%,NMNAT2;ME1;PRPSAP2;RRM1;NMNAT1;RRM2B;PRPS2;GART;PRPS1;PRPS1L1
prerank,regulation of fibroblast growth factor receptor signaling pathway (GO:0040036),0.6356080140230026,1.5496389763952594,0.03125,0.6432998945435567,1.0,6/20,13.69%,SULF1;CREB3L1;FGF2;SHISA2;GPC1;SMOC2
prerank,negative regulation of chemokine production (GO:0032682),0.6978650909905152,1.548431966405912,0.03625377643504532,0.6440213947329664,1.0,1/14,0.03%,APOD
prerank,microtubule anchoring (GO:0034453),0.710396666987203,1.5471395703522588,0.029985007496251874,0.6461356343080218,1.0,5/12,10.80%,SAXO2;BICD1;PCM1;CLASP1;BICD2
prerank,negative regulation of fibroblast growth factor receptor signaling pathway (GO:0040037),0.6925947288416844,1.5470592301484876,0.030390738060781478,0.6409283024029223,1.0,6/14,13.20%,SULF1;CREB3L1;FGF2;SHISA2;GPC1;GATA3
prerank,extracellular matrix organization (GO:0030198),0.48323063301894587,1.5465962584104385,0.0,0.6381404301721255,1.0,52/276,9.48%,LAMA2;VIT;DCN;COL15A1;TGFBI;MMP2;HSPG2;ADAMTS12;VCAN;A2M;ADAM19;HAS2;LUM;ADAMTS20;CREB3L1;FGF2;COL5A3;COL20A1;GSN;COL28A1;LAMC1;P4HA1;COL5A2;PXDN;RECK;HTRA1;CAPN1;COL4A2;COL27A1;COL26A1;TGFB1;GPM6B;ITGB8;NF1;COLGALT2;NID1;COL9A2;MMP15;PLEC;CTSK;ADAMTS1;LOXL3;BCAN;POSTN;CYP1B1;TNR;COL18A1;TLL2;ADAMTS4;COL3A1;PLOD1;SPARC
prerank,positive regulation of nuclear division (GO:0051785),-0.48233604139718733,-1.546341337699707,0.029045643153526972,0.5870685803629377,1.0,7/25,9.93%,IGF1;LRP5;IGF2;INSR;TGFA;RGCC;PDGFRB
prerank,negative regulation of cell-matrix adhesion (GO:0001953),0.5901632007751468,1.545975597117382,0.02038216560509554,0.6359694062892978,1.0,10/32,12.65%,APOD;DLC1;PTEN;SEMA3E;HOXA7;MAP4K4;RASA1;NF2;AJAP1;MYOC
prerank,protein auto-ADP-ribosylation (GO:0070213),-0.6015999611687592,-1.5455063799126312,0.04504504504504504,0.5803220699389705,1.0,5/12,11.03%,PARP3;PARP10;PARP1;PARP6;PARP12
prerank,negative regulation of intracellular protein transport (GO:0090317),0.6255077965690665,1.5441397951482412,0.03234501347708895,0.640934774684719,1.0,2/22,0.83%,APOD;MDFIC
prerank,negative regulation of myoblast differentiation (GO:0045662),0.681287178864494,1.5424830981106536,0.041791044776119404,0.6448272075871232,1.0,6/13,12.80%,SOSTDC1;SOX8;SOX9;TGFB1;PRICKLE1;EID2B
prerank,regulation of neuron projection development (GO:0010975),0.4931077386740888,1.54218975238106,0.0,0.6411828788202639,1.0,39/163,12.50%,ROR2;RELN;SIPA1L1;ROR1;TENM3;NTRK3;PTEN;IL1RAPL1;LPAR1;FRMD7;NCS1;SEMA3A;CSMD3;PSEN1;NTRK2;MT3;TANC2;CTNNA2;LRRC4C;WNT5A;FBXO7;PAK1;ALKAL2;CHN1;CDKL5;DISC1;NTNG2;NTNG1;RAP1A;GAK;BAG5;DCC;HDAC2;PPFIA2;FKBP4;MAGI2;CDK5R1;LZTS3;MYLIP
prerank,camera-type eye morphogenesis (GO:0048593),0.7475425444090281,1.5394492979090213,0.046948356807511735,0.6511906844701189,1.0,3/10,5.06%,TENM3;VEGFA;NF1
prerank,protein kinase C-activating G protein-coupled receptor signaling pathway (GO:0007205),-0.6212469250875284,-1.5374025205303286,0.03611111111111111,0.6033216170488176,1.0,4/10,10.76%,PLPP1;GAP43;PARD3;DGKH
prerank,regulation of lymphocyte migration (GO:2000401),-0.6180329647162535,-1.5365358907003315,0.06133333333333333,0.5968579646464347,1.0,5/10,22.44%,WASL;SLC8B1;STK10;MSN;AKT1
prerank,ubiquinone biosynthetic process (GO:0006744),-0.5564671271729481,-1.5345804179816362,0.031545741324921134,0.5947635074791323,1.0,10/15,26.69%,COQ8B;COQ10B;PDSS1;COQ9;COQ3;NDUFA9;FDXR;PDSS2;COQ6;COQ8A
prerank,myotube cell development (GO:0014904),-0.6285509704477937,-1.533869770156603,0.047619047619047616,0.5879878677028697,1.0,2/10,7.30%,IGF1;SIX1
prerank,divalent inorganic cation homeostasis (GO:0072507),0.6193499060195434,1.5338417379098954,0.04,0.6781065488343351,1.0,5/25,4.84%,ANK3;PRKN;KCNA1;TMTC2;MT3
prerank,bicarbonate transport (GO:0015701),-0.4830346608103937,-1.5331050269612994,0.019230769230769232,0.5817714381132714,1.0,11/25,24.60%,SLC26A7;SLC4A10;SLC4A3;SLC39A8;CYB5R4;CA4;SLC4A8;CYB5R1;SLC26A6;CA2;CYB5RL
prerank,odontogenesis of dentin-containing tooth (GO:0042475),0.6740319729439843,1.5319051903256513,0.04184704184704185,0.6834926469428254,1.0,5/15,10.11%,EDA;GLI2;SCN5A;AMELX;HDAC2
prerank,basement membrane organization (GO:0071711),0.6853468185464182,1.5315680877752689,0.037142857142857144,0.6798252958166424,1.0,5/14,6.82%,NTN4;PXDN;NID1;NTNG2;NTNG1
prerank,tight junction assembly (GO:0120192),-0.40213293869772054,-1.5314809554615365,0.0,0.57882541484252,1.0,12/49,8.89%,AFDN;PARD6G;CDH5;PECAM1;CLDN5;OCLN;ESAM;PRKCI;PARD3;CLDN14;PAK2;MPP7
prerank,T cell differentiation in thymus (GO:0033077),0.6769838265165364,1.5296291614782318,0.04747774480712166,0.6860611762933756,1.0,5/14,12.08%,RAG2;FADD;RABL3;ZFP36L2;MR1
prerank,regulation of myelination (GO:0031641),0.6097657218543108,1.5282774448727758,0.034482758620689655,0.6881842663485314,1.0,5/25,8.97%,LGI4;NKX6-2;EIF2AK3;TMEM98;NSUN5
prerank,regulation of ERK1 and ERK2 cascade (GO:0070372),0.4777841836863553,1.5267141834086586,0.0030425963488843813,0.6912162753916458,1.0,35/214,7.42%,ROR2;FFAR4;ROR1;WNK2;CCL11;PRKCA;PDGFRA;GLIPR2;NTRK3;FGF2;PYCARD;FGF10;PTEN;PTPN22;GAREM1;DUSP4;ERBB2;EGFR;PTPN2;EPHB2;FBXW7;TGFB1;CCL4;NTRK2;MT3;CNKSR3;DUSP6;YWHAZ;ALKAL2;LMO3;SPRED2;CARD9;ACKR3;SPRED1;RAP1A
prerank,regulation of mitochondrial depolarization (GO:0051900),0.7253908230866493,1.5267098941689479,0.046224961479198766,0.6858764702621148,1.0,2/10,1.76%,DCN;BCL2
prerank,glycolytic process through glucose-6-phosphate (GO:0061620),-0.4823560011993411,-1.5263646825286514,0.05555555555555555,0.5890757090364284,1.0,12/25,29.82%,FOXK1;PFKP;PGK1;PGAM1;GPI;PFKM;PFKL;ENO1;GAPDHS;ENO3;ADPGK;PKM
prerank,ERBB signaling pathway (GO:0038127),0.5357575549070225,1.52502622273188,0.017162471395881007,0.6905103939611874,1.0,17/64,12.63%,EFEMP1;PRKCA;ERBB3;REPS2;GAREM1;SOX9;ERBB2;EGFR;TGFB1;ERBIN;BTC;ERBB4;PIK3R1;CBL;PTPN11;MAPK1;PTPN18
prerank,external encapsulating structure organization (GO:0045229),0.479128291181162,1.524818739578854,0.0010245901639344263,0.6865277160915739,1.0,39/205,10.98%,LAMA2;VIT;DCN;COL15A1;TGFBI;MMP2;HSPG2;ADAMTS12;VCAN;ADAM19;LUM;ADAMTS20;FGF2;COL5A3;COL28A1;LAMC1;TGM1;COL5A2;PXDN;RECK;COL4A2;COL27A1;ITGB8;NF1;NID1;COL9A2;MMP15;ADAMTS1;BCAN;POSTN;TNR;COL18A1;HRNR;ADAMTS4;COL3A1;SPARC;NCAN;MMP16;COL1A2
prerank,sphingosine biosynthetic process (GO:0046512),-0.599659358422656,-1.523694700119062,0.054945054945054944,0.5821168656072587,1.0,6/11,25.70%,ACER2;SPTLC2;ASAH2;SPHK1;SPHK2;SPTLC1
prerank,sphingoid biosynthetic process (GO:0046520),-0.599659358422656,-1.523694700119062,0.054945054945054944,0.5821168656072587,1.0,6/11,25.70%,ACER2;SPTLC2;ASAH2;SPHK1;SPHK2;SPTLC1
prerank,"synaptic transmission, cholinergic (GO:0007271)",0.6413735265992297,1.523408231313445,0.04426002766251729,0.6891187789428025,1.0,3/19,4.08%,RAPSN;NQO1;CHRNA4
prerank,positive regulation of neuron projection development (GO:0010976),0.5096544260909756,1.522255068450228,0.004347826086956522,0.69058113099047,1.0,10/85,7.42%,ROR2;RELN;ROR1;BMP5;TENM3;NTRK3;NTRK2;WNT5A;ALKAL2;RAP1A
prerank,cellular response to estradiol stimulus (GO:0071392),0.6427631859908829,1.5207659918593872,0.03943661971830986,0.6941259603150413,1.0,8/18,19.24%,SSTR1;EGFR;ESR1;NRIP1;LCOR;NCOA3;FAM210B;RUVBL2
prerank,regulation of metal ion transport (GO:0010959),0.6617946712557281,1.5194808764212044,0.05070422535211268,0.696407839985176,1.0,4/16,1.85%,IL16;BCL2;CACNA2D1;ANK2
prerank,protein mono-ADP-ribosylation (GO:0140289),-0.6062250004880437,-1.5186948364266781,0.06793478260869565,0.5932113059183927,1.0,6/11,15.90%,PARP3;PARP4;PARP10;PARP6;PARP12;PARP14
prerank,triglyceride homeostasis (GO:0070328),0.5968477283345831,1.5114592917002427,0.036755386565272496,0.7388419982347123,1.0,6/26,15.20%,RORA;MLXIPL;IL18;PNPLA8;MTLN;LIPC
prerank,chondroitin sulfate catabolic process (GO:0030207),0.6808476537990437,1.5111481624660374,0.05555555555555555,0.7351267399319089,1.0,7/13,17.54%,DCN;VCAN;BCAN;NCAN;IDS;HYAL1;CSPG4
prerank,lymphocyte chemotaxis (GO:0048247),0.5714466833606925,1.5109849959529085,0.049872122762148335,0.7306414647786291,1.0,6/34,10.16%,CCL11;CXCL10;CCL4;SLC12A2;CKLF;CYP7B1
prerank,dermatan sulfate proteoglycan biosynthetic process (GO:0050651),0.6527629679701055,1.5103213393102342,0.05217391304347826,0.7293474479688955,1.0,5/15,10.03%,DCN;VCAN;BCAN;CSGALNACT1;NCAN
prerank,regulation of adaptive immune response (GO:0002819),0.6472413577551235,1.5098710576771255,0.04486251808972504,0.7266625110604066,1.0,6/18,13.21%,PYCARD;FADD;SAMSN1;IL4I1;IL6ST;AHR
prerank,negative regulation of antigen receptor-mediated signaling pathway (GO:0050858),0.623066383723627,1.5091055093333856,0.04986149584487535,0.7260565382222696,1.0,4/22,4.80%,LGALS3;PTPN22;PTPN2;PRNP
prerank,negative regulation of lipid biosynthetic process (GO:0051055),0.6313995392915861,1.5090276240570029,0.04583333333333333,0.7212699888350721,1.0,6/20,8.59%,BMP5;SLC27A1;ERLIN2;FBXW7;ASXL3;BRCA1
prerank,positive regulation of ERK1 and ERK2 cascade (GO:0070374),0.4821693327498803,1.5087213416311127,0.005165289256198347,0.7179985841636172,1.0,23/151,7.42%,ROR2;FFAR4;ROR1;CCL11;PRKCA;PDGFRA;GLIPR2;NTRK3;FGF2;PYCARD;FGF10;PTPN22;GAREM1;EGFR;FBXW7;TGFB1;CCL4;NTRK2;MT3;ALKAL2;CARD9;ACKR3;RAP1A
prerank,cardiac conduction system development (GO:0003161),-0.47046169648843233,-1.508458268436887,0.02834008097165992,0.6230341684352001,1.0,6/24,4.38%,NOTCH2;GJA1;BMP4;GJB6;MAML1;CACNA1G
prerank,positive regulation of transporter activity (GO:0032411),0.6775632337604572,1.5082607703906243,0.043674698795180725,0.7156840912179673,1.0,5/13,9.41%,SYNGR3;KMT2A;WNK3;STK39;SGK2
prerank,positive regulation of lymphocyte migration (GO:2000403),0.6891301089505203,1.5075734308806261,0.054252199413489736,0.7146282917876545,1.0,2/12,1.40%,CXCL10;PYCARD
prerank,negative regulation of microtubule polymerization (GO:0031115),-0.5679442673455626,-1.5074609395037688,0.06552706552706553,0.6177983540636063,1.0,4/12,5.30%,CDH5;MAP2;CLIP3;EML2
prerank,peptidyl-tyrosine dephosphorylation (GO:0035335),0.5728630065401826,1.5057914649755133,0.04419191919191919,0.7198039674961332,1.0,13/34,14.80%,UBASH3B;PTPN22;DUSP4;PTPRT;PTPN2;DUSP6;PTPN13;PTPN1;PTPRJ;PTPN11;PTPN18;PTPRZ1;PTPRF
prerank,diol metabolic process (GO:0034311),-0.5046712581615879,-1.505006611308157,0.06563706563706563,0.6189470217906468,1.0,9/19,24.24%,PLPP1;NOS3;DEGS2;ASAH2;HSP90AA1;SPR;SPHK1;AKT1;SPHK2
prerank,regulation of protein exit from endoplasmic reticulum (GO:0070861),0.695639881172072,1.504725597767906,0.050078247261345854,0.7207969300948488,1.0,1/13,0.13%,SEC16B
prerank,positive regulation of protein secretion (GO:0050714),-0.3680059212140377,-1.5039622719161325,0.0,0.6145960658200696,1.0,19/69,13.13%,BMP6;WLS;IGF1;MYRIP;RBP4;NLGN2;TLR4;EXOC1;PPIA;NNAT;ABCG1;C1QTNF3;UNC13B;APBB1;SYTL4;AACS;TGFB2;LRRC8A;MYH10
prerank,Golgi organization (GO:0007030),0.4902546716137874,1.5036659995645236,0.012725344644750796,0.7220784034620661,1.0,35/112,18.98%,SEC16B;TMED6;ATP8B1;GORASP1;HACE1;VAMP4;BLZF1;GOLGB1;OBSL1;YWHAZ;ARL1;GBF1;GAK;BAG5;TRIP11;TMED10;HUWE1;CLASP1;PI4K2A;GORASP2;ARHGAP21;RAB1A;ATL3;USP6NL;CSNK1A1;TBC1D20;TMED3;TMED2;SEC23IP;ARFGEF1;SURF4;HTT;STX17;RAB30;COG1
prerank,embryonic limb morphogenesis (GO:0030326),0.5602408747381734,1.5023279501423485,0.046019900497512436,0.7250120123376581,1.0,4/34,1.94%,OSR2;PTCH1;AFF3;WDPCP
prerank,mitochondrial outer membrane permeabilization (GO:0097345),0.6875507077445983,1.5019160038558137,0.059001512859304085,0.7222319253902262,1.0,7/13,21.80%,VDAC2;BMF;BNIP3;RHOT2;BCL2L11;RHOT1;BNIP3L
prerank,COPII-coated vesicle cargo loading (GO:0090110),0.6919889502762431,1.5018546619309767,0.04061624649859944,0.7178545816202867,1.0,14/14,30.86%,SEC24D;SEC31B;SEC24C;RAB1A;TBC1D20;SEC24A;SEC23B;MIA3;SEC23A;SCAP;SAR1A;SEC13;SEC31A;SEC24B
prerank,positive regulation of cation channel activity (GO:2001259),0.553426509197193,1.5018165538303543,0.03132832080200501,0.7132475877293152,1.0,5/40,5.23%,RELN;ANK3;ANK2;EPHB2;CCR2
prerank,heparan sulfate proteoglycan metabolic process (GO:0030201),0.6159547464227109,1.5014504261526902,0.05174825174825175,0.710587069076276,1.0,11/21,22.30%,SULF1;HS6ST1;EXT1;EXTL3;GLCE;GPC1;HS2ST1;UGDH;SGSH;XYLT1;SULF2
prerank,regulation of sodium ion transport (GO:0002028),0.5691927178818115,1.5006512595842998,0.04230769230769231,0.710421520713274,1.0,11/34,15.13%,WNK2;ANK3;NKAIN2;WNK3;CNKSR3;SCN5A;FGF12;DRD2;PER1;AHCYL1;PKP2
prerank,nitric oxide mediated signal transduction (GO:0007263),-0.5153895792792701,-1.5006262483530903,0.05863192182410423,0.6190776627057992,1.0,8/16,22.91%,NOS3;GUCY1B1;DDAH2;NOS1;APOE;NDNF;KCNC2;AGT
prerank,regulation of cell-cell adhesion mediated by cadherin (GO:2000047),-0.4886980530501969,-1.4994105613019872,0.05263157894736842,0.6159380735203386,1.0,9/19,16.19%,BMP6;AFDN;TJP1;RGCC;NOTCH4;NEXMIF;PTPRU;FLOT1;PPM1F
prerank,cell-cell junction maintenance (GO:0045217),-0.6010819004033321,-1.4990963600405611,0.0712166172106825,0.6090479464402688,1.0,2/11,3.26%,TJP1;NLGN2
prerank,2-oxoglutarate metabolic process (GO:0006103),0.6753541014366685,1.4988457746229782,0.060650887573964495,0.7159863642071609,1.0,5/13,13.62%,AADAT;IDH2;DLST;GOT2;GPT2
prerank,negative regulation of cellular component movement (GO:0051271),-0.5513552690132639,-1.4974630383477239,0.056666666666666664,0.6070587852407419,1.0,5/15,9.35%,SP100;FRMD5;FBLN1;ACTN1;CCDC125
prerank,serine family amino acid biosynthetic process (GO:0009070),0.7020173250135684,1.4970312047397967,0.05198776758409786,0.7216662069497966,1.0,5/12,6.89%,CTH;CBS;PSPH;PSAT1;PHGDH
prerank,muscle tissue morphogenesis (GO:0060415),-0.5461871363472796,-1.4959302952476086,0.06315789473684211,0.6048070129228261,1.0,7/16,19.45%,BMP4;MYLK;TBX1;EFEMP2;PROX1;HEY2;ZFPM1
prerank,cell-cell adhesion via plasma-membrane adhesion molecules (GO:0098742),0.4726795337512271,1.495223310645651,0.0041279669762641896,0.7273412868102577,1.0,31/159,10.12%,DCHS1;CDH19;MPZ;TENM2;CLDN19;TENM3;IL1RAPL1;PTPRT;ACVR1;DSG2;CDH10;CLDN1;CDH22;PCDHGB4;LRRC4C;GRID2;OBSL1;CDH8;NLGN1;CADM3;TGFBR2;KIRREL3;NTNG1;HMCN1;CNTN6;CADM1;CNTN2;CDH20;CDH7;DSCAM;PALLD
prerank,positive regulation of signaling receptor activity (GO:2000273),0.5602113726259738,1.4952044031516116,0.03807106598984772,0.7227700144325784,1.0,14/36,18.82%,RELN;EPHB2;FBXW7;NCF1;CCR2;BTC;HIF1A;HDAC2;HDAC6;ITGB1;HBEGF;NCOA3;PARK7;TAF1
prerank,cellular lipid catabolic process (GO:0044242),0.5807892401572811,1.494400267518773,0.05419354838709677,0.7228624598888016,1.0,6/27,8.14%,PLBD1;CEL;MT3;ACBD5;CYP1B1;ACOX1
prerank,positive regulation of insulin receptor signaling pathway (GO:0046628),-0.5920655558467148,-1.4941205280645897,0.05389221556886228,0.6033019123391014,1.0,5/12,9.29%,SORBS1;SNX5;IGF2;GKAP1;PRKCZ
prerank,extracellular matrix disassembly (GO:0022617),0.5289127468114302,1.4931012757150637,0.03416856492027335,0.7260798649053373,1.0,14/53,14.87%,MMP2;A2M;GSN;LAMC1;HTRA1;CAPN1;MMP15;CTSK;TLL2;ADAMTS4;MMP16;MMP19;SCUBE1;WASHC1
prerank,negative regulation of calcium ion transport (GO:0051926),-0.5494913367712569,-1.4927975283389456,0.05177993527508091,0.6007642272235093,1.0,10/15,37.46%,ATP1A2;SLC30A1;ADRA2A;NOS1;CBARP;PLN;TMBIM6;STC1;EPO;LILRB1
prerank,positive regulation of dendritic spine development (GO:0060999),0.6070125669168703,1.4922618185641274,0.04878048780487805,0.7261203072169198,1.0,4/20,8.00%,RELN;PSEN1;NLGN1;CPEB3
prerank,plasma membrane bounded cell projection morphogenesis (GO:0120039),0.5261903406024218,1.4913472671249446,0.03558718861209965,0.7272752678685548,1.0,21/51,16.91%,KIF20B;NGF;MAP4K4;GAS7;TNIK;NYAP1;PAK1;ALS2;CNTNAP2;GPM6A;EPB41L3;DCLK1;BMP7;TAOK3;WASF1;TRIO;SNX1;ANKRD27;UBB;SGK1;CTTN
prerank,estrogen metabolic process (GO:0008210),0.6468351202324192,1.4909708623957527,0.05539772727272727,0.7249128241747453,1.0,3/15,7.15%,HSD17B7;HSD17B11;CYP1B1
prerank,extracellular structure organization (GO:0043062),0.46872761829154475,1.4908462096017265,0.0010235414534288639,0.7211819690235305,1.0,37/204,10.98%,LAMA2;VIT;DCN;COL15A1;TGFBI;MMP2;HSPG2;ADAMTS12;VCAN;ADAM19;LUM;ADAMTS20;FGF2;COL5A3;COL28A1;LAMC1;COL5A2;PXDN;RECK;COL4A2;COL27A1;ITGB8;NF1;NID1;COL9A2;MMP15;ADAMTS1;BCAN;POSTN;TNR;COL18A1;ADAMTS4;COL3A1;SPARC;NCAN;MMP16;COL1A2
prerank,regulation of lamellipodium organization (GO:1902743),-0.5444869391205145,-1.4894858401904225,0.07142857142857142,0.6043703802407315,1.0,6/14,27.67%,CAPZB;PDPN;CDC42;EPHA2;DMTN;TWF2
prerank,positive regulation of cellular response to insulin stimulus (GO:1900078),-0.5787429772217831,-1.486564394143996,0.05362776025236593,0.6082140149754943,1.0,6/13,12.78%,SORBS1;SNX5;IGF2;GKAP1;PRKCZ;ECHDC3
prerank,positive regulation of lymphocyte activation (GO:0051251),0.5717839894866023,1.4856574697633256,0.056578947368421055,0.7461216184321103,1.0,10/28,21.40%,PRKCQ;PYCARD;FGF10;CCR2;XRCC6;SH3KBP1;TICAM1;SIRPA;HSPD1;TNIP2
prerank,tryptophan catabolic process (GO:0006569),0.6919675281267517,1.4853937519265317,0.06055900621118013,0.7429742801542989,1.0,3/11,9.64%,AADAT;KYNU;IL4I1
prerank,endodermal cell fate commitment (GO:0001711),-0.6021654615129488,-1.4851133545263249,0.052941176470588235,0.6062581275239752,1.0,5/10,16.80%,CTR9;LEO1;SOX17;RTF1;PAF1
prerank,embryonic appendage morphogenesis (GO:0035113),0.6863756362747921,1.4849619037721409,0.05521472392638037,0.7411149083350395,1.0,1/12,0.46%,PTCH1
prerank,blood vessel endothelial cell migration (GO:0043534),-0.473495139496363,-1.4847027062413682,0.05343511450381679,0.6003909436154674,1.0,9/22,4.56%,ROBO1;CDH5;NRP1;MYH9;PIK3R3;ID1;SLIT2;EPHB4;KDR
prerank,cellular component disassembly (GO:0022411),0.5293944947295102,1.4844794287380603,0.03356481481481482,0.7394454057483001,1.0,14/53,14.87%,MMP2;A2M;GSN;LAMC1;HTRA1;CAPN1;MMP15;CTSK;TLL2;ADAMTS4;MMP16;MMP19;SCUBE1;WASHC1
prerank,positive regulation of phosphatidylinositol 3-kinase signaling (GO:0014068),0.5053760335688371,1.4832260766189356,0.02367531003382187,0.74204704450236,1.0,11/72,4.52%,ROR2;DCN;ROR1;PDGFRA;ERBB3;NTRK3;FGF2;IRS2;SOX9;NCF1;NTRK2
prerank,sulfur amino acid metabolic process (GO:0000096),0.5992226734466635,1.4820847693874382,0.05652759084791386,0.7437726724545011,1.0,9/24,15.09%,CTH;TST;DPEP1;CBS;AHCY;SMS;MTRR;ADI1;MTR
prerank,negative regulation of axonogenesis (GO:0050771),0.583574990997323,1.4813895562537056,0.0610079575596817,0.7431162143236314,1.0,11/27,16.43%,FGF13;LRP4;PTEN;RNF6;MT3;CDKL3;DCC;NGFR;EFNB3;RTN4;DIP2B
prerank,regulation of membrane protein ectodomain proteolysis (GO:0051043),-0.49388361615145476,-1.48138070946482,0.02564102564102564,0.6055977593997314,1.0,10/22,24.26%,SNX9;ROCK1;TIMP3;ADRA2A;TIMP2;NRDC;APOE;TIMP4;SNX33;SH3D19
prerank,positive regulation of cartilage development (GO:0061036),0.6310191058426484,1.4811650993286039,0.05439330543933055,0.7400573752698849,1.0,5/17,8.89%,SOX6;PKDCC;SOX9;ZBTB16;SOX5
prerank,negative regulation of viral process (GO:0048525),-0.38244484603897644,-1.4780646264016915,0.0,0.6101404613049732,1.0,20/57,21.83%,ZC3HAV1;CHMP3;PLSCR1;IFITM3;PPIA;IFIH1;PARP10;TRIM5;TNIP1;IFITM2;LARP7;OAS2;PROX1;PML;TRIM21;ISG15;IFIT1;BST2;HEXIM1;RSAD2
prerank,RNA interference (GO:0016246),-0.5200815508266189,-1.4780196175076494,0.05555555555555555,0.6032551581428125,1.0,10/17,30.18%,AGO1;NRDE2;AGO3;TERT;TARBP2;CLP1;MRPL44;AGO2;DICER1;AGO4
prerank,calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338),0.6369203782023487,1.4777988376895834,0.07894736842105263,0.7548276977544452,1.0,2/16,4.63%,CLDN19;CLDN1
prerank,regulation of leukocyte activation (GO:0002694),-0.5251116196174344,-1.47767947785395,0.06990881458966565,0.5977014243892468,1.0,4/14,3.82%,CD200;MFHAS1;PLSCR1;LYN
prerank,apical junction assembly (GO:0043297),-0.37453309836512116,-1.4776251697979195,0.012903225806451613,0.5911730783769574,1.0,13/53,9.34%,AFDN;PARD6G;CDH5;PECAM1;CLDN5;OCLN;ESAM;PRKCI;PARD3;CLDN14;PAK2;MPP7;RHOA
prerank,axon guidance (GO:0007411),0.46503743780510015,1.4770681602912867,0.0041025641025641026,0.7545594557210208,1.0,53/201,13.43%,LAMA2;RELN;GFRA1;NTN4;PRKCA;LGR6;ENAH;PRKCQ;GLI2;EFNA4;SEMA3E;IRS2;EPHB6;PLXNC1;GFRA4;SEMA6C;EFNA5;VEGFA;EPHB2;MAPK7;SEMA3A;NRXN1;WNT5A;SPTBN1;CHN1;CNTN6;FYN;GAB2;CNTN2;TNR;DOK6;SMO;DOK4;DSCAM;DCC;PALLD;PIK3R1;GDNF;KIF5C;USP33;PTPN11;GPC1;MAPK1;OPHN1;EFNB1;CDK5R1;PTPRA;NRP2;UNC5C;RHOH;EFNB3;SH3KBP1;LYPLA2
prerank,negative regulation of protein localization to nucleus (GO:1900181),0.6213546403060535,1.4768634383251684,0.04950495049504951,0.7513045433808699,1.0,3/18,6.17%,APOD;MDFIC;OTUD7B
prerank,wound healing (GO:0042060),0.515527034425882,1.4755435069458027,0.030927835051546393,0.7543024111822981,1.0,19/62,13.71%,DCBLD2;PDGFRA;ERBB3;EPB41L4B;FGF2;FGF10;ERBB2;CLDN1;NF1;WNT5A;PAK1;PLEC;FZD7;PPP3CA;COL3A1;SYT11;ANXA6;RAB3A;CORO1B
prerank,positive regulation of keratinocyte migration (GO:0051549),0.699160747176958,1.4752311422098625,0.07472178060413355,0.7518701332482719,1.0,3/10,2.99%,EPB41L4B;FGF10;MAP4K4
prerank,negative regulation of fat cell differentiation (GO:0045599),0.5578822669427189,1.473000896478239,0.039540816326530615,0.7603819206447086,1.0,8/34,13.40%,RORA;TGFB1;WNT5A;ZFP36L2;WWTR1;ZFPM2;GATA3;TRIO
prerank,quinone biosynthetic process (GO:1901663),-0.54432736123258,-1.4700430860117324,0.056074766355140186,0.6105737321573006,1.0,9/14,26.69%,COQ8B;COQ10B;PDSS1;COQ9;COQ3;FDXR;PDSS2;COQ6;COQ8A
prerank,mesonephric tubule development (GO:0072164),-0.5148920664273824,-1.469928100338832,0.051194539249146756,0.6042429127622827,1.0,6/15,8.66%,OSR1;BMP4;SLIT2;SIX1;FGFR2;SALL1
prerank,rRNA pseudouridine synthesis (GO:0031118),-0.601493848857645,-1.4696145140747683,0.05337078651685393,0.5988353074875963,1.0,10/10,39.89%,NAF1;DKC1;RPUSD4;GAR1;TSR3;RPUSD1;NHP2;RPUSD2;RPUSD3;NOP10
prerank,vasculogenesis (GO:0001570),0.5591928264616594,1.4688707864310853,0.04712041884816754,0.778753236931531,1.0,8/32,7.08%,HAS2;GLMN;VEGFA;TGFB1;ITGB8;RASA1;TGFBR2;SPRED1
prerank,covalent chromatin modification (GO:0016569),0.6556764261885933,1.4681438732301648,0.07692307692307693,0.7785112975733262,1.0,10/14,27.42%,MT3;HLCS;UFL1;MBD2;HELLS;SETD5;PARK7;CHD1;HDAC1;SIRT1
prerank,energy derivation by oxidation of organic compounds (GO:0015980),0.580298024893273,1.4681294127976832,0.07631578947368421,0.7742452163416194,1.0,6/24,14.76%,GFPT2;MYC;MT3;PID1;COX10;MTLN
prerank,regulation of alcohol biosynthetic process (GO:1902930),0.6704098063990581,1.4668535391005437,0.07526881720430108,0.7771982625970825,1.0,8/12,28.92%,H6PD;KPNB1;CLCN2;SREBF2;MBTPS1;SEC14L2;DGKQ;MBTPS2
prerank,fatty-acyl-CoA metabolic process (GO:0035337),0.6052655045132125,1.4662473753719665,0.07133058984910837,0.7761097634118034,1.0,8/20,15.26%,GCDH;ACACA;SCD5;ACLY;FASN;PPT2;FAR1;ACSL3
prerank,protein heterotetramerization (GO:0051290),0.6535956389309687,1.4650891790615082,0.07929515418502203,0.7783505419720939,1.0,5/13,14.68%,FARSA;CPSF6;GRIN2B;FARSB;PKD1
prerank,dorsal/ventral pattern formation (GO:0009953),0.6080164077294972,1.464599228838988,0.06064690026954178,0.7768951889935642,1.0,4/20,5.81%,PTCH1;GLI2;ACVR1;FBXL15
prerank,epithelium development (GO:0060429),0.4790361935129531,1.4644374022750157,0.015906680805938492,0.7736974271691688,1.0,22/107,9.87%,LGALS3;PTCH1;MEOX1;MEOX2;SOX8;FGF10;TST;CD34;SOX9;VEGFA;CNN3;TGFB1;SOX11;UPK1B;CASP6;LOXL3;GATA6;CTSB;PPP2R3A;SMO;RCN3;PIH1D1
prerank,sphingosine metabolic process (GO:0006670),-0.509571903361093,-1.464370763870308,0.06944444444444445,0.6109519405014205,1.0,7/17,25.70%,PLPP1;ACER2;SPTLC2;ASAH2;SPHK1;SPHK2;SPTLC1
prerank,establishment of endothelial barrier (GO:0061028),-0.42990919915502596,-1.4628212403105305,0.04132231404958678,0.6098227338295273,1.0,10/29,14.23%,AFDN;TJP1;PECAM1;RAP1B;PPP1R16B;TJP2;ICAM1;PDE2A;ROBO4;MSN
prerank,regulation of proteasomal protein catabolic process (GO:0061136),0.514892330256539,1.4614776641656593,0.046539379474940336,0.7861944251316368,1.0,17/53,15.16%,GLMN;RAD23B;XPO1;PRKN;NUDT15;ARAF;FBXW7;UCHL5;UFL1;OPHN1;TMF1;PRKACA;TMTC3;PKD1;USP14;GABARAPL2;UBB
prerank,endoplasmic reticulum to Golgi vesicle-mediated transport (GO:0006888),0.46558669271889946,1.4611694203162833,0.005128205128205128,0.7836159682630722,1.0,44/173,15.86%,SEC16B;TMED6;DYNLL1;ANK3;ANK1;ANK2;GORASP1;PGAP1;GRIA1;SEC24D;VAMP4;COG5;COPZ2;GOLGB1;SPTBN1;TRAPPC6B;GBF1;COPB2;COPG2;TRIP11;TMED10;SEC24C;KDELR2;CUL3;DYNC1I1;VAPA;ARF4;BET1L;RAB1A;ATL3;PROS1;DCTN4;KLHL12;TBC1D20;TMED3;DYNC1I2;TMED2;COPA;ARFGAP3;ARFGAP1;COPG1;TRAPPC6A;KDELR3;CNIH4
prerank,cell communication by electrical coupling involved in cardiac conduction (GO:0086064),-0.5072728825517232,-1.4609937112835105,0.07903780068728522,0.6093961494027536,1.0,6/17,10.77%,CACNA1C;ATP1A2;GJA1;ATP1A1;GJC1;GJD3
prerank,embryonic digestive tract development (GO:0048566),0.6092818556824815,1.4603465295751634,0.056910569105691054,0.7840528070449713,1.0,5/18,8.79%,PDGFRA;GLI2;PKDCC;SOX11;RARB
prerank,chondroitin sulfate biosynthetic process (GO:0030206),0.6004551713745938,1.459728469864175,0.056022408963585436,0.7832747527852831,1.0,6/21,10.03%,DCN;VCAN;BCAN;CSGALNACT1;CHSY1;NCAN
prerank,SNARE complex assembly (GO:0035493),0.6835457872058431,1.4588111107058477,0.0811232449297972,0.7841659665647897,1.0,2/10,3.39%,STXBP6;VAMP4
prerank,tryptophan metabolic process (GO:0006568),0.6718146163048055,1.4581932224084793,0.07796101949025487,0.7833954670119057,1.0,3/11,9.64%,AADAT;KYNU;IL4I1
prerank,regulation of Rac protein signal transduction (GO:0035020),0.6339001605160605,1.4565763956676419,0.07692307692307693,0.7883032635608613,1.0,4/16,6.14%,ARHGAP24;CADM4;AUTS2;ALS2
prerank,cellular response to oxygen levels (GO:0071453),-0.5961484341874074,-1.4565308005669215,0.0718232044198895,0.6188813882957341,1.0,8/10,31.18%,ATP6V0D1;NDUFS2;ATP6AP1;ATP6V0A2;TMEM199;ATP6V1G1;CCDC115;ATP6V1A
prerank,chordate embryonic development (GO:0043009),0.5132750979917042,1.4552105655843413,0.041666666666666664,0.7922400568675028,1.0,19/55,17.16%,PTCH1;BMP5;SULF1;SOX8;VEGFA;TGFB1;WNT5A;FGFR1;EGFL8;BRCA1;BMP7;KIAA1217;DVL1;GATA3;COL1A1;PKD1;DACT1;TGFB3;MYH6
prerank,positive regulation of cell cycle G1/S phase transition (GO:1902808),0.5565600337302392,1.454458741740274,0.058007566204287514,0.792589081033914,1.0,15/33,19.99%,FGF10;STXBP4;EGFR;UBE2E2;PLCB1;GLI1;ADAMTS1;EIF4G1;CCND2;HYAL1;CDC73;RPTOR;KMT2E;RDX;PHB2
prerank,endomembrane system organization (GO:0010256),0.4594103361727991,1.45418079379845,0.00408997955010225,0.7901331088964306,1.0,54/178,19.16%,SEC16B;TMED6;USP50;ANK3;DNM1;ATP8B1;GORASP1;SPAG4;HACE1;EIF2AK3;BLZF1;GOLGB1;OBSL1;SPTBN1;ALS2;LAPTM4B;NUP155;ARL1;GBF1;SEC31B;GAK;BAG5;TRIP11;TMED10;VPS11;HUWE1;VAPA;CLASP1;PI4K2A;GORASP2;ARHGAP21;PHETA2;RAB22A;SNX10;RAB1A;ATL3;USP6NL;AKTIP;CSNK1A1;OTOF;TBC1D20;TMED3;TMED2;SEC23IP;BNIP1;ARFGEF1;SURF4;DYSF;HTT;STX17;REEP5;RAB30;COG1;HOOK2
prerank,positive regulation of behavior (GO:0048520),0.6923466497379287,1.4535996223629348,0.09917355371900827,0.7895192447281508,1.0,3/10,5.72%,SGIP1;CRH;NLGN1
prerank,positive regulation of B cell proliferation (GO:0030890),0.56111083196086,1.4523411166159965,0.055408970976253295,0.7923949797995918,1.0,6/29,8.66%,BCL2;IRS2;BST1;EPHB2;CD320;VAV3
prerank,transforming growth factor beta receptor signaling pathway (GO:0007179),-0.34566344610389643,-1.452237498868292,0.011627906976744186,0.6279074068171782,1.0,24/87,13.38%,PTPRK;GCNT2;SMAD6;CDH5;FMOD;CLDN5;ITGB5;APPL2;ACVRL1;SMAD7;ENG;ID1;USP9X;SMAD9;TGFBR1;PARD3;TWSG1;PRKCZ;RHOA;NLK;LRRC32;MAP3K7;TGFB2;USP15
prerank,protein heterooligomerization (GO:0051291),0.6182209693082931,1.4521075851742604,0.07714285714285714,0.789674980247241,1.0,8/17,21.48%,FARSA;CPSF6;GRIN2B;FARSB;TMEM120A;PKD1;MAT2A;PKD2
prerank,serine family amino acid metabolic process (GO:0009069),0.6317753621360706,1.4518880219905483,0.07848837209302326,0.7871181177046669,1.0,4/16,5.58%,CTH;CBS;PSPH;DAO
prerank,neutrophil chemotaxis (GO:0030593),0.5077746457708711,1.451774374533807,0.053738317757009345,0.7837664442887772,1.0,8/53,11.59%,LGALS3;CCL11;CXCL10;CCL4;PDE4B;GBF1;CKLF;EDN3
prerank,glial cell development (GO:0021782),0.5752859423563489,1.4508192668539877,0.07027027027027027,0.7854755562401061,1.0,7/25,8.97%,MXRA8;SOX11;MT3;NF1;CDK6;EIF2B5;NSUN5
prerank,sodium ion export across plasma membrane (GO:0036376),-0.5341972717255875,-1.4502466748481035,0.0712166172106825,0.6279787579909648,1.0,3/13,6.72%,ATP1A2;ATP1B3;ATP1A1
prerank,fatty acid beta-oxidation using acyl-CoA dehydrogenase (GO:0033539),0.7022375548828506,1.4494542462080653,0.0806697108066971,0.7894468436753161,1.0,3/10,5.93%,GCDH;IVD;ETFA
prerank,positive regulation of telomere capping (GO:1904355),0.61672304617987,1.4489695232953843,0.07960893854748603,0.7881776422072344,1.0,5/17,14.20%,PRKCQ;MAPK1;NEK7;MAP3K4;RTEL1
prerank,actin filament-based transport (GO:0099515),-0.474143990395069,-1.4485110947242092,0.06273062730627306,0.6278689653237136,1.0,11/21,27.08%,SYNE2;MYO1D;WASL;FNBP1L;MYO1E;MYO5B;MYO1C;ACTN4;MYO5C;MYO1F;MYO15A
prerank,regulation of cell-cell adhesion mediated by integrin (GO:0033632),-0.601441338532458,-1.4469850869161236,0.09322033898305085,0.6270386279070028,1.0,3/10,8.34%,PODXL;WNK1;DPP4
prerank,positive chemotaxis (GO:0050918),0.6196041026020824,1.4454231924009355,0.06531204644412192,0.8046957730301982,1.0,7/17,15.00%,LGALS3;FGF10;VEGFA;PTPRJ;FGF7;SCRIB;MET
prerank,odontogenesis (GO:0042476),0.5509468684431408,1.445205352223372,0.07425742574257425,0.8020698524251881,1.0,7/35,10.98%,OSR2;EDA;GLI2;SCN5A;AMELX;HDAC2;COL1A2
prerank,negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902236),0.6383982655111186,1.4450879313102327,0.07670043415340087,0.7989587387857159,1.0,6/14,18.76%,CREB3L1;PRKN;SELENOS;HERPUD1;OPA1;PARK7
prerank,regulation of phosphatidylinositol 3-kinase signaling (GO:0014066),0.4788534568072685,1.4444667188662454,0.02054054054054054,0.7985073746800729,1.0,22/100,12.65%,ROR2;DCN;ROR1;PDGFRA;ERBB3;NTRK3;FGF2;PTEN;IRS2;SOX9;EGFR;NCF1;NTRK2;PTPN13;FGFR1;IL18;PIK3R1;CBL;MAPK1;MYDGF;FBXL2;MYOC
prerank,negative regulation of smoothened signaling pathway (GO:0045879),0.5710695587880704,1.4444180991020028,0.07152682255845942,0.7950210487379138,1.0,4/23,5.28%,GPC3;PTCH1;PTCH2;HHIP
prerank,dermatan sulfate biosynthetic process (GO:0030208),0.6539584557283095,1.444033690858612,0.0725925925925926,0.7932166942854952,1.0,4/12,10.03%,DCN;VCAN;BCAN;NCAN
prerank,"positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516)",0.6892646927492825,1.443717672252073,0.09090909090909091,0.7912778573631082,1.0,3/10,6.38%,PRKCQ;SOCS1;TGFBR2
prerank,myoblast differentiation (GO:0045445),-0.5303898879929101,-1.4433351278306188,0.08256880733944955,0.634140201108086,1.0,4/14,9.50%,IGF1;DDX5;JAG1;MAPK12
prerank,dopaminergic neuron differentiation (GO:0071542),0.6139883380347877,1.4426450969339792,0.0651872399445215,0.7933460845370164,1.0,3/19,5.30%,CDNF;VEGFA;PHOX2A
prerank,positive regulation of protein exit from endoplasmic reticulum (GO:0070863),0.6572861410606271,1.441704575922026,0.07851851851851852,0.7945571207344316,1.0,1/13,0.13%,SEC16B
prerank,ribonucleoside bisphosphate metabolic process (GO:0033875),0.5537798414210703,1.441634365811817,0.06573957016434892,0.7875688288494914,1.0,11/29,20.99%,THEM4;OXSM;ACOT11;ACLY;ACSF2;ACSL6;GPAT4;GLYAT;DBI;ACOT8;ACBD6
prerank,purine nucleoside bisphosphate metabolic process (GO:0034032),0.5537798414210703,1.441634365811817,0.06573957016434892,0.7875688288494914,1.0,11/29,20.99%,THEM4;OXSM;ACOT11;ACLY;ACSF2;ACSL6;GPAT4;GLYAT;DBI;ACOT8;ACBD6
prerank,regulation of epithelial cell proliferation (GO:0050678),0.48752441417860204,1.4414891166477846,0.027870680044593088,0.784700285302324,1.0,14/85,5.51%,OSR2;BMP5;EPB41L4B;FGF2;MYC;FGF10;SOX9;ERBB2;LAMC1;CDKN2B;EGFR;VEGFA;TGFB1;SCN5A
prerank,positive regulation of cellular component movement (GO:0051272),-0.44684954532070564,-1.4408291436302385,0.043478260869565216,0.6367530028811086,1.0,14/24,26.77%,ETS1;LYN;TGFBR1;CCDC25;RPS19;PDPN;SPOCK2;CAVIN1;TWIST1;ACTN4;TUBB2B;CSF1R;STK11;CCL19
prerank,fatty acid derivative biosynthetic process (GO:1901570),0.5407556324605758,1.4398584733976934,0.05889724310776942,0.7901738047790564,1.0,11/35,13.16%,GCDH;ACACA;ACSS3;HMGCLL1;SCD5;ACLY;FASN;PPT2;FAR1;ALOX5AP;GGTA1
prerank,negative regulation of neuron projection development (GO:0010977),0.5070408258989494,1.4397740655461546,0.04608294930875576,0.7869861169222357,1.0,21/56,20.13%,LRP4;PTEN;LPAR1;SEMA3A;MT3;NLGN1;GAK;BAG5;DCC;HDAC2;NGFR;FKBP4;MYLIP;EFNB3;RTN4;STX1B;EFNB2;RTN4RL1;KANK1;DENND5A;PTPRS
prerank,cell proliferation in forebrain (GO:0021846),0.6791521414131285,1.4392693014098603,0.09697933227344992,0.7862848278304345,1.0,3/10,5.44%,DOCK7;PCM1;NUMBL
prerank,epidermal growth factor receptor signaling pathway (GO:0007173),0.5268112387072165,1.4391774936039212,0.05575326215895611,0.7832233367543835,1.0,17/45,20.76%,EFEMP1;REPS2;GAREM1;SOX9;EGFR;TGFB1;ERBIN;BTC;PIK3R1;CBL;PTPN11;IQGAP1;GAB1;HBEGF;GRB2;AAMP;SOS1
prerank,kidney development (GO:0001822),0.49950957336548435,1.4390424493552518,0.04044943820224719,0.7803256761558205,1.0,11/65,6.27%,OSR2;SULF1;HAS2;GLI2;LRP4;FGF10;PRKX;VEGFA;ARL3;NF1;ZBTB16
prerank,cellular response to alcohol (GO:0097306),0.5260391778767327,1.4387611158481801,0.06288532675709001,0.7783276797721409,1.0,14/42,16.10%,PTCH1;PTGFR;GRAMD1A;BRCA1;SMO;GRAMD1C;GNAI1;GRAMD1B;AHR;JUP;KLF9;BLM;SPIDR;GPLD1
prerank,dermatan sulfate metabolic process (GO:0030205),0.6381082074254969,1.4386183686406087,0.0847953216374269,0.775543389729665,1.0,4/13,10.03%,DCN;VCAN;BCAN;NCAN
prerank,positive regulation of vascular permeability (GO:0043117),-0.5737080279757824,-1.4384980913457694,0.07909604519774012,0.6390559851355019,1.0,6/12,7.66%,BMP6;TJP1;ANGPT1;OCLN;PDE3A;TJP2
prerank,negative regulation of voltage-gated potassium channel activity (GO:1903817),0.681366169569664,1.438114509915932,0.09672619047619048,0.774818248500065,1.0,3/10,14.57%,ANK3;SUMO1;KCNRG
prerank,outer dynein arm assembly (GO:0036158),-0.5268400608932917,-1.437983561715022,0.09615384615384616,0.6345683875481739,1.0,11/14,42.13%,LRRC49;ODAD1;DNAH8;DNAAF5;DNAH5;ODAD2;ODAD3;ODAD4;DNAH17;DNAAF4;CCDC63
prerank,regulation of AMPA receptor activity (GO:2000311),0.564945874527901,1.4369987682605234,0.06957708049113233,0.7771716961501549,1.0,4/25,5.72%,RELN;CACNG7;SHISA9;NLGN1
prerank,negative regulation of neurogenesis (GO:0050768),0.5471994190036151,1.435806931168632,0.06658130601792574,0.7800618678464213,1.0,9/34,14.55%,CCL11;LRP4;PTEN;GORASP1;PCM1;NF1;NGFR;EFNB3;RTN4
prerank,negative regulation of androgen receptor signaling pathway (GO:0060766),-0.549919934040858,-1.4347593860024677,0.08579881656804733,0.6396333756864249,1.0,2/12,0.13%,DAB2;FOXP1
prerank,regulation of small molecule metabolic process (GO:0062012),0.5601411885383051,1.4347190797882532,0.07901554404145078,0.7823755572562677,1.0,4/28,7.17%,RORA;PRKN;RORC;PDK3
prerank,central nervous system development (GO:0007417),0.44527678053321296,1.4343566512823427,0.0020100502512562816,0.780897539553492,1.0,50/250,14.68%,APOD;RELN;VIT;SOX6;PTCH1;HSPG2;VCAN;SOX8;PTEN;SOX9;GSN;PRKN;ADAM23;NRCAM;CHST8;THOC6;SOX11;GBA2;GRIN2B;EML1;NF1;ZBTB16;TGFBR2;PHGDH;LOXL3;BCAN;PAFAH1B3;CNTN6;KLK6;EIF2B5;DHX30;CNTNAP2;GRIK1;SMO;SOX12;NHEJ1;NCAN;PTPN11;DCLK1;ADGRL3;CDK5R1;PHF8;JARID2;PTPRZ1;ALDH5A1;GRIN2D;ZFHX2;GRIN2A;NES;PKD1
prerank,positive regulation of branching involved in ureteric bud morphogenesis (GO:0090190),0.6595497684675738,1.4339613059969374,0.0858433734939759,0.7797796031148626,1.0,5/12,10.49%,SOX8;SOX9;VEGFA;SMO;GDNF
prerank,embryonic skeletal system development (GO:0048706),0.5432697877172256,1.4339499276874177,0.06364749082007344,0.7764334569568084,1.0,6/35,5.53%,OSR2;SULF1;PDGFRA;SOX11;WNT5A;HOXD3
prerank,iron ion transmembrane transport (GO:0034755),0.6674249049172368,1.4334909723607383,0.09341500765696784,0.7753656323322278,1.0,1/10,0.17%,SCARA5
prerank,negative regulation of MAPK cascade (GO:0043409),0.4791846948116703,1.4328561638647896,0.025274725274725275,0.775401727903889,1.0,19/87,11.41%,WNK2;MYC;PTEN;DUSP4;PTPN2;EPHB2;IRAK3;NF1;CNKSR3;DUSP6;LMO3;SPRED2;SPRED1;FOXM1;UCHL1;PTPN1;SPRED3;PTPRJ;BMP7
prerank,positive regulation of cell communication (GO:0010647),0.5532889630275057,1.4324264623756386,0.07741935483870968,0.7742768334014084,1.0,11/28,15.49%,ANK3;CLSTN2;SOX11;GRIK2;SYT1;NMU;RIMS1;EDN3;GATA3;CLSTN1;HOMER1
prerank,nervous system development (GO:0007399),0.4400595620765013,1.4323957057599286,0.0,0.7711111636844733,1.0,95/429,15.53%,DCHS1;RELN;MPZ;GFRA1;PRX;PCDHA4;SOX6;CHRM3;VCAN;RBFOX1;ERBB3;FGF13;FGF2;SOX8;LSAMP;PTEN;WDPCP;GSN;NGF;NAB1;PRKN;ADAM23;GFRA4;LPAR1;EFNA5;SCN2A;ATXN10;NRCAM;VEGFA;PCDHA1;CHST8;EPHB2;THOC6;MAB21L2;TGFB1;GPM6B;NRXN1;GBA2;GSS;NF1;ACVR1C;NUMBL;OBSL1;NLGN1;APAF1;FGF12;NAV1;ZBTB16;KIRREL3;BCAN;PAFAH1B3;BPNT1;LIMK1;CNTN6;KLK6;DHX30;SCD5;GRIK1;GPM6A;SMO;LDB2;PMP22;NHEJ1;DSCAM;NCAN;ERBB4;GDNF;DCLK1;OPHN1;ADGRL3;APC2;DVL1;JARID2;MYLIP;WWTR1;EFNB3;DRD2;BTBD1;PTPRZ1;ALDH5A1;NRSN2;TRPC5;APBA1;MSI1;RBM45;NES;PKD1;MET;MTR;ZEB2;POU3F1;NDUFV2;GFRA2;DACT1;FZD9
prerank,embryonic organ morphogenesis (GO:0048562),0.5279199030561202,1.432225098283381,0.048426150121065374,0.7685664908822568,1.0,7/42,8.49%,OSR2;EFEMP1;PDGFRA;ACVR1;SOX11;HOXD3;RARG
prerank,positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:0036003),0.5675298125199103,1.4321074385577315,0.0778688524590164,0.765944906119059,1.0,8/24,15.90%,CREB3L1;VEGFA;MAPK7;MT3;HIF1A;NFE2L2;GCN1;TP53
prerank,regulation of leukocyte migration (GO:0002685),0.6313592481977498,1.4319114223497393,0.08029197080291971,0.7637422321508529,1.0,4/16,12.13%,BST1;HOXA7;VEGFA;RHOH
prerank,mesonephros development (GO:0001823),0.6706371345271785,1.431612741572077,0.0916030534351145,0.7620346137651671,1.0,5/11,13.20%,OSR2;FGF10;ZBTB16;BMP7;GATA3
prerank,regulation of cytokine production involved in inflammatory response (GO:1900015),0.5413972422680909,1.4315035212235137,0.05795314426633785,0.7594856848358392,1.0,12/37,20.81%,APOD;PYCARD;CARD9;HIF1A;MAPK14;CHID1;PER1;TICAM1;ABCD2;PDCD4;STAT3;SIRPA
prerank,negative regulation of stress fiber assembly (GO:0051497),-0.4514375079909141,-1.4310600139879848,0.08171206225680934,0.6467531873224291,1.0,8/24,8.23%,PHLDB2;TJP1;CGNL1;ARHGAP28;WASF2;RHPN2;ARAP1;PAK2
prerank,neuropeptide signaling pathway (GO:0007218),0.49686972782876226,1.4294924701579343,0.04833141542002301,0.7668155623825523,1.0,4/58,2.34%,SSTR1;SORCS2;SORCS1;SORCS3
prerank,positive regulation of metaphase/anaphase transition of cell cycle (GO:1902101),0.6482469426561477,1.4292853675139365,0.09523809523809523,0.7584901012622408,1.0,8/12,23.62%,CUL3;ANAPC7;CDC23;CDC27;ANAPC4;ANAPC5;RB1;CDC16
prerank,positive regulation of mitotic metaphase/anaphase transition (GO:0045842),0.6482469426561477,1.4292853675139365,0.09523809523809523,0.7584901012622408,1.0,8/12,23.62%,CUL3;ANAPC7;CDC23;CDC27;ANAPC4;ANAPC5;RB1;CDC16
prerank,positive regulation of mitotic sister chromatid separation (GO:1901970),0.6482469426561477,1.4292853675139365,0.09523809523809523,0.7584901012622408,1.0,8/12,23.62%,CUL3;ANAPC7;CDC23;CDC27;ANAPC4;ANAPC5;RB1;CDC16
prerank,negative regulation of cell junction assembly (GO:1901889),0.5718821658197374,1.428672729300147,0.08122503328894808,0.7584985372774204,1.0,3/25,1.66%,APOD;DLC1;PTEN
prerank,peptidyl-glutamic acid modification (GO:0018200),0.5554036697233772,1.4284685576240836,0.08155080213903744,0.7564539776268691,1.0,10/24,17.33%,TTLL10;TTLL5;TTLL11;AGBL4;TTLL4;VKORC1;CFAP20;TPGS1;VKORC1L1;NAA10
prerank,regulation of muscle cell differentiation (GO:0051147),-0.42030164880153503,-1.4282836367932323,0.04950495049504951,0.6508510342897565,1.0,11/31,13.33%,CDH2;BOC;CTNNB1;CDON;IGF2;BNIP2;CAMK1;FGFR2;MAPK12;ID2;CDC42
prerank,myelin maintenance (GO:0043217),0.6845397199701136,1.4281282636377033,0.0926517571884984,0.7551509573721129,1.0,3/10,8.51%,PRX;PTEN;EPB41L3
prerank,regulation of dendritic spine morphogenesis (GO:0061001),0.5544154395065446,1.4272317505267162,0.06812339331619537,0.7564636574501993,1.0,8/31,12.44%,RELN;SIPA1L1;PTEN;TANC2;NLGN1;PPFIA2;CDK5R1;LZTS3
prerank,spliceosomal tri-snRNP complex assembly (GO:0000244),-0.543015857334469,-1.4270270839704882,0.10734463276836158,0.6492207930519956,1.0,8/13,23.61%,PRPF3;SRSF10;PRPF31;DDX20;SRSF12;SART3;USP4;AAR2
prerank,neuron cell-cell adhesion (GO:0007158),0.6308997172833184,1.4268893331939503,0.08662613981762918,0.7551594262789728,1.0,5/14,5.72%,CEL;ASTN2;NRXN1;NCAM2;NLGN1
prerank,copper ion transport (GO:0006825),0.6699213775141895,1.4258553030204757,0.09653092006033183,0.7572709885346429,1.0,3/11,2.60%,STEAP4;STEAP2;STEAP3
prerank,positive regulation of synaptic transmission (GO:0050806),0.4813974722826994,1.4247249641512658,0.04124860646599777,0.7599857686687161,1.0,19/72,15.56%,RELN;TSHZ3;CLSTN2;CACNG7;EPHB2;NRXN1;GRIN2B;GRIK2;CCR2;MPP2;SYT1;NLGN1;SLC8A2;NMU;RIMS1;GRIN2D;CLSTN1;GRIN2A;STX1B
prerank,response to UV-A (GO:0070141),0.6365791813556939,1.4244532158780752,0.09037900874635568,0.7583665298553911,1.0,3/14,8.91%,MMP2;EGFR;PPID
prerank,central nervous system neuron axonogenesis (GO:0021955),0.6472438026521823,1.4237793829515495,0.09781021897810219,0.7588904499278658,1.0,3/12,3.35%,PTEN;EPHB6;EPHB2
prerank,cyclooxygenase pathway (GO:0019371),-0.5784603451217494,-1.423594830393766,0.08064516129032258,0.6554956338039903,1.0,5/10,13.34%,PTGIS;PTGDS;PTGS1;PTGS2;HPGDS
prerank,positive regulation of DNA replication (GO:0045740),0.6219401226980489,1.423089676051508,0.07692307692307693,0.7593221226026085,1.0,4/16,6.05%,GLI2;EGFR;GLI1;STN1
prerank,regulation of protein localization to membrane (GO:1905475),0.5597050224414137,1.422837887716746,0.07552083333333333,0.7576102624136404,1.0,9/28,13.44%,GPC3;GSN;PRKN;SLC5A3;SPTBN1;FYN;GPC1;GPC4;STX8
prerank,sphingoid metabolic process (GO:0046519),-0.5611913283405494,-1.4226602040478598,0.07987220447284345,0.6531654479918816,1.0,9/12,37.22%,PLPP1;KDSR;DEGS2;ASAH2;SPHK1;SPHK2;PLPP2;SPTLC3;NAAA
prerank,regulation of pathway-restricted SMAD protein phosphorylation (GO:0060393),-0.3655611503323003,-1.4219226632144772,0.039473684210526314,0.6500458203436394,1.0,10/56,4.03%,BMP6;DAB2;RBPMS;SMAD6;ACVRL1;SMAD7;BMP4;ENG;BMPR2;TGFBR1
prerank,V(D)J recombination (GO:0033151),0.6576525595712733,1.4218005913795098,0.09969325153374232,0.759650896847566,1.0,1/11,0.19%,RAG2
prerank,regulation of glucose metabolic process (GO:0010906),0.5356125473469335,1.4210844727979524,0.07369758576874205,0.7602637544345796,1.0,6/34,9.85%,RORA;IRS2;PRKN;RORC;PDK3;SELENOS
prerank,granulocyte chemotaxis (GO:0071621),0.49403025176968324,1.4208877799405908,0.05997693194925029,0.7582817472535174,1.0,8/55,11.59%,LGALS3;CCL11;CXCL10;CCL4;PDE4B;GBF1;CKLF;EDN3
prerank,organelle fission (GO:0048285),0.5691945983183565,1.4206434511276764,0.07874015748031496,0.7565968234993878,1.0,3/24,2.35%,SEC16B;DNM1;PRKN
prerank,positive regulation of monocyte chemotaxis (GO:0090026),0.6102425834320742,1.420445248478547,0.0947075208913649,0.7546256891227442,1.0,4/17,7.02%,CXCL10;ANO6;CCR2;PLA2G7
prerank,homologous chromosome segregation (GO:0045143),0.5764818182487428,1.4193682781331785,0.07386363636363637,0.7570520892405825,1.0,7/20,23.00%,MEIOB;FMN2;PRDM9;SGO1;CENPC;PTTG1;MEI4
prerank,cellular response to copper ion (GO:0071280),0.6122720077498168,1.4192670334548316,0.09985734664764621,0.7545709568695397,1.0,12/16,28.18%,PRNP;MT3;AOC1;SNCA;MT1G;MT1B;MT1X;MT1H;MT1F;MT1E;MT1M;MT1A
prerank,endothelial tube morphogenesis (GO:0061154),-0.5704699707338698,-1.417933320241847,0.07964601769911504,0.6581903363287628,1.0,4/10,9.34%,ACVRL1;CTNNB1;BMP4;RHOA
prerank,positive regulation of tissue remodeling (GO:0034105),-0.5760076846681169,-1.417821513044961,0.10354223433242507,0.6527887587563584,1.0,2/10,1.73%,ROCK2;ROCK1
prerank,inositol lipid-mediated signaling (GO:0048017),-0.3703736808890063,-1.4160539539641288,0.034722222222222224,0.6533340963327643,1.0,17/50,10.58%,IGF1;IGF1R;ADAP2;PITPNM2;PLCL1;PI4KA;PIK3C2A;PLCB3;PLCD1;EXOC1;PLCL2;OGT;RPS6KB1;RHOA;PDGFRB;PIK3C2B;TNFAIP8L3
prerank,renal absorption (GO:0070293),0.6725464816807618,1.4158194150171106,0.09494640122511486,0.768860331842781,1.0,2/10,2.24%,HAS2;GSN
prerank,negative regulation of oxidoreductase activity (GO:0051354),0.6778422982808077,1.4155995901742888,0.10064935064935066,0.767056673217039,1.0,4/10,13.88%,PRKN;MT3;HDAC6;SNCA
prerank,regulation of cardiac muscle cell differentiation (GO:2000725),0.6709671937497854,1.4150957085205536,0.09076175040518639,0.7664961071958245,1.0,3/11,7.26%,SOX6;TGFB1;FZD7
prerank,regulation of RIG-I signaling pathway (GO:0039535),-0.4946206790418851,-1.414099973896929,0.057432432432432436,0.6547788142143781,1.0,8/18,20.69%,ANKRD17;DDX60;BIRC3;NOP53;USP15;UFD1;GPATCH3;RNF125
prerank,cellular response to nerve growth factor stimulus (GO:1990090),0.5889278374718093,1.4128551683839519,0.06805555555555555,0.7750027147023111,1.0,7/22,12.45%,NTRK3;NGF;NTRK2;RAP1A;MAGI2;WASF1;ACAP2
prerank,cellular response to cadmium ion (GO:0071276),0.5714859308490589,1.4127633371780162,0.085219707057257,0.7725370787837514,1.0,16/24,28.18%,EGFR;NCF1;MT3;MAPK9;MAPK1;SUMO1;CHUK;JUN;MT1G;MT1B;MT1X;MT1H;MT1F;MT1E;MT1M;MT1A
prerank,positive regulation of non-canonical Wnt signaling pathway (GO:2000052),-0.545419985551445,-1.4113544214014353,0.0935672514619883,0.6590838343267353,1.0,5/11,5.90%,DAB2;WNT5B;RSPO3;MLLT3;NKD1
prerank,metanephros development (GO:0001656),0.5587477327998289,1.410524151944001,0.09043927648578812,0.7810767533616563,1.0,6/26,11.41%,OSR2;PTCH1;FGF10;NF1;GDNF;BMP7
prerank,response to ATP (GO:0033198),0.5968732635295445,1.4102383012590034,0.09626436781609195,0.7794382420648708,1.0,8/18,21.50%,P2RY2;HSP90B1;P2RY12;P2RY1;SSH1;TAF1;RYR3;P2RX7
prerank,DNA packaging (GO:0006323),0.6108929236555902,1.4101605252447824,0.09565217391304348,0.7768432047981253,1.0,6/16,17.73%,BANF2;HAT1;RBBP4;TP53;NAA10;AIFM1
prerank,negative regulation of lipid storage (GO:0010888),-0.4660950550668095,-1.4089091574737291,0.09027777777777778,0.6613575449016332,1.0,9/19,20.71%,OSBPL8;ABCA1;NFKBIA;PPARD;ABCG1;NR1H2;TTC39B;PNPLA2;NR1H3
prerank,retinoid metabolic process (GO:0001523),0.48546292012531916,1.4089011875875075,0.052873563218390804,0.7803095304845135,1.0,14/71,12.81%,GPC3;CYP2S1;HSPG2;RHO;LRP1;SDC2;AKR1B10;SDC4;CYP1B1;RDH10;DHRS3;GPC1;SDC3;GPC4
prerank,secretory granule organization (GO:0033363),-0.5767659050050162,-1.4081955866715867,0.10526315789473684,0.6584760537676625,1.0,3/10,9.40%,ABCA1;DTNBP1;SRGN
prerank,regulation of delayed rectifier potassium channel activity (GO:1902259),0.6157559573032981,1.4075148403552236,0.08297567954220315,0.7843757413936159,1.0,5/17,19.83%,ANK3;AKAP6;SUMO1;KCNRG;NOS1AP
prerank,regulation of cell junction assembly (GO:1901888),-0.4322658602704378,-1.4071828853290156,0.06666666666666667,0.6567735872156376,1.0,8/27,1.98%,TJP1;ROCK2;PRKCH;PDLIM5;RAP1B;ROCK1;CLDN5;OCLN
prerank,axoneme assembly (GO:0035082),0.5421169022422812,1.4066589161020493,0.09517766497461928,0.7858370166129611,1.0,10/30,18.07%,DNAI4;CCDC39;RSPH1;CFAP46;CFAP74;CCDC65;FOXJ1;DNAAF2;RSPH9;DCX
prerank,negative regulation of peptidyl-lysine acetylation (GO:2000757),0.6834901739816028,1.4057100990029407,0.09294871794871795,0.7878091552338726,1.0,5/10,17.62%,KLF15;BRCA1;SNCA;TAF7;CTBP1
prerank,anterograde trans-synaptic signaling (GO:0098916),0.43876449415490837,1.4053184615510876,0.008121827411167513,0.7869385606737944,1.0,42/224,14.50%,MPZ;SLC6A2;CHRM3;RAPSN;CRH;SLC1A3;CEL;CACNA1E;HRH1;PDE7B;GRIA1;KCNA1;DLGAP1;GRIA3;CACNA1A;CHRNA4;PLP1;NRXN1;GRIN2B;GRIK2;PRKAR1B;DLG2;SYT1;NLGN1;CACNB4;KCND2;GRIK1;PMP22;SYN1;SPG11;GRM5;HTR2C;SLC12A4;MAPK1;PRKACA;PENK;APBA1;SNCA;RPS6KA2;NOVA1;GRIN2A;CALM1
prerank,positive regulation of developmental process (GO:0051094),0.44733584478878635,1.4052604586003146,0.00823045267489712,0.7843271837151604,1.0,33/164,15.05%,RELN;DCN;SOX6;BMP5;PHLDB1;SOX8;SPIRE1;SOX9;PRKN;ACVR1;VEGFA;PSEN1;NRXN1;PLCB1;WNT5A;NLGN1;ZBTB16;BNIP3;FGFR1;CPEB3;PPP1R13L;SOX5;GDNF;CLASP1;BMP7;EDN3;ANAPC2;DVL1;CORO1B;COBL;RTN4;BMPR1A;LMNA
prerank,protein alkylation (GO:0008213),-0.4614375026357497,-1.404704648348004,0.06859205776173286,0.6604273905755387,1.0,10/22,14.77%,CAMKMT;GSPT1;FAM98A;METTL21A;PRMT2;LCMT1;SNRPD3;PCMT1;PRMT8;SNRPB
prerank,response to cadmium ion (GO:0046686),0.5584917638677331,1.404516577696355,0.08157894736842106,0.7852655013728411,1.0,16/26,28.18%,EGFR;NCF1;MT3;MAPK9;MAPK1;SUMO1;CHUK;JUN;MT1G;MT1B;MT1X;MT1H;MT1F;MT1E;MT1M;MT1A
prerank,cellular biogenic amine catabolic process (GO:0042402),0.6834975266460691,1.4036048383775936,0.10062893081761007,0.7869873255381838,1.0,6/10,19.40%,SMOX;COMT;SARDH;LRTOMT;SLC44A1;ALDH7A1
prerank,negative regulation of DNA-dependent DNA replication (GO:2000104),0.6567125080109644,1.4032961783264655,0.104199066874028,0.7857280903108369,1.0,6/11,19.26%,ZRANB3;TIPIN;FBH1;BLM;FBXO5;LIG3
prerank,carnitine metabolic process (GO:0009437),-0.5286933773162156,-1.4030923581532038,0.11452513966480447,0.6610342690749269,1.0,5/12,12.61%,CPT1C;CPT1A;ACADM;TMLHE;ALDH9A1
prerank,cellular response to estrogen stimulus (GO:0071391),-0.512562841395863,-1.4024335848653335,0.0707395498392283,0.6578397726333834,1.0,5/14,19.29%,PELP1;SERPINB9;SRA1;ARID5A;RARA
prerank,pteridine-containing compound metabolic process (GO:0042558),-0.5167643223723618,-1.4023229999853335,0.09404388714733543,0.6528801978204865,1.0,6/13,22.44%,NOS3;FPGS;HSP90AA1;SPR;QDPR;AKT1
prerank,regulation of mesenchymal cell proliferation (GO:0010464),0.6526570548779745,1.4016502216320426,0.11649016641452345,0.7911714889110818,1.0,4/11,6.38%,MYC;SOX9;WNT5A;TGFBR2
prerank,response to axon injury (GO:0048678),0.5938426336204987,1.4016287544091084,0.10683760683760683,0.7884637439221676,1.0,1/18,0.03%,APOD
prerank,B cell activation (GO:0042113),0.48117109702926536,1.401506598311641,0.05011389521640091,0.7862785979807215,1.0,13/68,13.22%,RAG2;FCRL1;BCL2;PTPN2;EPHB2;DNAJB9;CHRNA4;RABL3;LAX1;NHEJ1;PTPRJ;DCAF1;MALT1
prerank,regulation of cellular pH (GO:0030641),-0.42393561891473447,-1.401294999682236,0.07024793388429752,0.6510673318589036,1.0,14/29,25.91%,SLC4A10;SLC9A6;SLC9A2;SLC9A8;SLC4A3;SLC4A8;SLC9A9;SLC9A7;ATP6AP1;TM9SF4;SLC26A6;SLC9B1;CA2;LACC1
prerank,positive regulation of T cell migration (GO:2000406),0.5794161322348027,1.4012315841043468,0.09428950863213811,0.7848680746782637,1.0,5/20,9.18%,CXCL10;PYCARD;CCR2;WNT5A;STK39
prerank,regulation of regulatory T cell differentiation (GO:0045589),0.5816901104642848,1.399312748195792,0.09739368998628258,0.7915926319749979,1.0,7/22,17.76%,IL2RA;CBFB;SOCS1;SOX12;IL4I1;RUNX1;MDK
prerank,branched-chain amino acid catabolic process (GO:0009083),0.5815726746551348,1.3991837968912508,0.08977900552486189,0.7866297522542686,1.0,10/20,22.13%,IVD;BCKDHB;MCCC1;MCCC2;HIBADH;HIBCH;DBT;AUH;BCKDK;ALDH6A1
prerank,branched-chain amino acid metabolic process (GO:0009081),0.5815726746551348,1.3991837968912508,0.08977900552486189,0.7866297522542686,1.0,10/20,22.13%,IVD;BCKDHB;MCCC1;MCCC2;HIBADH;HIBCH;DBT;AUH;BCKDK;ALDH6A1
prerank,chondroitin sulfate proteoglycan biosynthetic process (GO:0050650),0.5474395049372293,1.3987843192595772,0.0801068090787717,0.7856983575789507,1.0,6/27,10.03%,DCN;VCAN;BCAN;CSGALNACT1;CHSY1;NCAN
prerank,negative regulation of cilium assembly (GO:1902018),-0.5400259364163814,-1.3978536131135302,0.09235668789808917,0.6576450245728446,1.0,6/12,17.85%,ODF2L;EVI5L;CCP110;TBC1D7;TBC1D30;CDK10
prerank,regulation of establishment or maintenance of cell polarity (GO:0032878),-0.48888797893049457,-1.3976501597601194,0.09556313993174062,0.6531668920290501,1.0,6/18,4.22%,ROCK2;CDH5;TEK;RAP1B;ROCK1;CYRIB
prerank,sodium-independent organic anion transport (GO:0043252),-0.5691954212493417,-1.3976190747516828,0.08163265306122448,0.6481113974949394,1.0,4/10,8.79%,SLCO3A1;SLCO2A1;SLCO1C1;SLC16A2
prerank,regulation of cysteine-type endopeptidase activity (GO:2000116),0.574425409186909,1.396251733165656,0.09745762711864407,0.7955588849477531,1.0,8/21,13.71%,USP50;PYCARD;NGF;MT3;GRIN2B;FYN;NGFR;TTBK1
prerank,"G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger (GO:0007187)",0.49343469768334874,1.3959934103959681,0.060859188544152745,0.7940614419381914,1.0,5/53,9.85%,SSTR1;CHRM3;HRH1;TSHR;HTR2C
prerank,regulation of steroid metabolic process (GO:0019218),0.5640445236373575,1.3957091986930366,0.09504685408299866,0.7926950418823508,1.0,2/23,6.31%,RORA;RORC
prerank,positive regulation of cell projection organization (GO:0031346),0.4532998010048209,1.3955264940276948,0.02335456475583864,0.7909173048155332,1.0,16/115,7.42%,ROR2;RELN;ROR1;TENM3;NTRK3;CHODL;NGF;PLXNC1;IL1RAPL1;NTRK2;WNT5A;OBSL1;ALKAL2;CDKL5;CDKL3;RAP1A
prerank,regulation of cytoplasmic transport (GO:1903649),-0.5408102055340867,-1.3954399825086508,0.10919540229885058,0.6503014935883296,1.0,4/11,8.34%,USP7;CHMP3;ATP9A;MAP2K1
prerank,regulation of execution phase of apoptosis (GO:1900117),0.6494901184182377,1.3945384548848982,0.1109375,0.7930523747488721,1.0,2/11,1.18%,DLC1;FAP
prerank,regulation of T cell chemotaxis (GO:0010819),0.6474410552081293,1.394173273044625,0.13432835820895522,0.7920086629531389,1.0,4/11,9.18%,CXCL10;CCR2;WNT5A;STK39
prerank,negative regulation of angiogenesis (GO:0016525),0.47331878129418287,1.3940971936056092,0.04927211646136618,0.7896896371547507,1.0,13/84,7.08%,DCN;HSPG2;SULF1;CXCL10;CREB3L1;SEMA3E;COL4A2;E2F2;CCR2;SLC12A2;PDE3B;ADAMTS1;SPRED1
prerank,negative regulation of lymphocyte migration (GO:2000402),0.6673123747071384,1.3934512079612742,0.10476190476190476,0.7902390754790982,1.0,1/10,0.03%,APOD
prerank,regulation of sodium ion transmembrane transport (GO:1902305),0.558865328623378,1.3934252806155776,0.08933333333333333,0.7876759350501066,1.0,7/27,14.26%,FXYD3;UTRN;SCN5A;FGF12;FXYD6;FXYD1;NEDD4L
prerank,regulation of histone methylation (GO:0031060),0.6390028911962091,1.3927799823106433,0.12481426448736999,0.7881303233911053,1.0,4/13,12.24%,FAM47E;AASS;PIH1D1;JARID2
prerank,"synaptic transmission, glutamatergic (GO:0035249)",0.5850991607343041,1.3920625952236074,0.08531468531468532,0.7889207491235567,1.0,6/18,8.05%,GRIK3;GRIK5;GRIK2;GRID2;CDH8;GRIK1
prerank,positive regulation of nitric oxide metabolic process (GO:1904407),-0.42801895888762465,-1.3917004891010427,0.0653061224489796,0.6578965055487233,1.0,12/26,22.44%,TLR4;INSR;KLF2;PTGS2;KLF4;DDAH2;HSP90AA1;ASS1;EDN1;HSP90AB1;CLU;AKT1
prerank,peptide biosynthetic process (GO:0043043),-0.3019158529020603,-1.3916537527373802,0.0,0.6529811666332321,1.0,66/153,26.80%,RPS14;GSPT1;RPL24;RPL18A;RPS16;RPL38;RPL28;RPS19;RPL37;RPS2;SARS1;MRPL10;RPL19;RPL5;RPL34;RPS25;RPS15;TNIP1;RPLP1;RPL31;PABPC4;RPL3;MRPL24;MRPL3;EEF1A1;RPS6;RPS8;EIF4EBP2;RPL11;RPL12;RPS6KB2;RPL7A;RPL13;MRPS7;COPS5;MRPL43;IGF2BP3;YARS2;RPS21;RPL35A;ASMT;RPL26;RPS9;MRPS17;RPL32;RPS29;RPS23;RPLP2;MRPS11;RPL8;MRPS16;PCSK1;RSL24D1;DMD;RPL41;RPS17;DHPS;RPS5;RPS15A;RPL37A;GGT5;RPS10;MRPL55;RPL6;WARS1;RPL9
prerank,negative regulation of actin filament bundle assembly (GO:0032232),-0.4240656068932682,-1.3914015152564259,0.09561752988047809,0.6487774599643703,1.0,9/27,8.23%,PHLDB2;TJP1;CGNL1;ARHGAP28;SHANK3;WASF2;RHPN2;ARAP1;PAK2
prerank,metal ion homeostasis (GO:0055065),0.5095302246995997,1.3913143647189434,0.07481296758104738,0.7900113212182045,1.0,11/40,16.10%,ANK3;SLC12A3;LETM1;KCNA1;TMTC2;MT3;SLC12A2;SLC12A4;SLC7A8;SNCA;KCNH2
prerank,glutamate receptor signaling pathway (GO:0007215),0.5203689117340857,1.390456779125234,0.0785276073619632,0.7913569141057349,1.0,12/37,15.49%,GRIK3;GRIA3;PLCB1;GRIN2B;GRIK2;GRID2;GRIK1;GRM5;CDK5R1;HOMER2;GRIN2A;HOMER1
prerank,T cell migration (GO:0072678),0.6299881263908612,1.389547230957092,0.11179173047473201,0.7931970641205321,1.0,2/13,5.24%,CXCL10;SLC12A2
prerank,positive regulation of cellular component organization (GO:0051130),0.4563912813709865,1.389391704702177,0.04302203567681007,0.7912769381703924,1.0,30/107,17.04%,RELN;GPC3;LGALS3;CLDN19;HRK;LRP4;LRP1;VEGFA;TGFB1;NRXN1;PPP1R15A;NOX1;BMF;BNIP3;BRK1;PIH1D1;SLF2;BMP7;ANAPC2;RHOC;SNCA;NEDD4L;SUMO1;MTLN;RUNX1;SPIDR;BCL2L11;TGFB3;HYAL1;SURF4
prerank,negative regulation of phosphorylation (GO:0042326),0.470374476787063,1.388503510112363,0.04456521739130435,0.7928293691608712,1.0,20/85,12.78%,DYNLL1;NTRK3;PIP5KL1;PTEN;IRS2;PRKN;CDKN2B;NPRL2;EPHB2;CADM4;TGFB1;PRNP;PTPN13;NIBAN1;CBFA2T3;MEN1;PID1;BMP7;WWTR1;PRDX3
prerank,protein localization to chromatin (GO:0071168),0.5899424258914889,1.3878979265265665,0.11015736766809728,0.7931347179593097,1.0,5/18,10.72%,FAM47E;LRWD1;MRNIP;PIH1D1;ESR1
prerank,collagen fibril organization (GO:0030199),0.4622977672695898,1.3874655784908356,0.05200433369447454,0.7927627631402349,1.0,23/88,11.55%,COL15A1;LUM;COL5A3;COL20A1;COL28A1;P4HA1;COL5A2;PXDN;COL4A2;COL27A1;COL26A1;NF1;COLGALT2;COL9A2;PLEC;LOXL3;CYP1B1;COL18A1;TLL2;COL3A1;PLOD1;COL1A2;COL14A1
prerank,regulation of Wnt signaling pathway (GO:0030111),0.45757811051703723,1.3867368400233508,0.0314192849404117,0.7937870115840855,1.0,26/108,11.58%,GPC3;SOSTDC1;SULF1;LGR6;MDFIC;TAX1BP3;CBFB;VGLL4;PRKN;DEPDC1B;LRP1;FRZB;TLE1;PSEN1;WIF1;SHISA2;DISC1;FZD7;OTULIN;SPIN1;FAM53B;DAAM2;SFRP4;ESR1;EMD;PPP1CA
prerank,neurotransmitter uptake (GO:0001504),0.6355592451100556,1.3866345614789901,0.12369597615499255,0.7916369452715437,1.0,3/12,5.90%,SLC22A3;SLC1A3;SLC29A1
prerank,chemical synaptic transmission (GO:0007268),0.4299403623187531,1.3863881805102394,0.001004016064257028,0.7904030021784229,1.0,56/284,14.50%,MPZ;SLC6A2;CHRM3;RAPSN;CRH;SLC1A3;CEL;CACNA1E;PTEN;NQO1;HRH1;PDE7B;GRIA1;GRIK3;KCNA1;DLGAP1;GRIA3;CACNA1A;CHRNA4;PLP1;NRXN1;GRIN2B;GRIK5;GRIK2;PRKAR1B;GRID2;DLG2;CDH8;SYT1;NLGN1;CACNB4;KCND2;GRIK1;PDLIM4;PMP22;SYN1;SPG11;GRM5;HTR2C;RIMS1;SLC12A4;MAPK1;TSPOAP1;DVL1;PRKACA;RAB3A;DRD2;GRIN2D;PENK;APBA1;SNCA;RPS6KA2;CHAT;NOVA1;GRIN2A;CALM1
prerank,chemokine-mediated signaling pathway (GO:0070098),0.5029816967619243,1.3861452636819456,0.08620689655172414,0.7890104754095979,1.0,6/42,9.18%,CCL11;CXCL10;CCL4;CCR2;ACKR3;STK39
prerank,immune response-regulating cell surface receptor signaling pathway (GO:0002768),-0.5732045501216937,-1.3855879517588854,0.11731843575418995,0.6643569767201577,1.0,6/10,30.86%,KIT;LYN;CD40;BTLA;BAG6;FGR
prerank,regulation of stress fiber assembly (GO:0051492),-0.33094650333219705,-1.385143320755495,0.011363636363636364,0.6607997684936021,1.0,20/74,9.34%,PHLDB2;TJP1;CGNL1;ROCK2;ARHGAP28;NRP1;CCN2;ROCK1;LIMCH1;WASF2;TGFBR1;RHPN2;TPM1;FHOD1;ARAP1;RGCC;PAK2;PFN2;ARHGEF15;RHOA
prerank,amino acid transmembrane transport (GO:0003333),-0.37179414171574154,-1.3841157837314937,0.0670391061452514,0.6591377701926163,1.0,14/45,14.83%,SLC7A11;SLC47A1;SLC6A6;SLC22A4;SLC6A13;SLC7A5;SLC38A11;SLC38A7;SLC16A2;SLC38A5;SLC25A12;SLC38A10;SLC36A4;SFXN3
prerank,positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770),-0.5613470489810177,-1.3832910626344883,0.11049723756906077,0.6571379942422617,1.0,3/10,4.56%,TLR4;NAMPT;KDR
prerank,regulation of filopodium assembly (GO:0051489),-0.370586770350872,-1.3827701333734475,0.02631578947368421,0.6540393665447174,1.0,10/38,3.56%,CAPZB;NRP1;MYO10;RAB5A;WASL;PPP1R16B;PRKCD;GAP43;AGRN;FNBP1L
prerank,negative regulation of cardiac muscle hypertrophy (GO:0010614),0.6470903397169763,1.3824306170768461,0.10494752623688156,0.804676971361014,1.0,3/11,15.05%,MLIP;GLRX3;LMNA
prerank,positive regulation of long-term synaptic potentiation (GO:1900273),0.6212435496518139,1.3823267653301514,0.10075187969924812,0.8025725940305047,1.0,2/13,3.35%,RELN;EPHB2
prerank,positive regulation of sodium ion transmembrane transport (GO:1902307),0.6537389446603106,1.3821918599464846,0.12652439024390244,0.8006903907716372,1.0,3/12,3.54%,WNK2;ANK3;WNK3
prerank,regulation of protein import into nucleus (GO:0042306),0.5222389973790339,1.3811019098060873,0.08849557522123894,0.8033977827697535,1.0,6/36,10.37%,APOD;MDFIC;TGFB1;PSEN1;FLNA;PIK3R1
prerank,nuclear membrane organization (GO:0071763),-0.452022270277445,-1.380974011275312,0.08487084870848709,0.6553443314323818,1.0,11/19,27.60%,UBXN2A;TOR1B;VPS4A;DCTN1;TMEM43;UBXN2B;GPER1;CHMP7;TARDBP;NSFL1C;TOR1AIP1
prerank,positive regulation of glycogen biosynthetic process (GO:0045725),-0.5292565117111422,-1.380910240862037,0.12612612612612611,0.6507968921864405,1.0,4/12,5.85%,SORBS1;IGF1;IGF2;INSR
prerank,regulation of calcium ion import (GO:0090279),0.5663474037287591,1.3805236931025875,0.12043301759133965,0.8037429944268335,1.0,6/21,14.33%,LGALS3;WNK3;PRNP;FYN;PLPP4;PSEN2
prerank,cellular response to chemokine (GO:1990869),0.49762138479411544,1.3800713712544592,0.08034610630407911,0.803358281552735,1.0,7/46,9.18%,CCL11;CXCL10;CCL4;CCR2;SLC12A2;ACKR3;STK39
prerank,pinocytosis (GO:0006907),0.6577589300363484,1.379597390179034,0.11848341232227488,0.803052862419193,1.0,4/10,7.69%,PYCARD;MAPKAPK3;MAPKAPK2;RAB34
prerank,negative regulation of nervous system development (GO:0051961),0.5865005350666637,1.3792508805757637,0.12756598240469208,0.8021948028496281,1.0,2/17,4.93%,CCL11;PCM1
prerank,regulation of IRE1-mediated unfolded protein response (GO:1903894),0.6103761364788446,1.3792419268077152,0.11561561561561562,0.7996989716156749,1.0,6/14,16.77%,DNAJB9;UFL1;PTPN1;TMEM33;BCL2L11;FICD
prerank,cellular response to inorganic substance (GO:0071241),0.5643411641518133,1.3792418068721144,0.10833333333333334,0.7971762619260355,1.0,9/21,15.98%,DDX11;DPEP1;NSMCE3;MT3;AOC1;ATRX;MTR;BLM;SPIDR
prerank,secretion (GO:0046903),-0.5096706842551255,-1.3791267724491623,0.10759493670886076,0.6520424130138557,1.0,4/14,6.40%,SLC22A4;SLC22A6;PRKCI;NPR1
prerank,regulation of secretion (GO:0051046),0.6136736562299244,1.3788749907941606,0.12576687116564417,0.7964813552967773,1.0,6/13,16.79%,ERBB3;FGF10;ACSL3;GPLD1;OPRK1;SGK1
prerank,androgen metabolic process (GO:0008209),0.5978857577772801,1.3781708288794732,0.12116991643454039,0.7975305001262913,1.0,2/18,4.64%,HSD17B7;HSD17B11
prerank,DNA catabolic process (GO:0006308),0.6423661773227609,1.377905904755653,0.13975155279503104,0.7963472051900649,1.0,4/11,10.68%,SETMAR;XRN2;REXO4;FBH1
prerank,aminoglycan catabolic process (GO:0006026),0.5311866039438702,1.376805503003033,0.0987012987012987,0.7991341201887214,1.0,9/28,15.41%,GPC3;HSPG2;SDC2;SDC4;GPC1;CTBS;SDC3;GPC4;IDS
prerank,regulation of nitric oxide biosynthetic process (GO:0045428),-0.3865331139662732,-1.3765562708003063,0.07881773399014778,0.6558751837384603,1.0,15/38,22.44%,ROCK2;PTGIS;TLR4;INSR;KLF2;PTGS2;KLF4;DDAH2;HSP90AA1;ASS1;CAV1;EDN1;HSP90AB1;CLU;AKT1
prerank,positive regulation of epithelial cell proliferation (GO:0050679),0.4515060180846242,1.376110256752849,0.039832285115303984,0.800015383599125,1.0,19/113,5.52%,OSR2;BMP5;CCL11;PRKCA;FGF2;MYC;FGF10;SOX9;STXBP4;ERBB2;LAMC1;EGFR;TGM1;VEGFA;EGR3;SOX11;CLDN1;SCN5A;WNT5A
prerank,metanephric mesenchyme development (GO:0072075),-0.5543488323370431,-1.375347141885139,0.12021857923497267,0.6553242425931068,1.0,3/10,7.30%,WNT4;OSR1;SIX1
prerank,negative regulation of cell-cell adhesion (GO:0022408),-0.3812991591771153,-1.3750941452829875,0.043010752688172046,0.6515392994318041,1.0,14/39,16.19%,BMP6;PODXL;MAP2K5;CDH1;WNK1;RGCC;KLF4;JAG1;NOTCH4;NEXMIF;FXYD5;AKNA;ASS1;PPM1F
prerank,regulation of intracellular transport (GO:0032386),-0.3733377959872562,-1.3744648101763206,0.04830917874396135,0.6491369175312789,1.0,11/38,10.96%,MAP2;RAB11B;GAS1;LAMP1;ATP9A;SCFD1;ATPSCKMT;WWC1;DYNLT2B;NUMA1;NUP214
prerank,oligodendrocyte differentiation (GO:0048709),0.5736466994749355,1.3737270408091955,0.13131313131313133,0.808965003439329,1.0,6/19,13.02%,SOX6;SOX8;SOX9;EIF2B5;NSUN5;PTPRZ1
prerank,histone lysine methylation (GO:0034968),0.5135541497974566,1.3736478003120327,0.10051546391752578,0.8068197039764679,1.0,14/33,20.48%,SUV39H1;KMT2A;SETD3;CXXC1;SETMAR;MEN1;PRDM9;TRMT112;KDM6A;WDR5B;ASH2L;N6AMT1;SETDB1;KMT2D
prerank,positive regulation of smoothened signaling pathway (GO:0045880),0.55777292557811,1.373523873417187,0.10655737704918032,0.8049400308176065,1.0,6/21,8.63%,STK36;EVC;GLI1;UCHL5;RAB34;SMO
prerank,neutrophil migration (GO:1990266),0.4755726576130584,1.3733516760172833,0.08975834292289989,0.8032436036179548,1.0,8/58,11.59%,LGALS3;CCL11;CXCL10;CCL4;PDE4B;GBF1;CKLF;EDN3
prerank,regulation of cell-substrate adhesion (GO:0010810),0.5102906739538398,1.3721202265441537,0.07590361445783132,0.8067286436175635,1.0,7/42,9.96%,VIT;BST1;FBLN2;NF1;TSC1;FZD7;ARL2
prerank,protein ADP-ribosylation (GO:0006471),-0.4179348687832437,-1.3721184034375549,0.06147540983606557,0.6527058029387383,1.0,10/28,16.88%,ZC3HAV1;PARP3;PARP4;PARP10;PARP1;SIRT3;PARP6;PARP12;PARP14;SIRT4
prerank,aromatic amino acid family catabolic process (GO:0009074),0.6023364801179472,1.3720069822278806,0.09867452135493372,0.8048605551389842,1.0,3/15,9.64%,AADAT;KYNU;IL4I1
prerank,xenobiotic transport (GO:0042908),-0.47795752611596287,-1.371414221191132,0.1048951048951049,0.6505355575418407,1.0,6/17,3.59%,ABCG2;ABCA3;SLC47A1;GJA1;SLC22A4;SLC7A5
prerank,regulation of cellular metabolic process (GO:0031323),0.49314930292972026,1.371330658069683,0.08926417370325694,0.8058142056563209,1.0,14/45,14.53%,PRKN;PARL;ACACA;MKLN1;CYP1B1;PDK3;FOXM1;EIF6;ACLY;FASN;ARF4;PID1;SSH1;NCOR2
prerank,response to interleukin-1 (GO:0070555),0.47012274825251454,1.3706658315193918,0.06538895152198422,0.8065895189319277,1.0,8/73,4.10%,CCL11;ADAMTS12;PRKCA;HAS2;PYCARD;SOX9;IRAK3;CCL4
prerank,response to reactive oxygen species (GO:0000302),0.49013892577934826,1.3702561930929202,0.08168028004667445,0.806068417953008,1.0,12/54,12.83%,APOD;PDGFRA;EGFR;APTX;NCF1;FYN;MAPK9;HIF1A;MAPK1;ERCC6L2;PRDX3;SOD2
prerank,regulation of T cell receptor signaling pathway (GO:0050856),0.521962755689952,1.3702362031423245,0.11498708010335917,0.8037422490203218,1.0,6/33,12.73%,LGALS3;PTPN22;PTPN2;PRNP;PTPRJ;NECTIN2
prerank,positive regulation of ion transmembrane transporter activity (GO:0032414),0.5530918983411487,1.3699369769460557,0.10641200545702592,0.8027285142958025,1.0,7/25,13.72%,WNK2;ANK3;ANK2;WNK3;STK39;NDUFA4;TCAF1
prerank,negative regulation of transferase activity (GO:0051348),0.5354902409769396,1.369934905854347,0.12317880794701987,0.8003338045435826,1.0,14/28,20.38%,IRS2;NPRL2;ERCC4;LIMK1;MEN1;BAG5;PRDX3;ABL1;TP53;HNRNPU;EIF4A2;FBXO5;PARK7;ZFP36
prerank,diterpenoid metabolic process (GO:0016101),0.48060500183999033,1.3698601673161586,0.08070175438596491,0.7983164040922238,1.0,12/55,12.81%,GPC3;HSPG2;RHO;LRP1;SDC2;AKR1B10;SDC4;RDH10;DHRS3;GPC1;SDC3;GPC4
prerank,DNA alkylation (GO:0006305),0.5712676622572967,1.3695405240869432,0.14609929078014183,0.7951366120180697,1.0,6/19,11.01%,GATAD2A;ATF7IP;ATRX;MTRR;TEX15;HELLS
prerank,DNA methylation or demethylation (GO:0044728),0.5712676622572967,1.3695405240869432,0.14609929078014183,0.7951366120180697,1.0,6/19,11.01%,GATAD2A;ATF7IP;ATRX;MTRR;TEX15;HELLS
prerank,positive regulation of protein targeting to membrane (GO:0090314),0.5473446478694457,1.3679764535910448,0.10307898259705489,0.8001941082903241,1.0,5/24,8.06%,ANK3;ERBB2;C2CD5;PRNP;FYN
prerank,T cell differentiation (GO:0030217),0.5097089261846394,1.3674750554379942,0.09634146341463415,0.8002564992720425,1.0,10/40,13.20%,RAG2;PTPN22;FADD;PTPN2;RABL3;NHEJ1;ZFP36L2;MR1;RHOH;GATA3
prerank,protein localization to vacuole (GO:0072665),-0.5016531386248346,-1.3666427261894512,0.12302839116719243,0.6623167467175733,1.0,8/13,25.92%,LMBRD1;MFSD1;RNF128;KPTN;SH3GLB1;SH3BP4;ATP13A2;SZT2
prerank,L-serine metabolic process (GO:0006563),0.6534164266042894,1.365797234434202,0.13862928348909656,0.8058511171685643,1.0,5/10,13.39%,CBS;PSPH;PSAT1;PHGDH;SRR
prerank,positive regulation of mitochondrion organization (GO:0010822),0.4708369757398725,1.3656579026149704,0.08508158508158509,0.8041388999359171,1.0,8/57,7.73%,DCN;HRK;PYCARD;SPIRE1;PRKN;FBXO7;BMF;BNIP3
prerank,embryonic eye morphogenesis (GO:0048048),0.6359158067223455,1.3650267192384464,0.12121212121212122,0.804798779056012,1.0,5/11,23.45%,EFEMP1;RARG;ALDH1A3;FBN2;TBX2
prerank,regulation of neutrophil chemotaxis (GO:0090022),-0.4276992689475762,-1.3646300769394286,0.08,0.6646112304073153,1.0,9/23,13.93%,MOSPD2;SLIT2;MPP1;JAM3;DAPK2;CAMK1D;DPP4;NCKAP1L;TIRAP
prerank,ubiquinone metabolic process (GO:0006743),-0.49819279430690855,-1.3644814953858468,0.1167192429022082,0.6606615425033358,1.0,9/15,26.69%,COQ8B;COQ10B;PDSS1;COQ9;COQ3;FDXR;PDSS2;COQ6;COQ8A
prerank,regulation of macrophage migration (GO:1905521),-0.544527539878112,-1.3636470340197293,0.1444141689373297,0.6589364504660706,1.0,2/10,1.32%,CD200;MTUS1
prerank,positive regulation of vascular endothelial cell proliferation (GO:1905564),0.6295080587906512,1.3635175364851448,0.12463343108504399,0.8099063294932216,1.0,5/13,11.46%,FGF2;FGFR1;AKT3;SP1;SIRT6
prerank,calcium-mediated signaling (GO:0019722),0.44962609294766404,1.362798533285903,0.05343511450381679,0.8112049400516762,1.0,24/93,17.45%,CHRM3;ANK2;PPP1R9A;EGFR;EIF2AK3;PTGFR;PRNP;CCR2;PPP3CB;ACKR3;RCAN1;PPP3CA;RCAN3;GRM5;MCTP1;PTPRJ;PRKACA;TPCN2;P2RY12;PPP3CC;ACKR4;LAT2;STIMATE;SLC9A1
prerank,negative regulation of complement activation (GO:0045916),0.6565661606038242,1.3624568145081235,0.12695924764890282,0.810403460233292,1.0,1/10,0.82%,A2M
prerank,regulation of ion transmembrane transport (GO:0034765),0.5204255994916798,1.3624015167692758,0.10627400768245839,0.8083206732635015,1.0,9/33,16.10%,CHRM3;ANO6;WNK3;AKAP6;AHCYL1;KCNJ3;NEDD4L;KCNJ10;KCNH2
prerank,negative regulation of macromolecule biosynthetic process (GO:0010558),0.6434913178782523,1.3620544611685148,0.13530326594090203,0.8077017914850715,1.0,4/12,14.80%,TGFB1;SELENOS;HDAC2;TAF7
prerank,positive regulation of excitatory postsynaptic potential (GO:2000463),0.5869533028142805,1.3613395737964917,0.12073863636363637,0.8086146243882836,1.0,4/18,5.72%,RELN;PTEN;NRXN1;NLGN1
prerank,regulation of branching involved in ureteric bud morphogenesis (GO:0090189),0.5936344262675359,1.3606817982155308,0.12408759124087591,0.8092871603984285,1.0,5/15,10.49%,SOX8;SOX9;VEGFA;SMO;GDNF
prerank,negative regulation of alcohol biosynthetic process (GO:1902931),0.6239140928592422,1.35818431897541,0.13031161473087818,0.8191689219348853,1.0,4/13,15.46%,BMP5;ERLIN2;DKK3;ERLIN1
prerank,negative regulation of developmental growth (GO:0048640),0.5159770042172691,1.357402525169834,0.10918774966711052,0.8205114853877851,1.0,7/30,10.02%,PTCH1;FGF13;PTEN;RNF6;MT3;CDKL3;DCC
prerank,positive regulation of small GTPase mediated signal transduction (GO:0051057),0.5307360461277988,1.3568782499312335,0.11818181818181818,0.8205330457064367,1.0,8/30,11.65%,RELN;FGF10;IRS2;NGF;ERBIN;SHOC2;STK19;MMD2
prerank,anterior/posterior pattern specification (GO:0009952),-0.35767352733795005,-1.3564143992214575,0.06040268456375839,0.6781456544304464,1.0,16/53,20.26%,WLS;LRP5;HOXB9;HOXA3;BMPR2;TGFBR1;HOXC6;HOXC5;TBX1;HOXC4;HOXA9;HEY2;HOXB3;HOXA6;HOXD4;HHEX
prerank,COPII-coated vesicle budding (GO:0090114),0.47220956076404164,1.3559969177799522,0.0739514348785872,0.8224027642940683,1.0,27/68,24.24%,SEC16B;GORASP1;GRIA1;ANKRD28;SEC24D;TRAPPC6B;SEC31B;TMED10;SEC24C;CUL3;VAPA;RAB1A;KLHL12;TBC1D20;TMED2;SEC23IP;TRAPPC6A;CNIH3;SEC24A;SEC23B;TRAPPC3;PEF1;TRAPPC2L;LMAN1;TRAPPC10;MIA3;PPP6R1
prerank,regulation of clathrin-dependent endocytosis (GO:2000369),-0.47102043073208427,-1.3558759838229808,0.13395638629283488,0.675473441017435,1.0,7/15,27.32%,DAB2;WASL;SNAP91;HIP1R;TNK2;PIK3CB;BMP2K
prerank,energy reserve metabolic process (GO:0006112),0.5576628535546915,1.3555240693812314,0.13943661971830987,0.8221843881670441,1.0,6/19,11.37%,PYGL;GFPT2;MYC;MT3;PHKB;PID1
prerank,regulation of mitochondrial fission (GO:0090140),0.5379912963181718,1.3550930171275246,0.11655629139072848,0.821959086111005,1.0,5/24,11.05%,DCN;SPIRE1;PRKN;BNIP3;MYO19
prerank,membrane protein intracellular domain proteolysis (GO:0031293),0.5663025618277092,1.3546922095472644,0.12448132780082988,0.8216537167335283,1.0,11/20,21.21%,HM13;TGFB1;PSEN1;NGFR;NCSTN;APH1A;PSEN2;SPPL2B;MBTPS1;NFKB1;RHBDD1
prerank,regulation of double-strand break repair (GO:2000779),0.495635820397275,1.3537542427652265,0.10110974106041924,0.8238670240450283,1.0,12/39,16.41%,DDX11;SPIRE1;FMN2;MRNIP;FOXM1;SETD2;SLF2;SIRT6;RPA2;RTEL1;SPIDR;TERF2IP
prerank,positive regulation of protein-containing complex disassembly (GO:0043243),-0.5199926339955663,-1.3529461993444,0.14325842696629212,0.6811318118252457,1.0,7/12,22.32%,IGF1R;INSR;IRGM;UVRAG;SMCR8;JMJD4;ADRB2
prerank,limb development (GO:0060173),0.5277475939728798,1.3526996428307896,0.11503267973856209,0.8267446515397507,1.0,4/28,2.04%,PTCH1;LRP4;FGF10;KAT2B
prerank,positive regulation of cardiac muscle cell proliferation (GO:0060045),0.6027330783971969,1.3526983179598238,0.15174506828528073,0.8244417416468823,1.0,5/13,14.61%,FGF2;GLI1;ERBB4;ZFPM2;BMPR1A
prerank,receptor clustering (GO:0043113),0.5280303795334798,1.3513784644299116,0.11517615176151762,0.8286369133039271,1.0,9/27,12.72%,LRP4;SAV1;NRXN1;DLG2;NLGN1;FLNA;MAGI2;DVL1;SCRIB
prerank,regulation of reactive oxygen species metabolic process (GO:2000377),0.47697681295635724,1.350879471888015,0.089728453364817,0.8286167131315972,1.0,19/55,19.23%,BST1;PRKN;PARL;MT3;TGFBR2;CYP1B1;PDK3;FOXM1;EIF6;BRCA1;MAPK14;ARF4;PID1;SNCA;TP53;PAX2;RIPK1;AATF;GRB2
prerank,prostaglandin biosynthetic process (GO:0001516),-0.4634637643516577,-1.3506781451184589,0.11371237458193979,0.684187169945011,1.0,5/18,7.97%,PLA2G4A;PTGIS;PTGDS;PTGS1;PTGS2
prerank,regulation of cardiac muscle cell contraction (GO:0086004),0.5409763639941535,1.3503236119530242,0.10441767068273092,0.828871239734254,1.0,9/27,15.41%,FGF13;ANK2;PDE4B;DSG2;SCN5A;CTNNA3;PDE4D;PKP2;JUP
prerank,negative regulation of leukocyte chemotaxis (GO:0002689),-0.5384257123005622,-1.3500433089344666,0.12928759894459102,0.6820115344686509,1.0,4/11,13.96%,NBL1;SLIT2;RIN3;PADI2
prerank,regulation of protein tyrosine kinase activity (GO:0061097),0.49776662828086893,1.349953723241567,0.09268292682926829,0.8283373527026473,1.0,7/38,9.79%,RELN;ERBB3;RAP2B;GPRC5B;PRNP;PTPN1;GRM5
prerank,proteolysis (GO:0006508),0.42455278175860756,1.3498347854311041,0.01609657947686117,0.8267219284796007,1.0,59/252,19.67%,HGFAC;KLK12;PTCH1;MMP2;ADAMTS12;ADAM19;FAP;BACE2;CAPN5;HTRA3;HM13;PARL;HTRA1;CAPN1;MIPEP;NAALAD2;PSEN1;PCSK4;PCSK6;MMP15;CTSK;CTSO;CASP6;TRHDE;CTSB;UFSP2;SPCS3;LNPEP;CAPN6;THOP1;MMP16;NCSTN;RSPRY1;UBA3;FBXL2;APH1A;YME1L1;MALT1;MMP19;CPD;NEDD8;TYSND1;ADAM33;PSEN2;PAPPA2;CASP2;RNPEPL1;USP25;FAM111A;ATG4C;SUFU;MDM2;CASP7;ERMP1;CAPN11;SENP1;CPNE1;SPPL2B;MBTPS1
prerank,neuron projection morphogenesis (GO:0048812),0.43385390226031245,1.3475303503387763,0.05851619644723093,0.8355363570388881,1.0,49/137,19.93%,ANK3;DOCK7;LRP4;KIF20B;PTEN;NGF;MAP4K4;MAP1B;GAS7;NRCAM;EPHB2;SDC2;CTNNA2;TNIK;NYAP1;NLGN1;PAK1;ALS2;BAIAP2;DOCK10;NTNG2;NTNG1;S100A6;CNTNAP2;GPM6A;EPB41L3;DCC;DCLK1;DIP2A;BMP7;TAOK3;PLPPR4;DVL1;RAB3A;DRD2;TRIO;IQGAP1;ANKRD27;UBB;LRP2;SGK1;CTTN;PAX2;KLF7;CNTN4;NCKAP1;CPNE1;MAP6;SHTN1
prerank,morphogenesis of an epithelium (GO:0002009),0.530277447536361,1.346853047620153,0.1402359108781127,0.8364231788132505,1.0,4/25,7.60%,SOX8;SOX9;PRKX;TBX18
prerank,stabilization of membrane potential (GO:0030322),0.5829745105572682,1.3464244383447568,0.14504881450488144,0.8361559264155776,1.0,2/16,3.10%,KCNK15;KCNK1
prerank,regulation of nuclear division (GO:0051783),0.5567430950690325,1.346126848709377,0.14037626628075253,0.8353550963687129,1.0,5/20,10.81%,KIF20B;OBSL1;CDK13;RCC1;PKMYT1
prerank,platelet degranulation (GO:0002576),-0.3148594943045097,-1.3459384528500857,0.0,0.691757807136898,1.0,33/118,14.90%,IGF1;ABCC4;VWF;PECAM1;VEGFC;STXBP1;VEGFD;VTI1B;LYN;GTPBP2;CYRIB;IGF2;TEX264;THBS1;F8;HABP4;ACTN1;TIMP3;CD109;APP;ACTN2;FN1;SRGN;MANF;TMX3;SOD1;TMSB4X;SERPINE1;SYTL4;TGFB2;BRPF3;LGALS3BP;QSOX1
prerank,chromatin organization (GO:0006325),0.43786169334341263,1.345650478207753,0.046826222684703434,0.8352622003127331,1.0,42/132,20.29%,FAM47E;DDX11;PRDM16;MYC;KAT2B;LRWD1;SOX9;HMGN1;SUV39H1;SATB1;KDM5B;BAZ1A;EZH1;PAK1;KDM4B;MTA2;MCM3AP;ATRX;SETD2;PIH1D1;HDAC2;MYSM1;ESR1;SMARCC2;JARID2;ZBTB1;SETD5;RBBP4;SMARCC1;BAZ2B;KDM6A;BAZ1B;PHF19;SMARCE1;PBRM1;NUDT5;RUVBL2;HMG20A;TOP1;HP1BP3;SMARCA4;SETDB1
prerank,adherens junction organization (GO:0034332),0.4873302676060221,1.3454777995796765,0.08716707021791767,0.8338811975824034,1.0,11/48,9.72%,DCHS1;CDH19;CDH10;CDH22;CDH8;CADM3;CSK;CADM2;CADM1;CDH20;CDH7
prerank,negative regulation of cellular protein localization (GO:1903828),-0.3719728040834416,-1.34542990905532,0.07488986784140969,0.6891338775360436,1.0,11/34,9.20%,ROCK2;LZTFL1;MFHAS1;TTBK2;LATS2;COMMD1;LEPROTL1;GSK3B;ACTN2;GOPC;FLCN
prerank,ion homeostasis (GO:0050801),0.5167334642947286,1.3450581794304028,0.11513583441138421,0.8335742500260883,1.0,4/30,7.95%,P2RY2;WNK2;WNK3;SLC30A4
prerank,hydrogen peroxide metabolic process (GO:0042743),0.5554412049580925,1.3446756639223698,0.13737075332348597,0.833113282991346,1.0,7/19,18.76%,PXDN;NOX1;ACOX1;GPX3;PRDX3;CAT;PARK7
prerank,cAMP-mediated signaling (GO:0019933),0.5347543710467548,1.3444444538677511,0.13385826771653545,0.8319794397376715,1.0,7/24,13.21%,SOX9;PDE7B;MAPK7;KSR1;AKAP6;PDE4D;AHR
prerank,UDP-N-acetylglucosamine biosynthetic process (GO:0006048),0.626242974527507,1.344150225847494,0.15448504983388706,0.8311174638067448,1.0,2/11,3.68%,GFPT2;NAGK
prerank,regulation of ubiquitin-dependent protein catabolic process (GO:2000058),0.4959596653891675,1.3441479811599026,0.10840438489646773,0.8289062980491346,1.0,7/40,6.81%,GLMN;PTEN;RAD23B;XPO1;ARAF;FBXW7;UFL1
prerank,amino sugar biosynthetic process (GO:0046349),0.6079483110437178,1.3439984985439821,0.15335463258785942,0.827433324969659,1.0,2/12,3.68%,GFPT2;NAGK
prerank,response to interferon-beta (GO:0035456),-0.43279646944781924,-1.343931542034159,0.08846153846153847,0.689857852987552,1.0,14/22,28.38%,PLSCR1;IFITM3;AIM2;IRGM;IRF1;IFITM2;UBE2G2;BST2;HTRA2;IFNAR2;CDC34;IKBKE;XAF1;TRIM6
prerank,COPII vesicle coating (GO:0048208),0.4724984465637424,1.3433733374820913,0.08893956670467502,0.8239115998271194,1.0,21/61,22.16%,SEC16B;GORASP1;GRIA1;ANKRD28;SEC24D;TRAPPC6B;TMED10;SEC24C;CUL3;RAB1A;KLHL12;TBC1D20;TMED2;SEC23IP;TRAPPC6A;CNIH3;SEC24A;TRAPPC3;PEF1;TRAPPC2L;LMAN1
prerank,vesicle coating (GO:0006901),0.4724984465637424,1.3433733374820913,0.08893956670467502,0.8239115998271194,1.0,21/61,22.16%,SEC16B;GORASP1;GRIA1;ANKRD28;SEC24D;TRAPPC6B;TMED10;SEC24C;CUL3;RAB1A;KLHL12;TBC1D20;TMED2;SEC23IP;TRAPPC6A;CNIH3;SEC24A;TRAPPC3;PEF1;TRAPPC2L;LMAN1
prerank,"vesicle targeting, rough ER to cis-Golgi (GO:0048207)",0.4724984465637424,1.3433733374820913,0.08893956670467502,0.8239115998271194,1.0,21/61,22.16%,SEC16B;GORASP1;GRIA1;ANKRD28;SEC24D;TRAPPC6B;TMED10;SEC24C;CUL3;RAB1A;KLHL12;TBC1D20;TMED2;SEC23IP;TRAPPC6A;CNIH3;SEC24A;TRAPPC3;PEF1;TRAPPC2L;LMAN1
prerank,generation of neurons (GO:0048699),0.42492392612318947,1.3426683793506071,0.03248730964467005,0.8250833465174969,1.0,27/190,8.16%,RELN;DOCK7;LHX5;FGF13;ASTN2;ERBB2;IL1RAPL1;OTP;MAP1B;NRCAM;SEMA3A;AUTS2;SOX11;NTRK2;EML1;CEP85L;WNT5A;NGRN;CDKL5;NAV1;DISC1;SDCCAG8;FZD7;TAFA1;CDK6;FGFR1;GPM6A
prerank,blood circulation (GO:0008015),-0.3613763771467023,-1.342507168428335,0.05673758865248227,0.6902489439617872,1.0,15/49,11.94%,MYOF;ROCK2;ELN;TBC1D8;ROCK1;ACVRL1;NOS3;COL4A3;NPR1;ACE;AGTR1;GUCY1B1;ADORA2A;SOD1;GPX1
prerank,"chemical synaptic transmission, postsynaptic (GO:0099565)",0.5388655356410381,1.3421030231477373,0.13386880856760375,0.8255877749477382,1.0,8/25,14.38%,CHRNA4;GRIN2B;GRID2;MPP2;INSYN1;DRD2;GRIN2D;GRIN2A
prerank,positive regulation of protein localization to membrane (GO:1905477),0.4427295468146457,1.34141749594187,0.06472491909385113,0.8267995304824293,1.0,17/98,8.27%,LGALS3;ANK3;BCL2;ERBB2;PRKN;EGFR;SLC5A3;LRP1;C2CD5;EPHB2;WNK3;PRNP;SPTBN1;YWHAZ;DPP10;FYN;ZDHHC8
prerank,neuron development (GO:0048666),0.4348159805615793,1.341333078026489,0.04100946372239748,0.8250591016569986,1.0,28/141,13.05%,LGI4;ETV1;TENM2;CDNF;TENM3;DOCK7;GLI2;PPP1R9A;ATXN10;HS6ST1;ARL3;GPM6B;PLP1;NTRK2;GBA2;NLGN1;UNK;CNTNAP2;GPM6A;VAPA;GDNF;PRMT1;OPHN1;STMN4;CDK5R1;ATP8A2;MYOC;CDK16
prerank,negative regulation of epithelial to mesenchymal transition (GO:0010719),0.5247803218294123,1.3411659972858376,0.11210191082802548,0.8237198307078145,1.0,7/29,14.70%,BMP5;PTEN;SPRED2;SPRED1;SPRED3;GATA3;LDLRAD4
prerank,superoxide anion generation (GO:0042554),0.6002774098766368,1.3408563058840883,0.13643410852713178,0.8230418150979277,1.0,4/13,9.76%,NCF1;NOX1;TAFA4;NCF2
prerank,regulation of protein targeting to membrane (GO:0090313),0.5281256468775676,1.3394400025000475,0.1227154046997389,0.8274356125648035,1.0,5/28,8.06%,ANK3;ERBB2;C2CD5;PRNP;FYN
prerank,regulation of platelet activation (GO:0010543),0.5561870390366405,1.3392308305056593,0.12297297297297298,0.8262153036572393,1.0,4/21,4.19%,PRKCA;PDGFRA;PRKCQ;TEC
prerank,positive regulation of nervous system development (GO:0051962),0.48826601790424434,1.3376724443680408,0.12004950495049505,0.8313668130105065,1.0,13/42,16.58%,CLSTN2;IL1RAPL1;EPHB2;SOX11;NRXN1;GRID2;NUMBL;NLGN1;SYNDIG1;CLSTN1;LRP2;IL1RAP;FAIM
prerank,NAD biosynthetic process (GO:0009435),-0.43476293098478236,-1.3373484173366301,0.11764705882352941,0.7034325543831994,1.0,7/20,10.07%,PTGIS;NMNAT2;NAMPT;NAXD;PARP10;PTGS2;NMNAT1
prerank,positive regulation of phospholipid transport (GO:2001140),-0.5396562417987059,-1.337347016729787,0.14824120603015076,0.6990430503471775,1.0,5/10,21.90%,ABCA3;ABCB4;APOE;ABCA7;TMEM30A
prerank,regulation of ATP biosynthetic process (GO:2001169),-0.4714289328874287,-1.3365114672835248,0.13836477987421383,0.6974843927284919,1.0,11/16,28.53%,PARP1;ATPSCKMT;FLCN;TMSB4X;ENO1;PINK1;AK4;SPHK2;ANTKMT;DNAJC30;VCP
prerank,transition metal ion transport (GO:0000041),-0.3838276495924391,-1.3364132765033887,0.07547169811320754,0.6935015242865005,1.0,9/35,10.28%,SLC30A10;SLC31A1;ATP7A;SLC31A2;FTH1;SLC39A8;SLC30A1;TRPC6;TFRC
prerank,regulation of dendrite extension (GO:1903859),0.5681902028912139,1.3362578685065416,0.13559322033898305,0.8357326163528395,1.0,9/18,23.56%,RNF157;SYT1;RIMS1;NEDD4L;PLAA;SYT2;RIMS2;CPNE5;SYT3
prerank,cellular potassium ion homeostasis (GO:0030007),-0.49831410685940314,-1.3361708506175172,0.11782477341389729,0.6901064258926084,1.0,4/13,6.72%,ATP1A2;ATP1B3;KCNJ2;ATP1A1
prerank,UDP-N-acetylglucosamine metabolic process (GO:0006047),0.5926439359020912,1.3359639268202483,0.15773353751914243,0.8349038042561027,1.0,2/13,3.68%,GFPT2;NAGK
prerank,negative regulation of leukocyte cell-cell adhesion (GO:1903038),0.5647296425929513,1.3353163020909644,0.14788732394366197,0.835767631117403,1.0,5/18,9.64%,PTPN22;FGL1;TNFAIP8L2;LAX1;IL4I1
prerank,regulation of lymphocyte differentiation (GO:0045619),0.5540959363387754,1.335041699909373,0.1458625525946704,0.8349552689471615,1.0,6/18,15.54%,CCR2;METTL3;IL4I1;ZFP36L2;XRCC6;ABL1
prerank,negative regulation of Ras protein signal transduction (GO:0046580),0.5066825994189068,1.3348796101611933,0.12927756653992395,0.8336313106714084,1.0,9/35,15.00%,ARHGAP24;DLC1;EPHB2;SYNGAP1;MAPKAP1;CUL3;MYOC;ARHGAP44;MET
prerank,morphogenesis of an epithelial sheet (GO:0002011),0.6441078632394058,1.334280926087009,0.17084639498432602,0.8343497115850338,1.0,3/10,11.41%,BMP5;SOX11;BMP7
prerank,neuron maturation (GO:0042551),0.5726621898455189,1.3342113408133045,0.15549215406562053,0.8326015039616985,1.0,4/18,12.08%,LGI4;ADGRB3;FARP2;ANKS1A
prerank,actin filament bundle organization (GO:0061572),-0.3814750867550109,-1.3339515204106251,0.06372549019607843,0.6934852022313331,1.0,12/33,20.87%,PAWR;CALD1;BAIAP2L1;NEDD9;EPS8;FAM107A;LIMA1;SHROOM2;AIF1L;ADD2;LCP1;RFLNA
prerank,vesicle transport along actin filament (GO:0030050),-0.44128605127156184,-1.3321877486954212,0.13074204946996468,0.6949294096317977,1.0,10/19,27.08%,MYO1D;WASL;FNBP1L;MYO1E;MYO5B;MYO1C;ACTN4;MYO5C;MYO1F;MYO15A
prerank,regulation of small GTPase mediated signal transduction (GO:0051056),0.4322800679232051,1.3319321065527197,0.04275286757038582,0.8410157233874318,1.0,29/140,13.66%,RELN;ARHGAP24;DLC1;ARHGAP32;ARHGAP19;A2M;RHOJ;RHOD;DEPDC1B;AKAP13;FGD4;CHN1;ITSN1;FOXM1;ARHGAP9;RABL3;ARHGEF11;VAV3;ARHGAP11A;RHOT2;MYO9B;MYO9A;ARHGAP21;OPHN1;RHOH;RHOC;TRIO;ARHGAP4;ARHGEF3
prerank,cellular response to UV-A (GO:0071492),0.6194279468414609,1.3316428563887184,0.167427701674277,0.8402368398163168,1.0,2/11,8.91%,MMP2;PPID
prerank,endoderm development (GO:0007492),0.5975030479207748,1.3315651410368445,0.15572519083969466,0.8384991428874439,1.0,2/13,2.38%,DUSP4;LAMC1
prerank,positive regulation of glycogen metabolic process (GO:0070875),-0.5034433338782467,-1.331520153201048,0.14018691588785046,0.6929736033711233,1.0,4/13,5.85%,SORBS1;IGF1;IGF2;INSR
prerank,regulation of actin filament-based movement (GO:1903115),0.635483833217797,1.3298744519652197,0.16455696202531644,0.8440922518776907,1.0,4/10,12.05%,ANK2;PDE4B;SCN5A;PDE4D
prerank,positive regulation of dendrite extension (GO:1903861),0.5735810733493576,1.329818055756805,0.14184397163120568,0.8422064191697108,1.0,9/17,23.56%,RNF157;SYT1;RIMS1;NEDD4L;PLAA;SYT2;RIMS2;CPNE5;SYT3
prerank,regulation of pH (GO:0006885),-0.5234274813836506,-1.3287749206271404,0.14285714285714285,0.6980455784304787,1.0,7/11,27.81%,CLCN3;SLC9A7;ATP6V0A4;ATP6AP1;PDK2;LACC1;PDK4
prerank,positive regulation of stem cell differentiation (GO:2000738),0.5791789378105514,1.328578590053457,0.14427157001414428,0.8460077836251011,1.0,3/16,8.89%,SOX6;SOX9;SOX5
prerank,defense response to tumor cell (GO:0002357),0.6348929445018626,1.328085196560836,0.15048543689320387,0.8462753526291258,1.0,2/10,1.48%,DLEC1;RBMS3
prerank,regulation of cAMP-mediated signaling (GO:0043949),0.5334552469773546,1.327360250760896,0.1334214002642008,0.8476360717239925,1.0,8/24,16.89%,FFAR4;RNF157;PRKAR1B;PDE3B;PDE4D;GNAI1;CGAS;APLNR
prerank,cation transmembrane transport (GO:0098655),-0.3667229364875894,-1.3268043955086433,0.07894736842105263,0.7005487599363536,1.0,16/44,24.09%,TRPM3;SLC7A2;ATP1A2;SLC7A5;ABCC9;SLC38A5;SLC25A20;SLC36A4;SFXN3;SLC6A5;SLC25A19;ATP1B1;TRPM2;KCNJ8;SLC25A29;ATP13A2
prerank,positive regulation of granulocyte chemotaxis (GO:0071624),-0.43276319324375556,-1.3266939653177283,0.09271523178807947,0.6967587854128471,1.0,8/19,26.77%,MOSPD2;DAPK2;CAMK1D;NCKAP1L;TIRAP;DNM1L;RIPOR2;CCL19
prerank,positive regulation of cellular component biogenesis (GO:0044089),0.4409564426287909,1.3264402762811678,0.08924731182795699,0.8498620362893873,1.0,23/88,18.76%,LGALS3;CLDN19;PRKCA;HRK;VEGFA;TGFB1;SDC4;BMF;LIMK1;BRK1;PIH1D1;SLF2;BMP7;RHOC;SUMO1;PDCD6IP;MTLN;SPIDR;BCL2L11;HYAL1;RAB7A;FNIP1;PARK7
prerank,negative regulation of gluconeogenesis (GO:0045721),-0.522832264237302,-1.3260202952321736,0.14583333333333334,0.6948120745332483,1.0,4/11,17.18%,CLK2;SIK1;C1QTNF3;PGP
prerank,zinc ion transmembrane transport (GO:0071577),-0.41396348772162095,-1.3258266547193034,0.125,0.6913015491422612,1.0,10/22,26.20%,SLC30A10;SLC39A8;SLC39A6;SLC30A1;SLC30A6;SLC39A3;SLC39A10;TRPM2;SLC39A13;SLC39A1
prerank,bone morphogenesis (GO:0060349),0.5914007531533727,1.3257386369434554,0.16361071932299012,0.8510856420712306,1.0,1/14,0.11%,OSR2
prerank,cellular response to arsenic-containing substance (GO:0071243),-0.4810394711710646,-1.3241545417779,0.12658227848101267,0.6930940160025365,1.0,7/15,29.38%,MKNK2;HNRNPA1;PPIF;ZFAND1;VCP;GSTO2;ATF3
prerank,regulation of cellular ketone metabolic process (GO:0010565),-0.32800699960318286,-1.3240688190714938,0.04195804195804196,0.6894090530833598,1.0,19/61,17.47%,PRKAG2;PSMD14;AZIN1;OAZ1;PSMB3;PSMD12;PANK2;OAZ2;PSMD6;PSMA1;ODC1;PSMD7;PSMA5;PSMC5;FGFR4;CAV1;PSMC4;PDK2;PSMB6
prerank,muscle contraction (GO:0006936),-0.30386438692088147,-1.3236799595550022,0.03333333333333333,0.6866802560173747,1.0,24/126,15.74%,CALD1;MYOF;SORBS1;ROCK2;TMOD3;TPM3;ROCK1;ITGB5;SNTA1;MYL6;TPM1;MYLK;ACTN2;MYL12B;MYL12A;GJC1;MYH11;ITGA1;LMOD1;ACTA2;TPM2;TMOD1;NOS1;DES
prerank,cell morphogenesis involved in neuron differentiation (GO:0048667),0.4489001794651985,1.321848923173048,0.09830508474576272,0.8673843200355907,1.0,18/75,12.69%,ANK3;DOCK7;LRP4;MAP1B;NRCAM;SDC2;CTNNA2;BAIAP2;NTNG2;NTNG1;S100A6;UNK;DCC;OPHN1;PLPPR4;DVL1;RAB3A;DRD2
prerank,embryo development ending in birth or egg hatching (GO:0009792),0.5890260893204036,1.321593086629669,0.14468085106382977,0.8664175030442678,1.0,3/15,8.59%,OSR2;FGFR1;BRCA1
prerank,regulation of integrin activation (GO:0033623),-0.4700558354487713,-1.3215292296644994,0.1464968152866242,0.6898725840062078,1.0,3/15,6.06%,RAP1B;JAM3;RASIP1
prerank,nerve growth factor signaling pathway (GO:0038180),0.6325206716316095,1.3212272232130078,0.1661392405063291,0.8660255275987402,1.0,3/10,11.52%,NGF;RAP1A;MAGI2
prerank,positive regulation of cell junction assembly (GO:1901890),0.465562818763619,1.3210077423037112,0.11214953271028037,0.8649062951221365,1.0,17/56,16.54%,CLDN19;CLSTN2;IL1RAPL1;MAP4K4;VEGFA;EPHB2;NRXN1;GRID2;NLGN1;TSC1;CNTNAP2;PTPRJ;MYOC;SYNDIG1;CLSTN1;ABL1;IL1RAP
prerank,positive regulation of G1/S transition of mitotic cell cycle (GO:1900087),0.5266668969631555,1.3207020837249415,0.140625,0.8643504274558971,1.0,11/26,19.14%,FGF10;EGFR;UBE2E2;PLCB1;ADAMTS1;EIF4G1;CCND2;HYAL1;RPTOR;KMT2E;RDX
prerank,positive regulation of antigen receptor-mediated signaling pathway (GO:0050857),-0.42625699502579284,-1.319249653396984,0.127208480565371,0.6936098605009198,1.0,6/21,17.77%,FOXP1;PRKCH;PRKCB;PTPRC;IKBKG;SLC39A10
prerank,organic anion transport (GO:0015711),-0.32068866949010266,-1.3191508163975867,0.056074766355140186,0.6900429510218364,1.0,20/76,13.58%,SLCO3A1;ABCC4;ABCG2;SLC26A7;SLCO2A1;SLCO1C1;SLC4A10;SLC22A6;SLC35B4;SLC4A3;SLC39A8;SLC16A2;CYB5R4;ABCC6;CA4;SLC4A8;LRRC8C;SLC2A10;LRRC8A;MGST1
prerank,glycosaminoglycan biosynthetic process (GO:0006024),0.43412127969236236,1.3187687768651435,0.08423326133909287,0.8714034167281322,1.0,20/95,12.81%,DCN;GPC3;HSPG2;VCAN;HAS2;LUM;ST3GAL4;HS6ST1;SDC2;EXT1;SDC4;BCAN;CSGALNACT1;CHSY1;SLC10A7;NCAN;GLCE;GPC1;SDC3;GPC4
prerank,regulation of feeding behavior (GO:0060259),0.6279169966990187,1.3186223310086753,0.15912636505460218,0.8700309649773671,1.0,3/11,19.76%,SGIP1;CFAP20;STAT3
prerank,positive regulation of macrophage differentiation (GO:0045651),0.6187377508266974,1.3181918134067776,0.17425431711145997,0.8698780264806204,1.0,3/11,4.08%,PRKCA;FADD;TGFB1
prerank,regulation of calcium ion transmembrane transport (GO:1903169),0.5429118773057334,1.3180235161360025,0.1566757493188011,0.8685182207349291,1.0,5/23,8.06%,UBASH3B;CACNA2D1;ANK2;PRNP;FYN
prerank,renal filtration (GO:0097205),0.6248737575246763,1.3180074940279192,0.1634920634920635,0.8664998271313432,1.0,2/10,1.88%,SULF1;CD34
prerank,axon development (GO:0061564),0.4466570274499591,1.3178309034387,0.10669693530079455,0.8652335622288978,1.0,23/78,18.89%,ANK3;DOCK7;MAP1B;NRCAM;EPHB2;PLP1;CTNNA2;BAIAP2;NTNG2;NTNG1;S100A6;DCC;PLPPR4;CDK5R1;RAB3A;DRD2;RTN4;MTR;PAX2;NREP;RTN4RL1;KLF7;CNTN4
prerank,regulation of establishment of endothelial barrier (GO:1903140),-0.4564109258804406,-1.3169319430808193,0.12709030100334448,0.6934374380010955,1.0,4/17,1.86%,ROCK2;CDH5;ROCK1;CLDN5
prerank,alpha-amino acid metabolic process (GO:1901605),0.47701881373987043,1.3166278954348904,0.13017031630170317,0.8686602614547798,1.0,18/45,22.11%,AADAT;DPEP1;CBS;NAALAD2;GOT2;MTRR;ASNS;OAT;SRR;GPT2;KYAT3;GLS2;GLS;ASPA;RIMKLB;GLUD1;NAT8L;DDAH1
prerank,gastrulation (GO:0007369),0.5784015193503744,1.3155727541104716,0.14348462664714495,0.8716387863070375,1.0,1/15,0.27%,GPC3
prerank,phagolysosome assembly (GO:0001845),0.5999610499354053,1.3155595292439681,0.16095380029806258,0.8696091790646153,1.0,5/12,18.12%,RAB14;RAB34;RAB39A;RAB7A;RAB7B
prerank,positive regulation of neutrophil migration (GO:1902624),-0.43852627189018933,-1.3152341773084681,0.10921501706484642,0.6951230289319879,1.0,8/18,26.77%,MOSPD2;DAPK2;CAMK1D;NCKAP1L;TIRAP;DNM1L;RIPOR2;CCL19
prerank,camera-type eye development (GO:0043010),0.5273317544524814,1.3148341489465014,0.15446071904127828,0.8708339869049242,1.0,5/25,7.15%,EFEMP1;TENM3;VEGFA;NF1;CYP1B1
prerank,regulation of cellular component biogenesis (GO:0044087),-0.3642907767422556,-1.3138853973360722,0.06280193236714976,0.6956532733746222,1.0,8/39,7.77%,TJP1;SNCAIP;ROCK2;RAP1B;ROCK1;TIE1;PARP10;IRGM
prerank,ear morphogenesis (GO:0042471),0.5541754283548448,1.3134773692414183,0.14421768707482993,0.8752877266982739,1.0,2/20,3.35%,OSR2;EPHB2
prerank,vascular endothelial growth factor signaling pathway (GO:0038084),-0.48246915019821324,-1.3132760051025194,0.1504424778761062,0.6937634041353389,1.0,7/14,16.08%,NRP1;VEGFC;VEGFD;KDR;MYO1C;NUS1;FLT4
prerank,ameboidal-type cell migration (GO:0001667),0.46070920186212794,1.3131951239135962,0.12066905615292713,0.874476059331705,1.0,16/51,18.86%,GPC3;SOX8;SEMA3E;SEMA6C;SEMA3A;PKN1;ERBB4;GDNF;ANXA6;PDXDC1;SEMA6D;ITGB7;SEMA4B;CENPV;PKN2;SEMA4D
prerank,histone H4-K16 acetylation (GO:0043984),0.5512626907799808,1.3128467086695108,0.17110799438990182,0.8740218906630309,1.0,11/19,23.67%,JADE1;KMT2A;JADE3;KAT8;PHF20;ING4;KANSL1;MSL3;MCRS1;KANSL2;KAT7
prerank,positive regulation of cell adhesion (GO:0045785),0.44462217961630845,1.3120966895061374,0.10497237569060773,0.875693654733154,1.0,19/74,18.36%,VIT;PRKCA;EPB41L4B;RHOD;ERBB2;FBLN2;VEGFA;PPP3CA;MAGI1;ARL2;PTPRJ;P2RY12;CITED2;ATM;HYAL1;RELL2;RAC3;MDK;MEGF10
prerank,regulation of MHC class II biosynthetic process (GO:0045346),0.6106928284147841,1.311108657987811,0.1687116564417178,0.8783136202428646,1.0,3/11,14.80%,TMEM106A;HDAC2;TAF7
prerank,regulation of neuroinflammatory response (GO:0150077),-0.4412600673004777,-1.3107331491039436,0.11145510835913312,0.6981258784706262,1.0,6/19,17.29%,IGF1;CD200;PTGS2;NUPR1;SPHK1;DAGLA
prerank,hydrogen peroxide catabolic process (GO:0042744),0.6086467235737186,1.3106662116867724,0.1774960380348653,0.8783362177618805,1.0,4/11,18.05%,PXDN;GPX3;PRDX3;CAT
prerank,glycoprotein catabolic process (GO:0006516),0.5685424399518321,1.310186482848498,0.15607734806629833,0.8785169311346768,1.0,4/17,11.73%,ADAMTS12;FBXO27;EDEM2;FBXO17
prerank,positive regulation of positive chemotaxis (GO:0050927),0.5743688537439762,1.3094196432297687,0.15555555555555556,0.8800633475407429,1.0,3/15,3.14%,IL16;NTRK3;VEGFA
prerank,muscle tissue development (GO:0060537),0.5939766286159442,1.3093600581927896,0.1716867469879518,0.878288639829062,1.0,4/13,8.63%,PTCH1;CSRP1;NF1;SMO
prerank,negative regulation of response to stimulus (GO:0048585),0.4542796610521924,1.3090720548332522,0.12528735632183907,0.8776175222637441,1.0,13/60,9.97%,UBASH3B;ERBB3;CD34;ACVR1;MAP3K3;MAPK7;SOCS5;HHIP;CDK6;COL3A1;AKT3;PTPN1;MCTP1
prerank,central nervous system myelination (GO:0022010),0.6153665529158181,1.3090565293394505,0.1848341232227488,0.8756439880261043,1.0,2/11,4.28%,PTEN;PLP1
prerank,"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184)",-0.29585595963462435,-1.3088724796663767,0.031746031746031744,0.7007090145256681,1.0,52/110,26.80%,RPS14;GSPT1;RPL24;RPL18A;UPF3B;RPS16;RPL38;RPL28;RPS19;RPL37;CTIF;RPS2;RPL19;RPL5;RPL34;RPS25;RPS15;EIF4A3;RPLP1;RPL31;RPL3;HELZ2;RPS6;RPS8;RPL11;RPL12;PNRC2;SMG9;RPL7A;RPL13;RPS21;RPL35A;RPL26;RPS9;RPL32;RPS29;RPS23;RPLP2;RPL8;SMG5;RPL41;SMG8;RPS17;RPS5;RPS15A;UBA52;RPL37A;PPP2CA;RPS10;EIF3E;RPL6;RPL9
prerank,negative regulation of cellular carbohydrate metabolic process (GO:0010677),-0.40544673375669893,-1.3082646259950792,0.12121212121212122,0.6989433411503024,1.0,8/23,18.17%,CLK2;SIK1;NUPR1;GSK3A;C1QTNF3;HDAC4;PGP;GIT1
prerank,regulation of interleukin-2 production (GO:0032663),0.48645044354259476,1.3079164912644081,0.13959085439229843,0.8790147382416191,1.0,11/43,16.01%,GLMN;CD34;PDE4B;PRNP;CCR2;SPTBN1;PDE4D;MALT1;HOMER2;RUNX1;NAV3
prerank,cellular response to organic cyclic compound (GO:0071407),0.4206794702275985,1.3078911749650137,0.05219206680584551,0.8771228784438108,1.0,42/141,21.50%,RORA;P2RY2;SSTR1;HRH1;EGFR;TGFB1;AOC1;URI1;RORC;CASP6;CYP1B1;RAP1A;IL18;BRCA1;AKAP6;ESR1;ARL6IP5;NRIP1;GNAI1;HSP90B1;AHR;P2RY12;P2RY1;SSH1;LCOR;JUP;BLM;GABRG2;SPIDR;NCOA3;CASP7;FAM210B;TAF1;EGR1;RYR3;RUVBL2;HCN1;UBE2L3;ADCY8;TIPARP;PKD2;P2RX7
prerank,negative regulation of histone modification (GO:0031057),0.5868131444962986,1.3076314595963925,0.1695906432748538,0.8762849479657765,1.0,6/14,17.62%,AASS;BRCA1;JARID2;SNCA;TAF7;CTBP1
prerank,negative regulation of glucose transmembrane transport (GO:0010829),-0.5269972652290679,-1.3075696526716278,0.18873239436619718,0.697214787086341,1.0,5/10,12.98%,APPL2;GRB10;PRKCB;GSK3A;ENPP1
prerank,positive regulation of synapse assembly (GO:0051965),0.5154259725867785,1.3075536859452825,0.13154362416107382,0.874581123554831,1.0,10/27,18.86%,CLSTN2;IL1RAPL1;EPHB2;NRXN1;GRID2;NLGN1;SYNDIG1;CLSTN1;IL1RAP;SEMA4D
prerank,negative regulation of transport (GO:0051051),0.46829579987993564,1.3074046348557087,0.12009237875288684,0.8732813585928152,1.0,14/51,18.12%,LGALS3;ERBB3;PTEN;PRKN;CRYAB;SYT11;MCTP1;PXK;ARL6IP5;NDFIP1;SNCA;SNX12;DYSF;RAB7A
prerank,regulation of release of sequestered calcium ion into cytosol (GO:0051279),0.46928682582711434,1.3068909110830138,0.1188235294117647,0.873677110973571,1.0,11/48,16.89%,UBASH3B;CXCL10;ANK2;JPH3;AKAP6;PDE4D;PRKACA;SNCA;CALM1;CALM2;APLNR
prerank,cellular response to vascular endothelial growth factor stimulus (GO:0035924),-0.3849864207498257,-1.3063867654714707,0.12935323383084577,0.6972623526047425,1.0,13/34,17.75%,FLT1;NRP1;VEGFC;VEGFD;GAS1;MAP2K3;KDR;ERN1;NUS1;FLT4;ANXA1;SPHK1;HSPB1
prerank,regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307),0.5570826857615054,1.3063398184767492,0.1661764705882353,0.8741812334749014,1.0,3/17,5.51%,CACNA2D1;ANK2;SCN5A
prerank,positive regulation of lymphocyte proliferation (GO:0050671),0.4492238149422359,1.3061668250773182,0.13172966781214204,0.8729814011583887,1.0,9/63,11.09%,FGF10;BCL2;IRS2;BST1;EPHB2;CD320;IL18;VAV3;IL6ST
prerank,positive regulation of neutrophil chemotaxis (GO:0090023),-0.4470356252750202,-1.3060135574973173,0.11258278145695365,0.694948833347436,1.0,8/17,26.77%,MOSPD2;DAPK2;CAMK1D;NCKAP1L;TIRAP;DNM1L;RIPOR2;CCL19
prerank,regulation of proteolysis (GO:0030162),0.4604999445586902,1.305988277203127,0.1362530413625304,0.8718681831637782,1.0,11/48,13.90%,TBC1D10A;FADD;PARL;CSTB;SPOP;GSAP;SERPINE2;AURKAIP1;HDAC2;HDAC6;NEDD8
prerank,negative regulation of cell development (GO:0010721),0.526597483115055,1.3044502579172297,0.15579227696404793,0.877111197731362,1.0,4/25,4.93%,CCL11;PTHLH;FBXW7;PCM1
prerank,heparan sulfate proteoglycan biosynthetic process (GO:0015012),0.5422993844010442,1.3037781806295734,0.15857142857142856,0.8782602529951956,1.0,7/19,16.74%,HS6ST1;EXT1;EXTL3;CSGALNACT1;GLCE;HS2ST1;UGDH
prerank,neural tube development (GO:0021915),0.5506186042264269,1.303720381223367,0.1752873563218391,0.8766175972702127,1.0,6/15,15.38%,PTCH1;TGFB1;SOX11;DVL1;PKD1;DACT1
prerank,positive regulation of neuron migration (GO:2001224),0.6064440780929697,1.3034661461442647,0.17345399698340874,0.8758388049189361,1.0,5/11,19.93%,KIF20B;SEMA3A;PLAA;MDK;SHTN1
prerank,regulation of cardiac muscle cell membrane repolarization (GO:0099623),0.5380388820044198,1.3034244481638688,0.15512465373961218,0.8740549827727677,1.0,7/21,19.83%,CACNA2D1;ANK2;SCN5A;FLNA;KCNH2;KCNA5;NOS1AP
prerank,regulation of fatty acid metabolic process (GO:0019217),-0.4564627592927616,-1.3031657738003828,0.1310344827586207,0.7007212634899417,1.0,5/17,10.65%,PRKAG2;PPARD;PANK2;PRKAA2;ADIPOR2
prerank,negative regulation of peptidyl-threonine phosphorylation (GO:0010801),0.5566525755486433,1.3027845852367106,0.1622002820874471,0.8752438654826386,1.0,7/17,15.54%,CADM4;SPRED2;SPRED1;SPRED3;EIF4G1;CALM1;CALM2
prerank,neuron apoptotic process (GO:0051402),0.5435431733694842,1.3025916059602787,0.16809116809116809,0.8741797250084147,1.0,7/19,13.69%,ERBB3;BCL2;SCN2A;BNIP3;NAE1;NGFR;TRPC5
prerank,peptidyl-tyrosine modification (GO:0018212),0.45742385895131327,1.3021999474715595,0.11819235225955968,0.8740962593024054,1.0,10/56,8.06%,RELN;EFEMP1;PDGFRA;PKDCC;ERBB2;EGFR;EPHB2;TEC;FGFR1;FYN
prerank,myeloid leukocyte differentiation (GO:0002573),-0.3177771792766976,-1.3019820752340292,0.0625,0.7009495471041685,1.0,16/65,14.49%,FOXP1;LEF1;KIT;MYH9;IL31RA;BMP4;GLO1;PARP1;TNFRSF11A;SBNO2;CASP8;CAMK4;OSTM1;CDC42;PML;CDK2
prerank,membrane repolarization (GO:0086009),-0.4720090057076928,-1.3019677635302571,0.1423841059602649,0.6973071561665549,1.0,4/15,6.72%,ATP1A2;ATP1B3;KCNJ2;ATP1A1
prerank,positive regulation of ion transport (GO:0043270),0.462628723695968,1.301468593421207,0.12186379928315412,0.8753974818942861,1.0,12/48,15.13%,ANK3;ANK2;ANO6;WNK3;CCL4;CNKSR3;SCN5A;GDNF;DRD2;ATP2B1;AHCYL1;PKP2
prerank,synaptic vesicle transport along microtubule (GO:0099517),-0.4885479101954999,-1.2998512334572996,0.14545454545454545,0.6967844859634134,1.0,4/15,12.83%,DTNBP1;BLOC1S5;SNAPIN;AP3D1
prerank,anterograde synaptic vesicle transport (GO:0048490),-0.4885479101954999,-1.2998512334572996,0.14545454545454545,0.6967844859634134,1.0,4/15,12.83%,DTNBP1;BLOC1S5;SNAPIN;AP3D1
prerank,negative regulation of wound healing (GO:0061045),0.5071446109075861,1.2986220071474641,0.16688396349413298,0.8865503439575639,1.0,8/28,11.17%,CLDN19;FGF2;PTEN;CD34;SLC12A2;SERPINE2;CLASP1;AJAP1
prerank,regulation of macrophage differentiation (GO:0045649),0.5715662007621654,1.2986069460074567,0.17450682852807284,0.884661641387043,1.0,3/15,2.79%,PRKCA;FADD;PTPN2
prerank,negative regulation of DNA binding (GO:0043392),-0.38882022529530413,-1.2984475421248756,0.09954751131221719,0.697575748655055,1.0,11/28,18.78%,SP100;LEF1;NFKBIA;KDM1A;HABP4;MDFI;SUMO3;HMGA2;HEY2;TFAP4;SIN3A
prerank,substantia nigra development (GO:0021762),0.4826088337604259,1.2984366059731098,0.14160401002506265,0.8834368308011225,1.0,9/37,17.10%,DYNLL1;SYNGR3;NDRG2;PLP1;MAPKAP1;TTBK1;CALM1;CALM2;CNP
prerank,regulation of cholesterol storage (GO:0010885),-0.4680506232507501,-1.297893964762961,0.15824915824915825,0.6957739530329456,1.0,7/15,20.81%,ABCA1;PPARD;ABCG1;NR1H2;TTC39B;NR1H3;LPL
prerank,fat-soluble vitamin metabolic process (GO:0006775),-0.4221353546576672,-1.297645641669319,0.1423076923076923,0.6929357497010922,1.0,4/22,11.87%,ALDH1A2;RBP1;CUBN;LGMN
prerank,response to peptide (GO:1901652),0.490315100166918,1.2975999230143918,0.15031055900621118,0.8853685543189146,1.0,12/33,23.67%,MMP2;CACNA1A;PRNP;EIF2B5;FYN;ERBIN;GNAI1;EIF2B2;STAT3;STAT5A;STAT6;KAT7
prerank,regulation of sequestering of calcium ion (GO:0051282),0.6081551014559254,1.2974917207503924,0.1933028919330289,0.8838924759489957,1.0,4/12,14.76%,UBASH3B;ANK2;ANXA6;MTLN
prerank,positive regulation of potassium ion transmembrane transport (GO:1901381),0.47222846333143265,1.2971705092399797,0.1394517282479142,0.8834516746058858,1.0,12/44,17.39%,WNK2;ANK2;ANO6;WNK3;KCNMB2;KCNMB3;FLNA;AKAP6;KCNJ3;KCNJ10;KCNH2;KCNMA1
prerank,positive regulation of protein-containing complex assembly (GO:0031334),0.42456335726620803,1.2954447597029413,0.10193133047210301,0.8894429224873885,1.0,32/113,17.08%,LGALS3;USP50;HRK;VEGFA;GTF2H2;TGFB1;ERCC5;ERCC4;DDB2;RPA3;BMF;BRK1;XPA;PIH1D1;EIF4G1;SLF2;ESR1;RHOC;DDB1;TTBK1;RPA2;SNCA;SUMO1;DHX33;MTLN;MED25;ATM;TP53;SPIDR;BCL2L11;FSCN1;CUL4B
prerank,cellular response to hormone stimulus (GO:0032870),-0.32389670865339015,-1.2947740934999648,0.041666666666666664,0.6984885142881183,1.0,20/69,19.29%,THRB;ATP1A2;CTSH;TFPI;SLIT2;RAMP1;LMO2;STAT5B;ZFP36L1;ATP1A1;SLC5A5;PELP1;SERPINB9;ADRA2A;SRA1;CTSS;CAV1;ARID5A;GPER1;RARA
prerank,positive regulation of pathway-restricted SMAD protein phosphorylation (GO:0010862),-0.3537014995710335,-1.294588490001713,0.07647058823529412,0.6954960195187904,1.0,8/45,4.03%,BMP6;DAB2;RBPMS;ACVRL1;BMP4;ENG;BMPR2;TGFBR1
prerank,steroid hormone mediated signaling pathway (GO:0043401),-0.46730273260908445,-1.2942396326074186,0.1624203821656051,0.6931234004798014,1.0,6/13,18.87%,PLPP1;BMP4;CALCOCO1;NR3C2;ABHD2;GPER1
prerank,striated muscle cell development (GO:0055002),-0.47029829330245243,-1.293880276966776,0.16883116883116883,0.6908975514293115,1.0,5/14,19.73%,TMOD3;PGM5;LMOD1;TMOD1;SDC1
prerank,negative regulation of smooth muscle cell proliferation (GO:0048662),0.4894283710080328,1.293654942235927,0.1483375959079284,0.8955536736872451,1.0,2/33,1.66%,APOD;PTEN
prerank,regulation of postsynapse organization (GO:0099175),0.5091364141125957,1.2933767522935296,0.14966887417218544,0.8949280349538047,1.0,10/28,15.49%,SIPA1L1;IL1RAPL1;TANC2;WNT5A;CDKL5;PPFIA2;CDK5R1;LZTS3;ARHGAP44;HOMER1
prerank,positive regulation of response to cytokine stimulus (GO:0060760),0.5854521995032871,1.2932477323613525,0.1797583081570997,0.8935965028326186,1.0,6/13,18.99%,TRIM44;WNT5A;AGPAT2;TAF9;CD74;AXL
prerank,negative regulation of cell-cell adhesion mediated by cadherin (GO:2000048),-0.5176469726885256,-1.2931699534904972,0.15709969788519637,0.6896446427391695,1.0,5/10,16.19%,BMP6;RGCC;NOTCH4;NEXMIF;PPM1F
prerank,Golgi to plasma membrane transport (GO:0006893),0.4609501747324029,1.292340360335889,0.13317479191438764,0.8959299462879314,1.0,9/47,7.69%,STXBP6;ANK3;STEAP2;VAMP4;ARL3;BLZF1;OSBPL5;SPTBN1;RAB34
prerank,aorta morphogenesis (GO:0035909),-0.4362240153878803,-1.2922995594687818,0.12714776632302405,0.6892229195868175,1.0,9/17,15.31%,ACVRL1;ENG;MYLK;TBX1;EFEMP2;JAG1;PDGFRB;PROX1;HEY2
prerank,cilium-dependent cell motility (GO:0060285),0.5341087595705561,1.2918714076966173,0.16486486486486487,0.8960989458027595,1.0,7/22,17.71%,EFHC1;DNAH2;CCDC39;RFX3;CCDC65;DNAAF2;RSPH9
prerank,positive regulation of calcium ion transport (GO:0051928),0.4828567423683455,1.2913703192601333,0.14705882352941177,0.8965283480121825,1.0,4/36,4.10%,LGALS3;ANK2;WNK3;CCL4
prerank,vesicle organization (GO:0016050),0.4625803237391582,1.2912647488500444,0.14578313253012049,0.8950985503305253,1.0,12/46,12.88%,USP50;DNM1;CD34;ALS2;LAPTM4B;EPS15;VPS11;PI4K2A;PHETA2;RAB22A;SNX10;AKTIP
prerank,phasic smooth muscle contraction (GO:0014821),0.6189262596713139,1.291201057721744,0.1769352290679305,0.8934461079003826,1.0,4/10,12.69%,PTGER3;GDNF;EDN3;DRD2
prerank,presynaptic endocytosis (GO:0140238),0.5151697470548742,1.2911213797463836,0.15426251691474965,0.8919045525722469,1.0,9/24,18.63%,CEL;STON2;SYT1;NLGN1;STON1;OPHN1;SNCA;SYT2;SNCB
prerank,autonomic nervous system development (GO:0048483),0.5502588374789148,1.2907607965751515,0.18181818181818182,0.8915480933785259,1.0,7/17,13.20%,SOX8;SEMA3A;SOX11;NF1;PHOX2A;GDNF;GATA3
prerank,positive regulation of ubiquitin protein ligase activity (GO:1904668),0.6065234850645289,1.2903702904768979,0.17551622418879056,0.8914618327374332,1.0,3/12,12.00%,PTEN;GORASP1;RAB1A
prerank,regulation of interleukin-1 production (GO:0032652),-0.47500799758588197,-1.2898942240042253,0.16363636363636364,0.6934346548278899,1.0,4/15,16.23%,FOXP1;TLR4;CEACAM1;ANXA1
prerank,brain development (GO:0007420),0.41173200438241075,1.2898009403960506,0.07411273486430063,0.892227667058809,1.0,24/136,15.55%,APOD;RELN;SOX6;PTCH1;HSPG2;PTEN;GRIN2B;EML1;CTNNA2;NF1;TGFBR2;PHGDH;PAFAH1B3;CNTNAP2;PTPN11;ADGRL3;CDK5R1;PHF8;GRIN2D;ZFHX2;GRIN2A;NES;SCYL2;MEIS3
prerank,fatty-acyl-CoA biosynthetic process (GO:0046949),0.49691982528683465,1.2897767347621758,0.1514762516046213,0.8904446205115295,1.0,8/29,9.43%,GCDH;ACACA;SCD5;ELOVL6;ACLY;FASN;PPT2;ELOVL5
prerank,negative regulation of protein polymerization (GO:0032272),-0.39274495724547703,-1.2896535426556142,0.1,0.6907581671866659,1.0,8/27,5.30%,CDH5;MAP2;PRKCD;SLIT2;CLIP3;CYRIB;KANK3;EML2
prerank,cellular response to decreased oxygen levels (GO:0036294),0.4482344176321821,1.2896013331608107,0.12041284403669725,0.889322179370333,1.0,18/65,15.90%,RORA;MYC;SUV39H1;FMN2;SCN2A;VEGFA;MT3;TSC1;KCND2;GATA6;BNIP3;TBL2;HIF1A;BMP7;CPEB1;MDM4;LMNA;TP53
prerank,negative regulation of response to external stimulus (GO:0032102),0.4235170723408453,1.2893950770715872,0.10239651416122005,0.8883868792940246,1.0,17/105,13.20%,RORA;FFAR4;CLDN19;FGF2;PTEN;PTPN2;MAPK7;IRAK3;TNFAIP8L2;CTNNA2;GRID2;OTULIN;PPM1B;SELENOS;AJAP1;DRD2;GATA3
prerank,DNA methylation (GO:0006306),0.5209574869885388,1.2889749125733672,0.19669876203576342,0.8884983976486431,1.0,8/23,19.52%,GATAD2A;ATF7IP;ATRX;MTRR;TEX15;HELLS;KMT2E;N6AMT1
prerank,positive regulation of response to biotic stimulus (GO:0002833),-0.3649900043830916,-1.2881341751285789,0.09223300970873786,0.6924465434501627,1.0,9/38,14.04%,BMP6;SASH1;ANKRD17;DDX60;PLSCR1;RIOK3;CYBA;USP15;NMI
prerank,peptidyl-lysine dimethylation (GO:0018027),0.5415437941279739,1.2880963563660017,0.18945868945868946,0.8905785185031565,1.0,6/18,9.87%,SUV39H1;KMT2A;SETD3;SETMAR;PRDM9;SETD2
prerank,membrane protein proteolysis (GO:0033619),0.4860511540837479,1.2880417482562327,0.1626733921815889,0.8889460394230373,1.0,11/37,14.33%,ADAM19;PRKCQ;BACE2;HM13;PARL;TGFB1;PSEN1;NGFR;NCSTN;APH1A;PSEN2
prerank,regulation of cytoplasmic translation (GO:2000765),0.5733817987248833,1.2875896125026869,0.17365269461077845,0.8892202601466568,1.0,7/14,26.29%,UNK;CPEB3;CPEB1;CNBP;YBX3;FMR1;CPEB4
prerank,transcription preinitiation complex assembly (GO:0070897),0.5826369284710384,1.2874890702413464,0.15868263473053892,0.8877738976024491,1.0,7/12,28.18%,GTF2B;TAF11;TAF7;TAF1;TBP;DR1;BDP1
prerank,cellular response to metal ion (GO:0071248),0.4178328884330612,1.2866024886070069,0.07908428720083246,0.8899453331136825,1.0,44/123,23.56%,ANK3;CPNE8;DPEP1;PRKN;EGFR;KCNA1;HPCA;NCF1;PRNP;MT3;SLC12A2;DLG2;SCN5A;WNT5A;AOC1;SYT1;NLGN1;BNIP3;MAPK9;SYT11;SYT12;MAPK1;ALOX5AP;SNCA;SUMO1;IQGAP1;GPLD1;SLC25A24;CHUK;CPNE7;SYT2;RYR3;CPNE1;JUN;SYT13;ADCY8;CPNE3;PKD2;CACNA1H;PRKAA1;DLG4;CAMK2D;CPNE5;SYT3
prerank,regulation of cardiac muscle cell proliferation (GO:0060043),0.5293688548340437,1.286422923515487,0.19467787114845939,0.8889416603443457,1.0,7/19,15.48%,FGF2;VGLL4;GLI1;ERBB4;ZFPM2;BMPR1A;RUNX1
prerank,protein K11-linked ubiquitination (GO:0070979),0.504619420485836,1.28633464816293,0.17086092715231788,0.8874666543612179,1.0,14/27,25.08%,UBE2T;PRKN;UBE2E2;ANAPC7;ANAPC2;CDC23;RNF4;UBE2L3;CDC27;ANAPC4;UBE2D3;ANAPC5;CDC16;ANAPC13
prerank,regulation of dopamine secretion (GO:0014059),0.514204050232348,1.286000875737572,0.1581769436997319,0.8871036979724013,1.0,9/25,13.88%,KCNA2;PRKN;CHRNA4;SYT1;SYT11;SYT12;GDNF;DRD2;SNCA
prerank,membrane protein ectodomain proteolysis (GO:0006509),0.5343165452889974,1.2858625162424522,0.19148936170212766,0.8858413081261458,1.0,8/21,14.33%,ADAM19;PRKCQ;BACE2;HM13;PSEN1;NCSTN;APH1A;PSEN2
prerank,protein polyglutamylation (GO:0018095),0.5996987024561868,1.285646091549391,0.18553459119496854,0.8849485915322935,1.0,5/11,14.55%,TTLL5;TTLL11;TTLL4;CFAP20;TPGS1
prerank,regulation of melanin biosynthetic process (GO:0048021),-0.5165584488056614,-1.285031739380603,0.18498659517426275,0.6989023667870632,1.0,7/10,30.56%,ATP7A;GIPC1;APPL1;OPN3;CDH3;MFSD12;RAPGEF2
prerank,negative regulation of leukocyte migration (GO:0002686),0.6077249811439968,1.2837596097263175,0.18153364632237873,0.8914830517890905,1.0,2/10,2.97%,BMP5;HOXA7
prerank,positive regulation of muscle cell differentiation (GO:0051149),-0.40218627274048085,-1.2836610890355915,0.12955465587044535,0.6998871023394371,1.0,8/24,13.33%,CDH2;BOC;CTNNB1;CDON;BNIP2;CAMK1;MAPK12;CDC42
prerank,myelin assembly (GO:0032288),0.6131195319065902,1.282768052872419,0.19334389857369255,0.8941458536695867,1.0,5/10,20.24%,EPB41L3;PMP22;GPC1;CD9;NCMAP
prerank,negative regulation of metabolic process (GO:0009892),-0.33304582069911726,-1.282694783403463,0.07344632768361582,0.6996590987521135,1.0,21/54,21.17%,ALDH1A1;PLCL1;ID1;NPR3;TLR4;IP6K1;PLCL2;ZNF423;LGR4;FLCN;ZDHHC7;CCDC3;NR1H2;NOVA2;PGAM5;RHEB;NRDC;PCTP;NR1H3;ATF4;FOXC2
prerank,mononuclear cell differentiation (GO:1903131),-0.401989598317966,-1.2816925677306719,0.14007782101167315,0.6994867446521535,1.0,5/24,4.34%,MYH9;IL31RA;BMP4;LYN;RELB
prerank,hexose metabolic process (GO:0019318),0.4734702310703501,1.2813908831622023,0.14919852034525277,0.8984533589576172,1.0,6/39,13.35%,APOD;IRS2;PGM1;GALM;FUCA2;BRAT1
prerank,regulation of myotube differentiation (GO:0010830),-0.398933250908722,-1.2813074072315676,0.13765182186234817,0.697432711398253,1.0,9/24,23.02%,SIK1;MAML1;HDAC4;ATP11A;TMEM119;HDAC3;DMPK;HDAC5;SMYD1
prerank,positive regulation of mRNA metabolic process (GO:1903313),-0.4601873919692439,-1.2812087725129226,0.16666666666666666,0.6943869330021869,1.0,4/13,7.84%,ZC3HAV1;MOV10;CNOT1;GTPBP1
prerank,negative regulation of intracellular steroid hormone receptor signaling pathway (GO:0033144),-0.390290166494503,-1.2807439930833868,0.1206896551724138,0.6925188211269102,1.0,4/26,3.06%,DAB2;FOXP1;KANK2;CLOCK
prerank,positive regulation of kinase activity (GO:0033674),0.42548637882493306,1.2805557261969858,0.08485499462943072,0.900280609253082,1.0,17/107,7.80%,ROR2;RELN;ROR1;PDGFRA;ERBB3;NTRK3;EPHB6;ERBB2;EGFR;EPHB2;NTRK2;TRAF4;MRNIP;ALS2;VAC14;RAP1A;FGFR1
prerank,regulation of receptor-mediated endocytosis (GO:0048259),0.4718820732001589,1.280073694878874,0.17754569190600522,0.900625872176724,1.0,6/35,10.64%,SGIP1;BICD1;MKLN1;RAB21;HIP1;CBL
prerank,T-helper cell differentiation (GO:0042093),-0.47034194111431626,-1.2778268810303173,0.18685121107266436,0.6984412035825055,1.0,3/14,5.12%,FOXP1;LEF1;ATP7A
prerank,endosome organization (GO:0007032),0.47108134395727885,1.2773467469709223,0.16523867809057527,0.9111572196014436,1.0,10/41,12.88%,USP50;DNM1;ALS2;LAPTM4B;VPS11;PI4K2A;PHETA2;RAB22A;SNX10;AKTIP
prerank,transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0007178),-0.28346576642028865,-1.2771383829662701,0.018867924528301886,0.697344192312326,1.0,33/128,14.79%,BMP6;PTPRK;GCNT2;SMAD6;CDH5;CLDN5;ITGB5;APPL2;ACVRL1;SMAD7;BMP4;ENG;ID1;USP9X;SMAD9;BMPR2;TGFBR1;PARD3;DDX5;ACVR1B;TWSG1;STUB1;PRKCZ;RHOA;NLK;LRRC32;MAP3K7;TGFB2;INHBA;USP15;TMEM100;GDF1;HPGD
prerank,regulation of cell communication by electrical coupling (GO:0010649),0.5796895207042421,1.2770951347087909,0.2,0.9104544636976752,1.0,4/13,15.54%,ANK3;PDE4D;CALM1;CALM2
prerank,ganglioside biosynthetic process (GO:0001574),-0.4505038529765596,-1.2768549312070059,0.1526479750778816,0.6950831748481667,1.0,3/15,5.04%,ST6GALNAC3;ST8SIA4;ST3GAL1
prerank,regulation of protein neddylation (GO:2000434),-0.5132482948234575,-1.275902072633421,0.17183098591549295,0.6946532739041149,1.0,4/10,13.12%,DCUN1D3;RPL5;DCUN1D1;RPL11
prerank,negative regulation of blood vessel morphogenesis (GO:2000181),0.4384334664499912,1.2752440822412792,0.136568848758465,0.9171350371260093,1.0,10/75,7.08%,DCN;HSPG2;SULF1;CXCL10;SEMA3E;COL4A2;CCR2;PDE3B;ADAMTS1;SPRED1
prerank,response to laminar fluid shear stress (GO:0034616),-0.5279415487662276,-1.2752413095405333,0.19714285714285715,0.6936302174137805,1.0,6/10,8.82%,SMAD6;ABCA1;SMAD7;MAP2K5;KLF2;KLF4
prerank,negative regulation of extracellular matrix organization (GO:1903054),0.6010259400662624,1.274348589411482,0.20625,0.9192142446302999,1.0,2/10,4.08%,FAP;TGFB1
prerank,"nucleotide-excision repair, DNA incision, 3'-to lesion (GO:0006295)",0.5228203092511037,1.2730249504682398,0.20027816411682892,0.9215384283655033,1.0,9/21,17.08%,GTF2H2;ERCC5;ERCC4;DDB2;RPA3;XPA;DDB1;RPA2;CUL4B
prerank,"nucleotide-excision repair, preincision complex stabilization (GO:0006293)",0.5228203092511037,1.2730249504682398,0.20027816411682892,0.9215384283655033,1.0,9/21,17.08%,GTF2H2;ERCC5;ERCC4;DDB2;RPA3;XPA;DDB1;RPA2;CUL4B
prerank,cell morphogenesis involved in differentiation (GO:0000904),0.4371111512080552,1.2729382803207583,0.12542372881355932,0.9200246409057814,1.0,12/70,11.42%,RELN;NTN4;PEAK1;LAMC1;RILPL2;METTL3;MEGF9;NTNG2;NTNG1;UNK;PIK3R1;OPHN1
prerank,positive regulation of telomere maintenance (GO:0032206),0.4791536526136005,1.2725084055578155,0.17661388550548113,0.920254243991657,1.0,14/31,26.14%,PRKCQ;ATRX;MAPK1;SIRT6;NEK7;MAP3K4;RTEL1;ATM;RAD50;GNL3;PKIB;SLX4;HNRNPA2B1;NABP2
prerank,interstrand cross-link repair (GO:0036297),0.45513944599590556,1.2723685477056605,0.14911242603550295,0.9189612496077466,1.0,13/53,16.45%,UBE2T;POLN;ERCC4;RPA3;XPA;FANCC;MSH6;ERCC6L2;XRCC3;RPA2;UBB;FANCI;USP1
prerank,embryonic digit morphogenesis (GO:0042733),0.5348416067115804,1.2720519334083182,0.2,0.9186327849026877,1.0,2/18,1.94%,OSR2;WDPCP
prerank,regulation of dendrite morphogenesis (GO:0048814),0.48087413728911255,1.2720154701921738,0.16055625790139064,0.9169548136523322,1.0,8/32,8.91%,GORASP1;IL1RAPL1;SDC2;TNIK;OBSL1;CDKL5;CDKL3;ADGRB3
prerank,receptor recycling (GO:0001881),-0.5082290570754824,-1.2717755808252091,0.1945945945945946,0.7008047465790225,1.0,7/10,22.21%,RAB11B;EHD3;NSG1;ARFGEF2;PHETA1;PLEKHJ1;REP15
prerank,response to tumor necrosis factor (GO:0034612),0.4254753846661722,1.2716908685223078,0.12378902045209902,0.916542714392561,1.0,17/91,17.26%,AFF3;CCL11;ADAMTS12;HAS2;PYCARD;CCL4;BRCA1;ERBIN;ZFP36L2;NFE2L2;PID1;GATA3;ZFAND6;CCL14;HYAL1;RIPK1;CHUK
prerank,regulation of axon regeneration (GO:0048679),-0.49582252888969225,-1.271248612696349,0.16120218579234974,0.699242607341424,1.0,3/12,7.20%,EPHA4;PTN;SCARF1
prerank,transmembrane receptor protein tyrosine kinase signaling pathway (GO:0007169),0.39577676518461585,1.2710781288942523,0.022022022022022022,0.9175182223065258,1.0,87/390,15.29%,ROR2;SIPA1L1;SHC4;ROR1;MMP2;UBASH3B;SULF1;PDGFRA;DNM1;ERBB3;NTRK3;EFNA4;FGF2;FGF10;ARPC1B;IRS2;EPHB6;NGF;ERBB2;EGFR;PTPRT;PTPN2;EFNA5;VEGFA;EPHB2;RAB14;EIF2AK3;COL4A2;ARHGEF28;MAPKAPK3;PSEN1;ATP6V1B2;NCF1;NTRK2;SDC2;MAPKAPK2;PLCB1;GRIN2B;PAK1;RASA1;POLR2B;CHN1;BAIAP2;SPRED2;ITSN1;SPRED1;FGFR1;ANKS1B;FYN;BRK1;CEP57;VAV3;GRB14;SHOC2;POLR2K;DOCK1;SHCBP1;NCF2;NCBP1;ERBB4;PIK3R1;PTPRJ;NGFR;NCSTN;CBL;MAPK14;PTPN11;STYK1;MAPK1;EFNB1;CDK5R1;FGF7;NRP2;ANKS1A;APH1A;EFNB3;PRLR;POLR2G;NCK1;EPHA10;PSEN2;COL1A1;GALNT3;CYFIP1;MET;ELMO1;GFRA2
prerank,regulation of dendrite development (GO:0050773),0.4822512152643954,1.2704332639276077,0.1707920792079208,0.9186959663198487,1.0,11/37,14.73%,BMP5;CSMD3;SDC2;TNIK;CDKL5;ADGRB3;DCC;BMP7;COBL;NEDD4L;RTN4IP1
prerank,negative regulation of ion transport (GO:0043271),0.5184895298105674,1.2703802375595703,0.17218543046357615,0.9171638998819135,1.0,6/24,13.88%,WNK2;WNK3;GPM6B;SYT11;PXK;SNCA
prerank,negative regulation of neuron apoptotic process (GO:0043524),0.43423475776823806,1.269797937205409,0.14057142857142857,0.9180095520111374,1.0,18/69,18.76%,ERBB3;BCL2;CRLF1;NGF;PRKN;NTRK2;MT3;RASA1;HIF1A;SNX6;GDNF;GRN;SOD2;PTPRZ1;FZD9;TGFB3;MDK;PARK7
prerank,"base-excision repair, AP site formation (GO:0006285)",0.5460717978541395,1.2697112775411799,0.19574468085106383,0.9165691864673469,1.0,7/17,16.41%,MBD4;ERCC5;MPG;MUTYH;NEIL1;SMUG1;TERF2IP
prerank,pentose-phosphate shunt (GO:0006098),0.5935672957026028,1.2693234754034377,0.1953125,0.9166042325856565,1.0,8/11,25.67%,H6PD;RPE;SHPK;PGLS;TALDO1;RBKS;RPIA;PGM2
prerank,positive regulation of endocytosis (GO:0045807),0.46194137125165724,1.2691405395290232,0.15712545676004872,0.9156339321002978,1.0,11/45,14.26%,GPC3;SGIP1;BICD1;LRP1;ANO6;NLGN1;RAB21;HIP1;CBL;SNCA;NEDD4L
prerank,mesoderm formation (GO:0001707),-0.44587192953846067,-1.2684087556985306,0.1701388888888889,0.7052699290128049,1.0,4/17,14.56%,ITGA3;BMPR2;KDM6B;HMGA2
prerank,magnesium ion transport (GO:0015693),0.5724018405301702,1.2683210112663725,0.2073732718894009,0.9175819528201791,1.0,5/12,13.78%,MRS2;NIPA1;NIPAL2;MAGT1;TUSC3
prerank,chromatin remodeling (GO:0006338),0.4198291935150971,1.2679342733852215,0.12192513368983957,0.9174837048106176,1.0,36/100,22.05%,MYC;KAT2B;SOX9;SATB1;KDM5B;BAZ1A;EZH1;PAK1;KDM4B;MTA2;CHD3;ATRX;MBD2;PIH1D1;POLE3;HDAC2;MYSM1;ESR1;SMARCC2;JARID2;ZBTB1;RBBP4;SMARCC1;BAZ2B;KDM6A;BAZ1B;SMARCE1;PBRM1;NUDT5;RUVBL2;TOP1;SMARCA4;HNRNPC;GATAD2B;NPM3;ACTR5
prerank,positive regulation of phospholipase C activity (GO:0010863),0.4661242952627808,1.26767246281891,0.16113161131611317,0.9168018213821355,1.0,8/40,10.72%,PDGFRA;NTRK3;FGF2;EGFR;LPAR1;NTRK2;FGFR1;ESR1
prerank,negative regulation of immune system process (GO:0002683),0.5520421791299175,1.267643827843959,0.20054945054945056,0.915132857732169,1.0,4/16,9.11%,SOX9;FADD;HOXA7;COL3A1
prerank,phosphatidylglycerol acyl-chain remodeling (GO:0036148),-0.435063175615537,-1.2675426392768503,0.16611295681063123,0.7049652272795984,1.0,2/17,5.69%,PLA2G4A;CRLS1
prerank,heterochromatin assembly (GO:0031507),0.5174841043388676,1.2673572891268057,0.1934156378600823,0.9146395638138154,1.0,6/20,11.01%,SUV39H1;EZH1;ZNFX1;MBD2;POLE3;HELLS
prerank,regulation of ERBB signaling pathway (GO:1901184),0.5470671011167855,1.267085550529342,0.17276720351390923,0.9140218975913382,1.0,5/15,12.86%,ERBB2;MVB12B;EGFR;PTPN18;MVB12A
prerank,heart development (GO:0007507),0.4088317383224443,1.267084866444871,0.08212058212058213,0.9122401784927195,1.0,33/150,15.27%,GPC3;DLC1;BMP5;ERBB3;NTRK3;GLI2;PTEN;KAT2B;SOX9;AKAP13;ACVR1;SGCD;VEGFA;TGFB1;NF1;SGCZ;FGF12;TGFBR2;PDLIM4;COL3A1;ERBB4;PTPN11;DAND5;SMYD4;BMP7;ZFPM2;KDM6A;SCUBE1;LDB3;PKD1;CITED2;PKP2;NDUFV2
prerank,negative regulation of receptor signaling pathway via STAT (GO:1904893),0.591831166787752,1.2667097320108343,0.20958083832335328,0.9122323344931702,1.0,3/11,8.27%,PTPRT;SOCS1;NF2
prerank,chondroitin sulfate metabolic process (GO:0030204),0.4959077290393283,1.2657198006312234,0.18417639429312582,0.9148463620037031,1.0,11/30,18.14%,DCN;VCAN;BCAN;CSGALNACT1;CHSY1;NCAN;IDS;HYAL1;UGDH;CSPG4;CHSY3
prerank,positive regulation of interleukin-17 production (GO:0032740),0.5149493225338686,1.2656100659884717,0.18672199170124482,0.9135578505638282,1.0,4/22,7.90%,PRKCQ;TGFB1;CARD9;IL18
prerank,positive regulation of cell killing (GO:0031343),0.5706825453368911,1.2653074675517535,0.20909090909090908,0.913153601755322,1.0,3/13,7.26%,NOX1;WNT5A;FZD7
prerank,neurotransmitter transport (GO:0006836),0.4298914746866415,1.264532943109593,0.13882618510158012,0.9149010794163187,1.0,17/73,17.00%,SLC6A2;SLC22A3;SLC1A3;NRXN1;SYT1;SLC29A1;SYN1;PPFIA2;RIMS1;TSPOAP1;DVL1;RAB3A;APBA1;CHAT;GLS2;GLS;SLC6A15
prerank,neuron fate commitment (GO:0048663),-0.4552399127336627,-1.264207746606293,0.1762917933130699,0.7123862682373637,1.0,10/14,45.96%,TGFBR1;ID2;POU3F2;DLL4;DLL1;SHH;POU4F1;PAX6;ASCL1;ISL1
prerank,positive regulation of leukocyte cell-cell adhesion (GO:1903039),0.4939742041638276,1.264000226700035,0.16245006657789615,0.915500005055892,1.0,4/27,5.23%,HAS2;PRKCQ;PYCARD;CCR2
prerank,pharyngeal system development (GO:0060037),0.5565234652984493,1.263618812744163,0.19549929676511954,0.915411740178219,1.0,5/15,14.61%,PTCH1;BMP5;BMP7;GATA3;BMPR1A
prerank,positive regulation of ossification (GO:0045778),0.4704048085052664,1.2625238761376731,0.1642156862745098,0.9185638361306031,1.0,16/39,16.21%,OSR2;PKDCC;ACVR1;ANO6;TGFB1;GPM6B;SOX11;WNT5A;ZBTB16;PTPN11;BMP7;ATRAID;ATP2B1;BMPR1A;FZD9;TGFB3
prerank,embryonic skeletal system morphogenesis (GO:0048704),0.49709920720605066,1.2622302292023482,0.16731517509727625,0.9180965519496458,1.0,5/31,6.38%,OSR2;PDGFRA;SOX11;HOXD3;TGFBR2
prerank,positive regulation of interferon-beta production (GO:0032728),-0.3556289776408656,-1.2621926939109491,0.15458937198067632,0.7158537813987229,1.0,11/33,19.60%,TOMM70;TLR4;IFIH1;TRIM56;RIOK3;IRF1;OAS2;HSP90AA1;FLOT1;POLR3D;ISG15
prerank,modulation of excitatory postsynaptic potential (GO:0098815),0.5059179412273346,1.261375959793121,0.1869281045751634,0.9202866077344889,1.0,6/26,10.95%,RELN;PTEN;NRXN1;NLGN1;SLC8A2;RIMS1
prerank,skeletal system morphogenesis (GO:0048705),0.46573569368079615,1.2611344571674195,0.16105769230769232,0.9196704678448315,1.0,7/42,10.31%,OSR2;PDGFRA;SOX11;HHIP;HOXD3;FGFR1;SFRP4
prerank,cellular response to catecholamine stimulus (GO:0071870),0.5071813161055256,1.2609816552227437,0.1899070385126162,0.9185382504631122,1.0,7/23,17.45%,PRKN;PDE4B;MAPK1;PRKACA;SNCA;ABL1;SLC9A1
prerank,granulocyte differentiation (GO:0030851),-0.42293648655537647,-1.2601563415977648,0.1864406779661017,0.719240334414254,1.0,8/18,23.59%,LEF1;LBR;PML;CDK2;CDK4;TAL1;RARA;E2F1
prerank,"nucleotide-excision repair, preincision complex assembly (GO:0006294)",0.4909003916004365,1.2600447368316268,0.18850267379679145,0.9208929600734755,1.0,10/29,17.08%,RAD23B;GTF2H2;ERCC5;DDB2;RPA3;XPA;DDB1;RPA2;UBB;CUL4B
prerank,epithelial cell morphogenesis (GO:0003382),0.5354875859815883,1.2595505766570958,0.19708029197080293,0.9214036619506621,1.0,3/17,8.42%,COL15A1;RILPL2;COL18A1
prerank,regulation of macrophage cytokine production (GO:0010935),0.5540538552966687,1.259465072324883,0.2205056179775281,0.9200479304902652,1.0,6/13,17.14%,IRAK3;GPRC5B;TGFB1;WNT5A;TGFB3;CD74
prerank,carbohydrate derivative transport (GO:1901264),0.5369495381092958,1.2594438336457088,0.2039381153305204,0.9184090561024393,1.0,3/18,9.65%,SLC28A1;SLC29A1;SLC10A7
prerank,regulation of ossification (GO:0030278),0.4754515309600501,1.2588106034622377,0.16729559748427672,0.9195133925316337,1.0,9/36,10.85%,ANKH;LRP4;SOX9;ACVR1;SOX11;WNT5A;ZBTB16;CHSY1;PTPN11
prerank,negative regulation of endoplasmic reticulum unfolded protein response (GO:1900102),0.5677585846700456,1.2583517671755515,0.2072072072072072,0.9199374175717476,1.0,5/13,13.99%,DNAJB9;PPP1R15A;UFL1;PTPN1;NCK1
prerank,negative regulation of protein autophosphorylation (GO:0031953),-0.5150080901390104,-1.258180529364976,0.21348314606741572,0.7226214697381216,1.0,4/10,16.32%,ERRFI1;ENG;ENPP1;CAV1
prerank,negative regulation of secretion (GO:0051048),0.608772568470584,1.258157644927771,0.2168284789644013,0.9191062389935545,1.0,2/10,3.40%,ERBB3;PTGER3
prerank,acetyl-CoA metabolic process (GO:0006084),0.5545725563009125,1.2577286218832437,0.21286370597243492,0.9193718978964842,1.0,6/15,17.51%,ACACA;ACSS1;ACLY;DIP2A;PPCS;HMGCS2
prerank,serine family amino acid catabolic process (GO:0009071),0.6129019982410169,1.257644362350769,0.20251177394034536,0.9180225523655934,1.0,2/10,5.58%,CBS;DAO
prerank,regulation of peptidyl-serine phosphorylation (GO:0033135),0.4161504771646749,1.2573859165605872,0.14285714285714285,0.917389036213277,1.0,27/93,21.49%,DOCK7;NTRK3;PTEN;NGF;EGFR;VEGFA;ARAF;TGFB1;CNKSR3;PAK1;MLXIPL;EIF4G1;HDAC6;PDE4D;TBK1;SNCA;NCK1;SH2D3C;RASSF2;TERF2IP;RPTOR;FNIP1;PARK7;INPP5J;BCAR3;NSD1;PRKD2
prerank,anion transport (GO:0006820),0.4833891812334831,1.2569188722253988,0.17496807151979565,0.9177266375934056,1.0,5/33,5.60%,SLC22A3;VDAC2;SLC17A5;LRRC8D;SLCO2B1
prerank,regulation of kinase activity (GO:0043549),0.4208990097692615,1.2554687428357911,0.12899669239250275,0.9225310798356763,1.0,16/89,10.17%,ROR2;ROR1;PDGFRA;ERBB3;NTRK3;IRS2;EPHB6;ERBB2;EGFR;NPRL2;EPHB2;NTRK2;VAC14;FGFR1;LDB2;ERBB4
prerank,phospholipid transport (GO:0015914),-0.32177520446708663,-1.2553561686243992,0.09554140127388536,0.7284978185465163,1.0,22/52,20.42%,OSBPL8;ATP10A;ABCA3;ABCA1;PLTP;PITPNA;ATP9A;ABCA4;OSBPL2;ABCG1;TNFAIP8L3;ATP11A;ATP8B2;ATP11B;MFSD2A;ABCB4;PRELID2;ATP10B;ATP8A1;APOE;ABCA7;PCTP
prerank,cellular response to misfolded protein (GO:0071218),-0.40564929396845373,-1.2548429546162063,0.16605166051660517,0.7271045981393552,1.0,13/20,30.74%,POMT2;RNF185;DNAJB12;STUB1;UBE2W;AUP1;UFD1;KLHL15;UGGT1;RNF5;RNF126;VCP;BAG6
prerank,regulation of axonogenesis (GO:0050770),0.4450601374878873,1.2548242507151215,0.1590909090909091,0.9238122570607756,1.0,10/51,6.05%,SIPA1L1;CHODL;LRP4;PTEN;NGF;PLXNC1;NTRK2;LRRC4C;PAK1;CHN1
prerank,digestive tract morphogenesis (GO:0048546),0.5582571421076983,1.254579413281991,0.21637426900584794,0.9231583756785934,1.0,3/14,4.96%,PDGFRA;SOX11;GLI1
prerank,positive regulation of mesenchymal cell proliferation (GO:0002053),0.598525103035453,1.2543982280327142,0.2048,0.9222298816080556,1.0,3/10,6.38%,MYC;SOX9;TGFBR2
prerank,regulation of B cell proliferation (GO:0030888),0.45305347137030394,1.25348394039359,0.17132442284325639,0.9247229936253912,1.0,10/44,17.21%,BCL2;IRS2;BST1;EPHB2;CD320;VAV3;AHR;ATM;CD74;RC3H1
prerank,regulation of interleukin-17 production (GO:0032660),0.4796566300596784,1.2530939220394002,0.18980891719745224,0.9247423840957599,1.0,5/31,7.90%,PRKCQ;TGFB1;PRNP;CARD9;IL18
prerank,dicarboxylic acid metabolic process (GO:0043648),0.4526265221204665,1.2529624774474124,0.15165876777251186,0.9236436905697947,1.0,11/52,15.44%,AADAT;IDH2;DLST;ALDH1L1;GOT2;ACLY;MTRR;MTHFD2L;ALDH5A1;GPT2;ALDH1L2
prerank,isotype switching (GO:0045190),0.5984618375929001,1.2527567053993043,0.2323076923076923,0.9228719365934942,1.0,6/10,27.56%,MSH6;BATF;HSPD1;EXOSC3;LIG4;RNF168
prerank,regulation of response to biotic stimulus (GO:0002831),-0.38730772882168896,-1.252429912436309,0.13765182186234817,0.7314154493485153,1.0,9/28,9.67%,FOXP1;ERAP1;APPL2;BIRC3;TRIM5;CD55;SAMHD1;CASP8;IRF1
prerank,positive regulation of transcription by RNA polymerase I (GO:0045943),0.5069336000947992,1.2514205489281864,0.20107962213225372,0.9270314899604364,1.0,12/22,25.66%,DDX11;ERBB2;EIF2AK3;HEATR1;PIH1D1;PHF8;DHX33;UBTF;SMARCA4;WDR75;MTOR;SMARCB1
prerank,selective autophagy (GO:0061912),0.43743451460468386,1.2513127270077158,0.17142857142857143,0.925763175915463,1.0,20/56,22.86%,DYNLL1;PRKN;WDFY3;ACBD5;UFL1;ATG5;DYNC1I1;HDAC6;DYNC1I2;UBB;ATM;NBR1;RAB7A;PARK7;PHB2;PCNT;WDR81;VIM;UBQLN1;DYNC1H1
prerank,negative regulation of reactive oxygen species metabolic process (GO:2000378),0.5100840885578395,1.2513037805089995,0.2096551724137931,0.9241007342592642,1.0,9/21,18.76%,PRKN;MT3;BRCA1;HDAC6;ABCD2;PAX2;TRAP1;AATF;PARK7
prerank,spermatid development (GO:0007286),0.48485565715273377,1.2507521602337397,0.19483870967741934,0.9248255387024945,1.0,7/32,14.94%,RSPH1;RFX2;CEP57;CDYL;DDX25;NECTIN2;DPY19L2
prerank,synaptic vesicle endocytosis (GO:0048488),0.47195240066377814,1.2501276224336952,0.1896774193548387,0.9258922743879832,1.0,10/33,13.88%,DNM1;CEL;STON2;SYT1;NLGN1;STON1;ITSN1;GAK;OPHN1;SNCA
prerank,microtubule anchoring at microtubule organizing center (GO:0072393),0.5699702679251362,1.2500372971264184,0.23030303030303031,0.9246615780830536,1.0,8/12,24.43%,BICD1;PCM1;BICD2;CCDC120;KIF3A;NIN;HOOK3;BBS4
prerank,regulation of osteoblast differentiation (GO:0045667),-0.2944993897076258,-1.2499918138729385,0.1,0.7359225720985841,1.0,17/82,8.91%,BMP6;RANBP3L;CRIM1;SMOC1;IGF1;WNT4;SMAD6;LRP5;TMEM64;BMP4;NOCT;BMPR2;SUCO;ZHX3;DDX5;FGFR2;CCN1
prerank,positive regulation of pattern recognition receptor signaling pathway (GO:0062208),-0.4640908696340138,-1.249945348058143,0.2090032154340836,0.7328254683203055,1.0,3/14,13.38%,ANKRD17;DDX60;USP15
prerank,establishment of endothelial intestinal barrier (GO:0090557),-0.4954079435463558,-1.2490085999476792,0.1897018970189702,0.7327139396846899,1.0,2/11,0.18%,AFDN;TJP1
prerank,muscle cell development (GO:0055001),-0.3737282359276494,-1.248766458890575,0.1592920353982301,0.7304517612839907,1.0,6/30,3.87%,NEBL;MYOF;IGF1;CXADR;ENG;KDM1A
prerank,cell-cell junction assembly (GO:0007043),0.43314789841414175,1.2484064627087486,0.15945330296127563,0.930331546388487,1.0,17/63,16.62%,DCHS1;CDH19;PRKCA;CDH10;CDH22;CDH8;PATJ;EPB41L3;CDH20;CDH7;RHOC;FBF1;CD9;PKP2;JUP;CDH18;FSCN1
prerank,positive regulation of immune effector process (GO:0002699),-0.39241930311654694,-1.2482593634971677,0.12749003984063745,0.7289567471137849,1.0,4/27,4.51%,ANKRD17;APPL2;DDX60;RPS19
prerank,positive regulation of mitotic cell cycle phase transition (GO:1901992),0.4366093932173917,1.2479362212566634,0.16917728852838934,0.9306551487534138,1.0,22/56,23.62%,FGF10;EGFR;UBE2E2;PLCB1;ADAMTS1;CUL3;ANAPC7;EIF4G1;CDC25B;CDC23;CCND2;HYAL1;FBXO5;RPTOR;KMT2E;RDX;CDC27;PHB2;ANAPC4;ANAPC5;RB1;CDC16
prerank,microvillus organization (GO:0032528),0.5688919191244504,1.2477245120704108,0.22827687776141384,0.9299321444940104,1.0,4/13,7.42%,RAP2B;MAP4K4;TNIK;RAP1A
prerank,negative regulation of cold-induced thermogenesis (GO:0120163),-0.32499737575367327,-1.2473988975408417,0.11398963730569948,0.7285626136029432,1.0,19/46,21.17%,ALDH1A1;PLCL1;ID1;NPR3;TLR4;IP6K1;PLCL2;ZNF423;LGR4;FLCN;NR1H2;NOVA2;PGAM5;RHEB;NRDC;PCTP;NR1H3;ATF4;FOXC2
prerank,regulation of endopeptidase activity (GO:0052548),-0.3076417960498172,-1.2473407783257893,0.11188811188811189,0.7256011540398126,1.0,18/59,24.09%,VTN;BIRC3;TIMP3;SERPIND1;SPOCK2;SERPINB9;APH1B;SERPINE1;TIMP2;SERPINI1;NRDC;PSENEN;TIMP4;AKT1;AGT;SERPINC1;PSMB9;ATP13A2
prerank,MAPK cascade (GO:0000165),0.38630231279928057,1.247262233784289,0.05120481927710843,0.9303946717421169,1.0,53/295,11.99%,GFRA1;PDGFRA;ERBB3;PRKCQ;IL2RA;FGF13;FGF2;MYC;FGF10;IRS2;SOX9;ERBB2;EGFR;GFRA4;MAP4K4;MAP3K3;ARAF;TGFB1;MT3;MAPKAPK2;GRIN2B;NF1;DUSP6;TNIK;DLG2;SPTBN1;PAK1;SYNGAP1;RASA1;KSR1;SPRED1;MEN1;FGFR1;RGL1;IL18;LYPLA1;FYN;LAMTOR2;SHOC2;PSMB7;BTC;CUL3;ARL2;ZFP36L2;MRAS;ERBB4;PIK3R1;GDNF;MAPK1;TAOK3;CCM2;PTPRA;FGF7
prerank,cortical actin cytoskeleton organization (GO:0030866),-0.4185852345831955,-1.2470127500623174,0.16233766233766234,0.723521304601328,1.0,8/20,20.81%,ROCK2;ROCK1;FHOD1;RHOQ;NCKAP1L;IKBKB;LLGL2;LCP1
prerank,toxin transport (GO:1901998),0.6021500198432767,1.246802836939586,0.20270270270270271,0.9307633645233337,1.0,4/10,19.51%,SLC22A3;ANTXR2;ANTXR1;RAB40B
prerank,protein K48-linked deubiquitination (GO:0071108),0.5064853701570372,1.2467169522126815,0.19973890339425587,0.929441714456469,1.0,8/23,19.07%,USP50;OTUD7B;USP33;USP25;OTUD4;USP37;OTUD7A;USP5
prerank,regulation of sprouting angiogenesis (GO:1903670),0.4704341957906459,1.2467119599382281,0.19397116644823068,0.9277955838749833,1.0,5/33,5.21%,RHOJ;CREB3L1;FGF2;VEGFA;E2F2
prerank,positive regulation of fibroblast proliferation (GO:0048146),0.488257339921928,1.24637701509163,0.20350404312668463,0.9276394048682578,1.0,5/27,7.57%,PDGFRA;MYC;WNT5A;S100A6;CDK6
prerank,monocarboxylic acid transport (GO:0015718),-0.3221702747067761,-1.2461605397020672,0.1032258064516129,0.7232258849563358,1.0,10/51,5.23%,SLCO3A1;ABCC4;ABCG2;SLC16A12;SLC16A6;SLC6A12;SLCO2A1;SLCO1C1;SLC6A13;SLC16A11
prerank,tetrahydrobiopterin metabolic process (GO:0046146),-0.48417862661014544,-1.2459533303194887,0.1977401129943503,0.7209577957349579,1.0,5/11,22.44%,NOS3;HSP90AA1;SPR;QDPR;AKT1
prerank,gas transport (GO:0015669),0.5925438128707915,1.245851461015826,0.23950233281493002,0.9282607409172936,1.0,2/10,14.42%,MYC;MB
prerank,regulation of extracellular matrix disassembly (GO:0010715),0.5439741945342867,1.2447401374829905,0.2153179190751445,0.9313720191593898,1.0,4/15,10.67%,FAP;LRP1;TGFB1;CLASP1
prerank,cell-substrate junction assembly (GO:0007044),0.4723960756641663,1.2445268004806407,0.19776119402985073,0.9306115960946029,1.0,7/33,9.12%,DLC1;RHOD;PEAK1;LAMC1;TESK2;PLEC;TRIP6
prerank,cognition (GO:0050890),0.4574423437605393,1.2442738243059113,0.18932038834951456,0.930078852396668,1.0,14/42,14.94%,ST3GAL4;CHRNA4;NF1;RP9;GPR155;SLC8A2;NSUN5;MGAT3;GRM5;MAGT1;CBR3;SETD5;TUSC3;CYFIP1
prerank,negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902176),0.5207099481342381,1.244245375126948,0.2105997210599721,0.9285365626952413,1.0,8/18,18.76%,PRKN;MAPK7;BAG5;HIF1A;NFE2L2;SOD2;TRAP1;PARK7
prerank,detection of mechanical stimulus involved in sensory perception (GO:0050974),0.5471569773428071,1.2440974724695846,0.20916905444126074,0.9275610363815486,1.0,3/15,3.61%,PIEZO2;LHFPL5;KCNA1
prerank,mitotic DNA integrity checkpoint signaling (GO:0044774),0.5725297017762158,1.243907996563785,0.2287878787878788,0.9267888266656403,1.0,5/12,14.08%,SETMAR;NAE1;STK33;ORC1;TOPBP1
prerank,regulation of blood coagulation (GO:0030193),0.4867726026991321,1.2436479296108789,0.19973368841544606,0.9263177584354872,1.0,5/27,8.22%,FAP;ST3GAL4;CD34;EPHB2;SERPINE2
prerank,histone H4-K5 acetylation (GO:0043981),0.5535226777351127,1.243485234696269,0.21842496285289748,0.9238190223244569,1.0,9/15,23.67%,JADE1;JADE3;KAT8;PHF20;ING4;KANSL1;MCRS1;KANSL2;KAT7
prerank,histone H4-K8 acetylation (GO:0043982),0.5535226777351127,1.243485234696269,0.21842496285289748,0.9238190223244569,1.0,9/15,23.67%,JADE1;JADE3;KAT8;PHF20;ING4;KANSL1;MCRS1;KANSL2;KAT7
prerank,regulation of leukocyte adhesion to vascular endothelial cell (GO:1904994),-0.4778967773708322,-1.2428869235701325,0.1921921921921922,0.7275246130001988,1.0,3/13,9.34%,ETS1;NFAT5;RHOA
prerank,regulation of retinoic acid receptor signaling pathway (GO:0048385),-0.4934862246974189,-1.242671376555953,0.2005813953488372,0.7252249509338877,1.0,7/12,23.42%,CYP26B1;KLF2;SNW1;CNOT1;TRIM16;CTBP2;CALR
prerank,regulation of myoblast differentiation (GO:0045661),0.46107923311191834,1.2425854633582463,0.19770408163265307,0.9261781764525849,1.0,6/32,4.92%,SOSTDC1;SOX8;SOX9;XKR8;TGFB1;PLCB1
prerank,histone H3-K4 methylation (GO:0051568),0.4898326389909064,1.2424761064186747,0.21208053691275167,0.9250765166282845,1.0,11/26,20.48%,KMT2A;CXXC1;SETMAR;MEN1;PRDM9;KDM6A;TET3;WDR5B;ASH2L;SETD4;KMT2D
prerank,regulation of focal adhesion assembly (GO:0051893),0.44057878124462985,1.242357007256397,0.17073170731707318,0.9240142114782909,1.0,14/54,12.65%,APOD;DLC1;PTEN;PEAK1;EFNA5;MAP4K4;VEGFA;GPM6B;TSC1;SLK;PTPRJ;CLASP1;PTPRA;MYOC
prerank,glutamate metabolic process (GO:0006536),0.5173058415109333,1.242108957524415,0.18013245033112582,0.9235056900291296,1.0,6/19,16.78%,AADAT;GOT2;OAT;ALDH5A1;GLS2;GLS
prerank,purine ribonucleotide metabolic process (GO:0009150),0.43189208866633866,1.2418583356536472,0.16610169491525423,0.9229635714482365,1.0,20/68,20.99%,ADSS1;THEM4;PTHLH;OXSM;NT5C2;ACOT11;BPNT1;PDE9A;ACLY;BPNT2;ACSF2;HINT1;AK3;OPA1;ACSL6;GPAT4;GLYAT;DBI;ACOT8;ACBD6
prerank,phosphatidylethanolamine biosynthetic process (GO:0006646),0.56056489278314,1.2414183773578789,0.21732954545454544,0.9232724740775341,1.0,3/14,12.71%,SLC27A1;SELENOI;ETNK1
prerank,amyloid-beta metabolic process (GO:0050435),0.5356921920477927,1.2409395614008034,0.22238805970149253,0.9238136173530828,1.0,6/16,14.33%,BACE2;PSEN1;MGAT3;NCSTN;APH1A;PSEN2
prerank,positive regulation of calcium ion transmembrane transport (GO:1904427),0.4834215879431919,1.240833663752049,0.19576719576719576,0.9227024041134582,1.0,5/25,16.89%,CXCL10;ANK2;AKAP6;SNCA;APLNR
prerank,DNA biosynthetic process (GO:0071897),-0.43208667892272734,-1.2406698083015932,0.20317460317460317,0.7285920219156853,1.0,11/16,34.56%,POLD3;PPIA;POLH;POLA1;TERT;RFC3;POLD2;POLE;POLD4;POLD1;POLL
prerank,negative regulation of bone remodeling (GO:0046851),0.5766376599147123,1.2396945032167936,0.23766816143497757,0.9261397894273823,1.0,1/11,0.55%,UBASH3B
prerank,protein methylation (GO:0006479),-0.3421123771710972,-1.2390783651507709,0.10256410256410256,0.730588555344387,1.0,15/40,14.77%,CAMKMT;GSPT1;PRMT7;FAM98A;ATPSCKMT;NTMT1;METTL21A;NSD3;PRMT5;PRMT2;LCMT1;SNRPD3;PCMT1;PRMT8;SNRPB
prerank,cellular response to BMP stimulus (GO:0071773),0.42531864913362993,1.238706426425781,0.17660550458715596,0.9288773174066528,1.0,8/66,4.73%,BMP5;ADAMTS12;RGMB;SOX9;HIVEP1;ACVR1;TGFB1;GDF9
prerank,signal peptide processing (GO:0006465),0.5839984058853867,1.2386964716787467,0.2350230414746544,0.9273163789675015,1.0,3/11,8.76%,HM13;PARL;SPCS3
prerank,detection of calcium ion (GO:0005513),0.5678886379410558,1.2385649968910688,0.2273381294964029,0.9262267586926384,1.0,5/13,15.54%,SYT1;KCNMB2;KCNMB3;CALM1;CALM2
prerank,cell projection organization (GO:0030030),0.48102630587235456,1.2377101737343499,0.19528178243774574,0.9282572848065698,1.0,10/30,20.40%,RHOJ;GSN;PACSIN2;RHOH;P2RY12;CYFIP1;ITGB1;RAC3;NCKAP1;RHOU
prerank,regulation of granulocyte chemotaxis (GO:0071622),-0.4126216342567882,-1.2376806165084238,0.1795774647887324,0.7320631754878643,1.0,6/19,7.52%,IL34;MPP1;JAM3;THBS1;CAMK1D;AKIRIN1
prerank,purine nucleotide biosynthetic process (GO:0006164),-0.4660638602310625,-1.2374846905996504,0.21865889212827988,0.7297415089285504,1.0,5/12,22.58%,PRPSAP2;PRPS2;GART;PRPS1;PRPS1L1
prerank,positive regulation of interferon-gamma production (GO:0032729),0.44352714693041295,1.2372599248413223,0.18465227817745802,0.9286059124201527,1.0,8/48,12.72%,PYCARD;PTPN22;FADD;PDE4B;CCR2;IL18;PDE4D;SCRIB
prerank,regulation of macrophage chemotaxis (GO:0010758),-0.39820715275156404,-1.2371219839581271,0.17228464419475656,0.7278717876642776,1.0,4/21,7.52%,MTUS1;IL34;THBS1;AKIRIN1
prerank,microvillus assembly (GO:0030033),0.5541170859085951,1.2364581253747646,0.23503649635036497,0.93054261722443,1.0,4/14,7.42%,RAP2B;MAP4K4;TNIK;RAP1A
prerank,response to estradiol (GO:0032355),0.484186346905499,1.2361481330620128,0.2,0.9302316850455069,1.0,10/31,19.76%,SSTR1;EGFR;TGFB1;ESR1;NRIP1;LCOR;NCOA3;FAM210B;RUVBL2;STAT3
prerank,positive regulation of interleukin-1 production (GO:0032732),0.44443921314848683,1.2358674581626927,0.2037914691943128,0.9298244757308943,1.0,6/51,9.16%,USP50;IL16;PYCARD;WNT5A;TMEM106A;TMED10
prerank,positive regulation of response to external stimulus (GO:0032103),-0.26887485175569287,-1.2346443233140212,0.05555555555555555,0.7327613955893995,1.0,27/128,14.04%,BMP6;PTN;SASH1;ETS1;ANKRD17;DDX60;THBD;NFKBIA;PLSCR1;GPR4;TLR4;THBS1;APP;SCARF1;AGTR1;RIOK3;TNIP1;PDGFRB;TNFRSF1A;CYBA;OPTN;LRSAM1;SERPINE1;PDE2A;CCN4;USP15;NMI
prerank,negative regulation of oxidative stress-induced cell death (GO:1903202),0.4836065989049645,1.2345787734587441,0.20967741935483872,0.933987483210788,1.0,8/26,12.83%,PRKN;MAPK7;FBXO7;FYN;BAG5;GPR37;NFE2L2;SOD2
prerank,actin filament organization (GO:0007015),-0.2655941453062262,-1.233709457097389,0.075,0.7329421383925717,1.0,41/151,15.98%,NEBL;CGNL1;RHOBTB1;BAIAP2L1;TMOD3;TPM3;MYO1D;NEDD9;WASL;ARHGAP17;SHROOM4;SHROOM3;TPM1;ACTN1;FHOD1;BCAR1;INPPL1;VILL;EPS8;RHOA;ABI2;MYO1E;DSTN;ARPC4;EVL;EFS;PROX1;WHAMM;CDC42EP2;CDC42;MYO5B;MYO1C;GAS2;SHROOM2;AVIL;LMOD1;MPRIP;TPM2;TMOD1;HIP1R;TRPV4
prerank,regulation of glycogen biosynthetic process (GO:0005979),-0.3837336414076737,-1.2335830132685477,0.15447154471544716,0.7303483986235129,1.0,8/24,12.98%,SORBS1;IGF1;IGF2;INSR;GSK3B;PPP1R3B;GSK3A;ENPP1
prerank,positive regulation of morphogenesis of an epithelium (GO:1905332),0.5000465306777822,1.2329850655844712,0.20604395604395603,0.9394368782461254,1.0,7/23,11.46%,FGF2;SOX8;SOX9;VEGFA;SMO;GDNF;SIRT6
prerank,cellular modified amino acid catabolic process (GO:0042219),0.5400428509708733,1.2329078205556256,0.22158273381294963,0.9381494240219418,1.0,3/15,8.24%,DPEP1;SARDH;GOT2
prerank,positive regulation of Ras protein signal transduction (GO:0046579),0.43006208146196623,1.2328781192614713,0.16647531572904709,0.9367073944672938,1.0,14/62,11.65%,FGF10;IRS2;NGF;AKAP13;LPAR1;MAP4K4;GPR65;AUTS2;ALS2;ERBIN;SHOC2;COL3A1;STK19;MMD2
prerank,positive regulation of mitotic cell cycle (GO:0045931),0.48887160206387614,1.2326354624751765,0.22002635046113306,0.93612907515608,1.0,9/26,18.13%,PRKCA;CCDC57;CUL3;ASNS;CDC25B;SMOC2;USP2;PKN2;MDM2
prerank,hyaluronan metabolic process (GO:0030212),0.4982553289343974,1.2324229279019012,0.2058432934926959,0.9355004542600536,1.0,3/23,4.08%,HAS2;FGF2;TGFB1
prerank,positive regulation of cell migration involved in sprouting angiogenesis (GO:0090050),0.5254953310966656,1.2322126772625202,0.21934604904632152,0.9348853693576964,1.0,4/18,3.25%,RHOJ;FGF2;VEGFA;MAP3K3
prerank,rhodopsin mediated signaling pathway (GO:0016056),0.5850242175564367,1.2321078177472764,0.22935779816513763,0.9337401417080831,1.0,1/10,1.69%,RHO
prerank,positive regulation of release of sequestered calcium ion into cytosol (GO:0051281),0.4665963266825441,1.2314893525761286,0.21374045801526717,0.9349141607859621,1.0,9/32,23.36%,CXCL10;AKAP6;SNCA;CALM1;CALM2;APLNR;HTT;PKD2;CEMIP
prerank,platelet aggregation (GO:0070527),0.47237405999117255,1.2309550503276319,0.20603015075376885,0.9356057126674773,1.0,4/33,2.62%,UBASH3B;PDGFRA;CSRP1;RAP2B
prerank,regulation of G protein-coupled receptor signaling pathway (GO:0008277),-0.30381333815266204,-1.2308841646030806,0.08823529411764706,0.7358817486284637,1.0,26/75,20.85%,GRK5;ROCK2;CAMKMT;ROCK1;ZDHHC3;RGS3;RGS5;MGRN1;GNG7;GRK4;ZDHHC7;MGLL;KCTD8;CAMK2A;RGS12;RGS4;FNTB;RPGRIP1L;FRMPD1;EDN1;GIT1;NMT1;RGS6;GPER1;ADCYAP1;MRAP2
prerank,outflow tract septum morphogenesis (GO:0003148),-0.3902310925213413,-1.2304631783598774,0.16141732283464566,0.7341588772646424,1.0,8/24,8.70%,ROBO1;SMAD6;NRP1;BMP4;ENG;BMPR2;FGFR2;TBX1
prerank,artery morphogenesis (GO:0048844),-0.36413973393369864,-1.2302900577650846,0.13063063063063063,0.7318093295067851,1.0,13/30,15.31%,NRP1;SMAD7;BMP4;ENG;BMPR2;TGFBR1;TBX1;JAG1;PDGFRB;STRA6;TGFB2;HPGD;HEY2
prerank,regulation of intracellular steroid hormone receptor signaling pathway (GO:0033143),0.4566899860201225,1.2300000657756285,0.20561941251596424,0.9380584521445922,1.0,12/33,19.15%,CBFB;RNF6;PKN1;UFL1;UFSP2;CARM1;NCOA2;ESR1;HDAC6;RUNX1;PARK7;KLK2
prerank,postsynaptic membrane organization (GO:0001941),0.5292380768108124,1.2296778584768404,0.23378582202111614,0.9378500182754742,1.0,6/17,13.53%,CEL;LRP4;NRXN1;NLGN1;LHFPL4;GPHN
prerank,negative regulation of cellular protein catabolic process (GO:1903363),-0.49536706990778884,-1.2293658438454913,0.21891891891891893,0.7317333298881413,1.0,2/10,2.98%,EPHA4;RIC1
prerank,regulation of endocytosis (GO:0030100),0.4321247107418936,1.228877700628363,0.1953216374269006,0.9397791740068111,1.0,17/61,15.54%,GPC3;LGALS3;LRP1;STON2;PACSIN2;STON1;HIP1;SYT11;PTPN1;MCTP1;OPHN1;RAB4B;RAB4A;SNCA;NEDD4L;ARFGAP1;ABL1
prerank,regulation of smooth muscle contraction (GO:0006940),0.5122084027450278,1.2288274493359528,0.2269021739130435,0.9384616190699512,1.0,5/20,16.91%,CHRM3;SETD3;NMU;ATP2B1;CTTN
prerank,positive regulation of alpha-beta T cell differentiation (GO:0046638),0.548053752060057,1.2274151270089224,0.24620060790273557,0.9430777085953536,1.0,3/13,6.38%,CBFB;SOCS1;TGFBR2
prerank,regulation of mononuclear cell migration (GO:0071675),0.5006972487565715,1.2272135072268195,0.22496570644718794,0.9423917786198259,1.0,2/23,0.52%,LGALS3;BMP5
prerank,negative regulation of intrinsic apoptotic signaling pathway (GO:2001243),0.4204838667901709,1.2271332025170267,0.1823329558323896,0.941201502659065,1.0,17/62,18.76%,CREB3L1;BCL2;PRKN;MAPK7;URI1;ACKR3;BAG5;SELENOS;HERPUD1;NFE2L2;RTKN2;SOD2;OPA1;NDUFA13;DNAJA1;MDM2;PARK7
prerank,focal adhesion assembly (GO:0048041),0.4984713447502913,1.226789266323033,0.21370967741935484,0.9410715602039185,1.0,5/21,9.12%,DLC1;RHOD;PEAK1;TESK2;TRIP6
prerank,integrin-mediated signaling pathway (GO:0007229),-0.2997178721657653,-1.2261546335073026,0.12244897959183673,0.7388985764764969,1.0,19/73,16.15%,DAB2;PTN;NRP1;MYH9;FBLN1;NEDD9;ITGB5;SEMA7A;FYB1;BCAR1;ITGA10;FN1;ADAM10;LAMA3;CDC42;ADAM15;CEACAM1;PTK2B;ITGA11
prerank,intestinal lipid absorption (GO:0098856),0.5819580061583911,1.226089282834137,0.2398190045248869,0.9426182811620044,1.0,1/11,1.19%,CEL
prerank,macrophage differentiation (GO:0030225),-0.4484481899769148,-1.2256694378971977,0.2113564668769716,0.7376173248506918,1.0,5/13,13.33%,IL31RA;BMP4;PARP1;CASP8;CDC42
prerank,actin filament bundle assembly (GO:0051017),-0.3520755743300146,-1.2249656398686097,0.18811881188118812,0.7368364522353511,1.0,4/33,2.13%,PAWR;CALD1;BAIAP2L1;NEDD9
prerank,sensory perception of pain (GO:0019233),0.5096991282423767,1.2247610939611804,0.22829131652661064,0.9469341037684763,1.0,7/21,21.50%,KCNA2;CHRNA4;CCR2;NIPSNAP1;OPRK1;PTGES;P2RX7
prerank,negative regulation of axon extension (GO:0030517),0.4677813431977939,1.2246139229212407,0.2102496714848883,0.9459910512287892,1.0,12/30,20.13%,SEMA3E;SEMA6C;SEMA3A;RNF6;MT3;CDKL3;RTN4;SEMA6D;DIP2B;SEMA4B;SEMA4D;PTPRS
prerank,actin cytoskeleton reorganization (GO:0031532),0.4291912334360053,1.2243363023412641,0.19332566168009205,0.9455710479873015,1.0,15/63,10.30%,SIPA1L1;CLDN19;FGF10;GSN;GPR65;AUTS2;TNIK;THSD7A;PAK1;MKLN1;PDLIM4;FLNA;THSD7B;PTPN1;FARP2
prerank,negative regulation of protein modification by small protein conjugation or removal (GO:1903321),-0.3101548470117826,-1.2237176399674223,0.09154929577464789,0.7379148851439431,1.0,21/54,24.42%,NXN;DCUN1D3;CTNNB1;SMAD7;HDAC8;OGT;RPL5;SH3RF2;SQSTM1;RPL11;PINX1;CAV1;TRIM21;ISG15;AKT1;COPS9;TNFAIP3;U2AF2;USP4;VPS28;SIRT7
prerank,negative regulation of cell differentiation (GO:0045596),0.390499259725436,1.2233015401775171,0.10243407707910751,0.9484336268460636,1.0,31/181,13.40%,RORA;PTCH1;SOSTDC1;BMP5;ADAMTS12;EFEMP1;SOX8;PTEN;HOXB8;SOX9;EGFR;COL5A2;PTHLH;TGFB1;WNT5A;ZBTB16;SPRED2;TWIST2;SPRED1;CDK6;MEN1;SPRED3;ZFP36L2;PTPN11;ABCA5;BMP7;WWTR1;EID2B;ZFPM2;GATA3;TRIO
prerank,embryonic axis specification (GO:0000578),0.5450863192026852,1.2231609471950524,0.2323529411764706,0.9474800790941101,1.0,2/15,2.36%,PTCH1;RIPPLY2
prerank,resolution of meiotic recombination intermediates (GO:0000712),0.5238663195235583,1.2230074746469446,0.24929178470254956,0.9466483240009493,1.0,3/16,9.98%,MEIOB;ERCC4;HFM1
prerank,muscle cell differentiation (GO:0042692),0.4648995733722099,1.2226652595581669,0.21374045801526717,0.9465948885718694,1.0,5/32,7.60%,RORA;GLMN;SGCZ;GATA6;TBX18
prerank,phosphatidylserine acyl-chain remodeling (GO:0036150),-0.3891971070730013,-1.2225968838037833,0.19924812030075187,0.7383551008038102,1.0,4/21,4.25%,OSBPL8;PLA2G4A;PLA1A;OSBPL10
prerank,response to steroid hormone (GO:0048545),-0.3650685552213089,-1.2224462790437094,0.14948453608247422,0.7360575472848072,1.0,11/31,20.71%,ATP1A2;PAQR7;TFPI;THBS1;ATP1A1;PAQR8;TGFB2;CAV1;ABHD2;CATSPER3;NR1H3
prerank,negative regulation of interleukin-1 beta production (GO:0032691),0.5150420104865864,1.222184106254942,0.22454672245467225,0.9471629840207855,1.0,1/19,0.29%,FFAR4
prerank,neuron differentiation (GO:0030182),0.3924774516636307,1.2204170154120542,0.12757201646090535,0.9533390756154699,1.0,16/165,7.26%,TENM2;CDNF;TENM3;LHX5;GLI2;ERBB2;IL1RAPL1;OTP;VEGFA;HS6ST1;SOX11;NTRK2;PHOX2A;WNT5A;NGRN;FZD7
prerank,positive regulation of lymphocyte differentiation (GO:0045621),0.5023411930385693,1.2201785577407955,0.2524137931034483,0.9527971438343195,1.0,10/19,26.81%,ZMIZ1;RHOH;ZBTB1;XRCC6;GATA3;MDK;AXL;PRKDC;SYK;MMP14
prerank,histone mRNA metabolic process (GO:0008334),-0.3774411835042905,-1.219786483566253,0.1581196581196581,0.7415266868094368,1.0,12/27,15.66%,XRN1;LSM1;MTPAP;ERI1;SLBP;DCP2;CPSF2;TUT7;SNRPD3;SNRPE;SNRPB;EXOSC10
prerank,cellular response to steroid hormone stimulus (GO:0071383),-0.41526378607060577,-1.219081122064729,0.21428571428571427,0.7409690352340279,1.0,4/17,6.72%,ATP1A2;TFPI;BMP4;ATP1A1
prerank,DNA-dependent DNA replication maintenance of fidelity (GO:0045005),0.4521184322576811,1.218983853439323,0.21137206427688504,0.9563765271525936,1.0,11/40,17.24%,DDX11;ZRANB3;TIPIN;SETMAR;ATRX;FBH1;EXD2;RTEL1;BLM;FAM111A;WRN
prerank,regulation of phospholipase C activity (GO:1900274),0.5353604488325199,1.2189182587499903,0.2446351931330472,0.9550903248353788,1.0,6/15,10.72%,PDGFRA;NTRK3;FGF2;BICD1;FGFR1;ESR1
prerank,cell junction assembly (GO:0034329),0.4026236160491913,1.2185742802596484,0.1603875134553283,0.9550315480343335,1.0,20/100,12.69%,DCHS1;CDH19;PTEN;NRCAM;CDH10;NRXN1;CDH22;OBSL1;CDH8;NLGN1;KIRREL3;GPM6A;FLNA;CDH20;CDH7;DSCAM;MYO9A;OPHN1;ADGRL3;DRD2
prerank,endoplasmic reticulum calcium ion homeostasis (GO:0032469),0.49629708433717623,1.2182768585579897,0.22622478386167147,0.9547621271979402,1.0,6/20,13.39%,BCL2;PACS2;PSEN1;THADA;HERPUD1;CCDC47
prerank,regulation of cardiac muscle cell action potential (GO:0098901),0.49132685689209926,1.2179306639337386,0.22837837837837838,0.9546261099020104,1.0,8/25,15.41%,FGF13;ANK2;DSG2;CTNNA3;TBX18;CALM1;PKP2;JUP
prerank,regulation of peptidyl-tyrosine phosphorylation (GO:0050730),0.4064313484470761,1.217054850253193,0.18688524590163935,0.956915865828931,1.0,17/86,11.99%,RELN;FGF10;BST1;EGFR;RAP2B;ACVR1;EFNA5;VEGFA;CADM4;TGFB1;TEC;PRNP;SAMSN1;FYN;PTPRJ;PTPN11;FGF7
prerank,retinoic acid metabolic process (GO:0042573),0.5420991687505969,1.21657467026964,0.2563338301043219,0.9573813985501977,1.0,1/14,0.28%,CYP2S1
prerank,gliogenesis (GO:0042063),0.5445109334535359,1.216408373392488,0.24707602339181287,0.9565497716590656,1.0,3/15,7.57%,RELN;METTL3;CDK6
prerank,regulation of cell migration involved in sprouting angiogenesis (GO:0090049),0.47271598067747145,1.2163025033994483,0.22755227552275523,0.9554930819398717,1.0,5/32,3.25%,RHOJ;MEOX2;FGF2;VEGFA;MAP3K3
prerank,phosphatidylethanolamine metabolic process (GO:0046337),0.4809939254686995,1.2156989767519522,0.22435897435897437,0.956580437467248,1.0,6/27,13.50%,SLC27A1;SELENOI;PLAAT5;PLAAT3;ETNK1;PNPLA8
prerank,alpha-linolenic acid metabolic process (GO:0036109),0.5503583769534652,1.2141814184744684,0.22686567164179106,0.9616747145077253,1.0,7/12,24.47%,FADS2;ACOX1;ELOVL5;ACOT8;SCP2;ELOVL1;HSD17B4
prerank,regulation of potassium ion transmembrane transport (GO:1901379),0.42908902831218154,1.2137720839194317,0.21754385964912282,0.9619562479068693,1.0,17/54,19.83%,DPP10;BIN1;KCNMB2;KCNMB3;FLNA;STK39;AKAP6;KCNAB2;KCNJ3;KCNIP4;NEDD4L;KCNJ10;KCNH2;KCNMA1;CD63;CAB39;NOS1AP
prerank,cytoskeleton-dependent cytokinesis (GO:0061640),0.4293217016887727,1.213608178898925,0.20348837209302326,0.9611886077523566,1.0,8/56,6.92%,RTKN;ANK3;EFHC1;SPIRE1;ARL3;SPTBN1;RASA1;SON
prerank,positive regulation of cation transmembrane transport (GO:1904064),0.4420725107232016,1.2134230352717432,0.22469135802469137,0.9604449284469352,1.0,10/41,17.39%,ANK3;ANK2;KCNMB2;KCNMB3;FLNA;AKAP6;KCNJ3;KCNJ10;KCNH2;KCNMA1
prerank,ether lipid biosynthetic process (GO:0008611),-0.4979576737056753,-1.2130925568969946,0.2413793103448276,0.7577229586089023,1.0,4/10,8.33%,PLA2G4A;PEX7;DHRS7B;GNPAT
prerank,cell differentiation in spinal cord (GO:0021515),0.5822582904155612,1.2127868969347113,0.26226993865030673,0.9616952954226055,1.0,2/10,6.66%,SOX6;MDGA2
prerank,regulation of fat cell differentiation (GO:0045598),0.41124128401406046,1.2125399298564514,0.2071269487750557,0.961242718443163,1.0,24/74,23.34%,RORA;FRZB;WDFY2;TGFB1;WNT5A;ZBTB16;RORC;LMO3;CARM1;ZFP36L2;WWTR1;ZFPM2;GATA3;TRIO;ASXL2;CCDC85B;PPARG;TAF8;CCDC71L;ZFP36;RARRES2;TRPM4;CEBPB;BMP2
prerank,regulation of cardiac conduction (GO:1903779),0.4296367514723581,1.2124910611671464,0.19427890345649582,0.9600007934260878,1.0,12/54,13.52%,FXYD3;CORIN;ANK2;NPR2;ATP2B3;TMEM65;SLC8A2;FXYD6;FXYD1;PRKACA;ATP2B1;AHCYL1
prerank,cellular response to cytokine stimulus (GO:0071345),0.3778787152943529,1.2117766683311426,0.042,0.9616582556058532,1.0,86/416,17.35%,RORA;MMP2;CCL11;ADAMTS12;CXCL10;IL16;HAS2;IL2RA;FGF2;PYCARD;MYC;BCL2;SOX9;CRLF1;IL20RB;IL1RAPL1;PTPRT;PTPN2;EPRS1;VEGFA;NPR2;IRAK3;SOCS5;TGFB1;CCL4;TEC;CCR2;SLC12A2;AQP4;ZEB1;PTPN13;NUMBL;WNT5A;SOCS1;YWHAZ;RORC;CSK;IL1RL2;CSF3R;IL18;FYN;GAB2;BRCA1;UBE2K;ERBIN;STK39;HIF1A;NDN;ZFP36L2;PIK3R1;PTPRJ;TYK2;CBL;AKAP6;NFE2L2;PTPN11;COL1A2;IL6ST;PID1;UPF1;TBK1;PRKACA;PTPN18;PRLR;HSP90B1;PTPRZ1;SHPK;GATA3;TXLNA;KHSRP;ZFAND6;UBB;CCL14;ITGB1;TP53;BCL2L11;NDUFA13;PNPT1;HNRNPU;HYAL1;IL1RAP;FSCN1;RC3H1;RIPK1;CHUK;SELPLG
prerank,response to copper ion (GO:0046688),0.5041853148822599,1.2116496734915059,0.24930362116991645,0.9606986231530573,1.0,12/20,28.18%,PRNP;MT3;AOC1;SNCA;MT1G;MT1B;MT1X;MT1H;MT1F;MT1E;MT1M;MT1A
prerank,positive regulation of cell-cell adhesion (GO:0022409),-0.33544883794983194,-1.2115240723050864,0.15675675675675677,0.7598809068142427,1.0,5/41,2.50%,AFDN;TJP1;GCNT2;PODXL;SMAD7
prerank,mitotic nuclear membrane disassembly (GO:0007077),0.5485732990717387,1.2112617148187375,0.2556732223903177,0.960780241754838,1.0,1/12,0.67%,PRKCA
prerank,positive regulation of protein localization to cell periphery (GO:1904377),0.4314141793128902,1.2106032921813519,0.20960187353629978,0.9621049019098332,1.0,12/52,12.87%,LGALS3;GPSM2;EGFR;LRP1;EPHB2;WNK3;SPTBN1;DPP10;ZDHHC8;PIK3R1;EPB41L2;GNAI1
prerank,cellular response to epidermal growth factor stimulus (GO:0071364),0.48341700035590884,1.210595112447702,0.23544631306597671,0.9606316142671101,1.0,6/26,10.85%,GAREM1;SOX9;ERBB2;EGFR;ZFP36L2;PTPN11
prerank,positive regulation of interleukin-2 production (GO:0032743),0.4881619189776714,1.2103617579769659,0.23622047244094488,0.9600932561676873,1.0,7/25,15.48%,GLMN;PDE4B;CCR2;SPTBN1;PDE4D;MALT1;RUNX1
prerank,positive regulation of peptidyl-serine phosphorylation (GO:0033138),0.4083387714980993,1.2102572913152583,0.20066889632107024,0.9590482923098131,1.0,17/73,18.76%,DOCK7;NTRK3;NGF;EGFR;VEGFA;ARAF;TGFB1;PAK1;EIF4G1;HDAC6;TBK1;SNCA;SH2D3C;TERF2IP;RPTOR;FNIP1;PARK7
prerank,phagosome-lysosome fusion (GO:0090385),0.5724372319748665,1.2101450893023356,0.2492354740061162,0.9580111303060393,1.0,5/10,23.59%,RAB34;RAB39A;RAB7A;RAB7B;ARL8B
prerank,negative regulation of protein localization to cell periphery (GO:1904376),-0.40504937362787813,-1.2091732209249457,0.25,0.7648021536817673,1.0,4/20,8.85%,DAB2;LZTFL1;NUMB;RHOQ
prerank,regulation of transcription by RNA polymerase I (GO:0006356),0.5211561416452548,1.208962520024248,0.2338935574229692,0.9615918441139479,1.0,7/18,14.36%,ERBB2;EIF2AK3;FLNA;HEATR1;POLR2K;PHF8;DHX33
prerank,peptide hormone secretion (GO:0030072),0.48039090867549544,1.2087690369571333,0.25098554533508544,0.9609198346743056,1.0,6/26,18.76%,FFAR4;EDN3;RAB1A;CDK16;RIMS2;PARK7
prerank,bone development (GO:0060348),0.443995715703711,1.2081791130037773,0.20989143546441497,0.9618539959167315,1.0,7/39,12.65%,OSR2;SULF1;AKAP13;SLC10A7;SFRP4;VKORC1;MYOC
prerank,glycine transport (GO:0015816),0.5798393451947998,1.20791189305776,0.26080246913580246,0.9614778678580578,1.0,4/10,19.24%,SLC36A2;SLC25A38;SLC7A8;SLC6A9
prerank,regulation of postsynaptic membrane potential (GO:0060078),0.4559643636075266,1.2078142332123307,0.22997416020671835,0.9604135133621876,1.0,13/34,21.86%,CHRNA4;GRIN2B;GRID2;MPP2;INSYN1;DRD2;GRIN2D;GRIN2A;GABRG2;GABRA3;GABRA2;RAB3GAP1;ARRB2
prerank,zymogen activation (GO:0031638),0.4409040351371245,1.2074896852251444,0.21273885350318472,0.9602637425733426,1.0,4/39,7.58%,HGFAC;TBC1D10A;FADD;KLK1
prerank,negative regulation of cellular response to growth factor stimulus (GO:0090288),0.41046994400168246,1.207259606008228,0.17817371937639198,0.9597558649381002,1.0,15/79,16.36%,SOSTDC1;ADAMTS12;SULF1;CREB3L1;FGF2;HTRA3;CADM4;SHISA2;PTPN1;DAND5;GPC1;BMPER;BMPR1A;LRP2;VWC2
prerank,positive regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030949),-0.4971339154420448,-1.206964443424855,0.22077922077922077,0.7690814027304631,1.0,4/10,5.12%,VTN;GRB10;PRKCB;ARNT
prerank,protein localization to organelle (GO:0033365),0.3876336998483478,1.206888987830376,0.16822429906542055,0.9598745940888427,1.0,34/133,15.34%,BICD1;ANK2;ARL3;PACSIN2;IFT140;WDR83OS;PRNP;PPP1R15A;OBSL1;BBS9;FAM83H;ARL1;GBF1;LAMP5;GAK;XPA;WDR35;VAPA;BICD2;UBE2J2;TSPAN17;TOLLIP;EMD;BMP7;SNX10;SYS1;DVL1;OTOF;CCDC47;RPA2;COL1A1;GABARAPL2;LMNA;SEC61G
prerank,endoplasmic reticulum organization (GO:0007029),0.41168981504859353,1.20687535686899,0.18680089485458612,0.9584424574121596,1.0,27/72,24.85%,SEC16B;EIF2AK3;WDR83OS;PRNP;SEC31B;GAK;VAPA;TMEM33;UBE2J2;EMD;ATL3;OTOF;CCDC47;RTN4;SEC61G;BNIP1;REEP5;CYB5A;SHTN1;SGTA;LMAN1;RAB18;ZBED3;STX18;MIA3;REEP3;ATL1
prerank,ceramide transport (GO:0035627),-0.4748738534272524,-1.2067804683286147,0.24390243902439024,0.7667704994345788,1.0,5/12,25.77%,PLTP;GLTP;ABCB4;CERT1;PLEKHA8
prerank,negative regulation of macromolecule metabolic process (GO:0010605),-0.24626212510636103,-1.2066190171438032,0.0,0.7643931192866107,1.0,45/182,12.99%,FOXP1;NOTCH2;IGF1;ROBO1;ROCK2;WNT4;CLDN5;OCLN;ACVRL1;BMP4;ENG;NOCT;REL;SLC7A5;ANXA7;MOV10;SETDB2;KDR;AGO1;ERP29;TERF2;APP;PARP10;RIN3;MAP2K1;MTMR2;TET1;KLF4;FLCN;RACK1;ADAM10;XDH;SLC24A3;PRKAA2;CCDC3;OPTN;ATOH8;LGMN;GATA2;AGO3;MAPT;TGFB2;ID2;SLC2A10;VHL
prerank,monocyte chemotaxis (GO:0002548),0.4564977861991938,1.2060003436935862,0.23876765083440307,0.9607325782886423,1.0,3/32,4.10%,LGALS3;CCL11;CCL4
prerank,positive regulation of MAP kinase activity (GO:0043406),-0.2953999060395571,-1.2055882668431472,0.10743801652892562,0.7647715846506684,1.0,7/66,1.35%,FLT1;PDGFD;ROBO1;SASH1;MAP3K5;KIT;IL34
prerank,regulation of endothelial cell migration (GO:0010594),-0.2919723119367174,-1.2053256393063365,0.10843373493975904,0.7627651486619321,1.0,18/85,6.75%,FOXP1;PTPRM;ANXA3;SP100;PTN;ROCK2;SASH1;ETS1;NRP1;TEK;ANGPT1;ACVRL1;BMP4;BMPR2;SLIT2;KDR;THBS1;BCAR1
prerank,branching morphogenesis of an epithelial tube (GO:0048754),0.4480401988062246,1.2051113334680468,0.2400990099009901,0.9630215920384372,1.0,8/39,6.38%,GLI2;FGF2;MYC;FGF10;SEMA3E;VEGFA;PAK1;TGFBR2
prerank,negative regulation of autophagosome assembly (GO:1902902),-0.450568997359478,-1.2047021235028648,0.2314540059347181,0.7621303805486402,1.0,5/13,18.89%,FEZ2;SCFD1;NUPR1;SMCR8;PINK1
prerank,regulation of toll-like receptor signaling pathway (GO:0034121),-0.37152598342012966,-1.2046487814039293,0.21052631578947367,0.7594873226153969,1.0,20/26,39.37%,APPL2;BIRC3;GPS2;LGR4;GPR108;IRF1;LRRC14;FLOT1;APPL1;CACTIN;NLRP2B;TYRO3;SMPDL3B;TLR3;BIRC2;IRF7;TREM2;CD36;NFKBIL1;TLR5
prerank,polyamine metabolic process (GO:0006595),0.5353997248988104,1.204056958421896,0.239067055393586,0.9658743625129829,1.0,5/13,11.21%,SMOX;SMS;AOC1;PAOX;HDAC6
prerank,neurotransmitter biosynthetic process (GO:0042136),-0.4430341732262775,-1.2036983921309226,0.24579124579124578,0.7596889144191169,1.0,6/14,26.46%,MOXD1;ALDH9A1;NOS1;DAGLA;SLC22A2;DAGLB
prerank,regulation of epidermal growth factor-activated receptor activity (GO:0007176),0.4724778573278757,1.2032654421985642,0.250334672021419,0.9677902371818307,1.0,8/26,12.38%,CBLB;SOCS5;FBXW7;NCF1;BTC;SNX6;CBL;ZGPAT
prerank,inhibitory synapse assembly (GO:1904862),0.5460432274459567,1.2018166417951024,0.2545731707317073,0.9724227717006827,1.0,5/11,20.50%,FGF13;WNT5A;GABRG2;CBLN4;GABRA2
prerank,NLS-bearing protein import into nucleus (GO:0006607),0.5474158824374289,1.2015205121184542,0.260806916426513,0.9721061708490122,1.0,7/13,19.83%,CBLB;RANBP2;KPNB1;KPNA6;KPNA1;IPO5;KPNA3
prerank,positive regulation of cellular amide metabolic process (GO:0034250),-0.28651346369467406,-1.2014427608995935,0.09345794392523364,0.7639017366525732,1.0,21/80,10.68%,EPHA4;ROCK2;SAMD4A;PRKCD;LARP4B;ZCCHC4;YTHDF1;NPM1;UPF3B;THBS1;RBM3;METTL14;SIRT3;RPL5;RPS6KB1;RACK1;GSK3A;ABCG1;EIF4A3;TNFRSF1A;ELAVL1
prerank,neuron projection regeneration (GO:0031102),-0.483708188960762,-1.2013976787871208,0.2514450867052023,0.7612445266609418,1.0,2/10,2.86%,PTN;GAP43
prerank,manganese ion transport (GO:0006828),-0.44300937817663705,-1.2005220176596214,0.20569620253164558,0.7612989870634662,1.0,5/14,17.62%,SLC30A10;SLC39A8;TRPC6;TRPC3;TRPC7
prerank,regulation of calcium ion transmembrane transport via high voltage-gated calcium channel (GO:1902514),0.5589846237463694,1.199807776140364,0.2558139534883721,0.97790562413515,1.0,3/11,8.10%,SESTD1;CACNA2D1;BIN1
prerank,regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043122),0.379457225789113,1.1997554470711784,0.13524590163934427,0.9766547311612978,1.0,47/208,19.55%,RORA;ROR1;PYCARD;S100A4;PRKN;AKAP13;FADD;LPAR1;ALPK1;MAP3K3;GPRC5B;TLE1;TNFRSF10B;TRAF4;SLC44A2;WNT5A;TMEM106A;OTUD7B;NLRX1;UFL1;CARD9;PELI1;PPM1B;FLNA;VAPA;MID2;ESR1;RHOH;RHOC;TBK1;PER1;MALT1;NDFIP1;GOLT1B;ZFAND6;TICAM1;PIM2;TERF2IP;CD74;RIPK1;CHUK;OTUD7A;ZMYND11;MAPKBP1;TAB3;CPNE1;BCL10
prerank,positive regulation of amyloid precursor protein catabolic process (GO:1902993),-0.39593985967408146,-1.1996697003362538,0.2196969696969697,0.7613408757628367,1.0,5/22,10.06%,EPHA4;ROCK2;LYN;GSK3A;ABCG1
prerank,entry into host (GO:0044409),-0.4477960757401509,-1.1996230746730439,0.2540192926045016,0.7586936626094846,1.0,4/13,7.58%,CTNNB1;CDH1;PPIA;CTNND1
prerank,regulation of fatty acid oxidation (GO:0046320),-0.4192317188783098,-1.199385185153416,0.22435897435897437,0.7567061882127949,1.0,3/16,5.49%,PRKAG2;APPL2;LONP2
prerank,regulation of vascular endothelial growth factor signaling pathway (GO:1900746),0.49330336244965545,1.1991323378651138,0.26618705035971224,0.9778609252694649,1.0,2/19,3.45%,DCN;CADM4
prerank,regulation of neutrophil migration (GO:1902622),0.5585228082771558,1.198931508177065,0.2764612954186414,0.9772607597603656,1.0,3/10,12.13%,OLFM4;BST1;RHOH
prerank,lipid transport (GO:0006869),0.3973591857200518,1.1987333501802264,0.19358288770053475,0.9766624156943896,1.0,14/97,9.19%,ABCA6;ABCA9;SLC27A1;ATP8B1;NCOA1;PITPNB;SLC27A4;OSBPL5;SLCO2B1;PEX3;GM2A;GOT2;MTTP;NCOA2
prerank,chromatin organization involved in regulation of transcription (GO:0034401),0.5395912266405483,1.1986693143711509,0.26231884057971017,0.9754721698608968,1.0,2/13,9.14%,FAM47E;ZMIZ1
prerank,negative regulation of defense response (GO:0031348),0.4062063613384951,1.1963590753762348,0.20693512304250558,0.9838027160372174,1.0,9/77,9.85%,RORA;FFAR4;PTPN2;MAPK7;IRAK3;TNFAIP8L2;OTULIN;PPM1B;SELENOS
prerank,negative regulation of fatty acid metabolic process (GO:0045922),0.5234033055844909,1.1961052158525152,0.254985754985755,0.9833502844679549,1.0,4/16,15.46%,SOX9;ERLIN2;BRCA1;ERLIN1
prerank,alcohol catabolic process (GO:0046164),0.5723233806323571,1.1957602813831185,0.2714285714285714,0.9833985348288425,1.0,3/10,14.24%,CEL;MT3;CYP27A1
prerank,protein import into peroxisome matrix (GO:0016558),-0.48023257175510015,-1.1950670864313018,0.25073746312684364,0.767959558042468,1.0,8/12,27.26%,PEX13;PEX7;PEX14;PEX26;PEX2;PEX10;PEX6;PEX16
prerank,response to light stimulus (GO:0009416),0.41875351935114413,1.1949659257240612,0.22018348623853212,0.985286824912964,1.0,14/55,17.26%,RHO;ZRANB3;GTF2H2;ERCC5;ERCC4;DDB2;MEN1;MSH6;GPR88;DRD2;CRY1;FECH;USP1;REV1
prerank,phosphatidylethanolamine acyl-chain remodeling (GO:0036152),0.48385953259937237,1.1948195938533952,0.2550335570469799,0.9844699120589128,1.0,5/23,13.50%,PLBD1;MBOAT2;PLA2G12A;PLAAT3;PNPLA8
prerank,regulation of Ras protein signal transduction (GO:0046578),0.40344700425908936,1.1947281045785916,0.21373200442967885,0.9833511250785875,1.0,19/86,11.65%,DLC1;FGF10;IRS2;NGF;AKAP13;EPHB2;CADM4;ARHGEF28;SYNGAP1;MAPKAP1;EPS8L1;FOXM1;RABL3;ERBIN;SHOC2;MYO9B;STK19;OPHN1;MMD2
prerank,phospholipid catabolic process (GO:0009395),0.4765705618182212,1.1935092498568272,0.25466666666666665,0.9871309107803483,1.0,2/24,1.15%,PRDX6;PLBD1
prerank,cellular protein catabolic process (GO:0044257),0.4201873486480575,1.1934870100348773,0.22184300341296928,0.9857730915204543,1.0,19/59,22.26%,ADAMTS12;FAP;PRKN;CTSK;CTSO;BNIP3;CTSB;RSPRY1;AFG1L;MYLIP;YME1L1;MALT1;RIPK1;RAB7A;MDM2;MAGEC2;UBE2G1;BNIP3L;RNF123
prerank,inositol phosphate-mediated signaling (GO:0048016),0.4991624726406675,1.1929344872643768,0.2611731843575419,0.9866497134771192,1.0,6/19,13.96%,HRH1;PPP3CB;PPP3CA;NFATC3;EDN3;PPP3CC
prerank,peptidyl-tyrosine phosphorylation (GO:0018108),0.41017664073099375,1.1927042473003584,0.2319004524886878,0.9860918359095077,1.0,10/67,8.06%,RELN;EFEMP1;PDGFRA;PKDCC;ERBB2;EGFR;EPHB2;TEC;FGFR1;FYN
prerank,glycerol metabolic process (GO:0006071),-0.484663386462448,-1.1924826673534676,0.25,0.7736124219914059,1.0,5/10,27.49%,COQ3;PGP;GOT1;ANGPTL3;TKFC
prerank,cholesterol homeostasis (GO:0042632),0.41326720696016866,1.1923502706778208,0.22598870056497175,0.9861929603981595,1.0,11/64,16.66%,RORA;NPC1;CYP39A1;IL18;MTTP;CYP7B1;ABCA5;GRAMD1B;LIPC;TMEM97;ABCG4
prerank,regulation of hippo signaling (GO:0035330),-0.41487192542126694,-1.191890643205145,0.22742474916387959,0.772613091933251,1.0,8/17,9.58%,WWC2;SCHIP1;MOB3B;MAP2K3;WTIP;CIT;SHANK2;WWC1
prerank,myeloid dendritic cell activation (GO:0001773),0.5484518104171824,1.1918106520377614,0.27492447129909364,0.9870219569005214,1.0,2/12,6.38%,PYCARD;TGFBR2
prerank,proteolysis involved in cellular protein catabolic process (GO:0051603),0.40439999947080657,1.1916515772582965,0.21300448430493274,0.9861691534079873,1.0,26/71,23.03%,ADAMTS12;FAP;HM13;PRKN;OTUD7B;CTSK;CTSO;CTSB;RSPRY1;HDAC6;YME1L1;DDB1;MALT1;NEDD8;PDCD6IP;UBB;CHMP4C;CUL4B;MDM2;ZER1;OTUD7A;PSMA8;RHBDD1;FBXO44;RNF123;ZYG11B
prerank,mitotic cytokinesis (GO:0000281),0.42867060265678514,1.1915587536086953,0.22130177514792898,0.9851055159490103,1.0,7/47,6.92%,RTKN;ANK3;EFHC1;ARL3;SPTBN1;RASA1;SON
prerank,"positive regulation of mRNA splicing, via spliceosome (GO:0048026)",0.520892324901399,1.1914100529346887,0.27092198581560284,0.9842666575854322,1.0,4/16,12.97%,PRDX6;TRA2B;NCBP1;DAZAP1
prerank,regulation of signal transduction (GO:0009966),0.3745063980326299,1.1910439651829607,0.15,0.9843640231191654,1.0,29/190,10.72%,RORA;PTCH1;UBASH3B;SULF1;MDFIC;ERBB3;ZFAND2B;CBFB;BST1;ACVR1;PTPN2;SIK2;SOCS5;TGFB1;PRNP;PLCB1;GLI1;HHIP;RGS11;CSK;FRRS1L;SLC8A2;FYN;DHRS3;CASTOR2;PTPN1;GDNF;USP33;ESR1
prerank,limb morphogenesis (GO:0035108),0.49495790523761196,1.190964917438695,0.27385892116182575,0.9832821039767903,1.0,1/20,0.46%,PTCH1
prerank,regulation of B cell receptor signaling pathway (GO:0050855),-0.3798360173548475,-1.190791304627807,0.2328767123287671,0.773479375782723,1.0,6/21,8.98%,FOXP1;PRKCH;LYN;PRKCB;GPS2;ELF1
prerank,regulation of lipid storage (GO:0010883),0.4798122569956954,1.190592919381612,0.25686813186813184,0.9833735167978153,1.0,3/22,5.00%,PTPN2;FBXW7;MEST
prerank,sterol homeostasis (GO:0055092),0.41099029111101165,1.1905562627192103,0.22072072072072071,0.9820730783998094,1.0,11/65,16.66%,RORA;NPC1;CYP39A1;IL18;MTTP;CYP7B1;ABCA5;GRAMD1B;LIPC;TMEM97;ABCG4
prerank,positive regulation of cytokine-mediated signaling pathway (GO:0001961),0.44403925880793804,1.1905457100745618,0.25440806045340053,0.980682788268862,1.0,11/36,19.28%,PRKN;FADD;TRIM44;WNT5A;AGPAT2;UBE2K;HIF1A;CD74;RIPK1;AXL;CPNE1
prerank,sodium ion transport (GO:0006814),0.3993113764889172,1.190526310946627,0.20350109409190373,0.979313588311893,1.0,11/85,7.96%,SLC6A2;FGF13;SCN7A;SLC12A3;SCN2A;KCNK1;ANO6;SLC12A2;SCN5A;SCN3A;SLC8A2
prerank,positive regulation of integrin activation (GO:0033625),-0.46940820651288356,-1.190442361586985,0.25386996904024767,0.771850559669598,1.0,2/11,6.06%,RAP1B;RASIP1
prerank,positive regulation of neuron differentiation (GO:0045666),0.4334408754481743,1.190343817851177,0.25154130702836003,0.9786248593577277,1.0,12/40,20.21%,NGF;NRCAM;GPRC5B;SOX11;ZEB1;HOXD3;FGFR1;MMD2;VWC2;HEYL;CPNE1;PCP4
prerank,regulation of type I interferon-mediated signaling pathway (GO:0060338),0.47221059113064745,1.190273619846021,0.24968474148802017,0.9774548644499882,1.0,7/29,10.85%,FADD;PTPN2;WNT5A;METTL3;UBE2K;PTPN1;PTPN11
prerank,positive regulation of smooth muscle cell migration (GO:0014911),-0.4138641746692341,-1.1901268001993974,0.23247232472324722,0.7701504937380778,1.0,8/17,12.47%,DOCK4;IGF1;NRP1;VTN;IGFBP5;S100A11;PDGFRB;CCN4
prerank,positive regulation of MAPK cascade (GO:0043410),0.37598214130362956,1.1900728282239001,0.11967545638945233,0.9768950384032772,1.0,39/245,11.86%,ROR2;FFAR4;ROR1;CCL11;PRKCA;PDGFRA;GLIPR2;NTRK3;FGF2;PYCARD;FGF10;PTPN22;GAREM1;ERBB2;EGFR;LPAR1;VEGFA;FBXW7;TGFB1;CCL4;NTRK2;MT3;TMEM106A;ALKAL2;KSR1;CARD9;ACKR3;RAP1A;FGFR1;HTR2C;ERBB4;GPR37;PTPRJ;PTPN11;MTURN;ARL6IP5;EDN3;TAOK3;MYDGF
prerank,amino sugar metabolic process (GO:0006040),0.5584896274135761,1.1898388585276822,0.29102167182662536,0.9764707001309928,1.0,3/10,15.43%,GFPT2;CSGALNACT1;GNE
prerank,negative regulation of protein localization to membrane (GO:1905476),-0.3792131267986938,-1.1896329892470756,0.25311203319502074,0.7690203612194917,1.0,4/24,8.85%,DAB2;LZTFL1;NUMB;RHOQ
prerank,proteoglycan metabolic process (GO:0006029),0.4655937866720709,1.1894632423823708,0.25166444740346205,0.9766145908298207,1.0,4/26,7.77%,ADAMTS12;SULF1;CHST8;CSGALNACT1
prerank,negative regulation of secretion by cell (GO:1903531),0.44252145204705373,1.1890926932757186,0.2400990099009901,0.9767664919110521,1.0,6/38,13.88%,STXBP6;IL1RAPL1;PNKD;SYT11;DRD2;SNCA
prerank,negative regulation of phosphate metabolic process (GO:0045936),0.48553635532801864,1.188547559860055,0.25864453665283543,0.9776235787926065,1.0,2/22,2.40%,DYNLL1;CDKN2B
prerank,RNA biosynthetic process (GO:0032774),-0.34001616408239377,-1.1874560339106357,0.21266968325791855,0.7733167843160497,1.0,13/31,24.58%,NCOA6;BRF1;PRIM2;POLA1;TAF13;PRMT5;HELB;POLA2;TERT;SMARCA5;BRF2;TAF10;TBPL1
prerank,adipose tissue development (GO:0060612),0.5455032665285844,1.1873998129172256,0.29012345679012347,0.9810290376019495,1.0,4/11,7.04%,SOX8;PGRMC2;RORC;DYRK1B
prerank,Rac protein signal transduction (GO:0016601),0.4954897292665347,1.1872293267892802,0.2582025677603424,0.9803360163519625,1.0,8/18,19.03%,HACE1;BRK1;FARP2;RHOH;WASF1;CYFIP1;ELMO1;NCKAP1
prerank,actin nucleation (GO:0045010),0.48901229976595084,1.1868719566745132,0.286493860845839,0.9804383533915986,1.0,3/21,4.87%,SPIRE1;ARPC1B;IQGAP2
prerank,regulation of autophagy of mitochondrion (GO:1903146),0.4913822063787708,1.1867459693544768,0.28651685393258425,0.9795585055620042,1.0,8/19,18.94%,PRKN;FBXW7;FBXO7;HDAC6;SREBF2;HTT;PARK7;CSNK2A2
prerank,negative regulation of binding (GO:0051100),-0.28928261514794046,-1.1867197991700082,0.13333333333333333,0.7728311107635312,1.0,15/81,9.45%,DAB2;SP100;ARHGAP28;LEF1;ROCK1;WAPL;PRKCD;NFKBIA;IFIT2;KDM1A;HABP4;PEX19;GSK3B;CAMK1;RACK1
prerank,regulation of myeloid cell differentiation (GO:0045637),0.41880336145305574,1.186624912878006,0.24647887323943662,0.9786157393126993,1.0,9/62,8.35%,LGALS3;PRKCQ;CBFB;HOXB8;KAT2B;KMT2A;ZBTB16;CDK6;EIF6
prerank,positive regulation of lymphocyte chemotaxis (GO:0140131),0.5311611293189923,1.1863748374674652,0.28895184135977336,0.9782583972244326,1.0,4/14,9.18%,CCL4;CCR2;WNT5A;STK39
prerank,regulation of mitochondrial fusion (GO:0010635),0.5469403016228587,1.1858490087793994,0.2907692307692308,0.979103316241475,1.0,5/11,17.54%,PRKN;BNIP3;HUWE1;PID1;ADCK1
prerank,positive regulation of cysteine-type endopeptidase activity (GO:2001056),0.41436109249766323,1.185842096412097,0.232037691401649,0.9777298397187646,1.0,13/57,14.38%,USP50;PYCARD;MYC;TBC1D10A;FADD;GRIN2B;ACVR1C;CARD9;FYN;ARL6IP5;MALT1;TTBK1;GRIN2A
prerank,positive regulation of metabolic process (GO:0009893),0.39249353307414825,1.1857289968654814,0.20882669537136705,0.9767840297277506,1.0,17/103,13.94%,EBF2;FFAR4;PRDM16;VEGFA;ACACA;CCR2;PTH2R;PRKAB2;IL18;TSHR;ELOVL6;ACLY;FASN;SIRT6;CNOT3;PRLR;PIGA
prerank,regulation of lipid metabolic process (GO:0019216),0.40012135149953987,1.185393345833534,0.21092896174863388,0.976739710637068,1.0,16/88,11.00%,RORA;IRS2;NCOA1;C1QTNF2;SQLE;ACACA;IDI1;RORC;ELOVL6;FASN;CARM1;NCOA2;CHD9;SIN3B;TGS1;SP1
prerank,cellular response to hydroxyurea (GO:0072711),0.564818877971176,1.1851829493456298,0.296875,0.9762302016976575,1.0,5/10,15.98%,DDX11;NSMCE3;ATRX;BLM;SPIDR
prerank,positive regulation of blood vessel endothelial cell migration (GO:0043536),0.4307540470516347,1.1849903175504624,0.2488479262672811,0.975607709004972,1.0,11/48,11.00%,PRKCA;RHOJ;FGF2;VEGFA;MAP3K3;TGFB1;FGFR1;AKT3;HIF1A;MAPK14;SP1
prerank,regulation of ion transport (GO:0043269),0.40559610793008916,1.1846980365288877,0.21627647714604237,0.9754138072029258,1.0,17/76,14.63%,ANK3;KCNA2;NKAIN2;PRKN;CHRNA4;SYT1;SYT11;SYT12;SNX6;PXK;GDNF;DRD2;PER1;KCNJ3;SNCA;NEDD4L;KCNJ10
prerank,regulation of viral life cycle (GO:1903900),-0.387552408719091,-1.1839466304928554,0.22033898305084745,0.7788181200441756,1.0,10/21,28.38%,TSG101;TRIM25;PPIA;TRIM5;VPS4A;TRIM21;TRIM68;KPNA2;TYRO3;TRIM6
prerank,Ras protein signal transduction (GO:0007265),0.38032801729027693,1.1833376414281829,0.1875,0.9799362307130075,1.0,43/137,20.76%,USP50;RTKN;TAX1BP3;FGF2;RHOD;GPSM2;RAP2B;HACE1;CTNNAL1;PLD1;NF1;KSR1;EPS8L1;RALB;LIMK1;RAP1A;BRK1;ARHGEF11;SHOC2;MRAS;MYO9B;FARP2;NGFR;MAPK14;COL1A2;RHOH;WASF1;KPNB1;ARHGAP4;ARHGEF3;CYFIP1;CDC42EP1;ELMO1;TP53;NRAS;KRAS;PARK7;NCKAP1;GRB2;JUN;SHTN1;SETDB1;SOS1
prerank,positive regulation of ATPase activity (GO:0032781),0.43427943802249475,1.1830613296717334,0.24146341463414633,0.9796969090869269,1.0,12/41,21.52%,DYNLL1;FGF10;SETMAR;TNNT3;MSH6;AHSA1;GABARAPL2;HNRNPU;DNAJC10;SSBP1;VMP1;DNAJC9
prerank,amyloid fibril formation (GO:1990000),0.42509342442376635,1.182654154282291,0.24912280701754386,0.9799737464486321,1.0,4/51,2.35%,TGFBI;HSPG2;GSN;PRKN
prerank,monocyte differentiation (GO:0030224),-0.47206642816735367,-1.1826516201735686,0.2614942528735632,0.7801259354699723,1.0,3/10,2.72%,MYH9;IL31RA;BMP4
prerank,positive regulation of peptide hormone secretion (GO:0090277),0.4334818096180494,1.1825870946629737,0.24479804161566707,0.9788369796948331,1.0,3/39,1.98%,FFAR4;CRH;IRS2
prerank,post-transcriptional gene silencing by RNA (GO:0035194),-0.39958955152178927,-1.1823277871830065,0.2112676056338028,0.7785947069753136,1.0,6/20,12.43%,WTIP;MOV10;AGO1;CNOT1;NRDE2;AGO3
prerank,carboxylic acid transport (GO:0046942),-0.30585881528041764,-1.1816483543632064,0.18831168831168832,0.7780744082319045,1.0,17/55,18.92%,SLC13A3;SLC16A12;SLC16A6;SLC6A12;SLC6A6;SLC6A13;SLC7A5;SLC16A11;SLC16A2;SLC6A11;SLC66A1;SLC38A5;SLC16A9;SLC36A4;SLC6A7;SLC16A7;LLGL2
prerank,activation of GTPase activity (GO:0090630),0.3977950188341916,1.1813245256704128,0.2273706896551724,0.9826207887791512,1.0,11/89,6.35%,ARHGAP24;SIPA1L1;DOCK7;NTRK3;TAX1BP3;TBC1D10A;GPR65;SLC27A4;ARHGEF10;MTSS2;TSC1
prerank,cellular response to heat (GO:0034605),-0.32655694364460824,-1.1807469520200589,0.185,0.778224842927511,1.0,23/35,39.78%,ANO1;THBS1;STUB1;MAPT;HSP90AA1;TRPV4;HSP90AB1;HTRA2;TCIM;PDCD6;POLR2D;IER5;ZFAND1;VCP;SLU7;FGF1;HSPA1B;HMOX1;BAG3;ATXN3;HSF1;HSBP1L1;IL1A
prerank,regulation of cell-matrix adhesion (GO:0001952),0.40788042820848835,1.1803508609331066,0.2545454545454545,0.9852949581730958,1.0,18/64,12.65%,UTRN;SEMA3E;PEAK1;BST1;EFNA5;HOXA7;MAP4K4;GPM6B;NF1;RASA1;TSC1;CDK6;NF2;SLK;CLASP1;AJAP1;PTPRA;MYOC
prerank,epithelial cilium movement involved in extracellular fluid movement (GO:0003351),0.495475098434745,1.1802015070884178,0.26323119777158777,0.9845385542714116,1.0,3/18,6.19%,CCDC39;AQP4;RFX3
prerank,regulation of protein autophosphorylation (GO:0031952),-0.33462097733310414,-1.180165631184163,0.17587939698492464,0.7774572056708182,1.0,4/36,3.05%,PDGFD;EPHA7;ERRFI1;ENG
prerank,placenta development (GO:0001890),0.5469533787639226,1.1799350625829135,0.27121212121212124,0.9842947666456102,1.0,1/12,1.00%,ADAM19
prerank,B cell differentiation (GO:0030183),0.42729556000007396,1.1797740115694086,0.2427536231884058,0.9835949175904581,1.0,10/46,18.68%,RAG2;PTPN2;DNAJB9;RABL3;NHEJ1;PTPRJ;DCAF1;ITGB1;MS4A1;FNIP1
prerank,sympathetic nervous system development (GO:0048485),0.5243977425924665,1.1794638003897135,0.27546628407460544,0.9834929610534513,1.0,6/15,13.20%,SEMA3A;SOX11;NF1;GDNF;NRP2;GATA3
prerank,phosphatidylcholine metabolic process (GO:0046470),0.4114798067593712,1.179337542506868,0.21956769055745165,0.9826037157480112,1.0,20/70,20.03%,SLC27A1;PLBD1;MBOAT2;SLC44A2;PLA2G7;PLA2G12A;PCYT1B;PLAAT3;CHPT1;PNPLA8;CHAT;LIPC;GPLD1;GPAT4;SLC44A1;CSNK2A2;LPCAT2;DBI;PLA2G4E;STARD7
prerank,positive regulation of axon extension (GO:0045773),-0.375360682213131,-1.1791172895156823,0.23076923076923078,0.7779057403852823,1.0,4/22,3.01%,MACF1;NRP1;GOLGA4;SEMA7A
prerank,response to thyroid hormone (GO:0097066),-0.4412755680333179,-1.1790338683622426,0.2564935064935065,0.7755467749653205,1.0,3/13,4.61%,THRB;CTSH;LMO2
prerank,regulation of ruffle assembly (GO:1900027),0.4778242111149327,1.1790079463793997,0.2802721088435374,0.9826049591286429,1.0,3/23,6.47%,ARHGAP24;NLGN1;EPS8L1
prerank,negative regulation of leukocyte activation (GO:0002695),-0.41720441106390543,-1.1789171876031248,0.23615160349854228,0.7733059709860796,1.0,6/15,20.71%,CD200;IL31RA;CD300A;GPER1;HAVCR2;NR1H3
prerank,response to fatty acid (GO:0070542),0.5117356640475828,1.1786917508924086,0.3002832861189802,0.9824372297772102,1.0,3/17,11.37%,SOX9;PDK3;PID1
prerank,carboxylic acid catabolic process (GO:0046395),0.535718666819347,1.17844289403478,0.30045523520485584,0.9820688399479247,1.0,5/12,20.97%,NAGK;IL4I1;GNPDA1;BCKDK;ACOT8
prerank,tRNA wobble uridine modification (GO:0002098),-0.4335094979369421,-1.1784101327134529,0.24584717607973422,0.7722751895166794,1.0,6/14,16.43%,TRMT9B;URM1;ELP3;ELP1;MTO1;DPH3
prerank,positive regulation of signaling (GO:0023056),0.4384711170876685,1.1783593536706967,0.25375,0.9810328819808376,1.0,12/37,15.49%,CLSTN2;SOX11;GRIK2;SYT1;NMU;RIMS1;EDN3;SCRIB;GATA3;SNCA;CLSTN1;HOMER1
prerank,insulin secretion (GO:0030073),-0.395584756235285,-1.1780658881278827,0.22569444444444445,0.7709057795673014,1.0,6/19,20.12%,RAB11B;SELENOT;CAMK2G;CYB5R4;ANXA1;ADCYAP1
prerank,regulation of isotype switching (GO:0045191),-0.4244076242414068,-1.1778941151755329,0.25766871165644173,0.768871707221805,1.0,5/14,24.29%,RIF1;PARP3;TFRC;PAXIP1;MAD2L2
prerank,regulation of receptor binding (GO:1900120),-0.48859467079131536,-1.1774980195191536,0.275,0.7675229090247546,1.0,5/10,22.57%,GREM2;ADAM15;ATP2A3;HFE;ATP2A2
prerank,regulation of dephosphorylation (GO:0035303),-0.41576953246065557,-1.177448440837641,0.22686567164179106,0.7650860993012252,1.0,6/15,25.33%,PPP1R16B;MTMR2;IGBP1;MTMR9;SMG5;MTMR3
prerank,PERK-mediated unfolded protein response (GO:0036499),0.5629551219343583,1.1770258281793662,0.2778649921507064,0.985159407806055,1.0,4/10,16.48%,EIF2AK3;HERPUD1;NFE2L2;QRICH1
prerank,extrinsic apoptotic signaling pathway via death domain receptors (GO:0008625),0.45625893942418644,1.176684816921262,0.2800528401585205,0.9851463292817105,1.0,5/28,6.95%,BCL2;NGF;FADD;TNFRSF10B;DEDD
prerank,central nervous system projection neuron axonogenesis (GO:0021952),0.5353427190899327,1.1766715344031582,0.28417818740399386,0.9838258345775692,1.0,3/12,3.35%,GLI2;EPHB6;EPHB2
prerank,negative regulation of hippo signaling (GO:0035331),-0.45401119379865196,-1.1765455208241618,0.2478134110787172,0.7652525756976862,1.0,6/12,9.58%,WWC2;MAP2K3;WTIP;CIT;SHANK2;WWC1
prerank,T cell mediated immunity (GO:0002456),-0.44286877004607245,-1.1764136144021797,0.26153846153846155,0.7630205084164804,1.0,3/13,9.24%,CTSH;CD55;JAG1
prerank,regulation of DNA recombination (GO:0000018),0.4483501294056505,1.1763398989332217,0.2544529262086514,0.9836926600341888,1.0,10/32,16.41%,ZRANB3;SETD2;MSH6;SIRT6;RPA2;RTEL1;BLM;KPNA1;SPIDR;TERF2IP
prerank,positive regulation of epithelial cell differentiation (GO:0030858),0.495300193056565,1.1761570049449617,0.2849002849002849,0.9830725935256974,1.0,4/17,10.31%,FGF2;SOX9;RFX3;SFRP4
prerank,regulation of heart rate by cardiac conduction (GO:0086091),0.4376042339138874,1.1760776452345167,0.24090338770388958,0.9820104349844252,1.0,11/38,16.10%,CACNA2D1;ANK2;DSG2;SCN5A;CTNNA3;KCND3;BIN1;KCNJ3;PKP2;JUP;KCNH2
prerank,aminoglycan biosynthetic process (GO:0006023),0.4198496962117237,1.1757135978838906,0.24729891956782712,0.9821753428655208,1.0,10/49,12.81%,GPC3;HSPG2;HS6ST1;SDC2;EXT1;B3GNT9;SDC4;GPC1;SDC3;GPC4
prerank,maintenance of blood-brain barrier (GO:0035633),0.4551068156184924,1.1753785093625781,0.275,0.9821798251969789,1.0,5/30,5.24%,LAMA2;LAMC1;WNK3;CLDN1;SLC12A2
prerank,inner dynein arm assembly (GO:0036159),0.5563074738555744,1.1753666743707805,0.30745341614906835,0.9808770129438892,1.0,1/10,2.93%,CCDC39
prerank,regulation of potassium ion transport (GO:0043266),0.458088080004724,1.1752845588007914,0.2690863579474343,0.9798436718957559,1.0,9/31,19.21%,ANK3;ANK2;DPP10;DRD2;KCNAB2;KCNIP4;KCNH2;KCNA5;CD63
prerank,apoptotic process (GO:0006915),0.367051656059407,1.1749435574480411,0.17025641025641025,0.9799363082498671,1.0,59/203,21.06%,DLC1;BCL2L14;ERBB3;IL2RA;MAGI3;FAP;PYCARD;MYC;BCL2;FADD;EFNA5;SCN2A;JADE1;PAK4;TNFRSF10B;PAK5;PPP1R15A;BNIPL;APAF1;ZBTB16;TGFBR2;BMF;CASP6;BNIP3;NAE1;HIP1;DCC;NGFR;ING4;CASP12;YARS1;RFK;AHR;BRAT1;AHCYL1;TRPC5;PAX3;TRAF7;RTN4;ELMO1;CASP2;BNIP1;IFT57;BCL2L11;AKAP1;RIPK1;AIFM1;MRPS30;MDM2;IRF3;CASP7;NCKAP1;HK2;PDCD4;TRAIP;IER3;HSPD1;DPF2;KREMEN1
prerank,cellular response to thyroid hormone stimulus (GO:0097067),-0.4518510673966894,-1.1743450939712665,0.2693498452012384,0.7668598113802008,1.0,3/12,4.61%,THRB;CTSH;LMO2
prerank,global genome nucleotide-excision repair (GO:0070911),0.46226728625171265,1.1743261447150013,0.28514588859416445,0.9811502819894555,1.0,9/26,17.08%,RAD23B;GTF2H2;ERCC4;DDB2;XPA;DDB1;UBB;RNF111;CUL4B
prerank,negative regulation of striated muscle cell differentiation (GO:0051154),0.5082881178558291,1.1743132576917859,0.2849002849002849,0.9798494107932418,1.0,2/18,7.26%,SOX6;FZD7
prerank,regulation of toll-like receptor 4 signaling pathway (GO:0034143),-0.37283365497813525,-1.1741265385973725,0.24199288256227758,0.7649784516914435,1.0,11/22,23.14%,APPL2;MFHAS1;LYN;WDFY1;TIRAP;FLOT1;APPL1;IFI35;NINJ1;NR1H3;TNFAIP3
prerank,positive regulation of cold-induced thermogenesis (GO:0120162),0.394447257816803,1.1740451325157026,0.22875816993464052,0.9795542755214109,1.0,10/90,8.18%,EBF2;FFAR4;PRDM16;VEGFA;CCR2;PTH2R;PRKAB2;IL18;TSHR;ELOVL6
prerank,aorta development (GO:0035904),-0.4315427067402462,-1.1733866294517696,0.2361963190184049,0.7647919626751837,1.0,7/14,12.43%,ROBO1;TBX1;EFEMP2;JAG1;PDGFRB;HECTD1;PDE2A
prerank,inner ear receptor cell stereocilium organization (GO:0060122),-0.4882496866858262,-1.1726726760999366,0.2757731958762887,0.7643223395792385,1.0,4/10,24.29%,ADGRV1;SOD1;PDZD7;TSKU
prerank,lipid catabolic process (GO:0016042),0.5019664947381306,1.1726541372626376,0.2979942693409742,0.983969521519352,1.0,4/18,15.20%,CEL;MT3;PLAAT3;LIPC
prerank,cellular polysaccharide biosynthetic process (GO:0033692),0.46943805524254334,1.1723446126803556,0.29517241379310344,0.9838541560412671,1.0,4/25,7.77%,HAS2;EXT1;B3GNT9;CSGALNACT1
prerank,positive regulation of T cell differentiation (GO:0045582),0.4405453976253297,1.1722780928816776,0.26049382716049385,0.9827463019655763,1.0,10/36,18.11%,GLI2;SOCS1;SOX12;ZMIZ1;IL4I1;RHOH;ZBTB1;GATA3;MDK;SART1
prerank,negative regulation of T cell proliferation (GO:0042130),0.4625069673049798,1.1720910334804895,0.2656875834445928,0.982147711327847,1.0,6/28,17.21%,GLMN;PRNP;SDC4;IL4I1;SCRIB;RC3H1
prerank,negative regulation of blood pressure (GO:0045776),-0.4393877436991798,-1.1718588864178094,0.2309941520467836,0.7643935717836442,1.0,3/13,15.27%,NOS3;BMPR2;NOS1
prerank,inorganic cation import across plasma membrane (GO:0098659),-0.27972454962164384,-1.1716435053991243,0.14893617021276595,0.7625230271653539,1.0,18/75,13.07%,ATP1A2;ATP1B3;SLC8A3;SLC12A7;SLC9A6;SLC9A2;KCNJ2;ABCC9;ATP1A1;SLC12A9;SLC39A8;SLC39A6;SLC9A9;SLC9A7;KCNK9;SLC6A1;TRPV2;SLC12A8
prerank,negative regulation of interleukin-1 production (GO:0032692),0.4745521743934925,1.1715754749019027,0.2640990371389271,0.9828835789459108,1.0,1/23,0.29%,FFAR4
prerank,digestive tract development (GO:0048565),0.44642009638793195,1.1713386340630751,0.25224071702944945,0.9825172256969752,1.0,9/32,14.68%,GLI2;PKDCC;CCDC39;GLI1;GATA6;SMO;RARB;COBL;PKD1
prerank,GTP metabolic process (GO:0046039),-0.41656521372237376,-1.1712015684359844,0.23648648648648649,0.7614046979895149,1.0,7/15,19.65%,GTPBP1;RHOQ;ENTPD7;GNAI3;IMPDH1;AK4;IMPDH2
prerank,fibroblast growth factor receptor signaling pathway (GO:0008543),0.406554680509311,1.1709147790148033,0.25681818181818183,0.9829913003500531,1.0,18/72,14.75%,FGF2;FGF10;RAB14;POLR2B;SPRED2;SPRED1;FGFR1;CEP57;SHOC2;POLR2K;SHCBP1;NCBP1;CBL;PTPN11;MAPK1;FGF7;POLR2G;GALNT3
prerank,axonal transport (GO:0098930),-0.33735096314785684,-1.1704368245907049,0.17982456140350878,0.7612076032724308,1.0,10/36,12.83%,KIF3B;PAFAH1B1;DTNBP1;KIF1B;BLOC1S5;DCTN1;SOD1;SNAPIN;MAPT;AP3D1
prerank,linoleic acid metabolic process (GO:0043651),0.49372016048828654,1.1700385543979457,0.2706222865412446,0.9853250818416436,1.0,3/17,13.50%,FADS2;ELOVL5;PNPLA8
prerank,synaptic vesicle recycling (GO:0036465),0.44470510691656606,1.1696908362477263,0.2647058823529412,0.9853826761210265,1.0,10/31,18.63%,CEL;STON2;SYT1;NLGN1;STON1;OPHN1;RAB3A;SNCA;SYT2;SNCB
prerank,negative regulation of neuroinflammatory response (GO:0150079),-0.4316937318597567,-1.1695606195743469,0.2422360248447205,0.7612413354621046,1.0,2/14,0.89%,IGF1;CD200
prerank,nuclear transport (GO:0051169),0.5018472596761503,1.1695023908528763,0.27728613569321536,0.9848062444120732,1.0,6/16,16.73%,XPO1;RSRC1;PSIP1;NUP205;NXT1;AAAS
prerank,regulation of intracellular estrogen receptor signaling pathway (GO:0033146),0.456749062075101,1.1693007230944104,0.2701298701298701,0.9842691410183834,1.0,8/29,10.72%,CBFB;PAK1;UFL1;UFSP2;BRCA1;CARM1;VPS11;ESR1
prerank,"nucleotide-excision repair, DNA damage recognition (GO:0000715)",0.4695674231007567,1.1685038351497754,0.276536312849162,0.9861372610105243,1.0,8/23,20.96%,RAD23B;DDB2;XPA;DDB1;UBB;CUL4B;COPS6;COPS7A
prerank,regulation of lipase activity (GO:0060191),0.5407229342439235,1.1682132306764352,0.2833333333333333,0.9859648292197274,1.0,6/13,21.04%,PCSK6;LMF1;RHOC;SNCA;LIPC;FURIN
prerank,protein localization to condensed chromosome (GO:1903083),-0.4455869412893908,-1.168147575530786,0.25882352941176473,0.7631232647321807,1.0,10/12,47.90%,BUB3;IK;KNL1;ZW10;TTK;SPDL1;CDK1;MTBP;AURKB;CHAMP1
prerank,regulation of apoptotic signaling pathway (GO:2001233),0.4430792497033068,1.167952307981952,0.25157232704402516,0.9857072426014912,1.0,4/36,4.25%,BCL2L14;PYCARD;BCL2;DEPTOR
prerank,nuclear-transcribed mRNA catabolic process (GO:0000956),-0.25335208018033645,-1.1677029752247132,0.09523809523809523,0.7620529873683081,1.0,76/168,27.91%,SAMD4A;RPS14;GSPT1;RPL24;RPL18A;XRN1;UPF3B;RPS16;LSM1;RPL38;RPL28;RPS19;RPL37;AGO1;MTPAP;CTIF;ERI1;ZFP36L1;DCP2;RPS2;EXOSC7;DDX5;CNOT1;RPL19;RPL5;PATL1;RPL34;RPS25;RPS15;EIF4A3;RPLP1;RPL31;RPL3;HELZ2;TUT7;RPS6;PAN2;RPS8;RPL11;RPL12;PNRC2;SMG9;EXOSC10;RPL7A;RPL13;CNOT11;CNOT9;RPS21;TENT4B;RPL35A;RPL26;RPS9;RPL32;RPS29;RC3H2;RPS23;RPLP2;PDE12;POLR2D;RPL8;SMG5;RPL41;SMG8;RPS17;RPS5;RPS15A;UBA52;RPL37A;PPP2CA;RPS10;EIF3E;RPL6;RPL9;RPS27;PAN3;PELO
prerank,motile cilium assembly (GO:0044458),0.5509143736557011,1.167396173855149,0.30269413629160064,0.986624076390852,1.0,3/12,8.05%,CCDC39;SPATA6;BBS5
prerank,regulation of synapse assembly (GO:0051963),0.41944564227650144,1.1667805138549354,0.26193390452876375,0.9877273425873636,1.0,13/46,14.19%,CLSTN2;IL1RAPL1;EPHB2;NRXN1;GRID2;NLGN1;LHFPL4;EIF4G1;SETD5;GPC4;SYNDIG1;SNCA;CLSTN1
prerank,protein processing (GO:0016485),0.3845145893143042,1.166081067815997,0.22761596548004315,0.9892927885886044,1.0,20/102,15.30%,HGFAC;PTCH1;ADAM19;HM13;PARL;PSEN1;PCSK4;PCSK6;ATP23;KLK1;KLK6;SPCS3;MMP16;NCSTN;APH1A;YME1L1;CPD;TYSND1;PSEN2;CASP2
prerank,protein K48-linked ubiquitination (GO:0070936),0.4096750392763142,1.1655935836596534,0.2523809523809524,0.9899417992897313,1.0,9/54,9.84%,UBE2T;PRKN;UBE2E2;HACE1;RNF6;FBXO38;PELI1;UBE2K;CUL3
prerank,lymphocyte migration (GO:0072676),0.4429725839769174,1.1654637500930363,0.2703751617076326,0.9891342612242346,1.0,5/32,15.17%,CCL11;CCL4;CKLF;GATA3;CCL14
prerank,cytoskeleton organization (GO:0007010),0.37939798321656654,1.164698856442017,0.20572640509013787,0.9909914102138084,1.0,24/114,13.64%,CCL11;ANK1;RHOD;WDPCP;RND3;FGD4;RHOBTB3;PAK4;FMNL2;MAST2;PACSIN2;PAK5;TNIK;OBSL1;PDZD8;BIN1;EPB41L3;PALLD;ZMYM6;RHOH;RHOC;NECTIN2;SH3KBP1;ARHGAP4
prerank,positive regulation of transcription of Notch receptor target (GO:0007221),0.501796486774673,1.1645123293884931,0.29083094555873923,0.990428804787439,1.0,3/17,3.73%,MAML3;KAT2B;MAML2
prerank,positive regulation of natural killer cell activation (GO:0032816),0.510390460114051,1.1644281090065025,0.2701492537313433,0.9894428746037812,1.0,5/13,18.99%,AP1G1;IL18;ZBTB1;TICAM1;AXL
prerank,positive regulation of dendrite development (GO:1900006),0.5674387874511357,1.1644006845446724,0.3132530120481928,0.988226285897416,1.0,3/10,14.09%,BMP5;BMP7;COBL
prerank,organelle transport along microtubule (GO:0072384),0.4484832608321528,1.1642330693182557,0.2750642673521851,0.9876068641253886,1.0,13/31,18.47%,BICD1;NDE1;COPG2;RHOT2;DYNC1I1;BICD2;ARHGAP21;RAB1A;COPG1;UBB;TRAK2;RHOT1;HTT
prerank,histone H3-K36 demethylation (GO:0070544),0.5591097851598553,1.1642023402287602,0.3125,0.986426610312171,1.0,4/10,19.50%,KDM8;KDM4B;PHF8;RIOX2
prerank,mesenchymal cell differentiation (GO:0048762),-0.30744492636984133,-1.1638982042894446,0.19078947368421054,0.7717320781216823,1.0,17/51,15.31%,RANBP3L;ROCK2;LEF1;WNT4;ROCK1;CTNNB1;ENG;TGFBR1;DDX5;GSK3B;FBXL17;FGFR2;NOTCH4;TGFB2;AKNA;HMGA2;HEY2
prerank,ventricular cardiac muscle cell action potential (GO:0086005),0.5078421879604574,1.1634829623538065,0.3072463768115942,0.988063229898749,1.0,5/17,16.10%,ANK2;SCN5A;NEDD4L;PKP2;KCNH2
prerank,negative regulation of fibroblast proliferation (GO:0048147),0.4941689657337893,1.163183942456304,0.2863070539419087,0.9879449916019339,1.0,6/18,17.23%,MYC;NF1;EMD;MED25;TP53;CDC73
prerank,regulation of actin filament-based process (GO:0032970),0.3976674466448395,1.1626790791170825,0.24272930648769575,0.988696721026281,1.0,11/70,6.44%,DLC1;RHOD;BST1;LRP1;RND3;EFNA5;RHOBTB3;GPM6B;IQGAP2;PAK1;BAIAP2
prerank,long-term synaptic potentiation (GO:0060291),0.48053526984911404,1.162228910343201,0.28551336146272854,0.9892798886365443,1.0,7/21,18.10%,TSHZ3;GRIN2B;MPP2;SLC8A2;GRIN2D;GRIN2A;SLC24A2
prerank,cellular response to calcium ion (GO:0071277),0.398605948069119,1.162101671998238,0.23707865168539327,0.9884963389928065,1.0,26/67,24.07%,CPNE8;DPEP1;HPCA;SCN5A;WNT5A;SYT1;NLGN1;SYT11;SYT12;ALOX5AP;IQGAP1;GPLD1;SLC25A24;CPNE7;SYT2;RYR3;CPNE1;SYT13;ADCY8;CPNE3;PKD2;PRKAA1;CAMK2D;CPNE5;SYT3;MEF2A
prerank,hippo signaling (GO:0035329),0.44908054769879024,1.1620077242464353,0.27097661623108665,0.9875639246571682,1.0,2/26,3.17%,DCHS1;SAV1
prerank,regulation of smooth muscle cell proliferation (GO:0048660),-0.31325751393551166,-1.1611258930041946,0.18404907975460122,0.7781271082845056,1.0,14/46,12.61%,FOXP1;IGF1;ELN;CDH13;CTNNB1;BMP4;IGFBP3;IGFBP5;THBS1;OGN;PDGFRB;IL6R;CCN4;ID2
prerank,regulation of acrosome reaction (GO:0060046),0.5497885647374626,1.1607453296782464,0.30261136712749614,0.9913799232999996,1.0,1/10,4.92%,PLCB1
prerank,cellular response to dsRNA (GO:0071359),-0.4059118151194475,-1.1606253289903248,0.26129032258064516,0.7771817667461739,1.0,9/15,23.12%,NPM1;IFIH1;RIOK3;FLOT1;CAV1;IFIT1;COLEC12;PDE12;MUL1
prerank,negative regulation of macrophage derived foam cell differentiation (GO:0010745),-0.4593917519115872,-1.1603795666281436,0.2804878048780488,0.7754436638989973,1.0,4/12,11.12%,ABCA1;NFKBIA;ABCG1;NR1H2
prerank,regulation of NLRP3 inflammasome complex assembly (GO:1900225),0.513888261743249,1.160224052435621,0.28674351585014407,0.9921955914629641,1.0,1/15,0.50%,USP50
prerank,positive regulation of neurogenesis (GO:0050769),0.3930307487921396,1.1600795789406235,0.2717889908256881,0.9914540163262245,1.0,13/68,6.62%,CHODL;SOX8;NGF;PLXNC1;IL1RAPL1;VEGFA;SOX11;NTRK2;NUMBL;OBSL1;CDKL5;CDKL3;DISC1
prerank,enzyme linked receptor protein signaling pathway (GO:0007167),0.37646872447745416,1.159883742063297,0.20333680917622524,0.9909427362560053,1.0,14/138,4.52%,ROR2;SHC4;ROR1;PDGFRA;ERBB3;NTRK3;EPHB6;NGF;ERBB2;EGFR;PTPRT;NPR2;EPHB2;NTRK2
prerank,histone H4 acetylation (GO:0043967),0.4192893484125816,1.1598016194338798,0.2684964200477327,0.9900031345255934,1.0,15/47,15.62%,JADE1;KMT2A;HAT1;JADE3;KAT8;BRD8;MORF4L2;ATF2;PHF20;ING4;EPC1;PER1;KANSL1;TRRAP;MSL3
prerank,protein homooligomerization (GO:0051260),0.3779721114996694,1.1589744858798623,0.23834745762711865,0.9920319073660462,1.0,30/114,20.22%,SCARA5;STEAP4;CTH;PYCARD;SLC1A5;ACACA;LETM1;AQP4;MPP2;ALS2;CARD9;PRMT1;ATL3;ALOX5AP;ZBTB1;SOD2;TMEM120A;NACC2;PDCD6IP;BLM;PNPT1;ALDH1A3;GLS;FUS;RYR3;MLKL;HCN1;BCL10;ADCY8;DISP1
prerank,negative regulation of epidermal growth factor-activated receptor activity (GO:0007175),0.5231580288820645,1.1578683273043602,0.30401234567901236,0.9951399366304957,1.0,5/13,12.38%,CBLB;SOCS5;SNX6;CBL;ZGPAT
prerank,protein localization to kinetochore (GO:0034501),-0.43050769287410384,-1.1573988695075836,0.267741935483871,0.7822084221684965,1.0,7/14,34.36%,BUB3;IK;CENPT;KNL1;ZW10;TTK;SPDL1
prerank,lung development (GO:0030324),0.44166280296483346,1.1572861868452844,0.2786259541984733,0.9962606299823543,1.0,9/33,11.99%,GLI2;FGF2;FGF10;CCDC39;VEGFA;SOX11;LOXL3;RCN3;FGF7
prerank,coenzyme A biosynthetic process (GO:0015937),-0.460298668784367,-1.156541074109447,0.2811594202898551,0.7773353160317515,1.0,5/11,18.21%,PANK1;PANK2;PANK3;PPCDC;PANK4
prerank,purine nucleoside bisphosphate biosynthetic process (GO:0034033),-0.460298668784367,-1.156541074109447,0.2811594202898551,0.7773353160317515,1.0,5/11,18.21%,PANK1;PANK2;PANK3;PPCDC;PANK4
prerank,ribonucleoside bisphosphate biosynthetic process (GO:0034030),-0.460298668784367,-1.156541074109447,0.2811594202898551,0.7773353160317515,1.0,5/11,18.21%,PANK1;PANK2;PANK3;PPCDC;PANK4
prerank,cyclic-nucleotide-mediated signaling (GO:0019935),0.4343028113843619,1.1565317058490616,0.2795969773299748,0.9979988675254721,1.0,9/35,13.21%,SOX9;PDE7B;MAPK7;KSR1;PDE9A;HTR2C;AKAP6;PDE4D;AHR
prerank,positive regulation of interleukin-10 production (GO:0032733),0.4447663772611133,1.1559364669269712,0.3049095607235142,0.9990803983886974,1.0,2/30,1.88%,PYCARD;CD34
prerank,excitatory postsynaptic potential (GO:0060079),0.4897443322265859,1.155441348803723,0.2959770114942529,0.9997178076951971,1.0,8/19,21.86%,GRIN2B;GRID2;MPP2;DRD2;GRIN2D;GRIN2A;RAB3GAP1;ARRB2
prerank,positive regulation of production of molecular mediator of immune response (GO:0002702),0.43472353504483296,1.1554083836204223,0.2723833543505675,0.998549369697074,1.0,4/34,5.52%,PTPN22;EPHB2;DNAJB9;WNT5A
prerank,lamellipodium assembly (GO:0030032),-0.3516582849973926,-1.15509498546011,0.2446351931330472,0.7794687257478662,1.0,9/26,14.82%,ABLIM1;KIT;CDH13;PARVB;ARHGEF6;ABLIM2;WHAMM;PTPRO;S1PR1
prerank,regulation of neuron apoptotic process (GO:0043523),0.383558215366668,1.1550569598881073,0.24672489082969432,0.9987231933287504,1.0,19/96,13.02%,ERBB3;BCL2;CRLF1;NGF;PRKN;NTRK2;PRNP;MT3;NF1;GRID2;RASA1;TRIM2;NAE1;SNX6;GDNF;CDK5R1;GRN;SOD2;PTPRZ1
prerank,L-glutamate transmembrane transport (GO:0015813),0.5621961174567514,1.1546671261156087,0.3273615635179153,0.9989961970131409,1.0,3/10,12.94%,SLC1A3;ARL6IP5;PRAF2
prerank,epithelial cell-cell adhesion (GO:0090136),-0.4632672067670123,-1.1541976320156553,0.29310344827586204,0.7798933964835317,1.0,2/11,2.17%,KIT;ITGB5
prerank,cell-cell junction organization (GO:0045216),0.3944563583129246,1.1541272239040083,0.2640449438202247,0.9998132609070302,1.0,14/79,9.72%,DCHS1;CDH19;TGFB1;DSG2;CDH10;CLDN1;CDH22;CDH8;CADM3;CSK;CADM2;CADM1;CDH20;CDH7
prerank,leukocyte cell-cell adhesion (GO:0007159),-0.3767973733748239,-1.153702940601948,0.2578125,0.778893709320104,1.0,10/24,28.69%,PECAM1;ROCK1;ICAM1;TNIP1;MSN;VCAM1;GFUS;CERCAM;FERMT3;ITGB2
prerank,G protein-coupled acetylcholine receptor signaling pathway (GO:0007213),0.480621117747916,1.153563109285269,0.29790209790209793,1.0,1.0,3/18,11.86%,CHRM3;PLCB1;CDK5R1
prerank,negative regulation of tyrosine phosphorylation of STAT protein (GO:0042532),0.5567506739304596,1.1534083228788892,0.30307941653160453,1.0,1.0,3/10,8.27%,PTPN2;SOCS1;NF2
prerank,amyloid precursor protein catabolic process (GO:0042987),0.506458178451465,1.1523623998387436,0.30338733431516934,1.0,1.0,5/14,14.33%,ADAM19;PSEN1;NCSTN;APH1A;PSEN2
prerank,neurogenesis (GO:0022008),0.41769453777082444,1.152092755804248,0.27423167848699764,1.0,1.0,4/43,7.57%,DCHS1;LPAR1;METTL3;CDK6
prerank,regulation of actin cytoskeleton organization (GO:0032956),0.38573835482678465,1.1516909865481257,0.23939064200217627,1.0,1.0,13/87,6.44%,DLC1;PDGFRA;SEMA3E;RHOD;BST1;LRP1;RND3;EFNA5;RHOBTB3;GPM6B;IQGAP2;PAK1;BAIAP2
prerank,peptidyl-arginine modification (GO:0018195),-0.42122577234764835,-1.1511663334997728,0.25757575757575757,0.7842970994450909,1.0,5/15,13.96%,PRMT7;PRMT5;KRTCAP2;PRMT8;PADI2
prerank,positive regulation of chromosome organization (GO:2001252),0.500690599072509,1.150918909253397,0.3188405797101449,1.0,1.0,4/15,14.20%,DDX11;ATRX;SIRT6;RTEL1
prerank,response to interferon-alpha (GO:0035455),-0.4108967819946061,-1.1508752058404932,0.24390243902439024,0.7828281446130659,1.0,7/16,22.46%,IFITM3;KLHL20;IFITM2;BST2;IFNAR1;IFNAR2;PDE12
prerank,negative regulation of insulin receptor signaling pathway (GO:0046627),0.45092040467199274,1.1507282784490367,0.2858990944372574,1.0,1.0,8/27,13.99%,PRKCQ;PTPN2;SLC27A4;SOCS1;GRB14;PTPN1;PID1;NCK1
prerank,regulation of histone H3-K9 acetylation (GO:2000615),0.5433998145455224,1.1506622624905378,0.30428134556574926,1.0,1.0,3/10,9.87%,KMT2A;BRCA1;PIH1D1
prerank,regulation of programmed necrotic cell death (GO:0062098),-0.37456180945453244,-1.1501207305536711,0.24087591240875914,0.7828041328441006,1.0,9/20,18.72%,BIRC3;OGT;STUB1;NUPR1;CASP8;HSP90AA1;FLOT1;SPATA2;CFLAR
prerank,intracellular sterol transport (GO:0032366),-0.42858806473512956,-1.1500904034334603,0.2664576802507837,0.7805156467106651,1.0,6/13,12.31%,ABCA1;OSBP;OSBPL2;VPS4A;ABCG1;STARD4
prerank,metal ion transport (GO:0030001),0.3833827070935424,1.1498789593318848,0.2588105726872247,1.0,1.0,17/86,14.33%,CACNA1E;CACNA2D1;MRS2;CACNG7;NIPA1;CACNA1A;CHRNA4;PSEN1;MT3;NIPAL2;SLC8A2;FYN;MAGT1;NDFIP1;TRPC5;TUSC3;PSEN2
prerank,regulation of peptidyl-lysine acetylation (GO:2000756),0.5605029031186829,1.1497110081116768,0.3209076175040519,1.0,1.0,6/10,21.94%,KLF15;DIP2A;SETD5;DIP2B;PARK7;PRKAA1
prerank,response to hydroxyurea (GO:0072710),0.5380380645846491,1.149630431525884,0.3313161875945537,1.0,1.0,5/11,15.98%,DDX11;NSMCE3;ATRX;BLM;SPIDR
prerank,chloride transport (GO:0006821),0.3891873383352524,1.1493641177928817,0.25904977375565613,1.0,1.0,14/74,15.81%,FXYD3;ANO2;SLC1A3;SLC12A3;ANO6;SLC12A2;TTYH3;TTYH1;SLC12A4;FXYD1;ANO10;CLIC1;CLCN2;GABRG2
prerank,negative regulation of protein modification process (GO:0031400),0.3905104156339882,1.1493270510011766,0.2718232044198895,1.0,1.0,18/79,12.61%,NTRK3;PIP5KL1;PTEN;PRKN;EPHB2;CADM4;TGFB1;PRNP;PPP1R15A;PTPN13;NIBAN1;MEN1;ENSA;PPP1R8;CDYL;PID1;FXYD1;WWTR1
prerank,nucleic acid phosphodiester bond hydrolysis (GO:0090305),0.3895388047450125,1.149186769693242,0.2671081677704194,1.0,1.0,18/72,15.16%,RNASE6;GTF2H2;ERCC5;DXO;ERCC4;DDB2;RPA3;SETMAR;XRN2;XPA;DCP1B;REXO4;EDC4;FBH1;DDB1;EXD2;RPA2;UBB
prerank,negative regulation of neuron death (GO:1901215),0.38127314714182614,1.1488964349021071,0.26043956043956046,1.0,1.0,22/93,19.35%,ERBB3;BCL2;CD34;CRLF1;NGF;PRKN;NTRK2;MT3;FBXO7;RASA1;SNX6;EIF4G1;GDNF;GRN;SOD2;PTPRZ1;SNCA;FZD9;TGFB3;MDK;PARK7;BTBD10
prerank,response to histamine (GO:0034776),0.5438788526986761,1.148579280820156,0.3073322932917317,1.0,1.0,4/10,15.81%,HRH1;AOC1;DRD2;GABRG2
prerank,lipid oxidation (GO:0034440),0.5251462873316011,1.1485759361408086,0.3293591654247392,1.0,1.0,2/12,8.14%,PLA2G7;ACOX1
prerank,regulated exocytosis (GO:0045055),-0.251304048844611,-1.1477072313700127,0.1,0.7858380270071468,1.0,40/173,12.58%,IGF1;ABCC4;VWF;MYH9;PECAM1;VEGFC;RAB11B;SYT9;STXBP1;VEGFD;RAB31;VTI1B;ARHGAP17;LYN;GTPBP2;CYRIB;IGF2;TEX264;THBS1;F8;HABP4;ACTN1;TIMP3;CD109;APP;ACTN2;SDF4;FN1;SRGN;MANF;CPLX1;TMX3;SOD1;SYT10;TMSB4X;SERPINE1;SYTL4;SNAPIN;TGFB2;SYT6
prerank,negative regulation of endothelial cell migration (GO:0010596),0.42823097881350597,1.1472510027804015,0.2866161616161616,1.0,1.0,3/36,4.08%,DCN;FGF2;TGFB1
prerank,regulation of long-term neuronal synaptic plasticity (GO:0048169),-0.4655757255880581,-1.1471453368602258,0.30303030303030304,0.7852406821482821,1.0,3/10,6.90%,SHANK3;RAB5A;APP
prerank,mRNA splice site selection (GO:0006376),0.44148661429988617,1.1469708436259847,0.2880921895006402,1.0,1.0,11/30,20.55%,CELF5;LUC7L2;PSIP1;CELF6;SRSF6;YTHDC1;LUC7L;PRPF39;SF3A1;SF1;CELF4
prerank,Golgi inheritance (GO:0048313),0.5383569293533635,1.146775970669965,0.3011093502377179,1.0,1.0,2/11,7.30%,YWHAZ;GBF1
prerank,regulation of neurogenesis (GO:0050767),0.40029078806728147,1.1462157343385733,0.27176470588235296,1.0,1.0,5/55,5.44%,CCL11;DOCK7;SOX11;PCM1;NUMBL
prerank,phosphatidylcholine biosynthetic process (GO:0006656),0.4437970620558641,1.1459817540213748,0.29389312977099236,1.0,1.0,9/32,20.03%,SLC27A1;SLC44A2;PCYT1B;CHPT1;CHAT;GPAT4;SLC44A1;CSNK2A2;STARD7
prerank,epithelial cell differentiation (GO:0030855),0.37826330958125054,1.145298141467831,0.2631016042780749,1.0,1.0,18/88,14.13%,LGALS3;TST;VEGFA;CNN3;GLI1;UPK1B;CASP6;FZD7;GATA6;CTSB;PIH1D1;HDAC2;ERBB4;TOLLIP;SCRIB;GATA3;SCUBE1;PTER
prerank,tRNA aminoacylation (GO:0043039),0.4213679593107129,1.1452045920017433,0.30472636815920395,1.0,1.0,9/37,14.03%,IARS2;EPRS1;FARSA;GATB;SARS2;FARSB;FARS2;YARS1;HARS1
prerank,peptidyl-lysine trimethylation (GO:0018023),0.45168859049696664,1.1450623822654533,0.295364238410596,1.0,1.0,13/26,26.92%,SUV39H1;KMT2A;SETD3;PRDM9;SETD2;SETD5;TET3;SETD4;KMT2D;TET2;KMT5B;VCPKMT;KMT5C
prerank,phosphatidylcholine acyl-chain remodeling (GO:0036151),0.44271545584064653,1.144971480677531,0.31202046035805625,1.0,1.0,8/29,19.94%,PLBD1;MBOAT2;PLA2G12A;PLAAT3;PNPLA8;LPCAT2;DBI;PLA2G4E
prerank,protein localization to membrane (GO:0072657),0.3617402923372168,1.144826817475155,0.22448979591836735,1.0,1.0,42/187,15.41%,PTCH1;ANK3;ANK1;HPS6;FGF13;ANK2;RAB38;C2CD5;SAV1;WNK3;ARL3;PACS2;NPC1;NRXN1;TSPAN32;TNIK;DLG2;SPTBN1;NLGN1;NUP155;DPP10;RAP1A;RAB34;GAK;EPB41L3;FLNA;RAB3D;ARL5C;NDC1;TSPAN17;MAGI2;DVL1;RAB3A;SCRIB;MAP7;KCNIP4;P2RY1;TMED2;TTC7A;EHD2;PKP2;JUP
prerank,positive regulation of endothelial cell chemotaxis (GO:2001028),0.5065244879123618,1.1446221791624567,0.3245997088791849,1.0,1.0,5/15,15.00%,FGF2;VEGFA;FGFR1;SMOC2;MET
prerank,protein localization to plasma membrane (GO:0072659),0.3704752155862668,1.1446009209874137,0.23774765380604795,1.0,1.0,30/129,15.41%,PTCH1;ANK3;ANK1;FGF13;ANK2;GORASP1;C2CD5;WNK3;PACS2;TSPAN32;TNIK;SPTBN1;DPP10;RAP1A;RAB34;GAK;EPB41L3;FLNA;RAB3D;TSPAN17;GORASP2;RAB3A;MAP7;KCNIP4;P2RY1;TMED2;TTC7A;EHD2;PKP2;JUP
prerank,snRNA metabolic process (GO:0016073),0.48738850954144997,1.1438204985568567,0.3177966101694915,1.0,1.0,7/17,15.73%,INTS11;INTS6;INTS4;INTS2;INTS8;RBM7;MEPCE
prerank,positive regulation of calcium ion transmembrane transporter activity (GO:1901021),0.4695424966054083,1.1437942698755013,0.29740791268758526,1.0,1.0,8/22,21.48%,ANK2;AKAP6;CALM1;CALM2;SLC9A1;HTT;VMP1;PKD2
prerank,negative regulation of cell population proliferation (GO:0008285),0.35547935276183523,1.1436817693028791,0.16733466933867736,1.0,1.0,64/351,16.21%,APOD;ROR2;DLC1;SSTR1;WNK2;BMP5;CLDN19;FAP;GLMN;MYC;PTEN;KAT2B;SOX9;NGF;VGLL4;CDKN2B;FRZB;PTPN2;PTHLH;TGFB1;SOX11;NUPR2;NF1;ACVR1C;WNT5A;PAK1;BNIPL;PODN;TSC1;ADAMTS1;CYP1B1;CBFA2T3;GATA6;CDK6;MEN1;NF2;COL18A1;RARG;ERBB4;SFRP4;PTPRJ;EMD;ATRAID;MAGI2;ING4;ATP8A2;DRD2;SOD2;ATF5;ADARB1;STRN;GATA3;RBBP4;NACC2;RPS6KA2;PDS5B;MDM4;CD164;LMNA;MED25;PIM2;TP53;GPLD1;TGFB3
prerank,positive regulation of alpha-beta T cell activation (GO:0046635),0.49838145336784606,1.1428226778908288,0.2989985693848355,1.0,1.0,2/15,5.23%,HSPH1;CCR2
prerank,regulation of oxidative phosphorylation (GO:0002082),-0.3981008181375003,-1.1424140341411388,0.25,0.7975417281297409,1.0,9/16,28.53%,ATP7A;SLC25A33;NUPR1;PINK1;AK4;PDE12;COX7A2;PPIF;VCP
prerank,homotypic cell-cell adhesion (GO:0034109),0.4256159344213852,1.1421737307764879,0.29927007299270075,1.0,1.0,4/39,2.62%,UBASH3B;PDGFRA;CSRP1;RAP2B
prerank,response to muramyl dipeptide (GO:0032495),0.5270504797424116,1.1418825059401874,0.33634992458521873,1.0,1.0,3/12,11.27%,PTPN22;ERBIN;TRIM41
prerank,negative regulation of G protein-coupled receptor signaling pathway (GO:0045744),0.4804442717935869,1.1417431448376283,0.31456043956043955,1.0,1.0,5/20,15.00%,RNF157;BICD1;SNCA;CRY1;MET
prerank,synaptic vesicle fusion to presynaptic active zone membrane (GO:0031629),0.5265767915622114,1.1408951556057003,0.32608695652173914,1.0,1.0,5/12,24.33%,SNAP23;SNAP29;STX1B;STX2;SNAP47
prerank,negative regulation of G2/M transition of mitotic cell cycle (GO:0010972),-0.28104468473578775,-1.1401561953774602,0.1780821917808219,0.8020858644277702,1.0,26/65,30.00%,PSMD14;FBXL7;USP47;PSMB3;PSMD12;VPS4A;PSMD6;PSMA1;PSMD7;NABP1;PSMA5;PSMC5;PINX1;PSMC4;PSMB6;PSMA4;CHFR;PSMB1;PSMB9;AVEN;ZFYVE19;PSMC6;PSMD3;PSMD10;PSME3;CHEK1
prerank,regulation of hemopoiesis (GO:1903706),0.5523739658745084,1.13988342446602,0.3231240428790199,1.0,1.0,2/10,1.89%,LGALS3;CBFB
prerank,"retrograde protein transport, ER to cytosol (GO:0030970)",0.4790306742516853,1.1397534581481585,0.3026874115983027,1.0,1.0,5/17,13.00%,HM13;DERL2;SELENOS;HERPUD1;HSP90B1
prerank,positive regulation of endopeptidase activity (GO:0010950),0.44914254429060585,1.1396777427217721,0.29649595687331537,1.0,1.0,7/26,13.71%,USP50;PYCARD;GRIN2B;FYN;NCSTN;APH1A;TTBK1
prerank,positive regulation of cell-substrate adhesion (GO:0010811),0.39512194848485516,1.1395574656972929,0.30371203599550056,1.0,1.0,15/67,17.76%,VIT;UTRN;OLFM4;FBLN2;DOCK5;CDK6;FLNA;DOCK1;ARL2;MYOC;JUP;ABL1;RELL2;RAC3;MDK
prerank,regulation of cellular component organization (GO:0051128),0.3649030168723016,1.139452751139878,0.2513089005235602,1.0,1.0,37/135,16.92%,PTCH2;PRKCQ;ANGPTL7;STON2;NRG3;PAK4;IRAK3;PACSIN2;PAK5;WNT5A;URI1;STON1;RAP1A;LAMTOR2;ARHGEF11;BAG5;HIP1;ANKRA2;SGK3;SGK2;PTPN1;PTPN11;OPHN1;HJURP;RAB4B;CHPT1;SETD5;ATF5;RAB4A;ARFGAP1;GFAP;PAPPA2;TMEM97;ABL1;HNRNPU;SGK1;SNX12
prerank,positive regulation of double-strand break repair (GO:2000781),0.4199436746782292,1.139409341791961,0.2983770287141074,1.0,1.0,7/39,10.55%,DDX11;SPIRE1;FMN2;MRNIP;SETMAR;FOXM1;SLF2
prerank,regulation of interleukin-6 production (GO:0032675),0.3772064727848695,1.139298640199274,0.2683982683982684,1.0,1.0,22/96,20.89%,IL16;PYCARD;PTPN22;IRAK3;MAPKAPK2;WNT5A;TMEM106A;CARD9;SYT11;SELENOS;TLR1;PTPN11;IL33;FOXJ1;CD74;RAB7B;LBP;SETD4;BCL10;STAT3;SIRPA;HSPD1
prerank,negative regulation of oxidative stress-induced neuron death (GO:1903204),0.5246694420600626,1.1391036852889096,0.31942215088282505,1.0,1.0,3/11,9.47%,PRKN;FBXO7;HIF1A
prerank,neural tube closure (GO:0001843),0.4283425606487078,1.139014078951847,0.3016905071521456,1.0,1.0,10/34,21.46%,DLC1;TGFB1;PRICKLE1;DVL1;SCRIB;COBL;LRP2;PAX2;BCL10;DVL3
prerank,regulation of cellular component movement (GO:0051270),-0.29866449846501486,-1.138757126593099,0.23529411764705882,0.8040137548353671,1.0,16/49,9.34%,SP100;ROCK2;ETS1;ROCK1;DIAPH1;LYN;YTHDF1;TGFBR1;ABL2;RPS19;ZSWIM6;PDPN;ACTN1;ARAP1;ZSWIM4;RHOA
prerank,rRNA modification (GO:0000154),-0.36887387735581445,-1.1385490743526825,0.2980392156862745,0.8021268713731361,1.0,11/21,30.33%,ZCCHC4;NSUN3;DKC1;BUD23;DIMT1;GAR1;METTL5;TFB2M;TSR3;MRM2;NHP2
prerank,protein destabilization (GO:0031648),0.4278779549266773,1.1378031452499286,0.31505102040816324,1.0,1.0,10/32,18.47%,GSN;PRKN;KDM8;PRNP;CUL3;SNCA;SENP2;CDC73;MDM2;HTT
prerank,negative regulation of myotube differentiation (GO:0010832),-0.44763393007708313,-1.1375528591848285,0.2976878612716763,0.8029411733349815,1.0,4/12,22.43%,HDAC4;TMEM119;HDAC3;HDAC5
prerank,positive regulation of epidermal growth factor-activated receptor activity (GO:0045741),0.5472302442567427,1.137370438772973,0.32457496136012365,1.0,1.0,4/10,17.28%,FBXW7;NCF1;BTC;HBEGF
prerank,negative regulation of RNA metabolic process (GO:0051253),0.47622183910029725,1.137186464100149,0.31029810298102983,1.0,1.0,5/18,14.53%,KAT2B;TGFB1;SHQ1;ESR1;NCOR2
prerank,regulation of heterotypic cell-cell adhesion (GO:0034114),-0.357286789033826,-1.1371689735747847,0.25287356321839083,0.8017226252354539,1.0,4/22,8.82%,GCNT2;MAP2K5;WNK1;KLF4
prerank,positive regulation of glucose metabolic process (GO:0010907),0.5085063646250826,1.1369179866444536,0.3263473053892216,1.0,1.0,4/14,16.10%,IRS2;PTPN2;DDB1;GPLD1
prerank,renal system development (GO:0072001),0.4056922779642594,1.1365712910139643,0.2842227378190255,1.0,1.0,6/52,3.63%,SULF1;HAS2;GLI2;LRP4;VEGFA;ARL3
prerank,positive regulation of phospholipase activity (GO:0010518),0.4662678463162078,1.1365034881526137,0.31393775372124494,1.0,1.0,7/22,10.80%,PDGFRA;NTRK3;FGF2;ARL1;FGFR1;ESR1;ARF4
prerank,primary neural tube formation (GO:0014020),0.4363205712800752,1.1358255175870502,0.3253968253968254,1.0,1.0,8/30,19.55%,DLC1;TGFB1;PRICKLE1;SCRIB;COBL;LRP2;PAX2;BCL10
prerank,positive regulation of T cell mediated cytotoxicity (GO:0001916),0.5124974794605757,1.135762145274851,0.312406576980568,1.0,1.0,3/13,12.73%,FADD;MR1;NECTIN2
prerank,regulation of protein localization (GO:0032880),-0.2818938434063022,-1.135304945410409,0.2222222222222222,0.8052799623061219,1.0,21/58,20.12%,AFDN;MAP2;KDM1A;TRIM25;RABGAP1L;PARP1;TRIM5;CAMK1;RACK1;ZDHHC7;VPS4A;RAB9A;HSP90AA1;ATCAY;PPM1F;TRIM21;PLEKHM2;TRIM17;HSP90AB1;TRIM68;ADCYAP1
prerank,histone acetylation (GO:0016573),0.38910304431178866,1.1352945907068615,0.2916201117318436,1.0,1.0,18/69,15.62%,KAT2B;JADE1;HAT1;TADA1;TAF5L;JADE3;KAT8;BRD8;MORF4L2;POLE3;ATF2;PHF20;TAF9;ING4;EPC1;PER1;TRRAP;MSL3
prerank,cell-matrix adhesion (GO:0007160),0.3785533034500512,1.135266143117837,0.2612021857923497,1.0,1.0,21/95,17.75%,DLC1;ADAMTS12;RHOD;CD34;PEAK1;ITGB8;TESK2;HOXD3;TSC1;MKLN1;COL3A1;TRIP6;SGCE;PPFIA2;TMEM8B;PKD1;ITGB1;ZYX;CTTN;ITGB7;PIP5K1A
prerank,response to calcium ion (GO:0051592),0.37375219119928166,1.1352540357493623,0.28324324324324324,1.0,1.0,36/102,24.07%,CPNE8;DPEP1;HPCA;SCN5A;WNT5A;SYT1;NLGN1;PPP3CA;KCNMB2;KCNMB3;ANXA11;SYT11;SYT12;ALOX5AP;AHCYL1;CALM1;IQGAP1;HOMER1;CALM2;GPLD1;SLC25A24;KCNMA1;CPNE7;SYT2;RYR3;CPNE1;SYT13;ADCY8;PEF1;CPNE3;PKD2;PRKAA1;CAMK2D;CPNE5;SYT3;MEF2A
prerank,mitochondrion disassembly (GO:0061726),0.43022380455719905,1.135146200036152,0.3116883116883117,1.0,1.0,8/34,14.97%,PRKN;FBXO7;WIPI1;CTSK;BNIP3;ATG5;ATG3;GABARAPL2
prerank,regulation of insulin-like growth factor receptor signaling pathway (GO:0043567),0.48827424176588463,1.1347582546344932,0.3111432706222865,1.0,1.0,2/16,1.34%,BMP5;ZFAND2B
prerank,"nucleotide-excision repair, DNA duplex unwinding (GO:0000717)",0.45872779192800217,1.1344948779255684,0.3143254520166898,1.0,1.0,7/22,17.08%,RAD23B;GTF2H2;DDB2;XPA;DDB1;UBB;CUL4B
prerank,regulation of mitochondrial membrane permeability (GO:0046902),0.4874803030821893,1.1340976210086897,0.32210834553440704,1.0,1.0,3/18,7.73%,BCL2;THEM4;BNIP3
prerank,activation of phospholipase C activity (GO:0007202),0.4386340788539501,1.1332162957254346,0.3110236220472441,1.0,1.0,3/29,4.52%,EGFR;LPAR1;NTRK2
prerank,protein insertion into membrane (GO:0051205),0.44008467107376675,1.1330491777584721,0.3104325699745547,1.0,1.0,12/32,20.60%,EGFR;WDR83OS;PRNP;COX18;VAPA;UBE2J2;EMD;OTOF;CCDC47;SEC61G;CYB5A;SGTA
prerank,organic substance transport (GO:0071702),0.368323706228058,1.132755748517858,0.2631027253668763,1.0,1.0,15/121,11.36%,ABCA6;SLC6A2;ABCA9;SLC22A3;RAB38;CD320;SCAMP2;SLCO2B1;PEX3;GM2A;SLC50A1;RCN3;ABCA5;NDC1;ARL6IP5
prerank,tube closure (GO:0060606),0.4324903820125455,1.132642533951487,0.32717678100263853,1.0,1.0,8/31,19.55%,DLC1;TGFB1;PRICKLE1;SCRIB;COBL;LRP2;PAX2;BCL10
prerank,anterior/posterior axis specification (GO:0009948),-0.4148175947941108,-1.1325605562012868,0.3343949044585987,0.8114095412193485,1.0,2/15,3.72%,WLS;TBX3
prerank,positive regulation of bone mineralization (GO:0030501),0.42811387846595167,1.132250597264404,0.31021437578814626,1.0,1.0,12/35,16.21%,OSR2;PKDCC;ACVR1;ANO6;TGFB1;GPM6B;BMP7;ATRAID;ATP2B1;BMPR1A;FZD9;TGFB3
prerank,phosphatidylinositol-mediated signaling (GO:0048015),0.391109528493463,1.1319351268949704,0.29398663697104677,1.0,1.0,12/69,8.25%,PDGFRA;ERBB3;PTEN;IRS2;NGF;ERBB2;PLCB1;NF1;NYAP1;PI4KB;FGFR1;GAB2
prerank,snRNA 3'-end processing (GO:0034472),0.4769465836124105,1.1318823321478106,0.33379120879120877,1.0,1.0,6/19,13.91%,USB1;INTS6;EXOSC8;EXOSC2;INTS2;INTS8
prerank,negative regulation of immune effector process (GO:0002698),0.5068681596958549,1.1318514874142431,0.3307926829268293,1.0,1.0,1/13,0.37%,LGALS3
prerank,regulation of T cell proliferation (GO:0042129),0.3975395852110038,1.1313260480591383,0.2954808806488992,1.0,1.0,6/61,13.99%,LGALS3;GLMN;SDC4;IL4I1;IL6ST;NCK1
prerank,membrane lipid catabolic process (GO:0046466),0.5308109043096267,1.1309057613667242,0.3297709923664122,1.0,1.0,3/10,12.21%,NAGA;CYP1B1;PDXDC1
prerank,anterograde axonal transport (GO:0008089),-0.3215172739584514,-1.1308408480671779,0.2457627118644068,0.8145355676686838,1.0,10/37,12.83%,KIF3B;KIF1C;TRAK1;DTNBP1;KIF1B;KIF5B;BLOC1S5;SOD1;SNAPIN;AP3D1
prerank,positive regulation of leukocyte migration (GO:0002687),0.44556798796016533,1.130785811692636,0.31729518855656696,1.0,1.0,2/27,3.14%,LGALS3;VEGFA
prerank,nucleotide-sugar biosynthetic process (GO:0009226),0.46610959854546385,1.130619011358591,0.3352685050798258,1.0,1.0,2/19,3.68%,GFPT2;NAGK
prerank,glucose 6-phosphate metabolic process (GO:0051156),0.46578403334912766,1.1305970311592095,0.3385490753911807,1.0,1.0,11/21,27.68%,H6PD;RPE;SHPK;PGLS;HK2;TALDO1;HK1;RBKS;RPIA;PGM2;GCK
prerank,atrioventricular valve development (GO:0003171),0.49928498091119483,1.1302761646769002,0.31791044776119404,1.0,1.0,6/14,17.57%,ACVR1;TGFBR2;MDM4;BMPR1A;APLNR;HEYL
prerank,negative regulation of blood coagulation (GO:0030195),0.42090040827387826,1.1302016154590544,0.2922885572139303,1.0,1.0,3/38,1.88%,A2M;PDGFRA;CD34
prerank,positive regulation of T-helper 1 type immune response (GO:0002827),0.5162993016250313,1.1297919507481644,0.35118110236220473,1.0,1.0,2/12,7.90%,CCR2;IL18
prerank,pre-miRNA processing (GO:0031054),-0.4227455560225303,-1.129774631563022,0.2873900293255132,0.8155144532711655,1.0,9/14,30.18%,AGO1;TUT7;AGO3;TARBP2;LIN28B;MRPL44;AGO2;DICER1;AGO4
prerank,positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress (GO:1990440),0.527618804287557,1.129628123787619,0.3312597200622084,1.0,1.0,1/11,1.22%,CREB3L1
prerank,cellular response to transforming growth factor beta stimulus (GO:0071560),-0.2616159834173695,-1.1295113376440244,0.1791044776119403,0.8138942173835692,1.0,27/112,12.51%,PTPRK;GCNT2;WNT4;SMAD6;CDH5;CLDN5;ITGB5;APPL2;ACVRL1;SMAD7;ENG;ID1;USP9X;SMAD9;TGFBR1;PDCD5;PARD3;ZFP36L1;PDE3A;TWSG1;PRKCZ;RHOA;NLK;LRRC32;MAP3K7;PDE2A;TGFB2
prerank,positive regulation of B cell activation (GO:0050871),0.40173612011439996,1.1295080305812675,0.3069544364508393,0.9997860816302853,1.0,5/50,3.90%,BCL2;IRS2;BST1;EPHB2;CD320
prerank,positive regulation of transferase activity (GO:0051347),0.3654840594319639,1.129398587940808,0.2588357588357588,0.9990341600602604,1.0,15/142,4.52%,ROR2;ROR1;PDGFRA;ERBB3;PRKCQ;NTRK3;MYC;EPHB6;ERBB2;EGFR;EPHB2;FBXW7;CHTF18;TGFB1;NTRK2
prerank,positive regulation of axonogenesis (GO:0050772),-0.3013837334020341,-1.129024755378553,0.18994413407821228,0.81306279859827,1.0,12/43,13.22%,MACF1;PLXNA2;ROBO1;GOLGA4;SEMA7A;SLIT2;RHOA;PLXNB1;ZFYVE27;MAPT;PLXNA1;PLXNA4
prerank,regulation of protein-containing complex assembly (GO:0043254),0.3721803389271615,1.1288059874616467,0.28286014721345953,1.0,1.0,24/110,16.06%,LGALS3;HRK;GSN;VEGFA;TGFB1;ATF7IP;RALB;BMF;BRK1;ANKRA2;CRYAB;PIH1D1;FARP2;SLF2;PTPN11;HDAC6;RHOC;HJURP;SUMO1;GFAP;MTLN;STX1B;SPIDR;BCL2L11
prerank,lipopolysaccharide-mediated signaling pathway (GO:0031663),0.46002347622838224,1.128115778664568,0.3042291950886767,1.0,1.0,9/20,26.58%,PTPN22;TGFB1;IL18;TICAM1;LBP;BCL10;PRKCE;HCK;IRAK1
prerank,natural killer cell mediated immunity (GO:0002228),-0.4157277284204321,-1.1276344681131698,0.30067567567567566,0.8152110851480451,1.0,5/15,25.48%,KIF5B;TUBB4B;PLEKHM2;CEBPG;ULBP1
prerank,regulation of cell-cell adhesion (GO:0022407),-0.3185838686764857,-1.127356014689121,0.2647058823529412,0.8136966729255728,1.0,6/39,3.20%,AFDN;EPHA7;PTPRG;PODXL;SMAD7;CDH1
prerank,protein localization to cell periphery (GO:1990778),0.36564033993910483,1.1272757615462592,0.26834381551362685,1.0,1.0,29/133,15.41%,PTCH1;ANK3;ANK1;FGF13;ANK2;C2CD5;WNK3;ARL3;PACS2;TSPAN32;TNIK;SPTBN1;DPP10;RAP1A;RAB34;GAK;EPB41L3;FLNA;RAB3D;TSPAN17;RAB3A;MAP7;KCNIP4;P2RY1;TMED2;TTC7A;EHD2;PKP2;JUP
prerank,negative regulation of epidermal growth factor receptor signaling pathway (GO:0042059),0.4145669675310088,1.126635930383365,0.2928311057108141,1.0,1.0,14/43,19.23%,CBLB;EGFR;PTPN2;SOCS5;EPS15;BTC;SNX6;PTPRJ;CBL;ZGPAT;SH3KBP1;HBEGF;RAB7A;GRB2
prerank,inner ear morphogenesis (GO:0042472),0.46791752561505384,1.1265609811300192,0.33063427800269907,1.0,1.0,4/22,7.60%,SOX9;EPHB2;TTC39C;TBX18
prerank,positive regulation of multicellular organismal process (GO:0051240),0.3508118884689057,1.1265378784473472,0.19759277833500502,1.0,1.0,34/308,8.89%,EBF2;FFAR4;SOX6;ETV4;GLIPR2;CRH;SLC27A1;GLMN;FGF2;SOX8;PRDM16;SOX9;LRP1;ACVR1;VEGFA;TGFB1;SOX11;PLCB1;CCR2;WNT5A;NLGN1;AGPAT2;RFX3;PTH2R;ZBTB16;TGFBR2;PRKAB2;CARD9;IL18;TSHR;CADM1;ELOVL6;SMO;SOX5
prerank,regulation of platelet aggregation (GO:0090330),0.4737066118924237,1.1262584275702443,0.33766233766233766,1.0,1.0,3/17,8.22%,PRKCA;PRKCQ;SERPINE2
prerank,regulation of extrinsic apoptotic signaling pathway (GO:2001236),0.392297444027865,1.1261091814954287,0.3077816492450639,1.0,1.0,7/63,4.25%,LGALS3;BCL2L14;PYCARD;FADD;ACVR1;TNFRSF10B;DEPTOR
prerank,positive regulation of mRNA catabolic process (GO:0061014),-0.2990401037979741,-1.1260487963321857,0.24242424242424243,0.8155720433794095,1.0,9/44,7.84%,ROCK2;ZC3HAV1;ROCK1;YTHDF1;MOV10;ZFP36L1;METTL14;CNOT1;GTPBP1
prerank,positive regulation of catabolic process (GO:0009896),0.3868393554220924,1.1259504973923866,0.2805017103762828,1.0,1.0,12/65,16.25%,GPC3;PRKN;HACE1;WNT5A;ASB5;HUWE1;APC2;DDB1;NEDD4L;AREL1;DACT1;NDUFA13
prerank,natural killer cell mediated cytotoxicity (GO:0042267),-0.4113147988922402,-1.1255958555013619,0.3088235294117647,0.8146519361859192,1.0,6/16,25.48%,KIF5B;TUBB4B;PLEKHM2;CEBPG;VAMP7;ULBP1
prerank,lymphocyte differentiation (GO:0030098),0.39186879408558306,1.1253382508530458,0.29770114942528736,1.0,1.0,21/68,25.77%,RAG2;PTPN22;PTPN2;DNAJB9;RABL3;NHEJ1;PTPRJ;DCAF1;RHOH;GATA3;ITGB1;MS4A1;AXL;PBX1;CR2;KAT7;NFAM1;LMBR1L;SOX4;TPD52;ITGA4
prerank,T cell homeostasis (GO:0043029),0.5454497242871141,1.1248188629109117,0.3628048780487805,1.0,1.0,2/10,7.55%,FADD;ZC3H8
prerank,negative regulation of myeloid leukocyte differentiation (GO:0002762),0.4528575225140037,1.1247401430588106,0.32763157894736844,1.0,1.0,4/26,7.57%,MYC;PTPN2;HOXA7;CDK6
prerank,presynapse organization (GO:0099172),0.5187847207395124,1.1246314148571253,0.3385579937304075,1.0,1.0,4/10,16.30%,WNT5A;NLGN1;DVL1;LRRTM3
prerank,amino acid import across plasma membrane (GO:0089718),-0.35512413088486866,-1.1245303120264705,0.28515625,0.8158549156825121,1.0,6/24,3.59%,SLC7A2;SLC47A1;SLC6A6;SLC22A4;SLC6A13;SLC7A5
prerank,inflammatory response (GO:0006954),0.3568769874851957,1.1244204458941809,0.24696356275303644,1.0,1.0,20/195,10.43%,HSPG2;CCL11;CXCL10;CRH;IL2RA;TAC1;HRH1;PTGER3;NFX1;TGFB1;CCL4;PTGFR;MAPKAPK2;CCR2;NOX1;LOXL3;IL18;NFATC3;PXK;TLR1
prerank,negative regulation of DNA replication (GO:0008156),-0.4243064715442386,-1.1243599372934823,0.29559748427672955,0.8140164443956804,1.0,2/13,6.25%,WAPL;S100A11
prerank,regulation of bone mineralization (GO:0030500),0.400265020768951,1.1239549143760559,0.32175925925925924,1.0,1.0,7/55,4.11%,OSR2;ANKH;PKDCC;ACVR1;ANO6;TGFB1;GPM6B
prerank,regulation of developmental growth (GO:0048638),-0.33298920100926827,-1.1238843550692943,0.2465753424657534,0.81315027608903,1.0,12/29,18.78%,IGF1;LATS2;INSR;STAT5B;APP;SIX1;GSK3B;SOD1;DNM2;MFSD2A;APOE;SIN3A
prerank,regulation of B cell activation (GO:0050864),0.43638093034954484,1.1238790707607638,0.31799729364005414,1.0,1.0,7/25,21.40%,SAMSN1;IL4I1;ZFP36L2;AHR;SH3KBP1;FOXJ1;TNIP2
prerank,regulation of antigen receptor-mediated signaling pathway (GO:0050854),0.5118081982230174,1.1238151559862322,0.3323170731707317,1.0,1.0,2/12,1.89%,PTPN22;CBFB
prerank,regulation of axon extension involved in axon guidance (GO:0048841),0.43982433520676883,1.123734676356711,0.34,0.9997189405971402,1.0,8/24,18.86%,SEMA3E;SEMA6C;VEGFA;SEMA3A;DSCAM;SEMA6D;SEMA4B;SEMA4D
prerank,regulation of interleukin-1 beta production (GO:0032651),0.3846362125689417,1.123728375990967,0.32142857142857145,0.9985973622589466,1.0,5/66,5.57%,FFAR4;USP50;PYCARD;WNT5A;TMEM106A
prerank,fat cell differentiation (GO:0045444),0.39241921730498774,1.123643280433443,0.3010262257696693,0.9977912478756517,1.0,10/57,14.36%,FFAR4;STEAP4;SOX8;PRDM16;BBS9;FAM120B;PID1;TMEM120A;ATF5;SENP2
prerank,transport along microtubule (GO:0010970),0.5093132418453163,1.1235873349789673,0.35846153846153844,0.9968813223213492,1.0,7/13,15.04%,COPG2;SPG11;DYNC1I1;ARHGAP21;APBA1;DYNC1I2;COPG1
prerank,regulation of wound healing (GO:0061041),0.4083973783734509,1.1233022522082985,0.3038130381303813,0.9968638720014334,1.0,10/42,17.28%,CLDN19;FGF2;EPHB2;CADM4;CLDN1;AJAP1;SRSF6;ITGB1;ARFGEF1;HBEGF
prerank,cellular biogenic amine metabolic process (GO:0006576),0.5120254584593991,1.1231166497274447,0.3318840579710145,0.9964072566758926,1.0,2/12,5.04%,SLC22A3;SMS
prerank,positive regulation of endoplasmic reticulum unfolded protein response (GO:1900103),0.5125054820503746,1.1225128077373079,0.34023668639053256,0.9975397934362221,1.0,4/12,16.06%,PTPN1;PIK3R1;TMEM33;BCL2L11
prerank,regulation of microtubule depolymerization (GO:0031114),0.4460416353013377,1.1224204205897037,0.3469656992084433,0.9968040900965998,1.0,8/25,18.72%,FGF13;MAP1B;CLASP1;APC2;KATNB1;NAV3;ATXN7;CAMSAP1
prerank,vasodilation (GO:0042311),-0.415826896270858,-1.1224118875203977,0.3102409638554217,0.8155515197112775,1.0,6/13,22.32%,NOS3;KLF2;SOD1;NOS1;GPER1;ADRB2
prerank,ESCRT III complex disassembly (GO:1904903),-0.4581775618477819,-1.1223750309860188,0.32142857142857145,0.8110153765838328,1.0,5/10,23.97%,VPS4A;CHMP1A;VPS4B;CHMP7;CHMP2B
prerank,ESCRT complex disassembly (GO:1904896),-0.4581775618477819,-1.1223750309860188,0.32142857142857145,0.8110153765838328,1.0,5/10,23.97%,VPS4A;CHMP1A;VPS4B;CHMP7;CHMP2B
prerank,negative regulation of anoikis (GO:2000811),0.5033197030691207,1.1223309492026436,0.3352941176470588,0.9960339438761165,1.0,2/14,3.82%,BCL2;TLE1
prerank,mitochondrial protein processing (GO:0034982),0.5188393548946646,1.1222019000557,0.3275039745627981,0.9954360559334012,1.0,6/11,22.67%,MIPEP;ATP23;PMPCB;YME1L1;PMPCA;IMMP2L
prerank,cell migration involved in sprouting angiogenesis (GO:0002042),-0.3850979030502344,-1.1219008534108894,0.3024054982817869,0.8103223595936703,1.0,6/17,4.56%,ROBO1;NRP1;PIK3R3;SLIT2;EPHB4;KDR
prerank,potassium ion export across plasma membrane (GO:0097623),0.5022006540326653,1.1218027040472653,0.3251088534107402,0.9957631845803021,1.0,4/13,19.17%,KCND3;KCNT2;KCNH2;KCNA5
prerank,positive regulation of endothelial cell migration (GO:0010595),-0.273602676991582,-1.1217686582272268,0.208955223880597,0.8084142644113173,1.0,21/84,12.04%,FOXP1;ANXA3;ROCK2;SASH1;ETS1;NRP1;TEK;ANGPT1;NOS3;BMP4;MAP2K3;BMPR2;KDR;THBS1;BCAR1;GPI;ATOH8;TMSB4X;LGMN;GATA2;PROX1
prerank,positive regulation of leukocyte proliferation (GO:0070665),-0.41655644775598216,-1.1217384814567641,0.2991202346041056,0.8062028509475934,1.0,2/12,3.82%,IL34;LYN
prerank,carnitine shuttle (GO:0006853),-0.4442131985057742,-1.1217304863922544,0.35555555555555557,0.8039537819599604,1.0,5/11,12.85%,PRKAG2;CPT1A;ACACB;PRKAA2;SLC25A20
prerank,cellular response to DNA damage stimulus (GO:0006974),0.34654631143535064,1.1209180112578248,0.19377510040160642,0.9979348143813018,1.0,86/336,18.82%,UBE2T;DDX11;MYC;BCL2;STXBP4;SUV39H1;UBE2E2;ZRANB3;FMN2;APTX;MBD4;WAC;POLE2;CHRNA4;PSEN1;NUPR2;NSMCE3;MAPKAPK2;PPP1R15A;MRNIP;ERCC4;PAK1;DDB2;METTL3;NUDT1;UFL1;MUTYH;MEN1;BRCA1;VAV3;XPA;TLK2;REXO4;TDP1;POLE3;ZBTB38;FBXO45;ENDOV;ATF2;SLF2;FBH1;MAPK14;FANCC;TAF9;ASF1A;MSH6;UPF1;TAOK3;STK33;ZBTB1;AKTIP;DDB1;HPF1;BRAT1;XRCC3;TOPBP1;PDS5B;RTEL1;SUMO1;CRY1;BAZ1B;CGAS;CASP2;ATM;TRRAP;ABL1;CSNK1E;RAD52;BLM;TP53;SPIDR;BCL2L11;XIAP;FAM111A;CUL4B;CEP63;WRN;NSMCE4A;UBA1;FBXO31;IRF3;ASH2L;AATF;PARK7;BATF;TAF1
prerank,copper ion homeostasis (GO:0055070),-0.3929457662083687,-1.1208698409036812,0.2937062937062937,0.8043097194114445,1.0,5/17,7.08%,SLC31A1;ATP7A;COMMD1;APP;SLC31A2
prerank,regulation of innate immune response (GO:0045088),-0.2857565719854606,-1.1208172946938628,0.2894736842105263,0.8022031367383756,1.0,25/57,27.49%,ERAP1;APPL2;BIRC3;PLSCR1;ABCE1;SAMHD1;CASP8;RIOK3;IRF1;TIRAP;NMI;TRIM21;APPL1;USP18;IFI35;POLR3D;HSP90AB1;IFNAR2;CACTIN;MUL1;TNFAIP3;TYRO3;LYAR;PTPN6;TKFC
prerank,regulation of response to endoplasmic reticulum stress (GO:1905897),-0.41990348428128266,-1.1207239355163714,0.31378299120234604,0.8002511936235535,1.0,7/13,22.12%,USP19;NUPR1;MANF;NR1H2;AQP11;NR1H3;CLU
prerank,positive regulation of response to wounding (GO:1903036),-0.3434343984079513,-1.1206813068772936,0.2873134328358209,0.7981304850109237,1.0,7/24,11.99%,PTN;VTN;OCLN;SCARF1;MYLK;ADRA2A;ACTG1
prerank,positive regulation of protein localization to plasma membrane (GO:1903078),0.3976289035730755,1.1204797227366576,0.2944640753828033,0.9984392142184972,1.0,9/52,10.37%,LGALS3;EGFR;LRP1;EPHB2;WNK3;SPTBN1;DPP10;ZDHHC8;PIK3R1
prerank,microtubule polymerization (GO:0046785),0.43605133916758143,1.1204533543709922,0.3329015544041451,0.997418036553922,1.0,7/28,13.07%,FGF13;CCDC57;NDE1;TUBGCP5;CLASP1;SLAIN2;CKAP5
prerank,second-messenger-mediated signaling (GO:0019932),0.3765412152733578,1.120119595631002,0.29262926292629265,0.9975556026475485,1.0,13/82,14.06%,CHRM3;HRH1;PPP1R9A;EIF2AK3;CCR2;ACKR3;RCAN1;RCAN3;MCTP1;EDN3;TPCN2;P2RY12;ACKR4
prerank,cranial nerve development (GO:0021545),0.5216885620327195,1.1186746118624906,0.34365781710914456,1.0,1.0,1/11,1.00%,ERBB3
prerank,regulation of nitric-oxide synthase activity (GO:0050999),-0.31211149230667534,-1.118125301318289,0.26,0.8042126182779264,1.0,13/36,18.76%,WASL;NOS3;NPR3;NOSTRIN;TERF2;DNM2;DDAH2;HSP90AA1;TERT;NUS1;SPR;CAV1;APOE
prerank,steroid hormone biosynthetic process (GO:0120178),0.43759966562542707,1.1179056681564745,0.32871536523929473,1.0,1.0,3/29,11.54%,HSD17B7;HSD17B11;TSPOAP1
prerank,positive regulation of membrane protein ectodomain proteolysis (GO:0051044),-0.4046395969203966,-1.1174018738541232,0.3353658536585366,0.8043103423488267,1.0,6/15,24.26%,SNX9;ADRA2A;NRDC;APOE;SNX33;SH3D19
prerank,regulation of telomere capping (GO:1904353),0.45142699808844733,1.1173094152917704,0.34054054054054056,1.0,1.0,7/23,16.25%,PRKCQ;MAPK1;NEK7;MAP3K4;RTEL1;ATM;SMG6
prerank,P-body assembly (GO:0033962),0.5083069142098332,1.1171717362611369,0.357032457496136,1.0,1.0,7/12,22.86%,ATXN2;LSM3;EIF4ENIF1;RC3H1;LIMD1;DDX6;DYNC1H1
prerank,internal peptidyl-lysine acetylation (GO:0018393),0.44308894055524506,1.117148467758945,0.3469119579500657,1.0,1.0,10/27,24.04%,KAT2B;KAT8;BRD8;MORF4L2;PHF20;TRRAP;MSL3;RUVBL2;KAT7;ATAT1
prerank,spliceosomal snRNP assembly (GO:0000387),-0.3251762547243813,-1.1171419317516644,0.25654450261780104,0.802899385258362,1.0,19/38,32.25%,PRPF3;PRMT7;SRSF10;STRAP;PRMT5;PRPF31;SNRPD3;SNRPE;DDX20;SNRPB;SRSF12;SART3;USP4;AAR2;SNRPD1;SNRPC;PRPF19;LSM4;SNRPG
prerank,response to organonitrogen compound (GO:0010243),0.41212265092083555,1.1170677474545185,0.32503113325031135,1.0,1.0,14/38,25.62%,KYNU;PRKN;IRAK3;HLCS;RCN3;DRD2;CCDC47;GLRB;UBXN6;RHBDD1;KAT7;MTOR;IRF5;ERLEC1
prerank,negative regulation of cell migration (GO:0030336),0.36094373741564917,1.1169208645403672,0.2803347280334728,1.0,1.0,30/137,14.77%,DLC1;CLDN19;SULF1;FGF2;PIP5KL1;PTEN;DPEP1;LRP1;PTPRT;RAP2B;HOXA7;RECK;NF1;ACVR1C;PODN;CYP1B1;NF2;COL3A1;MCTP1;PTPRJ;NGFR;CLASP1;MAGI2;DRD2;ADARB1;ARHGAP4;TCAF1;BMPR1A;LDLRAD4;CITED2
prerank,muscle filament sliding (GO:0030049),-0.31510085751583305,-1.1164734006889179,0.26903553299492383,0.800665847003771,1.0,20/38,41.93%,TPM3;MYL6;TPM1;ACTN2;TPM2;TMOD1;DES;MYBPC1;DMD;MYL4;TNNI1;TTN;MYL1;NEB;TNNC1;TNNI3;MYBPC2;TCAP;MYL3;ACTA1
prerank,actin-myosin filament sliding (GO:0033275),-0.31510085751583305,-1.1164734006889179,0.26903553299492383,0.800665847003771,1.0,20/38,41.93%,TPM3;MYL6;TPM1;ACTN2;TPM2;TMOD1;DES;MYBPC1;DMD;MYL4;TNNI1;TTN;MYL1;NEB;TNNC1;TNNI3;MYBPC2;TCAP;MYL3;ACTA1
prerank,Rho protein signal transduction (GO:0007266),0.3927979872985726,1.1158611150308995,0.2966002344665885,1.0,1.0,14/53,15.07%,RTKN;RHOJ;TAX1BP3;RHOD;CTNNAL1;EPS8L1;LIMK1;ARHGEF11;MYO9B;NGFR;COL1A2;ARHGAP4;ARHGEF3;CDC42EP1
prerank,nuclear membrane disassembly (GO:0051081),0.4917090370227174,1.1158311502220584,0.3559822747415066,1.0,1.0,1/14,0.67%,PRKCA
prerank,regulation of brown fat cell differentiation (GO:0090335),-0.38589414804386274,-1.1155989997557745,0.26498422712933756,0.8014667794042108,1.0,7/16,21.70%,SOX13;SIX1;PTGS2;FLCN;RREB1;VSTM2A;ZBTB7B
prerank,activation of cysteine-type endopeptidase activity (GO:0097202),0.49328239017647524,1.1155922252298862,0.32061068702290074,1.0,1.0,2/13,2.66%,TBC1D10A;FADD
prerank,regulation of axon guidance (GO:1902667),-0.45084413084154823,-1.1151921277826338,0.3333333333333333,0.8004769901292847,1.0,4/10,8.49%,NRP1;YTHDF1;ZSWIM6;ZSWIM4
prerank,regulation of establishment of cell polarity (GO:2000114),-0.39666518848887666,-1.115143332026139,0.2953020134228188,0.7984291617618119,1.0,5/16,4.22%,ROCK2;CDH5;RAP1B;ROCK1;CYRIB
prerank,hyaluronan catabolic process (GO:0030214),0.4727124694067313,1.114543873184062,0.3528610354223433,1.0,1.0,8/18,25.74%,FGF2;TGFB1;SPAM1;HYAL1;SLC9A1;CEMIP;HEXB;CEMIP2
prerank,cellular response to fibroblast growth factor stimulus (GO:0044344),0.3785608353181314,1.1144088603255333,0.30952380952380953,1.0,1.0,27/87,21.62%,FGF2;FGF10;EGR3;RAB14;POLR2B;SPRED2;SPRED1;FGFR1;CEP57;SHOC2;POLR2K;SHCBP1;NCBP1;ZFP36L2;CBL;PTPN11;MAPK1;FGF7;POLR2G;GALNT3;HYAL1;POLR2A;GRB2;ZFP36;FLRT1;RBFOX2;FGF9
prerank,acetylcholine receptor signaling pathway (GO:0095500),0.45949963355789825,1.1140964441416694,0.3637640449438202,1.0,1.0,2/20,4.92%,CHRM3;PLCB1
prerank,sphingolipid biosynthetic process (GO:0030148),-0.27237645717704373,-1.1137580389751598,0.2403846153846154,0.8004140671703028,1.0,24/71,21.95%,SGMS1;ELOVL7;PLPP1;CERS5;KDSR;ACER2;HACD4;SPTLC2;DEGS2;CERS4;SPNS2;ALDH3A2;SGPL1;VAPB;ASAH2;CERS1;SPHK1;A4GALT;SPTSSB;ST6GALNAC5;CERT1;CLN8;LARGE1;ALDH3B1
prerank,positive regulation of transforming growth factor beta receptor signaling pathway (GO:0030511),-0.3473962145571993,-1.1136001547257712,0.31451612903225806,0.7966043918952965,1.0,10/23,20.22%,DAB2;THBS1;SNW1;GIPC1;ING2;FLCN;SLC2A10;CREBBP;HSP90AB1;TGFB1I1
prerank,positive regulation of cellular response to transforming growth factor beta stimulus (GO:1903846),-0.3473962145571993,-1.1136001547257712,0.31451612903225806,0.7966043918952965,1.0,10/23,20.22%,DAB2;THBS1;SNW1;GIPC1;ING2;FLCN;SLC2A10;CREBBP;HSP90AB1;TGFB1I1
prerank,positive regulation of G protein-coupled receptor signaling pathway (GO:0045745),0.4836997129524696,1.1126747933392398,0.33841886269070737,1.0,1.0,2/16,7.59%,PRKCA;KLK6
prerank,negative regulation of potassium ion transmembrane transport (GO:1901380),0.5120859680670812,1.1126630643656252,0.337442218798151,1.0,1.0,5/11,19.41%,BIN1;STK39;NEDD4L;KCNH2;CAB39
prerank,"retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum (GO:0006890)",0.37245915011085073,1.1123713688630903,0.3004484304932735,1.0,1.0,28/80,20.43%,PITPNB;ATP9B;COPZ2;GBF1;COPB2;COPG2;TMED10;KDELR2;NBAS;ARF4;BICD2;RAB1A;TMED3;TMED2;COPA;ARFGAP3;ARFGAP1;KIF22;COPG1;BNIP1;KDELR3;SURF4;HTT;KIF3A;KIF2A;ERGIC3;RINT1;COG4
prerank,positive regulation of biomineral tissue development (GO:0070169),0.4140422833062792,1.111984548547135,0.3284132841328413,1.0,1.0,13/40,16.21%,OSR2;PKDCC;ACVR1;ANO6;TGFB1;GPM6B;AMELX;BMP7;ATRAID;ATP2B1;BMPR1A;FZD9;TGFB3
prerank,ribosomal small subunit assembly (GO:0000028),-0.3956785049547929,-1.111957923959014,0.30847457627118646,0.7997290357501635,1.0,8/16,27.56%,RPS14;RPS19;RPS15;MRPS7;MRPS11;RPS5;PWP2;RPS27
prerank,regulation of neuron migration (GO:2001222),0.4396104810377817,1.1117354881521755,0.3438735177865613,1.0,1.0,6/26,9.11%,KIF20B;SEMA3A;CTNNA2;NTNG2;NTNG1;COL3A1
prerank,positive regulation of phosphate metabolic process (GO:0045937),0.4462233474830937,1.1111237916662349,0.33378016085790885,1.0,1.0,7/25,13.88%,GLMN;EGFR;PSEN1;FZD7;DSCAM;KCTD20;SNCA
prerank,intracellular cholesterol transport (GO:0032367),-0.3970397342122326,-1.110741863329665,0.313915857605178,0.8014350386632332,1.0,6/15,12.31%,ABCA1;OSBP;OSBPL2;VPS4A;ABCG1;STARD4
prerank,regulation of anatomical structure morphogenesis (GO:0022603),0.36404285818513943,1.1104459857043447,0.291005291005291,1.0,1.0,29/118,14.82%,SIPA1L1;PHLDB1;FGF2;ERBB2;EFNA5;FMNL2;TGFB1;SDC2;TANC2;NF1;TNIK;LRRC4C;PAK1;CHN1;PDZD8;ADGRB3;SPARC;BCL9L;PPFIA2;GDNF;CLASP1;MYO19;PID1;ZMYM6;CDK5R1;LZTS3;BMPER;NEDD4L;ARHGAP44
prerank,positive regulation of cardiac muscle tissue growth (GO:0055023),0.47959969602306707,1.1103856735564381,0.35829662261380324,1.0,1.0,6/16,14.61%,FGF2;GLI1;ERBB4;AKAP6;ZFPM2;BMPR1A
prerank,regulation of protein catabolic process (GO:0042176),0.3661935682551307,1.1103672826048003,0.3143164693218515,1.0,1.0,26/99,21.28%,GPC3;PRKN;EGFR;FMN2;HACE1;IRAK3;WNT5A;ASB5;FLNA;HUWE1;APC2;DDB1;MDM4;NEDD4L;GFAP;AREL1;DACT1;NDUFA13;SNX12;AZIN2;RAB7A;MDM2;SF3B3;FURIN;AGAP2;TIPARP
prerank,negative regulation of response to endoplasmic reticulum stress (GO:1903573),0.45079865786271683,1.1103363002224298,0.33289473684210524,1.0,1.0,7/24,18.76%,CREB3L1;PRKN;SELENOS;HERPUD1;OPA1;USP25;PARK7
prerank,response to amyloid-beta (GO:1904645),0.4026718458340852,1.1102033514215632,0.3238213399503722,1.0,1.0,10/44,10.58%,MMP2;CACNA2D1;LRP1;CACNA1A;PSEN1;PRNP;FYN;GRM5;SNX6;NGFR
prerank,epithelial tube morphogenesis (GO:0060562),0.4172905473224209,1.110190431902301,0.3408521303258145,1.0,1.0,10/32,15.00%,GLI2;FGF10;ACVR1;PRKX;PAK1;CCM2;SCRIB;GATA3;PKD1;MET
prerank,glucose metabolic process (GO:0006006),0.3881130700019826,1.1098330388300763,0.31770222743259086,1.0,1.0,9/58,16.03%,APOD;IRS2;PGM1;GOT2;GALM;SLC25A10;BRAT1;CRY1;SLC25A11
prerank,ATP-dependent chromatin remodeling (GO:0043044),0.4126744321092524,1.1097006037177874,0.3395061728395062,1.0,1.0,21/42,28.06%,MTA2;CHD3;VPS72;MBD2;HDAC2;SMARCC2;ANP32E;RBBP4;SMARCC1;SMARCE1;PBRM1;NASP;SMARCA4;HNRNPC;GATAD2B;ACTR5;SMARCB1;SPTY2D1;HDAC1;SMARCA1;INO80B
prerank,secondary alcohol biosynthetic process (GO:1902653),0.43093781578934737,1.1091111166015168,0.3388116308470291,1.0,1.0,4/30,8.57%,HSD17B7;SQLE;IDI1;ACLY
prerank,ERK1 and ERK2 cascade (GO:0070371),0.4583419747158586,1.1088266260342305,0.35704323570432356,1.0,1.0,6/21,11.40%,MYC;FGF10;SOX9;MT3;ZFP36L2;MAPK1
prerank,smooth muscle tissue development (GO:0048745),0.5225821889695373,1.1087137760678298,0.36391912908242613,1.0,1.0,3/10,8.63%,PTCH1;NF1;SMO
prerank,atrial septum morphogenesis (GO:0060413),-0.43751500914925406,-1.1086011818709265,0.3217391304347826,0.8057015059847602,1.0,5/10,19.45%,NOTCH2;BMPR2;TGFB2;HEY2;ZFPM1
prerank,DNA replication-independent nucleosome organization (GO:0034724),0.5204319405978868,1.1084640705494326,0.3579109062980031,1.0,1.0,5/11,17.97%,HAT1;ATRX;ASF1A;RBBP4;NASP
prerank,fructose 6-phosphate metabolic process (GO:0006002),0.5285211060450907,1.108427250091095,0.3533950617283951,1.0,1.0,1/10,0.88%,GFPT2
prerank,regulation of microtubule polymerization or depolymerization (GO:0031110),0.43392733800267214,1.1083638916589773,0.33549222797927464,1.0,1.0,9/28,18.72%,MAP1B;GBA2;ARL2;CLASP1;FKBP4;STMN4;ABL1;MAPRE3;CAMSAP1
prerank,regulation of membrane repolarization (GO:0060306),0.4926090704176809,1.1080734357095527,0.3343239227340267,1.0,1.0,4/13,16.10%,CACNA2D1;AKAP6;NEDD4L;KCNH2
prerank,regulation of lipopolysaccharide-mediated signaling pathway (GO:0031664),-0.38418618961245277,-1.108021529583459,0.30844155844155846,0.8053429265738341,1.0,4/17,7.73%,BMP6;SASH1;TRIM5;CD55
prerank,response to retinoic acid (GO:0032526),-0.2839568526618892,-1.1077644118460879,0.2932330827067669,0.8039751640149194,1.0,11/59,8.70%,WNT5B;CTSH;RBP4;EPHA3;ACER2;LYN;ABL2;WNT6;SNW1;WNT9A;TBX1
prerank,regulation of protein targeting to mitochondrion (GO:1903214),0.41416084947131193,1.1075474882397753,0.3271375464684015,1.0,1.0,14/38,22.16%,PRKN;PARL;FBXW7;VPS11;HUWE1;UBE2J2;SREBF2;CSNK2A2;UBE2L3;MICALL2;RHOU;NPEPPS;UBE2D3;LMAN1
prerank,regulation of extracellular matrix organization (GO:1903053),0.49048580377687057,1.107357225419632,0.3541666666666667,1.0,1.0,3/15,2.97%,FAP;LRP1;ANGPTL7
prerank,mature B cell differentiation involved in immune response (GO:0002313),-0.4324566289904724,-1.1072137703723839,0.345565749235474,0.8035077523290557,1.0,4/12,18.70%,NOTCH2;PTK2B;LFNG;MFNG
prerank,positive regulation of gene expression (GO:0010628),0.3439494436388066,1.1071342275661036,0.2,1.0,1.0,63/442,11.41%,OSR2;SEC16B;CLDN19;ANK3;ADAM19;NTRK3;EPB41L4B;GLMN;FGF2;MYC;RBMS3;FGF10;PTPN22;ANK2;CD34;KAT2B;SOX9;GSN;NGF;ERBB2;PRKN;EGFR;VEGFA;EPHB2;ELAVL4;EIF2AK3;TLE1;UPF3A;PLD1;TGFB1;PSEN1;SOX11;NTRK2;ITGB8;MT3;TAF1A;NIBAN1;WNT5A;HOXD3;AGPAT2;METTL3;CARD9;EIF3C;CPEB3;CADM1;EIF6;BRCA1;SMO;NSUN5;PASK;POLR2K;MAPK9;HIF1A;SFRP4;PIK3R1;ATF2;NFE2L2;MAPK14;RIMS1;SP1;PID1;MAPK1;BMP7
prerank,positive regulation of viral process (GO:0048524),0.3910398527538128,1.106716730088428,0.32009345794392524,1.0,1.0,16/60,18.99%,MDFIC;FKBP6;PABPC1;POLR2B;PPID;POLR2K;ADARB1;DDB1;TBC1D20;KPNA6;POLR2G;PPIH;PKN2;RAB7A;POLR2A;AXL
prerank,regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902041),0.413005968650102,1.106696646831677,0.35286783042394015,1.0,1.0,4/38,3.96%,LGALS3;BMP5;FADD;TNFRSF10B
prerank,leukotriene metabolic process (GO:0006691),0.4679881575876417,1.1066590632147721,0.34685314685314683,1.0,1.0,6/19,17.07%,DPEP1;MAPKAPK2;LTA4H;DPEP2;ALOX5AP;ABCC1
prerank,pyruvate metabolic process (GO:0006090),-0.2851709456907267,-1.1062953101429387,0.2356687898089172,0.8041812731380872,1.0,10/52,10.55%,BSG;ME1;GLO1;HAGH;PDHX;PGK1;PGAM4;PGAM1;GPI;PDHA1
prerank,regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032434),0.36164358588637147,1.1061634718332316,0.3094983991462113,1.0,1.0,37/100,23.12%,GLMN;RAD23B;XPO1;PRKN;ARAF;WAC;SOCS5;UCHL5;UFL1;CBFA2T3;BAG5;TLK2;HERPUD1;TAF9;PRICKLE1;DVL1;CSNK1A1;DET1;DDA1;SUMO1;RNF19A;RCHY1;CSNK1E;N4BP1;FBXO22;MDM2;ZER1;PARK7;TAF1;USP5;NKD2;BBS7;UBQLN4;CAMLG;ELOB;ZYG11B;COP1
prerank,epiboly involved in wound healing (GO:0090505),-0.38760927548591784,-1.1059754280688499,0.3089171974522293,0.8030951206995567,1.0,6/16,14.78%,PDPN;ARHGAP35;CCN1;RHOA;DDR1;CEACAM1
prerank,membrane lipid biosynthetic process (GO:0046467),-0.27813600353860624,-1.1055216861901378,0.25,0.8023931595982774,1.0,14/58,9.46%,SGMS1;ELOVL7;PLPP1;CERS5;KDSR;ACER2;HACD4;SPTLC2;DEGS2;CERS4;SPNS2;ALDH3A2;SGPL1;VAPB
prerank,hemopoiesis (GO:0030097),-0.26173487121453703,-1.1049686126027374,0.21176470588235294,0.8018616793220652,1.0,21/87,14.37%,FLT1;NOTCH2;MECOM;TEK;KIT;NCOA6;BMP4;ETV6;KDR;KITLG;FLT3LG;MKNK2;FGFR2;FLCN;JAG1;NOTCH4;TGFB2;INHBA;PTPRC;TIRAP;BMI1
prerank,regulation of catecholamine secretion (GO:0050433),0.4308187381160838,1.1048369151481146,0.3445161290322581,1.0,1.0,8/29,13.88%,KCNA2;PRKN;CHRNA4;SYT1;SYT11;SYT12;DRD2;SNCA
prerank,positive regulation of embryonic development (GO:0040019),-0.3757449847941249,-1.1047422150552753,0.3116438356164384,0.800454551975047,1.0,4/19,14.73%,WNT4;OSR1;RACK1;RBM19
prerank,organophosphate ester transport (GO:0015748),-0.3440750331278919,-1.104239731498316,0.32196969696969696,0.8000386271624591,1.0,6/24,10.58%,OSBPL8;ABCA3;PLTP;PITPNA;OSBPL2;TNFAIP8L3
prerank,potassium ion transport (GO:0006813),0.36261648940370783,1.1039797011447645,0.32275132275132273,1.0,1.0,33/120,22.90%,KCNK15;SLC1A3;KCNA2;KCNH8;KCNK1;KCNA1;KCNA6;KCND1;KCND2;KCND3;KCNMB2;KCNMB3;KCNAB2;KCNJ3;KCNJ10;SLC9A5;KCNH2;KCNMA1;SLC9A1;SLC24A4;SLC24A2;KCNA5;HCN1;KCNS3;KCNH7;KCNK10;LRRC55;PKD2;KCNQ3;KCNK6;KCNA4;KCNC1;KCNJ13
prerank,positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus (GO:1901522),0.4569933706543484,1.102984730638506,0.33008356545961004,1.0,1.0,4/20,10.76%,VEGFA;MT3;HIF1A;NFE2L2
prerank,regulation of monocyte chemotaxis (GO:0090025),0.44273713128627395,1.1028300849135835,0.369826435246996,1.0,1.0,4/24,7.02%,CXCL10;ANO6;CCR2;PLA2G7
prerank,regulation of actin filament bundle assembly (GO:0032231),-0.3423505822720745,-1.1027942787430733,0.29435483870967744,0.8025396425686785,1.0,8/26,14.50%,ROCK2;SHANK3;ROCK1;FHOD1;PFN2;ACTG1;CDC42;SYNPO2
prerank,chromosome organization (GO:0051276),0.3678296418419193,1.1020643830851156,0.3282608695652174,1.0,1.0,24/99,20.96%,MYC;RAD23B;LRWD1;HMGN1;SUV39H1;SATB1;EZH1;DDB2;NUP155;XPA;POLE3;HDAC2;MSH6;DDB1;UBB;ABL1;PHF19;CUL4B;CENPV;NUF2;HMG20A;COPS6;SMARCA4;COPS7A
prerank,regulation of protein kinase activity (GO:0045859),0.3652965161812828,1.1019609228782254,0.3108974358974359,1.0,1.0,24/106,18.76%,RELN;UBASH3B;RAP2B;DEPTOR;TRAF4;NF1;MRNIP;ALS2;SPRED1;RAP1A;MMD2;DVL1;WWTR1;XRCC6;SNCA;TAF7;IQGAP1;RASSF2;PYDC1;DBNDD2;JTB;PPM1E;MAPRE3;PARK7
prerank,cell projection assembly (GO:0030031),0.4514028420736723,1.1017792874954033,0.3469945355191257,1.0,1.0,7/22,20.40%,RHOJ;GSN;RHOH;CYFIP1;RAC3;NCKAP1;RHOU
prerank,negative regulation of mononuclear cell migration (GO:0071676),0.5080254210894275,1.1016591648518752,0.3640625,1.0,1.0,2/12,4.92%,BMP5;PLCB1
prerank,icosanoid metabolic process (GO:0006690),0.40533827818938994,1.1015200157299907,0.3496932515337423,1.0,1.0,8/40,13.50%,CYP2S1;DPEP1;MAPKAPK2;LTA4H;CYP1B1;DPEP2;ALOX5AP;PNPLA8
prerank,negative regulation of signaling receptor activity (GO:2000272),0.4381561024532818,1.1006126831041492,0.3448275862068966,1.0,1.0,9/25,21.57%,CBLB;EPHB2;SOCS5;SNX6;CBL;ZGPAT;SLC6A9;PPARG;CNRIP1
prerank,negative regulation of vascular permeability (GO:0043116),-0.4250663280397033,-1.1005249332157294,0.3423913043478261,0.8072630314738444,1.0,6/12,14.78%,CLDN5;ANGPT1;SLIT2;PDE3A;PDE2A;CEACAM1
prerank,cochlea morphogenesis (GO:0090103),0.5277783752820668,1.0998763839066383,0.36923076923076925,1.0,1.0,3/10,16.97%,SOX9;TBX18;PAX2
prerank,protein transmembrane import into intracellular organelle (GO:0044743),-0.32859740061005427,-1.0998548757830884,0.3157894736842105,0.8072687624963567,1.0,16/31,29.32%,TOMM70;TIMM23;PEX7;DNAJC15;PEX14;PEX26;TIMM17A;PEX2;PEX10;ROMO1;GRPEL1;PEX6;PEX16;DNLZ;TOMM40L;TOMM40
prerank,G2/M transition of mitotic cell cycle (GO:0000086),0.3557679483700526,1.09974195712982,0.3252885624344176,1.0,1.0,25/128,14.59%,DYNLL1;CDKN2B;HAUS3;CNTRL;KDM8;CCDC57;PLCB1;PCM1;FBXL15;NDE1;SDCCAG8;PHLDA1;FOXM1;ENSA;CEP57;PPP2R2A;CLASP1;PKMYT1;CDC25B;TAF2;PRKACA;CKAP5;CEP76;DYNC1I2;NES
prerank,positive regulation of histone methylation (GO:0031062),0.4476316339827352,1.0992577365984675,0.35781041388518026,1.0,1.0,5/24,12.24%,FAM47E;KMT2A;AUTS2;BRCA1;JARID2
prerank,phosphatidylinositol metabolic process (GO:0046488),0.35935527956963137,1.099256123612976,0.32800851970181044,1.0,1.0,18/109,12.35%,PLEKHA4;INPP4B;SLC27A1;PLBD1;FGF2;PTEN;PGAP1;RAB14;MTMR14;PLCB1;PTPN13;PI4KB;VAC14;PLA2G12A;PIK3R1;PI4K2A;MTMR12;PLAAT3
prerank,metal ion export (GO:0070839),-0.3170776855808558,-1.09914369797473,0.3080357142857143,0.8073580010005431,1.0,5/31,7.25%,ATP1A2;ATP1B3;ATP7A;ATP1A1;SLC40A1
prerank,neuromuscular process controlling balance (GO:0050885),0.5049888239278056,1.0989941603271236,0.37251908396946565,1.0,1.0,2/12,4.74%,PCDH15;NRXN1
prerank,negative regulation by host of viral process (GO:0044793),0.5233565580670557,1.0988814243874656,0.366306027820711,1.0,1.0,2/10,10.41%,PRKN;VAPA
prerank,lymphocyte mediated immunity (GO:0002449),-0.43103657786234906,-1.0986726090249685,0.358600583090379,0.8066652818262631,1.0,4/12,29.98%,CD55;JAG1;GNL1;MSH2
prerank,sulfur compound biosynthetic process (GO:0044272),0.36124628565818406,1.0983116860129574,0.3133047210300429,1.0,1.0,17/104,13.25%,DCN;VCAN;CTH;LUM;ST3GAL4;CBS;GSS;PAPSS2;BCAN;CSGALNACT1;CHSY1;SLC10A7;NCAN;GLCE;GGCT;GGTA1;SLC35B3
prerank,mitochondrial gene expression (GO:0140053),0.39831196298900473,1.0982948268065977,0.34213685474189676,1.0,1.0,10/42,14.97%,MRPL47;IARS2;MRPS18A;MRPL16;GATB;MRPS28;TFAM;POLRMT;HARS1;MRPL51
prerank,N-terminal protein amino acid modification (GO:0031365),0.48535022336495126,1.0976133981770335,0.36592592592592593,1.0,1.0,8/14,27.26%,NAA35;NAA16;NAA10;NAA15;METAP1;METAP1D;NAA40;NAA50
prerank,mitochondrion transport along microtubule (GO:0047497),0.5100304311201325,1.0973056476686553,0.3734567901234568,1.0,1.0,6/13,22.74%,HIF1A;RHOT2;OPA1;UBB;RHOT1;SYBU
prerank,negative regulation of innate immune response (GO:0045824),0.4133176288207921,1.0971913367810506,0.345088161209068,1.0,1.0,4/34,6.20%,A2M;PTPN2;IRAK3;METTL3
prerank,cell cycle G2/M phase transition (GO:0044839),0.3545220365965726,1.097162056779018,0.3410283315844701,1.0,1.0,25/129,14.59%,DYNLL1;CDKN2B;HAUS3;CNTRL;KDM8;CCDC57;PLCB1;PCM1;FBXL15;NDE1;SDCCAG8;PHLDA1;FOXM1;ENSA;CEP57;PPP2R2A;CLASP1;PKMYT1;CDC25B;TAF2;PRKACA;CKAP5;CEP76;DYNC1I2;NES
prerank,cellular response to drug (GO:0035690),0.43219340989813054,1.0968656407285942,0.33714285714285713,1.0,1.0,7/25,18.15%,MYC;DPEP1;PDE4B;TP53;KCNH2;GPLD1;PPM1E
prerank,negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902254),0.47614179265396356,1.0967352478068744,0.3554572271386431,1.0,1.0,5/15,18.13%,BCL2;PRKN;TAF9;CD74;MDM2
prerank,positive regulation of blood coagulation (GO:0030194),0.46905286647432665,1.0961202124330465,0.37117903930131,1.0,1.0,2/17,3.48%,ST3GAL4;ANO6
prerank,regulation of cell-substrate junction assembly (GO:0090109),-0.36095751375477436,-1.0958444511977095,0.3249097472924188,0.813255122786995,1.0,8/21,11.99%,MACF1;ROCK2;ROCK1;LIMCH1;EPHA3;DUSP3;RHOA;ACTG1
prerank,positive regulation of pri-miRNA transcription by RNA polymerase II (GO:1902895),0.4203168888583583,1.0956311675067227,0.362002567394095,1.0,1.0,12/33,20.23%,FGF2;TGFB1;KLF5;HIF1A;NGFR;GATA3;TP53;EGR1;PPARG;JUN;STAT3;SMARCA4
prerank,skeletal muscle tissue development (GO:0007519),-0.32781311518336453,-1.0954814227691423,0.319634703196347,0.8121877915866488,1.0,22/32,50.30%,MYL6;SIX1;LEMD2;CAV1;CFLAR;MYH14;SIX4;FOXL2;KLHL41;MSC;MEF2C;MYORG;POPDC3;RYR1;POPDC2;ACTA1;MYLK2;LMOD3;MYOZ2;CSRP3;MYL6B;EGR2
prerank,positive regulation of mRNA 3'-end processing (GO:0031442),0.5242604190592809,1.0953666946003957,0.378698224852071,1.0,1.0,4/10,17.23%,CPEB3;NCBP1;CPEB1;CDC73
prerank,regulation of neurotransmitter secretion (GO:0046928),-0.3141652155591934,-1.0952003198500926,0.3118811881188119,0.8109349136808689,1.0,9/32,12.29%,SNCAIP;RAB5A;DTNBP1;GSK3B;SLC30A1;CPLX1;CAMK2A;MCTP2;SNAPIN
prerank,regulation of DNA repair (GO:0006282),-0.30067920735180165,-1.0950885327458475,0.30434782608695654,0.8092362871440899,1.0,13/44,15.20%,EYA1;EYA2;PARG;ERCC8;EYA4;NPAS2;BABAM1;POLH;ABRAXAS1;WRAP53;PML;PCNA;UBE2N
prerank,cellular response to growth factor stimulus (GO:0071363),0.3508244034043633,1.0950364742056657,0.3237113402061856,1.0,1.0,28/151,11.52%,SOX6;ADAMTS12;HAS2;NTRK3;GAREM1;SOX9;ERBB2;EGFR;ACVR1;VEGFA;EGR3;MAPK7;TGFB1;NTRK2;MAPKAPK2;ACVR1C;WNT5A;URI1;MTSS2;TGFBR2;RAP1A;SOX5;ZFP36L2;MAPK14;PTPN11;EMD;BMP7;MAGI2
prerank,response to endoplasmic reticulum stress (GO:0034976),0.3562067499717104,1.094432210805134,0.34946236559139787,1.0,1.0,33/107,21.75%,CREB3L1;BCL2;PRKN;DNAJB9;EIF2AK3;TNFRSF10B;PPP1R15A;NIBAN1;CREB3L2;UFL1;EIF2B5;RCN3;SELENOS;HERPUD1;PIK3R1;TMEM33;GORASP2;HSP90B1;CCDC47;TMTC3;NCK1;TMEM117;TP53;BCL2L11;QRICH1;FICD;AIFM1;DNAJC10;MBTPS1;JUN;UBXN6;RHBDD1;ERO1A
prerank,"negative regulation of DNA-templated transcription, elongation (GO:0032785)",-0.3978386073094977,-1.0944040289334236,0.34,0.8092368820114291,1.0,5/13,24.38%,RECQL5;LARP7;NELFCD;HEXIM1;EAPP
prerank,chloride transmembrane transport (GO:1902476),0.38911774840436497,1.0941092611781031,0.34424242424242424,1.0,1.0,5/48,5.24%,ANO2;SLC1A3;SLC12A3;ANO6;SLC12A2
prerank,positive regulation of protein kinase activity (GO:0045860),0.3512445511262137,1.0928352929171377,0.3201663201663202,1.0,1.0,30/148,15.54%,RELN;ERBB3;SLC27A1;MAP4K4;VEGFA;PAK4;GPRC5B;PAK5;TRAF4;PRNP;MRNIP;TNIK;PAK1;ALS2;TGFBR2;RALB;RAP1A;SLC8A2;PTPN1;GRM5;PIH1D1;MMD2;TAOK3;XRCC6;TTBK1;SNCA;CALM1;IQGAP1;RASSF2;CALM2
prerank,pathway-restricted SMAD protein phosphorylation (GO:0060389),0.4995302571974223,1.0927272769705065,0.38580246913580246,1.0,1.0,3/11,6.38%,ACVR1;TGFB1;TGFBR2
prerank,detection of chemical stimulus involved in sensory perception of taste (GO:0050912),-0.43437323457410076,-1.092625167848459,0.33620689655172414,0.8127061760594722,1.0,10/11,56.59%,RTP4;PKD2L1;PKD1L3;LPO;RTP3;TAS1R2;GNAT3;GNAT2;PIGR;TAS1R3
prerank,positive regulation of macromolecule metabolic process (GO:0010604),0.3395880613262776,1.0924715764433282,0.268,1.0,1.0,47/348,11.52%,OSR2;SEC16B;CLDN19;ANK3;ADAM19;NTRK3;EPB41L4B;FGF2;MYC;RBMS3;FGF10;PTPN22;ANK2;CD34;SOX9;GSN;NGF;PRKN;VEGFA;EPHB2;MAPK7;EIF2AK3;TLE1;TGFB1;PSEN1;SOX11;NTRK2;ITGB8;MT3;ATF7IP;WNT5A;HOXD3;BRCA1;SMO;MAPK9;HIF1A;PTPN1;SFRP4;ATF2;NFE2L2;MAPK14;RIMS1;SP1;PID1;MAPK1;BMP7;MAGI2
prerank,development of primary male sexual characteristics (GO:0046546),0.4122282857427546,1.0924683812401983,0.3452229299363057,1.0,1.0,12/34,21.62%,SOX8;SOX9;WNT5A;MAMLD1;GATA6;GATA3;LRP2;LHFPL2;NR5A1;CSDE1;MEA1;FGF9
prerank,mitotic G1/S transition checkpoint signaling (GO:0044819),0.4947985603433272,1.092226456034569,0.38345864661654133,1.0,1.0,7/12,25.22%,WAC;RPA2;RPS27L;TP53;FBXO31;PLK5;PRKDC
prerank,negative regulation of fatty acid biosynthetic process (GO:0045717),0.5105455307742777,1.0921990153876122,0.3668730650154799,1.0,1.0,3/12,15.46%,ERLIN2;BRCA1;ERLIN1
prerank,negative regulation of protein phosphorylation (GO:0001933),0.35427832667168685,1.0919963862968276,0.32608695652173914,1.0,1.0,40/150,18.98%,UBASH3B;NTRK3;PIP5KL1;PTEN;PRKN;EPHB2;CADM4;TGFB1;DEPTOR;PRNP;NF1;CNKSR3;PTPN13;NIBAN1;MLXIPL;SPRED2;SPRED1;SAMSN1;MEN1;SPRED3;EIF4G1;PID1;PDE4D;DVL1;WWTR1;SNCA;NCK1;CALM1;LDLRAD4;TAF7;RASSF2;CALM2;TERF2IP;PYDC1;DBNDD2;PPM1E;PARK7;SEMA4D;DNAJC10;TESK1
prerank,regulation of microtubule-based process (GO:0032886),-0.30271544529991773,-1.09164348612446,0.2926829268292683,0.813677230856724,1.0,12/36,12.62%,PHLDB2;MACF1;ROCK1;DIAPH1;EPHA3;TRIM36;KLHL42;GSK3B;PRKAA2;MARK2;MAPT;FAM107A
prerank,regulation of tumor necrosis factor production (GO:0032680),0.35632693765423235,1.0909453562034581,0.33440514469453375,1.0,1.0,16/112,10.85%,PYCARD;PTPN22;CD34;FADD;EPHB2;IRAK3;PSEN1;MAPKAPK2;CCR2;WNT5A;TMEM106A;SYT11;SELENOS;TLR1;PTPRJ;PTPN11
prerank,cellular sodium ion homeostasis (GO:0006883),-0.38043106227457113,-1.0908095139406775,0.33225806451612905,0.8141789007632293,1.0,3/15,6.72%,ATP1A2;ATP1B3;ATP1A1
prerank,negative regulation of transcription elongation from RNA polymerase II promoter (GO:0034244),-0.4120803618415705,-1.0903154316323393,0.35327635327635326,0.8136138618144846,1.0,5/12,24.38%,RECQL5;LARP7;NELFCD;HEXIM1;EAPP
prerank,organonitrogen compound catabolic process (GO:1901565),0.3784564284196712,1.0900721568305092,0.3457508731082654,1.0,1.0,21/57,23.95%,CTH;TST;NAGK;LTA4H;PLA2G7;TRHDE;IL4I1;LNPEP;UCHL3;PDXDC1;PNPLA8;LIPC;GNPDA1;TXN2;BCKDK;NPEPPS;RIDA;SIAH1;TPP1;CLN6;MTOR
prerank,regulation of exocytosis (GO:0017157),0.4018274890201612,1.0899341505240896,0.3498233215547703,1.0,1.0,12/46,18.87%,STXBP6;IL1RAPL1;SYT1;RAB21;RAB3D;CLASP1;STXBP5;RAB3A;SNCA;UNC13D;RIMS2;RAB3B
prerank,ureteric bud morphogenesis (GO:0060675),0.47251524066694484,1.089540692264142,0.37695590327169276,1.0,1.0,7/16,23.34%,FGF2;MYC;GDNF;GATA3;PAX2;PKD2;BMP2
prerank,organelle organization (GO:0006996),0.33857360174177376,1.0894346610056411,0.25825825825825827,1.0,1.0,109/388,21.74%,SEC16B;TMED6;CCL11;ANK1;HPS6;MYC;ATP8B1;WDPCP;GORASP1;PRKN;RAB38;FGD4;PAK4;HACE1;PITPNB;RAB14;EIF2AK3;FMNL2;MAST2;PACSIN2;BLZF1;PAK5;GOLGB1;TNIK;OBSL1;PEX3;ARL1;PDZD8;GBF1;EPS15;RAB34;SEC31B;BIN1;GAK;TFAM;BAG5;TRIP11;PPID;TMED10;VPS11;RHOT2;PALLD;HUWE1;VAPA;KIF5C;CLASP1;PI4K2A;AFG1L;GORASP2;ARHGAP21;MREG;ZMYM6;HPS3;RAB1A;PLAAT3;ATL3;USP6NL;NECTIN2;PRDX3;CSNK1A1;YME1L1;SH3KBP1;POLRMT;TBC1D20;ARHGAP4;TMED3;TMED2;POLG2;PDCD6IP;SEC23IP;OPA1;CHMP4C;CFAP61;BNIP1;DIAPH3;ARFGEF1;ABCD2;GABPB1;SURF4;ADCK1;MDK;RAB7A;PEX1;RHOT1;CLUH;HTT;KIF3A;ATXN7;STX17;CAMSAP1;PARK7;REEP5;RAB30;PEX11A;COG1;CHMP1B;PHB2;CEP78;RHOU;COG4;RAB3GAP1;LIMD1;SSBP1;VMP1;TANGO2;WDR81;PKD2;CDC42BPB;MTFR1
prerank,positive regulation of nitric-oxide synthase activity (GO:0051000),-0.37899155554914266,-1.088909380979944,0.35135135135135137,0.8158496460117778,1.0,8/16,27.84%,NPR3;TERF2;TERT;NUS1;APOE;AKT1;PIK3CB;HTR2B
prerank,negative regulation of stress-activated MAPK cascade (GO:0032873),0.4081670117323404,1.088879265138758,0.35213032581453635,1.0,1.0,14/36,23.71%,MYC;PTPN22;PRKN;MEN1;FOXM1;TAOK3;PER1;DACT1;FKTN;ZMYND11;DUSP1;SIRPA;CYLD;AIDA
prerank,tricarboxylic acid metabolic process (GO:0072350),0.4899006539163797,1.0884052316806638,0.3835616438356164,1.0,1.0,4/12,14.44%,IDH2;IDH3B;ACLY;IDH3A
prerank,skin development (GO:0043588),0.373568588997677,1.088309773013751,0.34443168771526983,1.0,1.0,13/65,15.00%,COL5A3;CERS3;TGM1;COL5A2;CLDN1;WNT5A;GATA6;HRNR;COL3A1;COL1A2;COL1A1;PKD1;MET
prerank,regulation of peptidyl-threonine phosphorylation (GO:0010799),0.40570070484719545,1.0881430373400915,0.37593984962406013,1.0,1.0,15/37,19.41%,CADM4;WNK3;TGFB1;SPRED2;SPRED1;UBE2K;SPRED3;EIF4G1;MAPK1;BMP7;CALM1;CALM2;RPTOR;S1PR2;CAB39
prerank,negative regulation of axon extension involved in axon guidance (GO:0048843),0.43999471389010625,1.0881305578426248,0.3786407766990291,1.0,1.0,3/20,3.81%,SEMA3E;SEMA6C;SEMA3A
prerank,regulation of urine volume (GO:0035809),0.5248251885934399,1.0880194218673216,0.3772357723577236,1.0,1.0,1/10,1.04%,HAS2
prerank,regulation of gastrulation (GO:0010470),-0.3939222660795384,-1.0877619011946444,0.35202492211838005,0.8172025481544458,1.0,2/14,1.38%,PHLDB2;OSR1
prerank,regulation of plasma membrane bounded cell projection assembly (GO:0120032),-0.26795923148778605,-1.0874040906721503,0.2540983606557377,0.816274690302227,1.0,24/67,19.67%,CAPZB;PODXL;TBC1D8;MYO10;RAB5A;TBC1D14;PPP1R16B;TBC1D1;GAP43;TBC1D15;DCDC2;TBC1D13;DYNC2LI1;DYNLT2B;CDC42;RABEP2;CAV1;TBC1D10B;FXR2;TBC1D2;ABITRAM;TBC1D22B;TBC1D16;EPHA2
prerank,"wound healing, spreading of cells (GO:0044319)",0.43947786989698445,1.087028317269863,0.3724137931034483,1.0,1.0,1/24,0.13%,ARHGAP24
prerank,small GTPase mediated signal transduction (GO:0007264),0.3567610641496442,1.0859337457822695,0.3423913043478261,1.0,1.0,14/103,10.78%,ARHGAP32;USP50;FGF2;RAB38;ARL3;PLD1;NUCB1;NF1;KSR1;RALB;RGL1;SHOC2;MRAS;MAPK14
prerank,protein acetylation (GO:0006473),0.42427014054247036,1.0851569142587285,0.37296620775969963,1.0,1.0,8/30,18.52%,KAT2B;HAT1;NAA35;NAA16;GTF2B;ING4;NAA10;NAA15
prerank,regulation of transmembrane transport (GO:0034762),0.4147411540535707,1.0851388106145203,0.36926889714993805,1.0,1.0,6/31,14.63%,FFAR4;BCL2;KCNJ3;SNCA;NEDD4L;KCNJ10
prerank,regulation of phospholipase activity (GO:0010517),0.5275177765281062,1.085100719951885,0.3630769230769231,1.0,1.0,3/10,13.88%,LRP1;FGFR1;SNCA
prerank,oligodendrocyte development (GO:0014003),0.47377632820327314,1.0850633470902915,0.3926470588235294,1.0,1.0,5/15,20.63%,PLP1;EIF2B5;NSUN5;EIF2B2;B4GALT6
prerank,regulation of angiogenesis (GO:0045765),0.3459100418343697,1.0849123522765984,0.3120494335736354,1.0,1.0,40/192,16.89%,DCN;HSPG2;SULF1;PRKCA;CXCL10;RHOJ;FGF2;SEMA3E;CD34;ERBB2;VEGFA;PAK4;COL4A2;ITGB8;NF1;HSPB6;CCR2;PDE3B;WNT5A;ADAMTS1;SPRED1;CYP1B1;GATA6;BRCA1;HIF1A;SPARC;ATF2;SP1;MYDGF;GRN;SMOC2;PDCL3;BMPER;ITGB1;JUP;RUNX1;GAB1;HTATIP2;HYAL1;APLNR
prerank,negative regulation of interleukin-2 production (GO:0032703),0.46766510256033994,1.084457067145131,0.3678977272727273,1.0,1.0,5/18,20.38%,CD34;PRNP;HOMER2;NAV3;ZFP36
prerank,potassium ion homeostasis (GO:0055075),-0.34607299638646766,-1.0843982013430553,0.33955223880597013,0.8235768157534944,1.0,6/23,7.72%,ATP1A2;ATP1B3;SLC12A7;KCNJ2;ATP1A1;SLC12A9
prerank,retinol metabolic process (GO:0042572),0.48245593282352883,1.084361992796014,0.3715925394548063,1.0,1.0,3/14,8.29%,CYP1B1;RDH10;DHRS3
prerank,positive regulation of heterotypic cell-cell adhesion (GO:0034116),-0.41287364383829156,-1.0840958735766528,0.3495440729483283,0.8225655958663459,1.0,3/12,19.97%,GCNT2;FLOT1;SKAP1
prerank,post-Golgi vesicle-mediated transport (GO:0006892),0.3612262445553009,1.0836124552776534,0.34929270946681173,1.0,1.0,12/88,7.60%,STXBP6;STEAP2;SNAP23;SORCS1;RAB14;ARL3;GOLGB1;OSBPL5;SCAMP2;AP1G1;GBF1;EPS15
prerank,protein localization to phagophore assembly site (GO:0034497),0.49860139862267416,1.08349942726166,0.379746835443038,1.0,1.0,2/11,5.78%,PACS2;WIPI1
prerank,positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901030),-0.3125002386459833,-1.083486638555277,0.34763948497854075,0.8224362104872047,1.0,15/31,24.40%,PPP1R13B;YWHAQ;GSK3B;CASP8;GSK3A;TFDP2;BID;HIP1R;BOK;NMT1;BBC3;E2F1;BAK1;PPP3R1;MAPK8
prerank,protein localization to chromosome (GO:0034502),0.4091802361319092,1.0831195274636805,0.3738680465717982,1.0,1.0,7/34,16.41%,FAM47E;MRNIP;ATRX;SLF2;ESR1;RPA2;TERF2IP
prerank,protein localization to Golgi apparatus (GO:0034067),0.4278113842910657,1.0829046579534725,0.36507936507936506,1.0,1.0,8/27,11.97%,OBSL1;ARL1;GBF1;GAK;TMED10;ARL5C;BICD2;SYS1
prerank,peroxisome organization (GO:0007031),0.43301289131036275,1.0828734501599429,0.37869062901155326,1.0,1.0,7/25,20.97%,SEC16B;PEX3;PLAAT3;ABCD2;PEX1;PEX11A;ACOT8
prerank,negative regulation of cell motility (GO:2000146),0.3545454497907313,1.0826360819829413,0.3383137673425827,1.0,1.0,24/108,14.77%,DLC1;CLDN19;SULF1;PIP5KL1;PTEN;DPEP1;PTPRT;RAP2B;RECK;NF1;PODN;CYP1B1;NF2;MCTP1;PTPRJ;NGFR;MAGI2;DRD2;ADARB1;GATA3;ARHGAP4;TCAF1;LDLRAD4;CITED2
prerank,regulation of fibroblast proliferation (GO:0048145),0.3885464630234333,1.0823371111982922,0.36081242532855434,1.0,1.0,11/45,17.23%,PDGFRA;MYC;NF1;WNT5A;S100A6;CDK6;EMD;MED25;TP53;CD74;CDC73
prerank,ribosome assembly (GO:0042255),-0.28311000814644016,-1.0823209309260882,0.2804878048780488,0.8240346503355822,1.0,24/47,27.56%,RPS14;RPL24;NPM1;RPS19;RPL5;EIF2A;RPS15;RPL3;MRPL20;NOP53;RPL11;MRPS7;DHX37;MRPS11;MRPL22;RSL24D1;NLE1;PPAN;MPV17L2;RPS5;RPF2;RPL6;PWP2;RPS27
prerank,positive regulation of epithelial to mesenchymal transition (GO:0010718),-0.30506719185343223,-1.0820558844652453,0.3352601156069364,0.8227160498603979,1.0,8/40,9.24%,DAB2;GCNT2;LEF1;CTNNB1;TGFBR1;PDPN;RGCC;JAG1
prerank,cellular monovalent inorganic cation homeostasis (GO:0030004),-0.35146304178475535,-1.0812000913577635,0.33984375,0.8232791056523867,1.0,4/20,6.72%,ATP1A2;ATP1B3;KCNJ2;ATP1A1
prerank,negative regulation of cellular response to insulin stimulus (GO:1900077),0.4204103349153703,1.0809280190401311,0.36619718309859156,1.0,1.0,8/28,13.99%,PRKCQ;PTPN2;SLC27A4;SOCS1;GRB14;PTPN1;PID1;NCK1
prerank,negative regulation of cell-substrate adhesion (GO:0010812),0.39884565828425567,1.0807259497162751,0.38848920863309355,1.0,1.0,9/39,12.65%,SEMA3E;EFNA5;HOXA7;MAP4K4;RASA1;FZD7;NF2;AJAP1;MYOC
prerank,bile acid and bile salt transport (GO:0015721),0.43094881629174875,1.0804180953457168,0.36129905277401897,1.0,1.0,5/24,14.49%,ATP8B1;NCOA1;SLCO2B1;NCOA2;SLC10A1
prerank,regulation of cation transmembrane transport (GO:1904062),0.42048266315019406,1.0801462649133116,0.36503856041131105,1.0,1.0,9/29,19.21%,WNK3;SCN5A;FGF12;DPP10;KCNAB2;KCNIP4;HOMER1;KCNH2;CD63
prerank,sodium ion transmembrane transport (GO:0035725),0.36264813890351805,1.0799817976321524,0.3454746136865342,1.0,1.0,10/84,7.96%,SLC6A2;SCN7A;SLC12A3;SCN2A;KCNK1;ANO6;SLC12A2;SCN5A;SCN3A;SLC8A2
prerank,C-terminal protein amino acid modification (GO:0018410),0.5096331502622442,1.079761775437447,0.38221528861154447,1.0,1.0,4/11,16.10%,ATG5;AGBL4;AGBL1;GPLD1
prerank,negative regulation of biomineral tissue development (GO:0070168),-0.3559625852978837,-1.0795046326248816,0.3236514522821577,0.8265780789520485,1.0,8/21,15.38%,ROCK2;ROCK1;NOS3;ASPN;SRGN;ENPP1;HEY2;PTK2B
prerank,ER-associated misfolded protein catabolic process (GO:0071712),-0.4230303341704017,-1.0792213930502854,0.34782608695652173,0.8254022787530653,1.0,8/11,30.74%,POMT2;RNF185;AUP1;UFD1;UGGT1;RNF5;VCP;BAG6
prerank,regulation of defense response to virus (GO:0050688),0.4818408225217525,1.0790073590262217,0.3901734104046243,1.0,1.0,2/14,8.38%,ELMOD2;PPM1B
prerank,positive regulation of mitotic nuclear division (GO:0045840),-0.309031961149997,-1.0789798857237178,0.3064516129032258,0.8241477590275802,1.0,7/34,9.93%,IGF1;LRP5;IGF2;INSR;TGFA;RGCC;PDGFRB
prerank,cellular response to oxygen-containing compound (GO:1901701),0.3375720338777166,1.0789443389097289,0.31017119838872104,1.0,1.0,73/291,21.50%,RORA;P2RY2;SSTR1;CXCL10;PDGFRA;PYCARD;DPEP1;SOX9;EGFR;NCF1;PDE4B;MT3;WNT5A;AOC1;RORC;PDK3;FZD7;RAP1A;CPEB3;LAMTOR2;TSHR;MAPK9;SELENOS;AKAP6;ESR1;MAPK14;TRIM41;PID1;MAPK1;UPF1;ERCC6L2;NRIP1;PRDX3;HSP90B1;SHPK;AHR;CPEB1;P2RY12;P2RY1;SSH1;LCOR;TICAM1;PLAA;MTR;ATM;GPLD1;NDUFA13;PAX2;CDC73;CHUK;NCOA3;SPAAR;RPTOR;LBP;FAM210B;TAF1;AXL;EGR1;RYR3;RUVBL2;IPO5;PDCD4;HCN1;BCL10;JUN;RRAGA;ZFP36;SIRPA;NFKB1;TNIP2;PKD2;PXN;P2RX7
prerank,positive regulation of cytokine production (GO:0001819),0.33709517104250386,1.07884578070765,0.29518072289156627,1.0,1.0,56/292,19.04%,RORA;SULF1;IL16;PRKCQ;GLMN;PYCARD;PTPN22;CD34;FADD;EIF2AK3;TGFB1;PDE4B;PLCB1;CCR2;NOX1;WNT5A;SPTBN1;TMEM106A;AGPAT2;CARD9;CYP1B1;LRRFIP1;IL18;CADM1;BRCA1;TMED10;POLR2K;HIF1A;TLR1;MAPK14;PTPN11;IL6ST;RAB1A;PDE4D;TBK1;XRCC6;DRD2;SCRIB;GATA3;MALT1;DHX33;TICAM1;CGAS;IL33;RUNX1;CD74;RIPK1;POLR1C;MDK;RAB7B;IRF3;LBP;PARK7;BATF;SETD4;EGR1
prerank,cardiac muscle cell development (GO:0055013),0.44926999200841006,1.0786384328596321,0.37730870712401055,1.0,1.0,3/20,5.55%,PDGFRA;VEGFA;OBSL1
prerank,positive regulation of cellular respiration (GO:1901857),-0.4339914170814997,-1.0784999828930368,0.352,0.8236741757227928,1.0,7/11,36.47%,NUPR1;IL10RB;PINK1;IFNAR1;VCP;IFNLR1;ISCU
prerank,sphingolipid catabolic process (GO:0030149),-0.38523128043989546,-1.07823766357902,0.34824281150159747,0.8223676151295713,1.0,7/15,30.07%,ACER2;SGPL1;ASAH2;SPHK1;SMPDL3A;PPT1;GLA
prerank,regulation of DNA binding (GO:0051101),-0.29003322634432765,-1.078213095609001,0.3373493975903614,0.8204559980232954,1.0,20/44,24.40%,IGF1;SP100;LEF1;NFKBIA;KDM1A;HABP4;DOT1L;MDFI;SUMO3;HMGA2;NME1;CEBPG;TFAP4;HMGB2;TXN;CSNK2B;EGF;E2F1;PLAUR;MAPK8
prerank,regulation of dendritic spine development (GO:0060998),0.45367882982101954,1.0780799750556016,0.3841642228739003,1.0,1.0,5/19,10.41%,PSEN1;TANC2;NLGN1;CPEB3;PPFIA2
prerank,ceramide metabolic process (GO:0006672),-0.284064204612473,-1.0776698257408797,0.35119047619047616,0.8199894261109331,1.0,14/49,18.52%,SGMS1;ST6GALNAC3;PLPP1;CERS5;ACER2;SPTLC2;DEGS2;CERS4;SGPL1;ASAH2;CERS1;ORMDL3;PLA2G15;SPTSSB
prerank,negative regulation of response to wounding (GO:1903035),0.450984601145099,1.077455569313282,0.3848396501457726,1.0,1.0,2/19,1.27%,CLDN19;FGF2
prerank,regulation of macrophage derived foam cell differentiation (GO:0010743),-0.3347498722473778,-1.0768248073733877,0.35714285714285715,0.8206531758825388,1.0,6/27,11.12%,PRKCH;ABCA1;NFKBIA;AGTR1;ABCG1;NR1H2
prerank,cellular response to glucose starvation (GO:0042149),-0.29739610764534824,-1.0767839509933,0.32124352331606215,0.8187998387759277,1.0,17/41,25.92%,PRKAG2;NUAK1;SIK1;NIM1K;BECN1;PRKAA2;SESN2;PRKAG3;ATG14;KPTN;ATF4;NUAK2;HNRNPA1;SH3GLB1;BRSK2;MTMR3;SZT2
prerank,regulation of cardiac muscle contraction (GO:0055117),0.40399344083718675,1.076705634896322,0.3863912515188335,1.0,1.0,8/34,17.45%,ANK2;PDE4B;SCN5A;PDE4D;PRKACA;CALM1;CALM2;SLC9A1
prerank,hematopoietic progenitor cell differentiation (GO:0002244),-0.32067195887524363,-1.0761881298232698,0.2857142857142857,0.818600522311988,1.0,6/30,6.82%,FLT1;KIT;MLLT3;BMP4;KDR;ACE
prerank,regulation of non-canonical Wnt signaling pathway (GO:2000050),0.47018161613799603,1.0755424420310813,0.40828402366863903,1.0,1.0,5/15,15.64%,GPC3;DAAM2;SFRP4;DACT1;CSNK1E
prerank,negative regulation of heterotypic cell-cell adhesion (GO:0034115),-0.4248937535310262,-1.075496883483325,0.37752161383285304,0.8167088801829869,1.0,3/10,8.82%,MAP2K5;WNK1;KLF4
prerank,regulation of cell-cell adhesion involved in gastrulation (GO:0070587),-0.4248937535310262,-1.075496883483325,0.37752161383285304,0.8167088801829869,1.0,3/10,8.82%,MAP2K5;WNK1;KLF4
prerank,negative regulation of sprouting angiogenesis (GO:1903671),0.5003734575574821,1.0750754784739842,0.38161993769470404,1.0,1.0,2/11,5.21%,CREB3L1;E2F2
prerank,defense response to fungus (GO:0050832),0.4650638854889183,1.0750600426067227,0.3722943722943723,1.0,1.0,5/17,26.37%,CARD9;BCL10;RARRES2;FAM3A;RNASE7
prerank,positive regulation of T cell activation (GO:0050870),0.3698729814781812,1.0749664693491892,0.3805104408352668,1.0,1.0,9/62,13.99%,PRKCQ;PYCARD;CCR2;ZMIZ1;IL6ST;RHOH;ZBTB1;GATA3;NCK1
prerank,regulation of intracellular signal transduction (GO:1902531),0.33245940992322554,1.0749246147769567,0.283,1.0,1.0,100/420,18.30%,ARHGAP24;DLC1;ARHGAP32;ARHGAP19;A2M;RHOJ;NTRK3;PYCARD;PTEN;RHOD;PTPN22;BST1;DEPDC1B;EGFR;AKAP13;FGD4;MAP4K4;VEGFA;PAK4;ARAF;PAK5;NTRK2;TRAF4;PRKAR1B;TNIK;PTPN13;NOP2;WNT5A;NLGN1;PAK1;CHN1;MAPKAP1;MTA2;RPA3;PRKAB2;UFL1;ITSN1;SPRED1;ARHGAP9;CHD3;NF2;ARHGEF11;CASTOR2;TBCK;PPP1R13L;BRCA1;VAV3;RCN3;ARHGAP11A;RHOT2;HDAC2;MYO9B;PHF20;AKAP6;MAPK14;TAF9;MYO9A;ARHGAP21;TAF11;TAF2;MAPK1;OPHN1;TAOK3;CDK5R1;FBXL2;RHOH;RHOC;MYOC;GNAI1;RBBP4;TRIO;PRDM11;ARHGAP4;ARHGEF3;RPA2;TOPBP1;MDM4;TAF7;ARHGAP44;ZFAND6;RASSF2;ATM;GPAT3;TAF4;BLM;TP53;TAF4B;TTI1;XIAP;SGK1;USP2;ARHGEF4;WRN;RAC3;PLEKHG2;PIP5K1A;TP53RK;BOP1;MDM2;RHOT1
prerank,lipoprotein transport (GO:0042953),0.5071420872015735,1.0749132769061411,0.40649149922720246,1.0,1.0,6/10,25.42%,LRP1;PPARG;VMP1;UNC119B;MIA3;ZDHHC17
prerank,establishment of protein localization to extracellular region (GO:0035592),0.398366318934565,1.0745047750872485,0.35633626097867,1.0,1.0,19/39,28.75%,STEAP3;COPG2;MTTP;RCN3;RAB3D;RAB3A;ARFGAP3;COPG1;TANGO6;RAB3B;TANGO2;TVP23A;MIA3;MON1A;SCG2;SEL1L;LTBP2;PREB;RAB13
prerank,amino acid transport (GO:0006865),-0.28046531452316115,-1.0742177087531004,0.33121019108280253,0.8187770547112221,1.0,12/49,14.60%,SLC7A11;SLC7A2;SLC6A12;SLC6A6;SLC7A5;SLC38A11;PDPN;SLC38A7;SLC38A5;SLC25A47;SLC38A10;SLC36A4
prerank,erythrocyte development (GO:0048821),-0.43465225130140656,-1.073660315269786,0.37362637362637363,0.818547850768724,1.0,7/10,42.05%,ALAS1;NCKAP1L;DMTN;LYAR;ALAS2;ZBTB7A;SH2B3
prerank,translation (GO:0006412),-0.22002314212958088,-1.0730229665461202,0.13333333333333333,0.8185447673989864,1.0,88/208,26.80%,RPS14;GSPT1;RPL24;DRG1;RPL18A;RPS16;GTPBP2;RPL38;RPL28;RPS19;RPL37;ABCE1;RARS2;RPS2;FTSJ1;SARS1;MRPL10;GTPBP1;RPL19;RPL5;RPL34;RPS25;MRPS24;RPS15;TNIP1;EEF1G;RPLP1;RPL31;PABPC4;RPL3;MRPL24;MRPL3;QRSL1;EEF1A1;DRG2;FASTKD2;RPS6;GFM2;LARS1;RPS8;EIF4EBP2;AARS1;RARS1;RPL11;RPL12;KARS1;RPS6KB2;TSFM;RPL7A;RPL13;EEF1B2;MRPS7;COPS5;MRPL43;IGF2BP3;YARS2;RPS21;NOA1;RPL35A;ASMT;RPL26;RPS9;MRPS17;RPL32;RPS29;RPS23;EEF1E1;RPLP2;MRPS11;MRPL2;RPL8;MRPS16;RSL24D1;RPL41;VARS1;RPS17;GATC;DHPS;RPS5;RPS15A;UBA52;RPL37A;MRPL57;RPS10;MRPL55;RPL6;WARS1;RPL9
prerank,snRNA processing (GO:0016180),0.46310334363771094,1.0728856275376164,0.37926136363636365,1.0,1.0,5/16,13.91%,INTS11;INTS6;INTS4;INTS2;INTS8
prerank,photoreceptor cell development (GO:0042461),0.48138154508860276,1.072150754104481,0.39124087591240875,1.0,1.0,2/14,3.63%,VEGFA;ARL3
prerank,prostanoid metabolic process (GO:0006692),0.4886945497100899,1.071964245821437,0.3926940639269406,1.0,1.0,4/13,17.78%,CYP2S1;ACOX1;PLAA;PTGES
prerank,negative regulation of lymphocyte proliferation (GO:0050672),0.413300831748227,1.071719226541552,0.3811944091486658,1.0,1.0,6/31,17.21%,GLMN;SOX11;SDC4;IL4I1;ATM;RC3H1
prerank,amyloid precursor protein metabolic process (GO:0042982),0.4536305083038618,1.0717061558358787,0.37830319888734354,1.0,1.0,6/18,14.33%,ADAM19;PSEN1;KLK6;NCSTN;APH1A;PSEN2
prerank,regulation of keratinocyte proliferation (GO:0010837),0.4464483234090246,1.0717024027160884,0.3914780292942743,1.0,1.0,4/22,2.73%,EPB41L4B;FGF10;STXBP4;TGM1
prerank,negative regulation of locomotion (GO:0040013),-0.41619080330580766,-1.07157255490284,0.3830409356725146,0.8210481150193536,1.0,4/12,9.35%,FRMD5;FBLN1;DUSP3;CCDC125
prerank,glycoprotein biosynthetic process (GO:0009101),-0.25683122144658066,-1.071555011177211,0.31521739130434784,0.8191552004633693,1.0,18/79,16.55%,IGF1;GCNT2;ST3GAL6;ST8SIA4;FAM20B;BMPR2;ATP7A;CHST11;MGAT1;ST6GALNAC2;TNIP1;SERP1;FOXL1;CHST12;B4GALT7;NUS1;B3GALT1;B3GALT2
prerank,regulation of toll-like receptor 2 signaling pathway (GO:0034135),-0.42134358162559965,-1.0708845067660577,0.3767313019390582,0.8192663626720745,1.0,4/11,13.93%,MFHAS1;LYN;CYBA;TIRAP
prerank,clathrin coat assembly (GO:0048268),0.47787683233929057,1.0707427240480336,0.3978658536585366,1.0,1.0,3/15,8.71%,SGIP1;EPS15;HIP1
prerank,positive regulation of cell population proliferation (GO:0008284),0.33069161073373055,1.0705406077532256,0.29,1.0,1.0,70/423,12.88%,OSR2;BMP5;PDGFRA;ERBB3;HAS2;NTRK3;FGF2;SOX8;MYC;FGF10;KIF20B;PTEN;BCL2;GAREM1;IRS2;SOX9;CRLF1;BST1;ERBB2;LAMC1;EGFR;VEGFA;MAP3K3;PTHLH;CAPN1;SAAL1;TGFB1;TIPIN;PTGFR;SOX11;NTRK2;GDF9;GLI1;NOX1;NOP2;SCN5A;WNT5A;PAK1;CDK13;TGFBR2;MLXIPL;UFL1;S100A6;CDK6;FOXM1;FGFR1;IL18;TSHR;GAB2;BTC;DERL2;CUL3;HDAC2;ERBB4;GDNF;IL6ST;PRMT1;CDC25B;PID1;SIRT6;S1PR3;EDN3;FGF7;GRN;RTKN2;WWTR1;GLP2R;PRLR;PRDX3;ZFPM2
prerank,GPI anchor metabolic process (GO:0006505),0.41897129470613464,1.0705166216482944,0.37809647979139505,1.0,1.0,9/26,19.95%,PGAP1;PIGC;PIGP;PIGN;PIGA;PIGU;GPLD1;DPM1;PIGO
prerank,positive regulation of T cell chemotaxis (GO:0010820),0.5070519209395242,1.0703908144361403,0.39636913767019666,1.0,1.0,3/10,9.18%,CCR2;WNT5A;STK39
prerank,negative regulation of signal transduction in absence of ligand (GO:1901099),-0.3483095158512764,-1.0703532950747585,0.37593984962406013,0.8171010926555607,1.0,5/21,6.61%,EYA1;EYA2;MAP2K5;EYA4;MCL1
prerank,negative regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001240),-0.3483095158512764,-1.0703532950747585,0.37593984962406013,0.8171010926555607,1.0,5/21,6.61%,EYA1;EYA2;MAP2K5;EYA4;MCL1
prerank,phosphatidylinositol phosphate biosynthetic process (GO:0046854),-0.2999529396634469,-1.070100138336098,0.3279569892473118,0.8159164570440112,1.0,13/39,17.41%,PI4KA;PIK3R3;PIK3C2A;TTC7B;IP6K1;SOCS7;SOCS4;PIK3C2B;EFR3B;TMEM150A;ITPKC;PIP4K2B;ITPKB
prerank,snRNA transcription by RNA polymerase II (GO:0042795),0.3685434832441884,1.069577589144011,0.38895152198421645,1.0,1.0,19/69,15.66%,INTS11;SNAPC2;RPRD1A;POLR2B;INTS6;ZC3H8;GTF2B;POLR2K;NCBP1;INTS4;SP1;TAF9;TAF11;INTS2;POLR2G;INTS8;ELL;GTF2E2;GTF2E1
prerank,N-terminal protein amino acid acetylation (GO:0006474),0.4615760886567074,1.0690942288973886,0.4183098591549296,1.0,1.0,5/16,18.52%,KAT2B;NAA35;NAA16;NAA10;NAA15
prerank,regulation of interferon-gamma production (GO:0032649),0.36632706217192357,1.069019038473874,0.37911464245175935,1.0,1.0,9/71,12.72%,PYCARD;PTPN22;FADD;PDE4B;PRNP;CCR2;IL18;PDE4D;SCRIB
prerank,positive regulation of amyloid-beta formation (GO:1902004),-0.3771612170740759,-1.068932848520293,0.34814814814814815,0.817317935515237,1.0,4/18,10.06%,EPHA4;ROCK2;GSK3A;ABCG1
prerank,calcium-mediated signaling using intracellular calcium source (GO:0035584),0.4552909107883936,1.0688109514416135,0.37586685159500693,1.0,1.0,6/19,17.24%,PTGFR;PRNP;GRM5;PTPRJ;PRKACA;STIMATE
prerank,"regulation of mRNA splicing, via spliceosome (GO:0048024)",0.35763474240662874,1.0688099296678577,0.3576158940397351,1.0,1.0,30/84,26.10%,PRDX6;RBFOX1;CELF5;QKI;TRA2B;SON;KHDRBS3;NCBP1;PCBP4;DAZAP1;CELF6;RBM7;NOVA1;SRSF6;YTHDC1;HNRNPU;RNPS1;SF1;RBFOX3;CELF4;HNRNPL;RBFOX2;SRSF3;RBM25;FMR1;CIRBP;NSRP1;RBM4;RBM15;TRA2A
prerank,protein-DNA complex disassembly (GO:0032986),0.4629916297461352,1.0687813645824085,0.40028694404591103,1.0,1.0,5/16,20.23%,MYC;SMARCC2;SMARCC1;SMARCE1;SMARCA4
prerank,"Wnt signaling pathway, calcium modulating pathway (GO:0007223)",-0.3032782308959663,-1.0684989145217705,0.3670212765957447,0.8166371290703831,1.0,10/36,12.43%,LEF1;CTNNB1;PLCB3;MOV10;AGO1;FZD6;NLK;CAMK2A;MAP3K7;AGO3
prerank,positive regulation of pseudopodium assembly (GO:0031274),-0.4299402673800349,-1.0684647195096684,0.38461538461538464,0.812934492700123,1.0,4/10,13.33%,CDC42EP4;CDC42EP3;CDC42EP2;CDC42
prerank,regulation of pseudopodium assembly (GO:0031272),-0.4299402673800349,-1.0684647195096684,0.38461538461538464,0.812934492700123,1.0,4/10,13.33%,CDC42EP4;CDC42EP3;CDC42EP2;CDC42
prerank,positive regulation of lyase activity (GO:0051349),-0.3861074361830644,-1.0683899553345844,0.38650306748466257,0.8112366616944103,1.0,5/14,15.85%,CACNA1C;NOS3;STIM1;NOS1;FXN
prerank,regulation of nitric-oxide synthase biosynthetic process (GO:0051769),-0.3995730347633032,-1.0683889924190075,0.39762611275964393,0.8093587990515992,1.0,3/13,4.56%,TLR4;NAMPT;KDR
prerank,"mitochondrial electron transport, cytochrome c to oxygen (GO:0006123)",-0.3667505092450669,-1.0683770484690014,0.35973597359735976,0.8075512401782071,1.0,9/17,25.07%,COX7B;COX6B1;COX6A1;COX4I1;COX7C;COX5B;COX5A;COX6C;CYCS
prerank,female gamete generation (GO:0007292),0.4085583288346785,1.0681091830697458,0.38881664499349805,1.0,1.0,11/29,23.39%,FMN2;GDF9;METTL3;DIAPH2;PRDM9;MDK;MARF1;KMT2D;SPO11;MEI4;TOB2
prerank,positive regulation of interleukin-1 beta production (GO:0032731),0.3915075979261152,1.068075309708464,0.37454545454545457,1.0,1.0,4/45,5.57%,USP50;PYCARD;WNT5A;TMEM106A
prerank,positive regulation of intracellular protein transport (GO:0090316),0.3453485013261068,1.06787134349867,0.36507936507936506,1.0,1.0,19/144,11.39%,SEC16B;ANK3;KIF20B;BCL2;ERBB2;C2CD5;FBXW7;TGFB1;PSEN1;PRNP;PCM1;YWHAZ;FYN;FLNA;VPS11;HUWE1;PIK3R1;UBE2J2;EMD
prerank,cellular response to organonitrogen compound (GO:0071417),0.35212143409561036,1.06765588899941,0.37295528898582336,1.0,1.0,26/99,19.79%,P2RY2;SOX9;HRH1;AOC1;RAP1A;CPEB3;LAMTOR2;TSHR;BRCA1;AKAP6;HSP90B1;AHR;CPEB1;P2RY12;P2RY1;SSH1;JUP;GABRG2;SPAAR;RPTOR;TAF1;EGR1;RYR3;IPO5;HCN1;RRAGA
prerank,DNA duplex unwinding (GO:0032508),0.3779679540662257,1.067396905237218,0.37214885954381755,1.0,1.0,12/50,17.24%,DDX11;RAD23B;GTF2H2;DDB2;XPA;MCM4;DDB1;RTEL1;UBB;BLM;CUL4B;WRN
prerank,intrinsic apoptotic signaling pathway in response to oxidative stress (GO:0008631),-0.4269091948941107,-1.0672983956888769,0.3548387096774194,0.8089135208312105,1.0,4/11,10.56%,MAP3K5;PRKCD;DIABLO;GSKIP
prerank,regulation of calcium ion transport (GO:0051924),0.37791466638199667,1.0669611852408005,0.37822014051522246,1.0,1.0,6/54,4.10%,IL16;BCL2;CACNA2D1;ANK2;WNK3;CCL4
prerank,inositol phosphate metabolic process (GO:0043647),0.3832258302727417,1.0665154528291676,0.3843329253365973,1.0,1.0,5/46,4.92%,ITPK1;INPP4B;FGF2;PTEN;PLCB1
prerank,snRNA transcription (GO:0009301),0.36746074412498025,1.0664979007651962,0.3833145434047351,1.0,1.0,19/70,15.66%,INTS11;SNAPC2;RPRD1A;POLR2B;INTS6;ZC3H8;GTF2B;POLR2K;NCBP1;INTS4;SP1;TAF9;TAF11;INTS2;POLR2G;INTS8;ELL;GTF2E2;GTF2E1
prerank,establishment of apical/basal cell polarity (GO:0035089),0.47332294795252167,1.0664634497529109,0.38742690058479534,1.0,1.0,6/14,16.83%,PATJ;MYO9A;OPHN1;SCRIB;FSCN1;FOXJ1
prerank,response to growth factor (GO:0070848),0.38743601647915304,1.0662845199130564,0.3715651135005974,1.0,1.0,10/41,11.39%,MYC;ERBB2;ACVR1;MAPK7;ACVR1C;URI1;TGFBR2;GATA6;HDAC6;EMD
prerank,"energy coupled proton transport, down electrochemical gradient (GO:0015985)",-0.43032088445126726,-1.0661687714263315,0.416,0.8104535781722881,1.0,4/10,12.22%,ATP5MC3;ATP5PD;VPS9D1;ATP5F1D
prerank,negative regulation of epithelial cell differentiation (GO:0030857),0.4739749157519692,1.0661497163996894,0.3806646525679758,1.0,1.0,4/14,9.88%,ZEB1;SPRED2;SPRED1;SPRED3
prerank,cellular response to chemical stress (GO:0062197),0.3491872301577797,1.0661271592519623,0.36830601092896176,1.0,1.0,25/96,18.85%,PRDX6;SRXN1;LRRC8D;NCF1;MT3;NOX1;GPX3;MGAT3;NCF2;SELENOS;NFE2L2;FANCC;PRDX3;SOD2;SNCA;ATM;ABL1;VKORC1L1;RAD52;PNPT1;SLC25A24;TXNRD1;CAT;PARK7;ERMP1
prerank,positive regulation of mRNA processing (GO:0050685),0.44441453238850115,1.0660770689037695,0.3983957219251337,1.0,1.0,4/21,12.97%,PRDX6;TRA2B;NCBP1;DAZAP1
prerank,plasma membrane bounded cell projection assembly (GO:0120031),0.33520721621409616,1.065824346099011,0.33535353535353535,1.0,1.0,52/259,15.42%,DYNLL1;PTPDC1;RHOD;RHO;WDPCP;GSN;STK36;RAP2B;CC2D2A;FGD4;MAP4K4;ANO6;ARL3;NEK1;CCDC57;RFX2;TTC39C;IFT140;EMP1;PCM1;TNIK;RILPL2;SNAP29;BBS9;RFX3;DISC1;GBF1;RAP1A;CPLANE1;BBS5;FLNA;PMP22;SPATA13;WDR35;ARF4;HDAC6;OPHN1;SNX10;RAB1A;CEP89;CFAP20;FBF1;TRAPPC14;P2RY12;CCDC28B;RAB11FIP3;PKD1;EHD2;CYFIP1;CCDC65;ITGB1;CDC14A
prerank,cilium organization (GO:0044782),0.33596635079560283,1.0654325886622158,0.353596757852077,1.0,1.0,39/209,15.58%,DYNLL1;PTPDC1;RHO;WDPCP;GSN;STK36;CC2D2A;ARL3;NEK1;CCDC57;RFX2;TTC39C;IFT140;PCM1;RILPL2;SNAP29;BBS9;RFX3;DISC1;GBF1;CPLANE1;BBS5;FLNA;WDR35;ARF4;HDAC6;SNX10;RAB1A;CEP89;CFAP20;FBF1;TRAPPC14;CCDC28B;RAB11FIP3;PKD1;EHD2;CCDC65;CDC14A;CFAP61
prerank,synapse organization (GO:0050808),0.3434860321119388,1.0654206171233689,0.37898089171974525,1.0,1.0,29/125,14.94%,ANK3;PDZRN3;LRP4;PTEN;SEMA3E;NRCAM;PSEN1;NRXN1;LRRC4C;OBSL1;NLGN1;APBB2;CACNB4;KIRREL3;NTNG1;SLC8A2;GPM6A;CNTN2;DSCAM;GRM5;PPFIA2;ADGRL3;DVL1;DRD2;GPC4;GPHN;SNCA;PTPRF;CYFIP1
prerank,positive regulation of proteolysis involved in cellular protein catabolic process (GO:1903052),0.40969407406707686,1.0652995432759145,0.40264900662251657,1.0,1.0,3/28,3.89%,PTEN;PRKN;FBXW7
prerank,regulation of cell communication (GO:0010646),-0.3015245432092847,-1.064966033103142,0.34269662921348315,0.8121931412094978,1.0,8/35,11.23%,GRK5;IGFBP7;CXADR;SCG5;GRK4;GRK2;MGLL;UGCG
prerank,protein complex oligomerization (GO:0051259),0.3551167159984109,1.0649386947062156,0.37897042716319823,1.0,1.0,34/85,24.99%,PYCARD;LETM1;LRRC8D;CLDN1;CPSF6;MPP2;ALS2;CARD9;PRMT1;ATL3;ZBTB1;TMEM120A;YME1L1;NACC2;SNCA;PDCD6IP;OPA1;HOMER1;BLM;PNPT1;UGDH;SLC9A1;FUS;MS4A1;BCL10;ADCY8;MAT2A;PKD2;CARD11;KCNC1;G3BP2;ALAD;ATL1;CPSF7
prerank,cation transport (GO:0006812),0.3436519927245471,1.0647191044777553,0.3682051282051282,1.0,1.0,19/167,8.45%,SLC22A3;PIEZO2;FGF13;KCNA2;SCN7A;SLC12A3;SCN2A;KCNK1;ANO6;KCNA1;KCNA6;SLC36A2;SLC12A2;SCN5A;SCN3A;KCND3;SLC8A2;KCNMB2;KCNMB3
prerank,negative regulation of epithelial cell migration (GO:0010633),0.40593467076700807,1.0646199836929777,0.38481338481338484,1.0,1.0,2/33,1.66%,DCN;PTEN
prerank,"protein localization to chromosome, centromeric region (GO:0071459)",-0.3749508718096197,-1.0632395845992912,0.3717948717948718,0.8155251788364473,1.0,8/17,34.48%,BUB3;IK;BOD1;KNL1;ZW10;TTK;SPDL1;CENPA
prerank,cholesterol biosynthetic process (GO:0006695),0.4117576096706862,1.0632123077387565,0.4037735849056604,1.0,1.0,4/31,8.57%,HSD17B7;SQLE;IDI1;ACLY
prerank,positive regulation of macrophage chemotaxis (GO:0010759),-0.37979365095517825,-1.0627324125547153,0.3633633633633634,0.8150696359060295,1.0,3/14,7.52%,IL34;THBS1;AKIRIN1
prerank,phosphatidylglycerol metabolic process (GO:0046471),-0.3326458973461499,-1.0619582599178594,0.375968992248062,0.8155710420313916,1.0,4/24,5.69%,PLA2G4A;ABCA3;GPAM;CRLS1
prerank,epithelial cell migration (GO:0010631),-0.30439396936358215,-1.0618531709992995,0.3411764705882353,0.8140055568964242,1.0,10/37,9.34%,KANK2;NRP1;KIT;ROCK1;CDH13;NOS3;GIPC1;DPP4;TNFSF12;RHOA
prerank,peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine (GO:0018231),-0.3355141513026186,-1.0618031692160892,0.3724696356275304,0.8104656647641391,1.0,7/22,15.14%,ZDHHC14;ZDHHC3;CLIP3;ZDHHC18;ZDHHC7;ZDHHC20;ZDHHC4
prerank,peptidyl-L-cysteine S-palmitoylation (GO:0018230),-0.3355141513026186,-1.0618031692160892,0.3724696356275304,0.8104656647641391,1.0,7/22,15.14%,ZDHHC14;ZDHHC3;CLIP3;ZDHHC18;ZDHHC7;ZDHHC20;ZDHHC4
prerank,regulation of phospholipid metabolic process (GO:1903725),-0.43297572788541583,-1.0617096759927502,0.3994413407821229,0.8089022260483918,1.0,4/10,16.67%,ABCA3;MTMR2;MTMR9;MFSD2A
prerank,positive regulation of nitrogen compound metabolic process (GO:0051173),-0.354192158170874,-1.0617029300760996,0.37,0.8071079214735457,1.0,6/19,8.82%,MAP2K5;SLCO1C1;MTPN;KLF2;APP;KLF4
prerank,interleukin-27-mediated signaling pathway (GO:0070106),0.4769630943663381,1.0616807093270648,0.40956651718983555,1.0,1.0,3/13,11.09%,CRLF1;TYK2;IL6ST
prerank,regulation of T cell mediated immunity (GO:0002709),0.5074274856827723,1.0613547576473004,0.3923444976076555,1.0,1.0,2/10,12.59%,CCR2;ZBTB1
prerank,negative regulation of double-strand break repair (GO:2000780),-0.31797990736120224,-1.0612701293858795,0.3648068669527897,0.8065235419666209,1.0,16/30,28.93%,RIF1;HELB;HMGA2;POLQ;KLHL15;TWIST1;TRIP12;OGG1;ERCC6;FANCB;MAD2L2;RNF169;UBR5;NUDT16L1;RMI2;PARPBP
prerank,positive regulation of osteoblast differentiation (GO:0045669),-0.29172433113572027,-1.0609155178973904,0.3181818181818182,0.8057747473957814,1.0,8/43,5.92%,BMP6;IGF1;WNT4;LRP5;BMP4;BMPR2;SUCO;ZHX3
prerank,negative regulation of endothelial cell apoptotic process (GO:2000352),-0.3361074394016468,-1.060788513695827,0.3574144486692015,0.8044024553237729,1.0,7/24,12.08%,CDH5;TEK;ANGPT1;KDR;ICAM1;GATA2;SERPINE1
prerank,"negative regulation of mRNA splicing, via spliceosome (GO:0048025)",-0.3943795395569712,-1.0607425150419927,0.38562091503267976,0.8027409388285496,1.0,8/14,23.37%,RBMX;SRSF10;SRSF4;SAP18;PTBP1;SRSF12;SRSF7;U2AF2
prerank,regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway (GO:2001267),0.49118758659594786,1.060330541360944,0.39907550077041604,1.0,1.0,3/11,18.76%,GSN;PIH1D1;PARK7
prerank,nucleobase-containing compound catabolic process (GO:0034655),0.40778338388623075,1.0603163254544428,0.391358024691358,1.0,1.0,9/37,12.38%,NUDT15;RNASE6;ENTPD2;NUDT1;XRN2;PPP1R8;NCBP1;NUDT9;RNASEH2C
prerank,positive regulation of release of cytochrome c from mitochondria (GO:0090200),0.41833271405666583,1.0601507171054982,0.39348710990502034,1.0,1.0,4/25,7.73%,HRK;PYCARD;BMF;BNIP3
prerank,cellular transition metal ion homeostasis (GO:0046916),-0.24727376260585568,-1.059974530047413,0.32051282051282054,0.803337881060046,1.0,29/91,20.46%,BMP6;ABCG2;SLC30A10;SLC31A1;FLVCR1;ATP7A;FBXL5;ATP6V0D1;APP;SLC31A2;SLC40A1;FTH1;SLC39A8;FTL;SLC39A6;SLC30A1;TFRC;SOD1;CYB561A3;FRRS1;ATP6AP1;ATP6V0A2;FXN;SLC39A10;SLC22A17;ACO1;ABCB7;HFE;TMEM199
prerank,neural crest cell development (GO:0014032),0.3837418933246477,1.0598878865886454,0.3970223325062035,1.0,1.0,10/44,14.85%,SOX8;SEMA3E;SEMA6C;SEMA3A;SOX11;ERBB4;GDNF;ANXA6;KLHL12;SEMA6D
prerank,regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001239),-0.3184958220302271,-1.0598030940288246,0.35177865612648224,0.8020122746649438,1.0,6/26,6.83%,EYA1;EYA2;MAP2K5;EYA4;MCL1;PPP2R1B
prerank,branching involved in ureteric bud morphogenesis (GO:0001658),0.4545968901368256,1.0597611576360557,0.39488636363636365,1.0,1.0,2/16,1.47%,FGF2;MYC
prerank,neuron projection development (GO:0031175),0.3357664735245497,1.0594193379093553,0.3852544132917965,1.0,1.0,34/168,13.40%,CDNF;DOCK7;KIF20B;PTEN;NGF;PPP1R9A;MAP4K4;GAS7;ATXN10;EPHB2;GPM6B;PLP1;TNIK;NYAP1;NLGN1;PAK1;ALS2;DOCK10;CNTNAP2;GPM6A;EPB41L3;VAPA;GDNF;DCLK1;PRMT1;DIP2A;BMP7;OPHN1;STMN4;TAOK3;CDK5R1;MYOC;CDK16;TRIO
prerank,positive regulation of natural killer cell mediated immunity (GO:0002717),0.4523120135594999,1.0590407129480384,0.38636363636363635,1.0,1.0,3/16,12.73%,AP1G1;CADM1;NECTIN2
prerank,positive regulation of vascular associated smooth muscle cell proliferation (GO:1904707),0.43334628123611274,1.0586692962887472,0.3972602739726027,1.0,1.0,3/21,6.93%,MMP2;FGF2;ADAMTS1
prerank,peptidyl-serine modification (GO:0018209),0.3379982254529215,1.0586283364350122,0.37938144329896906,1.0,1.0,49/166,19.43%,PRKCA;STK32B;PRKCQ;PRKX;EIF2AK3;RPS6KA4;MAPKAPK3;MAST2;MAPKAPK2;DYRK4;PKN1;TGFBR2;DYRK1B;GALNT1;PDK3;STK39;TLK2;MAPK9;AKT3;SGK3;SGK2;MAPK14;STK32A;MAPK1;CDK5R1;TBK1;CSNK1G1;GALNT13;PRKACA;CSNK1A1;HPF1;TTBK1;RPS6KA2;PKD1;GALNT3;ATM;CSNK1E;CSNK1G2;SGK1;CHUK;NAA10;POGLUT2;PKN2;VRK3;TAF1;CSNK2A2;CSNK1G3;CAB39;TOP1
prerank,negative regulation of transforming growth factor beta receptor signaling pathway (GO:0030512),0.3667145756854295,1.057982251069571,0.3853932584269663,1.0,1.0,14/65,15.16%,PRDM16;HTRA3;TGFB1;TGFBR2;SPRED2;SPRED1;PEG10;BCL9L;SPRED3;SNX6;DAND5;LTBP1;LDLRAD4;UBB
prerank,cAMP biosynthetic process (GO:0006171),-0.43035571367067965,-1.0579656452333406,0.3983957219251337,0.8058773446335173,1.0,3/10,18.27%,ADCY9;ADCY4;ADCY3
prerank,positive regulation of macromolecule biosynthetic process (GO:0010557),0.34793188481437964,1.0575841896891216,0.3871308016877637,1.0,1.0,20/122,9.18%,GLI2;FGF2;MYC;IRS2;HSPH1;ERBB2;EGFR;UPF3A;PLD1;GLI1;NOX1;NIBAN1;TMEM106A;STN1;METTL3;EIF3C;CPEB3;EIF6;NSUN5;PASK
prerank,"negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515)",0.4983053021940753,1.0574876165719327,0.40476190476190477,1.0,1.0,2/11,15.48%,CBFB;RUNX1
prerank,"mitochondrial electron transport, ubiquinol to cytochrome c (GO:0006122)",-0.4128649234168949,-1.057424268853918,0.38591549295774646,0.8056565141664276,1.0,9/11,26.73%,UQCRB;UQCR11;CYC1;UQCR10;UQCRH;UQCRFS1;UQCRC1;CYCS;UQCC3
prerank,regulation of telomerase activity (GO:0051972),0.3768483207920231,1.0565935815406828,0.39371980676328505,1.0,1.0,11/45,16.25%,PRKCQ;MYC;ERCC4;MEN1;PARM1;MAPK1;NEK7;MAP3K4;ATM;TP53;SMG6
prerank,positive regulation of peptidyl-tyrosine phosphorylation (GO:0050731),0.34143883852324697,1.0565753398688864,0.3866525423728814,1.0,1.0,19/121,11.99%,RELN;ERBB3;FGF10;CRLF1;ACVR1;EFNA5;VEGFA;GPRC5B;TGFB1;TEC;PRNP;IL18;PTPN1;GRM5;ERBB4;PTPRJ;PTPN11;IL6ST;FGF7
prerank,circulatory system development (GO:0072359),0.34644793429627174,1.0563412554606302,0.4023354564755839,1.0,1.0,25/118,15.13%,HSPG2;ERBB3;NTRK3;GLI2;PTEN;KAT2B;SOX9;AKAP13;ACVR1;FBXW7;TGFB1;NF1;FGF12;TGFBR2;PDLIM4;COL3A1;ERBB4;PTPN11;SMYD4;ZFPM2;KDM6A;LDB3;PKD1;CITED2;PKP2
prerank,plasma membrane repair (GO:0001778),-0.39860444892744185,-1.0561838411809774,0.39937106918238996,0.8074763850766102,1.0,4/13,12.27%,MYOF;MYH9;AHNAK2;SYTL4
prerank,positive regulation of natural killer cell mediated cytotoxicity (GO:0045954),0.44270416690226866,1.0561829531021365,0.40168539325842695,1.0,1.0,3/17,12.73%,AP1G1;CADM1;NECTIN2
prerank,regulation of microtubule-based movement (GO:0060632),-0.4124401274978432,-1.0556773319158748,0.39244186046511625,0.8071256501431477,1.0,5/11,15.59%,MAP2;LAMP1;DYNLT2B;NEFH;IGBP1
prerank,beta-catenin-TCF complex assembly (GO:1904837),0.412939206527794,1.0554105371339613,0.4148527528809219,1.0,1.0,14/29,21.37%,MYC;TLE1;MEN1;BCL9L;BCL9;TRRAP;PYGO1;TLE3;CDC73;TLE4;ASH2L;SMARCA4;KMT2D;PYGO2
prerank,regulation of macrophage activation (GO:0043030),-0.3129210522216423,-1.055396471525077,0.3794642857142857,0.8061923994069575,1.0,5/30,5.90%,CD200;IL31RA;MFHAS1;TLR4;THBS1
prerank,autophagy of mitochondrion (GO:0000422),0.3925980773354488,1.0549048288900236,0.405852417302799,1.0,1.0,8/38,14.97%,PRKN;FBXO7;WIPI1;CTSK;BNIP3;ATG5;ATG3;GABARAPL2
prerank,Notch signaling involved in heart development (GO:0061314),-0.417620875308396,-1.0545057004848244,0.37464788732394366,0.8068798984872868,1.0,3/11,15.31%,NOTCH2;JAG1;HEY2
prerank,regulation of MAPK cascade (GO:0043408),0.34189023601877855,1.0543201002939528,0.4,1.0,1.0,30/157,14.88%,ROR2;ROR1;NTRK3;FGF2;FGF10;ERBB2;EGFR;LPAR1;MAP4K4;PAK4;PAK5;NTRK2;NF1;TNIK;TMEM106A;PAK1;YWHAZ;KSR1;SPRED1;FGFR1;GPR37;PTPRJ;MAPK1;TAOK3;MYDGF;MYOC;PRDM11;DHX33;TRAF7;IQGAP1
prerank,positive regulation of interleukin-6 production (GO:0032755),0.361245477037976,1.0539666763686615,0.3859060402684564,1.0,1.0,15/68,20.89%,IL16;PYCARD;WNT5A;TMEM106A;CARD9;TLR1;PTPN11;IL33;CD74;RAB7B;LBP;SETD4;BCL10;STAT3;HSPD1
prerank,cardiac muscle cell contraction (GO:0086003),0.44263267759165525,1.053326629699242,0.4152777777777778,1.0,1.0,4/19,6.08%,CACNA2D1;GSN;SCN5A;FGF12
prerank,positive regulation of transport (GO:0051050),0.35440949058889876,1.0530736407974577,0.4183783783783784,1.0,1.0,6/85,3.05%,GPC3;SYNGR3;PYCARD;LRP1;C2CD5;KMT2A
prerank,regulation of cellular component size (GO:0032535),0.40577330855298666,1.0529567653216116,0.4106217616580311,1.0,1.0,13/30,23.95%,PTEN;PPP1R15A;RARG;VAV3;RAB22A;PPP1CA;RPTOR;PEX11A;RAB3B;RDX;HP1BP3;VAV2;MTOR
prerank,regulation of endothelial cell apoptotic process (GO:2000351),-0.2974035572874596,-1.0528513966847692,0.34210526315789475,0.8099755517119517,1.0,10/39,12.08%,CDH5;TEK;ANGPT1;KDR;PRKCI;THBS1;ICAM1;RGCC;GATA2;SERPINE1
prerank,cilium assembly (GO:0060271),0.33050027229985846,1.0528079467387204,0.3463855421686747,1.0,1.0,56/296,15.64%,DYNLL1;PTPDC1;RHO;WDPCP;GSN;STK36;CC2D2A;CCDC39;RSPH1;HAUS3;CNTRL;ARL3;NEK1;CCDC57;RFX2;TTC39C;IFT140;PCM1;RILPL2;SNAP29;NDE1;BBS9;RFX3;DISC1;SDCCAG8;GBF1;SPATA6;CPLANE1;BBS5;FLNA;CEP57;TRIP11;CFAP46;WDR35;CFAP74;CLASP1;ARF4;HDAC6;SNX10;RAB1A;CEP89;PRKACA;CFAP20;CKAP5;FBF1;TRAPPC14;CEP76;DYNC1I2;CCDC28B;RAB11FIP3;PKD1;EHD2;CCDC65;CDC14A;CSNK1E;IFT57
prerank,protein kinase B signaling (GO:0043491),0.42660410429596973,1.0528060700719266,0.40821917808219177,1.0,1.0,4/23,4.84%,PTEN;THEM4;TGFB1;MT3
prerank,substrate-dependent cell migration (GO:0006929),-0.38041401125427493,-1.0527966917806852,0.3761467889908257,0.8083624220175167,1.0,5/14,16.15%,NRP1;VEGFC;EPHA8;PTPRC;ITGA11
prerank,neurotrophin signaling pathway (GO:0038179),0.43199993458897823,1.052416943617571,0.43081312410841655,1.0,1.0,5/21,11.52%,NGF;NTRK2;RAP1A;NGFR;MAGI2
prerank,glucose import (GO:0046323),0.4744614393871772,1.052270467685918,0.41973490427098675,1.0,1.0,3/13,12.41%,SLC27A1;SLC27A4;RAB4B
prerank,regulation of epidermal cell differentiation (GO:0045604),-0.34528160936409535,-1.0522564128691885,0.3968253968253968,0.8081395452233806,1.0,5/21,6.08%,ROCK2;ROCK1;ERRFI1;BMP4;ZFP36L1
prerank,protein localization to lysosome (GO:0061462),-0.31180473994002433,-1.0520154684349667,0.37209302325581395,0.807061951260146,1.0,14/28,32.73%,LMBRD1;M6PR;MFSD1;VPS4A;RNF128;KPTN;LAPTM5;SH3BP4;ATP13A2;SZT2;NAGPA;LAMTOR4;NEDD4;SORL1
prerank,positive regulation of cell migration (GO:0030335),0.3300628413485025,1.0520096872911469,0.37322515212981744,1.0,1.0,47/253,15.47%,ROR2;CCL11;PRKCA;LGR6;PDGFRA;GLIPR2;HAS2;NTRK3;FGF10;KIF20B;SEMA3E;RHOD;SOX9;EGFR;ACVR1;SEMA6C;MAP4K4;VEGFA;EPHB2;SEMA3A;TGFB1;CLDN1;DOCK5;CCR2;PAK1;FAM83H;TWIST2;PPP3CA;SMO;TRIP6;DOCK1;HIF1A;CLASP1;HDAC6;GRN;RHOC;MYOC;SOD2;RTN4;SPAG9;ELP5;COL1A1;SEMA6D;WASHC1;PLAA;ITGB1;ATM
prerank,protein insertion into mitochondrial inner membrane (GO:0045039),-0.416159954175773,-1.051527878618527,0.3949579831932773,0.8068235667770469,1.0,6/11,23.29%,TOMM70;TIMM9;TIMM22;TIMM10B;TIMM8B;ROMO1
prerank,positive regulation of bone resorption (GO:0045780),0.49692554152866947,1.0514475583944098,0.42476489028213166,1.0,1.0,1/11,0.67%,PRKCA
prerank,response to gamma radiation (GO:0010332),0.4096801221666974,1.0514453520161853,0.39841688654353563,1.0,1.0,9/24,18.13%,MYC;MEN1;CRYAB;TLK2;XRCC6;ATM;TP53;WRN;MDM2
prerank,pyrimidine deoxyribonucleotide catabolic process (GO:0009223),0.47227662477761173,1.0510485077149756,0.4279411764705882,1.0,1.0,5/13,22.14%,MBD4;NEIL1;SMUG1;NT5C;TDG
prerank,cGMP-mediated signaling (GO:0019934),-0.4001673346006996,-1.0506402835545825,0.36607142857142855,0.8075489057070342,1.0,6/13,19.53%,IRAG1;PDE3A;GUCY1B1;PDE2A;APOE;KCNC2
prerank,negative regulation of peptidyl-serine phosphorylation (GO:0033137),0.4313150033819381,1.050595518964601,0.40476190476190477,1.0,1.0,6/21,15.42%,PTEN;CNKSR3;MLXIPL;PDE4D;NCK1;RASSF2
prerank,"phagocytosis, engulfment (GO:0006911)",0.40030170209962085,1.0499165896719087,0.4015151515151515,1.0,1.0,4/36,2.81%,XKR7;GULP1;GSN;XKR8
prerank,replication fork processing (GO:0031297),0.39796553400530016,1.0497524032206158,0.41064638783269963,1.0,1.0,10/38,17.24%,DDX11;ZRANB3;SETMAR;ATRX;FBH1;EXD2;RTEL1;BLM;FAM111A;WRN
prerank,modulation by host of viral genome replication (GO:0044827),0.4762729687311353,1.0496150362493444,0.4039039039039039,1.0,1.0,4/13,13.56%,PRKN;VAPA;FBXL2;TBC1D20
prerank,positive regulation of actin filament polymerization (GO:0030838),0.3796293442156448,1.049246227939543,0.41605839416058393,1.0,1.0,6/44,8.10%,CCL11;PYCARD;SPIRE1;GSN;BAIAP2;BIN1
prerank,insulin receptor signaling pathway (GO:0008286),-0.25346121155359197,-1.0485980800386379,0.35714285714285715,0.8116284510570637,1.0,14/69,9.62%,SORBS1;IGF1R;PIK3R3;PIK3C2A;GRB10;NAMPT;IGF2;INSR;ATP6V0C;ATP6V0D1;BCAR1;GSK3B;RHOQ;GSK3A
prerank,positive regulation of phosphorylation (GO:0042327),0.3275967104969951,1.0482821531064745,0.38686868686868686,1.0,1.0,30/240,7.80%,ROR2;ROR1;CLDN19;PDGFRA;ERBB3;NTRK3;GLMN;FGF2;FGF10;ZBTB20;SOX9;EPHB6;ERBB2;EGFR;EFNA5;WDFY2;VEGFA;EPHB2;TGFB1;PSEN1;NTRK2;MT3;TNIK;NIBAN1;PAK1;VAC14;MLXIPL;RALB;FZD7;FGFR1
prerank,substrate adhesion-dependent cell spreading (GO:0034446),0.3815607595518893,1.048224854307203,0.4233490566037736,1.0,1.0,6/46,6.82%,NTN4;PEAK1;LAMC1;MEGF9;NTNG2;NTNG1
prerank,positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725),0.4771185505783357,1.0481198729714118,0.4059259259259259,1.0,1.0,2/12,7.90%,CARD9;IL18
prerank,cardiac epithelial to mesenchymal transition (GO:0060317),-0.349523520808803,-1.0478857814613534,0.3962962962962963,0.8119425132779774,1.0,5/20,4.03%,ACVRL1;BMP4;ENG;TBX3;TGFBR1
prerank,positive regulation of brown fat cell differentiation (GO:0090336),-0.38719386561751595,-1.0478582497933142,0.40061162079510704,0.8102896571981716,1.0,6/13,21.70%,SOX13;SIX1;PTGS2;RREB1;VSTM2A;ZBTB7B
prerank,regulation of macromolecule metabolic process (GO:0060255),0.33465861135977676,1.0477548283222844,0.38422131147540983,1.0,1.0,42/170,20.81%,AFF3;MYC;DHH;HNRNPDL;C1D;PTHLH;TRIM44;PSEN1;RFXANK;HNRNPAB;RASA1;UBAP2;MKLN1;TRIM11;CDK6;SLC8A2;ZNF462;ANKRA2;HIF1A;ZFP64;PRDM9;GDNF;PCBP4;POGZ;ATRAID;EDN3;AHR;PRDM11;KDM6A;NOVA1;KHSRP;STX1B;ZUP1;APLNR;FUBP1;CGGBP1;MARF1;HMG20A;PRDM2;FUBP3;AFF1;SIRPA
prerank,negative regulation of nucleic acid-templated transcription (GO:1903507),0.3239489699939099,1.0476281954522317,0.36536536536536535,1.0,1.0,91/417,17.68%,NKX6-2;MDFIC;TSHZ3;SCML4;CREB3L1;RCOR2;SOX8;PRDM16;ATP8B1;SOX9;NAB1;VGLL4;SUV39H1;HOXA7;KDM8;TLE1;FOXP2;TGFB1;GATAD2A;MT3;PLCB1;MBD1;ATF7IP;ZEB1;WNT5A;EED;CIPC;RFX3;ZBTB16;MLXIPL;MLX;TWIST2;LOXL3;CBFA2T3;KAT8;GATA6;CBX4;ZC3H8;MEN1;FOXM1;KCTD1;BRCA1;MBD2;CRYAB;DKK3;LANCL2;SNX6;HDAC2;ZBTB38;MBTD1;SMARCC2;SFPQ;HDAC6;RBAK;BMP7;PRICKLE1;ING4;CREBZF;CDK5R1;MIDEAS;L3MBTL4;EPC1;JARID2;ZGPAT;PATZ1;XRCC6;EID2B;ZFPM2;ATF5;PER1;SCML2;GATA3;AHR;PRDM11;NACC2;SUMO1;CRY1;NCOR2;CITED2;TAF7;TP53;SP3;MTA3;NDUFA13;EIF4A2;PAX2;SMARCE1;CCDC85B;HEYL;CTBP1;SFMBT2
prerank,regulation of cholesterol biosynthetic process (GO:0045540),0.457013792379144,1.047594204881341,0.43323863636363635,1.0,1.0,7/17,21.94%,ERLIN2;KPNB1;ERLIN1;SREBF2;MBTPS1;SEC14L2;PRKAA1
prerank,positive regulation of neural precursor cell proliferation (GO:2000179),0.426409619416867,1.047540266436638,0.40884718498659517,1.0,1.0,7/21,17.76%,VEGFA;DISC1;DRD2;NES;FZD9;LRP2;MDK
prerank,respiratory tube development (GO:0030323),0.41348369663219253,1.0473951190386233,0.4233289646133683,1.0,1.0,5/28,6.98%,GLI2;FGF2;CCDC39;VEGFA;LOXL3
prerank,protein import into mitochondrial matrix (GO:0030150),-0.35508371150258533,-1.0469882445423813,0.38333333333333336,0.8111564266306038,1.0,9/18,29.32%,TOMM70;TIMM23;DNAJC15;TIMM17A;ROMO1;GRPEL1;DNLZ;TOMM40L;TOMM40
prerank,response to lipid (GO:0033993),-0.23543460056175872,-1.0468618539749348,0.23529411764705882,0.8098123334734727,1.0,16/105,7.40%,FOXP1;SMAD6;CTSH;RBP4;CTNNB1;PAQR7;NOS3;ACER2;NOCT;TLR4;PPARD;OTUD5;STAT5B;ALPL;LIAS;TNFRSF11A
prerank,negative regulation of microtubule depolymerization (GO:0007026),0.4291373788580412,1.0467490357386113,0.42567567567567566,1.0,1.0,10/21,26.33%,FGF13;CLASP1;APC2;KATNB1;NAV3;ATXN7;CAMSAP1;TAOK1;CIB1;APC
prerank,positive regulation of fatty acid oxidation (GO:0046321),0.4709239765857111,1.0465621879084528,0.4188163884673748,1.0,1.0,3/12,16.67%,IRS2;MTLN;ABCD2
prerank,platelet-derived growth factor receptor signaling pathway (GO:0048008),-0.36284828412786246,-1.0464273342557744,0.4069400630914827,0.8094457164098698,1.0,5/16,9.93%,PDGFD;NRP1;PIK3C2A;BCAR1;PDGFRB
prerank,regulation of cell death (GO:0010941),0.34763577996749506,1.046087198029293,0.40728831725616294,1.0,1.0,20/94,16.37%,FGF2;OLFM4;PRKN;LRP1;SOX11;MT3;TSC1;BNIP3;ATG5;PACRG;CRYAB;DCC;EIF4G1;BMP7;TBK1;SNCA;NCK1;SRSF6;UBB;SLC25A24
prerank,negative regulation of synaptic transmission (GO:0050805),0.42018647502485784,1.0460117164940008,0.42140921409214094,1.0,1.0,5/23,12.69%,PTEN;GRIK3;PNKD;SYT11;DRD2
prerank,phosphatidylinositol 3-kinase signaling (GO:0014065),0.40571237068182253,1.045989396694167,0.42207792207792205,1.0,1.0,7/33,13.20%,ERBB3;PTEN;ERBB2;NF1;NYAP1;PIK3R1;GATA3
prerank,positive regulation of osteoclast differentiation (GO:0045672),-0.3891412448784791,-1.0458945166286318,0.41916167664670656,0.8091494161567117,1.0,11/14,51.69%,ATP6AP1;TYROBP;CSF1;POU4F1;CCR1;TNFSF11;OCSTAMP;IL23A;TNF;IL23R;IL12B
prerank,cellular copper ion homeostasis (GO:0006878),-0.3900334869985056,-1.045484231677656,0.37735849056603776,0.808681676055188,1.0,4/14,7.08%,SLC31A1;ATP7A;APP;SLC31A2
prerank,cobalamin metabolic process (GO:0009235),0.4492422048362037,1.0453763807412866,0.43564356435643564,1.0,1.0,5/17,17.07%,MMAB;CD320;MTRR;MTR;ABCC1
prerank,glycolipid metabolic process (GO:0006664),0.379375250312329,1.0452850133159166,0.41113744075829384,1.0,1.0,8/47,9.90%,ST3GAL4;PGAP1;GBA2;NAGA;GM2A;ST6GALNAC6;SCCPDH;GALC
prerank,regulation of protein kinase B signaling (GO:0051896),0.33181846898578843,1.045209013365973,0.38391038696537677,1.0,1.0,37/193,16.12%,PDGFRA;ERBB3;NTRK3;FGF2;FGF10;PTEN;IRS2;ERBB2;EGFR;THEM4;TGFB1;NTRK2;FGFR1;IL18;FYN;GAB2;HIP1;BTC;RCN3;ERBB4;PIK3R1;PTPRJ;ESR1;PTPN11;MAGI2;MYDGF;FGF7;MYOC;DRD2;STRN;GATA3;P2RY12;RTN4;MET;ITGB1;GAB1;LRP2
prerank,regulation of synapse organization (GO:0050807),0.40916172927059885,1.0451835808523258,0.4162234042553192,1.0,1.0,5/26,6.15%,IL1RAPL1;CTNNA2;WNT5A;YWHAZ;CDKL5
prerank,monosaccharide transmembrane transport (GO:0015749),0.44750229655286766,1.0451483212274237,0.4020771513353116,1.0,1.0,3/16,10.56%,SLC5A3;SLC50A1;SLC2A2
prerank,negative regulation of kinase activity (GO:0033673),0.3644891564496649,1.0450733129089629,0.4246575342465753,1.0,1.0,16/62,18.76%,UBASH3B;IRS2;NPRL2;DEPTOR;NF1;SPRED1;DVL1;WWTR1;PRDX3;SNCA;TAF7;HNRNPU;PYDC1;DBNDD2;PPM1E;PARK7
prerank,glycolipid biosynthetic process (GO:0009247),0.3862311600075266,1.0449723494349261,0.4092009685230024,1.0,1.0,11/38,20.63%,ST3GAL4;SCCPDH;PIGC;PIGP;ST8SIA1;PIGN;PIGA;PIGU;DPM1;PIGO;B4GALT6
prerank,cellular response to peptide (GO:1901653),0.3611983448582643,1.0444272351873078,0.413516609392898,1.0,1.0,12/56,11.27%,DDX11;PTPN22;CACNA2D1;LRP1;CACNA1A;PSEN1;PRNP;FYN;GRM5;SNX6;NGFR;TRIM41
prerank,proteoglycan biosynthetic process (GO:0030166),-0.3087747571536573,-1.0444163404450333,0.3688888888888889,0.8101895008926701,1.0,12/31,18.00%,IGF1;FAM20B;BMPR2;NDST3;PXYLP1;CHST11;FOXL1;CHST12;B4GALT7;HS3ST3B1;B3GAT1;CHST10
prerank,dopamine metabolic process (GO:0042417),0.4455371258611186,1.0443889822225174,0.4180790960451977,1.0,1.0,6/18,13.89%,PRKN;COMT;DAO;DRD2;SNCA;LRTOMT
prerank,response to nitric oxide (GO:0071731),0.46966420177285195,1.043852129399143,0.41347626339969373,1.0,1.0,2/13,4.84%,DPEP1;MT3
prerank,RNA transport (GO:0050658),0.3588312694045524,1.0435176782752738,0.4064587973273942,1.0,1.0,19/71,20.38%,RBFOX1;TST;THOC6;ATXN2;TGFBR2;NUP155;SRSF11;CASC3;NCBP1;KIF5C;CKAP5;SRSF6;POM121;PNPT1;NXF1;RNPS1;THOC7;SRRM1;ZFP36
prerank,regulation of cell migration (GO:0030334),0.32263888788075057,1.0434737565457608,0.37975951903807614,1.0,1.0,76/382,15.19%,ROR2;DLC1;CLDN19;CCL11;SULF1;PRKCA;LGR6;PDGFRA;HAS2;NTRK3;FGF2;PIP5KL1;FGF10;PTEN;SEMA3E;RHOD;DPEP1;PLXNC1;EGFR;PTPRT;RAP2B;ACVR1;SEMA6C;PRKX;MAP4K4;VEGFA;HACE1;EPHB2;RECK;SEMA3A;TGFB1;CLDN1;CTNNA2;NF1;PAK1;PODN;FAM83H;DOCK10;TWIST2;NTNG2;NTNG1;CYP1B1;PPP3CA;SERPINE2;NF2;FLNA;SMO;TRIP6;LDB2;SGK3;MGAT3;SPATA13;MCTP1;ERBB4;SLK;PTPRJ;NGFR;MAGI2;FGF7;GRN;RHOC;MYOC;DRD2;SOD2;ADARB1;ARHGAP4;TCAF1;SPAG9;ELP5;COL1A1;LDLRAD4;CITED2;SEMA6D;WASHC1;LMNA;ITGB1
prerank,protein dephosphorylation (GO:0006470),0.34088346603804637,1.0434245460784823,0.4031746031746032,1.0,1.0,30/135,14.80%,PTPRH;UBASH3B;PTEN;PTPN22;DUSP4;PTPRT;PTPN2;PPP1R15A;DUSP6;PTPN13;RPRD1A;PPP3CB;PPP3CA;PPM1B;PPM1J;PPP2R3A;PPP2R2A;PTPN1;DUSP11;PTPRJ;PTPN11;PPP1CA;PTPRA;PTPN18;PTPRZ1;PTPN21;PPP3CC;NCK1;SSH1;PTPRF
prerank,positive regulation of protein kinase B signaling (GO:0051897),0.3346207510143295,1.0424394576384406,0.4,1.0,1.0,36/150,19.28%,PDGFRA;ERBB3;FGF2;FGF10;IRS2;ERBB2;EGFR;THEM4;TGFB1;FGFR1;IL18;FYN;GAB2;HIP1;BTC;ERBB4;PIK3R1;PTPRJ;ESR1;PTPN11;MYDGF;FGF7;MYOC;STRN;GATA3;P2RY12;RTN4;MET;ITGB1;GAB1;LRP2;HBEGF;PARK7;AXL;GRB2;CPNE1
prerank,DNA geometric change (GO:0032392),0.4188834816116671,1.0423958989683648,0.41379310344827586,1.0,1.0,10/24,26.68%,DDX11;ZRANB3;RTEL1;BLM;WRN;RAD50;SUPV3L1;RECQL;HNRNPA2B1;DDX1
prerank,negative regulation of endocytosis (GO:0045806),0.41935204738682125,1.0423670826900306,0.4077025232403719,1.0,1.0,3/24,9.97%,LGALS3;SYT11;MCTP1
prerank,regulation of ventricular cardiac muscle cell action potential (GO:0098911),0.4824509109744808,1.0421658398633444,0.4377880184331797,1.0,1.0,5/12,15.41%,DSG2;CTNNA3;BIN1;PKP2;JUP
prerank,DNA double-strand break processing (GO:0000729),0.4489486288071161,1.042080788498134,0.42532005689900426,1.0,1.0,10/18,25.96%,SETMAR;BRCA1;EXD2;ATM;RAD52;BLM;RAD50;BARD1;SLX4;RBBP8
prerank,dosage compensation by inactivation of X chromosome (GO:0009048),0.47825353060998316,1.042074890529279,0.43778110944527737,1.0,1.0,8/12,26.01%,METTL3;BRCA1;CDYL;YTHDC1;HNRNPU;LRIF1;SMCHD1;RBM15
prerank,angiogenesis involved in wound healing (GO:0060055),0.4910495591318491,1.0419551736972559,0.4439461883408072,1.0,1.0,2/11,3.14%,CD34;VEGFA
prerank,regulation of G1/S transition of mitotic cell cycle (GO:2000045),0.36094354400282747,1.0412826173968486,0.41391106043329534,1.0,1.0,18/66,19.14%,FGF10;PTEN;CDKN2B;EGFR;UBE2E2;JADE1;PLCB1;ADAMTS1;CDK6;EIF4G1;PKD1;DACT1;CCND2;HYAL1;CDC73;RPTOR;KMT2E;RDX
prerank,homologous chromosome pairing at meiosis (GO:0007129),0.4009604067226406,1.0410793883844436,0.42236842105263156,1.0,1.0,6/29,23.00%,MEIOB;TEX11;PRDM9;SYCE2;SYCP2;MEI4
prerank,regulation of multicellular organism growth (GO:0040014),0.4555361169136613,1.0409988557724332,0.4218077474892396,1.0,1.0,1/15,0.46%,PTCH1
prerank,regulation of integrin-mediated signaling pathway (GO:2001044),0.46683806379575354,1.04082290607087,0.4279346210995542,1.0,1.0,3/14,8.56%,BST1;LOXL3;FLNA
prerank,protein-containing complex assembly (GO:0065003),0.3267567853142224,1.0407731392067967,0.403030303030303,1.0,1.0,77/259,23.01%,SEC16B;MYC;REPS2;SOX9;GORASP1;LAMC1;FADD;GRIA1;WIPF1;ANKRD28;EPRS1;KMT2A;SEC24D;ANO6;TLE1;CLDN1;TRAPPC6B;MEN1;PPID;TMED10;MAGI1;SEC24C;BCL9L;CUL3;FARP2;RIMS1;FANCC;BCL9;RAB1A;WASF1;CSNK1A1;KLHL12;TBC1D20;DET1;TMED2;MDM4;SEC23IP;OPA1;TRRAP;TRAPPC6A;NIFK;BLM;TP53;LPXN;PYGO1;PPIH;IL1RAP;TLE3;CD74;RIPK1;CDC73;SLC9A1;CNIH3;TLE4;RSPH9;SEC24A;MDM2;ASH2L;SKAP2;TRAPPC3;KPNA3;ADCY8;SMARCA4;NAPG;KMT2D;PEF1;TRAPPC2L;MITF;PYGO2;P2RX7;LMAN1;LLGL1;DLG4;SH3PXD2B;ELOB;KIFAP3;WASF3
prerank,positive regulation of apoptotic process (GO:0043065),0.3235328509860998,1.040718901282838,0.4150753768844221,1.0,1.0,71/293,18.00%,DLC1;HRK;FAP;PIP5KL1;PYCARD;NGF;AKAP13;FADD;FRZB;FGD4;ANO6;TNFRSF10B;PSEN1;SLC27A4;FANK1;PRNP;NF1;DUSP6;ACVR1C;APAF1;BMF;ITSN1;CYP1B1;SHQ1;PHLDA1;BNIP3;BIN1;ARHGEF11;RARG;VAV3;PPID;UBE2Z;SFRP4;NGFR;NCSTN;ARL6IP5;ING4;CDK5R1;GRN;APH1A;SCRIB;TRIO;PRDM11;ARHGEF3;SNCA;RPS6KA2;PSEN2;ITGB3BP;TRAF7;UBB;ITGB1;CASP2;CRADD;RASSF2;ATM;FZD9;ABL1;TP53;BCL2L11;GPLD1;TGFB3;QRICH1;ARHGEF4;RIPK1;RNPS1;KCNMA1;ADAMTSL4;PLEKHG2;CSRNP3;AIFM1;DNAJA1
prerank,mitochondrial fission (GO:0000266),0.44048076009120385,1.040637329887593,0.4198047419804742,1.0,1.0,2/16,2.35%,DNM1;PRKN
prerank,peptidyl-asparagine modification (GO:0018196),0.3940283340365737,1.040484611710917,0.42366412213740456,1.0,1.0,13/31,27.08%,UGGT2;STT3A;MAGT1;ALG5;TUSC3;ALG8;DPM1;RPN1;LMAN1;MGAT5;ST6GAL1;HIF1AN;UBE2J1
prerank,regulation of vascular associated smooth muscle cell proliferation (GO:1904705),0.38763335341569205,1.0403114271909222,0.42963885429638854,1.0,1.0,11/37,19.71%,MMP2;FGF2;PTEN;ADAMTS1;SOD2;BMPR1A;TGFB3;TAFA5;PDCD4;PPARG;JUN
prerank,negative regulation of protein depolymerization (GO:1901880),0.4182034170494048,1.040237006906021,0.4370860927152318,1.0,1.0,12/24,27.17%,FGF13;CLASP1;APC2;PLEKHH2;KATNB1;NAV3;ATXN7;CAMSAP1;TAOK1;CIB1;APC;PIK3CA
prerank,cellular response to lipopolysaccharide (GO:0071222),0.34578736110118286,1.0402228109589675,0.4146868250539957,1.0,1.0,27/101,24.33%,CXCL10;PYCARD;PTPN22;TGFB1;PDE4B;WNT5A;IL18;SELENOS;MAPK14;TRIM41;UPF1;SHPK;TICAM1;PLAA;CDC73;LBP;AXL;PDCD4;BCL10;ZFP36;SIRPA;NFKB1;TNIP2;VIM;CARD16;PRKCE;HCK
prerank,negative regulation of DNA biosynthetic process (GO:2000279),-0.3154607630905357,-1.0401881015009633,0.391304347826087,0.8209324991738072,1.0,12/30,19.33%,ACVRL1;DACH1;BMPR2;XRN1;TERF2;DCP2;CERS1;PINX1;EXOSC10;TEN1;TINF2;TENT4B
prerank,mitotic cell cycle phase transition (GO:0044772),0.3268279224868834,1.0399389415300788,0.39655172413793105,1.0,1.0,48/203,20.14%,DYNLL1;CRLF3;MYC;CDKN2B;ACVR1;CCNJ;HAUS3;CNTRL;KDM8;CCDC57;PLCB1;PCM1;FBXL15;NDE1;SDCCAG8;CDK6;PHLDA1;FOXM1;ENSA;CEP57;PPP2R2A;CUL3;ANAPC7;RCC1;CLASP1;PKMYT1;CDC25B;TAF2;PHF8;PRKACA;CKAP5;CEP76;DYNC1I2;NES;PIM2;CSNK1E;CDC23;CCND2;CUL4B;CEP63;NASP;USP37;TUBA1A;DBF4;FBXL12;CDC27;CEP78;SSNA1
prerank,ATP synthesis coupled proton transport (GO:0015986),-0.36159541833700104,-1.0398330828148405,0.38408304498269896,0.8202077385127011,1.0,6/17,14.57%,ATP5MC3;ATP5PD;STOML2;VPS9D1;ATP5F1D;ATP5MF
prerank,positive regulation of myoblast differentiation (GO:0045663),-0.3676060434226008,-1.0392922948320573,0.39457831325301207,0.8201006351926994,1.0,4/16,7.52%,RANBP3L;BOC;IGFBP3;AKIRIN1
prerank,intracellular lipid transport (GO:0032365),-0.32726747476031137,-1.038978748934156,0.39776951672862454,0.8192729978764296,1.0,5/21,12.85%,PRKAG2;CPT1A;ACACB;PRKAA2;SLC25A20
prerank,establishment or maintenance of epithelial cell apical/basal polarity (GO:0045197),0.3991631180957001,1.0388118797743136,0.42105263157894735,1.0,1.0,8/31,15.61%,ANK1;DLG2;ERBIN;MYO9A;OPHN1;SCRIB;PDCD6IP;PARD3B
prerank,detection of mechanical stimulus (GO:0050982),0.44254013169403605,1.0387216029646722,0.44244105409153955,1.0,1.0,4/19,15.41%,PIEZO2;LHFPL5;PKD1;JUP
prerank,adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002460),-0.3644412162033307,-1.0386874555844565,0.397887323943662,0.8185212522447042,1.0,4/17,9.24%,TLR4;BACH2;CD55;JAG1
prerank,inorganic anion transport (GO:0015698),0.366912706928673,1.0382983643601709,0.4387878787878788,1.0,1.0,11/53,16.03%,FXYD3;ANO6;TTYH3;TTYH1;FXYD1;SLC25A10;ANO10;XPR1;CLIC1;CLCN2;SLC25A11
prerank,intracellular steroid hormone receptor signaling pathway (GO:0030518),-0.29091497297041685,-1.0380953409622193,0.37373737373737376,0.8185115999540862,1.0,6/35,9.01%,PLPP1;PPARGC1B;CALCOCO1;DDX5;EGLN2;NR3C2
prerank,potassium ion transmembrane transport (GO:0071805),0.33889805587198374,1.0378808594802071,0.4323189926547744,1.0,1.0,34/135,22.90%,KCNK15;SLC1A3;KCNA2;KCNH8;SLC12A3;KCNK1;KCNA1;KCNA6;SLC12A2;KCND1;KCND2;KCND3;KCNT2;SLC12A4;KCNAB2;KCNJ3;KCNJ10;SLC9A5;KCNH2;SLC9A1;SLC24A4;SLC24A2;KCNA5;HCN1;KCNS3;KCNH7;KCNK10;LRRC55;PKD2;KCNQ3;KCNK6;KCNA4;KCNC1;KCNJ13
prerank,negative regulation of smooth muscle cell migration (GO:0014912),-0.37975863746705096,-1.0378029830207904,0.39664804469273746,0.8176157177899864,1.0,6/14,12.08%,IGFBP3;SLIT2;IGFBP5;TPM1;PRKG1;SERPINE1
prerank,skeletal muscle organ development (GO:0060538),-0.3245873879830809,-1.037718807348774,0.38910505836575876,0.8161409268592557,1.0,12/26,36.69%,MYL6;SIX1;STRA6;CAV1;CFLAR;LARGE1;MYH14;SIX4;FOXL2;MSC;MEF2C;FXR1
prerank,"regulation of transcription, DNA-templated (GO:0006355)",0.3170496067179776,1.0376850465726142,0.294,1.0,1.0,352/1646,20.37%,EBF2;RORA;OSR2;FAM47E;ETV1;MLF2;SOX6;NKX6-2;EFEMP1;KLF15;MDFIC;MEOX1;EBF4;ETV4;MEOX2;TSHZ3;PRKCQ;SCML4;LHX5;TLX3;GLI2;CREB3L1;RCOR2;FGF2;IFRD1;SOX8;PRDM16;CRLF3;MYC;DMRT2;TGIF2;ATP8B1;RGMB;EBF1;CBFB;HOXB8;ZNF25;ZBTB20;SOX9;SSBP2;NAB1;VGLL4;ERBB2;NCOA1;EGFR;SUV39H1;HIVEP1;ACVR1;ZBTB37;HOXA7;KMT2A;SATB1;VEGFA;CCNC;TFCP2;EGR3;WAC;KDM8;RPS6KA4;NFX1;TRIM44;TLE1;ZNF326;FOXP2;KDM5B;GTF2H2;TGFB1;BAZ1A;RFX2;GATAD2A;PSEN1;FANK1;NCF1;SOX11;NUPR2;MED31;SETD3;BICRAL;RFXANK;ZNF276;RNF6;MT3;PLCB1;MBD1;GLI1;RAI1;E2F2;ATF7IP;ZEB1;PHOX2A;CXXC1;NOP2;WNT5A;HOXD3;PGBD1;URI1;EED;HNRNPAB;CIPC;PKN1;APBB2;ZFP14;RFX3;ZBTB16;MAMLD1;RORC;MLXIPL;MLX;TRPS1;CREB3L2;TADA1;TAF5L;TWIST2;DRAP1;PPP3CB;LOXL3;DYRK1B;NAA16;E2F6;CBFA2T3;FZD7;KAT8;LRRFIP1;GATA6;CBX4;ZC3H8;TBX18;MEN1;BICRA;FOXM1;ZSCAN20;CHD3;SPIN1;MKX;ZBTB41;ATMIN;CDK15;ARHGEF11;ATRX;KCTD1;TFAM;PPP1R13L;BRCA1;MBD2;SOX12;SOX5;CRYAB;CARM1;ZMIZ1;NCOA2;POLR2K;DKK3;ZNF569;BBX;LANCL2;KLF5;REXO4;HIF1A;DBX2;PIAS2;ARID4B;ZBTB6;CHD2;SNX6;HDAC2;ERBB4;ZSCAN26;ZBTB38;MBTD1;MED13;NFATC3;ELP2;HINT1;ZNF260;PSIP1;ATF2;ZKSCAN8;PHF20;ESR1;NFE2L2;MAPK14;MYT1;LIN9;SMARCC2;SP1;ZNF112;SFPQ;HDAC6;RBAK;NSD2;BMP7;PRICKLE1;ING4;CREBZF;CDK5R1;MIDEAS;FGF7;ZFHX4;L3MBTL4;EPC1;RHOH;PHF8;DVL1;JARID2;SIX5;KLF13;ZGPAT;PATZ1;FOXP4;ZBTB1;NR6A1;WWTR1;SETD5;XRCC6;EID2B;SOD2;ZFPM2;ATF5;CDK16;PER1;SCML2;GATA3;AHR;ZNF83;SALL2;ZNF250;ZBTB39;PRDM11;SMARCC1;BAZ2B;ELP4;NACC2;ORC1;TGFBRAP1;PAX3;LCOR;ZFHX2;MDM4;HIVEP3;SUMO1;PCBD2;CRY1;NCOR2;COL1A1;BAZ1B;CITED2;TAF7;CREM;MED12;SLTM;IRX5;HOXB7;ZNF235;ZEB2;POU3F1;RUNX1;TRRAP;ABL1;MEIS3;PIM2;PURG;MSL3;KLF9;BLM;MED21;TP53;ZFX;LCORL;SP3;PHF19;KCNH2;ZXDB;MTA3;HTATIP2;TGFB3;NDUFA13;SREBF2;RNF111;TERF2IP;ING1;QRICH1;USP21;NFIA;FOXJ1;PAX2;CD74;RNF10;SMARCE1;CHUK;NFIX;CCDC85B;ZKSCAN1;HEYL;NR5A1;CTBP1;PCID2;SFMBT2;CSRNP3;SUFU;TCEA2;MLF1;FBXO5;FUS;APBB3;KLF16;MDM2;IRF3;MED30;ZNF697;ELOC;ZNF496;EPC2;EID2;KLF7;ZMYND11;NAA15;AATF;RNF4;MAPRE3;PSMD9;RFX7;BATF;POLR2A;KMT2E;EGR1;PHC2;MED8;RUVBL2;HMG20A;CNBP;PDCD4;BCL10;PRRX1;BCOR;UBE2L3;FOXJ3;PPARG;JUN;STAT3;PRDM2;YEATS2;ONECUT2;PHB2;POLR3G;TFE3;HP1BP3;CTDSP1;SMARCA4;JDP2;BBS7;USP13;FUBP3
prerank,positive regulation of canonical Wnt signaling pathway (GO:0090263),0.3354250243023747,1.0376456289503946,0.41201264488935724,1.0,1.0,30/129,19.45%,GPC3;WNK2;LGR6;PLEKHA4;FGF10;EGFR;GPRC5B;TGFB1;LGR5;FAM53B;PPM1B;PSMB7;DAAM2;SFRP4;CSNK1G1;COL1A1;PSMD2;ZEB2;PSMC1;DACT1;JUP;FZD9;CSNK1E;CSNK1G2;XIAP;PSMB2;PSMD9;CSNK1G3;KANK1;PSME4
prerank,regulation of sister chromatid cohesion (GO:0007063),-0.402329522629852,-1.0372598847832413,0.40476190476190477,0.8157726071289803,1.0,3/12,2.81%,WAPL;CTNNB1;HDAC8
prerank,neuromuscular junction development (GO:0007528),0.41336350649864145,1.0366594943282486,0.42779291553133514,1.0,1.0,6/24,13.53%,ANK3;PDZRN3;LRP4;CACNB4;DVL1;GPHN
prerank,regulation of DNA-dependent DNA replication (GO:0090329),0.4814646395835504,1.036579354768277,0.4166666666666667,1.0,1.0,5/12,25.71%,TIPIN;BLM;WRNIP1;KAT7;WDR18
prerank,regulation of canonical Wnt signaling pathway (GO:0060828),0.3259149909120705,1.0364541017357742,0.40162271805273836,1.0,1.0,60/248,19.45%,GPC3;WNK2;TPBGL;LGR6;PLEKHA4;RBMS3;LRP4;FGF10;SOX9;PRKN;EGFR;FRZB;JADE1;GPRC5B;TLE1;TGFB1;PSEN1;GLI1;WNT5A;LGR5;FZD7;OTULIN;FAM53B;PPM1B;PSMB7;DKK3;CUL3;DAAM2;SFRP4;TMEM131L;EMD;PRICKLE1;PPP1CA;APC2;DVL1;CSNK1G1;WWTR1;CSNK1A1;KLHL12;COL1A1;PSMD2;ZEB2;SCYL2;PSMC1;DACT1;JUP;FZD9;CSNK1E;CSNK1G2;XIAP;TLE3;PSMB2;TLE4;MDK;PSMD9;RUVBL2;CSNK1G3;KANK1;NKD2;PSME4
prerank,chemical homeostasis (GO:0048878),0.35559509745001167,1.0362371587032873,0.43317972350230416,1.0,1.0,8/61,9.74%,WNK2;IRS2;ZBTB20;WNK3;FBXW7;AQP4;ACOX1;THADA
prerank,positive regulation of protein catabolic process (GO:0045732),0.3446355783764444,1.0361330164372553,0.4213421342134213,1.0,1.0,15/84,16.25%,GPC3;VGLL4;PRKN;HACE1;WNT5A;ASB5;VPS11;HUWE1;APC2;DDB1;NEDD4L;AREL1;DACT1;GPLD1;NDUFA13
prerank,regulation of peptide hormone secretion (GO:0090276),0.35599006733488525,1.0361090634241574,0.42745535714285715,1.0,1.0,10/67,10.56%,PRKCA;CACNA1E;CACNA1A;RFX3;PPP3CB;RAP1A;ENSA;PASK;HTR2C;SLC2A2
prerank,regulation of nucleocytoplasmic transport (GO:0046822),-0.4031908204925344,-1.0359312043415334,0.3945945945945946,0.8177082325643619,1.0,4/12,10.96%,PTPN14;BMP4;IFI27;NUP214
prerank,synapse assembly (GO:0007416),0.3540059891426131,1.0358292761643768,0.43372093023255814,1.0,1.0,17/67,16.30%,FGF13;PTEN;NRCAM;NRXN1;GRID2;WNT5A;OBSL1;NLGN1;KIRREL3;GPM6A;DSCAM;ADGRL3;DVL1;DRD2;GABRG2;CBLN4;LRRTM3
prerank,amino acid import (GO:0043090),-0.33778348594987967,-1.0357831075496033,0.3993055555555556,0.8164938771057577,1.0,8/21,14.83%,SLC47A1;SLC6A6;SLC22A4;SLC6A13;SLC7A5;SLC16A2;SLC6A1;SFXN3
prerank,positive regulation of neuroinflammatory response (GO:0150078),0.4785708818114787,1.0356750049671661,0.45638629283489096,1.0,1.0,3/12,15.27%,IL18;TTBK1;IL33
prerank,negative regulation of RNA splicing (GO:0033119),-0.3404913610846855,-1.0354358176718754,0.3807829181494662,0.8157818010938869,1.0,9/19,23.37%,RBMX;SRSF10;SRSF4;SAP18;PTBP1;PTBP3;SRSF12;SRSF7;U2AF2
prerank,positive regulation of collagen biosynthetic process (GO:0032967),0.45017324050717145,1.0353805667064968,0.4327731092436975,1.0,1.0,6/16,16.21%,CREB3L1;TGFB1;AMELX;HDAC2;RUNX1;TGFB3
prerank,negative regulation of response to cytokine stimulus (GO:0060761),0.48264481345162125,1.0349750065739856,0.4467408585055644,1.0,1.0,2/10,3.52%,MAPK7;IRAK3
prerank,tetrapyrrole metabolic process (GO:0033013),0.4364233450597439,1.0347885154328818,0.44182825484764543,1.0,1.0,5/18,17.07%,MMAB;CD320;MTRR;MTR;ABCC1
prerank,regulation of response to oxidative stress (GO:1902882),0.48114304234736854,1.0347129971891418,0.42725880551301687,1.0,1.0,2/11,9.97%,PRKN;MCTP1
prerank,mRNA stabilization (GO:0048255),0.3785691272060488,1.0344904381592044,0.41843088418430885,1.0,1.0,15/40,22.58%,ELAVL4;PABPC1;MAPKAPK2;GDNF;MAPK14;EIF4ENIF1;HNRNPU;FUS;TENT5D;SYNCRIP;TENT5A;HNRNPC;ZFP36;TENT5C;YBX3
prerank,regulation of vascular associated smooth muscle cell migration (GO:1904752),0.46122453096339194,1.034486573522594,0.4281437125748503,1.0,1.0,3/12,6.93%,DOCK7;DOCK5;ADAMTS1
prerank,organic hydroxy compound transport (GO:0015850),0.38856179065490304,1.0342167746389623,0.42838874680306904,1.0,1.0,7/36,14.49%,ATP8B1;NCOA1;SLC5A3;SLCO2B1;NCOA2;SLC16A1;SLC10A1
prerank,regulation of cellular catabolic process (GO:0031329),-0.26684424280394453,-1.034209250994576,0.3515625,0.8175974352577874,1.0,21/62,20.00%,DAPK1;ITPR1;ROCK1;ACER2;RRAGC;ABL2;LONP2;DAPK2;NUPR1;KEAP1;RAB8A;MAPT;RMC1;DRAM2;PIP4K2B;BOK;OSBPL7;SMCR8;HSPB1;GPR137;RRAGB
prerank,myotube differentiation (GO:0014902),-0.36127097482313636,-1.034194111954737,0.40559440559440557,0.8159460562764218,1.0,4/17,15.27%,IGF1;MYEF2;SORT1;NOS1
prerank,peptidyl-serine phosphorylation (GO:0018105),0.3297041547887409,1.0338794823373352,0.44948453608247424,1.0,1.0,44/153,19.43%,PRKCA;STK32B;PRKCQ;PRKX;EIF2AK3;RPS6KA4;MAPKAPK3;MAST2;MAPKAPK2;DYRK4;PKN1;TGFBR2;DYRK1B;PDK3;STK39;TLK2;MAPK9;AKT3;SGK3;SGK2;MAPK14;STK32A;MAPK1;CDK5R1;TBK1;CSNK1G1;PRKACA;CSNK1A1;TTBK1;RPS6KA2;PKD1;ATM;CSNK1E;CSNK1G2;SGK1;RIPK1;CHUK;PKN2;VRK3;TAF1;CSNK2A2;CSNK1G3;CAB39;TOP1
prerank,cellular response to peptide hormone stimulus (GO:0071375),-0.2413832886123341,-1.0336921563981702,0.32,0.8157428361188696,1.0,18/102,9.76%,SORBS1;TBC1D4;ADCY9;SLC30A10;PRKCD;RAB31;PRKAR1A;PRKCI;INSR;LPIN2;ZFP36L1;PARP1;SLC25A33;RHOQ;RPS6KB1;GSK3A;ADCY4;INSIG2
prerank,regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903798),0.43784029144104936,1.0332939014995057,0.4248175182481752,1.0,1.0,6/18,17.21%,EGFR;TGFB1;ESR1;NCOR2;TP53;RIPK1
prerank,nucleotide-sugar metabolic process (GO:0009225),0.4766248673153731,1.0331704802134962,0.43894899536321486,1.0,1.0,2/12,7.77%,GFPT2;CSGALNACT1
prerank,positive regulation of chemotaxis (GO:0050921),0.38160460718712697,1.0330347277174343,0.425273390036452,1.0,1.0,10/43,15.00%,NTRK3;FGF2;VEGFA;TGFB1;CCR2;DSCAM;EDN3;SMOC2;P2RY12;MET
prerank,regulation of megakaryocyte differentiation (GO:0045652),0.37040556962831644,1.0327252054108154,0.4345738295318127,1.0,1.0,12/49,20.48%,PRKCQ;CBFB;KAT2B;KMT2A;EIF6;MTURN;PRMT1;RUNX1;RAB7B;ASH2L;KMT2E;KMT2D
prerank,peptidyl-proline modification (GO:0018208),-0.3190754525848295,-1.0326008470491437,0.4274193548387097,0.8170998624244994,1.0,6/25,8.49%,PPIC;PPIL2;OGFOD1;CWC27;PPIA;NTMT1
prerank,regulation of autophagosome maturation (GO:1901096),-0.3941093465919208,-1.0323812256898814,0.4074074074074074,0.8161386483579859,1.0,6/13,22.32%,IRGM;TBC1D25;UVRAG;SMCR8;RUBCN;ADRB2
prerank,tRNA 5'-leader removal (GO:0001682),0.45847131494648335,1.0323290010220945,0.4536082474226804,1.0,1.0,7/13,27.32%,RPP38;PRORP;POP1;RPP21;SSB;RPP30;RPP14
prerank,regulation of cell motility (GO:2000145),0.3315398794006509,1.0322554242279112,0.42071881606765327,1.0,1.0,25/121,13.20%,ERBB3;FGF2;FGF10;ERBB2;PLXNC1;EGFR;PRKX;HACE1;CADM4;TGFB1;PKN1;DOCK10;CDK6;SERPINE2;FLNA;BTC;LDB2;SGK3;MGAT3;SPATA13;ERBB4;SLK;FGF7;CFAP20;GATA3
prerank,negative regulation of telomere maintenance via telomerase (GO:0032211),-0.350738731117536,-1.0318480512589276,0.40604026845637586,0.815940828784545,1.0,9/19,22.05%,XRN1;TERF2;DCP2;PINX1;EXOSC10;TEN1;TINF2;TENT4B;HNRNPA1
prerank,defense response to bacterium (GO:0042742),-0.23275359179329902,-1.031725913850738,0.421875,0.8146160236093825,1.0,23/105,21.76%,ANXA3;ANKRD17;PRKCD;TLR4;RPS19;DEFA6;IRGM;IL6R;PGLYRP1;PPP1R11;OPTN;STAB1;OAS2;SERPINE1;TIRAP;CFP;GSDMD;MPEG1;ISG15;HMGB2;NOD1;FCER1G;COLEC12
prerank,RNA phosphodiester bond hydrolysis (GO:0090501),0.40841142065025604,1.0316879391772704,0.4367666232073012,1.0,1.0,3/27,8.08%,CSTF3;RNASE6;ZC3H12B
prerank,cholesterol metabolic process (GO:0008203),0.3626626684723508,1.0316287204725323,0.4398663697104677,1.0,1.0,9/68,10.88%,CEL;HSD17B7;SQLE;GBA2;MT3;OSBPL5;IDI1;ACLY;ABCA5
prerank,positive regulation of epithelial cell migration (GO:0010634),0.345561866385594,1.031424907187712,0.4340239912758997,1.0,1.0,24/92,16.48%,PRKCA;GLIPR2;EPB41L4B;FGF2;FGF10;SOX9;MAP4K4;VEGFA;DOCK5;WNT5A;DOCK1;HIF1A;SPARC;CLASP1;HDAC6;FGF7;NRP2;GRN;GATA3;SMOC2;RTN4;ABL1;GPLD1;HYAL1
prerank,fatty acid transport (GO:0015908),0.4440908628152728,1.0313201095762414,0.4405594405594406,1.0,1.0,3/17,8.24%,SLC27A1;SLC27A4;GOT2
prerank,regulation of lymphocyte activation (GO:0051249),-0.39949037579743807,-1.0308913648070623,0.404320987654321,0.8152532116272351,1.0,7/12,44.25%,KAT2A;LAT;IKZF3;THEMIS2;CCL5;CRTAM;LCK
prerank,cardiac muscle cell differentiation (GO:0055007),0.42146315336425877,1.0305209471717527,0.4418918918918919,1.0,1.0,3/21,3.14%,AKAP13;ACVR1;VEGFA
prerank,polyol metabolic process (GO:0019751),0.3696241781189086,1.0303647370760545,0.4317073170731707,1.0,1.0,5/46,4.92%,ITPK1;INPP4B;PTEN;SLC5A3;PLCB1
prerank,positive regulation of vasoconstriction (GO:0045907),-0.38112047173880925,-1.0303365970503782,0.4217252396166134,0.8152504959727486,1.0,3/13,17.26%,ADRA1B;CAV1;TBXA2R
prerank,glycosaminoglycan metabolic process (GO:0030203),0.3665893069743442,1.0303317045642189,0.43896713615023475,1.0,1.0,12/54,16.74%,GPC3;HSPG2;HS6ST1;SDC2;EXT1;SDC4;GPC1;SDC3;GPC4;IDS;HS2ST1;UGDH
prerank,intrinsic apoptotic signaling pathway in response to DNA damage (GO:0008630),0.3708008517787412,1.0301716945486077,0.4336075205640423,1.0,1.0,11/48,16.06%,PYCARD;BCL2;BRCA1;MSH6;CASP2;AEN;ATM;ABL1;RPS27L;TP53;BCL2L11
prerank,dicarboxylic acid transport (GO:0006835),-0.31346913365160683,-1.0301671498784974,0.3794466403162055,0.8140704763260226,1.0,6/28,6.64%,SLC13A3;SLC26A7;GJA1;SLC22A6;PDPN;GIPC1
prerank,negative regulation of ERBB signaling pathway (GO:1901185),0.38469779695161943,1.0297144296628382,0.4259028642590286,1.0,1.0,9/39,13.38%,ERBB2;EGFR;PTPN2;EPS15;BTC;PTPRJ;CBL;PTPN18;SH3KBP1
prerank,regulation of protein dephosphorylation (GO:0035304),0.38466034604317334,1.0294134671173967,0.41154791154791154,1.0,1.0,11/37,18.47%,DLC1;TGFB1;PPP1R15A;TSC1;ENSA;PPP1R8;HSP90B1;CALM1;CALM2;TIPRL;HTT
prerank,positive regulation of histone H3-K4 methylation (GO:0051571),0.4602251897230227,1.02900519775897,0.4306784660766962,1.0,1.0,4/14,9.84%,KMT2A;AUTS2;BRCA1;PRDM9
prerank,cellular response to lipid (GO:0071396),0.32713107022414756,1.0287119239614944,0.44771573604060916,1.0,1.0,43/191,21.40%,RORA;SSTR1;CXCL10;PYCARD;SOX9;EGFR;PDE4B;WNT5A;URI1;RORC;PDK3;FZD7;SELENOS;ESR1;MAPK14;TRIM41;PID1;UPF1;NRIP1;GNAI1;SHPK;AHR;LCOR;TICAM1;PLAA;ATM;GPLD1;NDUFA13;PAX2;CDC73;NCOA3;LBP;FAM210B;AXL;RUVBL2;PDCD4;BCL10;UBE2L3;ADCY8;ZFP36;SIRPA;NFKB1;TNIP2
prerank,positive regulation of nucleic acid-templated transcription (GO:1903508),0.31755069577811673,1.0284689765645705,0.4118236472945892,1.0,1.0,117/476,21.46%,RORA;OSR2;MDFIC;GLI2;FGF2;SOX8;PRDM16;CRLF3;MYC;RGMB;SOX9;NCOA1;EGFR;ACVR1;KMT2A;WAC;KDM8;TRIM44;TGFB1;PSEN1;FANK1;NCF1;SOX11;SETD3;BICRAL;RNF6;MT3;PLCB1;GLI1;RAI1;ATF7IP;CXXC1;WNT5A;HNRNPAB;RFX3;ZBTB16;RORC;MLXIPL;CREB3L2;PPP3CB;DYRK1B;NAA16;FZD7;KAT8;GATA6;BICRA;FOXM1;SPIN1;ATMIN;ARHGEF11;TFAM;BRCA1;ZMIZ1;HIF1A;HDAC2;ERBB4;MED13;ESR1;SMARCC2;SP1;BMP7;FGF7;EPC1;PHF8;XRCC6;ATF5;GATA3;AHR;PRDM11;SMARCC1;PAX3;HIVEP3;PCBD2;COL1A1;CITED2;MED12;POU3F1;RUNX1;PIM2;BLM;TP53;SP3;KCNH2;TGFB3;RNF111;ING1;QRICH1;USP21;PAX2;CD74;RNF10;CHUK;PCID2;MED30;ZNF496;NAA15;RNF4;MAPRE3;PSMD9;KMT2E;EGR1;CNBP;BCL10;PPARG;JUN;STAT3;TFE3;SMARCA4;FUBP3;CD38;NR1D2;SEC14L2;NFKB1;MITF;ZXDC;NSD1;DVL3
prerank,regulation of early endosome to late endosome transport (GO:2000641),-0.34801791505789903,-1.0284463869870688,0.36496350364963503,0.8173676276643894,1.0,4/18,8.41%,DAB2;CHMP3;MAP2K1;MTMR2
prerank,melanocyte differentiation (GO:0030318),0.47848073424059284,1.0283206870885282,0.4430379746835443,1.0,1.0,5/11,21.26%,HPS6;SLC24A5;MREG;USP13;MITF
prerank,regulation of glucose transmembrane transport (GO:0010827),0.43773194746971705,1.0280812022966972,0.4450784593437946,1.0,1.0,2/18,2.59%,FFAR4;C2CD5
prerank,protein monoubiquitination (GO:0006513),0.38839160776029297,1.0278793816988612,0.424812030075188,1.0,1.0,9/36,17.23%,UBE2T;PRKN;WAC;CUL3;HUWE1;KLHL12;KLHL22;UBE2O;CDC73
prerank,regulation of cellular response to heat (GO:1900034),0.3493070182899623,1.0276844334716018,0.41836734693877553,1.0,1.0,19/77,18.03%,CD34;HSPH1;RANBP2;MAPKAPK2;RPA3;NUP155;BAG5;CRYAB;NUP205;FKBP4;NDC1;NUP160;MAPK1;DNAJB6;RPA2;ATM;POM121;AAAS;RPTOR
prerank,negative regulation of protein secretion (GO:0050709),-0.29289832304339136,-1.0276781615931327,0.34946236559139787,0.8179851227719285,1.0,14/38,23.91%,CD200;MIDN;ERP29;OPRM1;ADRA2A;KCNB1;RHBDF2;DPH3;SIRT4;APOE;NR1H3;RSAD2;RAB11FIP1;SERGEF
prerank,positive regulation of coagulation (GO:0050820),0.48319622040974236,1.0276767278839636,0.456656346749226,1.0,1.0,1/10,1.60%,ST3GAL4
prerank,positive regulation of hemostasis (GO:1900048),0.48319622040974236,1.0276767278839636,0.456656346749226,1.0,1.0,1/10,1.60%,ST3GAL4
prerank,negative regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030948),0.47066458743174633,1.0273681676869804,0.44764795144157815,1.0,1.0,2/13,9.75%,CADM4;PTPN1
prerank,interleukin-2-mediated signaling pathway (GO:0038110),0.48840990325402955,1.0272557894141834,0.44245142002989535,1.0,1.0,1/11,1.09%,IL2RA
prerank,cellular response to interleukin-2 (GO:0071352),0.48840990325402955,1.0272557894141834,0.44245142002989535,1.0,1.0,1/11,1.09%,IL2RA
prerank,respiratory system development (GO:0060541),0.39053936098379344,1.0272196787367067,0.44154228855721395,1.0,1.0,5/32,6.98%,GLI2;FGF2;CCDC39;VEGFA;LOXL3
prerank,erythrocyte differentiation (GO:0030218),-0.2753383519943148,-1.0269332231221182,0.375609756097561,0.8184476888948817,1.0,15/44,19.45%,KIT;RPS14;MFHAS1;FLVCR1;LYN;ALAS1;RPS19;ACIN1;ID2;NCKAP1L;INHBA;TAL1;CEBPG;UBA5;ZFPM1
prerank,spliceosomal complex assembly (GO:0000245),0.36999983362974026,1.0268829109324644,0.43757431629013077,1.0,1.0,22/46,29.76%,CELF5;LUC7L2;TXNL4A;NCBP1;PRPF6;CELF6;SRSF6;YTHDC1;LUC7L;SF3A1;SF1;DDX23;CELF4;SNRNP200;SCAF11;DDX1;SRSF5;RBM5;CELF2;CELF1;USP39;SRSF9
prerank,positive regulation of catalytic activity (GO:0043085),0.3837170801677463,1.026869332901237,0.4268292682926829,1.0,1.0,12/37,17.96%,SLC5A3;PSEN1;MT3;NHEJ1;NCSTN;MAPK14;MSH6;APH1A;PSEN2;ABL1;WRN;AZIN2
prerank,activin receptor signaling pathway (GO:0032924),0.4421589746784429,1.0266265357564535,0.4581497797356828,1.0,1.0,2/15,5.43%,ACVR1;ACVR1C
prerank,endoderm formation (GO:0001706),0.3876588795594163,1.026518695501757,0.4318766066838046,1.0,1.0,5/35,9.87%,MMP2;DUSP4;COL4A2;MMP15;SETD2
prerank,cellular response to reactive oxygen species (GO:0034614),0.3618395045398526,1.0262956792077396,0.44495412844036697,1.0,1.0,21/59,21.50%,PDGFRA;EGFR;MAPK7;NCF1;CYP1B1;MAPK9;NFE2L2;HDAC6;MAPK1;ERCC6L2;PRDX3;ABL1;PAX2;RIPK1;CHUK;PARK7;OSER1;JUN;SIRPA;PKD2;PXN
prerank,regulation of response to interferon-gamma (GO:0060330),0.45447720857189433,1.0261840448230999,0.4329896907216495,1.0,1.0,3/14,14.35%,PTPN2;SOCS1;SUMO1
prerank,regulation of collagen biosynthetic process (GO:0032965),0.43282971238066054,1.0261162378194857,0.44049247606019154,1.0,1.0,6/19,16.21%,CREB3L1;TGFB1;AMELX;HDAC2;RUNX1;TGFB3
prerank,negative regulation of epithelial cell apoptotic process (GO:1904036),-0.2986039254353647,-1.0260110485924188,0.4212962962962963,0.8194699409963029,1.0,8/33,12.08%,CDH5;TEK;ANGPT1;KDR;ICAM1;NUPR1;GATA2;SERPINE1
prerank,regulation of steroid biosynthetic process (GO:0050810),0.4826498284809448,1.025491028147617,0.4405487804878049,1.0,1.0,1/11,0.52%,BMP5
prerank,regulation of erythrocyte differentiation (GO:0045646),-0.2895406575346878,-1.0251263483472917,0.39080459770114945,0.8203295625431026,1.0,13/35,20.37%,ETS1;LYN;ARNT;STAT5B;ZFP36L1;ACVR1B;NCKAP1L;INHBA;TAL1;MAFB;ANKRD54;ZFPM1;HMGB2
prerank,morphogenesis of a polarized epithelium (GO:0001738),-0.4064363078723267,-1.0248733450629017,0.4334470989761092,0.8193875217668746,1.0,4/12,14.92%,ZDHHC7;LAMA3;ACTG1;FUZ
prerank,G protein-coupled glutamate receptor signaling pathway (GO:0007216),0.44993586185338813,1.0247401490644539,0.4398826979472141,1.0,1.0,4/15,15.49%,GRIK3;GRM5;HOMER2;HOMER1
prerank,pattern recognition receptor signaling pathway (GO:0002221),0.36361474407853966,1.024267496518443,0.44100801832760594,1.0,1.0,19/56,28.11%,ALPK1;MAPKAPK3;MAPKAPK2;CTSK;CTSB;TLR1;HSP90B1;UNC93B1;UBB;LBP;TAB3;BCL10;RPS6KA3;TAB2;IRAK2;IRAK1;TRAF6;TAB1;CTSL
prerank,phosphatidylinositol acyl-chain remodeling (GO:0036149),0.43910964265085406,1.024267451380201,0.44866385372714485,1.0,1.0,3/17,12.35%,PLBD1;PLA2G12A;PLAAT3
prerank,intraciliary transport involved in cilium assembly (GO:0035735),0.387406563140624,1.0242569216746493,0.4316185696361355,1.0,1.0,5/37,10.01%,DYNLL1;IFT140;PCM1;TRIP11;WDR35
prerank,"regulation of phagocytosis, engulfment (GO:0060099)",-0.4079108590720837,-1.024233601589229,0.4117647058823529,0.8197301678836448,1.0,4/10,17.29%,APPL2;RAB31;NCKAP1L;CD300A
prerank,negative regulation of sodium ion transmembrane transporter activity (GO:2000650),-0.41840786766199384,-1.0241668404844577,0.4467455621301775,0.8182426782821204,1.0,2/10,1.38%,ATP1A2;OSR1
prerank,protein insertion into ER membrane (GO:0045048),0.38530906382425206,1.0241412117705175,0.44458281444582815,1.0,1.0,17/37,23.28%,WDR83OS;PRNP;VAPA;UBE2J2;EMD;OTOF;CCDC47;SEC61G;EMC10;CYB5A;EMC1;SGTA;EMC8;EMC3;CAMLG;EMC6;EMC2
prerank,regulation of cilium assembly (GO:1902017),-0.25534449737786324,-1.0236504748737814,0.3968253968253968,0.8181742577614148,1.0,22/62,19.25%,TBC1D8;ODF2L;TBC1D14;TBC1D1;TBC1D15;DCDC2;ARHGAP35;EVI5L;CCP110;TBC1D13;DYNC2LI1;DYNLT2B;RABEP2;TBC1D7;FUZ;TBC1D30;TBC1D10B;CDK10;CROCC;TBC1D2;TBC1D22B;TBC1D16
prerank,cellular response to interleukin-1 (GO:0071347),0.3287618584915871,1.023524119482572,0.4555903866248694,1.0,1.0,32/143,21.40%,CCL11;ADAMTS12;HAS2;PYCARD;SOX9;MAP3K3;IRAK3;RPS6KA4;CCL4;PLCB1;PELI1;PSMB7;HIF1A;TOLLIP;UPF1;PSMD2;UBB;CCL14;PSMC1;HYAL1;IL1RAP;PSMB2;RC3H1;CHUK;PSMD9;TAB3;EGR1;PSME4;PSMA8;SIRPA;NFKB1;TNIP2
prerank,regulation of muscle contraction (GO:0006937),0.4005667084228359,1.0226486907874686,0.44129554655870445,1.0,1.0,4/26,11.40%,MYBPH;KCNA1;TNNT3;ANXA6
prerank,calcineurin-mediated signaling (GO:0097720),0.48606163438295136,1.0224753521835463,0.4449838187702265,1.0,1.0,4/10,13.96%,PPP3CB;PPP3CA;NFATC3;PPP3CC
prerank,calcineurin-NFAT signaling cascade (GO:0033173),0.48606163438295136,1.0224753521835463,0.4449838187702265,1.0,1.0,4/10,13.96%,PPP3CB;PPP3CA;NFATC3;PPP3CC
prerank,negative regulation of histone methylation (GO:0031061),0.4933996135576192,1.022426800578225,0.44785276073619634,1.0,1.0,3/10,12.24%,AASS;BRCA1;JARID2
prerank,cellular macromolecule biosynthetic process (GO:0034645),-0.21717231902204168,-1.0223888525313187,0.5,0.8201420294470404,1.0,125/306,28.01%,THRB;RPS14;POLD3;GSPT1;RPL24;RRAGC;DRG1;RPL18A;RECQL5;RPS16;ALAS1;GTPBP2;RPL38;RPL28;RPS19;CREBL2;RPL37;MMS19;RPS2;SARS1;MRPL10;GTPBP1;RPL19;RPL5;RPL34;PTMS;RPS25;RPS15;POLA1;PWP1;TNIP1;EEF1G;MCM6;RPLP1;RPL31;PABPC4;RPL3;MRPL24;MRPL3;RMI1;EEF1A1;RPS6;HELB;RPS8;HUS1;MED20;EIF4EBP2;RPL11;RPL12;INHBA;ORC6;CDK2;RPS6KB2;TSFM;POLA2;TERT;RPL7A;RPL13;BAZ2A;POLR2C;EEF1B2;CLSPN;CDC7;MRPS7;KAT5;NT5M;DTX1;COPS5;MRPL43;IGF2BP3;APOE;YARS2;RPS21;RPL35A;DONSON;POLR2E;ASMT;RPL26;RPS9;MRPS17;RPL32;RPS29;RNASEH2A;LARGE1;RPS23;RPLP2;MRPS11;POLR2J;XAB2;DNA2;PTMA;GAL3ST2;POLR2D;RPL8;MRPS16;NBN;RFC3;TIMELESS;RSL24D1;ING5;E2F1;RPL41;TOP1MT;RPS17;RAD9B;DHPS;RPS5;RPS15A;THAP1;RPL37A;INHA;RPS10;MRPL55;POLD2;TBRG1;RPL6;WARS1;RPL9;MCM8;RAD9A;RPS27;RMI2;MRE11;CDC45;MRPL36
prerank,regulation of transcription elongation from RNA polymerase II promoter (GO:0034243),-0.31634346806317215,-1.0222181014593368,0.3984375,0.8190067389564568,1.0,10/25,24.38%,RECQL5;WDR43;EAF2;EAF1;LEO1;LARP7;CDK12;NELFCD;HEXIM1;EAPP
prerank,ncRNA transcription (GO:0098781),0.4640775812443654,1.0220467974334229,0.452914798206278,1.0,1.0,6/13,23.02%,SNAPC2;SPIN1;GTF3C1;NIFK;POLR1G;SNAPC3
prerank,protein N-linked glycosylation via asparagine (GO:0018279),0.38797850492200125,1.0220116924033371,0.45616264294790343,1.0,1.0,11/30,24.97%,UGGT2;STT3A;MAGT1;ALG5;TUSC3;ALG8;DPM1;RPN1;LMAN1;MGAT5;ST6GAL1
prerank,positive regulation of muscle hypertrophy (GO:0014742),-0.3614041190947398,-1.0216487598961217,0.4281437125748503,0.819051705463696,1.0,5/15,7.23%,IGF1;ROCK2;ROCK1;MTPN;PARP1
prerank,RNA processing (GO:0006396),0.32632493998527223,1.0216358632661844,0.4642857142857143,1.0,1.0,60/176,25.66%,CSTF3;BICD1;DHX8;USB1;ELAVL4;CPSF6;RNGTT;RSRC1;RP9;METTL3;XRN2;SON;IVNS1ABP;RNPC3;TUT4;DDX54;SRSF11;APOBEC1;AURKAIP1;ALKBH5;NCBP1;ADARB2;DUSP11;SFPQ;SNRNP40;LSM3;PRKACA;PRPF6;PRPF18;ADARB1;NOVA1;TSEN2;KHSRP;SF3A1;HNRNPU;RNPS1;FUS;DDX23;TENT2;PRMT9;SYNCRIP;SRRM1;HNRNPUL1;SF3B3;HNRNPC;TSEN34;HNRNPL;SNRPN;RBMS1;SF3B2;WBP4;PPP2R1A;TUT1;TFIP11;MAGOHB;SCAF11;SNRPA1;NONO;DROSHA;RBM4
prerank,positive regulation of purine nucleotide biosynthetic process (GO:1900373),-0.3782189479791619,-1.021635183616184,0.4264705882352941,0.8174593955782665,1.0,5/13,18.89%,NOS3;TMSB4X;NOS1;ENO1;PINK1
prerank,regulation of mitochondrial membrane potential (GO:0051881),0.3732840744930072,1.0211235944469506,0.42909987669543775,1.0,1.0,8/40,15.54%,PIP5KL1;BCL2;ARL6IP5;PID1;PRDX3;MTLN;UBB;ABL1
prerank,regulation of cell morphogenesis (GO:0022604),0.398173078625876,1.0210789443178412,0.45324675324675323,1.0,1.0,9/30,11.82%,EFNA5;FMNL2;NTNG2;NTNG1;PDZD8;SPARC;BCL9L;MYO9A;ZMYM6
prerank,microtubule nucleation (GO:0007020),0.4257676701692915,1.0209150132506315,0.45365168539325845,1.0,1.0,5/19,11.67%,CCDC57;NDE1;TUBGCP5;CLASP1;SLAIN2
prerank,muscle cell migration (GO:0014812),-0.41836536615582054,-1.0207110106115562,0.4112903225806452,0.8183866752351374,1.0,3/10,13.65%,ROCK1;SIX1;DDR1
prerank,nuclear body organization (GO:0030575),0.46208070362346065,1.020363026500483,0.4492307692307692,1.0,1.0,1/12,0.50%,USP50
prerank,secondary alcohol metabolic process (GO:1902652),0.3846226202183348,1.0201953308543554,0.45354523227383864,1.0,1.0,8/42,14.44%,IDH2;SQLE;GBA2;OSBPL5;IDH3B;ABCA5;CYP27A1;IDH3A
prerank,vasoconstriction (GO:0042310),-0.3960431228654305,-1.020105590005431,0.4622356495468278,0.8186142668991379,1.0,4/11,18.08%,PIK3C2A;ACTA2;EDNRB;EDN1
prerank,protein O-linked glycosylation via serine (GO:0018242),0.48862216971872785,1.020077548372387,0.4488817891373802,1.0,1.0,4/10,17.59%,GALNT1;GALNT13;GALNT3;POGLUT2
prerank,negative regulation of cell cycle G2/M phase transition (GO:1902750),-0.26121939234158564,-1.0200123056194976,0.40119760479041916,0.8172462819900372,1.0,21/55,29.33%,PSMD14;FBXL7;USP47;PSMB3;PSMD12;PSMD6;PSMA1;PSMD7;PSMA5;PSMC5;PINX1;PSMC4;PSMB6;PSMA4;PSMB1;PSMB9;AVEN;PSMC6;PSMD3;PSMD10;PSME3
prerank,negative regulation of cellular process (GO:0048523),0.3164549091689547,1.019992345970815,0.4574574574574575,1.0,1.0,100/521,17.86%,ROR2;TGFBI;DLC1;DCBLD2;SSTR1;WNK2;BMP5;CLDN19;ERBB3;GLMN;FGF2;CRLF3;MYC;PTEN;BCL2;CD34;KAT2B;NGF;VGLL4;PRKN;CDKN2B;PLXNC1;FRZB;PTPN2;JADE1;EPHB2;PTHLH;EIF2AK3;TGFB1;SOX11;NUPR2;MT3;PDE3B;BNIPL;APBB2;RASA1;PODN;TSC1;TMEM98;ADAMTS1;CYP1B1;CBFA2T3;CDK6;MEN1;BNIP3;FOXM1;ATG5;NF2;COL18A1;PACRG;RARG;CRYAB;TEX15;SYT11;DSCAM;ERBB4;SFRP4;PTPRJ;ANXA6;BMP7;MAGI2;ING4;ATP8A2;DRD2;SOD2;ATF5;ADARB1;STRN;GATA3;RBBP4;PRDM11;NACC2;CD9;RPS6KA2;NCK1;PDS5B;MDM4;SRSF6;RTN4;CD164;LMNA;PIM2;BLM;TP53;LPXN;GPLD1;TGFB3;NDUFA13;ING1;HYAL1;DYSF;CDC73;CCDC85B;FKTN;RNF167;NUDT6;CTBP1;MDK;PBRM1;FBXO5
prerank,RNA destabilization (GO:0050779),-0.3459602409347212,-1.0199577115021676,0.42214532871972316,0.8157942729954669,1.0,4/18,6.61%,ROCK2;ROCK1;YTHDF1;METTL14
prerank,peptide metabolic process (GO:0006518),0.3490377590017929,1.0197639853639926,0.44431946006749157,1.0,1.0,15/75,15.28%,BACE2;DPEP1;HM13;PARL;MIPEP;PSEN1;LTA4H;TRHDE;SPCS3;MGAT3;LNPEP;THOP1;CPD;PSEN2;ABCB9
prerank,regulation of nucleic acid-templated transcription (GO:1903506),0.31776058170813504,1.0195176622338082,0.4482412060301508,1.0,1.0,75/327,21.43%,RORA;MLF2;SOX6;NKX6-2;EFEMP1;PRKCQ;TGIF2;SSBP2;NAB1;RPS6KA4;NFX1;SOX11;RNF6;CXXC1;APBB2;RFX3;MLXIPL;MLX;TAF5L;DRAP1;FZD7;CHD3;SPIN1;ATRX;SOX12;CARM1;ZMIZ1;NCOA2;REXO4;HIF1A;ZSCAN26;ZBTB38;HINT1;ATF2;ESR1;MYT1;SP1;SFPQ;RBAK;NSD2;RHOH;DVL1;PATZ1;WWTR1;ATF5;AHR;TGFBRAP1;CREM;HOXB7;TRRAP;ABL1;MSL3;TP53;SP3;PHF19;TERF2IP;NFIA;SUFU;MLF1;FUS;APBB3;POLR2A;HMG20A;CNBP;UBE2L3;STAT3;PRDM2;HP1BP3;USP13;KMT2D;NR1D2;ZSCAN21;LIMD1;MITF;NSD1
prerank,regulation of stress-activated MAPK cascade (GO:0032872),0.364902201150758,1.0194267826991938,0.43565525383707204,1.0,1.0,12/47,18.73%,MYC;EGFR;MAP4K4;CARD9;FOXM1;ARL6IP5;MAPK1;TAOK3;PER1;KLHDC10;NBR1;MID1
prerank,respiratory chain complex IV assembly (GO:0008535),0.419852104344455,1.0191519586278484,0.4601889338731444,1.0,1.0,5/21,13.41%,COX20;COX18;SCO1;COX19;COX10
prerank,mRNA catabolic process (GO:0006402),0.3773085470006027,1.0191098193242454,0.4597839135654262,1.0,1.0,9/44,11.47%,DHX34;DXO;METTL3;XRN2;TUT4;MRTO4;ZFP36L2;NBAS;UPF1
prerank,O-glycan processing (GO:0016266),0.3569490936619766,1.018885339853011,0.4492924528301887,1.0,1.0,11/54,15.02%,ST3GAL4;GALNT9;GALNT1;GALNT15;GALNT7;C1GALT1;GALNT13;GALNT6;GALNT3;MUC3B;MUC3A
prerank,sphingolipid metabolic process (GO:0006665),-0.23204150042969704,-1.0187569633880489,0.359375,0.817670617191249,1.0,31/108,19.91%,SGMS1;ST6GALNAC3;ELOVL7;PLPP1;CERS5;KDSR;ACER2;HACD4;SPTLC2;ESYT2;DEGS2;CERS4;SPNS2;ALDH3A2;ESYT1;GLTP;SGPL1;SUMF2;VAPB;GAL3ST1;UGCG;ASAH2;CERS1;ORMDL3;ESYT3;PLA2G15;SPHK1;SERINC1;SPTSSB;CTSA;CERT1
prerank,positive regulation of plasma membrane bounded cell projection assembly (GO:0120034),-0.2386828701780913,-1.0185355104194767,0.4842105263157895,0.8166512755421255,1.0,22/80,14.92%,NRP1;OCLN;WASL;AGRN;PLEKHM1;FNBP1L;CDC42EP4;WASF2;ARHGAP35;ARAP1;FAM98A;AKIRIN1;CCP110;RHOQ;EPS8;CDC42EP3;ABI2;EPS8L2;CDC42EP2;CDC42;AVIL;FUZ
prerank,regulation of calcium ion transmembrane transporter activity (GO:1901019),0.40589060002592214,1.0183830937370246,0.43302990897269183,1.0,1.0,8/27,15.54%,ANK2;HPCA;JPH3;CACNB4;PDE4D;PRKACA;CALM1;CALM2
prerank,regulation of cytosolic calcium ion concentration (GO:0051480),0.32760694529042694,1.0182049945082496,0.46936656282450673,1.0,1.0,22/142,15.54%,PDGFRA;TAC1;LPAR1;PTGER3;ATP2B3;CACNA1A;PTGFR;CCR2;WNT5A;ACKR3;CD52;SLC8A2;ESR1;S1PR3;PRKACA;DRD2;ATP2B1;TRPC5;P2RY1;ACKR4;FZD9;ABL1
prerank,positive regulation of tumor necrosis factor production (GO:0032760),0.34884998040903775,1.0178588768009136,0.4608294930875576,1.0,1.0,10/69,10.85%,PYCARD;FADD;EPHB2;PSEN1;CCR2;WNT5A;TMEM106A;TLR1;PTPRJ;PTPN11
prerank,positive regulation of collagen metabolic process (GO:0010714),0.4379802955391393,1.0178238736808267,0.4556786703601108,1.0,1.0,6/17,16.21%,CREB3L1;TGFB1;AMELX;HDAC2;RUNX1;TGFB3
prerank,neural crest cell migration (GO:0001755),0.38005586876687963,1.0176977130599014,0.4516971279373368,1.0,1.0,10/36,18.86%,SOX8;SEMA3E;SEMA6C;SEMA3A;ERBB4;GDNF;ANXA6;SEMA6D;SEMA4B;SEMA4D
prerank,negative regulation of endothelial cell proliferation (GO:0001937),-0.287566259196856,-1.0174602015944816,0.3932038834951456,0.8180981461255099,1.0,7/35,11.15%,FLT1;PTPRM;COL4A3;THBS1;RGCC;XDH;ATOH8
prerank,regulation of cell projection organization (GO:0031344),-0.375673373167401,-1.0170421412145476,0.42902208201892744,0.8178455649766156,1.0,2/13,3.91%,MACF1;MOV10
prerank,regulation of programmed cell death (GO:0043067),0.321597017458479,1.0170385863559357,0.46790890269151136,1.0,1.0,36/161,17.24%,BCL2L14;RTKN;CXCL10;OLFM4;SOX9;PRKN;STEAP3;TNFRSF10B;FANK1;APAF1;CASP6;BNIP3;NAE1;NF2;CTSB;RARG;HIP1;SLK;ANP32E;MALT1;TM7SF3;DDX42;RTN4;CASP2;CRADD;ATM;ABL1;IFT57;TP53;BCL2L11;HTATIP2;GLS2;SGK1;PAX2;RIPK1;WRN
prerank,regulation of endocytic recycling (GO:2001135),-0.39366692491646077,-1.0169015412415219,0.4277286135693215,0.8166698930958117,1.0,3/11,8.12%,RAB11B;ATP9A;ACTN2
prerank,pre-mRNA cleavage required for polyadenylation (GO:0098789),0.4604074798100317,1.0167396636678059,0.46402349486049926,1.0,1.0,3/13,10.21%,CPSF6;NCBP1;FIP1L1
prerank,regulation of cell cycle G1/S phase transition (GO:1902806),0.38994318399110506,1.016715117473499,0.45513654096228867,1.0,1.0,4/33,4.96%,PTEN;STXBP4;FBXW7;GLI1
prerank,calcium ion transmembrane import into cytosol (GO:0097553),0.36971741232764993,1.0162957268026676,0.4560975609756098,1.0,1.0,12/41,21.75%,FGF2;CACNA2D1;GRIN2B;SLC8A2;HTR2C;DRD2;GRIN2D;GRIN2A;SLC24A2;RYR3;PKD2;ERO1A
prerank,epidermal cell differentiation (GO:0009913),0.3684240013699305,1.0162015554049633,0.440925700365408,1.0,1.0,6/41,10.11%,CERS3;TGM1;GLI1;WNT5A;GATA6;HDAC2
prerank,sulfur compound transport (GO:0072348),-0.31833849193441266,-1.0159830267032641,0.4100418410041841,0.8177462988004881,1.0,9/27,13.58%,ABCG2;SLC26A7;SLC6A6;SLC6A13;SLC25A26;SLC25A30;SLC13A4;SLC5A6;MGST1
prerank,positive regulation of GTPase activity (GO:0043547),0.3241408418082143,1.0159201010114647,0.4923391215526047,1.0,1.0,22/188,8.53%,ARHGAP24;SIPA1L1;CCL11;DOCK7;NTRK3;TAX1BP3;TBC1D10A;ERBB2;MAP4K4;GPR65;CCL4;SLC27A4;NF1;ARHGEF10;ALS2;CDKL5;MTSS2;TSC1;DOCK10;RAP1A;ZC3H15;TBCK
prerank,positive regulation of Wnt signaling pathway (GO:0030177),0.32460613837259816,1.0158541659775053,0.46328852119958636,1.0,1.0,31/152,17.23%,GPC3;WNK2;SULF1;LGR6;PLEKHA4;FGF10;DEPDC1B;EGFR;GPRC5B;TGFB1;DISC1;LGR5;SPIN1;FAM53B;PPM1B;PSMB7;DAAM2;SFRP4;CSNK1G1;COL1A1;PSMD2;ZEB2;PSMC1;DACT1;JUP;FZD9;CSNK1E;CSNK1G2;XIAP;PSMB2;CDC73
prerank,plasma membrane organization (GO:0007009),0.34901329879689036,1.0157586517351673,0.4531963470319635,1.0,1.0,15/61,17.09%,ANK3;ANK2;PLSCR4;ANO6;PACSIN2;SPTBN1;BIN1;EPB41L3;SYT11;ANXA6;RAB3A;OTOF;EHD2;ABCD2;DYSF
prerank,male gonad development (GO:0008584),0.38106346597551677,1.0157150588718213,0.4467005076142132,1.0,1.0,11/34,21.62%,SOX8;SOX9;WNT5A;MAMLD1;GATA6;GATA3;LRP2;NR5A1;CSDE1;MEA1;FGF9
prerank,positive regulation of receptor-mediated endocytosis (GO:0048260),0.3720022763576158,1.015510453187366,0.43975155279503103,1.0,1.0,8/40,11.52%,SGIP1;BICD1;VEGFA;RAB21;HIP1;SFRP4;CBL;MAGI2
prerank,activation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0006919),0.34448658395894766,1.0152806217520718,0.44370860927152317,1.0,1.0,19/73,19.68%,DLC1;PYCARD;NGF;FADD;EIF2AK3;TNFRSF10B;APAF1;HIP1;NGFR;CASP12;SNCA;CASP2;CRADD;IFT57;RPS27L;RIPK1;AIFM1;SENP1;PPARG
prerank,peptidyl-threonine modification (GO:0018210),0.3480765561161072,1.0150472142800402,0.4573732718894009,1.0,1.0,15/66,14.75%,PRKCA;GALNTL6;ACVR1;WNK3;DYRK4;TGFBR2;DYRK1B;GALNT1;STK39;MAPK1;CDK5R1;TBK1;GALNT13;TTBK1;GALNT3
prerank,heart morphogenesis (GO:0003007),0.3654448558864911,1.0150401303415748,0.4394977168949772,1.0,1.0,4/50,3.14%,DLC1;SOX9;ACVR1;VEGFA
prerank,positive regulation of secretion by cell (GO:1903532),-0.25529500362055557,-1.0147306973267531,0.4649122807017544,0.8197347359569683,1.0,22/70,19.65%,BMP6;IGF1;RAB5A;DTNBP1;EXOC1;PPIA;RGCC;GRK2;ABCG1;UNC13B;RAB9A;KCNB1;APBB1;SYTL4;TGFB2;MYH10;ATP6AP1;STX1A;EDN1;DNM1L;GPER1;BAIAP3
prerank,regulation of cellular response to growth factor stimulus (GO:0090287),0.4348469744014645,1.0136092123896618,0.4734576757532281,1.0,1.0,3/17,10.31%,SULF1;PCSK6;SFRP4
prerank,regulation of androgen receptor signaling pathway (GO:0060765),-0.2986318089751176,-1.0135806403137144,0.45267489711934156,0.8214643503666963,1.0,6/30,11.46%,DAB2;FOXP1;KDM1A;DDX5;KDM4C;PRMT2
prerank,positive regulation of DNA repair (GO:0045739),0.36988993659114333,1.013062510274195,0.4594272076372315,1.0,1.0,8/46,10.55%,DDX11;FGF10;SPIRE1;EGFR;FMN2;FOXM1;BRCA1;SLF2
prerank,extracellular transport (GO:0006858),-0.39250382914362814,-1.0119647997117658,0.48169014084507045,0.8242370784466228,1.0,10/12,42.06%,TSG101;ARRDC1;CABYR;WWP2;ROPN1L;ADCY10;SPAG17;SPA17;CCDC40;DNAAF4
prerank,positive regulation of fat cell differentiation (GO:0045600),-0.26467252822772463,-1.0116974427981869,0.4277456647398844,0.8234560026053925,1.0,10/47,7.97%,SOX13;LRP5;TMEM64;NOCT;CREBL2;PPARD;CDS1;ZFP36L1;SIX1;PTGS2
prerank,apoptotic mitochondrial changes (GO:0008637),0.3858749496349216,1.0113816844765449,0.45666235446313064,1.0,1.0,11/32,21.72%,BCL2;THEM4;BNIP3;ERBB4;ATG3;SOD2;GGCT;FZD9;HK2;HSPD1;AIFM2
prerank,positive regulation of protein transport (GO:0051222),-0.2488212051524821,-1.0112044074724778,0.39097744360902253,0.823228543991734,1.0,14/67,13.13%,BMP6;IGF1;OAZ1;EXOC1;PPIA;RACK1;ABCG1;CNST;UNC13B;OAZ2;APBB1;SYTL4;TGFB2;MYH10
prerank,apical protein localization (GO:0045176),0.49198568594766956,1.0111719658083798,0.4716981132075472,1.0,1.0,2/10,3.59%,ATP8B1;INSC
prerank,regulation of triglyceride biosynthetic process (GO:0010866),0.43936999404511873,1.0111480534610473,0.4474431818181818,1.0,1.0,2/15,3.89%,SLC27A1;FBXW7
prerank,negative regulation of mRNA catabolic process (GO:1902373),0.391664001425715,1.0110662326233808,0.43766233766233764,1.0,1.0,12/29,25.29%,DHX34;PABPC1;GDNF;NBAS;EIF4ENIF1;HNRNPU;FUS;TENT5D;TENT5A;TENT5C;FMR1;CIRBP
prerank,nucleosome organization (GO:0034728),0.3590975258460106,1.0110419056400974,0.4443127962085308,1.0,1.0,13/55,17.97%,SOX9;VPS72;MCM3AP;ATRX;PRDM9;SETD2;POLE3;SMARCC2;ASF1A;ANP32E;SMARCC1;SMARCE1;NASP
prerank,regulation of lipid biosynthetic process (GO:0046890),-0.29382775299814096,-1.010981385749079,0.41150442477876104,0.8223160668755549,1.0,11/32,18.87%,PRKAG2;SORBS1;CREBL2;PRKAA2;ADIPOR2;AVIL;CEACAM1;SIRT4;MID1IP1;APOE;GPER1
prerank,positive regulation of DNA biosynthetic process (GO:2000573),0.3530094418901936,1.0105193362673486,0.4742857142857143,1.0,1.0,12/60,15.47%,PRKCQ;FGF2;MYC;CCT7;CHTF18;PARM1;MAPK1;NEK7;SMOC2;MAP3K4;POLG2;ATM
prerank,regulation of response to cytokine stimulus (GO:0060759),0.42369085482132296,1.0101350747701925,0.47982708933717577,1.0,1.0,5/19,15.48%,CBFB;MAPK7;WNT5A;TAF9;RUNX1
prerank,positive regulation of programmed cell death (GO:0043068),0.31478555644593925,1.0097093348931718,0.48432760364004046,1.0,1.0,68/272,18.71%,HRK;PIP5KL1;PYCARD;NGF;AKAP13;FADD;FRZB;FGD4;ANO6;TNFRSF10B;PSEN1;SLC27A4;FANK1;NF1;DUSP6;ACVR1C;APAF1;BMF;ITSN1;CYP1B1;SHQ1;PHLDA1;BNIP3;BIN1;ARHGEF11;RARG;VAV3;PPID;UBE2Z;SFRP4;NGFR;NCSTN;HDAC6;ARL6IP5;ING4;APH1A;SCRIB;TRIO;ARHGEF3;SNCA;RPS6KA2;PSEN2;ITGB3BP;UBB;ITGB1;CASP2;CRADD;RASSF2;ATM;FZD9;ABL1;TP53;BCL2L11;GPLD1;HTATIP2;TGFB3;QRICH1;ARHGEF4;RIPK1;RNPS1;KCNMA1;ADAMTSL4;PLEKHG2;CSRNP3;AIFM1;DNAJA1;HTT;MAP3K11
prerank,cellular component assembly (GO:0022607),0.31602394377226173,1.0095532800627587,0.48484848484848486,1.0,1.0,53/253,18.13%,ANK3;RHOJ;HAS2;RHOD;REPS2;SOX9;GSN;LAMC1;WIPF1;EPRS1;KMT2A;RSPH1;TGFB1;GPM6B;WNT5A;SPTBN1;NLGN1;YWHAZ;BAIAP2;FLNA;TEX11;PPID;CFAP46;MAGI1;CFAP74;RIMS1;FANCC;MYO9A;GORASP2;OPHN1;RHOH;DVL1;WASF1;RBBP4;DET1;CORO1B;MDM4;RTN4;CYFIP1;PKP2;NIFK;TP53;LPXN;PPIH;LRRTM3;IL1RAP;FSCN1;FOXJ1;CD74;RAC3;RSPH9;DCX;MDM2
prerank,regulation of gene expression (GO:0010468),0.3103905139726491,1.0090424559145503,0.458,1.0,1.0,141/903,15.62%,RORA;OSR2;SEC16B;RAG2;PRX;MLF2;SOX6;NKX6-2;AFF3;CLDN19;ANK3;EFEMP1;ADAM19;PRKCQ;NTRK3;EPB41L4B;GLMN;CREB3L1;FGF2;MYC;RBMS3;TGIF2;FGF10;DHH;PTPN22;ANK2;CD34;SOX9;SSBP2;GSN;NGF;NAB1;PRKN;HNRNPDL;C1D;VEGFA;EPHB2;TRA2B;PTHLH;EIF2AK3;RPS6KA4;NFX1;TRIM44;TLE1;ZNF326;FBXW7;TGFB1;PSEN1;SOX11;NTRK2;ITGB8;RFXANK;RNF6;MT3;CXXC1;WNT5A;HOXD3;HNRNPAB;APBB2;UBAP2;RFX3;MLXIPL;MLX;TAF5L;DRAP1;SON;FZD7;TRIM11;CDK6;CHD3;SPIN1;SLC8A2;ATRX;ZNF462;BRCA1;SMO;SOX12;ANKRA2;CARM1;NCOA2;MAPK9;REXO4;HIF1A;ZFP64;PRDM9;ZSCAN26;ZBTB38;SFRP4;HINT1;GDNF;ATF2;PCBP4;ESR1;NFE2L2;MAPK14;MYT1;RIMS1;SP1;SFPQ;HDAC6;POGZ;RBAK;NSD2;PID1;DIP2A;MAPK1;BMP7;ATRAID;EDN3;FGF7;RHOH;DVL1;PATZ1;WWTR1;ATF5;PER1;GATA3;AHR;SPOUT1;NDFIP1;PRDM11;TTBK1;TGFBRAP1;KDM6A;PDCL3;NOVA1;YTHDC1;BMPR1A;CITED2;CREM;KHSRP;TICAM1;HOXB7;POU3F1;IL33;ATM;RUNX1;TRRAP;ABL1;STX1B;MSL3
prerank,positive regulation of intracellular signal transduction (GO:1902533),0.3117220098549951,1.0088762956445096,0.481,1.0,1.0,84/509,16.12%,ROR2;RELN;DCN;FFAR4;ROR1;PDGFRA;ERBB3;NTRK3;FGF2;S100A4;FGF10;BCL2;IRS2;SOX9;ERBB2;PRKN;EGFR;AKAP13;FADD;LPAR1;ALPK1;VEGFA;MIOS;MAP3K3;THEM4;GPRC5B;TRIM44;TNFRSF10B;TGFB1;CCL4;NCF1;SOX11;NTRK2;SLC44A2;WNT5A;TMEM106A;NLGN1;KSR1;CARD9;BMF;FGFR1;IL18;PELI1;FYN;LAMTOR2;GAB2;FLNA;HIP1;BTC;TRIP6;ERBB4;PIK3R1;VAPA;MID2;GPR37;PTPRJ;CBL;ESR1;PTPN11;MYDGF;FGF7;RHOC;TBK1;RTKN2;MYOC;STRN;GATA3;MALT1;NDFIP1;P2RY12;DHX33;GOLT1B;TRAF7;RTN4;IQGAP1;TICAM1;MET;ITGB1;CGAS;PIM2;GAB1;TP53;BCL2L11;LRP2
prerank,cellular component maintenance (GO:0043954),-0.3862536857405212,-1.0088113291986072,0.4535809018567639,0.8270580411272398,1.0,4/12,8.41%,IGF1R;ITGA3;INSR;MTMR2
prerank,histone mRNA catabolic process (GO:0071044),-0.3645738537005141,-1.0087694530581695,0.4327485380116959,0.8255921501266994,1.0,8/15,19.33%,XRN1;LSM1;MTPAP;ERI1;DCP2;TUT7;EXOSC10;TENT4B
prerank,positive regulation of T cell mediated immunity (GO:0002711),0.40416494042974144,1.0086720080338099,0.4617524339360223,1.0,1.0,4/22,13.22%,FADD;FBXO38;ZBTB1;MALT1
prerank,tRNA wobble base modification (GO:0002097),-0.3741826872498284,-1.0086107638117796,0.4334470989761092,0.8245236588911978,1.0,5/14,16.43%,TRMT9B;URM1;ELP3;MTO1;DPH3
prerank,ventricular septum morphogenesis (GO:0060412),-0.31011164039890127,-1.0085220840285847,0.43824701195219123,0.823197107415446,1.0,6/27,4.03%,ROBO1;SMAD7;BMP4;BMPR2;SLIT2;TGFBR1
prerank,negative regulation of cAMP-mediated signaling (GO:0043951),0.4789242573056822,1.008169618282501,0.4726443768996961,1.0,1.0,5/10,19.62%,RNF157;PDE3B;PDE4D;APLNR;PDE11A
prerank,regulation of transforming growth factor beta production (GO:0071634),0.4274380641940291,1.0080122465080779,0.4596888260254597,1.0,1.0,4/18,11.11%,CD34;ITGB8;HIF1A;LTBP1
prerank,negative regulation of cell adhesion mediated by integrin (GO:0033629),-0.410368724959813,-1.006776536418279,0.45231607629427795,0.8264371584800002,1.0,5/10,12.74%,ACER2;WNK1;JAM3;SERPINE1;NEXMIF
prerank,positive regulation of Notch signaling pathway (GO:0045747),-0.27766249020542527,-1.0067221993808793,0.4129353233830846,0.8250025016162528,1.0,11/39,13.86%,ROBO1;TSPAN5;NOS3;MAML1;PRKCI;SNW1;JAG1;JAG2;NOTCH4;TGFB2;NEPRO
prerank,potassium ion import across plasma membrane (GO:1990573),-0.2730953383446397,-1.0065874359117284,0.40331491712707185,0.8238381090243571,1.0,9/41,13.07%,ATP1A2;ATP1B3;SLC12A7;KCNJ2;ABCC9;ATP1A1;SLC12A9;KCNK9;SLC12A8
prerank,protein phosphorylation (GO:0006468),0.3103651104792328,1.00645627924426,0.4864864864864865,1.0,1.0,83/479,13.05%,RELN;WNK2;CCL11;EFEMP1;PRKCA;PDGFRA;STK32B;PRKCQ;PKDCC;PEAK1;STK36;ERBB2;EGFR;ACVR1;PRKX;MAP4K4;PAK4;MAP3K3;EPHB2;IRAK3;WNK3;SIK2;EIF2AK3;RPS6KA4;MAPKAPK3;MAST2;NEK1;TGFB1;TEC;PAK5;NTRK2;MAPKAPK2;DYRK4;TESK2;PRKAR1B;TNIK;EEF2K;ACVR1C;PAK1;PKN1;YWHAZ;CDKL5;CDK8;CDKL3;CDK13;TGFBR2;CSK;PPP3CB;DYRK1B;PDK3;LIMK1;CDK6;FGFR1;FYN;CDK15;TBCK;CDK19;STK39;PASK;TLK2;MAPK9;AKT3;SGK3;SGK2;ERBB4;SLK;PXK;TYK2;MAPK14;DCLK1;STK32A;STK19;CDC25B;MAPK1;TAOK3;CDK5R1;TBK1;STK33;CSNK1G1;PRKACA;CSNK1A1;NEK7;CDK16
prerank,positive regulation of potassium ion transport (GO:0043268),0.37268449311091556,1.0064024220240182,0.454320987654321,1.0,1.0,10/38,19.83%,ANK2;KCNMB2;KCNMB3;FLNA;AKAP6;KCNJ3;KCNJ10;KCNH2;KCNMA1;NOS1AP
prerank,negative regulation of catabolic process (GO:0009895),0.3646922631252572,1.0063580606075668,0.4682926829268293,1.0,1.0,15/47,24.09%,EGFR;FMN2;IRAK3;PDE3B;CBFA2T3;FLNA;MDM4;SNX12;AZIN2;SF3B3;PFKFB1;AGAP2;PRKAA1;PRKCG;HMGCR
prerank,extrinsic apoptotic signaling pathway in absence of ligand (GO:0097192),0.4160613728369341,1.005961349936799,0.4748299319727891,1.0,1.0,2/20,1.76%,ERBB3;BCL2
prerank,porphyrin-containing compound catabolic process (GO:0006787),-0.35707395548186316,-1.00578148879254,0.44666666666666666,0.8229673338276541,1.0,2/14,6.99%,ABCG2;BLVRA
prerank,heme catabolic process (GO:0042167),-0.35707395548186316,-1.00578148879254,0.44666666666666666,0.8229673338276541,1.0,2/14,6.99%,ABCG2;BLVRA
prerank,microtubule cytoskeleton organization involved in mitosis (GO:1902850),0.32612550201098667,1.0057520927855006,0.4894291754756871,1.0,1.0,20/125,14.45%,DYNLL1;EFHC1;XPO1;GPSM2;TBCE;RANBP2;EML1;NDE1;SETD2;DYNC1I1;RCC1;CLASP1;NUP160;SGO1;ZWINT;CKAP5;KPNB1;BUB1B;DYNC1I2;ITGB3BP
prerank,folic acid-containing compound metabolic process (GO:0006760),0.42588129975447864,1.0055838047422678,0.4829059829059829,1.0,1.0,5/19,20.80%,ALDH1L1;MTRR;MTHFD2L;ALDH1L2;SLC25A32
prerank,positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557),0.3425882761346898,1.0049867977308413,0.4874715261958998,1.0,1.0,16/73,19.76%,PYCARD;FADD;EPHB2;PSEN1;CCR2;WNT5A;TMEM106A;TLR1;PTPRJ;PTPN11;IL33;RIPK1;LBP;SETD4;BCL10;STAT3
prerank,negative regulation of ATPase activity (GO:0032780),0.4411055967665575,1.0047506667639794,0.4689265536723164,1.0,1.0,5/16,17.48%,TSC1;THADA;PXK;TP53;PAM16
prerank,response to alcohol (GO:0097305),0.3902954414924461,1.0044195613131401,0.47334200260078024,1.0,1.0,5/27,14.38%,TGFB1;GRIN2B;TGFBR2;GOT2;GRIN2A
prerank,positive regulation of cytosolic calcium ion concentration (GO:0007204),0.3253367850192499,1.0042851899266627,0.479957805907173,1.0,1.0,18/140,14.06%,PDGFRA;TAC1;CACNA2D1;LPAR1;PTGER3;GPR65;CACNA1A;PTGFR;CCR2;JPH3;ACKR3;CD52;HTR2C;ESR1;S1PR3;DRD2;P2RY1;ACKR4
prerank,antimicrobial humoral immune response mediated by antimicrobial peptide (GO:0061844),0.3787273455291239,1.0037988814112044,0.45219638242894056,1.0,1.0,2/32,3.93%,CXCL10;RNASE6
prerank,negative regulation of transcription regulatory region DNA binding (GO:2000678),0.45183301361655004,1.003336042672336,0.4698972099853157,1.0,1.0,2/13,4.44%,PSEN1;SOX11
prerank,regulation of cytokine-mediated signaling pathway (GO:0001959),0.3455880900612312,1.0032052390824024,0.4805045871559633,1.0,1.0,19/72,19.48%,PYCARD;CBFB;FADD;PTPN2;IRAK3;TRIM44;SOCS1;AGPAT2;OTULIN;PTPN1;PTPN11;TAX1BP1;SUMO1;RUNX1;CD74;RIPK1;CHUK;AXL;SPPL2B
prerank,positive regulation of cell cycle phase transition (GO:1901989),0.4434014033672849,1.0028711287792136,0.4795763993948563,1.0,1.0,5/15,19.99%,STXBP4;GLI1;CUL3;CDC73;PHB2
prerank,regulation of neurotransmitter transport (GO:0051588),-0.3476130575713039,-1.0027584064076056,0.4542483660130719,0.8298558598714109,1.0,5/16,15.26%,SNCAIP;CPLX1;CAMK2A;MCTP2;FLOT1
prerank,regulation of interleukin-12 production (GO:0032655),0.36109290032630414,1.0025860877829145,0.46335697399527187,1.0,1.0,4/47,4.92%,IL16;IRAK3;MAST2;PLCB1
prerank,regulation of cell adhesion (GO:0030155),0.3227299597911761,1.0025673209536279,0.49109947643979057,1.0,1.0,18/129,10.85%,TGFBI;PRKCA;ERBB3;EPB41L4B;RHOD;ERBB2;PLXNC1;PRKX;EFNA5;VEGFA;EPHB2;PDE3B;RASA1;IL18;PPP3CA;DSCAM;PTPRJ;PTPN11
prerank,lipoxygenase pathway (GO:0019372),-0.3800229314971473,-1.0024936345977717,0.4540059347181009,0.8290749483266766,1.0,5/14,22.02%,PTGS2;GPX1;HPGD;GPX4;ALOX12
prerank,positive regulation of glycoprotein biosynthetic process (GO:0010560),-0.376439168991214,-1.0024392279349141,0.4169184290030212,0.8276764582321656,1.0,2/13,4.02%,IGF1;RAMP1
prerank,phospholipase C-activating G protein-coupled receptor signaling pathway (GO:0007200),0.3381747648917024,1.002356011519196,0.46111111111111114,1.0,1.0,13/76,16.75%,GNA14;HRH1;LPAR1;PTGER3;GPR65;GRM5;HTR2C;ESR1;DRD2;P2RY12;P2RY1;HOMER1;OPRK1
prerank,cellular response to glucocorticoid stimulus (GO:0071385),0.42850219397959,1.0022378214528167,0.47776183644189385,1.0,1.0,7/18,20.38%,ZFP36L2;KLF9;BCL2L11;HNRNPU;PCK2;UBE2L3;ZFP36
prerank,"alternative mRNA splicing, via spliceosome (GO:0000380)",0.4448216846328603,1.0020232677313206,0.48214285714285715,1.0,1.0,6/16,22.12%,RSRC1;CDK13;SFPQ;SRSF6;CELF4;RBM17
prerank,regulation of mitotic metaphase/anaphase transition (GO:0030071),0.39165324597011203,1.0018606178441338,0.44036697247706424,1.0,1.0,11/26,23.62%,CUL3;ANAPC7;CDC23;FBXO5;CDC27;DUSP1;ANAPC4;CDK5RAP2;ANAPC5;RB1;CDC16
prerank,apoptotic cell clearance (GO:0043277),0.3917122950807461,1.00160096730052,0.4748677248677249,1.0,1.0,3/30,2.81%,XKR7;LRP1;XKR8
prerank,regulation of ubiquitin protein ligase activity (GO:1904666),0.418768762664211,1.0014124127692172,0.4712950600801068,1.0,1.0,2/21,2.13%,PTEN;GORASP1
prerank,response to organophosphorus (GO:0046683),-0.3607969190767777,-1.0014056386149606,0.4503311258278146,0.8291284352041167,1.0,5/16,25.43%,ABCC9;TRIM16;TRPC3;RFC3;VGF
prerank,intra-Golgi vesicle-mediated transport (GO:0006891),0.3927797303856587,1.0013762537112285,0.4660574412532637,1.0,1.0,14/29,26.90%,COG5;COPZ2;COPB2;COPG2;COPA;GABARAPL2;COPG1;COG1;TRAPPC3;NAPG;RAB6A;TRAPPC10;GOSR1;COG6
prerank,negative regulation of mRNA processing (GO:0050686),-0.3649926313865018,-1.0013650495084072,0.45484949832775917,0.8276811277013956,1.0,8/15,23.37%,RBMX;SRSF10;SRSF4;SAP18;PTBP1;SRSF12;SRSF7;U2AF2
prerank,cytosolic transport (GO:0016482),0.32937101136728947,1.0011161436732954,0.5005313496280552,1.0,1.0,36/108,23.30%,TBC1D10A;DENND2A;RHOBTB3;RAB14;VPS29;ARL1;CCDC91;AP1G1;GBF1;EPS15;GAK;HEATR5A;SNX6;VPS26B;PHETA2;BET1L;SYS1;AKTIP;STX8;SPAG9;SNX1;WASHC1;ANKRD27;UBE2O;AP4M1;RBSN;RAB7A;SNX16;HOOK2;DENND5A;WDR81;CORO7;RAB6A;HOOK1;HOOK3;ERC1
prerank,negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090101),0.3290021665106335,1.0010046932631111,0.4915254237288136,1.0,1.0,20/104,16.36%,SOSTDC1;PRDM16;HTRA3;ACVR1;TGFB1;TGFBR2;SPRED2;SPRED1;PEG10;BCL9L;SPRED3;SNX6;DAND5;MAGI2;BMPER;BMPR1A;LDLRAD4;UBB;LRP2;VWC2
prerank,dendritic spine morphogenesis (GO:0060997),0.43947224644620264,1.0009346644149566,0.466966966966967,1.0,1.0,4/15,11.37%,PTEN;EPHB2;DOCK10;DIP2A
prerank,cellular protein localization (GO:0034613),0.310702726106604,1.0009250584137424,0.4899598393574297,1.0,1.0,64/285,17.14%,TMED6;HPS6;FGF10;TBC1D10A;BICD1;ANK2;ARMCX3;RAB38;EGFR;RAB14;PACS2;VPS33A;COPZ2;SNX15;VPS29;GRID2;WNT5A;WIPI1;ARL1;ITSN1;RAB21;COPB2;SEC31B;CNTNAP2;LAMTOR2;RABL3;CNTN2;EPB41L3;TBCK;FLNA;TMED10;SNX6;COX18;VPS26B;ARL5C;NGFR;ARF4;BICD2;HDAC6;RAB22A;FGF7;RAB1A;USP6NL;STX8;SYNDIG1;CORO1B;RAB3GAP2;TMED3;TMED2;TRIM23;COPA;ARFGAP3;SNX1;SEC23IP;UNC93B1;SGSM1;RIC3;STX1B;PIGU;FOXJ1;TM9SF2;CTTN;AP4M1;CD74
prerank,synaptic vesicle transport (GO:0048489),-0.3954313647005303,-1.0009147978810122,0.45,0.8274608606095272,1.0,5/11,14.88%,SYNJ1;KIF5B;DNM2;SNAPIN;TMEM230
prerank,folic acid metabolic process (GO:0046655),0.43348370395377156,1.000898076255038,0.49570200573065903,1.0,1.0,5/18,20.80%,ALDH1L1;MTRR;MTHFD2L;ALDH1L2;SLC25A32
prerank,"retrograde transport, endosome to Golgi (GO:0042147)",0.33681180917454134,1.000873279536706,0.4829106945975744,1.0,1.0,20/80,18.12%,TBC1D10A;DENND2A;RHOBTB3;VPS29;ARL1;GBF1;HEATR5A;SNX6;VPS26B;PHETA2;BET1L;SPAG9;SNX1;WASHC1;UBE2O;SNX12;SURF4;RBSN;RAB7A;RAB7B
prerank,purine nucleotide catabolic process (GO:0006195),0.4449591271723907,1.0008600954248705,0.4717557251908397,1.0,1.0,3/13,10.38%,NUDT15;NT5C2;HINT1
prerank,regulation of cell population proliferation (GO:0042127),0.307418635980239,1.000684838415263,0.511,1.0,1.0,120/691,16.21%,ROR2;OSR2;DLC1;SSTR1;WNK2;BMP5;CLDN19;CXCL10;PDGFRA;ERBB3;HAS2;NTRK3;GLMN;FGF2;MYC;FGF10;KIF20B;PTEN;BCL2;GAREM1;IRS2;KAT2B;SOX9;CRLF1;NGF;BST1;ERBB2;CDKN2B;EGFR;SQLE;FRZB;PTPN2;VEGFA;CADM4;PTHLH;CAPN1;TGFB1;TIPIN;PTGFR;SOX11;NUPR2;NTRK2;GDF9;GLI1;NOX1;NOP2;PAK1;BNIPL;KSR1;CDK13;PODN;TSC1;TGFBR2;MLXIPL;UFL1;ADAMTS1;CYP1B1;CBFA2T3;CDK6;MEN1;FOXM1;FGFR1;TSHR;GAB2;NF2;COL18A1;RARG;BTC;DERL2;SGK3;SGK2;AMELX;SHCBP1;CUL3;HDAC2;ERBB4;SFRP4;GDNF;PTPRJ;IL6ST;PRMT1;CDC25B;MAGI2;S1PR3;EDN3;ING4;FGF7;ATP8A2;RTKN2;WWTR1;XRCC6;DRD2;GLP2R;PRLR;PRDX3;SOD2;ATF5;ADARB1;STRN;GATA3;RBBP4;TRAPPC14;NACC2;RPS6KA2;PDS5B;MDM4;BMPR1A;CD164;LMNA;CCL14;JUP;RUNX1;MEIS3;PIM2;TP53;CCND2;GPLD1;XIAP;TRNP1;TGFB3
prerank,intraciliary retrograde transport (GO:0035721),-0.38404222621596396,-1.0003708829296467,0.4437869822485207,0.8274749544994615,1.0,6/12,13.39%,WDR19;IFT43;DYNC2LI1;DYNLT2B;IFT122;DYNC2I2
prerank,regulation of heart contraction (GO:0008016),0.33294399539467034,1.0000643610415079,0.4730603448275862,1.0,1.0,17/90,17.16%,FXYD3;CORIN;ANK2;NPR2;ATP2B3;TMEM65;SLC8A2;FXYD6;PDE4D;FXYD1;PRKACA;ATP2B1;AHCYL1;CALM1;CALM2;NPPC;MYH6
prerank,negative regulation of cytokine-mediated signaling pathway (GO:0001960),-0.2660959660336776,-1.0000323333396361,0.4647058823529412,0.8268536197388442,1.0,18/48,23.43%,ROBO1;SLIT2;GPS2;SAMHD1;CCDC3;NR1H2;PTPRC;PADI2;PARP14;STAT2;USP18;PELI3;ISG15;NR1H3;RFFL;CACTIN;MUL1;NLRP2B
prerank,negative chemotaxis (GO:0050919),0.37731502381692766,0.9999900779906975,0.47066326530612246,1.0,1.0,4/33,3.81%,LGR6;SEMA3E;SEMA6C;SEMA3A
prerank,positive regulation of transcription by RNA polymerase II (GO:0045944),0.30681503887515943,0.9996311723774491,0.516,1.0,1.0,192/834,21.49%,RORA;OSR2;DCN;ETV1;BMP5;MLIP;KLF15;CXCL10;ETV4;MEOX2;MAML3;GLI2;MACC1;FGF2;SOX8;CRLF3;MYC;KAT2B;SOX9;SSBP2;PRKN;NCOA1;CDKN2B;EGFR;FADD;HIVEP1;ACVR1;HOXA7;KMT2A;VEGFA;CCNC;TFCP2;MAPK7;MAML2;CRTC1;RPS6KA4;TGFB1;AUTS2;SOX11;SETD3;RFXANK;GLI1;E2F2;PHOX2A;WNT5A;HOXD3;CDK8;RFX3;CDK13;MLXIPL;MLX;DRAP1;PPP3CB;KAT8;GATA6;MEN1;FOXM1;IL18;ASXL3;PPP3CA;ATMIN;ATRX;ZNF462;RARG;BRCA1;RARB;SOX12;ZMIZ1;NCOA2;LDB2;KLF5;BRD8;HIF1A;ZFP64;IL4I1;BCL9L;HDAC2;ZBTB38;MED13;NFATC3;PIK3R1;MYSM1;GDNF;ATF2;NGFR;ESR1;NFE2L2;ARF4;SP1;TAF9;SFPQ;POGZ;PID1;MYDGF;BCL9;EPC1;TMF1;DVL1;TBK1;WWTR1;XRCC6;NRIP1;PRPF6;ZFPM2;ATF5;PER1;GATA3;AHR;SALL2;NCK1;PAX3;BMPR1A;PKD1;CITED2;TAF7;MED12;MET;HOXB7;ELL;ZEB2;UBB;IL33;MED25;JUP;ATM;RUNX1;ABL1;MEIS3;GCN1;MEPCE;MED21;TP53;SP3;TET3;HTATIP2;TGFB3;SREBF2;RNF111;HNRNPU;ASXL2;NFIA;WWOX;FOXJ1;PAX2;GABPB2;GABPB1;RNF10;RIPK1;CDC73;CHUK;NFIX;NCOA3;SLC9A1;HEYL;NR5A1;CSRNP3;IRF3;MED30;KLF7;AATF;RNF4;PARK7;EGR1;SENP1;RUVBL2;CNBP;FOXJ3;PPARG;JUN;STAT3;PRDM2;ONECUT2;MCRS1;TFE3;SMARCA4;FUBP3;KMT2D;PBX1;ZBED4;NR1D2;MEIS1;ZSCAN21;DPF2;NFKB1;MITF;THRA;DCAF6;TNIP2;RPS6KA3;DVL3;PKD2;PRKD2
prerank,autophagy of nucleus (GO:0044804),0.4240137950907852,0.9995358079192197,0.4658753709198813,1.0,1.0,3/16,12.66%,WIPI1;ATG5;ATG3
prerank,catecholamine metabolic process (GO:0006584),0.45284909583244726,0.9995332426033825,0.5050798258345428,1.0,1.0,4/14,13.89%,PRKN;COMT;DRD2;LRTOMT
prerank,regulation of epithelial to mesenchymal transition (GO:0010717),0.3405411585118549,0.9995174016758467,0.4728682170542636,1.0,1.0,15/74,14.70%,BMP5;GLIPR2;PHLDB1;PTEN;TGFB1;TGFBR2;SPRED2;SPRED1;BCL9L;SPRED3;CLASP1;WWTR1;GATA3;COL1A1;LDLRAD4
prerank,regulation of interferon-beta production (GO:0032648),-0.2602098146000052,-0.9994921231689842,0.42857142857142855,0.826817308698405,1.0,12/46,15.26%,TOMM70;REL;RELB;TLR4;IFIH1;TRIM56;RIOK3;IRF1;OAS2;TIRAP;HSP90AA1;FLOT1
prerank,regulation of neuron differentiation (GO:0045664),0.3382257678150449,0.9994360397891351,0.4862183020948181,1.0,1.0,19/76,20.21%,NGF;NRCAM;GPRC5B;SOX11;ZEB1;HOXD3;NLGN1;FGFR1;BIN1;BMP7;MMD2;CDK5R1;ZFHX2;VWC2;NREP;HEYL;CNTN4;CPNE1;PCP4
prerank,regulation of cellular macromolecule biosynthetic process (GO:2000112),0.31095447856196756,0.9993926138493234,0.5140845070422535,1.0,1.0,82/366,20.98%,RORA;MLF2;SOX6;NKX6-2;EFEMP1;PRKCQ;TGIF2;SSBP2;NAB1;RPS6KA4;NFX1;SOX11;RNF6;CXXC1;APBB2;ATXN2;RFX3;TSC1;MLXIPL;MLX;TAF5L;DRAP1;FZD7;CHD3;SPIN1;RABL3;ATRX;SOX12;CARM1;NCOA2;REXO4;HIF1A;GRM5;ZSCAN26;ZBTB38;HINT1;ATF2;ESR1;MYT1;SP1;SFPQ;RBAK;NSD2;DDX25;RHOH;DVL1;PATZ1;WWTR1;ATF5;AHR;RBM4B;TGFBRAP1;CREM;CYFIP1;HOXB7;TRRAP;ABL1;MSL3;TP53;SP3;PHF19;TERF2IP;NFIA;SUFU;MLF1;FBXO5;FUS;APBB3;USP37;POLR2A;HMG20A;CNBP;UBE2L3;STAT3;PRDM2;HP1BP3;USP13;CCDC88A;KMT2D;NR1D2;ZSCAN21;LIMD1
prerank,regulation of immunoglobulin production (GO:0002637),0.39752590804148813,0.9993462907735392,0.4599728629579376,1.0,1.0,2/23,3.65%,EPHB2;DNAJB9
prerank,cellular response to organic substance (GO:0071310),0.3289012123159427,0.9992669989573594,0.48404255319148937,1.0,1.0,23/116,12.63%,ERBB2;NCOA1;IL1RAPL1;ACVR1;PTPN2;MAPK7;TGFB1;PTPN13;ACVR1C;URI1;TGFBR2;IL1RL2;CYP1B1;IL18;NCOA2;AKAP6;PTPN11;HDAC6;ARL6IP5;PID1;EMD;TBK1;PTPN18
prerank,hemidesmosome assembly (GO:0031581),0.4681492155095197,0.9990178751218433,0.4792284866468843,1.0,1.0,2/11,6.45%,LAMC1;PLEC
prerank,tRNA aminoacylation for protein translation (GO:0006418),0.3637807792063912,0.9983745421200466,0.47975460122699387,1.0,1.0,8/42,14.03%,IARS2;EPRS1;FARSA;SARS2;FARSB;FARS2;YARS1;HARS1
prerank,nucleobase-containing small molecule catabolic process (GO:0034656),0.45127140583869313,0.9982598211403179,0.4745762711864407,1.0,1.0,4/14,12.34%,NUDT15;ENTPD2;NUDT1;NUDT9
prerank,regulation of RNA polymerase II transcription preinitiation complex assembly (GO:0045898),0.48145335737064554,0.9982079838528237,0.48697068403908794,1.0,1.0,4/10,21.35%,ATF7IP;ESR1;TP53;THRA
prerank,lamellipodium organization (GO:0097581),-0.29229504364526954,-0.9981909051729235,0.46956521739130436,0.8289556223191907,1.0,9/29,14.82%,ABLIM1;KIT;CDH13;PARVB;ARHGEF6;ABLIM2;WHAMM;PTPRO;S1PR1
prerank,regulation of cellular respiration (GO:0043457),0.42204419162783435,0.9981640289611226,0.4577259475218659,1.0,1.0,4/17,17.49%,PRDM16;CBFA2T3;PNPT1;TRAP1
prerank,regulation of amyloid-beta formation (GO:1902003),-0.2927641880739271,-0.998056926035256,0.44075829383886256,0.8277975039388336,1.0,4/34,1.73%,EPHA4;IGF1;ROCK2;ROCK1
prerank,cellular response to mechanical stimulus (GO:0071260),0.35878989657779736,0.9980411139288743,0.48062953995157387,1.0,1.0,9/46,17.45%,PIEZO2;SOX9;FADD;TNFRSF10B;BNIP3;MAP2K4;CASP2;CRADD;SLC9A1
prerank,regulation of telomere maintenance (GO:0032204),0.3964384933865391,0.9971113201342675,0.48751642575558474,1.0,1.0,8/26,16.41%,MYC;ERCC4;ATRX;SIRT6;UPF1;RTEL1;SMG6;TERF2IP
prerank,negative regulation of JNK cascade (GO:0046329),0.3842133974266734,0.9970827189069689,0.4752604166666667,1.0,1.0,13/31,23.71%,PTPN22;PRKN;MEN1;TAOK3;PER1;DACT1;FKTN;DNAJA1;ZMYND11;PDCD4;SIRPA;CYLD;AIDA
prerank,histone deacetylation (GO:0016575),0.36641713174228674,0.9970401164543264,0.4830917874396135,1.0,1.0,12/43,16.15%,RCOR2;MTA2;MORF4L2;HDAC2;SIN3B;SFPQ;HDAC6;SIRT6;MIDEAS;PER1;MSL3;MTA3
prerank,gene silencing by miRNA (GO:0035195),-0.288023353422625,-0.996740555099204,0.45535714285714285,0.8299097547761208,1.0,7/32,12.43%,WTIP;MOV10;AGO1;ZC3H7B;CNOT1;NOTCH4;AGO3
prerank,3'-UTR-mediated mRNA stabilization (GO:0070935),0.4403758102353234,0.9964803468257749,0.47230320699708456,1.0,1.0,6/14,22.58%,ELAVL4;MAPKAPK2;MAPK14;HNRNPC;ZFP36;YBX3
prerank,negative regulation of cell activation (GO:0050866),-0.3660574834132336,-0.9961450583123619,0.4709480122324159,0.8300009495617936,1.0,3/14,2.67%,CD200;THBD;NOS3
prerank,lysosome organization (GO:0007040),0.3738239362306385,0.9960550839402718,0.48055207026348806,1.0,1.0,16/36,23.95%,GNPTAB;VPS33A;ACP2;GRN;TPCN2;AKTIP;CLVS1;HPS1;HOOK2;MBTPS1;CLVS2;HOOK1;HOOK3;TPP1;CLN6;MTOR
prerank,toll-like receptor 3 signaling pathway (GO:0034138),0.458373188385244,0.996008421222826,0.4633781763826607,1.0,1.0,6/11,21.40%,FADD;UNC93B1;TICAM1;RIPK1;SCARA3;TNIP2
prerank,"positive regulation of transcription, DNA-templated (GO:0045893)",0.3050139685593376,0.9959196432767226,0.521,1.0,1.0,252/1082,21.49%,RORA;OSR2;DCN;ETV1;BMP5;MLIP;KLF15;CXCL10;MDFIC;ETV4;MEOX2;MAML3;GLI2;MACC1;FGF2;SOX8;PRDM16;CRLF3;MYC;RGMB;KAT2B;SOX9;SSBP2;HMGN1;ERBB2;PRKN;NCOA1;CDKN2B;EGFR;FADD;HIVEP1;ACVR1;HOXA7;KMT2A;VEGFA;CCNC;TFCP2;MAPK7;WAC;KDM8;EIF2AK3;MAML2;CRTC1;RPS6KA4;TRIM44;TGFB1;AUTS2;PSEN1;FANK1;NCF1;SOX11;SETD3;BICRAL;RFXANK;RNF6;MT3;PLCB1;GLI1;RAI1;E2F2;ATF7IP;PHOX2A;CXXC1;WNT5A;HOXD3;HNRNPAB;CDK8;RFX3;ZBTB16;RORC;MLXIPL;MLX;CREB3L2;DRAP1;PPP3CB;DYRK1B;NAA16;FZD7;KAT8;GATA6;ZC3H8;MEN1;BICRA;FOXM1;SPIN1;IL18;ASXL3;PPP3CA;ATMIN;ARHGEF11;ATRX;ZNF462;TFAM;RARG;BRCA1;HEATR1;RARB;SOX12;ZMIZ1;NCOA2;LDB2;KLF5;BRD8;HIF1A;ZFP64;IL4I1;BCL9L;HDAC2;ERBB4;ZBTB38;MED13;NFATC3;PIK3R1;MYSM1;GDNF;ATF2;ESR1;NFE2L2;ARF4;SMARCC2;SP1;TAF9;ASF1A;SFPQ;POGZ;PID1;BMP7;MYDGF;BCL9;FGF7;EPC1;TMF1;PHF8;DVL1;TBK1;WWTR1;XRCC6;NRIP1;PRPF6;ZFPM2;ATF5;PER1;GATA3;AHR;SALL2;PRDM11;SMARCC1;NCK1;PAX3;HIVEP3;DHX33;PCBD2;BMPR1A;COL1A1;PKD1;CITED2;TAF7;MED12;MET;HOXB7;ELL;ZEB2;UBB;POU3F1;IL33;MED25;JUP;ATM;RUNX1;ABL1;MEIS3;PIM2;BLM;MED21;TP53;SP3;TET3;KCNH2;HTATIP2;TGFB3;SREBF2;RNF111;HNRNPU;ING1;ASXL2;QRICH1;USP21;NFIA;WWOX;FOXJ1;PAX2;GABPB2;GABPB1;CD74;RNF10;RIPK1;CHUK;NFIX;NCOA3;SLC9A1;HEYL;NR5A1;PCID2;CSRNP3;RPTOR;IRF3;MED30;ZNF496;KLF7;NAA15;AATF;RNF4;MAPRE3;PSMD9;PARK7;KMT2E;EGR1;SENP1;RUVBL2;CNBP;BCL10;FOXJ3;PPARG;JUN;STAT3;PRDM2;ONECUT2;MCRS1;UBTF;TFE3;SMARCA4;FUBP3;KMT2D;CD38;PBX1;ZBED4;NR1D2;MEIS1;ZSCAN21;DPF2;SEC14L2;NFKB1;MITF;ZXDC;THRA;DCAF6;TNIP2;RPS6KA3;NSD1;DVL3;PKD2;PRKD2
prerank,negative regulation of tumor necrosis factor production (GO:0032720),0.36526811623442296,0.9957867942181243,0.47630619684082626,1.0,1.0,5/41,9.85%,PTPN22;CD34;IRAK3;SYT11;SELENOS
prerank,regulation of telomerase RNA localization to Cajal body (GO:1904872),-0.34069500481885473,-0.9956761214615304,0.45051194539249145,0.8298082219846967,1.0,8/18,15.66%,DCP2;NAF1;DKC1;RUVBL1;CCT8;CCT6A;CCT4;EXOSC10
prerank,positive regulation of cellular protein localization (GO:1903829),0.34319465748366546,0.9955436211370249,0.5039106145251396,1.0,1.0,24/69,26.60%,BICD1;PRKN;SLC5A3;EIF2AK3;TGFB1;FYN;SYT11;NGFR;WWTR1;RTN4;RIC3;PARK7;TESK1;CCDC88A;PRKAA1;LIMK2;GNL3L;KAT7;GPR137B;GNL3;CARD10;ENTR1;APC;CDK5RAP3
prerank,positive regulation of cholesterol efflux (GO:0010875),0.4096878542735308,0.9954762119258301,0.49118046132971505,1.0,1.0,3/21,8.27%,PTCH1;LRP1;ZDHHC8
prerank,regulation of neuroblast proliferation (GO:1902692),0.4392053435223278,0.9952229853838507,0.47953216374269003,1.0,1.0,5/15,12.69%,VEGFA;NF1;DISC1;TAFA1;DRD2
prerank,maturation of SSU-rRNA (GO:0030490),-0.2842916916311622,-0.9951674952524867,0.45871559633027525,0.8296732213242769,1.0,16/34,26.90%,RPS14;RPS16;RPS19;NGDN;WDR3;RIOK3;HELB;RPS8;RIOK1;DHX37;MRPS11;DDX52;SNU13;TSR3;RIOK2;PWP2
prerank,nitrogen compound transport (GO:0071705),0.32009537201193294,0.9951136014473927,0.5010482180293501,1.0,1.0,28/141,18.48%,SLC6A2;SLC22A3;SLC1A5;RAB38;SLC38A4;SLC16A10;CD320;LRRC8D;SLC44A2;SLC36A2;SLC12A2;SCAMP2;SLC43A1;SEC14L1;RCN3;SLC7A7;NDC1;ARL6IP5;SLC7A8;HSP90B1;LRP2;SLC6A15;ABCC1;DENND10;RAB7A;SLC44A1;SLC6A4;KIF3A
prerank,water-soluble vitamin metabolic process (GO:0006767),0.343871166471214,0.9946226865805705,0.49142857142857144,1.0,1.0,14/68,15.44%,ACP5;MMAB;PDXK;CD320;ALDH1L1;MCCC1;HLCS;PNPO;MTRR;MCCC2;MTHFD2L;RFK;MTR;ALDH1L2
prerank,positive regulation of protein deacetylation (GO:0090312),-0.3762225206095142,-0.994573337869674,0.4579710144927536,0.8297968722105165,1.0,7/14,30.76%,SAP30BP;ING2;ZBTB7B;FNTA;BRMS1;NIPBL;NNMT
prerank,negative regulation of macrophage activation (GO:0043031),-0.35348721662113514,-0.9943635217052065,0.45514950166112955,0.8288670050759595,1.0,2/16,1.53%,CD200;IL31RA
prerank,epidermis development (GO:0008544),0.34787028002094855,0.9941320113262042,0.4834905660377358,1.0,1.0,8/56,11.99%,CERS3;PTHLH;EMP1;GLI1;GATA6;PLOD1;HDAC2;FGF7
prerank,establishment of protein localization to membrane (GO:0090150),-0.24922387160774415,-0.9940675225385819,0.488,0.828215970922365,1.0,21/66,18.07%,AFDN;RAB11B;ZDHHC14;ZDHHC3;RFTN1;PRKCI;SYNE3;PARD3;NECTIN3;VPS37C;ZDHHC18;ZDHHC7;AQP11;OXA1L;ZDHHC20;MYO1C;BID;ZDHHC4;MICALL1;FRMPD1;TAOK2
prerank,negative regulation of activated T cell proliferation (GO:0046007),0.47778870395125594,0.9939850925620819,0.4863123993558776,1.0,1.0,3/10,17.21%,PRNP;SCRIB;RC3H1
prerank,regulation of gluconeogenesis (GO:0006111),-0.3046760754609624,-0.9937791487441661,0.47232472324723246,0.8275693258177282,1.0,8/27,17.18%,USP7;CLK2;SIK1;OGT;ARPP19;C1QTNF3;PDK2;PGP
prerank,regulation of blood vessel endothelial cell migration (GO:0043535),0.3564567066034543,0.9936096908711193,0.497116493656286,1.0,1.0,10/54,11.00%,PRKCA;FGF2;VEGFA;TGFB1;NF1;FGFR1;AKT3;HIF1A;MAPK14;SP1
prerank,regulation of lamellipodium assembly (GO:0010591),-0.29130690281764265,-0.9933935413343429,0.4292682926829268,0.8271268261798415,1.0,9/34,16.92%,CAPZB;OCLN;SLIT2;WASF2;AKIRIN1;ABI2;CDC42;AVIL;ABI3
prerank,response to interleukin-4 (GO:0070670),-0.4106798697167001,-0.9932176579149147,0.4722222222222222,0.8260836459658417,1.0,1/10,0.63%,LEF1
prerank,positive regulation of activated T cell proliferation (GO:0042104),0.41720532148572864,0.9923976512820332,0.48179271708683474,1.0,1.0,3/18,7.90%,PYCARD;FADD;IL18
prerank,sulfate transport (GO:0008272),-0.36634545169739247,-0.9917316812210227,0.5043227665706052,0.8287861227169205,1.0,7/14,26.35%,SLC26A7;SLC26A2;SLC25A30;SLC13A4;SLC26A6;RACGAP1;SLC26A8
prerank,thymus development (GO:0048538),0.45053353657122786,0.9917051719918618,0.4888558692421991,1.0,1.0,2/13,2.66%,FGF10;FADD
prerank,regulation of transcription by RNA polymerase II (GO:0006357),0.30329586697275307,0.9916825981939085,0.556,1.0,1.0,315/1668,18.88%,EBF2;RORA;OSR2;DCN;ETV1;SOX6;NKX6-2;PTCH1;TENM2;BMP5;MLIP;KLF15;CXCL10;MEOX1;EBF4;ETV4;MEOX2;TSHZ3;LHX5;TLX3;MAML3;GLI2;MACC1;CREB3L1;RCOR2;FGF2;IFRD1;SOX8;AASS;PRDM16;CRLF3;MYC;DMRT2;TGIF2;PTEN;EBF1;CBFB;HOXB8;ZNF25;ZBTB20;KAT2B;SOX9;SSBP2;ERBB2;PRKN;RIPPLY2;NCOA1;CDKN2B;EGFR;SUV39H1;FADD;HIVEP1;ACVR1;OTP;ZBTB37;HOXA7;KMT2A;SATB1;VEGFA;CCNC;TFCP2;EGR3;MAPK7;MAML2;CRTC1;RPS6KA4;NFX1;FOXP2;KDM5B;GTF2H2;TGFB1;AUTS2;BAZ1A;RFX2;GATAD2A;PSEN1;EZH1;SOX11;NUPR2;MED31;SETD3;RFXANK;ZNF276;GLI1;RAI1;E2F2;ZEB1;PHOX2A;NOP2;WNT5A;HOXD3;RPRD1A;PGBD1;URI1;EED;PKN1;ZFP14;OTUD7B;CDK8;RFX3;ZBTB16;MAMLD1;CDK13;RORC;MTA2;MLXIPL;MLX;TRPS1;CREB3L2;TADA1;TWIST2;DRAP1;PPP3CB;E2F6;KAT8;LRRFIP1;GATA6;CBX4;TBX18;MEN1;FOXM1;ZSCAN20;CHD3;VPS72;IL18;MKX;CPEB3;ASXL3;PPP3CA;ZBTB41;ATMIN;ATRX;KCTD1;ZNF462;RARG;PPP1R13L;BRCA1;MBD2;RARB;SOX12;SOX5;PPID;ZMIZ1;NCOA2;ZNF569;BBX;LDB2;KLF5;BRD8;HIF1A;ZFP64;DBX2;PIAS2;IL4I1;ARID4B;BCL9L;ZBTB6;CHD2;HDAC2;ZSCAN26;ZBTB38;MED13;NFATC3;ELP2;PIK3R1;ZNF260;PSIP1;MYSM1;GDNF;ATF2;ZKSCAN8;PHF20;ESR1;NFE2L2;MAPK14;ARF4;MYT1;SIN3B;LIN9;SMARCC2;SP1;ZNF112;TAF9;SFPQ;POGZ;RBAK;PID1;SIRT6;DCAF1;CREBZF;MYDGF;BCL9;MIDEAS;ZFHX4;EPC1;TMF1;PHF8;DVL1;PER3;TBK1;SIX5;KLF13;ZGPAT;PATZ1;FOXP4;ZBTB1;NR6A1;WWTR1;XRCC6;NRIP1;PRPF6;SOD2;ZFPM2;ATF5;PER1;GATA3;AHR;ZNF83;SALL2;ZNF250;ZBTB39;SMARCC1;BAZ2B;ELP4;NACC2;SNCA;NCK1;PAX3;LCOR;ZFHX2;MDM4;NEDD4L;HIVEP3;SUMO1;CRY1;NCOR2;BMPR1A;PKD1;BAZ1B;CITED2;TAF7;CREM;MED12;SLTM;MET;IRX5;HOXB7;ZNF235;ZEB2;UBB;POU3F1;IL33;MED25;DACT1;JUP;ATM;RUNX1;ABL1;MEIS3;PURG;KLF9;MED21;TP53;ZFX;LCORL;SP3;TET3;ZXDB;MTA3;HTATIP2;TGFB3;SREBF2;RNF111;HNRNPU;ASXL2;NFIA;WWOX;FOXJ1;USP2;PAX2;GABPB2;GABPB1;RNF10;SMARCE1;RIPK1;CDC73;CHUK;NFIX;NCOA3;ZKSCAN1;SLC9A1;HEYL;NR5A1;CTBP1;CSRNP3;SUFU;FUS;KLF16;MDM2;IRF3;MED30;ZNF697;ELOC;ZNF496;EPC2;KLF7;AATF;RNF4;RFX7;FNIP1;PARK7;BATF;TAF1;SEMA4D;CGGBP1
prerank,regulation of cellular amino acid metabolic process (GO:0006521),-0.2583984368836502,-0.9915227220502022,0.4666666666666667,0.8278781860794745,1.0,16/53,19.43%,PSMD14;AZIN1;OAZ1;PSMB3;PSMD12;OAZ2;PSMD6;PSMA1;ODC1;PSMD7;PSMA5;PSMC5;PSMC4;PSMB6;PPM1K;PSMA4
prerank,negative regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903799),0.45244752117470605,0.9909342828916138,0.48043818466353677,1.0,1.0,4/12,19.76%,TGFB1;ESR1;NCOR2;STAT3
prerank,regulation of protein-containing complex disassembly (GO:0043244),0.4288834058068475,0.9905814685373311,0.48005908419497784,1.0,1.0,6/16,11.47%,IRAK3;ETF1;BNIP3;CLEC16A;HDAC6;UPF1
prerank,positive regulation of cell motility (GO:2000147),0.31235096548414915,0.9904667073681495,0.5213414634146342,1.0,1.0,21/205,6.75%,ROR2;CCL11;PRKCA;LGR6;PDGFRA;HAS2;NTRK3;SEMA3E;RHOD;EGFR;ACVR1;SEMA6C;MAP4K4;VEGFA;EPHB2;SEMA3A;TGFB1;CLDN1;PAK1;FAM83H;TWIST2
prerank,protein deacetylation (GO:0006476),0.3662854353414502,0.9898499188161292,0.49694749694749696,1.0,1.0,11/41,16.15%,RCOR2;MTA2;FLNA;MORF4L2;HDAC2;SIN3B;HDAC6;SIRT6;MIDEAS;MSL3;MTA3
prerank,positive regulation of cell cycle process (GO:0090068),-0.22890857714926338,-0.9897754728255651,0.5319148936170213,0.831250863453439,1.0,17/91,11.27%,IGF1;PKP4;LRP5;MAP3K20;PLSCR1;USP19;CIT;IGF2;INSR;GIPC1;TGFA;RGCC;RHOA;DYNC1LI1;PDGFRB;NUMA1;WIZ
prerank,regulation of mRNA processing (GO:0050684),0.37564439171747604,0.9895066902949594,0.4914586070959264,1.0,1.0,9/32,17.61%,QKI;SON;KHDRBS3;NCBP1;AHCYL1;YTHDC1;SLTM;PAPOLA;SF1
prerank,iron ion homeostasis (GO:0055072),-0.2516682380670577,-0.9891559423761573,0.44696969696969696,0.8315516603545838,1.0,21/58,20.46%,BMP6;ABCG2;FLVCR1;FBXL5;ATP6V0D1;SLC40A1;FTH1;FTL;BDH2;TFRC;SOD1;CYB561A3;FRRS1;ATP6AP1;ATP6V0A2;FXN;SLC22A17;ACO1;ABCB7;HFE;TMEM199
prerank,cytoplasmic translational initiation (GO:0002183),0.4339731853250469,0.989075130637296,0.48180494905385735,1.0,1.0,10/17,29.68%,EIF3M;EIF4G1;EIF4A2;DENR;DHX29;RBM4;MCTS1;EIF2S2;EIF3I;EIF2D
prerank,hematopoietic stem cell differentiation (GO:0060218),0.4689036123763328,0.9886506414008133,0.48628048780487804,1.0,1.0,4/10,18.77%,MEOX1;UFL1;TP53;BATF
prerank,Golgi to endosome transport (GO:0006895),0.42976194763370085,0.988459951887043,0.48337950138504154,1.0,1.0,7/16,17.58%,RAB14;WIPI1;GBF1;EPS15;SYS1;AP4M1;AP1AR
prerank,positive regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043280),0.32557914207006305,0.9884274080764099,0.5127659574468085,1.0,1.0,27/108,19.68%,DLC1;PYCARD;MYC;GSN;NGF;FADD;EIF2AK3;TNFRSF10B;ACVR1C;APAF1;CARD9;HIP1;NGFR;ARL6IP5;CASP12;MALT1;SNCA;CASP2;CRADD;IFT57;RPS27L;NDUFA13;RIPK1;AIFM1;SENP1;BCL10;PPARG
prerank,regulation of B cell apoptotic process (GO:0002902),-0.380979765523013,-0.9883838055822104,0.45348837209302323,0.8321308515339255,1.0,2/12,3.82%,FOXP1;LYN
prerank,cellular response to hypoxia (GO:0071456),0.3208081794776412,0.9882488470203217,0.5180084745762712,1.0,1.0,35/126,23.12%,RORA;MYC;SUV39H1;FMN2;SCN2A;VEGFA;MT3;KCND2;GATA6;BNIP3;TBL2;PSMB7;HIF1A;BMP7;CPEB1;MDM4;PSMD2;LMNA;UBB;PSMC1;TP53;PSMB2;MDM2;ELOC;PSMD9;ACAA2;PSME4;HP1BP3;NPEPPS;PSMA8;LIMD1;BNIP3L;ELOB;UBQLN1;CARD16
prerank,regulation of long-term synaptic potentiation (GO:1900271),0.3853939724180607,0.9880389067532537,0.5,1.0,1.0,2/28,3.35%,RELN;EPHB2
prerank,regulation of fibrinolysis (GO:0051917),0.4436306338909866,0.9878147406571893,0.4955357142857143,1.0,1.0,1/13,1.18%,FAP
prerank,actin crosslink formation (GO:0051764),0.45237145300728765,0.9875333523476678,0.5030487804878049,1.0,1.0,3/12,8.56%,GAS2L3;BAIAP2;FLNA
prerank,positive regulation of cellular protein metabolic process (GO:0032270),0.3263351516685518,0.9875185139870667,0.5118790496760259,1.0,1.0,18/101,10.27%,TBC1D10A;VGLL4;ERBB2;FADD;UPF3A;PLD1;TGFB1;NIBAN1;METTL3;EIF3C;CPEB3;EIF6;NSUN5;PASK;VPS11;AURKAIP1;HDAC2;EIF4G1
prerank,regulation of cell growth (GO:0001558),0.3147299263154549,0.987483278937073,0.5365111561866126,1.0,1.0,39/204,16.79%,DCBLD2;PTCH2;PRKCQ;CRLF3;BCL2;VGLL4;ERBB2;EGFR;FRZB;JADE1;NRG3;PAK4;TGFB1;PAK5;MT3;URI1;APBB2;LAMTOR2;ARHGEF11;DERL2;SGK3;SGK2;NCBP1;EIF4G1;EXOSC2;PTPRJ;AKAP6;CHPT1;BRAT1;PRDM11;RTN4;PAPPA2;KLHL22;TMEM97;TP53;NDUFA13;ING1;HYAL1;SGK1
prerank,Fc-epsilon receptor signaling pathway (GO:0038095),0.32381328140504656,0.9872130091616961,0.509719222462203,1.0,1.0,32/109,22.71%,PRKCQ;TEC;PAK1;PPP3CB;PPP3CA;GAB2;VAV3;PSMB7;MAPK9;NFATC3;PIK3R1;MAP2K4;MAPK1;MALT1;CALM1;PSMD2;PSMC1;LAT2;PSMB2;CHUK;PSMD9;TAB3;GRB2;PSME4;BCL10;JUN;PSMA8;SOS1;NFKB1;VAV2;CARD11;TAB2
prerank,positive regulation of sprouting angiogenesis (GO:1903672),0.43184036738206866,0.9870475680329649,0.49850299401197606,1.0,1.0,2/15,3.14%,FGF2;VEGFA
prerank,cellular response to amino acid stimulus (GO:0071230),0.37358538666150426,0.9863358505420623,0.5,1.0,1.0,14/33,26.29%,CPEB3;FYN;LAMTOR2;CASTOR2;CPEB1;KLHL22;SPAAR;RPTOR;IPO5;RRAGA;MTOR;SESN1;SLC38A9;CPEB4
prerank,"regulation of alternative mRNA splicing, via spliceosome (GO:0000381)",0.3487531298668602,0.9862985851770779,0.490104772991851,1.0,1.0,20/52,26.01%,RBFOX1;CELF5;TRA2B;KHDRBS3;CELF6;RBM7;NOVA1;SRSF6;YTHDC1;HNRNPU;RNPS1;RBFOX3;CELF4;HNRNPL;RBFOX2;RBM25;FMR1;NSRP1;RBM4;RBM15
prerank,response to ketone (GO:1901654),-0.31093090827919234,-0.9857978716414593,0.4592274678111588,0.8378271302789457,1.0,8/24,20.71%,SLIT2;THBS1;TGFB2;CAV1;ABHD2;ABCB4;CATSPER3;NR1H3
prerank,heart process (GO:0003015),0.4382683788066966,0.9857436313679224,0.515695067264574,1.0,1.0,3/14,8.06%,SGCD;SGCZ;FYN
prerank,negative regulation of cation channel activity (GO:2001258),0.38882994929201437,0.9854519903322287,0.49302915082382764,1.0,1.0,8/26,25.00%,EPHB2;DRD2;CALM1;CALM2;SLC6A9;PKD2;UBQLN1;FMR1
prerank,NIK/NF-kappaB signaling (GO:0038061),-0.24169700656941334,-0.9854326153316931,0.5333333333333333,0.8373686348904371,1.0,32/72,33.18%,PSMD14;BIRC3;REL;RELB;PSMB3;PSMD12;ZFP91;PSMD6;MAP3K7;PSMA1;TIRAP;PSMD7;PSMA5;PSMC5;PSMC4;PSMB6;NFKB2;PSMA4;AKT1;PSMB1;PSMB9;PSMC6;PSMD3;PSMD10;PSME3;DICER1;TLR3;BTRC;FBXW11;BIRC2;PSMA6;PSME2
prerank,Golgi to lysosome transport (GO:0090160),0.4571740960740601,0.9854212518386641,0.5015197568389058,1.0,1.0,5/11,17.06%,CCDC91;AP1G1;GAK;AP4M1;RBSN
prerank,establishment of protein localization to plasma membrane (GO:0061951),0.36864454407370384,0.985002539261921,0.4930817610062893,1.0,1.0,9/36,11.97%,ANK3;GORASP1;VAMP4;BLZF1;RILPL2;SPTBN1;RAB34;GORASP2;SYS1
prerank,response to interferon-gamma (GO:0034341),0.3386089297413461,0.9849347652944945,0.5079908675799086,1.0,1.0,6/67,5.52%,CCL11;KYNU;EPRS1;CCL4;AQP4;WNT5A
prerank,negative regulation of gene silencing by miRNA (GO:0060965),0.45272164578910734,0.9846449697726107,0.510670731707317,1.0,1.0,4/12,19.68%,TGFB1;ESR1;NCOR2;PPARG
prerank,regulation of actomyosin structure organization (GO:0110020),-0.3695613473562218,-0.9845790032023154,0.46006389776357826,0.838242096226885,1.0,5/13,13.33%,ROCK2;ROCK1;FHOD1;ACTG1;CDC42
prerank,negative regulation of toll-like receptor signaling pathway (GO:0034122),-0.28217827325247535,-0.9845712161354918,0.42424242424242425,0.8367677236599869,1.0,12/34,23.43%,MFHAS1;LYN;TLR4;GPS2;LGR4;GPR108;LRRC14;CD300A;GRAMD4;CACTIN;TNFAIP3;NLRP2B
prerank,nucleic acid-templated transcription (GO:0097659),-0.26866835198296474,-0.984055400249281,0.48717948717948717,0.836679580562277,1.0,17/42,23.59%,THRB;RRAGC;DRG1;CREBL2;MMS19;PWP1;MED20;TERT;BAZ2A;POLR2C;DTX1;POLR2E;POLR2J;XAB2;PTMA;POLR2D;E2F1
prerank,determination of left/right symmetry (GO:0007368),0.3698877717627203,0.9837116981736187,0.4910941475826972,1.0,1.0,10/36,21.48%,CCDC39;RFX3;SMO;DAND5;ENKUR;CITED2;FOXJ1;GALNT11;BBS7;PKD2
prerank,histone H2A acetylation (GO:0043968),0.4236255198214283,0.9835341482425993,0.47368421052631576,1.0,1.0,6/16,19.24%,BRD8;MORF4L2;EPC1;TRRAP;MSL3;RUVBL2
prerank,negative regulation of tumor necrosis factor superfamily cytokine production (GO:1903556),0.3584302290465455,0.9828963372219568,0.49939540507859737,1.0,1.0,5/43,9.85%,PTPN22;CD34;IRAK3;SYT11;SELENOS
prerank,cellular response to insulin stimulus (GO:0032869),-0.225678137664617,-0.9828385001148011,0.574468085106383,0.8384501982058326,1.0,24/124,9.79%,SORBS1;IGF1R;TBC1D4;PIK3R3;RAB31;PIK3C2A;GRB10;NAMPT;IGF2;PRKCI;INSR;LPIN2;ZFP36L1;ATP6V0C;ATP6V0D1;BCAR1;PARP1;GSK3B;SLC25A33;RHOQ;RPS6KB1;GSK3A;INSIG2;ZDHHC7
prerank,regulation of systemic arterial blood pressure (GO:0003073),-0.35828359415610644,-0.9828370936112053,0.4627831715210356,0.8369655558484104,1.0,4/16,9.62%,PLCB3;BMPR2;ACE;GSK3A
prerank,establishment of skin barrier (GO:0061436),0.4264750074007931,0.9823873464067849,0.4862914862914863,1.0,1.0,3/15,15.00%,CLDN1;HRNR;MET
prerank,regulation of water loss via skin (GO:0033561),0.4264750074007931,0.9823873464067849,0.4862914862914863,1.0,1.0,3/15,15.00%,CLDN1;HRNR;MET
prerank,production of siRNA involved in RNA interference (GO:0030422),-0.4054075535371991,-0.9823603775880316,0.484593837535014,0.8368027473870832,1.0,5/10,29.54%,TERT;TARBP2;MRPL44;AGO2;DICER1
prerank,negative regulation of extrinsic apoptotic signaling pathway (GO:2001237),0.3325617062454962,0.9823380555659925,0.4870641169853768,1.0,1.0,7/74,3.96%,LGALS3;BMP5;BCL2;FADD;ACVR1;MAPK7;TNFRSF10B
prerank,negative regulation of protein metabolic process (GO:0051248),0.35058543129877195,0.9821332607128638,0.47759433962264153,1.0,1.0,22/48,27.72%,EGFR;FMN2;IRAK3;PRNP;FLNA;CRYAB;MDM4;SNX12;AZIN2;SF3B3;CD84;NFKB1;AGAP2;PRKCG;INHBB;FLOT2;HMGCR;PFDN2;PIN1;CYP51A1;ITGAV;PFDN1
prerank,gland development (GO:0048732),0.35152243506676567,0.9820750129984513,0.5202780996523755,1.0,1.0,14/59,16.21%,GLI2;FGF10;SOX9;FADD;PRKCSH;NF1;HOXD3;DKK3;IGSF3;ZBTB1;COBL;CITED2;MET;TGFB3
prerank,zinc ion transport (GO:0006829),-0.31583628569998645,-0.9817597152540737,0.4555984555984556,0.8370353792958658,1.0,9/21,26.20%,SLC30A10;SLC39A8;SLC39A6;SLC30A1;SLC30A6;SLC39A3;TRPM2;SLC39A13;SLC39A1
prerank,engulfment of apoptotic cell (GO:0043652),0.43186410565188127,0.9814943265944173,0.4911242603550296,1.0,1.0,2/15,2.81%,XKR7;XKR8
prerank,negative regulation of viral entry into host cell (GO:0046597),0.44397097751792824,0.9813977569628113,0.497737556561086,1.0,1.0,3/12,10.42%,GSN;TRIM11;MID2
prerank,positive regulation of gene silencing by miRNA (GO:2000637),0.37864421341467,0.9809606802504747,0.5032509752925878,1.0,1.0,10/27,21.84%,EGFR;TGFB1;EIF4G1;EIF4ENIF1;TP53;RIPK1;STAT3;ZFP36;LIMD1;DDX6
prerank,negative regulation of organelle assembly (GO:1902116),-0.28127803454047207,-0.9808155397030179,0.48756218905472637,0.8381006318387835,1.0,14/35,22.59%,ODF2L;FEZ2;SCFD1;EVI5L;CCP110;NUPR1;RBM14;TBC1D7;TBC1D30;SMCR8;CDK10;PINK1;KAT2A;STYXL1
prerank,Golgi to plasma membrane protein transport (GO:0043001),0.3737696458668841,0.9808151046902602,0.4864516129032258,1.0,1.0,5/30,7.69%,ANK3;VAMP4;BLZF1;SPTBN1;RAB34
prerank,negative regulation of protein localization to cell surface (GO:2000009),0.4619234948996251,0.9803965891519898,0.49393939393939396,1.0,1.0,2/11,4.11%,TAX1BP3;GPM6B
prerank,glutamine family amino acid metabolic process (GO:0009064),0.37458421296539524,0.9803334489414335,0.49615384615384617,1.0,1.0,15/33,28.37%,AADAT;GOT2;OAT;ALDH5A1;GLS2;GLS;RIMKLB;GLUD1;DDAH1;DGLUCY;GCLM;NIT2;CAD;RIMKLA;PYCR2
prerank,ceramide biosynthetic process (GO:0046513),-0.27139448470805316,-0.9798933387884615,0.5,0.8391621334924656,1.0,7/40,7.92%,SGMS1;ST6GALNAC3;ST8SIA4;CERS5;SPTLC2;DEGS2;CERS4
prerank,regulation of interleukin-10 production (GO:0032653),0.3574854779575765,0.979487127959255,0.5171568627450981,1.0,1.0,2/44,1.88%,PYCARD;CD34
prerank,negative regulation of receptor signaling pathway via JAK-STAT (GO:0046426),0.43128499931729036,0.9793387123240344,0.5036818851251841,1.0,1.0,3/16,8.27%,PTPN2;SOCS1;NF2
prerank,cellular response to retinoic acid (GO:0071300),-0.2680844439587897,-0.9793192938514171,0.43258426966292135,0.8391685739146794,1.0,8/42,8.70%,WNT5B;EPHA3;LYN;ABL2;WNT6;SNW1;WNT9A;TBX1
prerank,regulation of embryonic development (GO:0045995),0.37056263985153026,0.9788036000260479,0.5089058524173028,1.0,1.0,4/34,4.92%,PHLDB1;WDPCP;RAB14;PLCB1
prerank,regulation of cell cycle G2/M phase transition (GO:1902749),0.331080776185255,0.9784768555092747,0.5044150110375276,1.0,1.0,23/82,23.31%,DYNLL1;HAUS3;CNTRL;PCM1;NDE1;SDCCAG8;CEP57;CLASP1;PRKACA;ATF5;CKAP5;CEP76;DYNC1I2;CSNK1E;TP53;CEP63;TUBA1A;CEP78;SSNA1;PCNT;CDK5RAP2;DYNC1H1;PPP2R1A
prerank,glycogen biosynthetic process (GO:0005978),0.4400971224372795,0.97835072031736,0.49846625766871167,1.0,1.0,7/12,30.97%,PGM1;GYS1;PGM2;GYG1;PER2;NR1D1;UGP2
prerank,glucan biosynthetic process (GO:0009250),0.4400971224372795,0.97835072031736,0.49846625766871167,1.0,1.0,7/12,30.97%,PGM1;GYS1;PGM2;GYG1;PER2;NR1D1;UGP2
prerank,purine ribonucleoside triphosphate metabolic process (GO:0009205),-0.36020007083344313,-0.9780921147588645,0.4952978056426332,0.841082792844299,1.0,5/13,18.91%,GTPBP1;RHOQ;ENTPD7;GNAI3;AK4
prerank,histone H3 acetylation (GO:0043966),0.36183467681570014,0.9778557897692833,0.5121654501216545,1.0,1.0,9/40,13.12%,KAT2B;JADE1;TADA1;TAF5L;JADE3;POLE3;TAF9;ING4;PER1
prerank,regulation of pri-miRNA transcription by RNA polymerase II (GO:1902893),0.3585336104892012,0.9777944569547454,0.5290556900726392,1.0,1.0,14/43,20.23%,FGF2;SOX9;TGFB1;KLF5;HIF1A;NFATC3;NGFR;GATA3;TP53;EGR1;PPARG;JUN;STAT3;SMARCA4
prerank,lipid translocation (GO:0034204),-0.3116369528244288,-0.977762584758109,0.4763779527559055,0.8405425501752826,1.0,12/21,21.90%,ATP10A;ABCA1;ATP9A;ABCA4;ATP11A;ATP8B2;ATP11B;ABCB4;ATP10B;ATP8A1;ABCA7;TMEM30A
prerank,positive regulation of leukocyte apoptotic process (GO:2000108),-0.3899920448940218,-0.9775976954667615,0.48255813953488375,0.8394929517691283,1.0,5/11,36.54%,LYN;ANXA1;PIK3CB;RAPGEF2;MEF2C
prerank,RNA-dependent DNA biosynthetic process (GO:0006278),-0.2978566077902845,-0.9774588054784493,0.4625,0.8384547788975135,1.0,12/29,18.97%,TERF2;PPIA;RFC1;DKC1;WRAP53;HSP90AA1;CDK2;TERT;PINX1;GAR1;HSP90AB1;TINF2
prerank,positive regulation of interleukin-8 production (GO:0032757),0.35046728990194,0.9773764188811629,0.5035377358490566,1.0,1.0,13/49,24.51%,PYCARD;FADD;TLR1;RAB1A;CD74;RIPK1;LBP;PARK7;BCL10;STAT3;PRKD2;MAVS;HSPA1A
prerank,transcription initiation from RNA polymerase II promoter (GO:0006367),0.3145023228683375,0.9773411837187527,0.5190525231719877,1.0,1.0,32/138,19.72%,RORA;MAML3;KAT2B;MAML2;GTF2H2;E2F2;POLR2B;RORC;GTF2B;RARG;RARB;POLR2K;ESR1;TAF9;TAF11;TAF2;NR6A1;WWTR1;NR2C2AP;POLR2G;NCOR2;TAF7;GTF2E2;GTF2E1;TAF4;TAF4B;NR5A1;NRBF2;TAF1;POLR2A;PPARG;TAF8
prerank,positive regulation of lipid localization (GO:1905954),0.4605251937245417,0.9773072511791542,0.5136876006441223,1.0,1.0,1/11,2.55%,LRP1
prerank,negative regulation of translation (GO:0017148),-0.23471190533173059,-0.9772691706187778,0.5238095238095238,0.8374918969051184,1.0,13/87,11.09%,DAPK1;ROCK2;SAMD4A;ROCK1;YBX1;YTHDF1;CAPRIN1;IGFBP5;METTL14;CNOT1;RACK1;EIF4A3;BTG2
prerank,negative regulation of heart contraction (GO:0045822),-0.38244744267033703,-0.9771380363047484,0.4596100278551532,0.8363602599506912,1.0,6/11,33.65%,ATP1A2;GRK2;SRI;PLN;SPX;PIK3CG
prerank,"negative regulation of transcription, DNA-templated (GO:0045892)",0.30071502095734093,0.9769359681007866,0.585,1.0,1.0,155/807,17.79%,OSR2;NKX6-2;PTCH1;TENM2;MLIP;MDFIC;TSHZ3;SCML4;GLI2;CREB3L1;RCOR2;SOX8;AASS;PRDM16;MYC;TGIF2;ATP8B1;CBFB;ZNF25;SOX9;NAB1;VGLL4;PRKN;RIPPLY2;SUV39H1;HIVEP1;OTP;HOXA7;SATB1;VEGFA;KDM8;NFX1;TLE1;FOXP2;TGFB1;GATAD2A;PSEN1;EZH1;SOX11;NUPR2;MT3;PLCB1;MBD1;ATF7IP;ZEB1;WNT5A;URI1;EED;CIPC;OTUD7B;RFX3;ZBTB16;RORC;MTA2;MLXIPL;MLX;TRPS1;TWIST2;DRAP1;LOXL3;E2F6;CBFA2T3;KAT8;LRRFIP1;GATA6;CBX4;ZC3H8;MEN1;FOXM1;CHD3;VPS72;CPEB3;KCTD1;RARG;FLNA;BRCA1;MBD2;RARB;PPID;CRYAB;DKK3;LDB2;LANCL2;SNX6;HDAC2;ZBTB38;MBTD1;ESR1;SIN3B;SMARCC2;SFPQ;HDAC6;RBAK;BMP7;SIRT6;PRICKLE1;ING4;DCAF1;CREBZF;CDK5R1;MIDEAS;L3MBTL4;EPC1;PER3;JARID2;ZGPAT;PATZ1;FOXP4;ZBTB1;NR6A1;XRCC6;NRIP1;EID2B;ZFPM2;ATF5;PER1;SCML2;GATA3;AHR;PRDM11;NACC2;SNCA;LCOR;MDM4;NEDD4L;SUMO1;CRY1;NCOR2;CITED2;TAF7;CREM;ZEB2;UBB;IL33;MED25;DACT1;RUNX1;TP53;SP3;MTA3;NDUFA13;SREBF2;HNRNPU;WWOX;FOXJ1;USP2;PAX2;SMARCE1;CDC73;NFIX;CCDC85B;HEYL;CTBP1;SFMBT2;SUFU
prerank,positive regulation of viral genome replication (GO:0045070),0.37918965024310924,0.9769110379462338,0.49238578680203043,1.0,1.0,7/29,17.81%,FKBP6;PABPC1;PPID;ADARB1;DDB1;PPIH;PKN2
prerank,recombinational repair (GO:0000725),0.33390588257842574,0.9768419374884177,0.5235955056179775,1.0,1.0,18/77,17.24%,POLN;MEIOB;AP5S1;ERCC5;REV3L;ERCC4;RPA3;BRCA1;FBH1;SFPQ;HELQ;XRCC3;EXD2;RPA2;RAD52;BLM;SPIDR;WRN
prerank,regulation of viral release from host cell (GO:1902186),-0.3180629898947826,-0.9767730137471441,0.5,0.8358136017609138,1.0,7/21,17.26%,CHMP3;TSG101;TRIM25;TRIM5;VPS4A;PML;TRIM21
prerank,modulation by symbiont of entry into host (GO:0052372),-0.348102330958459,-0.9765673479005269,0.45686900958466453,0.8349836348027901,1.0,6/16,20.01%,TRIM25;TRIM5;EXOC2;CAV1;TRIM21;TRIM68
prerank,negative regulation of intracellular signal transduction (GO:1902532),0.3120937918973284,0.976548622092733,0.5474974463738509,1.0,1.0,49/190,22.07%,RORA;PYCARD;PTEN;RNF157;BCL2;VGLL4;NPRL2;THEM4;TLE1;DEPTOR;NF1;PDE3B;URI1;OTUD7B;NLRX1;TSC1;SPRED1;PPM1B;HERPUD1;PTPRJ;ESR1;MAPK14;BMP7;MAGI2;PDE4D;RHOH;RTKN2;DRD2;PER1;NDUFA13;APLNR;RIPK1;MDM2;PIK3IP1;OTUD7A;ZMYND11;MAPKBP1;FNIP1;CPNE1;PDE11A;DUSP1;LIMD1;ARHGAP12;P2RX7;PDE10A;DEPDC5;ARRB2;PRKAA1;PPM1A
prerank,regulation of phosphorylation (GO:0042325),0.31481589915348324,0.9765433398537026,0.5248677248677248,1.0,1.0,19/120,11.41%,DYNLL1;GLMN;CDKN2B;EGFR;CADM4;PSEN1;RANBP2;SOCS1;NUP155;FZD7;EIF6;LDB2;HIF1A;DSCAM;GRM5;NUP205;NDC1;NUP160;BMP7
prerank,positive regulation of protein metabolic process (GO:0051247),0.3178964673173678,0.9764187248595761,0.5304812834224599,1.0,1.0,20/110,16.25%,GPC3;PRKN;HACE1;MAPK7;TGFB1;PSEN1;WNT5A;ASB5;CARD9;IL18;HUWE1;EIF4G1;PRMT1;APC2;RAB1A;DDB1;NEDD4L;AREL1;DACT1;NDUFA13
prerank,cellular glucose homeostasis (GO:0001678),0.35910115516104935,0.9761753127399702,0.529338327091136,1.0,1.0,14/41,22.83%,ZBTB20;TRA2B;LRRC8D;PDK3;HIF1A;PIK3R1;NGFR;PRKACA;PAX2;PCK2;HK2;ADCY8;PRKAA1;HK1
prerank,import into cell (GO:0098657),0.35992524145267063,0.9761174910575726,0.49489795918367346,1.0,1.0,8/41,11.77%,SLC1A3;SLC27A1;SLC5A3;LRRC8D;SLC29A1;NEURL1B;SLC12A4;SLC7A8
prerank,microtubule-based transport (GO:0099111),0.43493267426287885,0.9760377451594532,0.5144230769230769,1.0,1.0,4/12,18.47%,DYNC1I1;DYNC1I2;DNAAF2;HTT
prerank,mRNA destabilization (GO:0061157),-0.2773025026706657,-0.9756425927073834,0.5053191489361702,0.8361706717525232,1.0,7/38,7.65%,ROCK2;ROCK1;YTHDF1;MOV10;ZFP36L1;METTL14;CNOT1
prerank,regulation of cellular amine metabolic process (GO:0033238),-0.25761528321444205,-0.9748161459062776,0.5269461077844312,0.8370444248306311,1.0,15/50,19.43%,PSMD14;AZIN1;OAZ1;PSMB3;PSMD12;OAZ2;PSMD6;PSMA1;ODC1;PSMD7;PSMA5;PSMC5;PSMC4;PSMB6;PSMA4
prerank,cellular nitrogen compound biosynthetic process (GO:0044271),-0.2937394367715567,-0.9747152171985163,0.49783549783549785,0.8358389631823763,1.0,11/26,25.70%,NOS3;ACER2;SPTLC2;DDAH2;ASAH2;NOS1;SPR;SPHK1;AKT1;SPHK2;SPTLC1
prerank,endocytic recycling (GO:0032456),0.34623646711032896,0.9746054316871327,0.5181159420289855,1.0,1.0,24/50,29.08%,RAB14;VPS29;EPS15;VPS39;DENND1C;ACAP2;RAB11FIP3;EHD2;WASHC1;ANKRD27;SNX12;RAB7A;MICALL2;SNX4;EIPR1;DENND1A;ENTR1;VPS35;DENND1B;VPS53;VPS26C;RAB13;STX6;SNF8
prerank,protein polymerization (GO:0051258),0.34620125303215,0.9745763431597155,0.5108571428571429,1.0,1.0,10/55,15.98%,FGF13;SPIRE1;GSN;PRKN;GAS7;UBE2K;WASF1;CKAP5;COBL;DIAPH3
prerank,nucleic acid metabolic process (GO:0090304),0.3372253159843116,0.9740635464880781,0.5153234960272418,1.0,1.0,23/69,21.26%,DXO;ATXN2;POLR2B;METTL3;SETMAR;XRN2;DDX54;DDX24;POLR2K;NCBP1;DUSP11;HNRNPA3;EXD2;POLR2G;TOPBP1;POLG;HNRNPU;WRN;POLR2A;HNRNPC;HNRNPH2;HNRNPL;RBFOX2
prerank,positive regulation of heart contraction (GO:0045823),-0.32470543959730125,-0.9740436944253764,0.49328859060402686,0.8362567125763967,1.0,6/19,25.42%,ATP1A2;GSK3A;TGFB2;EDN1;ATP2A2;SCN3B
prerank,necroptotic process (GO:0070266),0.41866350795317864,0.9733856443825599,0.5070224719101124,1.0,1.0,5/16,23.27%,ITPK1;TICAM1;RIPK1;MLKL;CYLD
prerank,BMP signaling pathway (GO:0030509),0.33898359934180283,0.973331517502188,0.5173611111111112,1.0,1.0,6/62,4.73%,BMP5;RGMB;HIVEP1;ACVR1;TGFB1;GDF9
prerank,iron ion transport (GO:0006826),0.34761197735949356,0.97320368692057,0.5280373831775701,1.0,1.0,4/47,7.97%,SCARA5;STEAP3;ATP6V1B2;TTYH1
prerank,maintenance of gastrointestinal epithelium (GO:0030277),-0.3726831635827029,-0.9731590529306997,0.47214076246334313,0.8373111320394747,1.0,3/12,8.36%,RBP4;TLR4;STRAP
prerank,positive regulation of interleukin-12 production (GO:0032735),0.37236393502668674,0.972931125444667,0.4987309644670051,1.0,1.0,3/31,10.78%,IL16;PLCB1;MAPK14
prerank,inner mitochondrial membrane organization (GO:0007007),-0.2599418135524909,-0.9726012115513263,0.5,0.8373759021109393,1.0,17/47,23.29%,MTX2;TOMM70;MICOS10;DNAJC11;ATP5MC3;SPG7;IMMT;TMEM11;ATP5PD;ATP5F1D;ATP5MF;TIMM9;TIMM22;MTX1;TIMM10B;TIMM8B;ROMO1
prerank,inorganic cation transmembrane transport (GO:0098662),0.30714457673972867,0.9721762539430882,0.5730110775427996,1.0,1.0,23/268,7.96%,SCARA5;KCNK15;SLC6A2;SLC1A3;KCNA2;SCN7A;KCNH8;SLC12A3;SCN2A;KCNK1;ANO6;KCNA1;CACNA1A;KCNA6;SLC36A2;SLC12A2;SCN5A;KCND1;KCND2;SCN3A;KCND3;SLC30A4;SLC8A2
prerank,vasculature development (GO:0001944),-0.33944867211055174,-0.972066119216493,0.4745222929936306,0.837383331773613,1.0,7/16,12.34%,CDH5;ERRFI1;ACVRL1;BMPR2;PDGFRB;STRA6;NOTCH4
prerank,regulation of osteoclast differentiation (GO:0045670),0.37291751787696176,0.9718775241196649,0.5319949811794228,1.0,1.0,1/33,0.55%,UBASH3B
prerank,regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901028),-0.32956529350161395,-0.9716687525662725,0.5126353790613718,0.8370372061156209,1.0,8/18,24.03%,GSK3B;GSK3A;BID;HIP1R;BOK;SLC35F6;MUL1;BAK1
prerank,nucleobase-containing compound biosynthetic process (GO:0034654),-0.32996682694745616,-0.9716179943309814,0.4867549668874172,0.8357549190125513,1.0,11/19,34.56%,POLD3;AMPD3;TERT;DCK;APRT;CDA;POLD2;POLD1;PNP;ADA;POLL
prerank,response to unfolded protein (GO:0006986),0.3495311298668248,0.9715434266430361,0.5066026410564226,1.0,1.0,13/48,21.21%,HSPH1;PRKN;DNAJB4;PACRG;PTPN1;HERPUD1;HSPA4;TM7SF3;DNAJC4;DNAJA1;HSPA9;HSPD1;RHBDD1
prerank,Arp2/3 complex-mediated actin nucleation (GO:0034314),0.4247873624087505,0.9713894777956856,0.5167394468704513,1.0,1.0,2/15,4.87%,ARPC1B;IQGAP2
prerank,positive regulation of calcium ion transport into cytosol (GO:0010524),0.36895890617405047,0.9712166609422765,0.5170670037926675,1.0,1.0,6/32,23.36%,CXCL10;AKAP6;SNCA;APLNR;P2RX7;CEMIP
prerank,positive regulation of hydrolase activity (GO:0051345),-0.21495618803605296,-0.9708344529861588,0.5434782608695652,0.8364223673892726,1.0,27/137,12.39%,AFDN;PKP4;CD200;CTSH;SNX9;CCL25;AGRN;RIC1;MTCL1;ITGA6;CCL15;SNX18;NET1;ARAP1;EVI5L;ARHGAP27;GSK3B;TGM2;FLCN;RHOA;RACK1;MAPK12;PLXNB1;RSU1;LARS1;RALBP1;RASGRF1
prerank,establishment of protein localization to endoplasmic reticulum (GO:0072599),0.42547454476830676,0.970596302947579,0.5137481910274964,1.0,1.0,4/15,15.34%,ZFAND2B;SPCS3;RAB3GAP2;SEC61G
prerank,positive regulation of DNA recombination (GO:0045911),-0.28982439068815147,-0.9704057942816304,0.48616600790513836,0.8361344810022494,1.0,11/27,24.29%,RIF1;MMS19;PARP1;TFRC;WRAP53;ERCC2;PAXIP1;ERCC6;FANCB;TIMELESS;MAD2L2
prerank,regulation of actin polymerization or depolymerization (GO:0008064),-0.29324943112648594,-0.970366862669471,0.49377593360995853,0.8348036239973657,1.0,5/28,9.11%,ARHGAP28;FCHSD2;ESAM;ARHGAP35;PFN2
prerank,negative regulation of histone acetylation (GO:0035067),0.45655263882906305,0.9702104691998206,0.5195618153364632,1.0,1.0,4/11,17.62%,BRCA1;SNCA;TAF7;CTBP1
prerank,osteoclast differentiation (GO:0030316),-0.31080840511480967,-0.9698475256874325,0.5037878787878788,0.8347682231255394,1.0,5/22,12.36%,FOXP1;GLO1;TNFRSF11A;SBNO2;OSTM1
prerank,Fc-gamma receptor signaling pathway involved in phagocytosis (GO:0038096),0.3331044981061242,0.9698031467487165,0.5406006674082313,1.0,1.0,16/70,15.54%,ARPC1B;WIPF1;PAK1;BAIAP2;LIMK1;FYN;BRK1;VAV3;DOCK1;PIK3R1;MAPK1;PLPP4;NCK1;CYFIP1;ELMO1;ABL1
prerank,regulation of T cell differentiation in thymus (GO:0033081),0.4407913227810454,0.969787830818138,0.5022288261515602,1.0,1.0,2/13,7.55%,GLI2;ZC3H8
prerank,positive regulation of Rho protein signal transduction (GO:0035025),0.3694223106064829,0.9693236107688712,0.5070242656449553,1.0,1.0,5/30,13.66%,AKAP13;LPAR1;GPR65;COL3A1;ARHGEF3
prerank,cortical cytoskeleton organization (GO:0030865),0.3573332738706409,0.9691083193648434,0.5079950799507995,1.0,1.0,8/41,12.13%,RHOD;RND3;RHOBTB3;FMNL2;NLGN1;EPB41L3;RHOH;RHOC
prerank,cellular response to gamma radiation (GO:0071480),0.40345605183261113,0.968577393504691,0.49507735583684953,1.0,1.0,7/17,18.13%,CRYAB;TLK2;XRCC6;ATM;TP53;WRN;MDM2
prerank,regulation of mast cell activation (GO:0033003),-0.39793458140128035,-0.9683892572738739,0.49206349206349204,0.8371693577262245,1.0,2/10,3.82%,PLSCR1;LYN
prerank,nuclear migration (GO:0007097),0.4382853558118246,0.9683667741586179,0.5075301204819277,1.0,1.0,2/13,4.93%,DOCK7;PCM1
prerank,atrial cardiac muscle cell action potential (GO:0086014),-0.36149783754409,-0.968135116691584,0.5028248587570622,0.8364407720648462,1.0,3/13,1.46%,CACNA1C;GJA1;CACNB2
prerank,protein import into nucleus (GO:0006606),0.33605297760960284,0.9680268091688703,0.5343855693348365,1.0,1.0,20/66,21.11%,CBLB;RANBP2;NUP155;FAM53B;IPO9;PRICKLE1;KPNB1;IPO13;KPNA6;NXT1;EIF4ENIF1;KPNA1;POM121;TNPO3;IPO5;CSE1L;STAT3;KPNA3;PHB2;HEATR3
prerank,regulation of insulin receptor signaling pathway (GO:0046626),0.35216422238012396,0.9677428822225022,0.5109223300970874,1.0,1.0,9/43,11.37%,PRKCQ;PTPN2;SIK2;SLC27A4;SOCS1;GRB14;PTPN1;PTPN11;PID1
prerank,"regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370)",0.4755148357644815,0.9675033854899466,0.5303776683087028,1.0,1.0,2/10,5.68%,CBFB;SOCS1
prerank,chromatin assembly (GO:0031497),0.3578746507096809,0.9674423505469262,0.5184729064039408,1.0,1.0,8/38,15.90%,SOX9;EZH1;ATRX;PRDM9;POLE3;ASF1A;RBBP4;TP53
prerank,dephosphorylation (GO:0016311),0.31475275281077175,0.9672756737214531,0.5657620041753654,1.0,1.0,44/147,22.23%,PTPRH;PTEN;PTPN22;DUSP4;PSPH;PTPRT;ACP2;DUSP6;PTPN13;PPP3CB;PPP3CA;PPM1B;PPM1J;PPP2R3A;PPP2R2A;PTPN1;DUSP11;PTPRJ;PLPP4;PPP1CA;PLPPR4;PTPRA;PTPN18;HDHD2;PTPRZ1;PTPN21;PPP3CC;SSH1;PTPRF;PPM1E;DUSP16;NT5C;DAPP1;DUSP12;DUSP1;PTPRS;PLPPR2;CTDSP1;PPP4R1;PTPRN2;SSH2;PPM1A;PLPPR1;CTDSP2
prerank,negative regulation of calcium ion transmembrane transport (GO:1903170),0.4636781988315882,0.9672739448114395,0.5150554675118859,1.0,1.0,2/10,8.10%,SESTD1;BIN1
prerank,regulation of establishment of protein localization to telomere (GO:0070203),-0.3844172334799433,-0.9672172758700711,0.5014164305949008,0.8375803251014838,1.0,5/11,13.59%,DKC1;WRAP53;CCT8;CCT6A;CCT4
prerank,membrane fusion (GO:0061025),0.36910917988704117,0.9672141386164188,0.5110533159947984,1.0,1.0,10/33,17.09%,DNM1;SNAP23;HACE1;SNAP29;HUWE1;VAPA;RIMS1;OTOF;OPA1;DYSF
prerank,positive regulation of signal transduction (GO:0009967),0.30055454504879997,0.9668144631324024,0.563508064516129,1.0,1.0,45/238,15.56%,RELN;SULF1;PRKCA;LGR6;NTRK3;MAML3;PTEN;KAT2B;STK36;DEPDC1B;MAML2;TRIM44;EVC;NRXN1;MT3;GLI1;NLGN1;AGPAT2;UCHL5;LMO3;DISC1;LOXL3;KLK6;RAB34;SPIN1;FLNA;SMO;ZMIZ1;LANCL2;HIF1A;PIH1D1;PIK3R1;PTPN11;RIMS1;IL6ST;LY86;GATA3;SMOC2;TRAF7;CITED2;TM2D3;DACT1;CRADD;HOMER1;STX1B
prerank,semaphorin-plexin signaling pathway involved in neuron projection guidance (GO:1902285),-0.3653407229143352,-0.9667529664828465,0.4923547400611621,0.8374337897364932,1.0,5/13,13.22%,PLXNA2;NRP1;PLXNB1;PLXNA1;PLXNA4
prerank,actin filament polymerization (GO:0030041),0.37704745033027776,0.9666639443382914,0.5214564369310793,1.0,1.0,10/29,23.01%,SPIRE1;GSN;GAS7;WASF1;COBL;DIAPH3;WASHC3;MICALL2;CORO7;WASF3
prerank,macrophage activation (GO:0042116),-0.27845514842189845,-0.9666021028247725,0.45871559633027525,0.8364916577307261,1.0,9/34,19.44%,FOXP1;TLR4;APP;CD93;SBNO2;MAPT;NMI;IFI35;C1QA
prerank,branching involved in blood vessel morphogenesis (GO:0001569),0.43551111998697656,0.9663787713949933,0.5190615835777126,1.0,1.0,3/13,6.38%,SEMA3E;VEGFA;TGFBR2
prerank,gonad development (GO:0008406),0.35367839911131277,0.9662855472860656,0.5201958384332925,1.0,1.0,12/41,21.62%,SOX8;SOX9;WNT5A;MAMLD1;GATA6;GATA3;IRX5;LRP2;NR5A1;CSDE1;MEA1;FGF9
prerank,regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090092),0.3740384551013431,0.9657714984603913,0.53125,1.0,1.0,9/30,18.37%,TGFB1;SOX11;PCSK6;DKK3;SFRP4;BCL9;XIAP;NREP;EID2
prerank,regulation of apoptotic process (GO:0042981),0.2959023691824947,0.9657713823596349,0.614,1.0,1.0,154/676,18.99%,FFAR4;BCL2L14;RTKN;HRK;CXCL10;PIP5KL1;SOX8;PYCARD;MYC;OLFM4;RNF157;BCL2;DPEP1;SOX9;NGF;PRKN;EGFR;AKAP13;STEAP3;FADD;FRZB;FGD4;FMN2;MAP4K4;VEGFA;EGR3;ANO6;ARAF;THOC6;WNK3;TNFRSF10B;ERCC5;PSEN1;SLC27A4;FANK1;MT3;NF1;DUSP6;GRID2;ACVR1C;WNT5A;YWHAZ;RASA1;APAF1;NAA35;BMF;SON;ITSN1;CASP6;TRIM2;NAA16;CYP1B1;SHQ1;GATA6;CBX4;PHLDA1;BNIP3;NAE1;BIN1;NF2;ARHGEF11;CTSB;RARG;FLNA;VAV3;HIP1;PPID;CRYAB;PRDM9;ASNS;HDAC2;UBE2Z;SLK;SFRP4;PIK3R1;GDNF;NGFR;NCSTN;CBL;ARF4;TAF9;IL6ST;ARL6IP5;ING4;ANP32E;MYDGF;TAX1BP1;APH1A;SCRIB;PRLR;PRDX3;ATF5;HSP90B1;YME1L1;MALT1;TRIO;ARHGEF3;DDX42;SNCA;RPS6KA2;PSEN2;ITGB3BP;RTN4;CITED2;OPA1;ZFAND6;UBB;ITGB1;CASP2;AREL1;CRADD;UBE2O;RASSF2;ATM;FZD9;ABL1;PIM2;BNIP1;IFT57;TP53;CCND2;BCL2L11;GPLD1;LRP2;XIAP;HTATIP2;TGFB3;QRICH1;GLS2;SGK1;PAX2;ARHGEF4;CD74;RIPK1;WRN;RNPS1;KCNMA1;ADAMTSL4;PLEKHG2;PCID2;CSRNP3;AIFM1;DNAJA1;HSPA9;CAT;IRF3;HTT;NAA15;AATF;CHM;MAP3K11;PARK7;SEMA4D;AXL
prerank,negative regulation of MAP kinase activity (GO:0043407),0.3510360303388251,0.9653860129390291,0.5314769975786925,1.0,1.0,7/44,11.41%,PTPN22;IRAK3;NF1;UCHL1;PTPN1;PTPRJ;BMP7
prerank,negative regulation of multicellular organismal process (GO:0051241),0.3025206538773366,0.9652641818038742,0.5528205128205128,1.0,1.0,21/199,9.88%,FFAR4;PTCH1;SOSTDC1;BMP5;DOCK7;LRP4;PTEN;SOX9;EGFR;HOXA7;RPS6KA4;TGFB1;ACVR1C;SPRED2;ACOT11;SPRED1;TBX18;CHSY1;SYT11;LNPEP;SPRED3
prerank,cellular response to nitrogen compound (GO:1901699),0.4034311266622612,0.9651264770816244,0.5264623955431755,1.0,1.0,6/20,15.98%,DDX11;NSMCE3;AOC1;ATRX;BLM;SPIDR
prerank,microtubule anchoring at centrosome (GO:0034454),0.4611234579306475,0.9650379183075776,0.5323624595469255,1.0,1.0,6/10,24.43%,PCM1;CCDC120;KIF3A;NIN;HOOK3;BBS4
prerank,retinal metabolic process (GO:0042574),0.43784085001357825,0.9648786885104773,0.517503805175038,1.0,1.0,3/12,16.53%,CYP1B1;RDH10;ALDH1A3
prerank,respiratory electron transport chain (GO:0022904),-0.34790048105510984,-0.9648737345396884,0.4789156626506024,0.839638391733605,1.0,7/14,23.06%,SDHB;SLC25A12;ETFRF1;ETFB;SDHA;UQCRFS1;SLC25A18
prerank,regulation of aerobic respiration (GO:1903715),-0.3430650147166425,-0.964696315407981,0.49226006191950467,0.8386994481352983,1.0,7/15,28.53%,ATP7A;SLC25A33;NOP53;PINK1;AK4;COX7A2;VCP
prerank,regulation of intracellular pH (GO:0051453),-0.2760381739903512,-0.9645881443474005,0.49099099099099097,0.8376037382257916,1.0,8/34,11.86%,SLC4A10;SLC9A6;SLC9A2;SLC9A8;SLC4A3;SLC4A8;SLC9A9;SLC9A7
prerank,protein tetramerization (GO:0051262),0.33122750307135185,0.9645869949808686,0.5303370786516854,1.0,1.0,20/67,23.18%,CTH;ACACA;FARSA;CPSF6;GRIN2B;AQP4;FARSB;SOD2;SNCA;PKD1;HOMER1;ALDH1A3;GLS;MS4A1;RYR3;HCN1;SSBP1;PKD2;KCNC1;TRPM4
prerank,plasma membrane invagination (GO:0099024),0.37635231364416133,0.9644524875798787,0.49753086419753084,1.0,1.0,3/29,2.24%,SPIRE1;GULP1;GSN
prerank,regulation of fatty acid beta-oxidation (GO:0031998),0.4284325211198606,0.9643845935592508,0.5022556390977444,1.0,1.0,4/14,16.67%,IRS2;TYSND1;MTLN;ABCD2
prerank,positive regulation of cholesterol transport (GO:0032376),0.3759159379630433,0.9642155087172847,0.5159642401021711,1.0,1.0,4/27,10.88%,PTCH1;LRP1;ZDHHC8;ABCA5
prerank,methylguanosine-cap decapping (GO:0110156),-0.3939644200881658,-0.9641135031354571,0.48787061994609165,0.8374379679173684,1.0,5/10,18.98%,LSM1;DCP2;PATL1;PNRC2;EDC3
prerank,positive regulation of cell death (GO:0010942),0.33261047693099133,0.9640802137073257,0.5317460317460317,1.0,1.0,13/59,17.21%,LRP1;PRNP;MT3;GRIN2B;WNT5A;BNIP3;FYN;RARG;EIF4G1;SNCA;HTATIP2;EFNB2;RIPK1
prerank,Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation (GO:1904953),-0.39579791295784705,-0.9638931345037131,0.5027027027027027,0.8366834386081995,1.0,3/10,13.49%,CTNNB1;RYK;FZD1
prerank,regulation of supramolecular fiber organization (GO:1902903),0.3960128152149708,0.9636543374483404,0.5133333333333333,1.0,1.0,8/22,18.76%,AKAP13;MAP1B;GBA2;ARL2;ABL1;MAPRE3;CAMSAP1;PARK7
prerank,positive regulation of protein export from nucleus (GO:0046827),-0.34160208229128886,-0.9630697274123423,0.533724340175953,0.8374522003872353,1.0,3/15,8.21%,XPO4;GSK3B;CAMK1
prerank,mRNA polyadenylation (GO:0006378),0.38161551994851256,0.9625618206233518,0.5327978580990629,1.0,1.0,10/26,23.43%,CSTF3;PABPC1;FIP1L1;AHCYL1;PAPOLA;PNPT1;CDC73;TENT2;SYMPK;TUT1
prerank,RNA polyadenylation (GO:0043631),0.38161551994851256,0.9625618206233518,0.5327978580990629,1.0,1.0,10/26,23.43%,CSTF3;PABPC1;FIP1L1;AHCYL1;PAPOLA;PNPT1;CDC73;TENT2;SYMPK;TUT1
prerank,positive regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903800),0.4493613735163111,0.962304490829237,0.5391849529780565,1.0,1.0,4/11,17.21%,EGFR;TGFB1;TP53;RIPK1
prerank,peptidyl-threonine dephosphorylation (GO:0035970),0.3933302813458957,0.9620301552094428,0.532520325203252,1.0,1.0,8/22,22.07%,DUSP4;DUSP6;PPM1B;PPP1CA;PPM1E;DUSP16;DUSP1;PPM1A
prerank,midbrain dopaminergic neuron differentiation (GO:1904948),-0.3828992811823906,-0.9618860906430301,0.5258855585831063,0.8391437673073197,1.0,3/11,13.49%,CTNNB1;RYK;FZD1
prerank,adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway (GO:0007193),0.3363044056525066,0.9617984140546911,0.523094688221709,1.0,1.0,7/57,13.84%,CHRM3;LPAR1;FLNA;GPR37;DRD2;GNAI1;P2RY12
prerank,mitochondrial cytochrome c oxidase assembly (GO:0033617),0.4120884012596977,0.9612615504928245,0.5158045977011494,1.0,1.0,4/18,12.26%,COX20;COX18;SCO1;COX19
prerank,regulation of cytoskeleton organization (GO:0051493),0.317418379884393,0.9612545875331736,0.5599571734475375,1.0,1.0,23/108,15.54%,DLC1;PHLDB1;RHOD;BICD1;BST1;LRP1;RND3;EFNA5;RHOBTB3;GPM6B;IQGAP2;PAK1;BAIAP2;CAPN6;CLASP1;BICD2;MAPK1;RHOH;RHOC;ARHGAP44;IQGAP1;MAP6D1;ABL1
prerank,cellular response to osmotic stress (GO:0071470),0.38763386210548456,0.9608264988610457,0.5226277372262774,1.0,1.0,4/21,9.18%,SCN2A;WNK3;LRRC8D;STK39
prerank,keratinocyte differentiation (GO:0030216),0.3672741474852948,0.9607413992661825,0.5121638924455826,1.0,1.0,3/29,5.52%,CERS3;TGM1;WNT5A
prerank,neurotrophin TRK receptor signaling pathway (GO:0048011),0.416854653125005,0.9607072429432268,0.5209840810419681,1.0,1.0,5/15,20.76%,NGF;NTRK2;NGFR;GRB2;SOS1
prerank,protein maturation (GO:0051604),0.3181086958821225,0.9606249024878689,0.5446716899892358,1.0,1.0,20/95,17.33%,PTCH1;ADAM19;PSEN1;TSPAN32;PCSK4;PCSK6;NAA35;NAA16;LMF1;MMP16;NCSTN;TSPAN17;APH1A;CPD;TYSND1;GLRX3;PSEN2;CASP2;CIAO2B;NAA10
prerank,regulation of cell size (GO:0008361),0.39698736684273117,0.960586207085784,0.5275813295615276,1.0,1.0,9/23,23.95%,PTEN;DEPTOR;RARG;VAV3;PRR16;RPTOR;RDX;VAV2;MTOR
prerank,production of small RNA involved in gene silencing by RNA (GO:0070918),-0.3126408656446827,-0.9602155764197489,0.5034246575342466,0.8421942550312802,1.0,9/20,30.18%,AGO1;ZC3H7B;AGO3;TERT;TARBP2;MRPL44;AGO2;DICER1;AGO4
prerank,regulation of cell development (GO:0060284),-0.2728521450063321,-0.9596627354110707,0.5408163265306123,0.8422910294136067,1.0,8/36,16.03%,NOTCH2;CTNNB1;CLOCK;RPS19;RHEB;PRUNE1;HEY2;ADGRA2
prerank,regulation of activated T cell proliferation (GO:0046006),0.3698815693884516,0.9594662522013374,0.5019206145966709,1.0,1.0,5/30,12.72%,PYCARD;FADD;PRNP;IL18;SCRIB
prerank,negative regulation of cell adhesion (GO:0007162),0.3247348857597575,0.9594642306220539,0.5497737556561086,1.0,1.0,11/72,9.77%,TGFBI;ERBB3;PLXNC1;EPHB2;TGFB1;PDE3B;RASA1;CYP1B1;FZD7;NF2;DSCAM
prerank,JNK cascade (GO:0007254),-0.2690555858248412,-0.9592545409356199,0.5454545454545454,0.8420180729177111,1.0,15/40,25.17%,MAP3K5;TNFRSF19;GPS2;ARHGEF6;MAP3K7;UBE2N;IKBKG;MINK1;MAPK10;NOD1;CRKL;MAP3K13;GPS1;MAPK8;UBA52
prerank,amide transport (GO:0042886),-0.29334508477003807,-0.9592517577093359,0.5246636771300448,0.8406341086486374,1.0,7/26,12.64%,ABCG2;PLTP;PDPN;GLTP;AQP11;SLC38A5;SLC5A6
prerank,negative regulation of cytokine production (GO:0001818),0.30723294881631485,0.9591269062960857,0.5700934579439252,1.0,1.0,29/163,20.82%,APOD;FFAR4;PYCARD;PTPN22;CD34;IRAK3;RPS6KA4;PRNP;OTUD7B;NLRX1;SYT11;SELENOS;CHID1;TAX1BP1;TBK1;ATP2B1;HOMER2;NAV3;SSC5D;ABCD2;FOXJ1;N4BP1;IRF3;MAPKBP1;AXL;PDCD4;ZFP36;SIRPA;CD84
prerank,negative regulation of cellular metabolic process (GO:0031324),0.35596022901158886,0.9586755503867661,0.5252525252525253,1.0,1.0,10/37,22.42%,PRKN;MT3;ATXN2;BRCA1;PAX2;TRAP1;AP1AR;AATF;NFKB1;DLG4
prerank,cellular response to oxidative stress (GO:0034599),0.3091958300263809,0.9586222616931299,0.570230607966457,1.0,1.0,30/118,18.85%,PRDX6;PDGFRA;SRXN1;EGFR;NCF1;MT3;GPX3;MAPK9;HIF1A;MGAT3;NCF2;SELENOS;NFE2L2;FANCC;MAPK1;ERCC6L2;PRDX3;SOD2;SNCA;ABL1;VKORC1L1;RAD52;TP53;PNPT1;SLC25A24;CHUK;TXNRD1;CAT;PARK7;ERMP1
prerank,regulation of coagulation (GO:0050818),0.4470949708367648,0.9585630287687772,0.5184615384615384,1.0,1.0,1/11,3.35%,EPHB2
prerank,positive regulation of stress-activated protein kinase signaling cascade (GO:0070304),0.404974648191,0.9584681388960958,0.5049786628733998,1.0,1.0,9/17,26.20%,CARD9;ARL6IP5;TAOK3;KLHDC10;MID1;RNF13;TAOK1;EIF2AK2;SEMA4C
prerank,negative regulation of JUN kinase activity (GO:0043508),0.45676756093782134,0.9583890269790637,0.528,1.0,1.0,4/10,23.71%,PTPN22;DNAJA1;PDCD4;AIDA
prerank,positive regulation of endothelial cell proliferation (GO:0001938),0.32864851520150656,0.9582869125787942,0.554932735426009,1.0,1.0,13/75,12.07%,CCL11;PRKCA;FGF2;VEGFA;EGR3;WNT5A;FGFR1;AKT3;HIF1A;SP1;SIRT6;MYDGF;NRP2
prerank,positive regulation of leukocyte mediated cytotoxicity (GO:0001912),0.3671417870205934,0.9581548743762712,0.5182291666666666,1.0,1.0,4/29,12.73%,FADD;AP1G1;CADM1;NECTIN2
prerank,regulation of interleukin-4 production (GO:0032673),-0.3034387827363567,-0.9576835345879924,0.5,0.8434330628146086,1.0,8/21,20.70%,LEF1;SLC7A5;PRKCZ;CD86;RARA;ZFPM1;HAVCR2;FCER1G
prerank,Fc-gamma receptor signaling pathway (GO:0038094),0.32783181931694616,0.9575067338138733,0.5575221238938053,1.0,1.0,16/71,15.54%,ARPC1B;WIPF1;PAK1;BAIAP2;LIMK1;FYN;BRK1;VAV3;DOCK1;PIK3R1;MAPK1;PLPP4;NCK1;CYFIP1;ELMO1;ABL1
prerank,"DNA-templated transcription, initiation (GO:0006352)",0.30659331102678805,0.9572542125121711,0.5856410256410256,1.0,1.0,40/166,19.98%,RORA;MAML3;KAT2B;MAML2;GTF2H2;E2F2;TAF1A;POLR2B;RORC;GTF2B;TFAM;RARG;RARB;POLR2K;ESR1;TAF9;TAF11;TAF2;NR6A1;WWTR1;NR2C2AP;POLRMT;POLR1B;POLR2G;NCOR2;TAF7;GTF3C1;GTF2E2;GTF2E1;TAF4;TAF4B;POLR1C;NR5A1;POLR1G;NRBF2;TAF1;POLR2A;PPARG;TAF8;UBTF
prerank,DNA modification (GO:0006304),0.3928562013778024,0.9571307328372055,0.5370121130551817,1.0,1.0,9/22,23.60%,MBD4;MPG;MUTYH;NEIL1;SMUG1;TERF2IP;TDG;EXOSC3;ACD
prerank,supramolecular fiber organization (GO:0097435),0.2991988689508553,0.956764132652706,0.6265060240963856,1.0,1.0,49/333,12.31%,COL15A1;TGFBI;HSPG2;LUM;FGF13;COL5A3;RHOD;COL20A1;GSN;COL28A1;PRKN;PPP1R9A;RND3;P4HA1;COL5A2;RHOBTB3;PXDN;COL4A2;COL27A1;COL26A1;PCM1;NF1;COLGALT2;TNXB;COL9A2;PLEC;LOXL3;CYP1B1;COL18A1;TLL2;HIP1;COL3A1;PLOD1;KATNAL1;BFSP1;TUBGCP5;SLK;NCSTN;COL1A2;MYO19;STMN4;COL14A1;DNAJB6;FIGN;SLAIN2;RHOH;RHOC;APH1A;KATNB1
prerank,insulin-like growth factor receptor signaling pathway (GO:0048009),-0.38041954297323055,-0.9567599223041617,0.5225225225225225,0.8445000830528024,1.0,2/11,0.40%,IGF1;IGF1R
prerank,regulation of hormone secretion (GO:0046883),0.42823868138734833,0.95674568474528,0.5485714285714286,1.0,1.0,3/15,11.59%,SOX11;SNX6;EDN3
prerank,negative regulation of cytokine production involved in immune response (GO:0002719),0.4153413472595486,0.956745586072607,0.5435393258426966,1.0,1.0,2/15,4.08%,IRAK3;TGFB1
prerank,positive regulation of establishment of protein localization to telomere (GO:1904851),-0.3923241717657171,-0.9565151202623362,0.49008498583569404,0.8437651919102406,1.0,5/10,13.59%,DKC1;WRAP53;CCT8;CCT6A;CCT4
prerank,ciliary basal body-plasma membrane docking (GO:0097711),0.3200784861538778,0.9564441149728976,0.5436681222707423,1.0,1.0,25/94,23.43%,DYNLL1;CC2D2A;HAUS3;CNTRL;PCM1;NDE1;SDCCAG8;CEP57;CLASP1;CEP89;PRKACA;CKAP5;FBF1;CEP76;DYNC1I2;CSNK1E;CEP63;TUBA1A;CEP78;SSNA1;PCNT;CDK5RAP2;DYNC1H1;PPP2R1A;CEP97
prerank,positive regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043123),0.30576533834156966,0.9564104288770217,0.5925155925155925,1.0,1.0,28/158,17.26%,ROR1;S100A4;PRKN;AKAP13;FADD;LPAR1;ALPK1;MAP3K3;GPRC5B;TNFRSF10B;SLC44A2;TMEM106A;CARD9;PELI1;FLNA;VAPA;MID2;RHOC;TBK1;MALT1;NDFIP1;GOLT1B;TICAM1;PIM2;TERF2IP;CD74;RIPK1;CHUK
prerank,monocarboxylic acid catabolic process (GO:0072329),0.40047800100631037,0.9561237263101742,0.5492371705963939,1.0,1.0,3/21,8.14%,CEL;ACBD5;ACOX1
prerank,regulation of viral genome replication (GO:0045069),-0.241998710857134,-0.9560795951387459,0.5136986301369864,0.8435430945312867,1.0,18/56,22.46%,ZC3HAV1;PLSCR1;IFITM3;PPIA;IFIH1;PARP10;TNIP1;VAPB;IFITM2;OAS2;PROX1;PPIE;TARBP2;ISG15;IFIT1;BST2;RSAD2;PDE12
prerank,regulation of cardiac muscle hypertrophy (GO:0010611),0.3887281272185903,0.9557308814213554,0.5295698924731183,1.0,1.0,5/22,14.07%,MLIP;PRKCA;PDE9A;IL6ST;GLRX3
prerank,regulation of centriole replication (GO:0046599),0.4072124050013942,0.955645555118312,0.5193905817174516,1.0,1.0,5/17,13.91%,KAT2B;BRCA1;CEP295NL;CEP76;MDM1
prerank,neutrophil mediated immunity (GO:0002446),0.29471677312227434,0.9555706055151078,0.64,1.0,1.0,59/432,13.18%,PRDX6;DYNLL1;LGALS3;CRISPLD2;PYGL;PYCARD;OLFM4;SNAP23;GSN;BST1;RAP2B;TMEM63A;PDXK;ANO6;RAB14;CAPN1;PLD1;PSEN1;SLC44A2;IQGAP2;PGM1;CSTB;LTA4H;AOC1;SNAP29;AGPAT2;APAF1;GM2A;CDK13;CARD9;GALNS;PTGES2;RAP1A;ARHGAP9;LAMTOR2;GDI2;CTSB;ACLY;HRNR;PSMB7;RAB3D;CKAP4;MAGT1;HUWE1;VAPA;PTPRJ;NCSTN;MAPK14;COMMD3;TOLLIP;MAPK1;GRN;FUCA2;RAB4B;ARL8A;RAB3A;XRCC6;KCNAB2;KPNB1
prerank,"mitochondrial electron transport, NADH to ubiquinone (GO:0006120)",0.3570021902056878,0.9555259985226443,0.5440993788819876,1.0,1.0,15/38,23.86%,NDUFS5;NDUFA4;NDUFB2;NDUFA8;NDUFS8;NDUFV3;NDUFS6;NDUFV2;NDUFA13;NDUFA6;NDUFA12;NDUFC1;NDUFA5;NDUFV1;NDUFAF1
prerank,central nervous system neuron development (GO:0021954),0.4192211416241292,0.9553430286528293,0.5269286754002911,1.0,1.0,3/15,4.78%,PTEN;NTRK2;GBA2
prerank,regulation of endothelial cell proliferation (GO:0001936),0.3209282134270592,0.9550285051711122,0.5683060109289617,1.0,1.0,13/88,12.07%,CCL11;SULF1;PRKCA;FGF2;VEGFA;EGR3;NF1;WNT5A;AKT3;HIF1A;SPARC;MYDGF;NRP2
prerank,lipid droplet formation (GO:0140042),-0.3892545453498259,-0.9549956260460691,0.49859154929577465,0.8450905869610165,1.0,4/10,12.08%,ZFYVE1;CDS1;BSCL2;AUP1
prerank,neutrophil degranulation (GO:0043312),0.2947438253844931,0.9548922432771887,0.652,1.0,1.0,58/425,13.18%,PRDX6;DYNLL1;LGALS3;CRISPLD2;PYGL;PYCARD;OLFM4;SNAP23;GSN;BST1;RAP2B;TMEM63A;PDXK;ANO6;RAB14;CAPN1;PLD1;PSEN1;SLC44A2;IQGAP2;PGM1;CSTB;LTA4H;AOC1;SNAP29;AGPAT2;APAF1;GM2A;CDK13;GALNS;PTGES2;RAP1A;ARHGAP9;LAMTOR2;GDI2;CTSB;ACLY;HRNR;PSMB7;RAB3D;CKAP4;MAGT1;HUWE1;VAPA;PTPRJ;NCSTN;MAPK14;COMMD3;TOLLIP;MAPK1;GRN;FUCA2;RAB4B;ARL8A;RAB3A;XRCC6;KCNAB2;KPNB1
prerank,RNA splicing (GO:0008380),0.3174302593446454,0.9545867103613915,0.5511302475780409,1.0,1.0,32/95,25.58%,DHX8;USB1;TRA2B;RSRC1;RP9;IVNS1ABP;RNPC3;SRSF11;TXNL4A;NCBP1;SFPQ;SNRNP40;PRPF6;PRPF18;NOVA1;KHSRP;RNPS1;FUS;DDX23;SYNCRIP;SRRM1;SF3B3;DBR1;HNRNPC;SNRPN;SF3B2;WBP4;PPP2R1A;MAGOHB;SCAF11;SNRPA1;NONO
prerank,transcription by RNA polymerase II (GO:0006366),0.3002085972158355,0.9545657972095459,0.6080402010050251,1.0,1.0,70/305,19.75%,RORA;CSTF3;MAML3;CBFB;KAT2B;INTS11;TFCP2;MAML2;NFX1;GTF2H2;SNAPC2;MBD1;RNGTT;E2F2;TAF1A;RPRD1A;POLR2B;CDK13;RORC;TAF5L;INTS6;DRAP1;ZC3H8;GTF2B;RARG;TRIP11;RARB;SOX5;POLR2K;NCBP1;SETD2;FIP1L1;ELP2;INTS4;ESR1;SP1;TAF9;TAF11;TAF2;KLF13;ZBTB1;NR6A1;WWTR1;NR2C2AP;INTS2;ELP4;POLR2G;INTS8;NCOR2;TAF7;RNMT;ELL;GTF2E2;PAPOLA;GTF2E1;TAF4;TAF4B;CDC73;NFIX;NR5A1;PCID2;ELOC;NRBF2;TAF1;POLR2A;MLLT1;PRRX1;PPARG;TAF8;ELL2
prerank,negative regulation of vascular associated smooth muscle cell proliferation (GO:1904706),0.4091036562202721,0.9544936954867863,0.5150214592274678,1.0,1.0,6/17,19.68%,PTEN;SOD2;TGFB3;TAFA5;PDCD4;PPARG
prerank,regulation of cell killing (GO:0031341),0.4098459945365983,0.9542374009656143,0.5180897250361794,1.0,1.0,3/16,7.26%,NOX1;WNT5A;FZD7
prerank,fatty acid oxidation (GO:0019395),-0.2416851660242145,-0.9541977315382366,0.5531914893617021,0.8458372444883152,1.0,20/57,27.49%,ACAD10;ECHDC1;PEX13;PPARD;PHYH;ACADM;ALDH3A2;BDH2;ECHDC2;ADIPOR2;ECI1;PECR;ECHS1;PEX2;ALOX12;CROT;SLC27A2;ECI2;CPT2;MCAT
prerank,DNA replication initiation (GO:0006270),0.35393746396574766,0.9541852308468751,0.5315315315315315,1.0,1.0,11/37,20.12%,LRWD1;POLE2;RPA3;POLE3;MCM4;RPA2;ORC1;TOPBP1;ORC4;DBF4;ORC2
prerank,negative regulation of DNA metabolic process (GO:0051053),0.3763682472986364,0.9539314920317133,0.5288713910761155,1.0,1.0,7/24,16.41%,ZRANB3;KMT2A;ERCC4;MSH6;RTEL1;BLM;TERF2IP
prerank,regulation of fatty acid biosynthetic process (GO:0042304),0.3743952197485939,0.9534981748169893,0.5254010695187166,1.0,1.0,6/26,9.43%,ERLIN2;MLXIPL;PRKAB2;EIF6;BRCA1;ELOVL5
prerank,I-kappaB kinase/NF-kappaB signaling (GO:0007249),-0.24663077507359044,-0.9532125285847745,0.5033557046979866,0.847114746745038,1.0,7/59,4.37%,ROCK2;ROCK1;BIRC3;NFKBIA;REL;RELB;TLR4
prerank,positive regulation of acute inflammatory response (GO:0002675),0.4276285799511948,0.9532060333797331,0.5386904761904762,1.0,1.0,3/14,18.76%,PTGER3;IL6ST;PARK7
prerank,negative regulation of interleukin-6 production (GO:0032715),0.3686716685935642,0.953177875607184,0.5264516129032258,1.0,1.0,4/27,9.85%,PTPN22;IRAK3;SYT11;SELENOS
prerank,negative regulation of cysteine-type endopeptidase activity (GO:2000117),0.34679767522755095,0.9528277851263328,0.5565217391304348,1.0,1.0,12/44,18.68%,DPEP1;NGF;VEGFA;MT3;NGFR;DNAJB6;SNCA;XIAP;PAX2;PCID2;CAST;FNIP1
prerank,chondroitin sulfate proteoglycan metabolic process (GO:0050654),-0.38294837925884756,-0.952257942483506,0.5115606936416185,0.848254079225912,1.0,2/10,4.91%,DSE;PXYLP1
prerank,histone monoubiquitination (GO:0010390),0.39285509098871874,0.9521944033183584,0.5490463215258855,1.0,1.0,12/24,27.84%,WAC;DDB2;DDB1;CUL4B;CDC73;BCOR;UBE2E1;RNF2;PCGF1;RNF20;RNF168;TRIM37
prerank,neutrophil activation involved in immune response (GO:0002283),0.2940615869082292,0.9519754111121871,0.656,1.0,1.0,58/428,13.18%,PRDX6;DYNLL1;LGALS3;CRISPLD2;PYGL;PYCARD;OLFM4;SNAP23;GSN;BST1;RAP2B;TMEM63A;PDXK;ANO6;RAB14;CAPN1;PLD1;PSEN1;SLC44A2;IQGAP2;PGM1;CSTB;LTA4H;AOC1;SNAP29;AGPAT2;APAF1;GM2A;CDK13;GALNS;PTGES2;RAP1A;ARHGAP9;LAMTOR2;GDI2;CTSB;ACLY;HRNR;PSMB7;RAB3D;CKAP4;MAGT1;HUWE1;VAPA;PTPRJ;NCSTN;MAPK14;COMMD3;TOLLIP;MAPK1;GRN;FUCA2;RAB4B;ARL8A;RAB3A;XRCC6;KCNAB2;KPNB1
prerank,negative regulation of cellular macromolecule biosynthetic process (GO:2000113),0.29298228141106936,0.9519426052567804,0.646,1.0,1.0,87/497,14.80%,NKX6-2;MDFIC;TSHZ3;SCML4;CREB3L1;RCOR2;SOX8;PRDM16;ATP8B1;SOX9;NAB1;VGLL4;SUV39H1;HOXA7;EPRS1;KDM8;EIF2AK3;TLE1;FOXP2;TGFB1;GATAD2A;MT3;PLCB1;MBD1;ATF7IP;ZEB1;WNT5A;EED;CIPC;RFX3;ZBTB16;TSC1;MLXIPL;MLX;TWIST2;LOXL3;CBFA2T3;KAT8;GATA6;CBX4;ZC3H8;MEN1;FOXM1;CPEB3;KCTD1;BRCA1;MBD2;CRYAB;PASK;DKK3;LANCL2;SELENOS;SNX6;HDAC2;ZBTB38;MBTD1;SMARCC2;SFPQ;HDAC6;RBAK;BMP7;PRICKLE1;ING4;CREBZF;CDK5R1;MIDEAS;L3MBTL4;EPC1;JARID2;ZGPAT;PATZ1;XRCC6;EID2B;ZFPM2;ATF5;PER1;SCML2;GATA3;AHR;PRDM11;NACC2;PUS7;SUMO1;CRY1;NCOR2;CITED2;TAF7
prerank,positive regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060213),0.429954894240386,0.9517601524074983,0.5382395382395382,1.0,1.0,6/13,24.51%,PABPC1;CPEB3;POLR2G;EIF4ENIF1;ZFP36;TNRC6A
prerank,negative regulation of apoptotic signaling pathway (GO:2001234),0.3256665947288035,0.9515321864114167,0.5584562996594779,1.0,1.0,18/77,18.94%,LGALS3;BCL2;PRKN;ACVR1;URI1;HERPUD1;PIH1D1;RTKN2;OPA1;FZD9;NDUFA13;MPV17L;RIPK1;HTT;ZMYND11;PARK7;ACAA2;CSNK2A2
prerank,mRNA transport (GO:0051028),0.31635829598524545,0.9514866941723721,0.5628356605800214,1.0,1.0,37/101,26.36%,THOC6;RANBP2;NUP155;MCM3AP;SRSF11;CASC3;ALKBH5;NCBP1;FIP1L1;KIF5C;NUP205;NDC1;NUP160;UPF1;DDX25;NXT1;SRSF6;YTHDC1;POM121;SMG6;AAAS;NXF1;RNPS1;THOC7;SRRM1;ZFP36;SRSF3;FYTTD1;NUP42;GLE1;SYMPK;THOC5;MAGOHB;FMR1;NUP35;HNRNPA2B1;RAE1
prerank,regulation of histone deacetylation (GO:0031063),-0.3566029599909003,-0.9508667376620556,0.5217391304347826,0.8504455677538473,1.0,6/13,26.50%,SAP30BP;ING2;ZBTB7B;SPHK2;NIPBL;PRMT6
prerank,translational termination (GO:0006415),0.31353077854603223,0.9508009854339847,0.5743534482758621,1.0,1.0,28/95,22.44%,MRPL47;MRPS18A;ETF1;MRPL14;MRPL32;MRPL16;MRPL58;MRPS35;MRPS28;AURKAIP1;MRPL35;GSPT2;MRPL30;MRPL28;TRMT112;MRPL46;MRPL51;MRPS30;N6AMT1;MRPS14;MRPS9;MRPS31;MRPL1;PTCD3;DAP3;MRPS6;MRPL52;MRPL18
prerank,lytic vacuole organization (GO:0080171),0.363963456208388,0.9501849484682099,0.5238709677419355,1.0,1.0,15/32,23.95%,GNPTAB;ACP2;GRN;TPCN2;AKTIP;CLVS1;HPS1;HOOK2;MBTPS1;CLVS2;HOOK1;HOOK3;TPP1;CLN6;MTOR
prerank,positive regulation of double-strand break repair via nonhomologous end joining (GO:2001034),-0.32831468113820667,-0.9501082037504402,0.5,0.8510794061496759,1.0,4/16,12.70%,RIF1;PARP3;WRAP53;KDM4D
prerank,stress-activated protein kinase signaling cascade (GO:0031098),-0.28609079056428366,-0.9500109879600028,0.5263157894736842,0.8499757474992129,1.0,8/27,18.07%,MAP3K5;MAP3K20;MAP3K8;MAP3K7;IKBKB;CCDC88C;IKBKG;TAOK2
prerank,positive regulation of cellular process (GO:0048522),0.2936225323033547,0.9499070573620252,0.6766766766766766,1.0,1.0,77/565,12.78%,OSR2;BMP5;PRKCA;PDGFRA;ERBB3;HAS2;NTRK3;EPB41L4B;FGF2;PYCARD;MYC;FGF10;KIF20B;PTEN;RHOD;BCL2;GAREM1;IRS2;SOX9;CRLF1;BST1;ERBB2;EGFR;LRP1;TGM1;VEGFA;ACACA;PTHLH;CAPN1;TGFB1;TIPIN;PTGFR;SOX11;NTRK2;GDF9;MT3;GLI1;NOX1;NOP2;WNT5A;PAK1;CDK13;TGFBR2;MLXIPL;UFL1;FZD7;FOXM1;FGFR1;TSHR;PPP3CA;GAB2;PPP1R13L;ACLY;FASN;BTC;DERL2;NCBP1;CUL3;HDAC2;ERBB4;EIF4G1;EXOSC2;GDNF;PTPRJ;AKAP6;IL6ST;PRMT1;CDC25B;S1PR3;EDN3;FGF7;GRN;RTKN2;WWTR1;GLP2R;PRLR;PRDX3
prerank,inositol phosphate biosynthetic process (GO:0032958),0.4412696661300092,0.9497216846857339,0.5264797507788161,1.0,1.0,1/11,1.27%,FGF2
prerank,positive regulation of cellular catabolic process (GO:0031331),0.30452008658062457,0.9496161554291378,0.6019007391763463,1.0,1.0,27/132,17.21%,DCN;IRS2;ZBTB20;VGLL4;NPRL2;PSEN1;DXO;MLXIPL;UFL1;BNIP3;VPS11;HIF1A;PTPN1;MID2;UPF1;ZC3H18;SNCA;MTLN;KHSRP;TICAM1;DACT1;PIM2;GPLD1;PNPT1;ZSWIM8;ABCD2;RC3H1
prerank,positive regulation of actin cytoskeleton reorganization (GO:2000251),-0.32857189042141616,-0.9496054521277303,0.5163636363636364,0.8496907003730616,1.0,3/17,1.14%,BAIAP2L1;NRP1;TEK
prerank,regulation of DNA recombination at telomere (GO:0072695),0.3967327686257502,0.9490660181482713,0.508955223880597,1.0,1.0,8/19,24.22%,POLR2B;ATRX;POLR2K;POLR2G;TERF2IP;POLR2A;ACD;POLR2F
prerank,negative regulation of DNA recombination at telomere (GO:0048239),0.3967327686257502,0.9490660181482713,0.508955223880597,1.0,1.0,8/19,24.22%,POLR2B;ATRX;POLR2K;POLR2G;TERF2IP;POLR2A;ACD;POLR2F
prerank,regulation of biomineral tissue development (GO:0070167),0.3762172363232062,0.9490544565412499,0.5373525557011796,1.0,1.0,3/26,4.08%,ANKH;SOX9;TGFB1
prerank,synaptic vesicle exocytosis (GO:0016079),0.34829403931667924,0.9487670120576609,0.539119804400978,1.0,1.0,11/40,18.29%,SNAP23;SYT1;SNAP29;RIMS1;RAB3A;OTOF;SNCA;DOC2B;STX1B;SYT2;RIMS2
prerank,Fc receptor signaling pathway (GO:0038093),0.31203657814709157,0.9487247738590752,0.5732899022801303,1.0,1.0,32/110,22.71%,PRKCQ;TEC;PAK1;PPP3CB;PPP3CA;GAB2;VAV3;PSMB7;MAPK9;NFATC3;PIK3R1;MAP2K4;MAPK1;MALT1;CALM1;PSMD2;PSMC1;LAT2;PSMB2;CHUK;PSMD9;TAB3;GRB2;PSME4;BCL10;JUN;PSMA8;SOS1;NFKB1;VAV2;CARD11;TAB2
prerank,negative regulation of myeloid cell differentiation (GO:0045638),0.39870590249165083,0.948558365262276,0.529331514324693,1.0,1.0,8/20,20.70%,HOXB8;ZBTB16;CDK6;PRMT1;CDC73;HSPA9;ZFP36;MEIS1
prerank,regulation of mRNA polyadenylation (GO:1900363),0.40416823313802264,0.9482427294748211,0.5259467040673211,1.0,1.0,9/17,26.75%,CPSF6;CPEB3;NCBP1;CPEB1;VIRMA;CDK9;CPSF7;RNF20;NELFE
prerank,positive regulation of stem cell proliferation (GO:2000648),-0.3285458414107801,-0.9482354102740207,0.5287356321839081,0.8519106140063822,1.0,5/17,15.06%,GJA1;KDM1A;PTPRC;HMGA2;TERT
prerank,ketone body metabolic process (GO:1902224),0.46049648080910943,0.9479116894410423,0.5645933014354066,1.0,1.0,3/10,17.51%,ACSS3;HMGCLL1;HMGCS2
prerank,positive regulation of viral transcription (GO:0050434),0.38120779050485143,0.9477567940734178,0.5567715458276333,1.0,1.0,4/25,13.86%,MDFIC;POLR2B;POLR2K;POLR2G
prerank,negative regulation of ossification (GO:0030279),0.38769028602298594,0.9476245132098505,0.5557029177718833,1.0,1.0,3/23,8.60%,LRP4;SOX9;CHSY1
prerank,positive regulation of JUN kinase activity (GO:0043507),-0.3002397808710231,-0.9476040641977407,0.5143884892086331,0.8522098077615,1.0,7/23,20.04%,SASH1;MAP3K5;TNFRSF11A;MAP3K7;ARHGEF5;EDN1;DVL2
prerank,protein modification by small protein conjugation or removal (GO:0070647),0.42179536327257083,0.9472885025042272,0.5338345864661654,1.0,1.0,8/13,29.81%,UBA2;NAE1;UBA3;UBA1;SAE1;ATG10;DESI1;DESI2
prerank,regulation of nervous system process (GO:0031644),-0.3285520748895856,-0.9472141200121289,0.532871972318339,0.8519064255363775,1.0,4/18,6.90%,ROCK2;SLC8A3;NOS3;APP
prerank,negative regulation of peptidyl-tyrosine phosphorylation (GO:0050732),0.3641636203799516,0.9471181407052106,0.5411311053984575,1.0,1.0,5/30,8.27%,PTPN2;CADM4;SOCS1;SAMSN1;NF2
prerank,response to metal ion (GO:0010038),0.3252067945775361,0.9470622985315482,0.5585168018539977,1.0,1.0,16/67,18.63%,BCL2;MT3;SLC30A4;PPP3CA;ANXA11;HIF1A;PPP1CA;AHCYL1;GPHN;SNCA;NEDD4L;CALM1;HOMER1;CALM2;KCNMA1;SNCB
prerank,positive regulation of erythrocyte differentiation (GO:0045648),-0.29226368842103034,-0.9470271264596295,0.5404255319148936,0.8510534274102628,1.0,9/25,20.37%,ETS1;ARNT;STAT5B;ACVR1B;NCKAP1L;INHBA;TAL1;ANKRD54;HMGB2
prerank,organic acid transport (GO:0015849),0.3143291755914107,0.9468106962333729,0.5777537796976242,1.0,1.0,17/94,13.24%,SLC27A1;ATP8B1;SLC1A5;NCOA1;SLC38A4;SLC16A10;LRRC8D;SLC27A4;SLC36A2;SLCO2B1;SLC43A1;GOT2;NCOA2;SLC7A7;SLC7A8;SLC25A10;SLC16A1
prerank,regulation of epithelial cell migration (GO:0010632),0.33727725092525235,0.9466937300620417,0.5467625899280576,1.0,1.0,11/51,14.55%,RHOJ;GLIPR2;FGF10;SOX9;DOCK5;DOCK1;HIF1A;CLASP1;HDAC6;BMPER;RTN4
prerank,protein K63-linked ubiquitination (GO:0070534),0.349441889671102,0.9466577310315314,0.5428571428571428,1.0,1.0,4/41,7.91%,UBE2T;PRKN;UBE2E2;PELI1
prerank,vesicle transport along microtubule (GO:0047496),-0.3035477418573796,-0.9466548855300685,0.5243055555555556,0.8507510905080649,1.0,6/23,8.62%,KIF3B;KIF1C;TRAK1;PAFAH1B1;KIF5B;BICDL1
prerank,long-chain fatty acid import into cell (GO:0044539),0.4522700029047788,0.9464653932350231,0.5377643504531722,1.0,1.0,2/10,4.35%,SLC27A1;SLC27A4
prerank,organelle disassembly (GO:1903008),-0.27672515621534305,-0.9464060478153303,0.543859649122807,0.8500309749971727,1.0,10/33,21.19%,MTIF2;TEX264;KIF5B;KLC1;UFM1;GFM2;MTIF3;UFC1;UBA5;ULK1
prerank,DNA repair (GO:0006281),0.29525095589937156,0.9463294072674088,0.6331658291457286,1.0,1.0,61/284,17.48%,UBE2T;RAD23B;POLN;ZRANB3;APTX;MBD4;POLE2;GTF2H2;CHRNA4;ERCC5;NSMCE3;ERCC4;MPG;KDM4B;DDB2;RPA3;NUDT1;MUTYH;MEN1;BRCA1;XPA;REXO4;TDP1;ALKBH5;SETD2;HUWE1;NEIL1;ENDOV;FBH1;FANCC;ASF1A;MSH6;NSD2;UPF1;ERCC6L2;ZBTB1;DDB1;HPF1;MDC1;XRCC3;EXD2;RPA2;TOPBP1;PDS5B;SUMO1;SMUG1;BAZ1B;UBB;ATM;TRRAP;ABL1;CSNK1E;RAD52;BLM;TP53;FANCI;USP1;FAM111A;CUL4B;WRN;NSMCE4A
prerank,cellular modified amino acid biosynthetic process (GO:0042398),0.3974769941674967,0.9462566976229916,0.5506849315068493,1.0,1.0,4/20,12.98%,SLC27A1;GSS;PTDSS1;GGCT
prerank,positive regulation of cellular carbohydrate metabolic process (GO:0010676),0.4537587449957742,0.9461871058273357,0.5394321766561514,1.0,1.0,3/10,16.10%,IRS2;SNCA;GPLD1
prerank,regulation of transforming growth factor beta receptor signaling pathway (GO:0017015),0.3125516623882724,0.9460982836930899,0.5793991416309013,1.0,1.0,22/95,17.14%,PRDM16;HTRA3;CDKN2B;TGFB1;SOX11;TGFBR2;SPRED2;SPRED1;MEN1;PEG10;DKK3;BCL9L;SPRED3;SNX6;DAND5;BCL9;LDLRAD4;CITED2;ZEB2;UBB;RNF111;NREP
prerank,membrane organization (GO:0061024),0.29780828415018684,0.9458102217961247,0.6131979695431472,1.0,1.0,33/227,11.39%,ANK3;SGIP1;DNM1;ANK2;REPS2;SNAP23;EGFR;SPAG4;STON2;HACE1;VAMP4;PACSIN2;NPC1;WNT5A;SPTBN1;SYT1;SNAP29;SGCZ;NUP155;ITSN1;EPS15;BIN1;GAK;CNTN2;HIP1;BTC;COX18;HUWE1;VAPA;CBL;TMEM33;RIMS1;EMD
prerank,mRNA-containing ribonucleoprotein complex export from nucleus (GO:0071427),0.31551277830514407,0.9451872822235856,0.5720476706392199,1.0,1.0,29/96,22.57%,THOC6;RANBP2;NUP155;MCM3AP;SRSF11;CASC3;ALKBH5;NCBP1;FIP1L1;NUP205;NDC1;NUP160;UPF1;DDX25;NXT1;SRSF6;YTHDC1;POM121;SMG6;AAAS;NXF1;RNPS1;THOC7;SRRM1;SRSF3;FYTTD1;NUP42;GLE1;SYMPK
prerank,regulation of osteoblast proliferation (GO:0033688),-0.3164568750534311,-0.9451161785249445,0.5066666666666667,0.852072476286561,1.0,7/17,15.61%,NPR3;MN1;FGFR2;CCN1;RHOA;PLXNB1;TMEM119
prerank,Fc receptor mediated stimulatory signaling pathway (GO:0002431),0.322128604845906,0.9450090477941091,0.5843439911797134,1.0,1.0,16/73,15.54%,ARPC1B;WIPF1;PAK1;BAIAP2;LIMK1;FYN;BRK1;VAV3;DOCK1;PIK3R1;MAPK1;PLPP4;NCK1;CYFIP1;ELMO1;ABL1
prerank,positive regulation of RNA splicing (GO:0033120),0.37629869828997753,0.9449286534953301,0.5634920634920635,1.0,1.0,5/29,12.97%,PRDX6;TRA2B;NCBP1;PIK3R1;DAZAP1
prerank,protein autoubiquitination (GO:0051865),0.32896136963712724,0.9448629431015045,0.5694444444444444,1.0,1.0,9/61,9.99%,UBE2T;RNF157;PRKN;NFX1;DDB2;BRCA1;RNFT1;CUL3;UHRF2
prerank,regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645),0.41789859438210225,0.9444503502052658,0.5257879656160458,1.0,1.0,2/14,7.90%,CARD9;IL18
prerank,regulation of microtubule polymerization (GO:0031113),-0.26330904864565907,-0.9441388224427115,0.5748502994011976,0.8533578938058348,1.0,12/40,16.43%,CDH5;MAP2;OCLN;DRG1;CLIP3;CLIP1;EML2;DCTN1;NUMA1;MAPT;PRUNE1;TBCD
prerank,sodium ion import across plasma membrane (GO:0098719),-0.3223817660699976,-0.9437385988990642,0.5408805031446541,0.8530804109873826,1.0,5/17,12.23%,SLC9A6;SLC9A2;SLC9A9;SLC9A7;SLC6A1
prerank,phosphatidylinositol biosynthetic process (GO:0006661),0.30475386398929116,0.9436927552524145,0.589171974522293,1.0,1.0,21/119,14.51%,PLEKHA4;INPP4B;SLC27A1;FGF2;PTEN;RAB14;SOCS5;MTMR14;PTPN13;SOCS1;PI4KB;VAC14;PIGC;PIGP;PIK3R1;PI4K2A;MTMR12;RAB4A;PIGN;PIGA;TTC7A
prerank,positive regulation of protein phosphorylation (GO:0001934),0.29264131175303165,0.943624286241665,0.6663316582914572,1.0,1.0,74/348,19.08%,RELN;BMP5;CLDN19;DOCK7;NTRK3;FGF2;FGF10;SOX9;NGF;ERBB2;EGFR;ACVR1;EFNA5;WDFY2;VEGFA;ARAF;WNK3;RPS6KA4;TGFB1;TEC;NTRK2;TRAF4;GDF9;PRNP;MT3;MRNIP;TNIK;NIBAN1;PAK1;ALS2;RALB;RAP1A;UBE2K;ERBB4;EIF4G1;PTPRJ;FBH1;PTPN11;HDAC6;MAPK1;BMP7;MMD2;MYDGF;FGF7;TBK1;XRCC6;AKTIP;BRAT1;SNCA;P2RY1;SH2D3C;CALM1;BMPR1A;IQGAP1;RASSF2;ABL1;CALM2;TP53;CCND2;TGFB3;TERF2IP;APLNR;CD74;RIPK1;CSPG4;JTB;RPTOR;KRAS;MAPRE3;FNIP1;PARK7;SEMA4D;TESK1;S1PR2
prerank,positive regulation of cell morphogenesis involved in differentiation (GO:0010770),0.3408180166829745,0.9435992119298786,0.5624256837098692,1.0,1.0,19/48,25.51%,OLFM4;IL1RAPL1;DOCK5;OBSL1;CDKL5;CDKL3;FLNA;DOCK1;MYOC;ABL1;RAC3;MDK;TESK1;TRIOBP;CRK;CIB1;PRKDC;FBXW8;ARHGEF7
prerank,regulation of protein phosphorylation (GO:0001932),0.293358990410711,0.9433258664780579,0.6345381526104418,1.0,1.0,42/256,14.02%,CLDN19;NTRK3;FGF2;PIP5KL1;FGF10;PTEN;SOX9;BST1;ERBB2;PRKN;EGFR;EFNA5;WDFY2;VEGFA;EPHB2;CADM4;EIF2AK3;TGFB1;NTRK2;PRNP;MT3;TNIK;PTPN13;NIBAN1;SOCS1;PAK1;RALB;MEN1;FYN;GRM5;ERBB4;FBH1;PID1;BMP7;MYDGF;FGF7;WWTR1;AKTIP;BRAT1;P2RY1;PDCL3;BMPER
prerank,regulation of cytokine production (GO:0001817),0.3060569512935031,0.9432963388624659,0.5968586387434555,1.0,1.0,16/126,13.20%,FFAR4;GLMN;DTX4;RPS6KA4;MAST2;MAPKAPK2;CCR2;AGPAT2;CARD9;CADM1;SYT11;MAPK14;TBK1;ATP2B1;PER1;GATA3
prerank,cellular protein modification process (GO:0006464),0.2881462954092571,0.9428507644003501,0.735,1.0,1.0,161/983,14.08%,PTPRH;GPC3;CHRM3;WNK2;CCL11;VCAN;PRKCA;CTH;CEL;ST3GAL4;PTEN;PTPN22;MXRA8;PEAK1;FBXW9;CHRDL1;STK36;DUSP4;PGAP1;ERBB2;LAMC1;RAB38;PTPRT;TGM1;ACVR1;UBE2E2;MAP4K4;PAK4;ARAF;IRAK3;WNK3;SIK2;EIF2AK3;RPS6KA4;SOCS5;FBXW7;MAST2;SPSB4;PRKCSH;NEK1;TGFB1;TEC;ASB8;PAK5;NUCB1;NPC1;SETD3;SDC2;MT3;MAPKAPK2;KLHL13;TESK2;DUSP6;PRKAR1B;TNIK;PTPN13;HLCS;ACVR1C;OBSL1;FBXO7;PAK1;PKN1;WIPI1;FBXL15;YWHAZ;DDB2;CDKL5;ASB5;CDK8;FBXO32;CDKL3;ZBTB16;CDK13;MMP15;EVA1A;TGFBR2;B3GNT9;MAN2A2;CSK;UFL1;PPP3CB;DYRK1B;PDK3;RCN1;LIMK1;CDK6;MEN1;NAE1;FGFR1;ATG5;FYN;STT3A;VWA1;PPP3CA;CDK15;PPM1B;PPM1J;PPP2R3A;TBCK;FBXL16;CDK19;PSMB7;PPP2R2A;COL3A1;STK39;PASK;TLK2;MAPK9;AKT3;FBXO27;SGK3;SGK2;CKAP4;HIF1A;AMELX;PTPN1;CUL3;PXK;DUSP11;PTPRJ;TYK2;ST8SIA1;ARF4;DCLK1;UCHL3;LTBP1;STK19;CDC25B;MAPK1;SIRT6;CALU;UBA3;PPP1CA;SLC35A1;TAOK3;FBXO17;PTPRA;RAB1A;FBXL2;FUCA2;TBK1;PRKACA;ALG5;DCAF8;PTPN18;ATG3;RAB3A;BTBD1;CSNK1A1;HSP90B1;NEK7;PTPRZ1;CDK16;DDB1;PTPN21;PENK;TTBK1;SUMF1;NEDD8;PPP3CC;SSH1
prerank,negative regulation of autophagy (GO:0010507),0.333114781574757,0.9427480527827865,0.5855646100116414,1.0,1.0,17/54,22.71%,PTPN22;BCL2;MT3;TSC1;BMF;TLK2;EIF4G1;SNCA;WASHC1;MET;KLHL22;TAB3;STAT3;RRAGA;EIF4G3;NRBP2;TAB2
prerank,regulation of histone H3-K4 methylation (GO:0051569),0.4104469847059564,0.9422570093064689,0.5284900284900285,1.0,1.0,4/16,9.87%,KMT2A;AUTS2;BRCA1;PIH1D1
prerank,regulation of systemic arterial blood pressure by hormone (GO:0001990),-0.34301278468823204,-0.9421868589387355,0.541033434650456,0.8558473961353315,1.0,7/14,20.92%,NOS3;ACE;ENPEP;AGTR1;ECE1;EDN1;ACE2
prerank,negative regulation of protein dephosphorylation (GO:0035308),-0.30890282227147053,-0.9417080943280645,0.5399239543726235,0.8557365408062249,1.0,6/21,10.93%,MFHAS1;PPP1R16B;PTPA;GSK3B;ARPP19;PPP1R11
prerank,negative regulation of blood vessel endothelial cell migration (GO:0043537),0.3572461085177693,0.9411267947714209,0.5400739827373613,1.0,1.0,3/33,4.08%,MEOX2;FGF2;TGFB1
prerank,calcium import into the mitochondrion (GO:0036444),-0.37883035998698034,-0.9408807046156871,0.5317460317460317,0.8565261539004595,1.0,3/10,16.40%,MICU1;MCUB;MICU3
prerank,regulation of neuron death (GO:1901214),0.317177751430646,0.9406019369333397,0.5754189944134078,1.0,1.0,20/82,19.35%,CD34;PRKN;PRNP;GRIN2B;GRID2;WNT5A;TSC1;TRIM2;NAE1;FYN;DCC;EIF4G1;TBK1;SNCA;UBB;EFNB2;SNCB;PARK7;EGR1;BTBD10
prerank,interleukin-7-mediated signaling pathway (GO:0038111),0.4067220567315076,0.9405719735426817,0.5420827389443652,1.0,1.0,6/17,22.45%,IRS2;SOCS1;STAT3;SMARCA4;STAT5A;BRWD1
prerank,cellular response to interleukin-7 (GO:0098761),0.4067220567315076,0.9405719735426817,0.5420827389443652,1.0,1.0,6/17,22.45%,IRS2;SOCS1;STAT3;SMARCA4;STAT5A;BRWD1
prerank,chromatin-mediated maintenance of transcription (GO:0048096),-0.380051545661651,-0.94046345069096,0.5386904761904762,0.8563070838757769,1.0,7/11,30.00%,SERTAD2;SMARCD1;PADI2;SERTAD1;ELOF1;CDCA4;CHEK1
prerank,negative regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902042),0.36044332155726333,0.9404084359852071,0.5368421052631579,1.0,1.0,4/30,8.59%,BMP5;FADD;TNFRSF10B;BRCA1
prerank,Notch signaling pathway (GO:0007219),0.3271334712511848,0.940194665817022,0.5758980301274623,1.0,1.0,15/59,18.43%,MAML3;MYC;KAT2B;DTX4;MAML2;PSEN1;HOXD3;NCSTN;APH1A;PSEN2;TRAF7;MIB1;HEYL;MDK;GALNT11
prerank,growth hormone receptor signaling pathway (GO:0060396),0.42357465806338773,0.9401587762908493,0.5519203413940256,1.0,1.0,8/14,22.76%,PTPN1;PIK3R1;PRLR;STAT3;STAT5A;PXN;GHR;STAT6
prerank,mRNA cleavage involved in mRNA processing (GO:0098787),0.4180914955637997,0.9401458346263617,0.5426917510853835,1.0,1.0,3/14,10.21%,CPSF6;NCBP1;FIP1L1
prerank,regulation of anoikis (GO:2000209),0.3959983234875828,0.9401245946048328,0.5357643758765779,1.0,1.0,2/19,3.82%,BCL2;TLE1
prerank,regulation of inflammatory response (GO:0050727),0.2972111523850478,0.9393414730587991,0.6174358974358974,1.0,1.0,35/190,19.68%,RORA;FFAR4;ADAMTS12;IL16;BST1;PTPN2;MAPK7;GPRC5B;TNFAIP8L2;CCR2;WNT5A;IL1RL2;UFL1;PLA2G7;OTULIN;IL18;SELENOS;SNX6;CASP12;GRN;SHPK;GATA3;SNCA;IL33;AREL1;XIAP;ABCC1;RIPK1;MDK;PTGES;LRFN5;PARK7;SETD4;PDCD4;PPARG
prerank,cellular response to interleukin-4 (GO:0071353),-0.3816552604936022,-0.9393397805023836,0.5300546448087432,0.8578462968433869,1.0,1/10,0.63%,LEF1
prerank,endocardial cushion development (GO:0003197),-0.3070920841701449,-0.9392368714162727,0.5856573705179283,0.8567897062723056,1.0,5/21,3.78%,ACVRL1;NOS3;BMP4;ENG;BMPR2
prerank,DNA replication checkpoint signaling (GO:0000076),0.41016442705235134,0.93843606174789,0.5568513119533528,1.0,1.0,4/16,14.08%,TIPIN;NAE1;ORC1;TOPBP1
prerank,cardiac myofibril assembly (GO:0055003),0.4177001188742364,0.9380782906123859,0.5523255813953488,1.0,1.0,2/15,5.55%,PDGFRA;OBSL1
prerank,striated muscle tissue development (GO:0014706),0.3575500773978895,0.9379252678856175,0.5528031290743155,1.0,1.0,3/29,5.87%,BMP5;SGCD;SGCZ
prerank,response to hydrogen peroxide (GO:0042542),0.33537596344109166,0.9378569566206799,0.5530660377358491,1.0,1.0,14/45,20.81%,APTX;MAPK7;CYP1B1;FYN;NFE2L2;HDAC6;PRDX3;ABL1;PAX2;RIPK1;CAT;PARK7;OSER1;SIRPA
prerank,negative regulation of reproductive process (GO:2000242),0.40341363769584565,0.9378439334912158,0.5631205673758866,1.0,1.0,2/17,5.43%,SULF1;ACVR1C
prerank,integrated stress response signaling (GO:0140467),0.4117184890708287,0.9377217156355151,0.5604075691411936,1.0,1.0,4/14,16.48%,EIF2AK3;HERPUD1;NFE2L2;QRICH1
prerank,regulation of epithelial cell differentiation (GO:0030856),0.3964718397479083,0.9377054293289442,0.5420289855072464,1.0,1.0,4/17,13.20%,SOX9;PRKX;AJAP1;GATA3
prerank,mesenchymal cell development (GO:0014031),0.40030035126375824,0.9375339848220484,0.5601719197707736,1.0,1.0,6/18,22.34%,SOX8;SOX11;KLHL12;HEYL;PEF1;NRG1
prerank,glycerophospholipid catabolic process (GO:0046475),0.37193396026612274,0.9375273356585119,0.5485175202156334,1.0,1.0,8/27,21.32%,PRDX6;PLA2G7;ENPP6;PNPLA8;LIPC;GDPD3;PLA2G4E;ABHD16A
prerank,regulation of G0 to G1 transition (GO:0070316),0.3457615226788197,0.9374394601898776,0.5665024630541872,1.0,1.0,15/38,27.15%,CDKN2B;EED;APAF1;E2F6;BRCA1;EPC1;RBBP4;RBBP7;CBX5;RNF2;CBX3;EHMT2;RHNO1;RBBP8;EZH2
prerank,regulation of necroptotic process (GO:0060544),-0.2985595318341393,-0.9373190915300826,0.5807692307692308,0.8603612169808599,1.0,9/23,18.72%,BIRC3;OGT;STUB1;CASP8;HSP90AA1;FLOT1;ARHGEF2;SPATA2;CFLAR
prerank,negative regulation of cellular component organization (GO:0051129),0.3179497060768667,0.937119297841681,0.5706340378197998,1.0,1.0,9/74,11.57%,LGALS3;FAP;VEGFA;IRAK3;CRYAB;SYT11;MCTP1;HDAC6;DNAJB6
prerank,RNA metabolic process (GO:0016070),0.3056080335968417,0.9370737051267239,0.5930599369085173,1.0,1.0,46/127,26.12%,BICD1;DHX8;ELAVL4;RNASE6;RNGTT;ATXN2;POLR2B;METTL3;XRN2;DDX54;PPP1R8;DDX24;POLR2K;APOBEC1;NCBP1;ADARB2;DUSP11;SNRNP40;HNRNPA3;RNASEH2C;ADARB1;POLR2G;NOVA1;PAPOLA;PNPT1;HNRNPU;TP53RK;TENT2;POLR2A;SYNCRIP;HNRNPUL1;HNRNPC;HNRNPH2;HNRNPL;RBFOX2;RBMS1;ALKBH1;PCBP2;POLR2F;TFIP11;SUPV3L1;DROSHA;RBM4;RNASE3;SND1;HNRNPA2B1
prerank,"nucleotide-excision repair, DNA incision, 5'-to lesion (GO:0006296)",0.3537352604858967,0.9370735629832235,0.5523690773067331,1.0,1.0,10/37,17.08%,GTF2H2;ERCC5;ERCC4;DDB2;RPA3;XPA;DDB1;RPA2;UBB;CUL4B
prerank,telomere maintenance via recombination (GO:0000722),0.4414864008504112,0.93696759209799,0.5455927051671733,1.0,1.0,4/11,22.69%,ERCC4;XRCC3;TPRKB;RAD50
prerank,regulation of protein polymerization (GO:0032271),-0.2720764260269383,-0.9368926944044722,0.5879396984924623,0.8600937115255094,1.0,9/35,15.01%,ARHGAP28;FCHSD2;MAP2;ESAM;PFN2;MAPT;HAX1;HSP90AA1;PRUNE1
prerank,cell chemotaxis (GO:0060326),0.32611421815163766,0.9368521347086203,0.5597701149425287,1.0,1.0,7/60,7.06%,PDGFRA;PRKCQ;LPAR1;VEGFA;EGR3;CCR2;ACKR3
prerank,regulation of short-term neuronal synaptic plasticity (GO:0048172),0.41657371029368473,0.9365160753126809,0.5328244274809161,1.0,1.0,4/13,12.68%,SHISA9;GRIK2;SLC8A2;RAB3A
prerank,regulation of phosphatase activity (GO:0010921),0.37431276418848164,0.9363091214815638,0.5374331550802139,1.0,1.0,12/24,28.22%,URI1;TSC1;HSP90B1;TIPRL;HTT;ZCCHC9;BMP2;PPP6R2;PPP6R1;CDK5RAP3;GPATCH2;CHP1
prerank,small nucleolar ribonucleoprotein complex assembly (GO:0000491),0.44649221363256214,0.9362387482135741,0.5522620904836193,1.0,1.0,4/10,19.24%,SHQ1;PIH1D1;TAF9;RUVBL2
prerank,regulation of high voltage-gated calcium channel activity (GO:1901841),0.4444121197322359,0.93616383090115,0.5412130637636081,1.0,1.0,2/10,4.45%,CACNA2D1;PDE4B
prerank,3'-UTR-mediated mRNA destabilization (GO:0061158),0.4090927997627234,0.9357890162105148,0.5464949928469242,1.0,1.0,6/16,20.38%,CPEB3;ZFP36L2;UPF1;KHSRP;RC3H1;ZFP36
prerank,cellular amide metabolic process (GO:0043603),0.3103551148535731,0.9355305269974211,0.6195069667738478,1.0,1.0,26/102,20.99%,THEM4;MIPEP;OXSM;ALDH1L1;MCCC1;HLCS;ACOT11;MTRR;MCCC2;ACSF2;THOP1;PLAAT5;MTHFD2L;PLAAT3;CPD;ABCB9;GNE;ALDH1L2;ACSL6;GPAT4;GLYAT;DBI;PLA2G4E;SLC25A32;ACOT8;ACBD6
prerank,positive regulation of triglyceride biosynthetic process (GO:0010867),0.43638864508503894,0.9353028554099732,0.5358778625954198,1.0,1.0,1/11,1.07%,SLC27A1
prerank,vascular endothelial growth factor receptor signaling pathway (GO:0048010),0.32148829759971703,0.9342515134745151,0.5817972350230415,1.0,1.0,17/67,15.23%,SULF1;VEGFA;MAPKAPK3;NCF1;MAPKAPK2;BAIAP2;FYN;BRK1;VAV3;DOCK1;NCF2;PIK3R1;MAPK14;NRP2;NCK1;CYFIP1;ELMO1
prerank,positive regulation of neuroblast proliferation (GO:0002052),0.44809798525205213,0.9340140646133768,0.553968253968254,1.0,1.0,3/10,12.69%,VEGFA;DISC1;DRD2
prerank,regulation of insulin secretion (GO:0050796),0.309532672368412,0.9337819049153213,0.6114101184068891,1.0,1.0,11/101,7.97%,PRKCA;CACNA1E;IRS2;STXBP4;PRKN;EFNA5;CACNA1A;RFX3;PPP3CB;RAP1A;ENSA
prerank,regulation of neuronal synaptic plasticity (GO:0048168),0.3589532660990564,0.9328805377796886,0.5582901554404145,1.0,1.0,8/29,15.72%,EPHB2;SHISA9;GRIK2;SLC8A2;MCTP1;RAB3A;DRD2;NETO1
prerank,regulation of carbohydrate biosynthetic process (GO:0043255),-0.3750474915007752,-0.932075872436033,0.5481283422459893,0.8710650167908153,1.0,4/10,24.42%,USP7;OGT;PDK2;SIRT7
prerank,negative regulation of B cell activation (GO:0050869),-0.306825088069109,-0.9319620210724906,0.5145985401459854,0.8699995461070117,1.0,10/21,25.64%,LYN;PARP3;ID2;INHBA;CD300A;LAPTM5;TNFAIP3;TNFRSF21;TYROBP;INHA
prerank,endothelial cell development (GO:0001885),0.37140561471693584,0.9318587311569246,0.5735294117647058,1.0,1.0,5/25,15.00%,COL15A1;RAP1A;COL18A1;PDE4D;MET
prerank,immunoglobulin mediated immune response (GO:0016064),0.4455411409991279,0.9315479375404043,0.5700483091787439,1.0,1.0,2/10,17.14%,CARD9;CD74
prerank,phosphorylation (GO:0016310),0.28855542494686676,0.9313851300905766,0.6856856856856857,1.0,1.0,67/385,13.10%,WNK2;CCL11;PRKCA;PEAK1;STK36;ERBB2;ACVR1;MAP4K4;PAK4;EPHB2;GNPTAB;IRAK3;WNK3;SIK2;EIF2AK3;RPS6KA4;MAST2;NEK1;TGFB1;TEC;PAK5;MAPKAPK2;TESK2;PRKAR1B;TNIK;ACVR1C;PAK1;PKN1;YWHAZ;CDKL5;CDK8;CDKL3;CDK13;TGFBR2;CSK;PPP3CB;DYRK1B;PDK3;LIMK1;CDK6;FGFR1;FYN;CDK15;TBCK;CDK19;STK39;PASK;TLK2;MAPK9;AKT3;SGK3;SGK2;PXK;TYK2;DGKI;DCLK1;STK19;CDC25B;TOLLIP;MAPK1;TAOK3;TBK1;PRKACA;CSNK1A1;NEK7;CDK16;SHPK
prerank,regulation of striated muscle contraction (GO:0006942),0.36688016040566407,0.9312076249266847,0.5731225296442688,1.0,1.0,6/27,15.54%,MYBPH;ANK2;TNNT3;PRKACA;CALM1;CALM2
prerank,proton transmembrane transport (GO:1902600),-0.25686364500128134,-0.9311876423040778,0.5654761904761905,0.8705930787618946,1.0,7/36,15.49%,ATP1A2;ATP6V0C;ATP6V0D1;ATP1A1;ATP6V0A4;ATP5MF;NNT
prerank,positive regulation of telomerase activity (GO:0051973),0.352424243470549,0.931107865339566,0.5647208121827412,1.0,1.0,6/33,14.18%,PRKCQ;MYC;PARM1;MAPK1;NEK7;MAP3K4
prerank,regulation of protein serine/threonine kinase activity (GO:0071900),0.30881786747705814,0.9310230814716373,0.6132478632478633,1.0,1.0,40/104,29.29%,SLC27A1;PYCARD;CDKN2B;CCNJ;KSR1;RALB;SLC8A2;PIH1D1;PKMYT1;CDK5R1;SNCA;CALM1;CDK5R2;ABL1;CALM2;BLM;CCND2;RPTOR;HTT;TESK1;CAB39;BCCIP;RB1;PPEF2;CIB1;CCNT2;CCNH;CDC37;CDK5RAP3;CDKN1A;CCND3;EZH2;CCNI;SIRT1;GTPBP4;TELO2;CCNE1;SNF8;CDKN2D;CDKN1B
prerank,cardiac muscle tissue development (GO:0048738),0.33012173886880847,0.9306437949763451,0.5771028037383178,1.0,1.0,7/50,7.60%,BMP5;AKAP13;SGCD;SCN5A;SGCZ;GATA6;TBX18
prerank,cellular response to amyloid-beta (GO:1904646),0.3482075504593819,0.930586934136992,0.5772669220945083,1.0,1.0,9/35,10.58%,CACNA2D1;LRP1;CACNA1A;PSEN1;PRNP;FYN;GRM5;SNX6;NGFR
prerank,histone H2A ubiquitination (GO:0033522),0.39745467546227176,0.9305296476086973,0.5466101694915254,1.0,1.0,8/17,27.84%,DDB2;DDB1;CUL4B;BCOR;RNF2;PCGF1;RNF168;TRIM37
prerank,positive regulation of vacuole organization (GO:0044090),0.4440848941402036,0.9301002357884278,0.5548281505728314,1.0,1.0,4/10,20.52%,RALB;GRN;RAB3GAP2;RAB3GAP1
prerank,icosanoid secretion (GO:0032309),-0.36892088894674846,-0.9299168982578812,0.5558823529411765,0.8725959554312787,1.0,2/12,6.82%,ABCC4;ACE
prerank,phospholipid homeostasis (GO:0055091),-0.376519678776303,-0.9298177186795397,0.5373563218390804,0.8715226629063701,1.0,5/11,25.86%,ABCA1;ABCG1;TLCD1;TLCD2;ANGPTL3
prerank,ventricular cardiac muscle tissue morphogenesis (GO:0055010),-0.27426545454713547,-0.9297903340840308,0.5803571428571429,0.8702168072188572,1.0,7/31,12.51%,SMAD7;ENG;TGFBR1;TPM1;FGFR2;PROX1;TGFB2
prerank,phagosome acidification (GO:0090383),0.36766797352618413,0.9296485037020911,0.5870393900889453,1.0,1.0,11/26,27.43%,RAB38;ATP6V1B2;RAB39A;ATP6V1C1;RAB7A;ATP6V0E2;ATP6V0E1;ATP6V1G2;ATP6V1H;TCIRG1;ATP6V1D
prerank,"regulation of synaptic transmission, GABAergic (GO:0032228)",-0.33360060764940236,-0.9293538206205759,0.5705521472392638,0.8700459796310934,1.0,3/15,3.26%,ZDHHC3;STXBP1;NLGN2
prerank,activation of protein kinase activity (GO:0032147),0.30173884752579566,0.9288993134056422,0.593952483801296,1.0,1.0,15/106,7.90%,NTRK3;MAP4K4;VEGFA;PAK4;TNFRSF10B;PAK5;MT3;PRKAR1B;TNIK;WNT5A;PAK1;MAPKAP1;TGFBR2;PRRC1;IL18
prerank,stem cell differentiation (GO:0048863),-0.25930287867884416,-0.9287790080354719,0.6032608695652174,0.870176573124205,1.0,11/39,14.56%,KIT;OSR1;MLLT3;MTF2;ACE;FBXL17;FGFR2;TGFB2;PTPRC;EEF1AKMT4-ECE2;HMGA2
prerank,regulation of macroautophagy (GO:0016241),0.30672390558582635,0.928032881137239,0.6356756756756756,1.0,1.0,16/105,12.48%,DCN;WAC;CAPN1;ATP6V1B2;TSC1;PRKAB2;BNIP3;LAMTOR2;UCHL1;SNX6;VPS26B;CLEC16A;HDAC6;CDK5R1;TBK1;PRKACA
prerank,RNA export from nucleus (GO:0006405),0.3076455479666084,0.9279864987244657,0.6010695187165775,1.0,1.0,35/100,26.36%,THOC6;RANBP2;NUP155;MCM3AP;SRSF11;CASC3;ALKBH5;NCBP1;FIP1L1;NUP205;NDC1;NUP160;UPF1;DDX25;NXT1;SRSF6;YTHDC1;POM121;SMG6;AAAS;NXF1;RNPS1;THOC7;SRRM1;SRSF3;FYTTD1;NUP42;GLE1;SYMPK;XPO5;THOC5;MAGOHB;NUP35;HNRNPA2B1;RAE1
prerank,glycosphingolipid biosynthetic process (GO:0006688),-0.32400295559137476,-0.9279458430222027,0.5643564356435643,0.8709231451736,1.0,2/16,2.10%,ST6GALNAC3;ST8SIA4
prerank,regulation of amyloid precursor protein catabolic process (GO:1902991),-0.36300580899446583,-0.9276978787771513,0.5771428571428572,0.8703107013659375,1.0,2/12,1.73%,ROCK2;ROCK1
prerank,regulation of protein localization to plasma membrane (GO:1903076),0.31660264846471475,0.9276210037336656,0.5966850828729282,1.0,1.0,11/78,11.37%,LGALS3;EGFR;LRP1;EPHB2;WNK3;TGFB1;SPTBN1;DPP10;ZDHHC8;PIK3R1;PID1
prerank,superoxide metabolic process (GO:0006801),0.35562253430916446,0.9270467679206741,0.573490813648294,1.0,1.0,6/29,12.83%,NCF1;MT3;NOX1;TAFA4;NCF2;SOD2
prerank,positive regulation of cytokine production involved in immune response (GO:0002720),-0.29427700469457324,-0.9270226864422645,0.549618320610687,0.8707414922371193,1.0,9/25,28.38%,KIT;SLC7A5;CD55;MAP3K7;LAPTM5;SPHK2;LACC1;NOD2;TRIM6
prerank,IRE1-mediated unfolded protein response (GO:0036498),0.3266879226763173,0.926937674336483,0.5837264150943396,1.0,1.0,9/52,15.76%,DDX11;DNAJB9;CXXC1;WIPI1;EXTL3;MYDGF;ARFGAP1;LMNA;KDELR3
prerank,positive regulation of cell differentiation (GO:0045597),0.29132751948027524,0.9265631920908696,0.6838383838383838,1.0,1.0,38/237,11.65%,FFAR4;SOX6;GLIPR2;PKDCC;CD34;SOX9;NGF;ACVR1;FRZB;XKR8;WDFY2;NRCAM;GPRC5B;TGFB1;SOX11;PLCB1;CTNNA2;ZEB1;HOXD3;ZBTB16;TGFBR2;LMO3;RAP1A;FGFR1;IL18;PPP1R13L;SOX5;CARM1;MAPK9;BCL9L;GDNF;MAPK14;IL6ST;GPC1;BMP7;ATRAID;EDN3;MMD2
prerank,ncRNA export from nucleus (GO:0097064),0.34520284861551337,0.9262118432778572,0.572851805728518,1.0,1.0,10/36,17.36%,RANBP2;TSC1;NUP155;NUP205;NDC1;NUP160;XPOT;POM121;AAAS;SSB
prerank,stress-activated MAPK cascade (GO:0051403),-0.23327475748794266,-0.9261228669300071,0.6341463414634146,0.8717329207232922,1.0,21/61,25.17%,MAP3K5;TNFRSF19;MAP3K20;MAP2K3;MAP3K8;ZFP36L1;GPS2;ARHGEF6;MAP3K7;UBE2N;IKBKB;IKBKG;TAOK2;MINK1;MAPK10;NOD1;CRKL;MAP3K13;GPS1;MAPK8;UBA52
prerank,mitochondrial translational elongation (GO:0070125),0.3080569271867499,0.9260828446744948,0.5958605664488017,1.0,1.0,25/88,22.44%,MRPL47;MRPS18A;TUFM;MRPL14;MRPL32;MRPL16;MRPL58;MRPS35;MRPS28;AURKAIP1;MRPL35;MRPL30;MRPL28;MRPL46;MRPL51;MRPS30;MRPS14;MRPS9;MRPS31;MRPL1;PTCD3;DAP3;MRPS6;MRPL52;MRPL18
prerank,positive regulation of protein maturation (GO:1903319),-0.3652030687748762,-0.9259540190051492,0.5820433436532507,0.8708097673278026,1.0,1/11,1.25%,CCBE1
prerank,"protein alpha-1,2-demannosylation (GO:0036508)",0.3808713625915962,0.9257787290956537,0.5694249649368864,1.0,1.0,6/22,18.25%,EDEM3;UGGT2;DERL2;EDEM2;UBB;MAN1A2
prerank,regulation of viral transcription (GO:0046782),0.3374926278388226,0.9253038974091117,0.5765877957658779,1.0,1.0,12/39,24.41%,MDFIC;POLR2B;TRIM11;POLR2K;MID2;POLR2G;POLR2A;ZFP36;CDK9;TRIM14;POLR2F;UBP1
prerank,brain morphogenesis (GO:0048854),0.41713432714832405,0.9252674396417307,0.5685358255451713,1.0,1.0,4/12,18.47%,PTEN;CTNNA2;PAX2;SLC6A4
prerank,regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902175),0.3907124237343094,0.9252139650083877,0.5571030640668524,1.0,1.0,5/17,12.83%,MAPK7;BAG5;NFE2L2;SFPQ;SOD2
prerank,glycogen metabolic process (GO:0005977),-0.2813607932517496,-0.9249589141016569,0.570281124497992,0.872091003582705,1.0,6/27,10.01%,PRKAG2;PYGB;GSK3B;AGL;PYGM;GAA
prerank,regulation of Arp2/3 complex-mediated actin nucleation (GO:0034315),0.38822142554971917,0.9249503113176453,0.5545851528384279,1.0,1.0,7/17,19.03%,CTNNA2;BRK1;WASF1;CORO1B;CYFIP1;ARFIP1;NCKAP1
prerank,negative regulation of apoptotic process (GO:0043066),0.28587488570663333,0.9249467604682795,0.7144288577154309,1.0,1.0,97/444,18.99%,FFAR4;PRKCA;ERBB3;SOX8;MYC;RNF157;BCL2;DPEP1;SOX9;CRLF1;NGF;PRKN;EGFR;FMN2;MAP4K4;VEGFA;EGR3;ARAF;THOC6;WNK3;TLE1;ERCC5;PSEN1;FANK1;NTRK2;MT3;WNT5A;YWHAZ;RASA1;NAA35;SON;NAA16;GATA6;CBX4;BNIP3;FLNA;CRYAB;PRDM9;SNX6;ASNS;HDAC2;UBE2Z;PIK3R1;GDNF;NGFR;CBL;ARF4;TAF9;IL6ST;SFPQ;MAPK1;DNAJB6;MYDGF;GRN;TAX1BP1;PRLR;PRDX3;SOD2;ATF5;HSP90B1;PTPRZ1;YME1L1;MALT1;SNCA;PSEN2;CITED2;OPA1;ZFAND6;UBB;ITGB1;CASP2;AREL1;UBE2O;FZD9;PIM2;BNIP1;TP53;CCND2;LRP2;XIAP;HTATIP2;TGFB3;PAX2;CD74;RIPK1;PCID2;MDK;DNAJA1;HSPA9;CAT;NAA15;AATF;FNIP1;PARK7;SEMA4D;CSNK2A2;AXL
prerank,L-amino acid transport (GO:0015807),0.36678897084867895,0.9247758158831797,0.5962815405046481,1.0,1.0,5/28,12.94%,SLC1A3;SLC36A2;ARL6IP5;SLC7A8;PRAF2
prerank,negative regulation of phosphoprotein phosphatase activity (GO:0032515),0.37649070848696436,0.9247213451701645,0.5664429530201343,1.0,1.0,2/22,4.99%,LGALS3;PPP1R15A
prerank,protein autophosphorylation (GO:0046777),0.29488314698958096,0.9246997472971321,0.6421161825726142,1.0,1.0,23/157,10.25%,WNK2;PDGFRA;PEAK1;ERBB2;EGFR;PRKX;MAP3K3;WNK3;SIK2;EIF2AK3;MAPKAPK3;TEC;NTRK2;MAPKAPK2;TNIK;EEF2K;PAK1;CDKL5;FGFR1;STK39;PASK;ERBB4;SLK
prerank,aspartate family amino acid metabolic process (GO:0009066),0.3953783398696208,0.9242165643969729,0.5810616929698709,1.0,1.0,5/18,13.27%,NAALAD2;SMS;GOT2;ASNS;ADI1
prerank,aerobic respiration (GO:0009060),-0.303662168368238,-0.9240309070677419,0.5273972602739726,0.8730980182461888,1.0,10/20,28.41%,SDHB;SIRT3;OXA1L;UQCRB;ATP5F1D;UQCR10;UQCRH;UQCRC1;SURF1;MTFR2
prerank,positive regulation of ERAD pathway (GO:1904294),0.42489792614617755,0.9239525110443694,0.568081991215227,1.0,1.0,7/13,23.05%,RNFT1;HERPUD1;NFE2L2;USP13;SGTA;UBQLN1;UBQLN2
prerank,organic cation transport (GO:0015695),0.3811888981929541,0.9238273672659911,0.5712328767123288,1.0,1.0,3/20,9.03%,SLC22A3;SLC44A2;SEC14L1
prerank,double-strand break repair via homologous recombination (GO:0000724),0.3083341913942087,0.9236778241741346,0.6362637362637362,1.0,1.0,20/95,17.24%,POLN;MEIOB;AP5S1;ERCC5;REV3L;ERCC4;RPA3;BRCA1;GINS2;FBH1;MCM4;SFPQ;HELQ;XRCC3;EXD2;RPA2;RAD52;BLM;SPIDR;WRN
prerank,positive regulation of TOR signaling (GO:0032008),-0.25494593835708096,-0.9236360005122022,0.5841584158415841,0.8727287063972835,1.0,14/40,21.20%,SIK3;WDR59;RICTOR;RRAGC;FLCN;LARS1;PIP4P1;NCKAP1L;RHEB;SMCR8;GPR137;RRAGB;LAMTOR1;HDAC3
prerank,cytoplasmic microtubule organization (GO:0031122),-0.239929573791267,-0.9232943523286067,0.6024844720496895,0.8722991336793423,1.0,16/54,16.76%,CLIP4;CLIP3;CLIP1;FIGNL2;TUBGCP4;TUBGCP3;TUBGCP6;WDR73;RHOA;DCTN1;NUMA1;MAPT;TRPV4;CCDC88C;VPS4B;TUBGCP2
prerank,cell part morphogenesis (GO:0032990),0.4138621888758841,0.9231657054726198,0.5632530120481928,1.0,1.0,6/13,24.43%,PACSIN2;PID1;WASF1;PNPT1;MTM1;SUPV3L1
prerank,negative regulation of immune response (GO:0050777),0.2970239728752471,0.9229821930094728,0.6528066528066528,1.0,1.0,16/154,12.74%,LGALS3;CRH;DPEP1;IRAK3;PTHLH;CCR2;PRKAR1B;PTH2R;SAMSN1;FYN;TSHR;PPM1B;COL3A1;MAPK14;PRKACA;GLP2R
prerank,regulation of exit from mitosis (GO:0007096),0.34195593578382544,0.9228152860226171,0.5721271393643031,1.0,1.0,14/38,23.62%,ANAPC7;ANAPC2;BUB1B;UBB;CDC14A;CDC23;ANLN;ANAPC16;CDC27;PHB2;UBE2E1;ANAPC4;ANAPC5;CDC16
prerank,RNA 3'-end processing (GO:0031123),0.31982608030900944,0.922809830006761,0.5915178571428571,1.0,1.0,22/69,24.99%,CSTF3;THOC6;RPRD1A;TUT4;SRSF11;CASC3;NCBP1;FIP1L1;SRSF6;PAPOLA;PNPT1;RNPS1;TENT2;THOC7;SRRM1;SRSF3;SYMPK;TUT1;THOC5;SUPV3L1;MAGOHB;CPSF7
prerank,positive regulation of biosynthetic process (GO:0009891),0.3476858077633636,0.9227555640060523,0.5961070559610706,1.0,1.0,7/40,10.11%,CREB3L1;ZBTB20;SLC5A3;TGFB1;MLXIPL;AMELX;HDAC2
prerank,proteasome assembly (GO:0043248),-0.3666186045456427,-0.9225969372992436,0.5444126074498568,0.8727239642751918,1.0,5/11,29.16%,OTUD6B;PSMG2;PSMG1;ADRM1;PSMD10
prerank,regulation of amyloid precursor protein biosynthetic process (GO:0042984),0.4317479331345765,0.9224280324818305,0.5711974110032363,1.0,1.0,1/11,1.25%,BACE2
prerank,negative regulation of leukocyte mediated cytotoxicity (GO:0001911),-0.3763947404872441,-0.9223738180642207,0.5457063711911357,0.8719522789370349,1.0,2/10,14.78%,PTPRC;CEACAM1
prerank,positive regulation of cellular biosynthetic process (GO:0031328),0.29642178458577373,0.922321781659,0.6460268317853457,1.0,1.0,32/166,16.10%,SLC27A1;GLI2;FGF2;MYC;IRS2;ERBB2;EGFR;PTPN2;UPF3A;PLD1;GLI1;NIBAN1;STN1;METTL3;MLXIPL;EIF3C;CPEB3;EIF6;NSUN5;PASK;ELOVL5;HIF1A;PAOX;SP1;PRMT1;DDB1;SMOC2;SNCA;ZEB2;PRR16;RPS27L;GPLD1
prerank,phospholipid metabolic process (GO:0006644),-0.22115101219457878,-0.9222811126861752,0.6915887850467289,0.8708298552443416,1.0,20/71,23.46%,PLA2G4A;PLPP1;GPAM;PLCD1;GNPAT;MBOAT1;TNFAIP8L3;PIP4P1;ACP6;AGPAT4;PIP4K2B;GPX4;PLA2G15;PGP;ABHD12;PLPPR5;LPL;CLN8;PNPLA3;PLA2G4C
prerank,embryonic hemopoiesis (GO:0035162),-0.35793116232320116,-0.9221974044416893,0.5702479338842975,0.8697193284883616,1.0,7/12,20.90%,KIT;KDR;KITLG;FLT3LG;TAL1;ZFPM1;ATF4
prerank,cellular calcium ion homeostasis (GO:0006874),0.29414685479955904,0.9221218769392606,0.6325678496868476,1.0,1.0,23/133,15.53%,CCL11;BCL2;ANK2;LETM1;ATP2B3;PACS2;PSEN1;CCR2;PDZD8;SLC8A2;SLC24A5;SLC10A7;HTR2C;HERPUD1;ANXA6;EDN3;PRKACA;TPCN2;ATP2B1;CCDC47;TRPC5;CCL14;FZD9
prerank,pore complex assembly (GO:0046931),-0.30660462845469794,-0.9218507778952408,0.5833333333333334,0.8693297611056914,1.0,7/19,19.34%,AFDN;NUP93;NUP107;ADAM10;PDZD11;GSDMD;NUP98
prerank,regulation of ATP metabolic process (GO:1903578),-0.2356816763366263,-0.9218156936264119,0.61875,0.8680998421153542,1.0,15/54,19.34%,PRKAG2;NUP93;NUP107;ATP7A;OGT;SLC25A33;PGAM1;NUP214;NUP43;NUP210;NUP88;PINK1;AK4;BEND3;NUP98
prerank,reticulophagy (GO:0061709),-0.35691259657742586,-0.9217429552781508,0.544973544973545,0.8669883899294482,1.0,5/12,21.19%,TEX264;UFM1;UFC1;UBA5;ULK1
prerank,meiosis I (GO:0007127),0.37228974312399843,0.9216955358217387,0.5605442176870749,1.0,1.0,7/23,22.35%,MEIOB;SGO1;BCL2L11;FOXJ3;ZSCAN21;PTTG1;DDX4
prerank,negative regulation of protein transport (GO:0051224),0.36726028125986426,0.921305479617907,0.5830013280212484,1.0,1.0,5/25,16.92%,PKDCC;CSK;DRD2;NDFIP1;SNX12
prerank,positive regulation of cell adhesion mediated by integrin (GO:0033630),-0.322923050447448,-0.9211604965693906,0.587360594795539,0.8671269912025562,1.0,5/17,21.17%,PODXL;TGFB2;NCKAP1L;SKAP1;FOXC2
prerank,tRNA-containing ribonucleoprotein complex export from nucleus (GO:0071431),0.3461223910745946,0.9208246476224875,0.5846925972396487,1.0,1.0,9/32,17.36%,RANBP2;NUP155;NUP205;NDC1;NUP160;XPOT;POM121;AAAS;SSB
prerank,tRNA export from nucleus (GO:0006409),0.3461223910745946,0.9208246476224875,0.5846925972396487,1.0,1.0,9/32,17.36%,RANBP2;NUP155;NUP205;NDC1;NUP160;XPOT;POM121;AAAS;SSB
prerank,glycerophospholipid biosynthetic process (GO:0046474),0.2942415621715074,0.920796684100591,0.635523613963039,1.0,1.0,38/172,20.22%,PLEKHA4;INPP4B;SLC27A1;FGF2;PTEN;RAB14;PLD1;MTMR14;SLC44A2;PTPN13;AGPAT2;PI4KB;VAC14;PLA2G12A;PTDSS1;PIK3R1;PI4K2A;SELENOI;FAR1;MTMR12;PCYT1B;CHPT1;ETNK1;RAB4A;AGPAT5;CHAT;GPAT3;GPAT4;PIP5K1A;CPNE7;AGK;SLC44A1;CSNK2A2;LPCAT2;CPNE1;STARD7;DDHD1;INPP5J
prerank,regulation of nucleobase-containing compound metabolic process (GO:0019219),0.4343526411984632,0.9206226661662962,0.5782945736434109,1.0,1.0,3/11,14.37%,RASA1;PCBP4;NOVA1
prerank,regulation of response to DNA damage stimulus (GO:2001020),-0.25989426785158826,-0.9205409483988269,0.6098901098901099,0.8673358238818384,1.0,14/40,18.12%,PRKCD;PARG;NPAS2;MCL1;POLH;ING2;ARMT1;ETAA1;SMYD2;MAPT;HMGA2;UBE2N;BCLAF1;FXR2
prerank,regulation of cellular senescence (GO:2000772),-0.27729384182300304,-0.9203724647519947,0.6123348017621145,0.8664119615837252,1.0,12/28,22.03%,NUAK1;SLC30A10;YBX1;TERF2;ING2;HMGA2;TERT;ABI3;RBL1;TWIST1;EEF1E1;VASH1
prerank,mitochondrial calcium ion homeostasis (GO:0051560),-0.30334475027652785,-0.920271049506515,0.5609756097560976,0.86535336507412,1.0,5/21,9.13%,MICU1;SLC8A3;SLC8B1;TGM2;MCUB
prerank,endoplasmic reticulum to cytosol transport (GO:1903513),0.3963830106867392,0.9202207722414653,0.5663189269746647,1.0,1.0,4/15,13.00%,DERL2;SELENOS;HERPUD1;HSP90B1
prerank,endocrine system development (GO:0035270),0.3818276021882705,0.9201125822519679,0.5900537634408602,1.0,1.0,4/21,9.20%,GLI2;NF1;HOXD3;DKK3
prerank,DNA metabolic process (GO:0006259),0.28624105410521145,0.9199691655085813,0.7101010101010101,1.0,1.0,63/270,19.45%,UBE2T;CBS;LRWD1;NUDT15;ZRANB3;MBD4;POLE2;CHRNA4;ERCC5;NSMCE3;ERCC4;MPG;DDB2;STN1;RPA3;NUDT1;SETMAR;MUTYH;MEN1;BRCA1;XPA;REXO4;TDP1;UHRF2;POLE3;NEIL1;ENDOV;MCM4;FANCC;HELLS;ASF1A;MSH6;UPF1;ZBTB1;XRCC6;DDB1;XRCC3;EXD2;RPA2;ORC1;TOPBP1;PDS5B;RTEL1;SUMO1;SMUG1;UBB;ATM;TRRAP;CSNK1E;RAD52;BLM;POLG;TERF2IP;WRN;NSMCE4A;ORC4;DDX23;PARK7;DBF4;LIG3;CNBP;TOP1;PSME4
prerank,regulation of release of cytochrome c from mitochondria (GO:0090199),0.3365978308452432,0.9198932486978407,0.5923645320197044,1.0,1.0,5/40,7.73%,HRK;PYCARD;PRKN;BMF;BNIP3
prerank,stem cell development (GO:0048864),0.3904062871362972,0.919239495985778,0.56657223796034,1.0,1.0,2/16,4.44%,SOX8;SOX11
prerank,B cell activation involved in immune response (GO:0002312),0.41216473380765184,0.9188386667865996,0.5837037037037037,1.0,1.0,5/13,27.56%,MSH6;BATF;EXOSC3;LIG4;RNF168
prerank,negative regulation of protein tyrosine kinase activity (GO:0061099),0.37343865861053216,0.9187492063968298,0.5810055865921788,1.0,1.0,5/23,12.38%,CBLB;SOCS5;SNX6;CBL;ZGPAT
prerank,response to cytokine (GO:0034097),0.2939111066566218,0.9184502568149365,0.6407867494824017,1.0,1.0,20/141,12.63%,AFF3;PRKCA;KYNU;BCL2;IL1RAPL1;PTPN2;IRAK3;MAPKAPK3;MAPKAPK2;PTPN13;IL1RL2;COL3A1;SETD2;AKAP6;PTPN11;TAF9;IL6ST;PID1;TBK1;PTPN18
prerank,cardiac muscle tissue morphogenesis (GO:0055008),-0.2725446961226544,-0.9183867600353293,0.6061946902654868,0.8686568398447804,1.0,6/29,14.82%,SMAD7;ENG;TPM1;FGFR2;PROX1;S1PR1
prerank,regulation of rRNA processing (GO:2000232),0.4016503528149284,0.9181612972292823,0.5772005772005772,1.0,1.0,4/16,12.65%,KAT2B;SHQ1;HEATR1;TRMT112
prerank,intestinal absorption (GO:0050892),-0.34663012000331994,-0.9176567848224206,0.5652173913043478,0.8690844975873118,1.0,4/13,20.93%,TJP2;UGCG;ADRA2A;SLC26A6
prerank,positive regulation of receptor signaling pathway via STAT (GO:1904894),0.3751765436723258,0.917642076711304,0.5786516853932584,1.0,1.0,3/22,10.17%,CRLF3;CYP1B1;ERBB4
prerank,cellular response to UV (GO:0034644),0.3091007595484489,0.9176056987858003,0.6199551569506726,1.0,1.0,17/76,19.24%,MMP2;MYC;NSMCE3;ERCC4;DDB2;METTL3;BMF;XPA;PPID;ZBTB1;DDB1;TP53;HYAL1;N4BP1;CUL4B;TAF1;RUVBL2
prerank,negative regulation of cellular biosynthetic process (GO:0031327),0.32978710100339353,0.9173871110942053,0.5962219598583235,1.0,1.0,10/47,16.74%,SLC27A1;CD34;ERLIN2;FBXW7;FYN;BRCA1;CRY1;KHSRP;ERLIN1;MPV17L
prerank,negative regulation of hormone secretion (GO:0046888),-0.3752131675787013,-0.9169285887260299,0.5746478873239437,0.8695642961111425,1.0,1/10,1.42%,GJA1
prerank,ureteric bud development (GO:0001657),0.39647805560226274,0.9164181886254344,0.5796269727403156,1.0,1.0,1/17,0.27%,GPC3
prerank,positive regulation of cardiac muscle hypertrophy (GO:0010613),-0.3227126010756194,-0.9160254427282548,0.5498392282958199,0.8705494329008514,1.0,5/16,7.23%,IGF1;ROCK2;ROCK1;MTPN;PARP1
prerank,regulation of cell adhesion mediated by integrin (GO:0033628),-0.2687666179483542,-0.9159433117332777,0.6,0.8694542819196561,1.0,9/33,13.20%,ACER2;LYN;JAM3;DPP4;EPHA8;SERPINE1;TGFB2;NEXMIF;NCKAP1L
prerank,regulation of cellular protein localization (GO:1903827),0.32727990157505826,0.9156511758379599,0.5726290516206483,1.0,1.0,11/45,15.98%,GPC3;RALB;GBF1;PTPN1;SETD2;GPC1;DVL1;GPC4;KCNAB2;CSNK1E;SPIDR
prerank,positive regulation of telomere maintenance via telomere lengthening (GO:1904358),0.34193534973035133,0.9155809530207369,0.5920096852300242,1.0,1.0,7/35,15.47%,PRKCQ;CCT7;MAPK1;NEK7;MAP3K4;RTEL1;ATM
prerank,cardiac muscle cell action potential (GO:0086001),0.3523367060853296,0.9154181344380034,0.5645371577574967,1.0,1.0,5/30,7.67%,CACNA2D1;ANK2;SCN5A;FGF12;KCND3
prerank,peptidyl-proline hydroxylation (GO:0019511),-0.3582376829664239,-0.9153303984988236,0.5561959654178674,0.8697402408752217,1.0,4/11,8.44%,P4HB;OGFOD1;P4HA2;EGLN2
prerank,lung epithelium development (GO:0060428),0.4340979240027161,0.9151702765916213,0.5728155339805825,1.0,1.0,4/10,16.83%,FGF10;RCN3;PKD1;FOXJ1
prerank,regulation of transcription of nucleolar large rRNA by RNA polymerase I (GO:1901836),0.42492532477256023,0.915023971391255,0.600326264274062,1.0,1.0,2/11,9.87%,DDX11;PIH1D1
prerank,regulation of p38MAPK cascade (GO:1900744),0.34406535097660534,0.9150207110601506,0.5972568578553616,1.0,1.0,12/35,23.34%,PTPN22;VEGFA;NCF1;PRMT1;PER1;MAP3K4;RELL2;EMC10;DUSP1;PJA2;CYLD;BMP2
prerank,response to muscle stretch (GO:0035994),-0.32214747376514086,-0.9148738602674034,0.5724137931034483,0.8695490510371088,1.0,2/15,2.36%,CDH2;CTNNB1
prerank,positive regulation of protein targeting to mitochondrion (GO:1903955),0.3568846336140205,0.9148260177862375,0.5745784695201037,1.0,1.0,11/30,21.70%,FBXW7;VPS11;HUWE1;UBE2J2;SREBF2;CSNK2A2;UBE2L3;MICALL2;RHOU;NPEPPS;UBE2D3
prerank,"phototransduction, visible light (GO:0007603)",0.4073246533028877,0.9144037466534631,0.5739385065885798,1.0,1.0,1/14,1.69%,RHO
prerank,regulation of organelle assembly (GO:1902115),0.3151059391306573,0.9143384803143947,0.6036036036036037,1.0,1.0,16/72,14.70%,TBC1D10A;GSN;NPRL2;IFT140;ATXN2;CDKL5;SDCCAG8;ATG5;VPS11;TBC1D19;CEP295NL;USP6NL;ATG3;TBC1D20;CEP76;PDCD6IP
prerank,mammary gland development (GO:0030879),0.3838111582076887,0.9142720805845552,0.5938375350140056,1.0,1.0,6/21,17.71%,GLI2;VEGFA;ERBB4;PRLR;TGFB3;GPAT4
prerank,regulation of cellular biosynthetic process (GO:0031326),-0.2780276115371594,-0.913823615416806,0.5844155844155844,0.8708746700912474,1.0,5/28,15.46%,PRKAG2;PRKAA2;ADIPOR2;AVIL;FGFR4
prerank,positive regulation of lipid metabolic process (GO:0045834),-0.2883449564181565,-0.9137717573819805,0.5970149253731343,0.8697094410895584,1.0,3/22,4.65%,SORBS1;CREBL2;PPARD
prerank,regulation of cell cycle (GO:0051726),0.2856993714837822,0.9137455635350278,0.7106854838709677,1.0,1.0,67/271,20.04%,FAP;CRLF3;MYC;FGF10;KIF20B;KAT2B;SOX9;CDKN2B;TGM1;TGFB1;NUPR2;PPP1R15A;CKS1B;APBB2;METTL3;TSC1;MLXIPL;SETMAR;SON;GBF1;GATA6;CDK6;MEN1;FOXM1;BIN1;NF2;BRCA1;UHRF2;LIN9;BMP7;MAGI2;ING4;PRKACA;TMEM8B;NEK7;ADARB1;GATA3;RBBP4;PRDM11;RPS6KA2;PKD1;CITED2;IQGAP1;MED25;CDC14A;ATM;FZD9;ABL1;PIM2;TP53;XIAP;TRNP1;PNPT1;HNRNPU;RNF167;NUDT6;CTBP1;MLF1;FBXO5;BOP1;MDM2;CSNK2A2;PDCD4;FBXL12;JUN;STAT3;DUSP1
prerank,hexose biosynthetic process (GO:0019319),-0.2475930953192915,-0.9136351200005622,0.5897435897435898,0.8687872391426388,1.0,13/42,23.62%,RBP4;CHST15;PGK1;PGAM1;GPI;SORD;CRTC2;SLC25A12;ENO1;GOT1;ATF4;GAPDHS;ENO3
prerank,blood vessel morphogenesis (GO:0048514),0.3228631372991795,0.9134912645723886,0.6118343195266273,1.0,1.0,9/54,7.15%,HAS2;GLMN;VEGFA;TGFB1;ITGB8;NF1;RASA1;TGFBR2;CYP1B1
prerank,response to glucose (GO:0009749),0.32795880070449773,0.9132079221997291,0.5992779783393501,1.0,1.0,11/46,17.89%,IRS2;ZBTB20;TRA2B;PDK3;EIF2B5;SELENOS;PRKACA;GPLD1;PAX2;EIF2B2;PCK2
prerank,synaptic vesicle membrane organization (GO:0048499),0.3906768893457103,0.9131715191371542,0.5864022662889519,1.0,1.0,2/17,5.65%,SNAP23;SNAP29
prerank,positive regulation of macroautophagy (GO:0016239),0.32568254500205923,0.913020681565853,0.6086956521739131,1.0,1.0,4/48,7.73%,DCN;WAC;RALB;BNIP3
prerank,negative regulation of Wnt signaling pathway (GO:0030178),0.28865372780235776,0.9130093250791789,0.6785350966429298,1.0,1.0,41/186,19.45%,SOSTDC1;TPBGL;TAX1BP3;RBMS3;LRP4;SOX9;VGLL4;PRKN;LRP1;FRZB;JADE1;TLE1;WIF1;GLI1;WNT5A;SHISA2;PSMB7;DKK3;CUL3;SFRP4;TMEM131L;EMD;PRICKLE1;APC2;DVL1;WWTR1;CSNK1A1;KLHL12;PSMD2;SCYL2;PSMC1;DACT1;WWOX;TLE3;PSMB2;TLE4;MDK;PSMD9;RUVBL2;NKD2;PSME4
prerank,ribonucleoprotein complex biogenesis (GO:0022613),-0.23548434502415938,-0.9125518738120939,0.6333333333333333,0.8701872744704833,1.0,27/57,28.01%,NPM1;RPS16;RPL38;RPS19;NVL;RPL5;RPS25;RPS15;NAF1;RPS6;RPL11;EMG1;SURF6;BYSL;RIOK1;RPL35A;RPL26;PES1;DHX37;CUL4A;RPS17;NOC2L;RPF2;RIOK2;URB2;PAK1IP1;MRPL36
prerank,Rap protein signal transduction (GO:0032486),0.43455355538012896,0.9124296297479205,0.5848765432098766,1.0,1.0,2/10,7.42%,RAP2B;RAP1A
prerank,error-prone translesion synthesis (GO:0042276),0.37925368918393876,0.9123523094668409,0.5669398907103825,1.0,1.0,6/21,17.26%,POLE2;REV3L;RPA3;RPA2;UBB;REV1
prerank,negative regulation of interferon-beta production (GO:0032688),0.44126858964157356,0.9123240653590576,0.6112,1.0,1.0,4/10,20.81%,PYCARD;PPM1B;PTPRS;SIRPA
prerank,myofibril assembly (GO:0030239),0.3389134690806174,0.9122679955739378,0.589242053789731,1.0,1.0,4/42,8.42%,PDGFRA;CSRP1;OBSL1;TNNT3
prerank,regulation of monooxygenase activity (GO:0032768),0.3696755153569591,0.9119626127398491,0.5832205683355887,1.0,1.0,9/23,22.11%,POR;EGFR;LYPLA1;GDNF;SNCA;CALM1;NOS1AP;ZDHHC21;DDAH1
prerank,glutathione derivative metabolic process (GO:1901685),-0.3062010767077201,-0.9118525528183575,0.5539568345323741,0.8692362082851315,1.0,9/20,31.83%,GSTA4;GSTM1;HPGDS;MGST1;ESD;MGST3;GSTM5;GSTO2;GSTK1
prerank,glutathione derivative biosynthetic process (GO:1901687),-0.3062010767077201,-0.9118525528183575,0.5539568345323741,0.8692362082851315,1.0,9/20,31.83%,GSTA4;GSTM1;HPGDS;MGST1;ESD;MGST3;GSTM5;GSTO2;GSTK1
prerank,mitotic DNA damage checkpoint signaling (GO:0044773),0.31922774895337075,0.9116427878140358,0.6123853211009175,1.0,1.0,15/57,17.87%,WAC;TIPIN;MRNIP;BRCA1;ATF2;TAOK3;STK33;MDC1;RPA2;TOPBP1;ATM;BLM;RPS27L;TP53;FBXO31
prerank,neuron projection fasciculation (GO:0106030),0.42645440113188815,0.9113321263345465,0.56957928802589,1.0,1.0,5/10,18.89%,NRCAM;EPHB2;CDK5R1;RTN4;CNTN4
prerank,Golgi ribbon formation (GO:0090161),0.4052149773998221,0.9108988504025517,0.5694864048338368,1.0,1.0,2/13,8.69%,VAMP4;TRIP11
prerank,mRNA metabolic process (GO:0016071),0.3070079463579598,0.9108724345883304,0.6423200859291085,1.0,1.0,18/90,17.36%,CSTF3;DXO;CPSF6;METTL3;SON;SRSF11;AURKAIP1;ALKBH5;NCBP1;ZFP36L2;SFPQ;LSM3;PRKACA;PRPF18;TP53;PNPT1;SF3A1;SSB
prerank,transepithelial transport (GO:0070633),0.4058861255755471,0.9105509036388485,0.5834564254062038,1.0,1.0,4/15,17.07%,SLC1A3;SLC12A2;GPLD1;ABCC1
prerank,"positive regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043517)",0.41434400150490747,0.9104513485224461,0.5972434915773354,1.0,1.0,4/13,15.47%,SPRED2;SPRED1;SPRED3;ATM
prerank,negative regulation of receptor binding (GO:1900121),-0.37285187656580754,-0.9102889485781095,0.5561797752808989,0.8719268768987017,1.0,4/10,22.57%,ADAM15;ATP2A3;HFE;ATP2A2
prerank,phagosome maturation (GO:0090382),0.3421560781856116,0.9101481138187979,0.6090686274509803,1.0,1.0,14/35,27.43%,RAB38;RAB14;ATP6V1B2;RAB34;RAB39A;MREG;ATP6V1C1;RAB7A;ATP6V0E2;ATP6V0E1;ATP6V1G2;ATP6V1H;TCIRG1;ATP6V1D
prerank,negative regulation of protein localization to plasma membrane (GO:1903077),0.3825834452448864,0.9098208445904838,0.5945205479452055,1.0,1.0,4/20,11.37%,PKDCC;TGFB1;CSK;PID1
prerank,ERAD pathway (GO:0036503),0.3047101352913719,0.9094088907070559,0.6278563656147987,1.0,1.0,31/83,26.28%,PRKN;ERLIN2;DNAJB9;RHBDD2;UGGT2;RCN3;FBXO27;DERL2;SELENOS;HERPUD1;UBE2J2;RNF121;FBXO17;TMUB2;HSP90B1;CCDC47;JKAMP;ERLIN1;DNAJC10;USP13;SGTA;UBXN6;RHBDD1;FBXO44;UBQLN1;UBQLN2;MAN1B1;UBXN8;ERLEC1;TMEM67;SGTB
prerank,protein modification by small protein removal (GO:0070646),0.2854475634595145,0.9093202391283138,0.704225352112676,1.0,1.0,67/252,22.26%,USP50;MYC;PTEN;RAD23B;USP35;KAT2B;USP11;PRKN;SENP3;DDB2;OTUD7B;UCHL5;INO80E;BRCA1;PSMB7;UCHL1;USP46;HIF1A;TOMM20;MYSM1;USP33;ESR1;UCHL3;NFRKB;USP32;USP48;GATA3;NEDD8;USP40;MDM4;SENP2;PSMD2;USP14;UBB;IL33;PSMC1;TRRAP;TP53;USP1;ASXL2;USP25;USP21;PSMB2;USP2;RIPK1;OTUD4;MDM2;USP37;RHOT1;OTUD7A;PSMD9;ATXN7;USP5;SENP1;PSME4;COPS6;MCRS1;MBD6;USP13;PSMA8;COPS7A;JOSD1;TNIP2;ARRB2;USP31;ACTR5;RNF123
prerank,positive regulation of receptor signaling pathway via JAK-STAT (GO:0046427),0.3708440261984518,0.9092539635140384,0.5910987482614742,1.0,1.0,4/23,12.77%,CRLF3;CYP1B1;ERBB4;PRLR
prerank,DNA strand elongation (GO:0022616),-0.31181492892888085,-0.9092134504081703,0.5704225352112676,0.8731959429054758,1.0,11/18,30.86%,POLD3;POLA1;TERT;DCLRE1B;NBN;RFC3;GINS4;POLD2;MRE11;GINS1;MCM3
prerank,tRNA transport (GO:0051031),0.3390398031162696,0.9084578860589893,0.6027568922305765,1.0,1.0,10/35,17.36%,RANBP2;NUP155;TOMM20;NUP205;NDC1;NUP160;XPOT;POM121;AAAS;SSB
prerank,tRNA 5'-end processing (GO:0099116),0.39214902778807,0.90836379547787,0.5632183908045977,1.0,1.0,5/15,17.36%,RPP38;PRORP;POP1;RPP21;SSB
prerank,"negative regulation of gene expression, epigenetic (GO:0045814)",0.365930486703881,0.90834115315569,0.5862977602108037,1.0,1.0,14/24,31.27%,EED;CREBZF;EPC1;JARID2;RBBP4;PHF19;RBBP7;MPHOSPH8;AEBP2;EZH2;DNMT1;SMYD5;DNMT3B;PPHLN1
prerank,intrinsic apoptotic signaling pathway (GO:0097193),0.3024796058484532,0.9078918182845647,0.628632938643703,1.0,1.0,20/94,16.48%,PYCARD;BCL2;SCN2A;TNFRSF10B;PPP1R15A;APAF1;CYP1B1;BNIP3;BRCA1;CUL3;HINT1;MSH6;ARL6IP5;TMEM117;CASP2;ATM;ABL1;TP53;BCL2L11;QRICH1
prerank,positive regulation of endothelial cell apoptotic process (GO:2000353),-0.32630871634887204,-0.9076189860892743,0.6090909090909091,0.8758089892686546,1.0,6/14,21.65%,PRKCI;THBS1;RGCC;ECSCR;GPER1;CD40
prerank,retrograde axonal transport (GO:0008090),-0.3206753085907077,-0.9074706823848541,0.6006191950464397,0.8748709590559295,1.0,4/16,11.34%,KIF1C;PAFAH1B1;KIF5B;SOD1
prerank,positive regulation of intrinsic apoptotic signaling pathway (GO:2001244),0.337854719858107,0.9071662132496237,0.6111801242236025,1.0,1.0,9/37,16.06%,BCL2;BMF;FBH1;SFPQ;NACC2;NCK1;UBB;TP53;BCL2L11
prerank,mitotic spindle organization (GO:0007052),0.2901774533693975,0.9071611032443921,0.6652892561983471,1.0,1.0,22/153,14.45%,DYNLL1;EFHC1;XPO1;GPSM2;TBCE;RANBP2;EML1;ARHGEF10;NDE1;STAG2;FLNA;DYNC1I1;RCC1;CLASP1;NUP160;SGO1;ZWINT;CKAP5;KPNB1;BUB1B;DYNC1I2;ITGB3BP
prerank,regulation of response to external stimulus (GO:0032101),0.2935680628030034,0.9066470796137809,0.6440677966101694,1.0,1.0,24/121,17.78%,ADAMTS12;PDGFRA;RHO;PTPN22;BST1;EPHB2;ELMOD2;CCR2;WNT5A;IL1RL2;UFL1;GATA6;CASP12;GRN;SHPK;P2RY12;CALM1;USP14;AREL1;XIAP;N4BP1;EFNB2;SPAAR;PTGES
prerank,cellular senescence (GO:0090398),-0.27780147176369707,-0.9065962151245232,0.6157024793388429,0.8758411130129763,1.0,12/27,26.36%,PRKCD;TBX3;TERF2;MAP2K1;ID2;PML;HMGA2;ECRG4;ULK3;CALR;HRAS;SRF
prerank,sequestering of extracellular ligand from receptor (GO:0035581),0.41595074688347916,0.9065820422178552,0.5673652694610778,1.0,1.0,3/13,11.11%,CHRDL1;DAND5;LTBP1
prerank,negative regulation of type I interferon-mediated signaling pathway (GO:0060339),0.4044011192564134,0.9063178451537114,0.5811594202898551,1.0,1.0,2/15,6.20%,PTPN2;METTL3
prerank,"nucleotide-excision repair, DNA incision (GO:0033683)",0.3386564140005478,0.9062087310122618,0.5992555831265509,1.0,1.0,10/39,17.08%,GTF2H2;ERCC5;ERCC4;DDB2;RPA3;XPA;DDB1;RPA2;UBB;CUL4B
prerank,cellular response to interferon-beta (GO:0035458),-0.33398323533382335,-0.9058607894695387,0.5922330097087378,0.8764155040884076,1.0,7/14,23.07%,AIM2;IRGM;IRF1;IFITM2;UBE2G2;HTRA2;CDC34
prerank,cellular response to interferon-gamma (GO:0071346),-0.22308445264606044,-0.9058498355765617,0.7037037037037037,0.8751534825773792,1.0,18/88,15.58%,DAPK1;SP100;CCL25;PRKCD;TLR4;TRIM25;CCL15;IRF2;CAMK2G;TRIM5;ICAM1;GBP3;IRF1;CAMK2A;OAS2;PML;VCAM1;IRF9
prerank,extrinsic apoptotic signaling pathway (GO:0097191),0.31405227221743265,0.9047523182654569,0.6316989737742303,1.0,1.0,7/70,6.95%,ERBB3;BCL2;NGF;FADD;TNFRSF10B;TGFB1;DEDD
prerank,negative regulation of mitotic cell cycle phase transition (GO:1901991),-0.2125203458890376,-0.9047427970154419,0.7340425531914894,0.8766440363864292,1.0,24/87,19.43%,KANK2;DCUN1D3;PSMD14;BRD7;FBXL7;USP47;ZFP36L1;PSMB3;PSMD12;RGCC;KLF4;PRMT2;PSMD6;PSMA1;FAM107A;PSMD7;PSMA5;PSMC5;PINX1;PSMC4;CDK4;PSMB6;RBL1;PSMA4
prerank,protein targeting to mitochondrion (GO:0006626),0.31776985971965305,0.9045593031583669,0.6075205640423031,1.0,1.0,16/52,20.89%,MIPEP;FBXO7;TOMM22;PMPCB;AIP;TOMM20;HSPA4;GDAP1;NDUFA13;DNAJC19;PAM16;AIFM1;AGK;PMPCA;TSPO;HSPD1
prerank,glycolytic process (GO:0006096),-0.27289790937859876,-0.9042061222193729,0.5892116182572614,0.8766969311899134,1.0,12/28,30.52%,PGK1;PGAM4;PGAM1;GPI;PFKM;PFKL;ENO1;GAPDHS;ENO3;PKM;PFKFB2;LDHA
prerank,regulation of Rho protein signal transduction (GO:0035023),0.30659394009286567,0.9040750741753116,0.6216517857142857,1.0,1.0,14/72,15.54%,DLC1;AKAP13;LPAR1;GPR65;ARHGEF28;EPS8L1;COL3A1;CUL3;MYO9B;OPHN1;MYOC;ARHGEF3;MET;ABL1
prerank,mRNA export from nucleus (GO:0006406),0.30076506080263604,0.9040559841204205,0.646236559139785,1.0,1.0,36/102,26.36%,THOC6;RANBP2;NUP155;MCM3AP;SRSF11;CASC3;ALKBH5;NCBP1;FIP1L1;NUP205;NDC1;NUP160;UPF1;DDX25;NXT1;SRSF6;YTHDC1;POM121;SMG6;AAAS;NXF1;RNPS1;PCID2;THOC7;SRRM1;SRSF3;FYTTD1;NUP42;GLE1;SYMPK;THOC5;MAGOHB;ENY2;NUP35;HNRNPA2B1;RAE1
prerank,positive regulation of ubiquitin-protein transferase activity (GO:0051443),0.34810179467078817,0.9038803651292051,0.6024844720496895,1.0,1.0,3/31,3.89%,PTEN;GORASP1;FBXW7
prerank,membrane depolarization during action potential (GO:0086010),0.35745225071181935,0.9037415919301917,0.6056149732620321,1.0,1.0,4/26,6.94%,SCN7A;SCN2A;SCN5A;SCN3A
prerank,cellular zinc ion homeostasis (GO:0006882),-0.27457857708705236,-0.9036841136794526,0.6224899598393574,0.8766767331690632,1.0,8/26,24.09%,SLC30A10;SLC39A8;SLC39A6;SLC30A1;SLC39A10;MT2A;SLC39A13;ATP13A2
prerank,purinergic nucleotide receptor signaling pathway (GO:0035590),0.3798865481471366,0.9034973612555555,0.5825242718446602,1.0,1.0,3/20,7.90%,PYCARD;ANO6;IL18
prerank,cellular response to superoxide (GO:0071451),-0.3746427710196619,-0.9033537052811114,0.5284090909090909,0.8761888478191715,1.0,4/10,11.34%,NOS3;ATP7A;ADPRS;SOD1
prerank,cytoplasmic sequestering of protein (GO:0051220),-0.3323173494036096,-0.9033464951366136,0.5858895705521472,0.8749347112721034,1.0,5/13,14.08%,NFKBIA;GOPC;KEAP1;GET4;MDFI
prerank,intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:0042771),0.377125761021503,0.9030107270119695,0.5939643347050755,1.0,1.0,4/19,15.90%,PYCARD;AEN;RPS27L;TP53
prerank,glycerolipid metabolic process (GO:0046486),-0.3560522328013802,-0.9027233730694695,0.5735294117647058,0.8751802083441289,1.0,6/11,29.07%,GAL3ST1;PLA2G15;PGP;DGKG;PNPLA3;DGKB
prerank,negative regulation of interleukin-10 production (GO:0032693),-0.32486015607315527,-0.9025094097996726,0.5785953177257525,0.8744226646109412,1.0,12/16,51.69%,TNFRSF21;TYROBP;DLL1;VSIR;AGER;LILRB1;PDCD1LG2;IL23A;FOXP3;IL23R;TRIB2;IL12B
prerank,regulation of protein binding (GO:0043393),-0.2072958179588062,-0.9024606710415316,0.78125,0.8732714675738757,1.0,37/114,22.44%,DAB2;ROCK1;VTN;CLDN5;PRKCD;BMP4;EPB41;IFIT2;KDM1A;PRMT7;NVL;APP;GSK3B;CAMK1;RACK1;MARK2;HDAC4;SNAPIN;PRMT8;RPL11;STK3;PEX14;TERT;FLOT1;HIP1R;CAV1;TRIM21;GTF2F1;ZFPM1;CFHR2;HFE;ADD2;MARK3;IFIT1;GAS8;HDAC5;AKT1
prerank,myoblast fusion (GO:0007520),0.41829936080335894,0.9024366053151709,0.6050670640834576,1.0,1.0,4/12,21.90%,ADGRB3;CD9;ADAM12;CACNA1H
prerank,positive regulation of keratinocyte differentiation (GO:0045618),0.4282483437049396,0.9023950420707848,0.5806451612903226,1.0,1.0,1/10,0.88%,ETV4
prerank,regulation of cellular protein catabolic process (GO:1903362),0.37744749773160324,0.9021637814088185,0.5732574679943101,1.0,1.0,8/18,26.62%,VGLL4;VPS11;ATRAID;DACT1;RDX;PTTG1IP;CDK5RAP3;VPS35
prerank,regulation of interleukin-8 production (GO:0032677),0.31181006507496445,0.9020279402639694,0.6324689966178129,1.0,1.0,18/69,24.51%,PYCARD;PTPN22;FADD;OTUD7B;TLR1;RAB1A;SSC5D;CD74;RIPK1;MAPKBP1;LBP;PARK7;BCL10;STAT3;PRKD2;BCL3;MAVS;HSPA1A
prerank,long-chain fatty acid metabolic process (GO:0001676),0.3109361234047124,0.9015666846983663,0.6258581235697941,1.0,1.0,11/64,15.26%,FADS2;SLC27A4;LTA4H;CYP1B1;AIG1;ACOX1;ELOVL6;ELOVL5;PNPLA8;ACAD9;ACSL3
prerank,regulation of interleukin-13 production (GO:0032656),-0.33235023001993175,-0.9014163301322056,0.54375,0.8745498722851048,1.0,5/13,24.24%,LEF1;PRKCZ;RARA;TNFRSF21;SPHK2
prerank,post-translational protein modification (GO:0043687),0.2802698040144548,0.9013835961554432,0.7532729103726082,1.0,1.0,77/332,21.36%,GPC3;VCAN;MXRA8;FBXW9;CHRDL1;LAMC1;RAB38;SOCS5;FBXW7;SPSB4;PRKCSH;ASB8;NUCB1;SDC2;KLHL13;OBSL1;FBXO7;FBXL15;DDB2;ASB5;FBXO32;ZBTB16;EVA1A;RCN1;MEN1;NAE1;ATG5;STT3A;VWA1;FBXL16;PSMB7;FBXO27;CKAP4;HIF1A;AMELX;CUL3;UCHL3;LTBP1;CALU;UBA3;FBXO17;RAB1A;FUCA2;DCAF8;RAB3A;BTBD1;HSP90B1;DDB1;PENK;SUMF1;NEDD8;DDA1;PSMD2;KLHL22;PSMC1;FBXL4;PSMB2;CUL4B;FBXO31;FBXO22;ELOC;PSMD9;CHM;FBXO11;PSME4;FBXL12;MBTPS1;FAM20C;DCAF7;COPS6;RBBP7;DCAF11;PSMA8;COPS7A;PDIA6;RHBDD1;DCAF6
prerank,relaxation of cardiac muscle (GO:0055119),-0.3285850219071419,-0.9012802183793547,0.5922619047619048,0.8736200241061622,1.0,3/13,6.72%,ATP1A2;KCNJ2;ATP1A1
prerank,"positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900153)",0.3999034388252257,0.9012613432617543,0.6105563480741797,1.0,1.0,3/15,9.99%,PABPC1;CPEB3;ZFP36L2
prerank,"regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900151)",0.3999034388252257,0.9012613432617543,0.6105563480741797,1.0,1.0,3/15,9.99%,PABPC1;CPEB3;ZFP36L2
prerank,positive regulation of macrophage migration (GO:1905523),-0.2935431681821238,-0.9012269922887273,0.6245487364620939,0.8724749599676788,1.0,3/19,7.52%,IL34;THBS1;AKIRIN1
prerank,regulation of cyclin-dependent protein kinase activity (GO:1904029),0.32351061858079605,0.9007255628626473,0.6176821983273596,1.0,1.0,22/50,29.71%,CDKN2B;CCNJ;PKMYT1;CDK5R1;TTBK1;CDK5R2;BLM;CCND2;BCCIP;CCNT2;CCNH;CDC37;CDK5RAP3;CDKN1A;CCND3;CCNI;GTPBP4;CCNE1;CDKN1C;CDKN2D;CDKN1B;CAMK2N1
prerank,steroid metabolic process (GO:0008202),0.31292586073474665,0.900689355778913,0.6361607142857143,1.0,1.0,16/72,25.14%,HSD17B7;NPC1;GBA2;CYP39A1;CYP1B1;CYP7B1;PRLR;CYP27A1;LRP2;TSPO;SCP2;GC;HSD17B4;SULT1A1;STARD3;AMACR
prerank,regulation of keratinocyte differentiation (GO:0045616),0.36407042027069486,0.9004744573725124,0.6032608695652174,1.0,1.0,4/24,6.64%,ETV4;CBFB;HOXA7;CTSK
prerank,programmed necrotic cell death (GO:0097300),0.378153802845371,0.9004210446418272,0.6100543478260869,1.0,1.0,5/18,23.27%,ITPK1;TICAM1;RIPK1;MLKL;CYLD
prerank,oogenesis (GO:0048477),0.3892277385970775,0.9004183891835784,0.6072992700729927,1.0,1.0,6/15,23.00%,FMN2;METTL3;MDK;MARF1;KMT2D;MEI4
prerank,positive regulation of dephosphorylation (GO:0035306),0.35756387816117774,0.9000904839606366,0.6038961038961039,1.0,1.0,2/27,4.08%,DLC1;TGFB1
prerank,cellular respiration (GO:0045333),-0.24394007239825927,-0.9000755927183031,0.6878306878306878,0.8740353689039421,1.0,18/41,28.41%,COQ10B;SDHB;SIRT3;OXA1L;UQCRB;ATP5F1D;ETFRF1;ETFB;SDHA;SDHAF4;UQCR10;UQCRH;UQCRFS1;UQCRC1;CYCS;SURF1;NR4A3;MTFR2
prerank,positive regulation of autophagy (GO:0010508),0.30055493799146116,0.8996013367439358,0.6591928251121076,1.0,1.0,7/81,7.73%,DCN;PRKN;NPRL2;WAC;FBXO7;UFL1;BNIP3
prerank,regulation of sensory perception of pain (GO:0051930),-0.3534232665782423,-0.8993822173645475,0.5693215339233039,0.8745145318236107,1.0,6/11,34.07%,ATPSCKMT;MGLL;TMEM100;ACP3;SPX;F2R
prerank,positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway (GO:0051482),0.34658420230625364,0.8991635613236324,0.6030927835051546,1.0,1.0,4/27,12.69%,LPAR1;GPR65;HTR2C;DRD2
prerank,protein insertion into mitochondrial membrane (GO:0051204),0.3630512385107222,0.8987188925707948,0.5806896551724138,1.0,1.0,7/23,17.98%,BMF;TOMM22;COX18;HSPA4;BCL2L11;NDUFA13;AGK
prerank,positive regulation of vasculogenesis (GO:2001214),0.4256032706824112,0.898587896104073,0.567479674796748,1.0,1.0,2/10,7.42%,CD34;RAP1A
prerank,cilium movement (GO:0003341),0.3189111328996964,0.8983352422805454,0.6150121065375302,1.0,1.0,7/47,17.71%,DNAI4;CCDC39;DNHD1;CFAP91;CFAP61;DNAAF2;RSPH9
prerank,neural crest cell differentiation (GO:0014033),0.37747680705260295,0.8983344897196185,0.6008583690987125,1.0,1.0,2/18,4.44%,SOX8;SOX11
prerank,vascular transport (GO:0010232),0.3051757890824668,0.8978116165778229,0.6465997770345596,1.0,1.0,10/81,5.90%,SLC22A3;SLC1A3;SLC27A1;SLC1A5;SLC5A3;LRP1;SLC27A4;SLC12A2;SLCO2B1;SLC29A1
prerank,negative regulation of proteasomal protein catabolic process (GO:1901799),0.3366200414392761,0.8976728171889435,0.6129032258064516,1.0,1.0,14/36,24.93%,WAC;UCHL5;BAG5;TLK2;TAF9;OPHN1;GABARAPL2;USP25;N4BP1;PARK7;CAMLG;PRKCG;ALAD;FHIT
prerank,regulation of substrate adhesion-dependent cell spreading (GO:1900024),0.324245261275616,0.8971962547015246,0.6145710928319624,1.0,1.0,19/47,26.63%,OLFM4;EFNA5;DOCK5;FLNA;DOCK1;MYOC;ABL1;RAC3;AP1AR;MDK;TESK1;KANK1;TRIOBP;SPRY4;CRK;CIB1;ARHGEF7;CORO1C;LIMS1
prerank,carboxylic acid transmembrane transport (GO:1905039),0.3301486924831859,0.8967209642046883,0.6060975609756097,1.0,1.0,10/40,17.07%,SLC27A1;SLC25A21;SLC38A4;SLC36A2;SLC7A7;SLC7A8;SLC25A10;SLC16A1;SLC25A11;ABCC1
prerank,regulation of potassium ion transmembrane transporter activity (GO:1901016),0.3545108404670917,0.8963662423041421,0.6005221932114883,1.0,1.0,6/26,19.41%,ANK2;STK39;NEDD4L;ITGB1;NETO1;CAB39
prerank,negative regulation of transcription by RNA polymerase II (GO:0000122),0.27720251152310005,0.8963264005239908,0.816,1.0,1.0,129/572,22.09%,OSR2;PTCH1;TENM2;MLIP;GLI2;SOX8;AASS;PRDM16;MYC;TGIF2;CBFB;ZNF25;SOX9;PRKN;RIPPLY2;SUV39H1;HIVEP1;OTP;HOXA7;SATB1;VEGFA;NFX1;FOXP2;GATAD2A;PSEN1;EZH1;SOX11;NUPR2;ZEB1;URI1;EED;OTUD7B;ZBTB16;RORC;MTA2;MLX;TRPS1;DRAP1;E2F6;LRRFIP1;GATA6;CBX4;MEN1;FOXM1;CHD3;VPS72;CPEB3;ATRX;KCTD1;RARG;MBD2;RARB;PPID;LDB2;HDAC2;NFATC3;ESR1;SIN3B;SFPQ;SIRT6;DCAF1;EPC1;PER3;ZGPAT;FOXP4;ZBTB1;NR6A1;NRIP1;ZFPM2;PER1;GATA3;NACC2;SNCA;LCOR;MDM4;NEDD4L;SUMO1;CRY1;NCOR2;CITED2;TAF7;CREM;ZEB2;UBB;IL33;MED25;DACT1;RUNX1;TP53;MTA3;SREBF2;HNRNPU;WWOX;FOXJ1;USP2;CDC73;NFIX;CTBP1;SUFU;MDM2;KLF7;FNIP1;TAF1;SEMA4D;CGGBP1;CNBP;BCOR;PPARG;JUN;STAT3;PRDM2;YEATS2;ORC2;SMARCA4;JDP2;ZFP36;NR1D2;GATAD2B;DPF2;NFKB1;MITF;THRA;NSD1;ZMYM5;ZNF8;UBE2D3;CBX5;PPM1A;IRF8
prerank,mitochondrial genome maintenance (GO:0000002),0.427882622516086,0.8963077934247258,0.610062893081761,1.0,1.0,8/11,27.59%,AKT3;OPA1;TOP3A;MGME1;MEF2A;SLC25A36;MPV17;LONP1
prerank,establishment or maintenance of apical/basal cell polarity (GO:0035088),0.3663810049155299,0.8961024851112627,0.5986206896551725,1.0,1.0,7/19,16.83%,DLG2;PATJ;ERBIN;SCRIB;PARD3B;FSCN1;FOXJ1
prerank,toll-like receptor signaling pathway (GO:0002224),0.3028798247387793,0.896014699529961,0.6556655665566556,1.0,1.0,23/84,22.71%,FADD;IRAK3;MAPKAPK3;MAPKAPK2;CTSK;CTSB;TLR1;HSP90B1;UNC93B1;TICAM1;UBB;RIPK1;CHUK;TRIL;LBP;TAB3;BCL10;SCARA3;HSPD1;TNIP2;RPS6KA3;UBE2D3;TAB2
prerank,exit from mitosis (GO:0010458),-0.33948078691723294,-0.8959794517119055,0.5626822157434402,0.881261761528902,1.0,5/12,24.42%,PPP2R2D;EPS8;CTDP1;CHMP7;SIRT7
prerank,purine ribonucleotide catabolic process (GO:0009154),0.3646573620453363,0.8959666114961884,0.5975274725274725,1.0,1.0,6/21,12.50%,NT5C2;PDE9A;HINT1;PDE4D;NUDT10;NUDT3
prerank,long-chain fatty-acyl-CoA metabolic process (GO:0035336),-0.28324635129389647,-0.8956673143210605,0.6303501945525292,0.8808020769770387,1.0,4/23,7.14%,ACSL1;ELOVL7;FAR2;ACSL5
prerank,sensory organ development (GO:0007423),-0.23537562758021335,-0.8955873530643282,0.6815286624203821,0.879721738775392,1.0,12/51,17.57%,SMOC1;RBP4;SIPA1L3;PBX3;STRA6;ECE1;TGFB2;PBX4;SHROOM2;SMG9;MAFB;PBX2
prerank,replicative senescence (GO:0090399),-0.35188389655529473,-0.8953830018684847,0.5887323943661972,0.8789351719363285,1.0,8/12,30.00%,SERPINE1;TERT;PLA2R1;WNT16;ROMO1;MME;CHEK2;CHEK1
prerank,RNA catabolic process (GO:0006401),0.33086807826545417,0.8951440060155277,0.6224366706875754,1.0,1.0,8/46,12.38%,RNASE6;DXO;METTL3;XRN2;PPP1R8;NCBP1;ZFP36L2;RNASEH2C
prerank,hepatocyte growth factor receptor signaling pathway (GO:0048012),-0.3571058442530166,-0.8951390279585733,0.6086956521739131,0.8782856740934886,1.0,2/11,6.75%,NRP1;BCAR1
prerank,modification-dependent macromolecule catabolic process (GO:0043632),0.41951861459669937,0.8949185976038423,0.565149136577708,1.0,1.0,3/10,15.16%,TUT4;NEDD8;UBB
prerank,negative regulation of plasma membrane bounded cell projection assembly (GO:0120033),0.35269090845286494,0.8946375090348903,0.6010568031704095,1.0,1.0,1/25,0.13%,ARHGAP24
prerank,actin polymerization or depolymerization (GO:0008154),0.32010548655066556,0.8945965358911331,0.6138259833134684,1.0,1.0,4/50,3.06%,ENAH;SPIRE1;GSN;GAS7
prerank,negative regulation of interleukin-12 production (GO:0032695),0.39542640958677633,0.8944113227357582,0.5967976710334789,1.0,1.0,1/14,3.52%,IRAK3
prerank,transport across blood-brain barrier (GO:0150104),0.3032790679966725,0.8942732650680043,0.6511627906976745,1.0,1.0,10/83,5.90%,SLC22A3;SLC1A3;SLC27A1;SLC1A5;SLC5A3;LRP1;SLC27A4;SLC12A2;SLCO2B1;SLC29A1
prerank,negative regulation of hemostasis (GO:1900047),-0.34613724498848386,-0.8941267930493477,0.5882352941176471,0.8794421063268921,1.0,6/12,18.76%,VTN;THBD;TFPI;SERPINE1;EDN1;APOE
prerank,positive regulation of peptidyl-threonine phosphorylation (GO:0010800),0.3649582563324903,0.8940100586780965,0.6134800550206327,1.0,1.0,10/23,19.41%,WNK3;TGFB1;UBE2K;MAPK1;BMP7;CALM1;CALM2;RPTOR;S1PR2;CAB39
prerank,response to hexose (GO:0009746),0.3545588890885397,0.893670125099795,0.6092105263157894,1.0,1.0,5/25,17.18%,IRS2;EIF2B5;SELENOS;GPLD1;EIF2B2
prerank,regulation of transcription initiation from RNA polymerase II promoter (GO:0060260),0.3155167879043063,0.8936478242016792,0.6520231213872832,1.0,1.0,7/60,6.18%,PTEN;CBFB;SOX9;CCNC;MED31;ATF7IP;CDK8
prerank,protein modification by small protein conjugation (GO:0032446),0.2769261095527316,0.8935395768667248,0.7827827827827828,1.0,1.0,83/361,19.98%,UBE2T;PDZRN3;RNF157;PRKN;DTX4;HACE1;WAC;NFX1;TRIM44;FBXW7;SPSB4;RANBP2;RNF6;KLHL13;UBA2;FBXO7;FBXL15;ASB5;FBXO32;NUP155;UFL1;OTULIN;TRIM11;NAE1;BRCA1;UBE2K;VPS11;HIF1A;PIAS2;CUL3;SELENOS;UHRF2;UBE2Z;HUWE1;ANAPC7;FBXO45;CBL;FBH1;NUP205;NFE2L2;UBE2J2;UCHL3;NDC1;TSPAN17;TRIM41;NUP160;UBA3;FBXL2;MYLIP;ATG3;DDB1;DET1;NEDD8;TRIM23;NEDD4L;SUMO1;TRAF7;UBB;AREL1;RCHY1;CDC23;POM121;RNF111;ZSWIM8;ANAPC16;AAAS;RNF182;MIB1;CUL4B;CDC73;UBA1;MDM2;ELOC;USP5;PCNP;FBXO11;BCL10;UBE2L3;RRAGA;CDC27;TRAIP;TRIM35;UBE2G1
prerank,positive regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032436),0.2989582271646153,0.8930383378240647,0.630718954248366,1.0,1.0,28/78,23.12%,PRKN;SOCS5;CBFA2T3;HERPUD1;NFE2L2;SIRT6;PRICKLE1;DVL1;CSNK1A1;DET1;DDA1;SUMO1;RNF19A;RCHY1;CSNK1E;FBXO22;MDM2;ZER1;TAF1;USP5;NKD2;BBS7;SGTA;ELOB;UBQLN1;ZYG11B;UBQLN2;COP1
prerank,organelle assembly (GO:0070925),0.27616378365368277,0.892920442060472,0.7889447236180904,1.0,1.0,80/384,19.67%,DYNLL1;PTPDC1;RHO;BICD1;CD34;WDPCP;GSN;STK36;RAB38;SQLE;CC2D2A;HAUS3;ARL3;PACS2;NEK1;CCDC57;RFX2;STARD9;TTC39C;IFT140;PCM1;RILPL2;SNAP29;WIPI1;ATXN2;BBS9;RFX3;DISC1;GBF1;CPLANE1;ATG5;BBS5;FLNA;WDR35;TUBGCP5;VPS37B;FARP2;RCC1;ARF4;HDAC6;POGZ;GORASP2;VPS36;SNX10;RAB1A;LSM3;CEP89;ATG3;MVB12A;NEK7;CFAP20;FBF1;TRAPPC14;CCDC28B;RAB11FIP3;PKD1;PDCD6IP;EHD2;GABARAPL2;CCDC65;CHMP4C;EIF4ENIF1;CDC14A;TRAPPC6A;ANLN;FOXJ1;HPS1;CEP63;MYH6;RC3H1;RAB7A;GALNT11;KIF3A;MAPRE3;FLII;UBAP2L;IFT81;CENPC;CCDC66;CHMP1B
prerank,regulation of DNA replication (GO:0006275),0.31562018731759595,0.8929127101717447,0.623391812865497,1.0,1.0,16/49,24.74%,GLI2;EGFR;GLI1;STN1;ZBTB38;BLM;FBXO5;USP37;CCDC88A;BCAR3;CTC1;PPP2R1A;KAT7;ORC3;ATR;EHMT2
prerank,regulation of chemotaxis (GO:0050920),0.34680362978516777,0.8928505833377516,0.6297262059973925,1.0,1.0,7/30,16.91%,PDGFRA;PTPN2;TGFB1;P2RY12;USP14;ZSWIM8;EFNB2
prerank,protein prenylation (GO:0018342),-0.3740490028325947,-0.8928212703710385,0.6106194690265486,0.881175718644169,1.0,6/10,30.34%,PGGT1B;CHML;FNTB;RCE1;FNTA;RABGGTA
prerank,regulation of mRNA metabolic process (GO:1903311),0.4215346716517729,0.8924741507277686,0.5812883435582822,1.0,1.0,3/11,24.50%,NCBP1;SLTM;SAFB2
prerank,motor neuron axon guidance (GO:0008045),-0.33106574872340533,-0.892392538262211,0.5740740740740741,0.8810122659741811,1.0,3/15,6.20%,EPHA4;SLIT2;TMEFF1
prerank,positive regulation of developmental growth (GO:0048639),0.318555217509598,0.8922199069839042,0.6362530413625304,1.0,1.0,16/49,23.56%,RNF157;NGF;PLCB1;SYT1;CDKL5;LIMK1;RIMS1;NEDD4L;PLAA;SYT2;RIMS2;SEMA4D;SHTN1;GHR;CPNE5;SYT3
prerank,negative regulation of chemotaxis (GO:0050922),0.34037792172640546,0.8920552739897513,0.625169147496617,1.0,1.0,4/31,3.81%,SEMA3E;PTPN2;SEMA6C;SEMA3A
prerank,negative regulation of programmed cell death (GO:0043069),0.27682022418365215,0.8909545915294622,0.7703109327983951,1.0,1.0,81/355,18.99%,FFAR4;SOX8;MYC;RNF157;BCL2;DPEP1;SOX9;NGF;EGFR;FMN2;MAP4K4;VEGFA;EGR3;ARAF;THOC6;WNK3;ERCC5;PSEN1;FANK1;MT3;WNT5A;YWHAZ;RASA1;NAA35;SON;NAA16;GATA6;CBX4;BNIP3;FLNA;CRYAB;PRDM9;ASNS;HDAC2;UBE2Z;PIK3R1;GDNF;NGFR;CBL;ARF4;TAF9;IL6ST;MYDGF;TAX1BP1;PRLR;PRDX3;ATF5;HSP90B1;YME1L1;MALT1;TM7SF3;SNCA;PSEN2;CITED2;OPA1;ZFAND6;MET;UBB;CASP2;AREL1;UBE2O;PIM2;BNIP1;TP53;CCND2;LRP2;XIAP;HTATIP2;PAX2;CD74;RIPK1;PCID2;DNAJA1;HSPA9;CAT;RAB7A;NAA15;AATF;PARK7;SEMA4D;AXL
prerank,regulation of protein modification process (GO:0031399),0.3201087175131976,0.8908516819310113,0.6330935251798561,1.0,1.0,9/50,9.88%,KAT2B;CADM4;MT3;SOCS1;SPRED2;SPRED1;RABL3;GRM5;SPRED3
prerank,negative regulation of osteoblast differentiation (GO:0045668),0.34175198359898845,0.890762015655073,0.6435897435897436,1.0,1.0,5/31,7.62%,PTCH1;SOX9;TWIST2;CDK6;MEN1
prerank,regulation of MAP kinase activity (GO:0043405),0.29650690216304765,0.8904998203919254,0.6721491228070176,1.0,1.0,14/92,11.59%,FGF2;ERBB2;EGFR;VEGFA;IRAK3;TGFB1;NF1;KSR1;FGFR1;UCHL1;PTPN1;PTPRJ;BMP7;EDN3
prerank,positive regulation of histone modification (GO:0031058),0.3372799797735876,0.8900787142421752,0.5972045743329097,1.0,1.0,3/33,8.59%,FAM47E;RPS6KA4;BRCA1
prerank,regulation of vasculature development (GO:1901342),0.3530449743651551,0.8898861471298909,0.6030341340075853,1.0,1.0,3/26,5.06%,FGF2;ERBB2;NF1
prerank,regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0061178),0.3450091623098034,0.8898596719256666,0.6164921465968587,1.0,1.0,9/26,24.19%,STXBP4;EFNA5;PPP3CB;CDK16;GPLD1;KLF7;ADCY8;TRPM4;ADCY5
prerank,regulation of mitotic cell cycle (GO:0007346),0.2815698236083493,0.889827407718365,0.7125256673511293,1.0,1.0,52/171,25.90%,PRKCA;KIF20B;TGFB1;CCDC57;OBSL1;CKS1B;CDK13;GBF1;PSMB7;ASNS;ANAPC7;RCC1;PKMYT1;CDC25B;ANAPC2;SCRIB;TMEM8B;NEK7;DDB1;SMOC2;BUB1B;PSMD2;IQGAP1;PSMC1;PIM2;CDC23;ANAPC16;HNRNPU;PSMB2;USP2;PKN2;FBXO5;MDM2;PSMD9;PSME4;CDC27;TRIM35;UBE2E1;PSMA8;ANAPC4;HECA;ANAPC5;CDK9;RB1;CYLD;CDC16;BTG3;CUL1;RNF20;PSMD8;PSMD13;DAPK3
prerank,negative regulation of DNA recombination (GO:0045910),0.3225056847711231,0.8897746437806212,0.6306748466257669,1.0,1.0,11/43,16.41%,ZRANB3;POLR2B;ATRX;POLR2K;FBH1;MSH6;POLR2G;RTEL1;CGAS;BLM;TERF2IP
prerank,negative regulation of inflammatory response (GO:0050728),0.282911060141653,0.8895543876403893,0.7216494845360825,1.0,1.0,19/182,13.20%,RORA;FFAR4;CRH;DPEP1;PTPN2;MAPK7;PTHLH;TNFAIP8L2;PRKAR1B;PTH2R;OTULIN;FYN;TSHR;SELENOS;MAPK14;GRN;PRKACA;GLP2R;GATA3
prerank,protein deubiquitination (GO:0016579),0.2797645457572739,0.8895186245308129,0.7316582914572864,1.0,1.0,63/242,22.26%,USP50;MYC;PTEN;RAD23B;USP35;KAT2B;USP11;PRKN;DDB2;OTUD7B;UCHL5;OTULIN;INO80E;BRCA1;PSMB7;UCHL1;USP46;HIF1A;TOMM20;MYSM1;USP33;ESR1;UCHL3;NFRKB;USP32;USP48;GATA3;NEDD8;USP40;MDM4;PSMD2;USP14;UBB;IL33;PSMC1;TRRAP;TP53;USP1;ASXL2;USP25;USP21;PSMB2;USP2;RIPK1;OTUD4;MDM2;USP37;RHOT1;OTUD7A;PSMD9;ATXN7;USP5;PSME4;MCRS1;MBD6;USP13;PSMA8;JOSD1;TNIP2;ARRB2;USP31;ACTR5;RNF123
prerank,mitochondrial translational termination (GO:0070126),0.29648264584104245,0.8894797389315515,0.6597374179431073,1.0,1.0,24/88,22.44%,MRPL47;MRPS18A;MRPL14;MRPL32;MRPL16;MRPL58;MRPS35;MRPS28;AURKAIP1;MRPL35;MRPL30;MRPL28;MRPL46;MRPL51;MRPS30;MRPS14;MRPS9;MRPS31;MRPL1;PTCD3;DAP3;MRPS6;MRPL52;MRPL18
prerank,retina homeostasis (GO:0001895),-0.2893043076621888,-0.8894166262896968,0.6486486486486487,0.886779456304774,1.0,9/23,39.29%,POC1B;SOD1;ACTG1;HSPB1;TULP1;CDH3;CNGB1;JCHAIN;CRB2
prerank,calcium ion transport into cytosol (GO:0060402),0.3655701233379991,0.889306278084318,0.6053333333333333,1.0,1.0,6/21,18.22%,CACNA2D1;GRIN2B;JPH3;GRIN2D;GRIN2A;MS4A1
prerank,posttranslational protein targeting to endoplasmic reticulum membrane (GO:0006620),0.4050227430326133,0.8892590130898609,0.6036036036036037,1.0,1.0,7/12,26.57%,SEC61G;SEC63;SGTA;SEC61A2;SGTB;CHMP4A;CHMP4B
prerank,axonemal dynein complex assembly (GO:0070286),0.3501820435312541,0.8892043046755759,0.6145552560646901,1.0,1.0,2/27,2.93%,DNAI4;CCDC39
prerank,positive regulation of protein polymerization (GO:0032273),0.3065268078443305,0.8891434306477456,0.6602272727272728,1.0,1.0,15/65,16.91%,CCL11;PYCARD;PAK1;BAIAP2;BIN1;ARL2;CLASP1;SLAIN2;CDK5R1;TTBK1;NCK1;MET;CDC42EP1;NAV3;CTTN
prerank,regulation of fibroblast migration (GO:0010762),0.36710633643591606,0.8891180426196192,0.6022099447513812,1.0,1.0,2/20,4.08%,FGF2;TGFB1
prerank,positive regulation of cell growth (GO:0030307),0.3005427603037225,0.8889022350173655,0.6833688699360341,1.0,1.0,25/96,19.93%,RNF157;BCL2;NGF;ERBB2;EGFR;SYT1;CDKL5;LIMK1;DERL2;NCBP1;EIF4G1;EXOSC2;AKAP6;RIMS1;BRAT1;NEDD4L;KLHL22;PLAA;HYAL1;SYT2;RPTOR;RIMS2;SEMA4D;N6AMT1;SHTN1
prerank,histone H3-K4 trimethylation (GO:0080182),0.41056892952157675,0.8887720563322913,0.5997067448680352,1.0,1.0,5/11,23.88%,KMT2A;PRDM9;TET3;KMT2D;TET2
prerank,regulation of RNA export from nucleus (GO:0046831),0.4263223879715198,0.8886705759781776,0.6226708074534162,1.0,1.0,2/11,9.87%,CPSF6;SETD2
prerank,cellular response to zinc ion (GO:0071294),0.38742574032628,0.8884175521436481,0.6116642958748222,1.0,1.0,9/15,28.18%,MT3;MT1G;MT1B;MT1X;MT1H;MT1F;MT1E;MT1M;MT1A
prerank,positive regulation of leukocyte chemotaxis (GO:0002690),0.3186361286076539,0.8881758578999892,0.6531322505800464,1.0,1.0,7/51,11.59%,CXCL10;VEGFA;ANO6;CCR2;PLA2G7;MAPK1;EDN3
prerank,negative regulation of telomere maintenance via telomere lengthening (GO:1904357),-0.2810647575079249,-0.8879761918849807,0.675,0.8889173934423761,1.0,10/24,22.05%,XRN1;TERF2;DCP2;PARP1;PINX1;EXOSC10;TEN1;TINF2;TENT4B;HNRNPA1
prerank,positive regulation of reactive oxygen species biosynthetic process (GO:1903428),0.41703332671718424,0.8879368825488102,0.62,1.0,1.0,1/12,2.53%,SLC5A3
prerank,regulation of attachment of spindle microtubules to kinetochore (GO:0051988),-0.3615262530525577,-0.8877015809328922,0.6065573770491803,0.8883221970285868,1.0,5/10,31.45%,CDC42;RACGAP1;ECT2;KNSTRN;SPAG5
prerank,steroid catabolic process (GO:0006706),0.42615044394923557,0.8873557052422159,0.618380062305296,1.0,1.0,1/10,4.64%,HSD17B11
prerank,response to nutrient levels (GO:0031667),-0.2995302886447811,-0.8872420372414995,0.6082474226804123,0.8881275870303784,1.0,6/17,21.19%,RPS6KB1;PRKAA2;KCNB1;FAM107A;ATF4;ULK1
prerank,negative regulation of reactive oxygen species biosynthetic process (GO:1903427),0.4097455526349155,0.8872193230147206,0.6126543209876543,1.0,1.0,5/11,18.76%,FYN;ABCD2;MPV17L;TRAP1;PARK7
prerank,response to ethanol (GO:0045471),0.3917474732525653,0.8869782858896046,0.611353711790393,1.0,1.0,3/14,14.38%,GRIN2B;GOT2;GRIN2A
prerank,lysosome localization (GO:0032418),-0.24472588954641178,-0.8869231177509557,0.6558139534883721,0.8876324167571548,1.0,15/37,21.67%,KIT;MYH9;PLEKHM1;FAM98A;KIF5B;FLCN;BORCS5;SYTL4;SNAPIN;PIP4P1;TMEM106B;PLEKHM2;TFEB;LAMTOR1;DEF8
prerank,regulation of cholesterol efflux (GO:0010874),0.3443130795303152,0.8867784919297826,0.6218274111675127,1.0,1.0,4/30,10.88%,PTCH1;LRP1;ZDHHC8;ABCA5
prerank,purine-containing compound catabolic process (GO:0072523),0.3963300739011888,0.8867039346017406,0.6082317073170732,1.0,1.0,2/13,6.34%,NUDT15;NT5C2
prerank,response to lipopolysaccharide (GO:0032496),0.28780342620297106,0.885285725466507,0.6860706860706861,1.0,1.0,33/138,23.12%,CXCL10;PYCARD;PTPN22;IRAK3;MAPKAPK3;PDE4B;MAPKAPK2;WNT5A;PELI1;ERBIN;SELENOS;MAPK14;TRIM41;UPF1;PRDX3;SHPK;SRR;SNCA;TICAM1;PLAA;CDC73;LBP;AXL;PDCD4;BCL10;ZFP36;SIRPA;NFKB1;TNIP2;RPS6KA3;VIM;TAB2;CARD16
prerank,positive regulation of lipid kinase activity (GO:0090218),0.3401528798584841,0.8852052007461424,0.6458852867830424,1.0,1.0,3/29,4.08%,PDGFRA;FGF2;TGFB1
prerank,relaxation of muscle (GO:0090075),-0.3287166063832583,-0.8851593135627635,0.6085626911314985,0.8904070262442955,1.0,3/13,6.72%,ATP1A2;KCNJ2;ATP1A1
prerank,intermediate filament organization (GO:0045109),0.3812100041740521,0.8844274449618145,0.6169014084507042,1.0,1.0,6/17,23.96%,BFSP1;DNAJB6;GFAP;PKP2;VIM;MTM1
prerank,regulation of tyrosine phosphorylation of STAT protein (GO:0042509),0.3103971944491361,0.8843470710589184,0.6548042704626335,1.0,1.0,8/57,11.09%,CRLF1;PTPN2;VEGFA;SOCS1;IL18;NF2;ERBB4;IL6ST
prerank,protein-containing complex subunit organization (GO:0043933),0.28923505173068975,0.8837117728946896,0.7040598290598291,1.0,1.0,33/109,23.86%,REPS2;SOX9;LAMC1;WIPF1;EPRS1;KMT2A;PPID;MAGI1;NUP205;RIMS1;FANCC;NDC1;WASF1;DET1;MDM4;NIFK;TP53;LPXN;PPIH;IL1RAP;CD74;MDM2;SKAP2;KPNA3;NAPG;MITF;LLGL1;DLG4;ELOB;KIFAP3;WASF3;PPP2R1A;NDUFAF1
prerank,receptor-mediated endocytosis (GO:0006898),0.2855895812549541,0.8836959287340487,0.7129436325678496,1.0,1.0,23/132,16.91%,HSPG2;SGIP1;DNM1;HSPH1;LRP1;PI4KB;AP1G1;ACKR3;EPS15;GAK;AP1S1;SPARC;GPR107;WASF1;TPCN2;HSP90B1;CD9;SNCA;SNX1;ITGB1;LRP2;IGF2R;CTTN
prerank,positive regulation of ubiquitin-dependent protein catabolic process (GO:2000060),0.2976272000450115,0.8836096034811521,0.649393605292172,1.0,1.0,24/76,23.12%,PTEN;PRKN;SOCS5;FBXW7;CBFA2T3;PRICKLE1;DVL1;CSNK1A1;DET1;DDA1;SUMO1;RNF19A;RCHY1;CSNK1E;FBXO22;MDM2;ZER1;TAF1;USP5;NKD2;BBS7;ELOB;ZYG11B;COP1
prerank,calcium ion import (GO:0070509),-0.26592035883132065,-0.8835576383138354,0.6910569105691057,0.8928970266672153,1.0,4/28,4.38%,CACNA1C;MICU1;CACNB2;CACNA1G
prerank,neuromuscular process (GO:0050905),0.3782946886560685,0.8835370392069094,0.635846372688478,1.0,1.0,2/16,4.74%,KCNA1;NRXN1
prerank,calcium ion transmembrane transport (GO:0070588),0.2931928806620363,0.8831590004089024,0.6659364731653888,1.0,1.0,25/86,21.50%,CACNA2D1;PARL;ANO6;LETM1;ATP2B3;CACNA1A;GRIN2B;SLC8A2;SLC24A5;PMPCB;SLC25A23;ATP2B1;YME1L1;GRIN2D;TRPC5;GRIN2A;PKD1;CACNA2D4;SLC24A4;SLC24A2;PMPCA;RYR3;PHB2;PKD2;P2RX7
prerank,body fluid secretion (GO:0007589),0.387916617929915,0.8830361264215859,0.61794500723589,1.0,1.0,4/15,17.71%,VEGFA;ERBB4;PRLR;GPAT4
prerank,positive regulation of reproductive process (GO:2000243),0.34178839164754216,0.8826913790117241,0.626733921815889,1.0,1.0,8/31,23.26%,VEGFA;PLCB1;PRDM9;LHFPL2;CFAP69;CACNA1H;TAC4;INHBB
prerank,mitochondrial ATP synthesis coupled proton transport (GO:0042776),-0.31591868220481795,-0.8824861210289867,0.6301369863013698,0.8940276269981332,1.0,5/16,14.57%,ATP5MC3;ATP5PD;STOML2;ATP5F1D;ATP5MF
prerank,positive regulation of phosphatidylinositol 3-kinase activity (GO:0043552),0.342742566086674,0.8823448819978202,0.6240506329113924,1.0,1.0,3/27,4.08%,PDGFRA;FGF2;TGFB1
prerank,tumor necrosis factor-mediated signaling pathway (GO:0033209),-0.20546526204079846,-0.8822514776526931,0.7638888888888888,0.8933335843157685,1.0,49/114,33.85%,PSMD14;BIRC3;NFKBIA;TNFRSF11B;PSMB3;AIM2;PSMD12;TNFRSF11A;TNFSF12;TNFRSF1A;COMMD7;PSMD6;TMSB4X;PSMA1;CDIP1;EIF5A;PSMD7;PSMA5;PSMC5;PTK2B;IKBKB;BAG4;PSMC4;PSMB6;PSMA4;EDA2R;CD40;TRADD;PSMB1;ACTN4;PSMB9;TRAF1;ILK;PSMC6;EDAR;TNFSF13;CD27;PSMD3;PSMD10;PSME3;TNFSF8;JAK2;TNFRSF1B;BIRC2;PSMA6;PSME2;TNFSF13B;TNFRSF9;TNFRSF12A
prerank,regulation of vesicle-mediated transport (GO:0060627),0.29080316491964836,0.8820483923008635,0.6809881847475833,1.0,1.0,25/91,19.82%,OLFM4;STON2;PLD1;PACSIN2;SYT1;STON1;RAB21;HIP1;RAB3D;PTPN1;MAPK1;OPHN1;BET1L;STXBP5;RAB4B;RAB3A;RAB4A;ARFGAP1;ABL1;SNX12;DENND10;RIMS2;RAB3B;MBTPS1;RINT1
prerank,negative regulation of potassium ion transport (GO:0043267),0.4013028718923814,0.8817351025524781,0.6355421686746988,1.0,1.0,5/13,19.41%,BIN1;STK39;NEDD4L;KCNH2;CAB39
prerank,regulation of calcium-mediated signaling (GO:0050848),0.3545352103635428,0.8814741927181746,0.6230366492146597,1.0,1.0,3/25,7.96%,BST1;CCL4;SLC8A2
prerank,negative regulation of coagulation (GO:0050819),-0.32665216343196213,-0.8810946863412921,0.6328358208955224,0.8947204745362933,1.0,3/14,2.71%,VTN;THBD;TFPI
prerank,cellular protein-containing complex assembly (GO:0034622),0.28035162700861704,0.8804016507243475,0.700312174817898,1.0,1.0,23/159,15.07%,STXBP6;SGIP1;DNAI4;CCDC39;VAMP4;TBCE;TGFB1;SHQ1;EPS15;GTF2B;BIN1;HIP1;ARL2;HSPA4;NUP205;NDC1;POGZ;TBCC;PRLR;SNCA;NCK1;RTN4;CCDC65
prerank,regulation of tau-protein kinase activity (GO:1902947),-0.35542804373063075,-0.880391389819327,0.6147757255936676,0.8951035451443599,1.0,4/10,22.12%,HSP90AA1;NAB2;HSP90AB1;CLU
prerank,regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880),0.3687316706426009,0.8794050215814027,0.6262203626220363,1.0,1.0,6/21,15.54%,ANK2;AKAP6;PDE4D;PRKACA;CALM1;CALM2
prerank,mitotic sister chromatid cohesion (GO:0007064),0.3769065859029463,0.8793863183139342,0.6111111111111112,1.0,1.0,6/16,27.26%,POGZ;SGO1;PDS5B;RB1;SMC1A;NAA50
prerank,nucleocytoplasmic transport (GO:0006913),0.32747314062011684,0.8791199218179641,0.64366373902133,1.0,1.0,9/40,17.76%,XPO1;RSRC1;NCBP1;NUP205;MALT1;NXT1;HTATIP2;AAAS;GEMIN7
prerank,protein modification process (GO:0036211),0.2984697029535482,0.8790861926491238,0.6868008948545862,1.0,1.0,23/76,21.75%,CHRM3;TGM1;ARAF;CDKL3;MMP15;UBA3;SLC35A1;FBXL2;ATG3;NEDD8;ABL1;USP25;FBXO22;CSNK1G3;FBXO11;RPN1;UBE2L3;MCRS1;DUSP12;YES1;PLAT;UBE2D3;ERO1A
prerank,cytokine-mediated signaling pathway (GO:0019221),0.27175573268352543,0.8785927479741644,0.856,1.0,1.0,52/532,11.25%,RORA;MMP2;CCL11;EDA;CXCL10;IL16;SLC27A1;IL2RA;FGF2;PYCARD;MYC;BCL2;IRS2;CRLF1;IL20RB;HNRNPDL;VEGFA;MAP3K3;IRAK3;RPS6KA4;SOCS5;TGFB1;CCL4;TEC;MT3;PLCB1;CCR2;ZEB1;NUMBL;SOCS1;YWHAZ;RORC;CSK;IL1RL2;CSF3R;ACKR3;IL18;PELI1;FYN;GAB2;PSMB7;HIF1A;AIP;NDN;PIK3R1;PTPRJ;TYK2;CBL;PTPN11;COL1A2;IL6ST;TOLLIP
prerank,negative regulation of Notch signaling pathway (GO:0045746),0.3462220171689331,0.8784434585257922,0.648124191461837,1.0,1.0,3/28,6.20%,EGFR;FBXW7;METTL3
prerank,positive regulation of triglyceride metabolic process (GO:0090208),0.3837363716771465,0.8783880628994666,0.6147186147186147,1.0,1.0,1/16,1.07%,SLC27A1
prerank,actin filament capping (GO:0051693),0.36966270169498516,0.8783379081891599,0.5974930362116991,1.0,1.0,2/18,2.24%,ADD3;GSN
prerank,barbed-end actin filament capping (GO:0051016),0.36966270169498516,0.8783379081891599,0.5974930362116991,1.0,1.0,2/18,2.24%,ADD3;GSN
prerank,establishment of spindle localization (GO:0051293),0.39583055314601,0.8781935331192094,0.6290322580645161,1.0,1.0,5/14,23.72%,CLASP1;KPNB1;LLGL1;DYNC1H1;ZBED3
prerank,sensory perception of mechanical stimulus (GO:0050954),0.30041968820820114,0.8781878440357495,0.6786885245901639,1.0,1.0,13/85,16.12%,ROR1;PIEZO2;LHFPL5;PCDH15;LHFPL3;LHFPL4;HOMER2;LRTOMT;PAX3;COL1A1;CCDC50;CDC14A;LRP2
prerank,positive regulation of proteolysis (GO:0045862),-0.22537590720124373,-0.8778702801172755,0.7333333333333333,0.8996986855066557,1.0,15/55,18.89%,CTSH;CCBE1;SNX9;CTSC;OGT;STUB1;CASP8;TNIP1;MAPK12;ADRA2A;PERP;FGFR4;NRDC;APOE;PINK1
prerank,regulation of stem cell differentiation (GO:2000736),0.29394519067673924,0.8776155025702027,0.6940133037694013,1.0,1.0,20/89,20.75%,PDGFRA;CBFB;KMT2A;METTL3;PSMB7;ZFP36L2;GDNF;GATA3;PUS7;BMPR1A;PSMD2;PSMC1;RUNX1;ABL1;HNRNPU;PSMB2;PSMD9;PSME4;NSUN2;PSMA8
prerank,protein ubiquitination (GO:0016567),0.27043927658245087,0.8774326324103522,0.8598598598598599,1.0,1.0,112/471,20.49%,UBE2T;PDZRN3;RNF157;BCL2;CBFB;FBXW9;PRKN;DTX4;UBE2E2;HACE1;WAC;NFX1;TRIM44;FBXW7;SPSB4;RNF6;KLHL13;SPOP;FBXO7;ZNRF2;FBXL15;DDB2;ASB5;FBXO32;TRIM2;OTULIN;TRIM11;PELI1;BRCA1;UBE2K;HECTD2;FBXL16;PSMB7;RNFT1;VPS11;FBXO27;HIF1A;LNPEP;CUL3;SELENOS;UHRF2;UBE2Z;HUWE1;ANAPC7;THOP1;FBXO45;CBL;FBH1;NFE2L2;UBE2J2;UCHL3;TSPAN17;TRIM41;FBXO17;FBXL2;MYLIP;ATG3;AKTIP;KLHL12;DDB1;DET1;NEDD8;TRIM23;DDA1;NEDD4L;TRAF7;PSMD2;KLHL22;UBB;AREL1;PSMC1;UBE2O;RNF19A;RCHY1;UBOX5;CDC23;RNF111;FBXL4;ZSWIM8;ANAPC16;UBE2Q1;RNF182;PSMB2;MIB1;CUL4B;RNF10;RC3H1;CDC73;RNF167;UBA1;FBXO31;FBXO22;MDM2;ELOC;RNF4;PSMD9;TAF1;USP5;PCNP;FBXO11;PSME4;BCL10;FBXL12;UBE2L3;RRAGA;CDC27;TRAIP;TRIM35;UBE2G1;RNF13;UBE2E1;NPEPPS
prerank,mRNA 3'-end processing (GO:0031124),0.2986010594455755,0.8772966709298465,0.6783754116355654,1.0,1.0,23/78,24.99%,CSTF3;THOC6;PABPC1;CPSF6;RPRD1A;SRSF11;CASC3;NCBP1;FIP1L1;AHCYL1;SRSF6;PAPOLA;CDC73;RNPS1;TENT2;THOC7;SRRM1;SRSF3;SYMPK;TUT1;THOC5;MAGOHB;CPSF7
prerank,mitotic DNA replication (GO:1902969),-0.35712358694464075,-0.8771944951752225,0.6253369272237197,0.9001063108271729,1.0,7/10,33.48%,POLA1;MCM6;LIG1;CDC45;GINS1;MCM3;MCM2
prerank,protein O-linked glycosylation (GO:0006493),0.2884302730252257,0.8762371504140694,0.6955093099671413,1.0,1.0,23/96,18.62%,ST3GAL4;GALNTL6;TMTC2;GALNT9;GALNT1;PLOD1;POMGNT2;RXYLT1;GALNT15;GALNT7;C1GALT1;GALNT13;GALNT6;TMTC3;GALNT3;MUC3B;MUC3A;TET3;DPM1;FKTN;POGLUT2;GALNT11;FKRP
prerank,mitotic cytokinetic process (GO:1902410),-0.28654435516204346,-0.8760605741412925,0.6587301587301587,0.9014528125843425,1.0,7/20,23.97%,CHMP3;RHOA;VPS4A;CHMP1A;VPS4B;CHMP7;CHMP2B
prerank,photoperiodism (GO:0009648),-0.2696562347339477,-0.8760385827479203,0.6696428571428571,0.900251633280428,1.0,8/28,13.94%,SIK1;PPP1CB;CLOCK;MTA1;PPP1CC;FBXL17;ID2;PML
prerank,7-methylguanosine RNA capping (GO:0009452),0.33829316732035064,0.8757493019646327,0.6266318537859008,1.0,1.0,9/31,19.18%,GTF2H2;RNGTT;POLR2B;POLR2K;NCBP1;POLR2G;RNMT;POLR2A;CMTR2
prerank,7-methylguanosine mRNA capping (GO:0006370),0.33829316732035064,0.8757493019646327,0.6266318537859008,1.0,1.0,9/31,19.18%,GTF2H2;RNGTT;POLR2B;POLR2K;NCBP1;POLR2G;RNMT;POLR2A;CMTR2
prerank,porphyrin-containing compound biosynthetic process (GO:0006779),0.34743634308163274,0.8757299265303574,0.6412614980289093,1.0,1.0,12/24,26.79%,SLC25A38;UROS;RSAD1;SUCLA2;COX10;FECH;PGRMC1;TSPO;CPOX;ALAD;UROD;ABCB10
prerank,sensory perception (GO:0007600),0.31554922947058955,0.8756833300494437,0.6558752997601919,1.0,1.0,8/45,17.78%,KCNA2;CHRNA4;PCDH15;CCR2;PENK;NIPSNAP1;OPRK1;PTGES
prerank,positive regulation of substrate adhesion-dependent cell spreading (GO:1900026),0.3341882433740428,0.8756279892158906,0.6370463078848561,1.0,1.0,14/34,26.63%,OLFM4;DOCK5;FLNA;DOCK1;MYOC;ABL1;RAC3;MDK;TESK1;TRIOBP;CRK;CIB1;ARHGEF7;LIMS1
prerank,regulation of RNA metabolic process (GO:0051252),0.30666633268579374,0.8752728077089585,0.6594533029612756,1.0,1.0,16/59,23.89%,PRX;TRA2B;ZNF326;RASA1;SON;PCBP4;NOVA1;RC3H1;FUS;HNRNPH2;HNRNPL;MITF;AHNAK;PTBP2;AFF2;PCBP2
prerank,DNA damage checkpoint signaling (GO:0000077),-0.26718579249512897,-0.8751203550454228,0.6363636363636364,0.901073757911478,1.0,15/28,34.77%,MAP3K20;CLOCK;DOT1L;HUS1;CLSPN;DONSON;ERCC6;NBN;E2F1;RAD9A;CHEK2;CHEK1;PRPF19;ATRIP;FBXO6
prerank,early endosome to late endosome transport (GO:0045022),0.36226352642760185,0.874842600403403,0.6251673360107095,1.0,1.0,13/20,29.69%,AKTIP;STX8;ANKRD27;RAB7A;SNX16;HOOK2;WDR81;HOOK1;HOOK3;PIK3C3;EEA1;SNF8;EMP2
prerank,regulation of axon extension (GO:0030516),0.31979664023575505,0.8743468636574824,0.6316440049443758,1.0,1.0,13/37,20.13%,NRCAM;SEMA3A;RNF6;MT3;CDKL5;CDKL3;LIMK1;RTN4;ABL1;DIP2B;CTTN;SHTN1;PTPRS
prerank,protein localization to cilium (GO:0061512),0.33650240017265043,0.8739424285139694,0.65,1.0,1.0,5/32,11.70%,ARL3;IFT140;BBS9;WDR35;SNX10
prerank,positive regulation of T cell cytokine production (GO:0002726),-0.29573663100873593,-0.8738521273200398,0.6468646864686468,0.902749509497689,1.0,4/20,11.63%,IL1R1;CD55;PRKCZ;MAP3K7
prerank,regulation of histone modification (GO:0031056),-0.3335045680242022,-0.8737821831838206,0.6257668711656442,0.9016408475634985,1.0,5/13,19.18%,PARG;IGF2;FLCN;UBE2N;MYOCD
prerank,apoptotic DNA fragmentation (GO:0006309),-0.30771061720846704,-0.8734723201123954,0.6645962732919255,0.9011012031893604,1.0,8/16,29.90%,DFFA;H1-0;DNASE2;HMGB2;CASP3;FOXL2;DICER1;CECR2
prerank,"maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000462)",-0.2615901483009268,-0.8724995696156581,0.7058823529411765,0.9021356937811346,1.0,10/29,22.09%,RPS14;RPS16;RPS19;NGDN;HELB;RPS8;NOP9;RPS21;DHX37;MRPS11
prerank,cellular response to fluid shear stress (GO:0071498),0.391499932681009,0.8723766037381044,0.6217851739788199,1.0,1.0,4/12,16.26%,HAS2;MAPK7;NFE2L2;SREBF2
prerank,telomere maintenance via telomerase (GO:0007004),-0.26840264351878673,-0.8722501860339319,0.6544715447154471,0.9014818305050009,1.0,11/28,18.97%,TERF2;RFC1;DKC1;WRAP53;HSP90AA1;CDK2;TERT;PINX1;GAR1;HSP90AB1;TINF2
prerank,myeloid cell differentiation (GO:0030099),0.31006284753515795,0.8722479148652679,0.6571428571428571,1.0,1.0,7/47,7.38%,CDKN2B;PTPN2;PRKX;SLC25A38;ZBTB16;UFL1;KAT8
prerank,detection of visible light (GO:0009584),0.38255852785858474,0.8720282223716203,0.6387665198237885,1.0,1.0,1/16,1.69%,RHO
prerank,mitochondrial translation (GO:0032543),0.28429057424036,0.8716867077902776,0.7126068376068376,1.0,1.0,28/104,22.44%,MRPL47;IARS2;MRPS18A;TUFM;MRPL14;MRPL32;MRPL16;GATB;MRPL58;MRPS35;MRPS28;AURKAIP1;MRPL35;MRPL30;MRPL28;HARS1;MRPL46;MRPL51;MRPS30;MRPS14;MRPS9;MRPS31;MRPL1;PTCD3;DAP3;MRPS6;MRPL52;MRPL18
prerank,mRNA processing (GO:0006397),0.2717014503023269,0.8716241019054332,0.8002008032128514,1.0,1.0,93/287,26.12%,CSTF3;DHX8;THOC6;TRA2B;GTF2H2;PABPC1;CPSF6;RNGTT;RPRD1A;RSRC1;POLR2B;METTL3;DHX35;SON;RNPC3;SRSF11;CWF19L2;TXNL4A;RBM10;POLR2K;CASC3;AURKAIP1;ALKBH5;NCBP1;SNRPB2;FIP1L1;SFPQ;SNRNP40;HNRNPA3;LSM3;PRKACA;PRPF6;PRPF18;RBM4B;POLR2G;DDX42;NOVA1;SRSF6;YTHDC1;RNMT;PAPOLA;SNRPA;PPIH;SF3A1;HNRNPU;RAVER2;RNPS1;SF1;GEMIN7;FUS;SART1;DDX23;POLR2A;THOC7;CMTR2;PRMT9;SYNCRIP;SRRM1;HNRNPUL1;SF3B3;DBR1;HNRNPC;HNRNPH2;HNRNPL;SNRPN;SRSF3;RBM17;DNAJC8;SNIP1;RBMX2;SYMPK;PLRG1;SNRNP200;SF3B2;WBP4;CTNNBL1;PCBP2;THOC5;POLR2F;TFIP11;CCNH;MAGOHB;CPSF7;U2SURP;SCAF11;SNRPA1;NONO;RBM4;RBM15;SPEN;TRA2A;PRPF38A;HNRNPA2B1
prerank,response to organic cyclic compound (GO:0014070),0.3109609328151972,0.8715862821807027,0.6609392898052692,1.0,1.0,8/52,12.69%,KYNU;TGFB1;HLCS;CYP1B1;IL18;ESR1;ARL6IP5;DRD2
prerank,cellular response to molecule of bacterial origin (GO:0071219),0.2906503103990484,0.8715607192685231,0.6944745395449621,1.0,1.0,21/95,21.97%,CXCL10;PYCARD;PDE4B;WNT5A;SELENOS;MAPK14;TRIM41;UPF1;SHPK;TICAM1;PLAA;CDC73;LBP;AXL;PDCD4;BCL10;ZFP36;SIRPA;NFKB1;TNIP2;VIM
prerank,monocarboxylic acid metabolic process (GO:0032787),0.28547065213339584,0.871540141025162,0.7145855194123819,1.0,1.0,13/117,9.83%,CYP2S1;KYNU;THEM4;SLC27A4;NPC1;GBA2;MCCC1;HLCS;ACOT11;GOT2;FASN;MCCC2;ACSF2
prerank,peptidyl-lysine acetylation (GO:0018394),0.4234296122302826,0.8713568767681286,0.6234177215189873,1.0,1.0,1/10,2.04%,KAT2B
prerank,"positive regulation of DNA-templated transcription, elongation (GO:0032786)",0.35691557175211736,0.8712216707707121,0.6495956873315364,1.0,1.0,7/22,24.67%,HMGN1;CDK13;ELL;CDC73;KAT7;THOC5;CCNT2
prerank,negative regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043154),0.3052618033715889,0.8706269301394067,0.6481257557436517,1.0,1.0,12/50,18.76%,DPEP1;NGF;VEGFA;MT3;PIH1D1;NGFR;DNAJB6;SNCA;XIAP;PAX2;FNIP1;PARK7
prerank,phosphatidylserine metabolic process (GO:0006658),0.33363973887472353,0.8705816077046065,0.6377358490566037,1.0,1.0,6/32,12.35%,SLC27A1;MBOAT2;OSBPL5;PLA2G12A;PTDSS1;PLAAT3
prerank,regulation of vascular endothelial cell proliferation (GO:1905562),0.36774061091933874,0.8705097955346446,0.6217331499312242,1.0,1.0,5/18,11.46%,FGF2;FGFR1;AKT3;SP1;SIRT6
prerank,regulation of receptor signaling pathway via JAK-STAT (GO:0046425),0.32552904837435914,0.8704446443356045,0.66,1.0,1.0,5/35,10.17%,CRLF3;SOCS1;CYP1B1;NF2;ERBB4
prerank,glucan catabolic process (GO:0009251),0.3785073242261995,0.8704423309291257,0.6150442477876106,1.0,1.0,3/15,14.50%,PYGL;PHKB;CALM1
prerank,regulation of postsynaptic neurotransmitter receptor activity (GO:0098962),0.40554978437697164,0.8687495408638198,0.6150234741784038,1.0,1.0,3/10,21.31%,DLGAP1;BEGAIN;DLGAP3
prerank,regulation of synaptic vesicle exocytosis (GO:2000300),-0.2937621297368379,-0.8687112617543185,0.6420664206642066,0.9081735726806718,1.0,6/18,12.29%,RAP1B;RAB5A;DTNBP1;GSK3B;SLC4A8;SNAPIN
prerank,response to UV (GO:0009411),0.2849089758701009,0.8685248667442742,0.7028508771929824,1.0,1.0,24/95,19.97%,MYC;EGFR;ZRANB3;GTF2H2;ERCC5;NSMCE3;ERCC4;DDB2;METTL3;BMF;MEN1;XPA;MSH6;ZBTB1;MAP3K4;TP53;USP1;N4BP1;WRN;REV1;CAT;TAF1;RUVBL2;SCARA3
prerank,positive regulation of leukocyte adhesion to vascular endothelial cell (GO:1904996),-0.3074605640120221,-0.8684671839205741,0.6763754045307443,0.9074413189540935,1.0,3/16,9.34%,ETS1;NFAT5;RHOA
prerank,synaptic membrane adhesion (GO:0099560),0.3807472435394727,0.8683819726711988,0.6345029239766082,1.0,1.0,6/14,20.13%,LRRC4C;NTNG1;GPC4;PTPRF;LRFN5;PTPRS
prerank,histone lysine demethylation (GO:0070076),0.34958100798262354,0.8682270682695645,0.6358620689655172,1.0,1.0,5/25,13.88%,KDM8;KDM5B;KDM4B;PHF8;KDM6A
prerank,3'-phosphoadenosine 5'-phosphosulfate metabolic process (GO:0050427),0.3702273980903328,0.8679799740589884,0.6370056497175142,1.0,1.0,4/19,13.25%,PAPSS2;BPNT1;BPNT2;SLC35B3
prerank,positive regulation of transforming growth factor beta production (GO:0071636),0.40381546842774185,0.8678139296892722,0.6164179104477612,1.0,1.0,3/11,14.61%,CD34;GATA6;BMPR1A
prerank,regulation of gene silencing by miRNA (GO:0060964),0.29955875066839677,0.8676465800475055,0.6854190585533869,1.0,1.0,25/62,27.82%,TGFB1;RANBP2;POLR2B;NUP155;POLR2K;EIF4G1;NUP205;NDC1;NUP160;POLR2G;POM121;AAAS;POLR2A;PPARG;STAT3;ZFP36;LIMD1;NUP42;POLR2F;TNRC6A;FMR1;NUP35;RAE1;AJUBA;PUM2
prerank,regulation of histone acetylation (GO:0035065),0.3276312646173887,0.8676060961437109,0.6369426751592356,1.0,1.0,9/33,19.24%,KMT2A;RPS6KA4;BRCA1;SETD5;SNCA;TAF7;CTBP1;PARK7;RUVBL2
prerank,positive regulation of focal adhesion assembly (GO:0051894),0.36513158063935003,0.8672129830156559,0.6122448979591837,1.0,1.0,6/19,15.54%,MAP4K4;VEGFA;TSC1;PTPRJ;MYOC;ABL1
prerank,acute-phase response (GO:0006953),-0.3447916706307833,-0.8670634789572272,0.6184971098265896,0.909347277844348,1.0,2/12,10.11%,PLSCR1;IL6R
prerank,positive regulation of BMP signaling pathway (GO:0030513),0.34491996230790917,0.8667034380354294,0.6535326086956522,1.0,1.0,3/25,5.81%,SULF1;SOX11;FBXL15
prerank,regulation of hydrolase activity (GO:0051336),0.29325419659926255,0.866657927182672,0.6745495495495496,1.0,1.0,9/71,8.66%,SIPA1L1;PLXNC1;FGD4;EFNA5;NTRK2;NF1;CHN1;ARHGAP9;VAV3
prerank,aromatic amino acid family metabolic process (GO:0009072),0.4119811592471002,0.8660650206031472,0.648,1.0,1.0,2/10,9.64%,KYNU;IL4I1
prerank,positive regulation of defense response to virus by host (GO:0002230),0.34854737331662167,0.8660497639722858,0.6473829201101928,1.0,1.0,2/24,3.80%,PTPN22;TRIM44
prerank,"regulation of DNA-templated transcription, initiation (GO:2000142)",0.30411763132194675,0.8659968507474438,0.6697247706422018,1.0,1.0,18/59,23.22%,PTEN;CBFB;SOX9;CCNC;MED31;CDK8;MED13;MED12;MED25;TP53;MED30;MED8;JUN;NFKB1;MITF;THRA;MED24;CEBPB
prerank,"positive regulation of protein localization to chromosome, telomeric region (GO:1904816)",-0.3325800597344914,-0.8657428640860597,0.621301775147929,0.9110436240146844,1.0,5/12,13.59%,DKC1;WRAP53;CCT8;CCT6A;CCT4
prerank,regulation of transport (GO:0051049),0.32235394583462873,0.8654485574035203,0.6516290726817042,1.0,1.0,2/36,2.35%,CLDN19;PRKN
prerank,positive regulation of T-helper cell differentiation (GO:0045624),0.38457769261348135,0.8648971209791229,0.6401734104046243,1.0,1.0,3/14,13.22%,SOCS5;IL18;MALT1
prerank,positive regulation of heterochromatin assembly (GO:0031453),0.4049977859679387,0.8648734899287333,0.6296296296296297,1.0,1.0,6/11,28.28%,ATF7IP;SIRT6;SETDB1;MPHOSPH8;RESF1;DNMT1
prerank,endocardial cushion morphogenesis (GO:0003203),0.36866228779400145,0.8644273076372538,0.6614509246088194,1.0,1.0,6/18,17.57%,SOX9;ACVR1;TGFBR2;MDM4;BMPR1A;HEYL
prerank,calcium ion import into cytosol (GO:1902656),0.38179159967304654,0.8644244002037438,0.640117994100295,1.0,1.0,4/15,18.22%,CACNA2D1;SLC8A2;SLC24A2;MS4A1
prerank,fatty acid beta-oxidation (GO:0006635),0.31097346855412134,0.8644229493119654,0.6728971962616822,1.0,1.0,15/51,22.24%,GCDH;IVD;ETFA;HADHA;ACOX1;MTLN;ABCD2;AUH;CRAT;EHHADH;ACAA2;DECR1;ACOT8;ACADS;SCP2
prerank,DNA conformation change (GO:0071103),0.37406361654159115,0.8642941514667336,0.6385714285714286,1.0,1.0,5/17,21.73%,HAT1;ABL1;NAA10;TOP1;TOP3A
prerank,RNA stabilization (GO:0043489),-0.25064893923571707,-0.8640738270986809,0.6839622641509434,0.9135334598074616,1.0,7/33,10.91%,YBX1;NOCT;ZCCHC17;NAF1;ELAVL1;TAF15;DKC1
prerank,positive regulation of telomere maintenance via telomerase (GO:0032212),0.3290565661026004,0.8640037399788784,0.66875,1.0,1.0,6/32,15.47%,PRKCQ;CCT7;MAPK1;NEK7;MAP3K4;ATM
prerank,keratan sulfate catabolic process (GO:0042340),0.405695700282085,0.8638365846594223,0.6141141141141141,1.0,1.0,2/11,7.19%,LUM;GALNS
prerank,negative regulation of protein binding (GO:0032091),-0.21816059972861201,-0.8636656676516482,0.7295081967213115,0.9132557254000474,1.0,22/71,22.57%,DAB2;MAP2;ROCK1;PRKCD;IFIT2;TTBK2;KDM1A;GSK3B;CAMK1;RACK1;ADAM15;PEX14;ATP2A3;CAV1;GTF2F1;ZFPM1;CFHR2;HFE;IFIT1;ADRB2;AKT1;ATP2A2
prerank,positive regulation of protein localization to cell surface (GO:2000010),-0.3238784953994125,-0.8633766653894899,0.6125827814569537,0.9126779876621887,1.0,5/13,25.57%,TM9SF4;HSP90AB1;ABCA7;SNX33;TYROBP
prerank,regulation of BMP signaling pathway (GO:0030510),0.294798106934441,0.8630443482088623,0.7033707865168539,1.0,1.0,14/73,16.36%,SOSTDC1;SULF1;HTRA3;SOX11;FBXL15;PCSK6;SFRP4;DAND5;BMPER;BMPR1A;UBE2O;LRP2;XIAP;VWC2
prerank,response to interleukin-6 (GO:0070741),-0.35728203648866597,-0.8629335940687234,0.6771653543307087,0.912390042711804,1.0,3/10,8.50%,PTGIS;ST3GAL6;SBNO2
prerank,positive regulation of microtubule polymerization or depolymerization (GO:0031112),0.3425739093192041,0.8628917542773011,0.6609947643979057,1.0,1.0,8/26,16.01%,PAK1;ARL2;CLASP1;SLAIN2;CDK5R1;KATNB1;MET;NAV3
prerank,double-strand break repair (GO:0006302),0.2781881187660408,0.8627212693155738,0.7505154639175258,1.0,1.0,30/158,15.98%,POLN;MEIOB;APTX;AP5S1;ERCC5;REV3L;ERCC4;KDM4B;RPA3;SETMAR;ATP23;BRCA1;TDP1;NHEJ1;FBH1;SFPQ;NSD2;XRCC6;HPF1;MDC1;HELQ;XRCC3;EXD2;RPA2;SUMO1;BAZ1B;ATM;RAD52;BLM;SPIDR
prerank,transition metal ion homeostasis (GO:0055076),0.3365677555226978,0.8626633879953414,0.6419270833333334,1.0,1.0,3/28,5.56%,PRKN;MT3;CYBRD1
prerank,glycogen catabolic process (GO:0005980),0.37343688109392803,0.8624442020856729,0.625,1.0,1.0,3/15,14.50%,PYGL;PHKB;CALM1
prerank,dendritic spine organization (GO:0097061),0.3388833673301439,0.862428766200339,0.6326530612244898,1.0,1.0,6/26,11.37%,PTEN;EPHB2;PRNP;DOCK10;FYN;DIP2A
prerank,negative regulation of ion transmembrane transporter activity (GO:0032413),-0.2855547934991011,-0.8623334342880319,0.6666666666666666,0.9124634194799333,1.0,8/20,26.48%,OSR1;ACTN2;GOPC;ADRA2A;HECW2;TCAF2;CASQ2;PLN
prerank,activation of protein kinase B activity (GO:0032148),0.3351559168924739,0.861949525926038,0.6577540106951871,1.0,1.0,5/29,7.90%,NTRK3;MT3;WNT5A;MAPKAP1;IL18
prerank,ganglioside metabolic process (GO:0001573),-0.28580783641040797,-0.8617583585900311,0.6833976833976834,0.9124624693420739,1.0,2/20,2.10%,ST6GALNAC3;ST8SIA4
prerank,protein stabilization (GO:0050821),0.27363565680316726,0.8617237447928682,0.7590113285272915,1.0,1.0,41/168,21.46%,PTEN;ANK2;STXBP4;PRKN;CCT7;TRIM44;FBXW7;MT3;ATF7IP;TSC1;NAA16;RAB21;RABL3;FLNA;BAG5;HIP1;CRYAB;PIK3R1;USP33;TAF9;GRN;DVL1;PER3;PDCL3;MDM4;SUMO1;RTN4;RASSF2;PIM2;USP2;NAA15;PARK7;TAF1;PHB2;USP13;NAPG;LAMP2;HSPD1;TNIP2;WDR81;DVL3
prerank,striated muscle cell differentiation (GO:0051146),-0.3014656407598991,-0.8616039626812485,0.6421725239616614,0.9115475208147551,1.0,7/16,19.73%,SIK1;KDM6B;MYEF2;SORT1;CBY1;MYOCD;SDC1
prerank,negative regulation of developmental process (GO:0051093),-0.21102757899316862,-0.8614831247831303,0.7962962962962963,0.9105490595408036,1.0,19/69,16.75%,ROCK2;ROCK1;NFIB;NOS3;BMP4;PARP3;TBX1;ARHGEF15;TFRC;IL17D;VAT1;NOTCH4;MAPT;SINHCAF;ARPIN;FUZ;HEY2;RPS6KA6;SUZ12
prerank,ion transport (GO:0006811),0.279197793938312,0.8613937306685068,0.7147401908801697,1.0,1.0,9/111,5.24%,PIEZO2;SLC1A3;VDAC2;SLC12A3;SLC17A5;ANO6;CHRNA4;SLC36A2;SLC12A2
prerank,neutral amino acid transport (GO:0015804),0.33639635305734983,0.8613069227371863,0.6749672346002621,1.0,1.0,6/28,19.24%,SLC1A5;SLC36A2;SLC43A1;SLC7A8;SLC6A15;SLC6A9
prerank,cellular response to nutrient levels (GO:0031669),0.2941732163880598,0.8610901591693371,0.6685584562996595,1.0,1.0,20/62,24.74%,CDKN2B;NUPR2;WIPI1;TSC1;RALB;EIF4G1;USP33;CLEC16A;VPS41;SREBF2;WRN;RPTOR;FNIP1;RRAGA;LAMP2;PRKAA1;INHBB;MTOR;WDR45B;EHMT2
prerank,carbohydrate transport (GO:0008643),0.40315517096697184,0.8609067716481849,0.6260162601626016,1.0,1.0,2/11,10.56%,SLC50A1;SLC2A2
prerank,regulation of inclusion body assembly (GO:0090083),-0.33781178862748573,-0.8608674163540198,0.6473684210526316,0.9106621994411698,1.0,1/11,0.33%,SNCAIP
prerank,peptidyl-threonine phosphorylation (GO:0018107),0.29749266144509257,0.8603990790454615,0.6851851851851852,1.0,1.0,11/59,13.71%,PRKCA;ACVR1;WNK3;DYRK4;TGFBR2;DYRK1B;STK39;MAPK1;CDK5R1;TBK1;TTBK1
prerank,intracellular estrogen receptor signaling pathway (GO:0030520),-0.30243945310954234,-0.8599326085436152,0.6666666666666666,0.9114972471326795,1.0,4/16,13.96%,PPARGC1B;DDX5;EGLN2;PADI2
prerank,in utero embryonic development (GO:0001701),0.34878598993152776,0.8598239992069479,0.6742323097463284,1.0,1.0,6/25,17.16%,SOX8;VEGFA;EGFL8;PKD1;TGFB3;MYH6
prerank,histone H4 deacetylation (GO:0070933),-0.3470218354316215,-0.8597947304482789,0.629080118694362,0.9105765279936864,1.0,4/10,22.11%,HDAC8;HDAC4;HDAC3;SMARCAD1
prerank,protein insertion into ER membrane by stop-transfer membrane-anchor sequence (GO:0045050),0.41161127728094193,0.8594811823721423,0.64171974522293,1.0,1.0,7/10,27.66%,EMC10;EMC1;EMC8;EMC3;EMC6;EMC2;EMC7
prerank,positive regulation of cell cycle (GO:0045787),0.29701276065806625,0.8593185546186539,0.6811428571428572,1.0,1.0,14/62,18.56%,PRKCA;EGFR;TGM1;CCDC57;ASNS;CDC25B;SMOC2;PKD1;CITED2;CCND2;USP2;PKN2;MDM2;MAPRE3
prerank,receptor internalization (GO:0031623),0.31064278677922785,0.8591269928287449,0.6729411764705883,1.0,1.0,9/44,15.19%,DNM1;LRP1;GTF2H2;ACKR3;CD9;SNCA;SNX1;SCYL2;ITGB1
prerank,regulation of cell differentiation (GO:0045595),0.28032621943882474,0.8591096039988481,0.7512899896800825,1.0,1.0,23/148,13.20%,LGALS3;PHLDB1;CBFB;NGF;MBOAT2;PTHLH;TGFB1;NF1;NLGN1;RORC;TRPS1;CDK6;KLK6;FGFR1;BIN1;PPP1R13L;GDNF;CLASP1;EDN3;APC2;CDK5R1;PRKACA;GATA3
prerank,regulation of histone H3-K9 methylation (GO:0051570),0.41127911095765657,0.8590575241264115,0.6425196850393701,1.0,1.0,3/10,12.24%,ATRX;BRCA1;JARID2
prerank,plasma membrane bounded cell projection organization (GO:0120036),0.2804075755360374,0.85870840189122,0.7590618336886994,1.0,1.0,28/124,20.11%,CDNF;DOCK7;WDPCP;PPP1R9A;ATXN10;GPM6B;PLP1;NLGN1;CNTNAP2;GPM6A;VAPA;GDNF;PRMT1;OPHN1;STMN4;CDK5R1;MYOC;CDK16;CORO1B;CYFIP1;CFAP61;CTTN;CAMSAP1;CNTN4;LRP12;MICALL2;CEP78;NPY
prerank,positive regulation of epithelial cell apoptotic process (GO:1904037),0.3673437175589809,0.8587020397698171,0.6468926553672316,1.0,1.0,3/20,10.31%,GSN;ANO6;SFRP4
prerank,positive regulation of cell cycle G2/M phase transition (GO:1902751),-0.28255860868435484,-0.8586147805475826,0.6712328767123288,0.9120216624502455,1.0,6/21,19.71%,NPM1;VPS4B;CDK4;CDC7;RAD51C;MECP2
prerank,positive regulation of cyclase activity (GO:0031281),-0.31634541347734324,-0.8585553813106065,0.6534653465346535,0.9109228947783635,1.0,6/14,24.40%,CACNA1C;NOS3;STIM1;NOS1;CACNA1D;MAPK8
prerank,positive regulation of rRNA processing (GO:2000234),-0.35239843801307524,-0.8584761612560586,0.6436781609195402,0.9098555184915665,1.0,7/10,26.42%,WDR43;UTP15;BUD23;DIMT1;RIOK1;SIRT7;RIOK2
prerank,toll-like receptor 9 signaling pathway (GO:0034162),0.39599672956442933,0.8583943271715991,0.65625,1.0,1.0,8/13,31.85%,UNC93B1;TNIP2;IRAK2;IRAK1;PIK3C3;TRAF6;IRAK4;EPG5
prerank,positive regulation of filopodium assembly (GO:0051491),0.3424103675509897,0.8581247564130428,0.6644649933949802,1.0,1.0,6/24,16.62%,TENM2;NLGN1;GPM6A;PIK3R1;TGFB3;FSCN1
prerank,regulation of cilium movement (GO:0003352),0.41100353312600585,0.8580442815181671,0.6206349206349207,1.0,1.0,2/10,15.07%,CCDC39;CCDC65
prerank,regulation of tissue remodeling (GO:0034103),0.36381661078377325,0.857988230557245,0.6581560283687943,1.0,1.0,4/18,17.76%,TGFB1;IL18;RUNX1;MDK
prerank,ribosomal large subunit biogenesis (GO:0042273),-0.21770385110461332,-0.8578058707132371,0.7518248175182481,0.9100688097080173,1.0,25/54,27.61%,NSA2;RPL24;NPM1;NVL;RPL5;RPL3;MAK16;MRPL20;NOP53;LAS1L;RPL11;SURF6;RPL7A;RPL35A;RPL26;PES1;RSL24D1;NLE1;SNU13;PPAN;NOC2L;RPF2;RPL6;RPF1;PAK1IP1
prerank,negative regulation of viral life cycle (GO:1903901),0.37409060282743467,0.8577817032144119,0.6436950146627566,1.0,1.0,3/15,10.42%,GSN;TRIM11;MID2
prerank,negative regulation of protein catabolic process (GO:0042177),0.31787263947885525,0.8577032384756832,0.6851851851851852,1.0,1.0,16/40,27.46%,EGFR;FMN2;IRAK3;FLNA;ATRAID;SNCA;MDM4;SNX12;AZIN2;SF3B3;AGAP2;PRKCG;HMGCR;CDK5RAP3;PIN1;CYP51A1
prerank,regulation of chromatin binding (GO:0035561),0.4025552234537166,0.8576412503088304,0.633693972179289,1.0,1.0,1/10,1.37%,DDX11
prerank,eye development (GO:0001654),0.3063540387277648,0.857370758729512,0.6883886255924171,1.0,1.0,4/54,3.76%,EFEMP1;CHRDL1;COL5A2;MAB21L2
prerank,negative regulation of cell growth (GO:0030308),0.280793614218368,0.8570765518695217,0.7505307855626328,1.0,1.0,11/121,6.26%,DCBLD2;FGF13;CRLF3;VGLL4;FRZB;JADE1;TGFB1;RNF6;MT3;APBB2;CDKL3
prerank,regulation of protein localization to centrosome (GO:1904779),0.4109187479664424,0.8566518389504882,0.6381987577639752,1.0,1.0,1/10,1.79%,BICD1
prerank,regulation of monocyte differentiation (GO:0045655),0.38224456061443546,0.8565268027676926,0.6413690476190477,1.0,1.0,3/14,7.57%,MYC;HOXA7;CDK6
prerank,regulation of phosphoprotein phosphatase activity (GO:0043666),-0.24111300765533744,-0.8559009345222299,0.7819905213270142,0.9131247309084872,1.0,14/35,22.59%,NUAK1;PTPA;PPP1R15B;GSK3B;PDGFRB;PPP1R11;ITGA1;CD300A;HSP90AB1;MASTL;CSNK2B;PPP1R2;BOD1;STYXL1
prerank,epithelial to mesenchymal transition (GO:0001837),0.31178471298708393,0.8558808377779654,0.7115384615384616,1.0,1.0,10/47,11.41%,S100A4;SOX9;TGFB1;WNT5A;HNRNPAB;LOXL3;FGFR1;HIF1A;AMELX;BMP7
prerank,regulation of stem cell population maintenance (GO:2000036),-0.2932384003210581,-0.8558637829913448,0.658703071672355,0.9119782088137364,1.0,6/18,14.56%,PTN;WDR43;CNOT1;ELAVL1;TAF6L;HMGA2
prerank,androgen receptor signaling pathway (GO:0030521),-0.337849566253097,-0.8557578731570137,0.6353591160220995,0.9109940257638282,1.0,2/11,7.09%,PLPP1;DDX5
prerank,positive regulation of vasculature development (GO:1904018),0.28509432877342905,0.8555444889262123,0.7194323144104804,1.0,1.0,23/94,16.89%,PRKCA;FGF2;CD34;VEGFA;PAK4;ITGB8;HSPB6;WNT5A;CYP1B1;GATA6;BRCA1;HIF1A;SP1;MYDGF;GRN;SMOC2;PDCL3;ITGB1;JUP;RUNX1;GAB1;HYAL1;APLNR
prerank,negative regulation of cell aging (GO:0090344),0.3664357115035238,0.8555149528712633,0.6586402266288952,1.0,1.0,4/16,9.25%,MAP3K3;CDK6;FOXM1;AKT3
prerank,phosphate-containing compound metabolic process (GO:0006796),0.2702240931600509,0.8554011188612801,0.7696228338430173,1.0,1.0,52/198,23.95%,ITPK1;GFPT2;INPP4B;PLBD1;PTEN;DUSP4;PSPH;EPHB2;TGFB1;PLCB1;ACP2;PAK1;AGPAT2;PPP3CB;PPP3CA;TOLLIP;PPP1CA;PLPPR4;ACYP2;NUDT10;PLAAT3;NUDT3;HDHD2;SHPK;CALM1;PLAA;MINPP1;AGK;DUSP16;NUDT5;NT5C;HK2;BCKDK;TOP1;STAT3;CERKL;PLA2G4E;DUSP12;PLPPR2;INPP5J;PFKFB1;NUDT11;LIMD1;LIMK2;PPM1A;PLPPR1;HK1;SLC20A1;PRKCG;TAOK1;INPP5B;MTOR
prerank,ubiquitin-dependent ERAD pathway (GO:0030433),0.2931137060965506,0.8553547529542924,0.6918735891647856,1.0,1.0,15/69,15.46%,ERLIN2;DNAJB9;RHBDD2;FBXO27;DERL2;SELENOS;HERPUD1;EDEM2;UBE2J2;RNF121;FBXO17;TMUB2;HSP90B1;JKAMP;ERLIN1
prerank,calcium ion import across plasma membrane (GO:0098703),0.37962975148603706,0.855306660999772,0.6548148148148148,1.0,1.0,2/14,7.96%,CACNA2D1;SLC8A2
prerank,protein localization to synapse (GO:0035418),0.40005001790562333,0.8551102288519378,0.6576576576576577,1.0,1.0,2/12,5.72%,NRXN1;NLGN1
prerank,long-chain fatty-acyl-CoA biosynthetic process (GO:0035338),-0.29010079908347247,-0.8550700208944205,0.6678082191780822,0.9112596551444376,1.0,3/18,7.14%,ACSL1;ELOVL7;ACSL5
prerank,metallo-sulfur cluster assembly (GO:0031163),-0.26801259218180856,-0.854305496506205,0.6590909090909091,0.9116032550164797,1.0,10/22,26.33%,MMS19;ISCA1;LYRM4;FXN;CIAO3;ABCB7;NDOR1;CIAPIN1;GLRX5;NUBP1
prerank,regulation of actin cytoskeleton reorganization (GO:2000249),0.323188976755445,0.8539309556318458,0.6794081381011098,1.0,1.0,5/35,6.44%,PDGFRA;NTRK3;SEMA3E;IQGAP2;BAIAP2
prerank,triglyceride biosynthetic process (GO:0019432),0.3620031753197162,0.8537867270314042,0.6597796143250688,1.0,1.0,5/18,17.89%,AGMO;MOGAT3;GPAT3;GPAT4;PCK2
prerank,mesenchyme morphogenesis (GO:0072132),0.3688043377283574,0.8537789178794809,0.6614285714285715,1.0,1.0,7/17,23.45%,SOX9;ACVR1;MDM4;BMPR1A;HEYL;BMP2;TBX2
prerank,ribonucleoside monophosphate biosynthetic process (GO:0009156),0.37489354938736,0.8537576799705281,0.6477438136826783,1.0,1.0,5/14,21.53%,ADSS1;ADK;RFK;ADSL;PFAS
prerank,inorganic anion transmembrane transport (GO:0098661),0.2918814057454878,0.8532956363029678,0.7094515752625438,1.0,1.0,10/63,16.03%,ANO2;SLC1A3;SLC12A3;ANO6;SLC12A2;SLC12A4;SLC25A10;XPR1;GABRG2;SLC25A11
prerank,vesicle cytoskeletal trafficking (GO:0099518),-0.2376834891991839,-0.8532616495276414,0.6906077348066298,0.9126738681318928,1.0,10/39,14.04%,MYO1D;WASL;FNBP1L;TRAK1;PAFAH1B1;KIF5B;BICDL1;MYO1E;MYO5B;MYO1C
prerank,signal release from synapse (GO:0099643),0.30713943764642654,0.8531715111364723,0.6726835138387485,1.0,1.0,8/43,13.88%,NRXN1;SYT1;SYN1;RIMS1;DVL1;RAB3A;OTOF;SNCA
prerank,mitotic nuclear membrane organization (GO:0101024),0.3002763728716171,0.8528506235913179,0.6953955135773318,1.0,1.0,28/51,31.22%,NUP155;PPP2R2A;RCC1;NUP205;NDC1;NUP160;EMD;KPNB1;SUMO1;LMNA;CHMP4C;POM121;AHCTF1;PPP2R1A;REEP3;IST1;NUP35;UBE2I;CHMP4A;CHMP4B;SPAST;VRK1;SIRT2;CC2D1B;SEC13;ANKLE2;NUP85;RANGAP1
prerank,mitotic nuclear membrane reassembly (GO:0007084),0.3002763728716171,0.8528506235913179,0.6953955135773318,1.0,1.0,28/51,31.22%,NUP155;PPP2R2A;RCC1;NUP205;NDC1;NUP160;EMD;KPNB1;SUMO1;LMNA;CHMP4C;POM121;AHCTF1;PPP2R1A;REEP3;IST1;NUP35;UBE2I;CHMP4A;CHMP4B;SPAST;VRK1;SIRT2;CC2D1B;SEC13;ANKLE2;NUP85;RANGAP1
prerank,transferrin transport (GO:0033572),-0.23986496633834628,-0.8527304648103651,0.7313432835820896,0.9124831449583908,1.0,9/33,15.42%,RAB11B;ATP6V0C;ATP6V0D1;MCOLN1;TFRC;DNM2;ATP6V0A4;ATP6AP1;ATP6V0A2
prerank,mismatch repair (GO:0006298),0.33538417076334,0.8522880500578515,0.6593548387096774,1.0,1.0,7/27,15.54%,RPA3;MUTYH;SETD2;MSH6;RPA2;MSH5;ABL1
prerank,regulation of microglial cell activation (GO:1903978),0.37720087964885907,0.8519667266225006,0.6587887740029542,1.0,1.0,3/15,13.71%,SYT11;GRN;TTBK1
prerank,negative regulation of cholesterol transport (GO:0032375),0.40021032889218644,0.8515600074948814,0.6370839936608558,1.0,1.0,2/10,21.17%,SREBF2;NFKB1
prerank,cellular polysaccharide catabolic process (GO:0044247),0.36217204727563374,0.851529143643489,0.6282420749279539,1.0,1.0,3/16,14.50%,PYGL;PHKB;CALM1
prerank,lipid homeostasis (GO:0055088),0.29589756757627916,0.8512998723074442,0.6856810244470314,1.0,1.0,7/57,9.74%,IRS2;ZBTB20;FBXW7;MLXIPL;ACOX1;RCN3;THADA
prerank,negative regulation of cell division (GO:0051782),0.39837415889249966,0.8512428102727628,0.6636636636636637,1.0,1.0,3/11,15.80%,MYC;CHMP4C;BLM
prerank,ribosomal subunit export from nucleus (GO:0000054),0.38992699818410637,0.8512076058187005,0.6473214285714286,1.0,1.0,3/13,12.93%,XPO1;EIF6;SDAD1
prerank,bile acid metabolic process (GO:0008206),0.3412957001211334,0.8508501283852832,0.6808236808236808,1.0,1.0,10/27,25.14%,NPC1;GBA2;CYP39A1;CYP7B1;CYP27A1;OSBPL1A;ACOT8;SCP2;HSD17B4;AMACR
prerank,positive regulation of protein modification process (GO:0031401),0.26699074377057713,0.8507918881448506,0.8136456211812627,1.0,1.0,18/203,6.54%,DLC1;CLDN19;NTRK3;FGF2;FGF10;SOX9;ERBB2;EGFR;EFNA5;WDFY2;VEGFA;TGFB1;NTRK2;MT3;TNIK;NIBAN1;PAK1;RALB
prerank,membrane depolarization during cardiac muscle cell action potential (GO:0086012),0.3664588956963629,0.8504757449590565,0.6491228070175439,1.0,1.0,3/17,5.51%,CACNA2D1;ANK2;SCN5A
prerank,positive regulation of DNA binding (GO:0043388),0.32993574101254974,0.8503738466323653,0.6606217616580311,1.0,1.0,3/31,4.08%,NGF;PRKN;TGFB1
prerank,inositol phosphate dephosphorylation (GO:0046855),0.40123916880603383,0.8503267005501935,0.6511627906976745,1.0,1.0,1/11,1.66%,PTEN
prerank,phosphorylated carbohydrate dephosphorylation (GO:0046838),0.40123916880603383,0.8503267005501935,0.6511627906976745,1.0,1.0,1/11,1.66%,PTEN
prerank,positive regulation of interleukin-4 production (GO:0032753),0.3614301975857242,0.8501881509308417,0.656121045392022,1.0,1.0,1/17,1.04%,PRKCQ
prerank,protein import (GO:0017038),0.2869467379441662,0.8501280916062331,0.725576289791438,1.0,1.0,23/84,21.11%,ACBD5;PEX3;PXMP2;NUP155;FAM53B;TOMM22;HSPA4;IPO9;PRICKLE1;KPNB1;IPO13;NXT1;EIF4ENIF1;GDAP1;POM121;ABCD2;TNPO3;IPO5;CSE1L;STAT3;PHB2;LAMP2;HEATR3
prerank,positive regulation of toll-like receptor 4 signaling pathway (GO:0034145),0.40778079197464057,0.8499433207341923,0.6490683229813664,1.0,1.0,1/10,1.74%,PTPN22
prerank,negative regulation of calcineurin-mediated signaling (GO:0106057),0.3910616370482939,0.8495949724231363,0.6625386996904025,1.0,1.0,3/12,13.51%,PRNP;RCAN1;HOMER2
prerank,negative regulation of calcineurin-NFAT signaling cascade (GO:0070885),0.3910616370482939,0.8495949724231363,0.6625386996904025,1.0,1.0,3/12,13.51%,PRNP;RCAN1;HOMER2
prerank,response to insulin (GO:0032868),0.2904874507594446,0.8495059128222376,0.7399103139013453,1.0,1.0,10/80,10.37%,SLC27A1;IRS2;KAT2B;C2CD5;EPRS1;PDE3B;TSC1;EIF6;SELENOS;PIK3R1
prerank,anion transmembrane transport (GO:0098656),0.2949232956312022,0.84947412327974,0.7006802721088435,1.0,1.0,11/67,13.11%,SLC1A3;SLC27A1;SLC25A21;LRRC8D;SLC35C2;SLC25A38;ARL6IP5;SLC35A1;SLC7A8;PRAF2;SLC25A10
prerank,positive regulation of DNA-binding transcription factor activity (GO:0051091),0.26530866625946853,0.8494264189502678,0.8196555217831814,1.0,1.0,41/234,20.23%,RELN;ROR1;EDA;PRKCQ;PYCARD;PTEN;STK36;VEGFA;IRAK3;CRTC1;RPS6KA4;FANK1;WNT5A;CARD9;IL18;SMO;MID2;ATF2;ESR1;TRIM41;RTKN2;PRDX3;MALT1;DHX33;TICAM1;UBB;JUP;TERF2IP;IL1RAP;RIPK1;CHUK;RAB7B;PARK7;TAB3;TAF1;BCL10;PPARG;STAT3;PHB2;ADCY8;SMARCA4
prerank,purine-containing compound biosynthetic process (GO:0072522),-0.26658994097901595,-0.848874710983121,0.7217741935483871,0.9193029805778956,1.0,12/25,33.35%,AMPD3;PRPSAP2;PRPS2;DCK;GART;PRPS1;PRPS1L1;APRT;GMPS;PNP;ADA;SHMT2
prerank,positive regulation of reactive oxygen species metabolic process (GO:2000379),-0.22994278523719525,-0.848818233250693,0.7241379310344828,0.9182002577478798,1.0,11/47,12.50%,PRKCD;TLR4;THBS1;AGTR1;DHRS4;PDGFRB;XDH;RNF41;CYBA;SOD1;MAPT
prerank,sarcomere organization (GO:0045214),0.33765476548087003,0.8485484979551904,0.6840731070496083,1.0,1.0,2/27,8.42%,CSRP1;TNNT3
prerank,nitric oxide metabolic process (GO:0046209),0.3831767966757572,0.8480881659883825,0.6572700296735905,1.0,1.0,2/14,7.15%,NQO1;CYP1B1
prerank,purine ribonucleotide transport (GO:0015868),-0.3102055780607247,-0.8480682708138902,0.695364238410596,0.9185662916998811,1.0,4/16,13.06%,ABCC4;ABCC6;LRRC8C;LRRC8A
prerank,sterol transport (GO:0015918),0.36289940742471044,0.8480353482460642,0.6689098250336474,1.0,1.0,2/19,5.43%,NPC1;OSBPL5
prerank,glycerolipid catabolic process (GO:0046503),0.3565620331767736,0.8479115614966662,0.659634317862166,1.0,1.0,6/19,19.94%,PRDX6;ENPP6;LYPLA2;ABHD6;GDPD3;PLA2G4E
prerank,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902166),0.3930615285317453,0.8477286822978078,0.6666666666666666,1.0,1.0,3/11,17.14%,BCL2;TAF9;CD74
prerank,homophilic cell adhesion via plasma membrane adhesion molecules (GO:0007156),0.295833583955476,0.8476667800317674,0.7003484320557491,1.0,1.0,12/59,10.12%,TENM3;PTPRT;DSG2;OBSL1;CADM3;KIRREL3;HMCN1;CNTN6;CADM1;CNTN2;DSCAM;PALLD
prerank,positive regulation of leukocyte degranulation (GO:0043302),0.3785612161113082,0.847620039690288,0.6540697674418605,1.0,1.0,2/13,8.25%,AP1G1;GAB2
prerank,positive regulation of glycolytic process (GO:0045821),0.3494453541069195,0.8475582427745894,0.6470588235294118,1.0,1.0,9/20,22.02%,ZBTB20;PSEN1;MLXIPL;HIF1A;PFKFB1;P2RX7;PRKAA1;PRXL2C;SLC4A4
prerank,positive regulation of purine nucleotide metabolic process (GO:1900544),0.3494453541069195,0.8475582427745894,0.6470588235294118,1.0,1.0,9/20,22.02%,ZBTB20;PSEN1;MLXIPL;HIF1A;PFKFB1;P2RX7;PRKAA1;PRXL2C;SLC4A4
prerank,positive regulation of extracellular matrix organization (GO:1903055),0.3569348205436509,0.8472628661551269,0.6596638655462185,1.0,1.0,7/18,24.76%,TGFB1;CLASP1;RUNX1;FSCN1;RB1;BMP2;COLGALT1
prerank,regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis (GO:1903587),0.3638776110288904,0.8469247693486315,0.6504992867332382,1.0,1.0,3/16,10.58%,FGF2;VEGFA;NGFR
prerank,cytoplasmic sequestering of transcription factor (GO:0042994),-0.3073502773599359,-0.8468232920656746,0.6884735202492211,0.9200535737317593,1.0,4/14,14.08%,NFKBIA;KEAP1;TMSB4X;MDFI
prerank,negative regulation of centrosome duplication (GO:0010826),0.3928320103894465,0.8466058615163197,0.6423135464231354,1.0,1.0,3/11,13.91%,KAT2B;BRCA1;MDM1
prerank,positive regulation of protein dephosphorylation (GO:0035307),0.3302673147132854,0.8464251595966656,0.6918075422626788,1.0,1.0,3/32,4.99%,DLC1;TGFB1;PPP1R15A
prerank,negative regulation of cell migration involved in sprouting angiogenesis (GO:0090051),0.3819178995157865,0.8463905843123046,0.6529160739687055,1.0,1.0,1/14,0.94%,MEOX2
prerank,negative regulation of pri-miRNA transcription by RNA polymerase II (GO:1902894),-0.3249513991136885,-0.8457830792178049,0.6808510638297872,0.9210236194245649,1.0,3/13,4.65%,NFIB;BMP4;PPARD
prerank,regulation of catabolic process (GO:0009894),0.35570200566140875,0.8455871510850561,0.6611111111111111,1.0,1.0,6/18,21.62%,FAP;NEDD4L;ITGB1;MDM2;FURIN;RARRES2
prerank,carboxylic acid metabolic process (GO:0019752),0.318138855692831,0.8452576794994828,0.6670951156812339,1.0,1.0,3/33,7.77%,CYP2S1;DAO;CSGALNACT1
prerank,protein transport (GO:0015031),0.261402112467828,0.8451283756538897,0.850956696878147,1.0,1.0,95/332,24.29%,TMED6;ANK3;TBC1D10A;RAB38;LRP1;STEAP3;VAMP4;RAB14;ATP6V1B2;BLZF1;VPS33A;COPZ2;SNX15;VPS29;SCAMP2;SPTBN1;ARL1;RAB21;COPB2;RAB34;SEC31B;COPG2;RABL3;TBCK;MTTP;RCN3;TMED10;RAB3D;NEURL1B;SLC10A7;SNX6;VPS26B;ARL5C;NGFR;ARF4;NDC1;HDAC6;ARL6IP5;RAB22A;SYS1;RAB1A;USP6NL;RAB3A;HSP90B1;STX8;SYNDIG1;RAB3GAP2;TMED3;TMED2;TRIM23;COPA;ARFGAP3;SNX1;SEC23IP;UNC93B1;SGSM1;COPG1;STX1B;LRP2;TANGO6;CTTN;AP4M1;CD74;DENND10;ATP6V1C1;RAB7A;KIF3A;STX17;RAB3B;ARFIP1;CHMP1B;PPARG;TBC1D12;NAPG;ATP6V0E2;LAMP2;VMP1;TANGO2;TBC1D8B;TBC1D9B;KIF13A;ATP6V0E1;RAB18;FAM91A1;SNX4;RAB6A;UNC119B;TVP23A;SCFD2;STX2;ACD;STX7;ATP6V1G2;MIA3;ARRDC2
prerank,regulation of hydrogen peroxide-induced cell death (GO:1903205),0.3961943405341235,0.8448697424841426,0.6461538461538462,1.0,1.0,4/10,18.76%,GPR37;NFE2L2;RIPK1;PARK7
prerank,negative regulation of dephosphorylation (GO:0035305),0.3632831709896841,0.8448219284669422,0.6680851063829787,1.0,1.0,4/18,8.52%,PPP1R15A;URI1;ENSA;PPP1R8
prerank,regulation of chromatin organization (GO:1902275),-0.305435680409365,-0.8448165257627044,0.6996996996996997,0.9217737145663782,1.0,3/14,5.00%,MLLT3;PARG;IGF2
prerank,cyclic purine nucleotide metabolic process (GO:0052652),-0.2759159247914921,-0.8446996013117675,0.6808510638297872,0.9208055600045878,1.0,4/21,10.70%,ADCY9;NPR1;ADCY4;GUCY1B1
prerank,regulation of leukocyte cell-cell adhesion (GO:1903037),-0.33172325087385446,-0.8446595485591887,0.6846846846846847,0.9196802753631879,1.0,4/12,22.44%,WNK1;ASS1;SKAP1;AKT1
prerank,regulation of trophoblast cell migration (GO:1901163),0.37795168005171,0.8446006507839546,0.6633093525179856,1.0,1.0,2/14,5.43%,VEGFA;ACVR1C
prerank,cellular response to glucagon stimulus (GO:0071377),-0.28820226484187617,-0.8444437188498366,0.7129337539432177,0.9188915245830696,1.0,7/17,25.13%,ADCY9;PRKAR1A;ADCY4;ADCY3;CYSLTR2;PRKAR2A;PRKACB
prerank,cardiac ventricle morphogenesis (GO:0003208),-0.22851589678742726,-0.8443847892810243,0.8238636363636364,0.9178038570170147,1.0,9/41,12.51%,SMAD7;BMP4;ENG;TPM1;FGFR2;JAG1;GSK3A;PROX1;TGFB2
prerank,embryonic cranial skeleton morphogenesis (GO:0048701),0.37894720389213926,0.84438117437212,0.6614060258249641,1.0,1.0,2/15,6.38%,PDGFRA;TGFBR2
prerank,regulation of calcineurin-NFAT signaling cascade (GO:0070884),-0.2657633137483325,-0.8442948110494406,0.6790123456790124,0.9167642793490476,1.0,2/26,0.58%,IGF1;FHL2
prerank,positive regulation of carbohydrate metabolic process (GO:0045913),0.3426113503781046,0.8442260868472419,0.6831275720164609,1.0,1.0,10/23,22.02%,ZBTB20;PSEN1;MLXIPL;HIF1A;PFKFB1;NFKB1;P2RX7;PRKAA1;PRXL2C;SLC4A4
prerank,nitric oxide biosynthetic process (GO:0006809),0.3871571367460569,0.8441982470771211,0.6586466165413534,1.0,1.0,2/13,7.15%,NQO1;CYP1B1
prerank,"maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000466)",-0.2765127864465294,-0.8437138810007175,0.7191011235955056,0.9167766720107258,1.0,7/22,21.64%,ERI1;EXOSC7;URB1;NOP9;EXOSC10;RPS21;PES1
prerank,protein peptidyl-prolyl isomerization (GO:0000413),-0.2759486410815036,-0.8436848199402972,0.7044673539518901,0.9156392837890456,1.0,4/20,6.58%,PPIC;PPIL2;CWC27;PPIA
prerank,B cell mediated immunity (GO:0019724),0.401083558062024,0.8433907724814383,0.6619718309859155,1.0,1.0,2/10,17.14%,CARD9;CD74
prerank,negative regulation of T cell differentiation (GO:0045581),-0.3495335052023638,-0.8432987858567242,0.6694214876033058,0.9152563158717155,1.0,3/10,9.67%,BMP4;GLI3;IRF1
prerank,cellular response to low-density lipoprotein particle stimulus (GO:0071404),-0.31363812075648767,-0.8432627522686489,0.6507936507936508,0.9141253337090459,1.0,2/13,2.11%,ABCA1;CDH13
prerank,early endosome to Golgi transport (GO:0034498),0.39166083174665123,0.8430880746525841,0.6708074534161491,1.0,1.0,6/11,24.04%,SNX1;SURF4;RBSN;LMAN1;RAB6A;TRAPPC10
prerank,protein export from nucleus (GO:0006611),0.33088550530340344,0.8429782609464448,0.6835781041388518,1.0,1.0,3/27,4.08%,CCHCR1;XPO1;TGFB1
prerank,sensory perception of smell (GO:0007608),0.3978679209143463,0.8427378189653064,0.6711309523809523,1.0,1.0,4/11,24.43%,DRD2;SLC24A4;UBR3;BBS4
prerank,mitochondrial respiratory chain complex assembly (GO:0033108),0.2848618124060086,0.8427278296575589,0.7536231884057971,1.0,1.0,21/87,18.26%,NDUFAF4;COX20;NDUFS5;NDUFAF6;COX18;SCO1;NDUFB2;NDUFA8;COX19;NDUFS8;ACAD9;NDUFV3;NDUFS6;NDUFV2;NDUFA13;SDHAF1;NDUFA6;NDUFA12;AIFM1;UQCC1;NDUFC1
prerank,regulation of autophagy (GO:0010506),0.2646401891511531,0.8426771334184391,0.8081218274111676,1.0,1.0,37/216,15.59%,DCN;PTPN22;BCL2;PRKN;NPRL2;CAPN1;FBXW7;ATP6V1B2;MT3;VPS29;PRKAB2;UFL1;BMF;KAT8;BNIP3;LAMTOR2;UCHL1;TLK2;SNX6;VPS26B;EIF4G1;MID2;USP33;HDAC6;CDK5R1;FBXL2;PRKACA;TPCN2;DRAM1;GFAP;WASHC1;TICAM1;MET;KLHL22;ATM;ABL1;PIM2
prerank,negative regulation of canonical Wnt signaling pathway (GO:0090090),0.26889687637113596,0.8425474293128791,0.8006166495375129,1.0,1.0,35/161,19.45%,TPBGL;RBMS3;LRP4;SOX9;PRKN;FRZB;JADE1;TLE1;GLI1;WNT5A;TBX18;PSMB7;DKK3;CUL3;SFRP4;TMEM131L;EMD;PRICKLE1;APC2;DVL1;WWTR1;CSNK1A1;KLHL12;PSMD2;SCYL2;PSMC1;DACT1;TLE3;PSMB2;TLE4;MDK;PSMD9;RUVBL2;NKD2;PSME4
prerank,regulation of protein localization to Cajal body (GO:1904869),-0.3346719550509127,-0.8425176645639658,0.6714285714285714,0.9132519563727033,1.0,5/11,13.59%,DKC1;LARP7;CCT8;CCT6A;CCT4
prerank,positive regulation of protein localization to Cajal body (GO:1904871),-0.3346719550509127,-0.8425176645639658,0.6714285714285714,0.9132519563727033,1.0,5/11,13.59%,DKC1;LARP7;CCT8;CCT6A;CCT4
prerank,semaphorin-plexin signaling pathway (GO:0071526),0.3122163417033779,0.8425004145484475,0.6811224489795918,1.0,1.0,10/35,18.86%,SEMA3E;SEMA6C;SEMA3A;FLNA;FARP2;NRP2;SEMA6D;MET;SEMA4B;SEMA4D
prerank,nucleotide metabolic process (GO:0009117),-0.2653724978314229,-0.8424972331002581,0.6964285714285714,0.9121149795785768,1.0,10/23,25.12%,RNASEH2B;NMNAT2;ME1;NMNAT1;GUK1;DCK;AK4;AK1;NME2;ENPP3
prerank,"regulation of DNA-templated transcription, elongation (GO:0032784)",0.33503074638522734,0.8424364692691271,0.6758530183727034,1.0,1.0,9/25,24.67%,HMGN1;ZNF326;SETD5;ELL;TCEA2;ZMYND11;KAT7;THOC5;CCNT2
prerank,cellular macromolecule catabolic process (GO:0044265),0.30807164470001935,0.8424158171074907,0.7107728337236534,1.0,1.0,17/49,26.07%,PRKN;RNASE6;XRN2;PPP1R8;FBXO27;NCBP1;FBXO17;RNASEH2C;PNPT1;RIPK1;MAGEC2;UBE2G1;FBXO44;OGA;SUPV3L1;RNASE3;SND1
prerank,cellular response to interleukin-15 (GO:0071350),0.3851473728454881,0.8423729728045566,0.6466275659824047,1.0,1.0,7/13,31.11%,PLCB1;GRB2;STAT3;STAT5A;JAK3;SHC1;IL15RA
prerank,interleukin-15-mediated signaling pathway (GO:0035723),0.3851473728454881,0.8423729728045566,0.6466275659824047,1.0,1.0,7/13,31.11%,PLCB1;GRB2;STAT3;STAT5A;JAK3;SHC1;IL15RA
prerank,negative regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039532),-0.3464184289617691,-0.8418628130882548,0.6882352941176471,0.9122473765676511,1.0,6/10,31.84%,RIOK3;UFD1;GPATCH3;RNF125;TKFC;TSPAN6
prerank,piRNA metabolic process (GO:0034587),0.35672794231734334,0.8418569002883386,0.6884779516358464,1.0,1.0,4/19,22.35%,FKBP6;TEX15;TDRKH;DDX4
prerank,histone modification (GO:0016570),0.276063592869397,0.8418464840147906,0.7639484978540773,1.0,1.0,25/109,19.24%,RCOR2;RPS6KA4;MT3;HLCS;MTA2;UFL1;KAT8;CARM1;BRD8;MORF4L2;HDAC2;HUWE1;PHF20;SIN3B;PRMT1;HDAC6;MIDEAS;BAZ1B;TRRAP;MSL3;MTA3;USP21;ATXN7;PARK7;RUVBL2
prerank,regulation of protein kinase C signaling (GO:0090036),0.3794911358810914,0.8415924605181077,0.6578212290502793,1.0,1.0,2/14,5.52%,VEGFA;WNT5A
prerank,cellular response to acid chemical (GO:0071229),0.33231833397771626,0.8414381116386587,0.6753782668500687,1.0,1.0,11/27,26.29%,VEGFA;CPEB3;LAMTOR2;CPEB1;SPAAR;RPTOR;IPO5;RRAGA;MTOR;SLC38A9;CPEB4
prerank,DNA replication (GO:0006260),0.2751993057587129,0.8414082308025752,0.7505446623093682,1.0,1.0,33/105,24.75%,POLE2;BAZ1A;TIPIN;REV3L;RPA3;BRCA1;POLE3;MCM4;UPF1;ING4;RPA2;ORC1;TOPBP1;POLG2;ATM;BLM;POLG;FAM111A;WRN;REV1;ORC4;DBF4;TOP1;WRNIP1;ORC2;TOP3A;RBMS1;RAD50;KAT7;BARD1;ORC3;ATR;RHNO1
prerank,negative regulation of cellular amide metabolic process (GO:0034249),-0.195248374108987,-0.8408240839381786,0.8181818181818182,0.9130601316300325,1.0,22/84,22.29%,DAPK1;IGF1;SAMD4A;ROCK1;YBX1;CAPRIN1;IGFBP5;CNOT1;RACK1;EIF4A3;BTG2;ORMDL3;SPHK1;FXR2;CNOT9;IGF2BP3;APOE;ABCA7;CHRNA7;PCIF1;CLU;ORMDL1
prerank,fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540),0.37699170400484405,0.8407543857913283,0.6706408345752608,1.0,1.0,7/14,25.14%,ACOX1;CRAT;EHHADH;ACOT8;SCP2;HSD17B4;AMACR
prerank,release of cytochrome c from mitochondria (GO:0001836),0.3611956550055123,0.8404140159591178,0.675177304964539,1.0,1.0,4/17,15.53%,BCL2;SOD2;GGCT;FZD9
prerank,cellular response to tumor necrosis factor (GO:0071356),0.2685668330007379,0.8403084902109723,0.8037190082644629,1.0,1.0,23/175,17.26%,CCL11;ADAMTS12;EDA;HAS2;PYCARD;CCL4;BRCA1;ERBIN;PSMB7;ZFP36L2;NFE2L2;PID1;GATA3;PSMD2;ZFAND6;CCL14;PSMC1;TP53;HYAL1;PYDC1;PSMB2;RIPK1;CHUK
prerank,genitalia development (GO:0048806),0.38449092763612813,0.8400882631243483,0.6408345752608048,1.0,1.0,4/12,16.70%,WNT5A;PTPN11;PKD1;DNAJC19
prerank,base-excision repair (GO:0006284),0.30200176926069267,0.8400665813672615,0.7130750605326877,1.0,1.0,12/48,17.24%,MBD4;ERCC5;MPG;RPA3;MUTYH;XPA;HUWE1;NEIL1;RPA2;SMUG1;POLG;WRN
prerank,regulation of oxidative stress-induced cell death (GO:1903201),0.38713518294412497,0.839766797495651,0.6646341463414634,1.0,1.0,2/11,8.06%,PRKN;FYN
prerank,positive regulation of fatty acid biosynthetic process (GO:0045723),0.3923868785512325,0.8394913740381382,0.6561014263074485,1.0,1.0,3/10,16.67%,MLXIPL;ELOVL5;ABCD2
prerank,"Wnt signaling pathway, planar cell polarity pathway (GO:0060071)",0.2816117512710718,0.8391700259049389,0.7408637873754153,1.0,1.0,16/85,21.86%,ROR2;WNT5A;FZD7;PRICKLE2;PSMB7;MAGI2;PRICKLE1;DVL1;PSMD2;PSMC1;PSMB2;PSMD9;PSME4;PSMA8;DVL3;ARRB2
prerank,histone H3-K9 demethylation (GO:0033169),-0.3342027469057132,-0.8390536296008998,0.6648351648351648,0.9154133382747626,1.0,5/11,19.86%,KDM1A;KDM4C;KDM4D;KDM3B;HR
prerank,positive regulation of lipid biosynthetic process (GO:0046889),0.32605380747335116,0.8389777265996811,0.6886304909560723,1.0,1.0,4/29,9.43%,SLC27A1;ZBTB20;MLXIPL;ELOVL5
prerank,modulation by symbiont of host process (GO:0044003),-0.3480866517797206,-0.8386438930262369,0.6455331412103746,0.9151094246097965,1.0,4/10,25.17%,PGK1;ENO1;MRC1;UBA52
prerank,neuron projection extension (GO:1990138),0.32215276088871303,0.8384688527872006,0.6805736636245111,1.0,1.0,9/32,14.94%,MAP1B;SEMA3A;AUTS2;CDKL3;PPP3CB;SPG11;NRP2;IQGAP1;CYFIP1
prerank,positive regulation of establishment of protein localization to mitochondrion (GO:1903749),0.2978995287813098,0.8383584390731076,0.7260765550239234,1.0,1.0,15/52,21.70%,BCL2;FBXW7;YWHAZ;VPS11;HUWE1;UBE2J2;PPP3CC;TP53;SREBF2;CSNK2A2;UBE2L3;MICALL2;RHOU;NPEPPS;UBE2D3
prerank,production of miRNAs involved in gene silencing by miRNA (GO:0035196),-0.2519432497657682,-0.8383029592802169,0.7408906882591093,0.9145908100848499,1.0,13/29,30.18%,DGCR8;AGO1;ZC3H7B;TUT7;AGO3;SRRT;TARBP2;LIN28B;MRPL44;PUS10;AGO2;DICER1;AGO4
prerank,electron transport chain (GO:0022900),0.3674931057731152,0.8382689716283297,0.6434782608695652,1.0,1.0,2/15,5.93%,POR;ETFA
prerank,dendrite morphogenesis (GO:0048813),0.31341227763797797,0.8382383244035466,0.678117048346056,1.0,1.0,8/35,12.17%,LRP4;PTEN;EPHB2;SDC2;CTNNA2;DOCK10;DIP2A;DVL1
prerank,negative regulation of NF-kappaB transcription factor activity (GO:0032088),-0.20742865004540506,-0.8380133697540595,0.8333333333333334,0.9140061020423857,1.0,14/76,12.95%,PTGIS;CD200;USP7;MAP2K5;NFKBIA;COMMD1;AIM2;PARP10;ANXA4;KLF4;COMMD7;PRMT2;TMSB4X;LRRC14
prerank,positive regulation of nervous system process (GO:0031646),-0.2917499783498983,-0.8378839764989233,0.7040816326530612,0.9130947733068467,1.0,4/18,10.71%,NLGN2;PARD3;ATPSCKMT;UNC13B
prerank,macroautophagy (GO:0016236),0.2735790136883538,0.837613011748,0.7613997879109226,1.0,1.0,21/118,15.22%,DYNLL1;PRKN;MTMR14;VPS33A;LIX1;ACBD5;SNAP29;WIPI1;PRKAB2;VPS39;ATG5;TOMM22;TOMM20;VPS37B;VPS36;ATG3;MVB12A;GABARAPL2;PLAA;VPS41;CHMP4C
prerank,calcium-ion regulated exocytosis (GO:0017156),0.3296524053874105,0.8375546870531034,0.684,1.0,1.0,11/27,23.59%,SYT1;PPP3CB;SYT11;SYT12;RIMS1;DOC2B;SYT2;RIMS2;SYT13;SYT3;ARL8B
prerank,acylglycerol catabolic process (GO:0046464),-0.25019068423433033,-0.837515663056292,0.7215189873417721,0.9126365640985615,1.0,9/30,25.44%,MGLL;ABHD2;DAGLA;ABHD12;PNPLA2;LPL;PNPLA3;FAAH;LIPE
prerank,positive regulation of phosphoprotein phosphatase activity (GO:0032516),-0.289018535195222,-0.8372394519705677,0.7070707070707071,0.912026609641059,1.0,7/17,18.90%,PTPA;PPP1R15B;PDGFRB;ITGA1;PTPRC;CD300A;HSP90AB1
prerank,regulation of intrinsic apoptotic signaling pathway (GO:2001242),0.30294379285677264,0.8370980254801316,0.7070828331332533,1.0,1.0,10/49,16.25%,PYCARD;BCL2;EIF2AK3;URI1;BMF;HERPUD1;RTKN2;TP53;BCL2L11;NDUFA13
prerank,negative regulation of cell cycle G1/S phase transition (GO:1902807),0.3220808273510787,0.8366485932612987,0.6875816993464052,1.0,1.0,4/31,7.57%,PTEN;CDKN2B;JADE1;CDK6
prerank,cytoskeleton-dependent intracellular transport (GO:0030705),0.3355163685250179,0.8366378786713669,0.6770691994572592,1.0,1.0,12/23,24.26%,DYNC1I1;KIF5C;CCDC186;DYNC1I2;MAP6D1;TUBA1A;HOOK2;MAP6;CCDC88A;HOOK1;HOOK3;TUBA1B
prerank,positive regulation of posttranscriptional gene silencing (GO:0060148),0.38764076984069734,0.8363129286418209,0.6586102719033232,1.0,1.0,7/11,27.82%,STAT3;ZFP36;LIMD1;XPO5;FMR1;AJUBA;PUM2
prerank,primary alcohol metabolic process (GO:0034308),-0.2576023823042244,-0.8356703113124379,0.6818181818181818,0.9140702445600856,1.0,3/25,8.09%,IGF1;RBP4;ALDH3A2
prerank,hematopoietic stem cell proliferation (GO:0071425),0.3913202521600151,0.8355479132907984,0.6626506024096386,1.0,1.0,2/11,5.52%,CD34;WNT5A
prerank,negative regulation of transmembrane transport (GO:0034763),0.39662713162252483,0.835521768716529,0.6717557251908397,1.0,1.0,1/10,1.98%,IRS2
prerank,positive regulation of intracellular transport (GO:0032388),0.30663518372652143,0.8354039346366934,0.6715867158671587,1.0,1.0,10/38,23.74%,KIF20B;PGAP1;PCM1;TBC1D20;EHD2;PLA2G4E;PCNT;DYNC1H1;EIPR1;STX18
prerank,nuclear export (GO:0051168),0.2861851194046444,0.8348362668863714,0.750278706800446,1.0,1.0,17/80,19.63%,CCHCR1;XPO1;THOC6;TGFB1;NUP155;SRSF11;CASC3;NCBP1;MALT1;SRSF6;PKD1;POM121;NXF1;RNPS1;THOC7;CSE1L;SRRM1
prerank,axon extension (GO:0048675),0.3344004036714423,0.8347222680603115,0.6735537190082644,1.0,1.0,7/23,14.94%,MAP1B;SEMA3A;AUTS2;PPP3CB;SPG11;NRP2;CYFIP1
prerank,sterol biosynthetic process (GO:0016126),0.3196953001942855,0.8346635238579888,0.6971569839307787,1.0,1.0,4/33,8.57%,HSD17B7;SQLE;IDI1;ACLY
prerank,establishment of mitotic spindle localization (GO:0040001),0.328191762256412,0.833977899942187,0.6926121372031663,1.0,1.0,7/28,18.47%,GPSM2;INSC;NDE1;CLASP1;KPNB1;ITGB1;HTT
prerank,"regulation of gene expression, epigenetic (GO:0040029)",0.285853463600532,0.8336115029034479,0.7275822928490352,1.0,1.0,22/73,24.87%,GLMN;KAT2B;TAF1A;EED;POLR2K;HDAC6;CREBZF;EPC1;JARID2;RBBP4;POLR1B;BAZ1B;PHF19;POLR1C;POLR1G;CGGBP1;RBBP7;TDG;MPHOSPH8;AEBP2;POLR2F;TBP
prerank,adenine nucleotide transport (GO:0051503),-0.29818750732156624,-0.8329564389500244,0.7098976109215017,0.9183481373915601,1.0,4/17,13.06%,ABCC4;ABCC6;LRRC8C;LRRC8A
prerank,UV protection (GO:0009650),0.3956366139446485,0.8323927065159663,0.6618122977346278,1.0,1.0,4/10,19.97%,ERCC5;XPA;CAT;SCARA3
prerank,autophagy of peroxisome (GO:0030242),0.38408164023116426,0.8321311405575812,0.6749633967789166,1.0,1.0,3/12,18.07%,ACBD5;ATM;NBR1
prerank,UV-damage excision repair (GO:0070914),0.38414216053086436,0.8319740051768599,0.6732223903177005,1.0,1.0,5/12,22.05%,DDB2;XPA;DDB1;CUL4B;ACTR5
prerank,nucleotide catabolic process (GO:0009166),0.3538067202020172,0.8319033249168581,0.6916299559471366,1.0,1.0,4/16,18.57%,NUDT15;NT5C2;NUDT3;NT5C
prerank,skeletal muscle contraction (GO:0003009),-0.27054004821576777,-0.8317042595075345,0.7297297297297297,0.9195982579428736,1.0,8/19,37.75%,RCSD1;STAC;MYH14;STAC3;TNNI1;TNNC1;TNNI3;CCDC78
prerank,phospholipid translocation (GO:0045332),0.3248317479042854,0.8315229155957021,0.693196405648267,1.0,1.0,4/28,3.64%,ATP8B1;PLSCR4;ANO6;ATP9B
prerank,striated muscle contraction (GO:0006941),-0.2243166559659425,-0.8314896537182951,0.8283582089552238,0.9188289582079519,1.0,15/53,26.03%,ATP1A2;RCSD1;TPM1;GRK2;GAA;NOS1;ATP1B1;STAC;SCN4B;MYH14;STAC3;DMD;SCN3B;MYL4;CASQ2
prerank,regulation of establishment of planar polarity (GO:0090175),0.277253551267443,0.8311055549854174,0.7590361445783133,1.0,1.0,16/88,21.86%,ROR2;WNT5A;FZD7;PRICKLE2;PSMB7;PRICKLE1;DVL1;PSMD2;PSMC1;DACT1;PSMB2;PSMD9;PSME4;PSMA8;DVL3;ARRB2
prerank,negative regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032435),0.31856500601284415,0.831022552173662,0.6963151207115629,1.0,1.0,10/30,22.66%,WAC;UCHL5;BAG5;TLK2;TAF9;USP14;N4BP1;PARK7;SGTA;CAMLG
prerank,translational elongation (GO:0006414),0.2710789848694576,0.8310148025564347,0.7593582887700535,1.0,1.0,26/101,22.44%,MRPL47;MRPS18A;EEF2K;TUFM;MRPL14;MRPL32;MRPL16;MRPL58;MRPS35;MRPS28;AURKAIP1;MRPL35;MRPL30;MRPL28;MRPL46;MRPL51;MRPS30;MRPS14;MRPS9;MRPS31;MRPL1;PTCD3;DAP3;MRPS6;MRPL52;MRPL18
prerank,regulation of chromosome organization (GO:0033044),0.34099974502318225,0.8307470267313173,0.6961852861035422,1.0,1.0,6/22,17.73%,MYC;SETMAR;UPF1;SMG6;TERF2IP;CENPV
prerank,regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314),0.33573749127476454,0.830634448469296,0.6811594202898551,1.0,1.0,8/24,22.65%,JPH3;AKAP6;PDE4D;PRKACA;CALM1;CALM2;PKD2;CAMK2D
prerank,positive regulation of NIK/NF-kappaB signaling (GO:1901224),-0.21825303845509023,-0.8305298559087843,0.8520710059171598,0.9195086667526512,1.0,19/50,27.63%,SASH1;NFAT5;TLR4;APP;NR3C2;RHOA;NMI;SPHK1;IFI35;CD86;LAPTM5;NOD1;TCIM;TRADD;ACTN4;ILK;CCL19;NOD2;CD27
prerank,lipoprotein localization (GO:0044872),0.3810241238757076,0.8298883501925781,0.6899696048632219,1.0,1.0,6/11,25.42%,LRP1;PPARG;VMP1;UNC119B;MIA3;ZDHHC17
prerank,intracellular protein transport (GO:0006886),0.25755550890483864,0.8298618511763162,0.8667334669338678,1.0,1.0,75/304,21.18%,TMED6;CCHCR1;TBC1D10A;XPO1;RAB38;C2CD5;RAB14;TGFB1;VPS33A;COPZ2;SNX15;VPS29;NLGN1;NUP155;ARL1;RAB21;COPB2;SEC31B;FAM53B;RABL3;TBCK;TMED10;SNX6;COX18;VPS26B;ARL5C;NGFR;AKAP6;ARF4;IPO9;HDAC6;RAB22A;PRICKLE1;VPS36;RAB1A;KATNB1;USP6NL;KPNB1;STX8;SYNDIG1;IPO13;NXT1;RAB3GAP2;TMED3;TMED2;TRIM23;COPA;ARFGAP3;SNX1;PKD1;SEC23IP;UNC93B1;SGSM1;EIF4ENIF1;STX1B;POM121;CTTN;AP4M1;SURF4;CD74;TRAK2;RAB7A;TNPO3;STX17;ARFIP1;IPO5;CSE1L;STAT3;TBC1D12;PHB2;NAPG;LAMP2;HEATR3;TBC1D8B;TBC1D9B
prerank,pyrimidine-containing compound metabolic process (GO:0072527),-0.321649073911086,-0.8297211918571935,0.6666666666666666,0.9199895044871113,1.0,6/11,33.95%,DCK;SLC19A3;SLC25A19;ENPP3;TPK1;DCTD
prerank,fatty acid metabolic process (GO:0006631),0.27036133415896146,0.8296447000855853,0.7859424920127795,1.0,1.0,19/115,18.04%,CEL;ACACA;THEM4;SLC27A4;OXSM;ACBD5;ACOT11;ACOX1;ACLY;FASN;ACSF2;ALOX5AP;PNPLA8;ACAD9;LIPC;ACSL3;ABCD2;ACSL6;CRAT
prerank,negative regulation of cation transmembrane transport (GO:1904063),0.35999395444780036,0.8295699152443844,0.7017543859649122,1.0,1.0,7/18,22.65%,SLC43A1;BIN1;STK39;NEDD4L;KCNH2;CAB39;CAMK2D
prerank,negative regulation of Rho protein signal transduction (GO:0035024),0.3498184294207947,0.8295633805252581,0.6500711237553343,1.0,1.0,6/18,20.36%,DLC1;CUL3;MYOC;MET;KANK1;HEG1
prerank,postreplication repair (GO:0006301),-0.22289981241402873,-0.8294544888651096,0.7831325301204819,0.9193572085375804,1.0,23/45,31.35%,POLD3;TRIM25;PRIMPOL;PARP10;RFC1;POLH;UBE2A;PCNA;UBE2N;RAD18;POLK;ISG15;FAAP20;NSMCE1;RFC3;UBA52;USP43;POLD2;VCP;PCLAF;MSH2;POLD4;POLD1
prerank,negative regulation of bone mineralization (GO:0030502),-0.3129584684881011,-0.8294093731319224,0.6949152542372882,0.9182639335463925,1.0,8/13,40.39%,SRGN;ENPP1;PTK2B;RFLNA;GREM1;ECM1;AHSG;RFLNB
prerank,positive regulation of chemokine production (GO:0032722),0.2998264823919334,0.8292769790147044,0.7072599531615925,1.0,1.0,7/44,19.04%,PYCARD;WNT5A;IL18;HIF1A;IL33;CD74;EGR1
prerank,embryonic heart tube morphogenesis (GO:0003143),0.30805811697088736,0.8292188434360072,0.7269372693726938,1.0,1.0,5/43,8.63%,ACVR1;CCDC39;TGFBR2;BBS5;SMO
prerank,regulation of protein metabolic process (GO:0051246),-0.22389344998911365,-0.8290192337457931,0.7595628415300546,0.9178487765605392,1.0,17/44,24.55%,ROCK2;MAP2K5;MTPN;KLF2;ACE;APP;KLF4;CENATAC;ODC1;TMEM9;APOE;HSP90AB1;ABCA7;CHRNA7;PLAUR;MAPK8;ZDHHC2
prerank,protein polyubiquitination (GO:0000209),0.25636013864095514,0.8289150616713292,0.8629032258064516,1.0,1.0,90/297,26.04%,UBE2T;BCL2;CBFB;FBXW9;PRKN;UBE2E2;HACE1;FBXW7;RNF6;SPOP;FBXO7;FBXO38;ZNRF2;FBXL15;DDB2;FBXO32;TRIM2;PELI1;BRCA1;UBE2K;HECTD2;FBXL16;PSMB7;FBXO27;LNPEP;CUL3;HUWE1;ANAPC7;THOP1;UBE2J2;FBXO17;ANAPC2;MYLIP;AKTIP;DDA1;NEDD4L;PSMD2;UBB;AREL1;PSMC1;UBE2O;RNF19A;UBOX5;CDC23;FBXL4;UBE2Q1;PSMB2;RC3H1;RNF167;FBXO31;FBXO22;MDM2;ANKRD39;RNF4;PSMD9;TAF1;FBXO11;PSME4;FBXL12;UBE2L3;CDC27;UBE2G1;UBE2E1;NPEPPS;PSMA8;ANAPC4;MKRN1;RNF114;UBE2D3;TTC3;FBXO44;TPP2;ANAPC5;SIAH1;RNF187;UBE3C;CDC16;BARD1;TRIM14;WSB1;ANAPC13;UBE2Q2;FBXW8;CUL1;PELI2;RNF20;PSMD8;PSMD13;TOPORS;UBE2R2
prerank,cellular response to hexose stimulus (GO:0071331),0.3340924246100973,0.8287792989510195,0.6886792452830188,1.0,1.0,8/23,21.94%,ZBTB20;TRA2B;PDK3;PRKACA;PAX2;PCK2;ADCY8;PRKAA1
prerank,cytosolic calcium ion transport (GO:0060401),0.32197255189414226,0.8287080869217831,0.6934210526315789,1.0,1.0,6/28,12.92%,CACNA2D1;ATP2B3;JPH3;SLC8A2;SLC25A23;ATP2B1
prerank,regulation of generation of precursor metabolites and energy (GO:0043467),0.2960145754499131,0.8286930213491259,0.727810650887574,1.0,1.0,11/48,16.73%,PRDM16;RANBP2;NUP155;EIF6;HIF1A;NUP205;NDC1;NUP160;POM121;PNPT1;AAAS
prerank,positive regulation of myeloid leukocyte differentiation (GO:0002763),0.31924975063563016,0.8285783917126289,0.695137976346912,1.0,1.0,2/33,2.66%,PRKCA;FADD
prerank,positive regulation of supramolecular fiber organization (GO:1902905),0.2755801115131008,0.8285177628683934,0.7407002188183808,1.0,1.0,17/86,16.91%,CCL11;PYCARD;PSEN1;PAK1;BAIAP2;LIMK1;BIN1;ARL2;CLASP1;SLAIN2;CDK5R1;KATNB1;NCK1;MET;CDC42EP1;NAV3;CTTN
prerank,positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090100),0.275694273274951,0.8273406902241817,0.7623318385650224,1.0,1.0,16/86,16.29%,BMP5;SULF1;CDKN2B;ACVR1;TGFB1;SOX11;GDF9;FBXL15;MEN1;BMP7;BMPR1A;CITED2;ZEB2;UBE2O;TGFB3;RNF111
prerank,cGMP metabolic process (GO:0046068),0.3823315621208436,0.8272928813700864,0.6687797147385103,1.0,1.0,3/12,17.11%,NPR2;PDE9A;NPPC
prerank,regulation of cellular response to transforming growth factor beta stimulus (GO:1903844),0.3321334234221328,0.8268370966060714,0.7008310249307479,1.0,1.0,6/23,18.37%,TGFB1;SOX11;DKK3;BCL9;NREP;EID2
prerank,positive regulation of angiogenesis (GO:0045766),0.2693544987656964,0.8256569597467518,0.7585106382978724,1.0,1.0,27/108,17.94%,PRKCA;FGF2;CD34;VEGFA;PAK4;ITGB8;HSPB6;WNT5A;CYP1B1;GATA6;BRCA1;HIF1A;SP1;SIRT6;MYDGF;GRN;SMOC2;PDCL3;BMPER;ITGB1;JUP;RUNX1;GAB1;HYAL1;APLNR;MDK;EMC10
prerank,establishment of protein localization to organelle (GO:0072594),0.2809208578188402,0.824865761274261,0.7400442477876106,1.0,1.0,20/72,21.11%,NUP155;LAMP5;FAM53B;NEURL1B;IPO9;TSPAN17;PRICKLE1;KPNB1;IPO13;NXT1;EIF4ENIF1;POM121;TNPO3;HK2;IPO5;CSE1L;STAT3;PHB2;LAMP2;HEATR3
prerank,regulation of autophagosome assembly (GO:2000785),-0.24559294526127362,-0.8248466907872425,0.7347826086956522,0.9245534283314811,1.0,11/33,22.36%,RAB5A;TBC1D14;FEZ2;SCFD1;NUPR1;LRSAM1;PIP4K2B;SMCR8;PINK1;ADPRH;SH3GLB1
prerank,lymphocyte proliferation (GO:0046651),0.33088723832800465,0.8247004984467203,0.6744186046511628,1.0,1.0,7/22,25.17%,BCL2;PPP3CB;HELLS;MS4A1;HSPD1;CR2;LMBR1L
prerank,diacylglycerol metabolic process (GO:0046339),-0.2739875531270102,-0.8245804237173764,0.7300380228136882,0.9238974145500849,1.0,10/23,30.52%,GPAM;DGKH;PLA2G15;DAGLA;PNPLA2;DGKG;LIPE;DGKB;ANG;DGAT1
prerank,regulation of receptor recycling (GO:0001919),-0.29829684476106944,-0.824544548849694,0.7272727272727273,0.9227926681981308,1.0,6/16,21.55%,NSF;OPTN;ECE1;TBC1D16;LAMTOR1;INPP5F
prerank,cardiac muscle cell action potential involved in contraction (GO:0086002),0.31976639960934344,0.8244797998463856,0.7066492829204694,1.0,1.0,7/30,16.10%,CACNA2D1;ANK2;SCN5A;FGF12;NEDD4L;PKP2;KCNH2
prerank,response to iron ion (GO:0010039),-0.32342488476299935,-0.8243680837435983,0.693939393939394,0.9219788836157621,1.0,1/12,0.02%,BMP6
prerank,regulation of natural killer cell mediated cytotoxicity (GO:0042269),0.32897727895977324,0.8241367450674698,0.6940700808625337,1.0,1.0,3/23,12.73%,AP1G1;CADM1;NECTIN2
prerank,keratan sulfate biosynthetic process (GO:0018146),0.3288063400595368,0.8239828792652092,0.7046070460704607,1.0,1.0,2/26,1.60%,LUM;ST3GAL4
prerank,microtubule bundle formation (GO:0001578),0.29747668939860256,0.8235660110359727,0.7283653846153846,1.0,1.0,11/42,19.60%,RSPH1;NAV1;CFAP46;CAPN6;CFAP74;CLASP1;AAAS;FOXJ1;RSPH9;DCX;CCDC66
prerank,protein oxidation (GO:0018158),-0.32366439719824647,-0.8229016812592022,0.7079889807162535,0.9236591209641142,1.0,3/11,10.30%,LOXL1;LOX;TMX3
prerank,positive regulation of TORC1 signaling (GO:1904263),-0.2974213259747038,-0.8225821809205542,0.7088607594936709,0.9231042926269202,1.0,6/16,20.00%,SIK3;FLCN;LARS1;PIP4P1;GPR137;RRAGB
prerank,endoplasmic reticulum mannose trimming (GO:1904380),0.34880711970786255,0.8222787751793967,0.7142857142857143,1.0,1.0,4/18,15.16%,UGGT2;DERL2;EDEM2;UBB
prerank,canonical Wnt signaling pathway (GO:0060070),0.27891248954274067,0.8215589069318686,0.7370786516853932,1.0,1.0,15/68,15.64%,PTEN;FRZB;WNT5A;FZD7;RARG;BCL9L;SFRP4;PPP1CA;BCL9;DVL1;CSNK1A1;GATA3;SCYL2;FZD9;CSNK1E
prerank,positive regulation of cell-substrate junction organization (GO:0150117),0.33067605301986075,0.8210805498457683,0.6916010498687664,1.0,1.0,7/24,15.54%,MAP4K4;VEGFA;TSC1;PIK3R1;PTPRJ;MYOC;ABL1
prerank,negative regulation of transforming growth factor beta production (GO:0071635),0.39176085448177733,0.8208927911803741,0.6796747967479675,1.0,1.0,2/10,7.41%,LAPTM4B;GATA6
prerank,cellular response to radiation (GO:0071478),0.30568086270457984,0.8206415193223187,0.7233250620347395,1.0,1.0,7/40,15.98%,RHO;NSMCE3;MAPK14;GPR88;BLM;TP53;SPIDR
prerank,acidic amino acid transport (GO:0015800),0.3530666919365228,0.820580874987287,0.6923076923076923,1.0,1.0,4/17,12.94%,SLC1A3;LRRC8D;ARL6IP5;PRAF2
prerank,positive regulation of smooth muscle cell proliferation (GO:0048661),0.3011940833674143,0.8201533686294198,0.7185554171855542,1.0,1.0,5/43,7.90%,MMP2;FGF2;NOX1;ADAMTS1;IL18
prerank,response to X-ray (GO:0010165),0.36370796055563476,0.8195794738882409,0.6695156695156695,1.0,1.0,6/14,29.33%,XRCC6;ATM;BLM;LIG4;XRCC4;NUCKS1
prerank,N-acetylneuraminate metabolic process (GO:0006054),0.3808253089302589,0.8193885966139205,0.6847133757961783,1.0,1.0,3/10,16.76%,NAGK;GNE;GNPDA1
prerank,mitotic intra-S DNA damage checkpoint signaling (GO:0031573),0.35587983335070267,0.8191541588701747,0.6863309352517986,1.0,1.0,3/15,13.42%,TIPIN;ATF2;MDC1
prerank,protein-DNA complex assembly (GO:0065004),0.2648406579640871,0.8191169315208778,0.759871931696905,1.0,1.0,25/116,20.75%,RAD23B;SOX9;GTF2H2;ERCC5;DDB2;RPA3;ATRX;XPA;PSMB7;MCM4;ASF1A;DDB1;RPA2;ORC1;PSMD2;UBB;PSMC1;PSMB2;CUL4B;CENPV;ORC4;PSMD9;PSME4;ORC2;PSMA8
prerank,negative regulation of sequestering of calcium ion (GO:0051283),0.3248797276875889,0.8191114050780608,0.7113821138211383,1.0,1.0,7/24,21.75%,FGF2;HTR2C;ANXA6;DRD2;RYR3;PKD2;ERO1A
prerank,regulation of oligodendrocyte differentiation (GO:0048713),0.3532594896953908,0.8188120253686405,0.7005730659025788,1.0,1.0,6/18,17.76%,NF1;TMEM98;DAAM2;PTPRZ1;OPALIN;MDK
prerank,protein hydroxylation (GO:0018126),-0.28936162624174744,-0.8187168616888483,0.7425149700598802,0.929409965644841,1.0,6/15,23.86%,OGFOD1;PLOD3;VIPAS39;EGLN3;JMJD4;VPS33B
prerank,reverse cholesterol transport (GO:0043691),-0.3065470665514786,-0.8182708854021468,0.7027027027027027,0.9290562961601112,1.0,4/13,22.12%,ABCA1;ABCG1;APOE;CLU
prerank,positive regulation of microtubule polymerization (GO:0031116),0.31947164349092566,0.8173142374080944,0.7023959646910467,1.0,1.0,8/28,16.01%,PAK1;ARL2;CLASP1;SLAIN2;CDK5R1;CKAP5;MET;NAV3
prerank,glomerular visceral epithelial cell differentiation (GO:0072112),0.37860231479581374,0.816929588944986,0.6818181818181818,1.0,1.0,3/12,14.88%,KLF15;MAGI2;IQGAP1
prerank,negative regulation of BMP signaling pathway (GO:0030514),0.2910439631619375,0.8168894664286379,0.7494199535962877,1.0,1.0,3/51,2.11%,SOSTDC1;HTRA3;CHRDL1
prerank,cellular response to alkaloid (GO:0071312),0.34928237152819,0.8167928475227016,0.7403846153846154,1.0,1.0,5/17,19.09%,CASP6;BLM;SPIDR;CASP7;RYR3
prerank,sensory perception of light stimulus (GO:0050953),0.273555983170249,0.8164601503647114,0.7672886937431395,1.0,1.0,15/87,20.72%,EFEMP1;CRYBG3;PCDH15;RDH10;DHRS3;COL18A1;OAT;MYO9A;COL1A1;OPA1;DNAJC19;PAX2;ATXN7;RGS16;COL11A1
prerank,positive regulation of insulin secretion (GO:0032024),-0.2293277205882922,-0.81627078435232,0.8121827411167513,0.9316495143863303,1.0,10/36,19.65%,MYRIP;RBP4;ANO1;NLGN2;NNAT;AACS;LRRC8A;C2CD2L;GPER1;BAIAP3
prerank,positive regulation of actin nucleation (GO:0051127),0.3766582507413945,0.8161731522141734,0.6891025641025641,1.0,1.0,5/11,19.03%,GSN;BRK1;WASF1;CYFIP1;NCKAP1
prerank,cellular response to unfolded protein (GO:0034620),0.3270534260680388,0.815890172813262,0.7060402684563758,1.0,1.0,7/26,21.21%,PRKN;PACRG;PTPN1;TM7SF3;HSPA9;HSPD1;RHBDD1
prerank,nucleoside phosphate catabolic process (GO:1901292),0.37735059446204455,0.8156842837976436,0.6863033873343152,1.0,1.0,2/13,5.19%,NUDT15;ENTPD2
prerank,positive regulation of stress-activated MAPK cascade (GO:0032874),0.2717411458481436,0.8155992274498103,0.7677208287895311,1.0,1.0,20/93,18.73%,PYCARD;VEGFA;SEMA3A;NCF1;TRAF4;PLCB1;CARD9;FZD7;MTURN;PRMT1;ARL6IP5;TAOK3;MAP3K4;RASSF2;KLHDC10;RELL2;RIPK1;EMC10;MAP3K11;MID1
prerank,purine nucleotide metabolic process (GO:0006163),-0.24805798234425802,-0.815574368717258,0.7394636015325671,0.9318352280065831,1.0,10/24,22.68%,PRPSAP2;ITPA;XDH;GPX1;PRPS2;GUK1;GART;PRPS1;PRPS1L1;NT5C1A
prerank,regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0000079),0.2767521183286815,0.8154857114141757,0.7508305647840532,1.0,1.0,30/78,29.29%,PTEN;CDKN2B;EGFR;CCNJ;MEN1;PKMYT1;CDK5R1;PKD1;CDK5R2;BLM;CCND2;MAPRE3;IPO5;BCCIP;PKD2;NR2F2;CCNY;CCNT2;CCNH;CDC37;APC;CDK5RAP3;CDKN1A;CCND3;CCNI;GTPBP4;CCNE1;CDKN1C;CDKN2D;CDKN1B
prerank,regulation of sequestering of triglyceride (GO:0010889),-0.2958643938258816,-0.8148298475391691,0.731629392971246,0.9320525236707118,1.0,1/15,0.23%,OSBPL8
prerank,neurotransmitter secretion (GO:0007269),0.2939314595763695,0.8143556005241324,0.7381818181818182,1.0,1.0,8/44,13.88%,NRXN1;SYT1;SYN1;RIMS1;DVL1;RAB3A;OTOF;SNCA
prerank,synaptic vesicle localization (GO:0097479),0.3628158640782683,0.8142725447801863,0.6941176470588235,1.0,1.0,4/13,13.45%,NLGN1;SPG11;KIF5C;SYNDIG1
prerank,positive regulation of cytoskeleton organization (GO:0051495),0.2740519859087105,0.8139185629360081,0.7771556550951848,1.0,1.0,7/76,8.10%,CCL11;NTRK3;PYCARD;GPSM2;BAIAP2;LIMK1;BIN1
prerank,glycoprotein metabolic process (GO:0009100),0.29196922957184257,0.8138012406897644,0.7608173076923077,1.0,1.0,9/53,11.73%,ST3GAL4;PRKCSH;PCSK6;MAN2A2;ST6GALNAC6;FBXO27;HIF1A;ST8SIA1;FBXO17
prerank,positive regulation of chromatin organization (GO:1905269),-0.3222274775108659,-0.8137723573200157,0.6997167138810199,0.93283845016604,1.0,5/12,18.97%,TERF2;UBE2N;TAL1;SIN3A;TINF2
prerank,cardiolipin metabolic process (GO:0032048),0.3657288265723137,0.8136827531723874,0.6788432267884322,1.0,1.0,3/13,13.50%,SLC27A1;HADHA;PNPLA8
prerank,regulation of vasoconstriction (GO:0019229),0.3221697442846368,0.8136039599867351,0.6997319034852547,1.0,1.0,3/27,12.92%,CHRM3;KCNMB2;ATP2B1
prerank,nucleosome assembly (GO:0006334),0.3157510498021422,0.8130103171416571,0.7137355584082157,1.0,1.0,5/31,13.34%,SOX9;HAT1;ATRX;ASF1A;RBBP4
prerank,regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060211),0.3576349540162715,0.8128122117093199,0.7090909090909091,1.0,1.0,5/15,20.38%,PABPC1;CPEB3;POLR2G;EIF4ENIF1;ZFP36
prerank,adenylate cyclase-modulating G protein-coupled receptor signaling pathway (GO:0007188),0.26082855542767275,0.8125314610983276,0.8300921187308086,1.0,1.0,18/152,14.52%,CXCL10;GNA14;LPAR1;PTGER3;GPR65;PTHLH;PTGFR;PTH2R;LGR5;TSHR;ADGRB3;GPR37;S1PR3;ADGRL3;GLP2R;GNAI1;P2RY12;ADGRG2
prerank,negative regulation of epithelial cell proliferation (GO:0050680),0.2813038913608187,0.8123321440961755,0.7516930022573364,1.0,1.0,8/66,9.48%,SULF1;SOX9;CDKN2B;FBXW7;TGFB1;NF1;CDK6;SPARC
prerank,regulation of endothelial cell chemotaxis (GO:2001026),0.35721664837651845,0.8120280790146762,0.7108792846497765,1.0,1.0,3/15,15.00%,FGF2;SMOC2;MET
prerank,negative regulation of T cell mediated immunity (GO:0002710),-0.3153038248762906,-0.8118955473446364,0.707774798927614,0.9351373873394703,1.0,4/11,19.84%,SMAD7;PTPRC;CEACAM1;HFE
prerank,negative regulation of nuclear division (GO:0051784),0.3766170239377624,0.8118300207887303,0.7067307692307693,1.0,1.0,3/11,17.86%,AURKAIP1;BMP7;FBXO5
prerank,arachidonic acid metabolic process (GO:0019369),0.301053091871163,0.811766778984407,0.70875,1.0,1.0,3/35,7.30%,CYP2S1;CYP1B1;PTGES2
prerank,N-glycan processing (GO:0006491),0.34534277300925914,0.8114238844360593,0.7073863636363636,1.0,1.0,6/18,18.25%,GNPTAB;PRKCSH;MAN2A2;ST8SIA1;GANC;MAN1A2
prerank,"endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000479)",0.3640155418659291,0.8112302033640817,0.7190839694656489,1.0,1.0,2/13,10.78%,BMS1;RCL1
prerank,cellular metal ion homeostasis (GO:0006875),0.2649277200285353,0.8104506838880128,0.8223896663078579,1.0,1.0,20/102,18.10%,CCL11;ANK2;LETM1;ATP2B3;MT3;CCR2;SLC12A2;SLC8A2;SLC24A5;SLC10A7;HTR2C;EDN3;TPCN2;ATP2B1;NEDD4L;CCL14;KCNMA1;SLC9A1;SLC24A4;SLC24A2
prerank,positive regulation of organelle assembly (GO:1902117),0.289005994331105,0.8103842701898963,0.7554744525547445,1.0,1.0,16/44,26.22%,GPSM2;RALB;SDC4;RAB3GAP2;PDCD6IP;FSCN1;HTT;CCDC88A;RAB3GAP1;CNOT6L;DYNC1H1;STX18;G3BP2;BBS4;ENTR1;TAPT1
prerank,synaptic vesicle cycle (GO:0099504),0.3131810521641888,0.8102881053257869,0.7195281782437746,1.0,1.0,6/30,13.88%,NLGN1;RIMS1;RAB3A;OTOF;SYNDIG1;SNCA
prerank,actin filament network formation (GO:0051639),0.38105507079602596,0.8102871256264103,0.7026627218934911,1.0,1.0,2/11,14.09%,SPIRE1;COBL
prerank,growth hormone receptor signaling pathway via JAK-STAT (GO:0060397),0.39107243838076905,0.8102346156791655,0.7235649546827795,1.0,1.0,6/10,22.76%,PTPN1;PRLR;STAT3;STAT5A;GHR;STAT6
prerank,inositol phosphate catabolic process (GO:0071545),0.3769268323037188,0.8101775845224782,0.6929012345679012,1.0,1.0,4/12,23.63%,PTEN;NUDT3;INPP5J;INPP5B
prerank,cellular response to glucose stimulus (GO:0071333),0.3071648710128589,0.8100495007500994,0.7170050761421319,1.0,1.0,10/30,21.94%,ZBTB20;TRA2B;MLXIPL;PDK3;PRKACA;PAX2;PCK2;ADCY8;PTPRN2;PRKAA1
prerank,regulation of gene silencing by RNA (GO:0060966),0.2864091358294116,0.8099258493458833,0.7626506024096386,1.0,1.0,18/50,26.36%,RANBP2;POLR2B;NUP155;POLR2K;EIF4G1;NUP205;NDC1;NUP160;POLR2G;POM121;AAAS;POLR2A;NUP42;POLR2F;TNRC6A;FMR1;NUP35;RAE1
prerank,regulation of posttranscriptional gene silencing (GO:0060147),0.2864091358294116,0.8099258493458833,0.7626506024096386,1.0,1.0,18/50,26.36%,RANBP2;POLR2B;NUP155;POLR2K;EIF4G1;NUP205;NDC1;NUP160;POLR2G;POM121;AAAS;POLR2A;NUP42;POLR2F;TNRC6A;FMR1;NUP35;RAE1
prerank,endodermal cell differentiation (GO:0035987),0.31567893932685354,0.8097530503659848,0.7328947368421053,1.0,1.0,4/31,9.87%,MMP2;COL4A2;MMP15;SETD2
prerank,histone deubiquitination (GO:0016578),-0.28170913115844276,-0.8097138555335089,0.7095588235294118,0.9380052786879426,1.0,6/18,28.16%,USP7;USP3;USP15;KAT2A;TAF10;UIMC1
prerank,oligosaccharide-lipid intermediate biosynthetic process (GO:0006490),0.3624362471246828,0.80966139000795,0.7052785923753666,1.0,1.0,5/13,19.74%,ALG9;ALG1;ALG8;DPAGT1;ALG6
prerank,ceramide catabolic process (GO:0046514),0.3659586440665633,0.8096022393697913,0.707492795389049,1.0,1.0,2/14,6.02%,NAGA;GM2A
prerank,negative regulation of ubiquitin-dependent protein catabolic process (GO:2000059),0.3031488801096489,0.8095168256934278,0.732685297691373,1.0,1.0,12/37,22.66%,WAC;UCHL5;BAG5;TLK2;TAF9;PDCL3;N4BP1;PARK7;TAF1;CSNK2A2;SGTA;CAMLG
prerank,fatty acid biosynthetic process (GO:0006633),0.2787916188096623,0.8093549084190539,0.7554285714285714,1.0,1.0,7/63,9.43%,ACACA;OXSM;LTA4H;SCD5;ELOVL6;ACLY;ELOVL5
prerank,regulation of RNA splicing (GO:0043484),0.27700635212402436,0.8092818611550842,0.7619047619047619,1.0,1.0,17/69,22.98%,PRX;QKI;TRA2B;ZNF326;SON;KHDRBS3;PIK3R1;YTHDC1;SF1;FUS;POLR2A;HNRNPH2;HNRNPL;SRSF3;AHNAK;PTBP2;AFF2
prerank,response to acidic pH (GO:0010447),-0.30628546820449154,-0.8087773916972097,0.7573770491803279,0.9385340602096927,1.0,4/13,14.95%,RAB11B;GPR4;LGMN;CTSS
prerank,fatty acid elongation (GO:0030497),-0.30752562863258165,-0.8085416221368539,0.7595307917888563,0.9377723753703178,1.0,2/13,3.24%,ELOVL7;HACD4
prerank,cellular response to virus (GO:0098586),0.31513458504011493,0.8083211363858646,0.7244501940491591,1.0,1.0,4/30,10.78%,CXCL10;GBF1;HIF1A;MAPK14
prerank,release of sequestered calcium ion into cytosol (GO:0051209),0.3157325939806487,0.8081432279206765,0.7390146471371505,1.0,1.0,7/26,21.75%,FGF2;LETM1;HTR2C;DRD2;RYR3;PKD2;ERO1A
prerank,I-kappaB phosphorylation (GO:0007252),-0.32628162331722343,-0.8080693158105835,0.7113702623906706,0.937470348643877,1.0,2/10,11.63%,TLR4;MAP3K7
prerank,protein targeting to membrane (GO:0006612),-0.19675646019758472,-0.8077688919141032,0.8775510204081632,0.9368403340937899,1.0,31/83,27.26%,ZDHHC14;ZDHHC3;PEX13;PRKCI;PARD3;VPS37C;PEX19;ALDH3A2;ZDHHC18;ZDHHC7;SRPRA;AQP11;SRP14;ZDHHC20;MYO1C;SSR2;PEX14;ZDHHC4;PEX26;MICALL1;TAOK2;PEX2;ATAD1;ICMT;SIL1;ZDHHC2;RTP4;GET3;SRP19;VPS37D;PEX16
prerank,lipid droplet organization (GO:0034389),-0.25941510444700616,-0.8073695328354491,0.7790262172284644,0.9363843252590408,1.0,9/22,26.25%,ZFYVE1;CDS1;PPIA;BSCL2;AUP1;PNPLA3;FAF2;PLA2G4C;FITM2
prerank,positive regulation of growth (GO:0045927),0.2859907692780901,0.8072624134431254,0.7696629213483146,1.0,1.0,13/64,18.03%,BCL2;ERBB2;EGFR;PLCB1;DERL2;NCBP1;EIF4G1;EXOSC2;AKAP6;BRAT1;KLHL22;HYAL1;RPTOR
prerank,regulation of protein processing (GO:0070613),0.3344128305947273,0.807144420450051,0.7034574468085106,1.0,1.0,6/21,21.21%,PRNP;SERPINE2;RUNX1;SNX12;NKD2;RHBDD1
prerank,positive regulation of neuron apoptotic process (GO:0043525),0.329667951905634,0.8066619761485972,0.7247340425531915,1.0,1.0,5/24,12.11%,FBXW7;PRNP;NF1;CDK5R1;GRN
prerank,transcription by RNA polymerase III (GO:0006383),0.311167264923878,0.8061096835626725,0.7110817941952506,1.0,1.0,11/27,25.20%,SNAPC2;IVNS1ABP;ZC3H8;POLR2K;ELL;GTF3C1;POLR3G;SNAPC3;POLR3K;TBP;GTF3C5
prerank,dendrite self-avoidance (GO:0070593),0.34638235476650436,0.8060155064659127,0.7051851851851851,1.0,1.0,4/16,10.12%,CNTN6;CNTN2;DSCAM;PALLD
prerank,"nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291)",0.31270532527341477,0.8057940075276245,0.7421465968586387,1.0,1.0,7/31,15.90%,EXOSC8;DCP1B;EXOSC2;EDC4;LSM3;POLR2G;NT5C3B
prerank,steroid biosynthetic process (GO:0006694),-0.20714792236601426,-0.8053496476053815,0.8688524590163934,0.9389772059960937,1.0,19/56,29.43%,PRKAG2;OSBP;LBR;OSBPL9;OSBPL2;INSIG2;DHRS11;OSBPL7;OSBPL3;FDXR;EBP;SLC27A2;OSBPL6;STAR;TM7SF2;HSD11B1;SRD5A1;HSD17B10;CH25H
prerank,positive regulation of calcineurin-mediated signaling (GO:0106058),-0.3107734281521291,-0.8052469139355092,0.7353760445682451,0.9368579181779276,1.0,3/12,16.89%,IGF1;CHERP;PTBP1
prerank,positive regulation of calcineurin-NFAT signaling cascade (GO:0070886),-0.3107734281521291,-0.8052469139355092,0.7353760445682451,0.9368579181779276,1.0,3/12,16.89%,IGF1;CHERP;PTBP1
prerank,smooth muscle cell differentiation (GO:0051145),-0.29570794032796455,-0.8051937121685063,0.7558823529411764,0.9357946488791148,1.0,6/12,19.18%,BMP4;TMEM204;HEY2;EDNRB;MRTFB;MYOCD
prerank,regulation of actin nucleation (GO:0051125),0.36846836618125484,0.804573860425786,0.7089201877934272,1.0,1.0,3/12,18.99%,GSN;CORO1B;ARFIP1
prerank,poly(A)+ mRNA export from nucleus (GO:0016973),-0.27676236394767595,-0.8044448997558682,0.7421602787456446,0.9360063213037033,1.0,3/18,5.73%,NUP93;DDX19B;DDX19A
prerank,preassembly of GPI anchor in ER membrane (GO:0016254),0.3457897228974702,0.8044062128828766,0.7202295552367288,1.0,1.0,4/16,13.94%,PIGC;PIGP;PIGN;PIGA
prerank,chaperone-mediated protein complex assembly (GO:0051131),-0.26936512848261107,-0.8042813922102301,0.7666666666666667,0.93512199589503,1.0,9/20,29.16%,PSMG2;PSMG1;HSP90AA1;HSP90AB1;PSMG3;CLU;HOPX;PFDN6;PTGES3L
prerank,negative regulation of proteolysis (GO:0045861),-0.23445591821809042,-0.8042709287618145,0.8177777777777778,0.9339854609507521,1.0,4/34,6.64%,EPHA4;ROCK1;GAS1;TIMP3
prerank,phosphate ion homeostasis (GO:0055062),0.3781565140585613,0.8042181547794126,0.6939721792890263,1.0,1.0,2/10,14.89%,SFRP4;XPR1
prerank,positive regulation of macrophage activation (GO:0043032),0.3503562197413009,0.804191309985387,0.717546362339515,1.0,1.0,6/17,21.40%,WNT5A;TTBK1;IL33;LBP;HSPD1;TNIP2
prerank,negative regulation of cell death (GO:0060548),0.2685543636075402,0.8040432027436156,0.7986942328618063,1.0,1.0,15/88,14.38%,FGF2;CD34;PRKN;SOX11;MT3;BNIP3;ATG5;FYN;PACRG;EIF4G1;BMP7;TM7SF3;SNCA;NCK1;SRSF6
prerank,regulation of tumor necrosis factor-mediated signaling pathway (GO:0010803),0.2854001753153414,0.8037987804320199,0.7568533969010727,1.0,1.0,13/54,19.89%,PYCARD;PRKN;FADD;PTPN2;OTULIN;UBE2K;TAX1BP1;PYDC1;RIPK1;CHUK;CPNE1;SPPL2B;TRAIP
prerank,antigen receptor-mediated signaling pathway (GO:0050851),0.2562070378234847,0.8037904882036514,0.8240165631469979,1.0,1.0,33/163,21.49%,PRKCQ;PTPN22;BCL2;TEC;PDE4B;PAK1;CSK;EIF2B5;FYN;LAX1;VAV3;PSMB7;PIK3R1;PTPRJ;PDE4D;GATA3;MALT1;NCK1;PSMD2;PSMC1;LAT2;PSMB2;EIF2B2;RC3H1;CHUK;MS4A1;PSMD9;PSME4;BCL10;CD38;PSMA8;NFKB1;PRKD2
prerank,GPI anchor biosynthetic process (GO:0006506),0.30693357299361645,0.8036530649689552,0.7451737451737451,1.0,1.0,8/30,19.95%,PGAP1;PIGC;PIGP;PIGN;PIGA;PIGU;DPM1;PIGO
prerank,regulation of transferase activity (GO:0051338),0.33969057658800234,0.8035426841205435,0.7244444444444444,1.0,1.0,5/17,16.25%,BAG5;LDB2;PPP1R3F;ATM;SMG6
prerank,miRNA metabolic process (GO:0010586),-0.25746045834607456,-0.8033059388309507,0.7426470588235294,0.9345414371028581,1.0,9/20,29.54%,DGCR8;TUT7;TENT4B;TARBP2;LIN28B;DDX17;BCDIN3D;AGO2;DICER1
prerank,regulation of voltage-gated calcium channel activity (GO:1901385),0.32986146085447043,0.8031599634746641,0.7362784471218207,1.0,1.0,4/22,12.69%,HPCA;PDE4B;CACNB4;DRD2
prerank,cellular response to fatty acid (GO:0071398),0.379856706061725,0.8027839087146783,0.7310030395136778,1.0,1.0,2/12,11.37%,PDK3;PID1
prerank,microtubule depolymerization (GO:0007019),0.3488467229014737,0.8027243807772692,0.7178002894356006,1.0,1.0,4/17,13.07%,KIF19;STMN4;KATNB1;CKAP5
prerank,negative regulation of double-strand break repair via homologous recombination (GO:2000042),-0.279722959843716,-0.80229719746684,0.7366666666666667,0.9352283864866285,1.0,8/16,28.93%,RIF1;HELB;POLQ;KLHL15;FANCB;MAD2L2;RMI2;PARPBP
prerank,positive regulation of myeloid cell differentiation (GO:0045639),-0.23358779511602676,-0.802280501786057,0.8272251308900523,0.9341122511963672,1.0,12/33,24.70%,ETS1;ARNT;STAT5B;ACVR1B;PITHD1;NCKAP1L;INHBA;TAL1;ANKRD54;HMGB2;FES;ACVR2A
prerank,protein palmitoylation (GO:0018345),-0.23337684147876464,-0.8020404704432575,0.7718446601941747,0.9334398009285821,1.0,7/30,15.14%,ZDHHC14;ZDHHC3;CLIP3;ZDHHC18;ZDHHC7;ZDHHC20;ZDHHC4
prerank,centromere complex assembly (GO:0034508),0.298007478702869,0.8019367485612896,0.7459727385377943,1.0,1.0,12/36,22.39%,HELLS;POGZ;HJURP;OIP5;RBBP4;ITGB3BP;CENPV;NASP;CENPL;CENPC;RBBP7;CENPU
prerank,positive regulation of lipid catabolic process (GO:0050996),0.331869329265435,0.801507234774256,0.7202797202797203,1.0,1.0,3/19,16.67%,IRS2;MTLN;ABCD2
prerank,negative regulation of TORC1 signaling (GO:1904262),0.361341684935512,0.8011389679187095,0.7317784256559767,1.0,1.0,6/13,24.79%,CASTOR2;ATM;SPAAR;DEPDC5;SESN1;ITFG2
prerank,cardiac right ventricle morphogenesis (GO:0003215),-0.3167588233695747,-0.8011279804871764,0.7045454545454546,0.9339257603623858,1.0,4/11,15.31%,BMP4;JAG1;TGFB2;HEY2
prerank,"DNA catabolic process, endonucleolytic (GO:0000737)",0.32070558189049597,0.8005600146937638,0.6997282608695652,1.0,1.0,5/23,15.84%,SETMAR;REXO4;FBH1;KPNB1;KPNA1
prerank,negative regulation of interleukin-17 production (GO:0032700),0.37638594106269824,0.8004669004642202,0.698340874811463,1.0,1.0,1/10,4.80%,PRNP
prerank,protein quality control for misfolded or incompletely synthesized proteins (GO:0006515),-0.2447047154038975,-0.8001615384312362,0.8141263940520446,0.9345300055589074,1.0,12/25,28.53%,POMT2;RNF185;STUB1;FBXL17;UBE2W;AUP1;UFD1;KLHL15;UGGT1;RNF5;OMA1;VCP
prerank,regulation of primary metabolic process (GO:0080090),0.26110954316990015,0.800119271318016,0.8082627118644068,1.0,1.0,29/126,20.75%,IRS2;NQO1;NCOA1;C1QTNF2;SQLE;ACACA;IDI1;PRKAB2;ELOVL6;FASN;PSMB7;CARM1;NCOA2;CHD9;SIN3B;TGS1;SP1;NCOR2;PSMD2;PSMC1;SREBF2;PSMB2;PSMD9;SC5D;PSME4;PPARG;CERS2;NR1D2;PSMA8
prerank,atrial septum development (GO:0003283),-0.29586254388223154,-0.7998604766535883,0.7412140575079872,0.9339232373662034,1.0,2/13,3.78%,NOTCH2;BMPR2
prerank,vitamin D metabolic process (GO:0042359),-0.30596543966844186,-0.7996325366720571,0.7109634551495017,0.9331730335024615,1.0,3/13,18.62%,CUBN;LGMN;CYP2R1
prerank,positive regulation of double-strand break repair via homologous recombination (GO:1905168),-0.29282124963214234,-0.7994410842352461,0.7249190938511327,0.9323448464260251,1.0,6/14,23.36%,MMS19;PARP1;WRAP53;ERCC6;FANCB;TIMELESS
prerank,coenzyme A metabolic process (GO:0015936),-0.29446132517280343,-0.7992001129744069,0.7246835443037974,0.9316172981143407,1.0,6/14,22.44%,PANK1;PANK2;PANK3;PPCDC;PANK4;CROT
prerank,endothelial cell migration (GO:0043542),0.30312182704547497,0.7991578799694268,0.7332506203473945,1.0,1.0,5/37,7.15%,FAP;PRKX;VEGFA;EGR3;CYP1B1
prerank,purine ribonucleotide biosynthetic process (GO:0009152),-0.2125311578432127,-0.798879965569098,0.8716216216216216,0.9310426489070613,1.0,14/48,19.65%,ADCY9;SLC26A2;AMPD3;NPR1;PANK1;PANK2;ADCY4;GUCY1B1;PANK3;PPCDC;PANK4;ADCY3;IMPDH1;IMPDH2
prerank,negative regulation of translational initiation (GO:0045947),-0.29298735473512727,-0.798678360206621,0.7102803738317757,0.9302834008014742,1.0,5/13,28.83%,EIF2AK1;EIF4EBP2;EIF3E;EIF2AK4;AGO2
prerank,negative regulation of gene expression (GO:0010629),0.24891365673422297,0.7985642686731227,0.9035175879396985,1.0,1.0,49/302,16.92%,FFAR4;CLDN19;CREB3L1;FGF2;RBMS3;PTPN22;CD34;KAT2B;PRKN;EPRS1;VEGFA;EIF2AK3;RPS6KA4;FBXW7;TGFB1;PSEN1;DXO;SOX11;ITGB8;EED;METTL3;TSC1;SHQ1;CPEB3;SMO;HIF1A;SYT11;ZFP36L2;ESR1;HELLS;DIP2A;CREBZF;EPC1;JARID2;ATP2B1;NDFIP1;RBBP4;TTBK1;PUS7;NCOR2;BMPR1A;CITED2;EIF4ENIF1;RUNX1;PHF19;PNPT1;APLNR;N4BP1;SNX12
prerank,regulation of cholesterol metabolic process (GO:0090181),0.32951184427209856,0.7978832841103054,0.7250341997264022,1.0,1.0,8/20,28.92%,KPNB1;SREBF2;MBTPS1;SEC14L2;EPHX2;LDLRAP1;DGKQ;MBTPS2
prerank,positive regulation of protein processing (GO:0010954),-0.2725389904870005,-0.7973628232165758,0.7770034843205574,0.9313553903597881,1.0,2/19,1.47%,CCBE1;MYH9
prerank,positive regulation of exocytosis (GO:0045921),0.30529393518590586,0.797115223560091,0.7669172932330827,1.0,1.0,9/35,18.12%,SDC4;RAB3D;CLASP1;STXBP5;RAB3A;SNCA;PDCD6IP;UNC13D;RAB7A
prerank,melanosome localization (GO:0032400),0.32931603031271306,0.7969875917584377,0.7289073305670816,1.0,1.0,8/21,25.46%,VPS33A;BBS5;MREG;BBS7;MYO5A;BLOC1S6;BBS4;RAB27B
prerank,positive regulation of toll-like receptor signaling pathway (GO:0034123),-0.251195323152099,-0.7968838966489201,0.7434782608695653,0.931096412934572,1.0,10/26,21.83%,MFHAS1;WDFY1;CYBA;TIRAP;FLOT1;CAV1;IFI35;NINJ1;NR1H3;RSAD2
prerank,fatty acid transmembrane transport (GO:1902001),0.33364002916835744,0.7965962255740113,0.7346938775510204,1.0,1.0,3/19,6.74%,SLC27A1;ACACA;PRKAB2
prerank,regulation of defense response (GO:0031347),0.26940429327834764,0.7965075431480685,0.7935267857142857,1.0,1.0,8/76,6.81%,ADAMTS12;PTPN22;BST1;ELMOD2;CCR2;WNT5A;IL1RL2;UFL1
prerank,regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043281),0.2700704404484269,0.7964633085924823,0.790304396843292,1.0,1.0,16/80,16.97%,PYCARD;MYC;DPEP1;NGF;VEGFA;MT3;ACVR1C;CARD9;NGFR;ARL6IP5;DNAJB6;MALT1;SNCA;XIAP;NDUFA13;PAX2
prerank,"nucleotide-excision repair, DNA gap filling (GO:0006297)",-0.2555566082004544,-0.7962824685882811,0.7769516728624535,0.9309817497329769,1.0,12/24,31.35%,POLD3;XRCC1;RFC1;PCNA;LIG1;POLK;RFC3;UBA52;POLD2;POLE;POLD4;POLD1
prerank,negative regulation of G1/S transition of mitotic cell cycle (GO:2000134),0.30338621128380117,0.7962031755013387,0.7341935483870968,1.0,1.0,7/33,17.23%,PTEN;CDKN2B;JADE1;CDK6;NACC2;DACT1;CDC73
prerank,negative regulation of telomere maintenance (GO:0032205),0.35066712232970537,0.7961288082686637,0.7244444444444444,1.0,1.0,7/15,25.08%,ERCC4;RTEL1;ATM;SMG6;TERF2IP;RAD50;SLX4
prerank,establishment of mitotic spindle orientation (GO:0000132),0.3232276774131394,0.7960158072771165,0.7379972565157751,1.0,1.0,3/23,6.12%,GPSM2;INSC;NDE1
prerank,regulation of protein localization to nucleus (GO:1900180),-0.21171486217200475,-0.7957552960989366,0.8106508875739645,0.9308002999154811,1.0,12/43,18.78%,MFHAS1;BMP4;LATS2;NVL;GSK3B;FLCN;TFRC;SESN2;SUMO3;ORMDL3;BYSL;SIN3A
prerank,visual perception (GO:0007601),0.26721366216216647,0.7949783534676698,0.7984665936473165,1.0,1.0,15/84,20.72%,EFEMP1;CRYBG3;RDH10;DHRS3;COL18A1;OAT;MYO9A;COL1A1;OPA1;DNAJC19;PAX2;CACNA2D4;ATXN7;RGS16;COL11A1
prerank,negative regulation of protein serine/threonine kinase activity (GO:0071901),0.2699265586820058,0.7949172285425248,0.7933333333333333,1.0,1.0,10/75,11.41%,PYCARD;PTEN;IRAK3;NF1;PRKAR1B;MEN1;UCHL1;PTPN1;PTPRJ;BMP7
prerank,microglial cell activation (GO:0001774),-0.252016213459954,-0.7945242700294249,0.7864406779661017,0.9317486113823723,1.0,11/21,35.28%,APP;MAPT;C1QA;CLU;TYROBP;ITGB2;ITGAM;JAK2;AGER;AIF1;TREM2
prerank,regulation of mitotic nuclear division (GO:0007088),0.278225577240591,0.7940906801345886,0.7584994138335287,1.0,1.0,9/55,11.59%,KIF20B;OBSL1;CDK13;BTC;AURKAIP1;RCC1;PKMYT1;BMP7;EDN3
prerank,DNA replication-independent nucleosome assembly (GO:0006336),0.29618397980285543,0.7940252164707956,0.7527812113720643,1.0,1.0,11/38,20.10%,HAT1;ATRX;ASF1A;HJURP;OIP5;RBBP4;ITGB3BP;NASP;CENPL;CENPC;RBBP7
prerank,axonal fasciculation (GO:0007413),0.35988458464278444,0.7939911433633343,0.7213622291021672,1.0,1.0,5/12,18.89%,NRCAM;EPHB2;CDK5R1;RTN4;CNTN4
prerank,regulation of store-operated calcium entry (GO:2001256),-0.3184854868543411,-0.7939514130665081,0.7325581395348837,0.9316094926284336,1.0,3/10,13.35%,SLC8B1;SARAF;STIM1
prerank,transcription initiation from RNA polymerase I promoter (GO:0006361),0.3029257648621082,0.7938984280828034,0.7411167512690355,1.0,1.0,12/32,24.87%,GTF2H2;TAF1A;POLR2K;POLR1B;POLR1C;POLR1G;TAF1;UBTF;RRN3;POLR2F;CCNH;TBP
prerank,positive regulation of oxidoreductase activity (GO:0051353),0.3367300349691471,0.7935618943283353,0.7254335260115607,1.0,1.0,6/18,18.76%,POR;GDNF;EDN3;RFK;ABL1;PARK7
prerank,glucosamine-containing compound metabolic process (GO:1901071),0.34953052499502346,0.7935486108395354,0.7252252252252253,1.0,1.0,2/13,9.60%,NAGK;MGAT3
prerank,negative regulation of viral release from host cell (GO:1902187),-0.3064308576127069,-0.7932384009127429,0.7422360248447205,0.9317379940204656,1.0,4/13,17.26%,CHMP3;TRIM5;PML;TRIM21
prerank,positive regulation of epidermal growth factor receptor signaling pathway (GO:0045742),0.29970717776889805,0.7926641809495609,0.7626262626262627,1.0,1.0,5/33,10.64%,FBXW7;NCF1;HIP1;BTC;CBL
prerank,lipid modification (GO:0030258),0.2988264811015619,0.7925961276794102,0.7576499388004896,1.0,1.0,15/37,28.52%,MBOAT2;PLA2G7;DGKI;PLPP4;PLPPR4;PLPPR2;PLPPR1;PORCN;EPHX2;DGKA;DGKK;SGPP1;DGKD;DGKZ;DGKQ
prerank,regulation of JNK cascade (GO:0046328),0.2614996143088326,0.7922259290446517,0.8126338329764454,1.0,1.0,20/101,18.71%,PYCARD;PRKN;EGFR;MAP4K4;SEMA3A;NCF1;TRAF4;PLCB1;CARD9;FZD7;MEN1;MTURN;TAOK3;PER1;DACT1;RASSF2;RIPK1;FKTN;ZMYND11;MAP3K11
prerank,negative regulation of actin filament polymerization (GO:0030837),0.3244531231545322,0.7921144452952977,0.7483176312247645,1.0,1.0,3/22,6.02%,KANK4;GSN;SSH3
prerank,regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902165),0.3611237798366522,0.7919890721408163,0.7289719626168224,1.0,1.0,3/12,17.14%,BCL2;TAF9;CD74
prerank,defense response to virus (GO:0051607),0.262223606150666,0.7918771173301877,0.8153347732181425,1.0,1.0,10/100,10.48%,CXCL10;PYCARD;BCL2;FADD;NDUFAF4;RNASE6;BNIP3;FLNA;SETD2;AGBL4
prerank,regulation of actin filament polymerization (GO:0030833),0.26986008470537026,0.7916956938153912,0.7918088737201365,1.0,1.0,8/69,8.10%,CCL11;PYCARD;KANK4;GBA2;RASA1;SSH3;BAIAP2;BIN1
prerank,negative regulation of sodium ion transmembrane transport (GO:1902306),-0.31871232574811137,-0.791160051648787,0.7351190476190477,0.9341847766485524,1.0,2/10,5.34%,OSR1;COMMD1
prerank,regulation of regulated secretory pathway (GO:1903305),0.2970266753340196,0.791120474952119,0.7527812113720643,1.0,1.0,11/34,20.02%,SYT1;RAB3D;SYN1;SYT11;SYT12;RIMS1;RAB3A;UNC13D;SYT2;RIMS2;SYT13
prerank,regulation of adenylate cyclase activity (GO:0045761),-0.26001311740646593,-0.7904215001420604,0.7829787234042553,0.9342832175379487,1.0,7/22,17.86%,CACNA1C;ADGRV1;STIM1;CAP1;GNAI3;GRM3;EDNRB
prerank,regulation of astrocyte differentiation (GO:0048710),-0.3043147343076115,-0.790267614592623,0.7372881355932204,0.9333880288320464,1.0,1/12,0.34%,EPHA4
prerank,positive regulation of binding (GO:0051099),0.26458005678547164,0.7902104953998269,0.8028322440087146,1.0,1.0,14/84,15.38%,DDX11;NGF;PRKN;LRP1;PSEN1;RALB;MEN1;NCBP1;USP33;AKTIP;PKD1;MET;MED25;DACT1
prerank,regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030947),0.31990793194239503,0.789848297129572,0.7472222222222222,1.0,1.0,4/24,9.75%,CADM4;MT3;HIF1A;PTPN1
prerank,positive regulation of protein import into nucleus (GO:0042307),0.3082541323805871,0.7897079863742066,0.7380025940337225,1.0,1.0,6/28,19.29%,TGFB1;PSEN1;FLNA;PIK3R1;JUP;IPO5
prerank,nucleoside triphosphate metabolic process (GO:0009141),-0.2838815420972035,-0.7887849609678016,0.7554179566563467,0.9347440696157652,1.0,8/14,28.37%,ITPA;ENPP1;AK4;SMPDL3A;AK1;NME2;ENPP3;AK7
prerank,regulation of GTPase activity (GO:0043087),0.25004755460205275,0.7887685852099903,0.8679050567595459,1.0,1.0,20/177,9.96%,SIPA1L1;CCL11;ERBB2;PLXNC1;FGD4;EFNA5;MAP4K4;CCL4;NTRK2;NF1;CHN1;ALS2;CDKL5;DOCK10;RAP1A;ARHGAP9;ZC3H15;VAV3;ARHGAP11A;ARL2
prerank,regulation of proteolysis involved in cellular protein catabolic process (GO:1903050),0.3182084866895021,0.7885897599947952,0.7253044654939107,1.0,1.0,7/24,15.16%,NUDT15;UCHL5;TMF1;PRKACA;PKD1;USP14;UBB
prerank,negative regulation of ubiquitin-protein transferase activity (GO:0051444),0.3479208906740663,0.7885484651439497,0.7040971168437026,1.0,1.0,5/15,18.76%,LIMK1;BAG5;ABL1;FBXO5;PARK7
prerank,positive regulation of cytoplasmic transport (GO:1903651),0.37254508557757493,0.788447462242944,0.7171561051004637,1.0,1.0,3/11,9.28%,PRKN;RAB21;VPS11
prerank,unsaturated fatty acid metabolic process (GO:0033559),0.2878034084459702,0.7876423963865624,0.7893432465923172,1.0,1.0,5/41,9.43%,FADS2;CYP1B1;SCD5;ACOX1;ELOVL5
prerank,regulation of cAMP-dependent protein kinase activity (GO:2000479),-0.28336327239995385,-0.7876390787101092,0.7904191616766467,0.9355349378454813,1.0,2/14,4.93%,PKIA;PRKAR1A
prerank,regulation of oxidoreductase activity (GO:0051341),-0.2976221124937524,-0.7875607947365831,0.7588235294117647,0.9345419456781621,1.0,5/13,16.88%,ABL2;ATP7A;ECSIT;OXA1L;SIRT4
prerank,intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress (GO:0070059),0.30362475107234016,0.7874918511211324,0.7392996108949417,1.0,1.0,9/28,23.22%,BCL2;TNFRSF10B;PPP1R15A;TMEM117;QRICH1;AIFM1;DNAJC10;ERO1A;CEBPB
prerank,calcium ion homeostasis (GO:0055074),0.25768732461218086,0.7874454448801721,0.8383297644539615,1.0,1.0,14/95,15.17%,CCL11;ANK2;TMTC2;ATP2B3;CCR2;SLC8A2;SLC24A5;SLC10A7;HTR2C;EDN3;TPCN2;ATP2B1;SNCA;CCL14
prerank,catecholamine biosynthetic process (GO:0042423),0.37021973415943565,0.787266047959876,0.7267175572519083,1.0,1.0,3/11,13.88%,DAO;GATA3;SNCA
prerank,peptidyl-lysine methylation (GO:0018022),0.3110782047285138,0.78716807304524,0.7683923705722071,1.0,1.0,6/26,19.52%,SUV39H1;SETD3;SETD2;TRMT112;SETD4;N6AMT1
prerank,positive regulation of translational initiation (GO:0045948),-0.27103806226825417,-0.7868152105873335,0.75177304964539,0.9347135897966724,1.0,6/18,22.88%,YTHDF1;HABP4;RPS6KB1;RPS6KB2;KHDRBS1;POLR2D
prerank,histone H3 deacetylation (GO:0070932),0.34703889311951164,0.7864893305782564,0.7262411347517731,1.0,1.0,4/15,13.12%,HDAC2;SFPQ;SIRT6;PER1
prerank,negative regulation of transcription from RNA polymerase II promoter in response to stress (GO:0097201),0.3790042844039941,0.7864313637740264,0.7177033492822966,1.0,1.0,6/10,28.82%,NCK1;CITED2;JUN;HSPA1A;HIF1AN;SIRT2
prerank,positive regulation of potassium ion transmembrane transporter activity (GO:1901018),0.34506001133897546,0.7863835253641662,0.7033132530120482,1.0,1.0,1/14,1.85%,ANK2
prerank,cardiac ventricle development (GO:0003231),0.3220204066484254,0.7863645608646963,0.730820995962315,1.0,1.0,6/20,17.57%,SCN5A;TMEM65;DAND5;GATA3;MDM4;HEYL
prerank,receptor metabolic process (GO:0043112),0.27480905188927857,0.786094395447259,0.8079161816065192,1.0,1.0,10/53,15.19%,DNM1;LRP1;TGFB1;ACKR3;PHETA2;MVB12A;CD9;SNCA;SNX1;ITGB1
prerank,ethanol metabolic process (GO:0006067),0.3617428228510907,0.7860521698951989,0.7259036144578314,1.0,1.0,2/12,7.11%,ACSS2;ACSS1
prerank,cell junction organization (GO:0034330),0.2663979704359873,0.7859495815268263,0.8027210884353742,1.0,1.0,13/71,12.17%,LRP4;SEMA3E;TGFB1;PSEN1;CLDN1;APBB2;SLC8A2;FLNA;GRM5;PPFIA2;MYO9A;OPHN1;DVL1
prerank,ganglion development (GO:0061548),0.3658359023280735,0.785845926610637,0.7256894049346879,1.0,1.0,3/11,12.09%,SEMA3A;NRP2;UNC5C
prerank,negative regulation of protein kinase B signaling (GO:0051898),0.2946199567111186,0.7857324271275449,0.7579462102689487,1.0,1.0,5/38,12.69%,PTEN;THEM4;PTPRJ;MAGI2;DRD2
prerank,positive regulation of response to stimulus (GO:0048584),0.2872119218393569,0.7857142027430017,0.7545787545787546,1.0,1.0,8/40,17.48%,MYC;WNT5A;TAF9;YPEL3;GATA3;CGAS;HOMER1;NSMCE4A
prerank,negative regulation of protein kinase activity (GO:0006469),0.26390435019102126,0.7856455856067335,0.8244274809160306,1.0,1.0,18/88,18.98%,UBASH3B;PYCARD;PTPRT;DEPTOR;NF1;SPRED1;PTPN1;DVL1;WWTR1;ADARB1;SNCA;TAF7;ABL1;PYDC1;DBNDD2;PPM1E;PARK7;TESK1
prerank,water transport (GO:0006833),0.3594126175693703,0.7855675732724735,0.7298937784522003,1.0,1.0,1/12,5.26%,AQP4
prerank,mitochondrial respiratory chain complex I assembly (GO:0032981),0.2772351682286244,0.7855369078748903,0.7851335656213705,1.0,1.0,15/56,19.88%,NDUFAF4;NDUFS5;NDUFAF6;NDUFB2;NDUFA8;NDUFS8;ACAD9;NDUFV3;NDUFS6;NDUFV2;NDUFA13;NDUFA6;NDUFA12;NDUFC1;NDUFA5
prerank,NADH dehydrogenase complex assembly (GO:0010257),0.2772351682286244,0.7855369078748903,0.7851335656213705,1.0,1.0,15/56,19.88%,NDUFAF4;NDUFS5;NDUFAF6;NDUFB2;NDUFA8;NDUFS8;ACAD9;NDUFV3;NDUFS6;NDUFV2;NDUFA13;NDUFA6;NDUFA12;NDUFC1;NDUFA5
prerank,toll-like receptor 4 signaling pathway (GO:0034142),-0.2742548704930731,-0.785423694343372,0.7475083056478405,0.9359199592156207,1.0,7/19,30.01%,TLR4;TIRAP;NMI;PIK3AP1;NR1H4;ITGB2;ITGAM
prerank,dicarboxylic acid catabolic process (GO:0043649),0.3569403969698987,0.7849917855626776,0.7253731343283583,1.0,1.0,4/13,21.02%,GOT2;ASPA;ACOT8;GLUD1
prerank,regulation of neuron projection arborization (GO:0150011),0.34527761350624264,0.784904149721918,0.7541229385307346,1.0,1.0,5/15,12.17%,WNT5A;NTNG2;NTNG1;MYO9A;DVL1
prerank,regulation of cellular localization (GO:0060341),0.2809984803761606,0.7848790723414253,0.7771084337349398,1.0,1.0,4/46,2.90%,STXBP4;GSN;PRKN;EFNA5
prerank,regulation of translation (GO:0006417),0.2502921616002593,0.7848063571507553,0.860204081632653,1.0,1.0,58/173,26.80%,ERBB2;EPRS1;EIF2AK3;UPF3A;PLD1;ETF1;NIBAN1;ATXN2;METTL3;TSC1;EIF1B;EIF3C;CPEB3;EIF6;NSUN5;PASK;GRM5;NCBP1;EIF4G1;UPF1;MTG1;DDX25;RBM4B;PUS7;EIF1;CYFIP1;EIF4ENIF1;PRR16;RPS27L;EIF4A2;EIF2B2;TRAP1;GIGYF2;SYNCRIP;CSDE1;PYM1;RPS6KA3;EIF4G3;DDX6;METAP1;VIM;RIDA;GLE1;BCL3;PAIP2B;ALKBH1;MTOR;FMR1;PRKDC;SOX4;CIRBP;EIF2AK2;RBM4;YTHDF3;DAPK3;KLHL25;DDX1;MTG2
prerank,intracellular pH reduction (GO:0051452),0.29823577100077747,0.7846075958600438,0.7683823529411765,1.0,1.0,12/33,27.43%,RAB38;ATP6V1B2;RAB39A;DMXL1;ATP6V1C1;RAB7A;ATP6V0E2;ATP6V0E1;ATP6V1G2;ATP6V1H;TCIRG1;ATP6V1D
prerank,regulation of cell cycle process (GO:0010564),0.25848800468397265,0.784381609668017,0.813903743315508,1.0,1.0,15/104,15.54%,KIF20B;SOX9;CDKN2B;TIPIN;KLHL13;OBSL1;CDK13;SETD2;RCC1;PKMYT1;MYO19;ATF5;RAB11FIP3;CALM1;CALM2
prerank,visual system development (GO:0150063),-0.2218275215352966,-0.7843352031983161,0.8571428571428571,0.9366395613412896,1.0,9/37,19.44%,SMOC1;RBP4;SIPA1L3;PBX3;TGFB2;PBX4;SMG9;PBX2;C1QA
prerank,cellular response to exogenous dsRNA (GO:0071360),-0.2947357344022402,-0.7840030918640917,0.754601226993865,0.936073873226342,1.0,7/12,27.41%,IFIH1;FLOT1;CAV1;IFIT1;COLEC12;MUL1;ZCCHC3
prerank,cell cycle G1/S phase transition (GO:0044843),0.2680343694497366,0.7836123177083325,0.7911464245175936,1.0,1.0,13/61,19.25%,CRLF3;MYC;ACVR1;CDK6;CUL3;RCC1;PHF8;PIM2;CUL4B;NASP;USP37;MAP3K11;DBF4
prerank,protein localization to mitochondrion (GO:0070585),0.3631384206590235,0.7834902921535787,0.7382445141065831,1.0,1.0,5/11,27.45%,COX18;DNAJA1;HK2;HK1;RALA
prerank,chromatin remodeling at centromere (GO:0031055),0.3020459946967405,0.7834396265748247,0.7641752577319587,1.0,1.0,11/31,22.39%,HELLS;HJURP;OIP5;RBBP4;ITGB3BP;CENPV;NASP;CENPL;CENPC;RBBP7;CENPU
prerank,"RNA splicing, via transesterification reactions with bulged adenosine as nucleophile (GO:0000377)",0.2451724002843751,0.7834307876842022,0.9089068825910931,1.0,1.0,76/241,26.12%,CSTF3;DHX8;TRA2B;PABPC1;RSRC1;POLR2B;METTL3;DHX35;RNPC3;SRSF11;CWF19L2;TXNL4A;RBM10;POLR2K;CASC3;NCBP1;SNRPB2;FIP1L1;SFPQ;SNRNP40;HNRNPA3;LSM3;PRPF6;RBM4B;POLR2G;DDX42;NOVA1;SRSF6;YTHDC1;PAPOLA;SNRPA;PPIH;SF3A1;HNRNPU;RAVER2;RNPS1;SF1;GEMIN7;FUS;SART1;DDX23;POLR2A;SYNCRIP;SRRM1;HNRNPUL1;SF3B3;DBR1;HNRNPC;HNRNPH2;HNRNPL;SNRPN;SRSF3;RBM17;DNAJC8;SNIP1;RBMX2;SYMPK;PLRG1;SNRNP200;SF3B2;WBP4;CTNNBL1;PCBP2;POLR2F;TFIP11;MAGOHB;CPSF7;U2SURP;SNRPA1;NONO;RBM4;RBM15;SPEN;TRA2A;PRPF38A;HNRNPA2B1
prerank,megakaryocyte differentiation (GO:0030219),0.36044078120529205,0.7829603701816256,0.7147335423197492,1.0,1.0,1/11,2.40%,CDKN2B
prerank,midbody abscission (GO:0061952),-0.2707368050025417,-0.7829362283658728,0.7785467128027682,0.9366530915758181,1.0,6/17,23.97%,CHMP3;VPS4A;CHMP1A;VPS4B;CHMP7;CHMP2B
prerank,acylglycerol biosynthetic process (GO:0046463),-0.25530068482889506,-0.7826193145747814,0.7916666666666666,0.9360571096683619,1.0,3/23,6.03%,PLA2G4A;GPAM;LPIN2
prerank,telomere organization (GO:0032200),-0.21576718769336006,-0.7822872035681145,0.8802395209580839,0.9355138572283412,1.0,10/43,15.14%,SP100;POLD3;RIF1;PARP3;TERF2;PARP1;DOT1L;HUS1;TERT;PCNA
prerank,regulation of intracellular protein transport (GO:0033157),0.2978247303356742,0.7814909084233658,0.7567567567567568,1.0,1.0,4/32,9.75%,KIF20B;TGFB1;PCM1;PTPN1
prerank,B cell proliferation (GO:0042100),0.3321820111274218,0.7810291504198615,0.7471098265895953,1.0,1.0,1/17,1.76%,BCL2
prerank,positive regulation of inflammatory response (GO:0050729),0.2590043726835751,0.7809330685287963,0.8178844056706652,1.0,1.0,16/86,19.48%,IL16;GPRC5B;CCR2;WNT5A;PLA2G7;IL18;IL6ST;GRN;SNCA;IL33;ABCC1;RIPK1;MDK;LBP;SETD4;PDCD4
prerank,establishment of spindle orientation (GO:0051294),0.3065372642278564,0.7802852552388615,0.7551813471502591,1.0,1.0,8/28,22.48%,GPSM2;INSC;NDE1;CLASP1;ITGB1;HTT;LLGL1;CDK5RAP2
prerank,membrane repolarization during action potential (GO:0086011),-0.2920910589462503,-0.7800253496507786,0.7704402515723271,0.9380841817579754,1.0,5/13,24.77%,KCNJ2;ATP1A1;ATP1B1;KCNIP2;KCNE4
prerank,plasma membrane tubulation (GO:0097320),-0.2918287513899217,-0.7799996334445605,0.7337278106508875,0.9370212782294178,1.0,4/13,17.03%,SNX9;FNBP1L;WHAMM;MICALL1
prerank,positive regulation of protein localization to nucleus (GO:1900182),0.26991403133365777,0.7799513046113723,0.7897727272727273,1.0,1.0,19/66,25.61%,CCT7;EIF2AK3;TGFB1;PSEN1;FLNA;PIK3R1;NGFR;WWTR1;JUP;MEPCE;PARK7;TESK1;IPO5;MCRS1;LIMK2;KAT7;MAVS;TCP1;CARD10
prerank,"mRNA splicing, via spliceosome (GO:0000398)",0.24318726955512004,0.7795950339631423,0.9214501510574018,1.0,1.0,86/264,27.00%,CSTF3;DHX8;TRA2B;PABPC1;RSRC1;POLR2B;METTL3;CDK13;DHX35;RNPC3;SRSF11;CWF19L2;TXNL4A;RBM10;POLR2K;CASC3;NCBP1;SNRPB2;FIP1L1;TGS1;CLNS1A;SFPQ;SNRNP40;HNRNPA3;LSM3;PRPF6;RBM4B;POLR2G;DDX42;NOVA1;SRSF6;YTHDC1;PAPOLA;SNRPA;PPIH;SF3A1;HNRNPU;RAVER2;RNPS1;SF1;GEMIN7;FUS;SART1;DDX23;POLR2A;SYNCRIP;SRRM1;HNRNPUL1;SF3B3;DBR1;HNRNPC;CELF4;HNRNPH2;HNRNPL;SNRPN;SRSF3;RBM17;DNAJC8;SNIP1;RBMX2;SYMPK;PLRG1;SNRNP200;SF3B2;WDR77;WBP4;CTNNBL1;PCBP2;POLR2F;TFIP11;MAGOHB;CPSF7;U2SURP;SCAF11;SNRPA1;NONO;RBM4;RBM15;SPEN;TRA2A;PRPF38A;HNRNPA2B1;DDX1;PPWD1;PRPF40A;UBL5
prerank,glutamine family amino acid catabolic process (GO:0009065),0.35228480720341593,0.7793914995106078,0.724087591240876,1.0,1.0,5/13,22.11%,DAO;GLS2;GLS;GLUD1;DDAH1
prerank,endothelial cell proliferation (GO:0001935),0.3437521962670105,0.7791726494528556,0.7525925925925926,1.0,1.0,2/17,2.85%,CD34;PRKX
prerank,response to glucocorticoid (GO:0051384),-0.23648811549558046,-0.7790865146899266,0.816,0.9372904515256626,1.0,6/26,20.37%,SLIT2;ZFP36L1;FAM107A;ANXA1;PDCD7;GOT1
prerank,adenylate cyclase-activating G protein-coupled receptor signaling pathway (GO:0007189),0.2562630525590276,0.7790717222242559,0.84994640943194,1.0,1.0,12/110,12.69%,CXCL10;LPAR1;PTGER3;GPR65;PTHLH;PTGFR;LGR5;TSHR;ADGRB3;S1PR3;ADGRL3;DRD2
prerank,cellular response to pH (GO:0071467),-0.2692806581611693,-0.7786470657224839,0.7902097902097902,0.9368884404168676,1.0,10/17,36.95%,RAB11B;MCOLN1;GPR68;PKD2L1;PKD1L3;IMPACT;HVCN1;RAB11FIP5;KCNK4;ASIC1
prerank,positive regulation of response to DNA damage stimulus (GO:2001022),0.27836589008263934,0.7786462448614332,0.7811004784688995,1.0,1.0,8/53,10.68%,MYC;FGF10;EGFR;SPRED2;SPRED1;BRCA1;SPRED3;FBH1
prerank,positive regulation of immune system process (GO:0002684),0.33992216915608187,0.7783333969721262,0.7387640449438202,1.0,1.0,1/16,3.14%,VEGFA
prerank,response to zinc ion (GO:0010043),0.31344581068970545,0.778223932562218,0.7506561679790026,1.0,1.0,12/25,30.16%,MT3;SLC30A4;D2HGDH;MT1G;MT1B;MT1X;MT1H;MT1F;MT1E;MT1M;MT1A;CRIP1
prerank,protein localization to centrosome (GO:0071539),0.33670249330065893,0.7782215883826088,0.7467994310099573,1.0,1.0,3/17,11.70%,PCM1;GOLGB1;SNX10
prerank,regulation of defense response to virus by host (GO:0050691),0.30144986060446644,0.7778405696526457,0.7698412698412699,1.0,1.0,2/30,3.80%,PTPN22;TRIM44
prerank,protein exit from endoplasmic reticulum (GO:0032527),0.3072730447417793,0.7773691109097701,0.7639077340569878,1.0,1.0,5/23,17.04%,DERL2;SELENOS;HERPUD1;HSP90B1;SURF4
prerank,purine ribonucleoside bisphosphate metabolic process (GO:0034035),0.35701314066028533,0.7770032040281286,0.7466467958271237,1.0,1.0,2/13,9.10%,BPNT1;BPNT2
prerank,positive regulation of transmembrane transport (GO:0034764),0.353698149001823,0.7769671933290593,0.7420814479638009,1.0,1.0,2/13,3.48%,C2CD5;ANO6
prerank,protein secretion (GO:0009306),0.27285210806145516,0.7767801789865698,0.7776484284051223,1.0,1.0,23/56,28.75%,STEAP3;COPG2;MTTP;RCN3;RAB3D;RAB3A;ARFGAP3;COPG1;TANGO6;RIMS2;PARK7;RAB3B;TANGO2;PORCN;TVP23A;MIA3;SNX19;MON1A;SCG2;SEL1L;LTBP2;PREB;RAB13
prerank,mammary gland epithelium development (GO:0061180),-0.2835951556114446,-0.7764988845252794,0.7673716012084593,0.9390120618471752,1.0,7/14,30.91%,WNT4;ID2;EPHA2;AKT1;CSF1R;LATS1;JAK2
prerank,cholesterol transport (GO:0030301),0.2851867767376959,0.7763803245597766,0.7860576923076923,1.0,1.0,7/45,16.66%,CEL;NPC1;OSBPL5;RELCH;ABCA5;LIPC;ABCG4
prerank,positive regulation of interleukin-13 production (GO:0032736),0.3710162589072796,0.7759595337512349,0.7214611872146118,1.0,1.0,2/10,13.20%,IL18;GATA3
prerank,vacuolar acidification (GO:0007035),-0.25457410020412874,-0.775768833301504,0.7857142857142857,0.9390414539875185,1.0,11/21,30.51%,ATP6V0D1;ATP6V0A4;DMXL2;TMEM9;ATP6V0A2;CLN5;TMEM199;ATP6AP2;CCDC115;PPT1;SLC11A1
prerank,negative regulation of protein-containing complex assembly (GO:0031333),-0.20461589966407973,-0.775758737726045,0.9,0.9379588685125279,1.0,8/49,13.33%,SMAD6;JAM3;GSK3B;RIOK3;PRKCZ;NOP53;LCMT1;CDC42
prerank,phosphatidic acid biosynthetic process (GO:0006654),0.2817560621477735,0.7755152860833043,0.8012048192771084,1.0,1.0,7/46,17.71%,SLC27A1;PLD1;AGPAT2;PLA2G12A;AGPAT5;GPAT3;GPAT4
prerank,cellular protein metabolic process (GO:0044267),0.23993859934693074,0.7754950258233922,0.9478957915831663,1.0,1.0,52/396,14.33%,GPC3;CHRM3;MMP2;VCAN;MXRA8;CHRDL1;HM13;PRKN;LAMC1;TGM1;MRPS18A;PARL;ARAF;PRKCSH;PSEN1;NUCB1;SDC2;RPL23A;LTA4H;MRPL32;CDKL3;MMP15;EVA1A;ATP23;RCN1;GATA6;MEN1;FARSB;SRBD1;VWA1;SPCS3;CKAP4;AMELX;MRPL35;EIF4G1;NCSTN;LTBP1;GSPT2;MRPL28;CALU;UBA3;SLC35A1;FBXL2;FUCA2;APH1A;ATG3;HSP90B1;YME1L1;PENK;NEDD8;HARS1;PSEN2
prerank,ether lipid metabolic process (GO:0046485),0.3490843793119669,0.7753572598864884,0.7533834586466165,1.0,1.0,4/14,12.35%,AGMO;PLA2G7;FAR1;PLAAT3
prerank,peptidyl-lysine monomethylation (GO:0018026),0.37141259285369116,0.774881882058036,0.7329192546583851,1.0,1.0,3/10,18.86%,SETD3;SETD2;SETD4
prerank,protein import into peroxisome membrane (GO:0045046),0.31653333262225447,0.7744656480603832,0.7337837837837838,1.0,1.0,5/22,16.67%,ACBD5;PEX3;PXMP2;GDAP1;ABCD2
prerank,positive regulation of receptor internalization (GO:0002092),0.31735011440639677,0.7742579796432087,0.761049723756906,1.0,1.0,8/22,25.97%,VEGFA;SFRP4;MAGI2;SCYL2;CD63;ARRB2;FMR1;AHI1
prerank,positive regulation of cell-matrix adhesion (GO:0001954),0.2854217325065586,0.7742548747147496,0.7942925089179548,1.0,1.0,9/42,15.54%,UTRN;MAP4K4;VEGFA;TSC1;CDK6;PTPRJ;MYOC;JUP;ABL1
prerank,long-chain fatty acid transport (GO:0015909),0.2994382556237983,0.7742169376715395,0.7759282970550576,1.0,1.0,4/30,6.74%,SLC27A1;ACACA;SLC27A4;PRKAB2
prerank,mitotic G1 DNA damage checkpoint signaling (GO:0031571),0.26639621345887654,0.7735214867284411,0.8032407407407407,1.0,1.0,14/63,18.13%,WAC;CARM1;PCBP4;PRMT1;CNOT3;RPA2;MDM4;CASP2;CRADD;ATM;RPS27L;TP53;FBXO31;MDM2
prerank,protein localization to cell surface (GO:0034394),0.30525719067137,0.7730165977720409,0.747675962815405,1.0,1.0,6/26,15.87%,FGF10;ANK2;FLNA;FGF7;RIC3;PIGU
prerank,nuclear-transcribed mRNA poly(A) tail shortening (GO:0000289),-0.2545882958871053,-0.7729678606445024,0.8111888111888111,0.9411921925258547,1.0,6/21,18.17%,SAMD4A;CNOT1;TUT7;PAN2;CNOT11;CNOT9
prerank,positive regulation of cell aging (GO:0090343),0.3609751060821228,0.7729481794775738,0.7643504531722054,1.0,1.0,3/11,15.21%,YPEL3;LMNA;CGAS
prerank,heart trabecula morphogenesis (GO:0061384),0.32608400647503805,0.7728233222960433,0.749665327978581,1.0,1.0,1/18,0.52%,BMP5
prerank,purine ribonucleoside monophosphate biosynthetic process (GO:0009168),-0.2720518730793448,-0.7725410895996309,0.7972972972972973,0.9407476043062086,1.0,6/16,19.65%,AMPD3;LHPP;ATIC;IMPDH1;GART;IMPDH2
prerank,positive regulation of peptidase activity (GO:0010952),0.31664969834886036,0.7724575275555345,0.7711511789181692,1.0,1.0,5/20,16.25%,RCN3;NCSTN;GRN;APH1A;NDUFA13
prerank,negative regulation of G0 to G1 transition (GO:0070317),0.2880138254186423,0.7724292230126912,0.7849196538936959,1.0,1.0,13/36,27.15%,EED;APAF1;E2F6;BRCA1;EPC1;RBBP4;RBBP7;CBX5;RNF2;CBX3;EHMT2;RBBP8;EZH2
prerank,"RNA splicing, via transesterification reactions (GO:0000375)",0.3029420721630395,0.7724143972269913,0.751004016064257,1.0,1.0,9/25,20.25%,TRA2B;TXNL4A;SNRNP40;PRPF6;KHSRP;DDX23;SRRM1;SF3B3;DBR1
prerank,rRNA catabolic process (GO:0016075),-0.2719233353415207,-0.7719399174889859,0.7804878048780488,0.9405680530763149,1.0,5/16,18.23%,XRN1;EXOSC7;DIS3;EXOSC10;DEDD2
prerank,proteasome-mediated ubiquitin-dependent protein catabolic process (GO:0043161),0.239551084458008,0.7718235698507337,0.9438314944834504,1.0,1.0,82/314,23.24%,ZFAND2B;RAD23B;PRKN;ERLIN2;HACE1;DNAJB9;FBXW7;SPSB4;RHBDD2;SPOP;FBXO38;FBXL15;TRIM2;HECTD3;PELI1;UBE2K;FBXL16;PSMB7;UCHL1;FBXO27;DERL2;CUL3;SELENOS;HERPUD1;HUWE1;ANAPC7;FBXO45;NFE2L2;UBE2J2;RNF121;FBXO17;ANAPC2;FBXL2;TMUB2;HSP90B1;DDB1;BUB1B;NEDD4L;JKAMP;PSMD2;KLHL22;PLAA;UBB;AREL1;PSMC1;ERLIN1;CDC23;FBXL4;ZSWIM8;ANAPC16;PSMB2;CUL4B;FBXO5;FBXO31;TRIM9;MDM2;RNF4;PSMD9;TAF1;DNAJC10;PCNP;PSME4;FBXL12;CDC27;UBE2G1;UBE2E1;DCAF11;SGTA;PSMA8;PTTG1;ANAPC4;UBE2D3;ARRB2;UBR3;FBXO44;ANAPC5;UBQLN1;SIAH1;RNF187;UBQLN2;COP1;RB1
prerank,positive regulation of establishment of protein localization (GO:1904951),-0.2604451114655055,-0.7718010975128982,0.8127090301003345,0.9396900815953249,1.0,5/18,13.59%,DKC1;WRAP53;CCT8;CCT6A;CCT4
prerank,positive regulation of calcium-mediated signaling (GO:0050850),0.3652515131422154,0.7717886632093903,0.7743431221020093,1.0,1.0,1/11,4.10%,CCL4
prerank,Golgi localization (GO:0051645),0.35896539377555264,0.7713678508425332,0.7428571428571429,1.0,1.0,5/11,24.92%,YWHAZ;ARHGAP21;COPG1;HOOK3;ARCN1
prerank,regulation of glycogen metabolic process (GO:0070873),-0.28985415154356503,-0.7713444436017262,0.7872340425531915,0.9392799410798356,1.0,8/12,42.40%,PPP1R3B;PPP1R3C;AKT1;RUBCNL;KHK;PPP1R3E;PPP1R3D;GCGR
prerank,carbohydrate derivative catabolic process (GO:1901136),0.3276886049346265,0.7712671765138999,0.7698630136986301,1.0,1.0,5/18,22.47%,NAGA;FBXO27;FBXO17;FBXO44;OGA
prerank,positive regulation of stress fiber assembly (GO:0051496),0.2842015052555768,0.7707376403848548,0.7768496420047732,1.0,1.0,15/44,21.50%,LPAR1;GPR65;ARHGEF10;PAK1;LIMK1;NF2;ARHGEF10L;RHOC;MYOC;ABL1;TGFB3;PPM1E;TESK1;CCDC88A;PXN
prerank,negative regulation of small GTPase mediated signal transduction (GO:0051058),0.3149223321955156,0.7700055513633074,0.7562582345191041,1.0,1.0,3/21,6.11%,EPHB2;SYNGAP1;MAPKAP1
prerank,negative regulation of substrate adhesion-dependent cell spreading (GO:1900025),0.3566728607276652,0.7698543482372975,0.7276923076923076,1.0,1.0,5/12,26.39%,EFNA5;AP1AR;KANK1;SPRY4;CORO1C
prerank,negative regulation of cell morphogenesis involved in differentiation (GO:0010771),0.3566728607276652,0.7698543482372975,0.7276923076923076,1.0,1.0,5/12,26.39%,EFNA5;AP1AR;KANK1;SPRY4;CORO1C
prerank,protein N-linked glycosylation (GO:0006487),0.26271048629671245,0.7691017877694903,0.8310502283105022,1.0,1.0,15/66,19.74%,GFPT2;UGGT2;ALG9;STT3A;MGAT3;MAGT1;ALG5;TUSC3;ALG1;MOGS;ALG8;DPM1;DPAGT1;RPN1;ALG6
prerank,atrioventricular valve morphogenesis (GO:0003181),0.32147125797529635,0.7689266956463222,0.7633053221288515,1.0,1.0,8/19,25.24%,ACVR1;TGFBR2;MDM4;BMPR1A;HEYL;BMP2;EFNA1;SOX4
prerank,regulation of mitotic cell cycle phase transition (GO:1901990),0.2437376765650218,0.7687235695926611,0.8908163265306123,1.0,1.0,47/184,23.70%,DYNLL1;HAUS3;CNTRL;PCM1;NDE1;SDCCAG8;CEP57;PSMB7;CUL3;ZFP36L2;ANAPC7;CLASP1;ANAPC2;PRKACA;CKAP5;DDB1;CEP76;BUB1B;DYNC1I2;PKD1;PSMD2;UBB;PSMC1;CDC14A;CSNK1E;CDC23;ANLN;ANAPC16;PSMB2;CEP63;FBXO5;TUBA1A;PSMD9;PSME4;CDC27;CEP78;SSNA1;UBE2E1;PSMA8;PCNT;ANAPC4;CDK5RAP2;ANAPC5;DYNC1H1;PPP2R1A;CDC16;PLK5
prerank,mitotic metaphase plate congression (GO:0007080),-0.2019215190466349,-0.7684199142842018,0.9177215189873418,0.942564159360586,1.0,25/51,34.93%,CHMP3;BECN1;NUDC;VPS4A;CHMP1A;KIF18A;PINX1;VPS4B;PIBF1;CHMP7;BOD1;CHMP2B;EML4;DCTN2;CENPE;EML3;ZW10;KIFC1;NUP62;NDC80;KIF14;SPDL1;MAD1L1;CDCA8;CEP55
prerank,response to progesterone (GO:0032570),-0.2611737149705545,-0.7682910796088676,0.7697841726618705,0.9416286813839875,1.0,6/18,20.71%,THBS1;TGFB2;CAV1;ABHD2;CATSPER3;NR1H3
prerank,monovalent inorganic cation homeostasis (GO:0055067),0.31022957043522026,0.7675940309193846,0.7513513513513513,1.0,1.0,5/23,17.45%,SLC12A3;SLC12A2;SLC12A4;KCNH2;SLC9A1
prerank,dolichol-linked oligosaccharide biosynthetic process (GO:0006488),0.3219718794119901,0.7672746474626929,0.7591036414565826,1.0,1.0,6/17,20.39%,ALG9;ALG1;ALG8;DPAGT1;ALG6;DHDDS
prerank,heterochromatin organization (GO:0070828),0.3389592169030201,0.7671627702359723,0.7611275964391692,1.0,1.0,3/14,10.06%,PRDM16;EZH1;POLE3
prerank,neuron remodeling (GO:0016322),0.3685000610116739,0.7668467525376422,0.7774244833068362,1.0,1.0,3/10,12.08%,ADGRB3;FARP2;ANKS1A
prerank,mesoderm development (GO:0007498),0.32600910557031504,0.7665811149754763,0.7647887323943662,1.0,1.0,2/18,5.00%,VEGFA;MEST
prerank,tRNA modification (GO:0006400),0.2689510271099152,0.766496970676952,0.8298850574712644,1.0,1.0,20/62,23.76%,THUMPD3;DTWD1;PUSL1;TRMT12;THADA;DTWD2;TRMT112;PUS7;THUMPD2;ELP5;PUS1;SSB;TPRKB;TRIT1;NSUN2;LCMT2;ALKBH8;ALKBH1;TRMT1;MOCS3
prerank,antibacterial humoral response (GO:0019731),0.32695942226792735,0.7661618237577245,0.7669064748201438,1.0,1.0,1/16,3.93%,RNASE6
prerank,positive regulation of leukocyte activation (GO:0002696),0.3285265145090958,0.766096857325366,0.7553648068669528,1.0,1.0,6/18,21.40%,WNT5A;NECTIN2;IL33;LBP;HSPD1;TNIP2
prerank,transcription by RNA polymerase I (GO:0006360),0.2911133704263399,0.7659883376067462,0.7926208651399491,1.0,1.0,13/34,26.50%,GTF2H2;TAF1A;POLR2K;POLR1B;POLR1C;POLR1G;TAF1;UBTF;RRN3;POLR2F;CCNH;TBP;TTF1
prerank,positive regulation of NF-kappaB transcription factor activity (GO:0051092),0.24435943837386695,0.7657479626019201,0.8775933609958506,1.0,1.0,35/149,24.51%,ROR1;EDA;PRKCQ;PYCARD;IRAK3;RPS6KA4;WNT5A;CARD9;IL18;MID2;RTKN2;PRDX3;MALT1;DHX33;TICAM1;UBB;TERF2IP;IL1RAP;RIPK1;CHUK;RAB7B;TAB3;BCL10;STAT3;NFKB1;PRKD2;CARD11;TAB2;CARD16;ERC1;FLOT2;IRAK2;TRIM14;CIB1;HSPA1A
prerank,regulation of protein localization to cell surface (GO:2000008),0.29440289078898174,0.7656210362719293,0.7881462799495587,1.0,1.0,6/33,15.31%,TAX1BP3;GPM6B;GBF1;KCNAB2;NEDD4L;RIC3
prerank,very long-chain fatty acid metabolic process (GO:0000038),0.2952363816976353,0.7641898517705688,0.779639175257732,1.0,1.0,10/30,24.45%,SLC27A4;ACOX1;ELOVL6;ELOVL5;ABCD2;ACSL6;HACD2;TECRL;ELOVL1;HACD3
prerank,response to estrogen (GO:0043627),-0.22045533446015736,-0.7639146719598753,0.8676470588235294,0.9471599639358185,1.0,8/31,19.29%,TRIM25;PELP1;SERPINB9;SRA1;CAV1;ARID5A;RBBP5;RARA
prerank,"regulation of retrograde protein transport, ER to cytosol (GO:1904152)",0.34911618212689755,0.7636005104480355,0.7643593519882179,1.0,1.0,2/13,10.09%,DERL2;EDEM2
prerank,regulation of protein acetylation (GO:1901983),-0.295868031581919,-0.7634633076893277,0.771513353115727,0.9467120590450081,1.0,4/12,20.83%,GSK3B;CAMK1;KAT5;CEP295
prerank,regulation of transcription from RNA polymerase II promoter in response to hypoxia (GO:0061418),-0.1808135605270631,-0.7634513199450682,0.9603174603174603,0.945631844035299,1.0,18/74,19.43%,PSMD14;ARNT;PSMB3;PSMD12;EGLN2;HIGD1A;PSMD6;PSMA1;VHL;PSMD7;PSMA5;PSMC5;PSMC4;CREBBP;PSMB6;CUL2;EGLN3;PSMA4
prerank,regulation of epidermal growth factor receptor signaling pathway (GO:0042058),0.26363363603501266,0.7632362413497562,0.827313769751693,1.0,1.0,10/65,13.38%,MVB12B;EGFR;PTPN2;EPS15;HIP1;BTC;PTPRJ;CBL;MVB12A;SH3KBP1
prerank,positive regulation of proteasomal protein catabolic process (GO:1901800),0.25500873394851226,0.7627365126538614,0.8324265505984766,1.0,1.0,23/85,20.32%,PRKN;SOCS5;FBXW7;CBFA2T3;RNFT1;PRICKLE1;DVL1;CSNK1A1;DET1;TMTC3;DDA1;SUMO1;RNF19A;RCHY1;CSNK1E;FBXO22;MDM2;ZER1;TAF1;USP5;NKD2;BBS7;USP13
prerank,negative regulation of protein processing (GO:0010955),0.3441546821929942,0.7623737590830951,0.7614138438880707,1.0,1.0,3/12,16.92%,PRNP;SERPINE2;SNX12
prerank,peptide catabolic process (GO:0043171),0.3041303607375391,0.7622924233269119,0.7547425474254743,1.0,1.0,4/23,9.81%,DPEP1;LTA4H;TRHDE;LNPEP
prerank,G1/S transition of mitotic cell cycle (GO:0000082),0.25269180061527885,0.761819838003842,0.8424507658643327,1.0,1.0,16/83,19.25%,CRLF3;MYC;ACVR1;CDK6;CDK15;CUL3;RCC1;PHF8;CDK16;ORC1;PIM2;CUL4B;FBXO5;NASP;USP37;DBF4
prerank,cellular response to corticosteroid stimulus (GO:0071384),0.3340173959792896,0.7616170833982651,0.757183908045977,1.0,1.0,5/15,20.38%,ZFP36L2;BCL2L11;HNRNPU;UBE2L3;ZFP36
prerank,"base-excision repair, gap-filling (GO:0006287)",0.2858480045015826,0.7615416426670706,0.7977099236641222,1.0,1.0,8/35,16.11%,MBD4;MPG;RPA3;MUTYH;NEIL1;RPA2;SMUG1;POLG
prerank,eye photoreceptor cell development (GO:0042462),0.3356244850228942,0.7610166554235038,0.7421289355322339,1.0,1.0,1/15,3.14%,VEGFA
prerank,negative regulation of cytoskeleton organization (GO:0051494),0.29235627050648133,0.7609172842485119,0.79,1.0,1.0,8/29,16.35%,KANK4;PRKN;SSH3;CLASP1;FKBP4;PLEKHH2;SSH1;ARFGEF1
prerank,Wnt signaling pathway (GO:0016055),0.25043878067823694,0.7608800148509844,0.8362637362637363,1.0,1.0,19/92,15.83%,PTEN;FRZB;VPS29;WNT5A;FZD7;RARG;BCL9L;SFRP4;BCL9;DVL1;CSNK1G1;GPC4;CSNK1A1;STRN;KLHL12;UBB;FZD9;CSNK1E;CSNK1G2
prerank,regulation of DNA biosynthetic process (GO:2000278),0.2950017689966077,0.760546906326007,0.7908496732026143,1.0,1.0,2/27,1.47%,FGF2;MYC
prerank,liver development (GO:0001889),0.29654730739201624,0.7604216305299166,0.7800252844500632,1.0,1.0,10/32,23.89%,CCDC39;PRKCSH;NF1;COBL;CITED2;MET;PCK2;PKD2;CEBPB;TGFBR3
prerank,phosphatidic acid metabolic process (GO:0046473),0.27467898544304087,0.7604172888318983,0.827710843373494,1.0,1.0,7/48,17.71%,SLC27A1;PLD1;AGPAT2;PLA2G12A;AGPAT5;GPAT3;GPAT4
prerank,rRNA methylation (GO:0031167),0.3094116590071972,0.7595882172601629,0.7587131367292225,1.0,1.0,5/22,12.65%,NOP2;NSUN5;FDXACB1;FBL;TRMT112
prerank,regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902229),0.3283870644252422,0.7594691007610118,0.7647058823529411,1.0,1.0,3/16,13.74%,ACKR3;FBH1;NACC2
prerank,cellular response to cAMP (GO:0071320),-0.228920824520023,-0.7590832672533452,0.8347107438016529,0.9509614575259189,1.0,4/30,7.01%,RAP1B;IGFBP5;ZFP36L1;SLC5A5
prerank,entrainment of circadian clock by photoperiod (GO:0043153),0.2951201945282366,0.758827805478174,0.7715404699738904,1.0,1.0,9/27,19.57%,CRTC1;PPP1CA;PER3;PER1;RBM4B;CRY1;TP53;USP2;FBXL12
prerank,positive regulation of cellular metabolic process (GO:0031325),0.24967203435394766,0.7585344631220072,0.8655737704918033,1.0,1.0,22/98,19.68%,VEGFA;ACACA;TGFB1;MT3;TGFBR2;ACLY;FASN;EIF4G1;SFRP4;MAPK14;PID1;MAGI2;RAB1A;SCRIB;GATA3;SNCA;SCYL2;TP53;RIPK1;CD63;GRB2;PPARG
prerank,regulation of mitochondrion organization (GO:0010821),0.27191357668057636,0.7583662956790308,0.8069544364508393,1.0,1.0,7/47,11.37%,PRKN;PARL;FBXW7;RHOT2;MYO19;HDAC6;PID1
prerank,mitochondrial calcium ion transmembrane transport (GO:0006851),0.31106370510923503,0.7583112367658578,0.7712230215827338,1.0,1.0,9/20,24.48%,PARL;LETM1;PMPCB;SLC25A23;YME1L1;PMPCA;PHB2;MCUR1;SMDT1
prerank,positive regulation of locomotion (GO:0040017),-0.2302146879082323,-0.7581306618616569,0.8452380952380952,0.9511760514516212,1.0,7/27,19.58%,CCDC25;THBS1;SPOCK2;PDGFRB;PPM1F;CAVIN1;TWIST1
prerank,keratan sulfate metabolic process (GO:0042339),0.2933176215308678,0.7577164045256876,0.8101430429128739,1.0,1.0,3/31,7.19%,LUM;ST3GAL4;GALNS
prerank,regulation of microtubule cytoskeleton organization (GO:0070507),0.28256897961516,0.757621119747499,0.8049689440993789,1.0,1.0,6/37,11.45%,PHLDB1;BICD1;EFNA5;CLASP1;BICD2;STMN4
prerank,glucose homeostasis (GO:0042593),0.25583896437213816,0.7575724761474903,0.8423373759647188,1.0,1.0,15/83,20.07%,PYGL;BACE2;PTPN2;LRRC8D;MLXIPL;HIF1A;PIK3R1;NGFR;CRY1;KLF7;PARK7;HK2;PPARG;STAT3;ADCY8
prerank,innate immune response in mucosa (GO:0002227),-0.3112507623667948,-0.7573973738570943,0.7978142076502732,0.9511343459516916,1.0,1/10,6.09%,DEFA6
prerank,regulation of activin receptor signaling pathway (GO:0032925),0.32896713470064093,0.7567424049459435,0.7700145560407569,1.0,1.0,3/15,15.38%,ACVR1;MAGI2;DACT1
prerank,positive regulation of protein serine/threonine kinase activity (GO:0071902),0.2504755911501189,0.7565338431212327,0.864516129032258,1.0,1.0,17/101,16.02%,SLC27A1;FGF2;ERBB2;EGFR;VEGFA;TGFB1;WNT5A;RALB;FGFR1;SLC8A2;PIH1D1;EDN3;SNCA;CALM1;PKD1;CALM2;CCND2
prerank,positive regulation of calcium ion-dependent exocytosis (GO:0045956),-0.2885373540230111,-0.7565148025537051,0.7882736156351792,0.9513546644349241,1.0,6/13,23.94%,CACNA1G;SYT10;KCNB1;STX1A;SYT4;CACNA1I
prerank,prostaglandin metabolic process (GO:0006693),0.29976562629083214,0.7561637218061779,0.7712328767123288,1.0,1.0,6/26,17.78%,CYP2S1;ACOX1;PNPLA8;PLAA;CD74;PTGES
prerank,positive regulation of apoptotic signaling pathway (GO:2001235),0.26602225869957,0.75614157349778,0.8317865429234339,1.0,1.0,10/55,17.21%,PYCARD;BCL2;FADD;BMF;TRAF7;CRADD;TP53;BCL2L11;WWOX;RIPK1
prerank,negative regulation of platelet activation (GO:0010544),0.3270908597553787,0.7558808079541232,0.763271162123386,1.0,1.0,3/16,13.83%,PDGFRA;SERPINE2;CD9
prerank,regulation of vasculogenesis (GO:2001212),0.33223960539161934,0.7558162824514284,0.7286356821589205,1.0,1.0,2/14,7.42%,CD34;RAP1A
prerank,negative regulation of hydrolase activity (GO:0051346),0.2693806607601294,0.7554039251277109,0.8155339805825242,1.0,1.0,10/49,20.83%,MAPK7;CSTB;URI1;ARL2;NEIL1;TMED2;ARFGEF1;FICD;RDX;ZCCHC9
prerank,negative regulation of lyase activity (GO:0051350),0.333321964748425,0.7549609374953619,0.7680115273775217,1.0,1.0,3/16,12.69%,CCR2;MTRR;DRD2
prerank,response to amino acid (GO:0043200),0.2904194188148194,0.7545712450379789,0.7898936170212766,1.0,1.0,12/31,27.61%,CPEB3;LAMTOR2;CPEB1;SPAAR;RPTOR;IPO5;RRAGA;GLRB;MTOR;SLC38A9;CPEB4;GLRA3
prerank,actin filament depolymerization (GO:0030042),0.35167605196842966,0.7543427040074586,0.754746835443038,1.0,1.0,1/11,2.24%,GSN
prerank,regulation of chemokine production (GO:0032642),0.28116363109717035,0.7541527355519165,0.7808716707021792,1.0,1.0,7/36,19.04%,PYCARD;WNT5A;IL18;HIF1A;IL33;CD74;EGR1
prerank,regulation of T cell mediated cytotoxicity (GO:0001914),0.32695226362984775,0.7540866536179255,0.7727272727272727,1.0,1.0,1/16,2.66%,FADD
prerank,negative regulation of peptidase activity (GO:0010466),-0.2012100733957758,-0.7539511414525768,0.935672514619883,0.953925257269878,1.0,8/47,13.74%,VTN;TIMP3;SERPIND1;SPOCK2;SERPINB9;SERPINE1;TIMP2;SERPINI1
prerank,"RNA phosphodiester bond hydrolysis, endonucleolytic (GO:0090502)",0.33018849735597533,0.7537743253401956,0.7839046199701938,1.0,1.0,6/15,30.81%,ZC3H12B;POP1;ZC3H12C;RPP30;KHNYN;ZC3H12A
prerank,mesenchymal to epithelial transition (GO:0060231),0.3571150198774665,0.7537033658608928,0.779874213836478,1.0,1.0,3/10,16.97%,FZD7;GATA3;PAX2
prerank,vitamin transport (GO:0051180),0.29254960899458293,0.7536490761845372,0.7745740498034076,1.0,1.0,2/29,3.90%,SLC27A1;CD320
prerank,negative regulation of TOR signaling (GO:0032007),0.283983535555878,0.7535918985225666,0.8092345078979344,1.0,1.0,11/36,24.79%,NPRL2;DEPTOR;TSC1;CASTOR2;ATM;SPAAR;FNIP1;DEPDC5;PRKAA1;SESN1;ITFG2
prerank,antigen processing and presentation of exogenous peptide antigen via MHC class II (GO:0019886),0.25472424043520375,0.7531990851002873,0.8304157549234136,1.0,1.0,15/78,19.16%,DYNLL1;SEC24D;AP1G1;AP1S1;SEC24C;DYNC1I1;DCTN4;DYNC1I2;KIF22;CD74;SEC24A;RAB7A;OSBPL1A;KIF3A;KIF2A
prerank,antigen processing and presentation of peptide antigen via MHC class II (GO:0002495),0.25472424043520375,0.7531990851002873,0.8304157549234136,1.0,1.0,15/78,19.16%,DYNLL1;SEC24D;AP1G1;AP1S1;SEC24C;DYNC1I1;DCTN4;DYNC1I2;KIF22;CD74;SEC24A;RAB7A;OSBPL1A;KIF3A;KIF2A
prerank,clathrin-dependent endocytosis (GO:0072583),0.300157914378078,0.7526909987490912,0.800266311584554,1.0,1.0,4/26,11.35%,SGIP1;ITSN1;GAK;GPR107
prerank,neutrophil activation (GO:0042119),-0.28859904857107876,-0.7523883287657565,0.7850467289719626,0.9549245442074327,1.0,1/12,2.60%,PRKCD
prerank,regulation of dendritic cell apoptotic process (GO:2000668),-0.30753089535160966,-0.7521527205993204,0.7821229050279329,0.954154505048693,1.0,5/10,37.46%,LYN;CCL19;RAPGEF2;GAS6;LILRB1
prerank,"nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway (GO:0035872)",-0.2380844894599732,-0.7520974614789103,0.8479087452471483,0.9531395713091666,1.0,9/24,27.19%,RNF34;CASP8;MAP3K7;UBE2N;IKBKG;NOD1;TNFAIP3;UBA52;NOD2
prerank,polyol biosynthetic process (GO:0046173),0.32604798314299743,0.752095895317111,0.7696709585121603,1.0,1.0,1/16,1.27%,FGF2
prerank,C21-steroid hormone biosynthetic process (GO:0006700),0.3524621516174837,0.7520548674329512,0.7627627627627628,1.0,1.0,4/12,25.10%,TSPOAP1;TSPO;CACNA1H;STARD3
prerank,antigen processing and presentation of exogenous peptide antigen (GO:0002478),0.25344873362797216,0.7517744797934872,0.8320610687022901,1.0,1.0,15/79,19.16%,DYNLL1;SEC24D;AP1G1;AP1S1;SEC24C;DYNC1I1;DCTN4;DYNC1I2;KIF22;CD74;SEC24A;RAB7A;OSBPL1A;KIF3A;KIF2A
prerank,peptidyl-lysine modification (GO:0018205),0.2466975970015089,0.7515569531146801,0.8699360341151386,1.0,1.0,13/99,11.28%,CTH;KAT2B;SENP3;RANBP2;UBA2;NUP155;LOXL3;PLOD1;PIAS2;NUP205;NDC1;HDAC6;NUP160
prerank,protein glycosylation (GO:0006486),0.2420325748749388,0.7512409159500598,0.8756585879873551,1.0,1.0,26/125,19.74%,GFPT2;ST3GAL4;NPC1;ALG9;B3GNT9;GALNT9;GALNT1;STT3A;PLOD1;MGAT3;MAGT1;ST8SIA1;POMGNT2;GALNT7;ALG5;GALNT6;TUSC3;ALG1;MOGS;TET3;ALG8;DPM1;FKTN;DPAGT1;RPN1;ALG6
prerank,very long-chain fatty acid biosynthetic process (GO:0042761),0.33890897008821275,0.7510352101585631,0.7719033232628398,1.0,1.0,6/13,24.45%,ELOVL6;ELOVL5;HACD2;TECRL;ELOVL1;HACD3
prerank,regulation of DNA methylation-dependent heterochromatin assembly (GO:0090308),0.3428267177739442,0.7508760239386323,0.7568740955137482,1.0,1.0,6/12,28.28%,ATF7IP;APOBEC1;SETDB1;MPHOSPH8;RESF1;DNMT1
prerank,fibrinolysis (GO:0042730),-0.275817589496527,-0.7508129236185109,0.8289855072463768,0.9537737672905257,1.0,9/13,52.54%,SERPINE1;PLAUR;PLAU;HRG;PLG;SERPINB2;CPB2;GP1BA;F2
prerank,positive regulation of protein depolymerization (GO:1901881),0.3482604730349116,0.7508068593376284,0.7645211930926217,1.0,1.0,4/11,26.15%,KATNB1;NES;CFL2;WDR1
prerank,tRNA methylation (GO:0030488),0.28274949708453956,0.7507848841202849,0.8027295285359801,1.0,1.0,11/34,23.38%,THUMPD3;TRMT12;THADA;PRORP;TRMT112;DALRD3;THUMPD2;NSUN2;LCMT2;ALKBH8;TRMT1
prerank,cellular glucan metabolic process (GO:0006073),0.3524951858457248,0.7507338391735221,0.7809076682316118,1.0,1.0,2/11,9.06%,PYGL;PHKB
prerank,positive regulation by host of viral transcription (GO:0043923),-0.2698397982992652,-0.7504507744640895,0.8117283950617284,0.9532117169775945,1.0,3/15,12.15%,LEF1;SNW1;CTDP1
prerank,positive regulation of RNA metabolic process (GO:0051254),0.2711934029944224,0.750061660062896,0.8256097560975609,1.0,1.0,15/45,24.51%,EGFR;TGFB1;DXO;HEATR1;PIK3R1;ZC3H18;TRMT112;TP53;PNPT1;RIPK1;POLR2A;NFKB1;WDR75;SUPV3L1;HSPA1A
prerank,cell junction maintenance (GO:0034331),-0.2786608734531331,-0.749791594334739,0.7905405405405406,0.9530228641647527,1.0,8/14,34.62%,NLGN2;DCTN1;CSF1R;CBLN2;MYADM;F2R;CBLN1;PRTN3
prerank,regulation of blood circulation (GO:1903522),-0.21489310380306031,-0.7497788356424179,0.8383838383838383,0.9519438988482911,1.0,11/34,26.48%,TPM1;ACE;AGTR1;ECE1;DES;SRI;ACE2;DMPK;AGT;KCNIP2;PLN
prerank,regulation of interferon-alpha production (GO:0032647),0.304169812541146,0.7493082922936055,0.7803921568627451,1.0,1.0,8/23,25.41%,SETD2;TBK1;CHUK;IRF3;PTPRS;HSPD1;MAVS;IRF5
prerank,positive regulation of secretion (GO:0051047),0.34737439999925385,0.7490789842233522,0.779969650986343,1.0,1.0,2/11,16.10%,ACSL3;GPLD1
prerank,cellular response to oxidised low-density lipoprotein particle stimulus (GO:0140052),-0.30816678651231055,-0.7487038663938921,0.7728531855955678,0.952310974814814,1.0,7/10,37.88%,TLR4;AKT1;MYD88;CD68;TREM2;CD36;TLR6
prerank,positive regulation of nucleocytoplasmic transport (GO:0046824),0.268981770423473,0.7485896301570659,0.8307508939213349,1.0,1.0,8/46,15.90%,TGFB1;PSEN1;CPSF6;FLNA;PIK3R1;EMD;JUP;TP53
prerank,transcription-coupled nucleotide-excision repair (GO:0006283),0.25235784676461437,0.7484786762797319,0.8429378531073446,1.0,1.0,17/72,20.96%,HMGN1;GTF2H2;ERCC5;ERCC4;POLR2B;RPA3;XPA;POLR2K;DDB1;RPA2;POLR2G;UBB;CUL4B;POLR2A;LIG3;COPS6;COPS7A
prerank,positive regulation of small molecule metabolic process (GO:0062013),0.33539556756234096,0.7483759448124755,0.804185351270553,1.0,1.0,7/15,28.67%,IRS2;GPLD1;PPARG;PRKCE;LDLRAP1;PPARA;ADM
prerank,protein mannosylation (GO:0035268),0.29917285574021674,0.748297875033068,0.7708333333333334,1.0,1.0,9/22,19.09%,TMTC2;POMGNT2;RXYLT1;TMTC3;DPY19L2;DPM1;FKTN;FKRP;DPY19L3
prerank,regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO:0010881),0.3254493855805469,0.7482360550153557,0.7771428571428571,1.0,1.0,4/16,15.54%,ANK2;PRKACA;CALM1;CALM2
prerank,embryonic organ development (GO:0048568),0.25872845046445464,0.7477857854303437,0.8468468468468469,1.0,1.0,11/61,14.61%,GLI2;PKDCC;KMT2A;TGFB1;TGFBR2;RARB;GDNF;GATA3;COBL;NES;BMPR1A
prerank,ribosomal large subunit assembly (GO:0000027),0.30406391960548473,0.7472218394337543,0.7877984084880637,1.0,1.0,4/24,7.70%,RPL23A;NOP2;BRIX1;DHX30
prerank,negative regulation of voltage-gated calcium channel activity (GO:1901386),0.35672624237596934,0.7470899991364071,0.782608695652174,1.0,1.0,2/10,14.50%,DRD2;CALM1
prerank,carbohydrate catabolic process (GO:0016052),-0.20689161066591416,-0.7470005301651786,0.8883248730964467,0.9534908353398917,1.0,12/38,23.62%,MANBA;MAN2B1;PGK1;PGAM4;PGAM1;GPI;PFKM;PFKL;ENO1;MAN2B2;GAPDHS;ENO3
prerank,embryonic heart tube development (GO:0035050),0.32934751026235026,0.7467389041437641,0.7649572649572649,1.0,1.0,2/14,14.77%,ACVR1;CITED2
prerank,calcium ion-regulated exocytosis of neurotransmitter (GO:0048791),0.3422722649983745,0.746695840956648,0.7644376899696048,1.0,1.0,5/12,18.29%,SYT1;RIMS1;DOC2B;SYT2;RIMS2
prerank,negative regulation of interleukin-8 production (GO:0032717),0.31883306412059054,0.7464218849927128,0.7892561983471075,1.0,1.0,2/17,6.17%,PTPN22;OTUD7B
prerank,positive regulation of JNK cascade (GO:0046330),0.25781541581546547,0.7462781620844723,0.8561643835616438,1.0,1.0,9/70,11.66%,PYCARD;SEMA3A;NCF1;TRAF4;PLCB1;CARD9;FZD7;MTURN;TAOK3
prerank,positive regulation of interferon-alpha production (GO:0032727),0.31724101809626026,0.7459872650633061,0.7900552486187845,1.0,1.0,7/19,25.41%,SETD2;TBK1;CHUK;IRF3;HSPD1;MAVS;IRF5
prerank,negative regulation of NIK/NF-kappaB signaling (GO:1901223),-0.2362112509364913,-0.7459576941004562,0.8259109311740891,0.9539085601930763,1.0,5/23,18.13%,UACA;C1QTNF3;TMSB4X;NMI;IFI35
prerank,positive regulation of cellular protein catabolic process (GO:1903364),0.3086540214094445,0.7459522251910695,0.787661406025825,1.0,1.0,4/18,19.14%,VGLL4;VPS11;DACT1;RDX
prerank,positive regulation of phagocytosis (GO:0050766),-0.20464547610354503,-0.7458184553419636,0.8807947019867549,0.9530032007083655,1.0,25/47,37.83%,APPL2;RAB31;CAMK1D;CYBA;DOCK2;GATA2;NCKAP1L;PTPRC;C2;ABCA7;TUB;FCER1G;CALR;TULP1;LYAR;RAB27A;C4B;SLC11A1;GAS6;CD300LF;CCL2;TREM2;IL2RG;AHSG;PLA2G5
prerank,positive regulation of histone deacetylation (GO:0031065),0.3344424157376129,0.7457500609866201,0.7823439878234398,1.0,1.0,4/12,21.49%,VEGFA;APLNR;CTBP1;PRKD2
prerank,glucose transmembrane transport (GO:1904659),0.3138147110165771,0.7453964909721383,0.7782672540381792,1.0,1.0,3/18,12.41%,SLC5A3;SLC2A2;RAB4B
prerank,cellular response to starvation (GO:0009267),0.24086865723970846,0.7453026513281664,0.8928571428571429,1.0,1.0,54/147,28.00%,MIOS;NPRL2;SIK2;EIF2AK3;ATP6V1B2;NUPR2;AOC1;WIPI1;RALB;TBL2;ATG5;LAMTOR2;CASTOR2;ASNS;ATF2;USP33;CLEC16A;MAPK1;XPR1;GABARAPL2;VPS41;GCN1;TP53;SREBF2;WRN;ATP6V1C1;RPTOR;FNIP1;RRAGA;ATP6V0E2;LAMP2;DEPDC5;PRKAA1;ATP6V0E1;CEBPB;INHBB;RRP8;MTOR;ATP6V1G2;WDR45B;EHMT2;SESN1;ITFG2;EIF2AK2;SLC38A9;ATP6V1H;CPEB4;CDKN1A;TCIRG1;PPARA;SIRT1;ATP6V1D;PIK3C3;PRKAG1
prerank,ventricular septum development (GO:0003281),0.27660443068570134,0.7452579514321894,0.8168130489335006,1.0,1.0,11/37,17.57%,ACVR1;SOX11;TGFBR2;DAND5;ZFPM2;GATA3;MDM4;BMPR1A;CITED2;APLNR;HEYL
prerank,nucleotide-excision repair (GO:0006289),0.24100196017409614,0.7447616474286793,0.8689581095596133,1.0,1.0,21/101,19.82%,RAD23B;HMGN1;GTF2H2;ERCC5;ERCC4;POLR2B;DDB2;RPA3;XPA;POLR2K;FANCC;DDB1;RPA2;POLR2G;UBB;TP53;RNF111;CUL4B;POLR2A;LIG3;COPS6
prerank,nucleoside diphosphate metabolic process (GO:0009132),-0.2682644543148381,-0.7447532578696422,0.8039867109634552,0.9533003577186082,1.0,8/15,28.37%,ENTPD1;ENTPD7;AK4;AK1;NME2;ENTPD3;ENTPD5;AK7
prerank,epithelial cell development (GO:0002064),-0.24545480723790086,-0.7436633014309876,0.835016835016835,0.9537219290917255,1.0,3/20,7.45%,WNT5B;RILPL1;SIPA1L3
prerank,positive regulation of translation (GO:0045727),0.2481830435579208,0.7432805279686023,0.8642241379310345,1.0,1.0,12/94,9.18%,ERBB2;UPF3A;PLD1;NIBAN1;NGRN;METTL3;EIF3C;EIF2B5;CPEB3;EIF6;NSUN5;PASK
prerank,cellular response to light stimulus (GO:0071482),0.25466490011831733,0.7429190778164235,0.8532423208191127,1.0,1.0,6/66,6.89%,MYC;RHO;NSMCE3;ERCC4;METTL3;BMF
prerank,T cell activation (GO:0042110),0.25332214802269676,0.7420867062837853,0.8523489932885906,1.0,1.0,11/69,17.76%,PTPN22;PTPN2;PPP3CB;PPP3CA;NHEJ1;RHOH;SCRIB;GATA3;NCK1;CD74;MDK
prerank,regulation of mitotic sister chromatid separation (GO:0010965),0.3261932550073947,0.7418852990712492,0.7674418604651163,1.0,1.0,5/15,23.62%,ANAPC7;CDC23;CDC27;PTTG1;CDC16
prerank,positive regulation of T cell proliferation (GO:0042102),0.2606450762781725,0.7411791082109567,0.8433874709976799,1.0,1.0,6/55,13.99%,PYCARD;FADD;CCR2;IL18;IL6ST;NCK1
prerank,T cell proliferation (GO:0042098),0.3334205597870661,0.7409970698900975,0.786910197869102,1.0,1.0,2/13,8.17%,PPP3CB;CADM1
prerank,regulation of cell communication by electrical coupling involved in cardiac conduction (GO:1901844),0.3420163343928897,0.7407113258494006,0.7553516819571865,1.0,1.0,4/12,22.65%,PDE4D;CALM1;CALM2;CAMK2D
prerank,monoacylglycerol metabolic process (GO:0046462),-0.2753827766688778,-0.740631320319408,0.8301282051282052,0.9566440223053623,1.0,6/13,31.04%,PLA2G4A;MGLL;ABHD12;FAAH;DGAT1;AWAT2
prerank,spindle assembly (GO:0051225),0.2549281795172445,0.7396562410995235,0.8759864712514093,1.0,1.0,15/67,20.15%,HAUS3;STARD9;ARHGEF10;STAG2;FLNA;TUBGCP5;RCC1;CLASP1;NEK7;KPNB1;AAAS;CEP63;MAPRE3;KIF2A;BCCIP
prerank,regulation of calcium ion-dependent exocytosis (GO:0017158),-0.22102845598195583,-0.7395707220462521,0.8863636363636364,0.9569259553228777,1.0,7/31,12.58%,SYT9;STXBP1;CACNA1G;ADRA2A;SYT10;KCNB1;SYT6
prerank,protein depolymerization (GO:0051261),-0.22759015770025243,-0.7390441481211019,0.868,0.9564391135679678,1.0,7/27,16.60%,NCKAP5;MICAL3;MICAL2;NCKAP5L;DSTN;KIF18A;VPS4B
prerank,protein-containing complex disassembly (GO:0032984),0.26102820896696477,0.7386194832655394,0.8399044205495818,1.0,1.0,15/54,22.80%,MYC;VPS33A;LIX1;SNAP29;PPP1CA;DVL1;CSNK1A1;GABARAPL2;STX17;SNX14;LAMP2;PYM1;DVL3;VPS16;UBQLN1
prerank,DNA dealkylation (GO:0035510),0.3510452644015044,0.7384546537011502,0.7880184331797235,1.0,1.0,2/10,9.78%,MPG;ALKBH5
prerank,DNA dealkylation involved in DNA repair (GO:0006307),0.3510452644015044,0.7384546537011502,0.7880184331797235,1.0,1.0,2/10,9.78%,MPG;ALKBH5
prerank,positive regulation of actin filament bundle assembly (GO:0032233),0.2658494167843203,0.7383884406613297,0.831603229527105,1.0,1.0,15/51,21.50%,LPAR1;GPR65;ARHGEF10;PAK1;LIMK1;NF2;ARHGEF10L;RHOC;MYOC;ABL1;TGFB3;PPM1E;TESK1;CCDC88A;PXN
prerank,regulation of plasminogen activation (GO:0010755),0.3392026525150602,0.7381980480650404,0.7884322678843226,1.0,1.0,3/12,15.48%,SERPINE2;PLGRKT;RUNX1
prerank,positive regulation of signal transduction by p53 class mediator (GO:1901798),0.3001982831755721,0.7379880015068191,0.7807848443843031,1.0,1.0,5/22,15.47%,SPRED2;SPRED1;SPRED3;UBB;ATM
prerank,tRNA processing (GO:0008033),-0.18634479086794875,-0.7379583251159766,0.9659863945578231,0.9567231561555531,1.0,21/61,22.85%,TRMT9B;FTSJ1;SARS1;URM1;TSEN15;METTL1;AARS1;KARS1;TYW5;PUS3;WDR4;ZBTB8OS;TRMT10A;CDKAL1;CPSF4;POP5;QTRT2;TRNT1;CLP1;NSUN6;ANKRD16
prerank,maintenance of protein localization in organelle (GO:0072595),0.31121849794941064,0.7377707606863594,0.7932489451476793,1.0,1.0,9/19,26.22%,ARL2;HNRNPU;HK2;TAF8;BCL3;HK1;BBS4;TOPORS;TAPT1
prerank,regulation of phosphatidylinositol 3-kinase activity (GO:0043551),0.2780921279732109,0.7376610329590672,0.8131188118811881,1.0,1.0,3/34,4.08%,PDGFRA;FGF2;TGFB1
prerank,regulation of TORC1 signaling (GO:1903432),-0.21873384137839122,-0.7376519674234583,0.9086538461538461,0.9560228003991841,1.0,13/33,26.40%,SIK3;RRAGC;FLCN;SESN2;LARS1;PIP4P1;SMCR8;KPTN;GPR137;RRAGB;CASTOR1;SZT2;STK11
prerank,sodium ion homeostasis (GO:0055078),0.3046995359139599,0.7375519050074504,0.7940379403794038,1.0,1.0,4/21,17.45%,SLC12A3;SLC12A2;NEDD4L;SLC9A1
prerank,nuclear membrane reassembly (GO:0031468),0.2594315671108556,0.7373329622530198,0.8613744075829384,1.0,1.0,28/54,31.22%,NUP155;PPP2R2A;RCC1;NUP205;NDC1;NUP160;EMD;KPNB1;SUMO1;LMNA;CHMP4C;POM121;AHCTF1;PPP2R1A;REEP3;IST1;NUP35;UBE2I;CHMP4A;CHMP4B;SPAST;VRK1;SIRT2;CC2D1B;SEC13;ANKLE2;NUP85;RANGAP1
prerank,cGMP biosynthetic process (GO:0006182),0.3508994590094202,0.7371717727985386,0.7696,1.0,1.0,1/10,3.33%,NPR2
prerank,cellular defense response (GO:0006968),-0.20038688202175992,-0.7370163913034667,0.9187817258883249,0.9558071912907798,1.0,7/40,15.38%,CCR9;DCDC2;LSP1;BECN1;ADORA2A;LGALS3BP;PTK2B
prerank,leukotriene biosynthetic process (GO:0019370),0.32741227441714704,0.7369717579362506,0.7813411078717201,1.0,1.0,3/14,13.16%,LTA4H;ALOX5AP;GGTA1
prerank,regulation of Notch signaling pathway (GO:0008593),0.2519159839872136,0.7368372884220763,0.8622620380739082,1.0,1.0,11/76,16.26%,MAML3;KAT2B;EGFR;MAML2;FBXW7;METTL3;ZMIZ1;IL6ST;RFNG;TM2D3;SREBF2
prerank,histone exchange (GO:0043486),0.27271409335578606,0.7366433946239165,0.8247549019607843,1.0,1.0,11/37,22.39%,VPS72;ANP32E;HJURP;OIP5;RBBP4;ITGB3BP;NASP;CENPL;CENPC;RBBP7;CENPU
prerank,T cell receptor signaling pathway (GO:0050852),0.23798607377905281,0.7366318838457352,0.9031578947368422,1.0,1.0,29/138,22.71%,PRKCQ;PTPN22;TEC;PDE4B;PAK1;CSK;EIF2B5;FYN;PSMB7;PIK3R1;PTPRJ;PDE4D;GATA3;MALT1;NCK1;PSMD2;PSMC1;PSMB2;EIF2B2;RC3H1;CHUK;PSMD9;PSME4;BCL10;PSMA8;NFKB1;PRKD2;CARD11;TAB2
prerank,pigment granule transport (GO:0051904),0.3140274036635483,0.7360130353902272,0.8005698005698005,1.0,1.0,7/18,25.46%,BBS5;MREG;BBS7;MYO5A;BLOC1S6;BBS4;RAB27B
prerank,melanosome transport (GO:0032402),0.3140274036635483,0.7360130353902272,0.8005698005698005,1.0,1.0,7/18,25.46%,BBS5;MREG;BBS7;MYO5A;BLOC1S6;BBS4;RAB27B
prerank,positive regulation of epidermal cell differentiation (GO:0045606),0.3202317451289881,0.7359002775525353,0.8034934497816594,1.0,1.0,2/15,10.31%,ETV4;SFRP4
prerank,regulation of protein sumoylation (GO:0033233),0.31885339918982625,0.7357735207976109,0.7903682719546742,1.0,1.0,7/17,25.95%,UBA2;ZMIZ1;PARK7;EGR1;GNL3L;GNL3;SAE1
prerank,positive regulation of striated muscle cell differentiation (GO:0051155),-0.2318294525257567,-0.7357624784354712,0.85,0.9562501878684625,1.0,6/23,19.18%,IGF1;MAML1;PROX1;ATP11A;EDN1;MYOCD
prerank,signal transduction in response to DNA damage (GO:0042770),-0.19508255139645259,-0.7356437972652504,0.9315068493150684,0.9553235874703717,1.0,24/49,32.86%,MAP3K20;ACER2;CLOCK;NDRG1;DOT1L;SESN2;HUS1;BID;CLSPN;PAXIP1;DONSON;ERCC6;NBN;E2F1;MAD2L2;CASP9;RAD9A;CHEK2;CHEK1;GADD45A;PRPF19;E2F7;TRIAP1;ATRIP
prerank,negative regulation of proteolysis involved in cellular protein catabolic process (GO:1903051),-0.22493681097820215,-0.7355842384422571,0.8755364806866953,0.9543315316564569,1.0,6/25,19.84%,EPHA4;RPL5;RPL11;PML;HSP90AB1;HFE
prerank,negative regulation of B cell proliferation (GO:0030889),-0.2916954796964266,-0.7355329632739568,0.8062678062678063,0.953320466477478,1.0,4/11,25.57%,LYN;CD300A;TNFRSF21;TYROBP
prerank,positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081),0.3227041085484051,0.7352475344987255,0.8058394160583942,1.0,1.0,5/14,19.55%,GPRC5B;WNT5A;TICAM1;CD74;BCL10
prerank,leukocyte adhesion to vascular endothelial cell (GO:0061756),-0.2498691839079098,-0.7350868759864739,0.8561643835616438,0.9528707449483121,1.0,4/18,20.30%,ROCK1;SLC39A8;VCAM1;ADD2
prerank,regulation of lipoprotein lipase activity (GO:0051004),0.3128417423995515,0.7349442895461369,0.8042553191489362,1.0,1.0,4/17,21.04%,PCSK6;LMF1;LIPC;FURIN
prerank,"antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO:0002479)",-0.18406309687055286,-0.7348185033044604,0.9635036496350365,0.9521328357995138,1.0,20/67,23.98%,ITGB5;PSMD14;TAPBP;PSMB3;PSMD12;CYBA;PSMD6;PSMA1;PSMD7;PSMA5;PSMC5;IKBKB;IKBKG;PSMC4;PSMB6;PSMA4;VAMP8;CALR;PSMB1;PSMB9
prerank,regulation of glycolytic process (GO:0006110),0.24939468789703487,0.7345434656788646,0.8720538720538721,1.0,1.0,11/68,11.28%,ZBTB20;PSEN1;RANBP2;NUP155;MLXIPL;CBFA2T3;EIF6;HIF1A;NUP205;NDC1;NUP160
prerank,long-term memory (GO:0007616),0.3025072259667103,0.733901880588613,0.8149171270718232,1.0,1.0,6/19,25.34%,PRNP;CPEB3;SGK1;PJA2;NFATC4;SHANK1
prerank,non-canonical Wnt signaling pathway (GO:0035567),0.2388119977425061,0.7338710369420032,0.8960763520678685,1.0,1.0,16/124,15.53%,ROR2;FRZB;PLCB1;WNT5A;PPP3CB;FZD7;PPP3CA;PRICKLE2;PSMB7;SFRP4;PRICKLE1;DVL1;CALM1;PSMD2;PSMC1;FZD9
prerank,modification-dependent protein catabolic process (GO:0019941),0.232560936713287,0.7334230973950958,0.9312114989733059,1.0,1.0,57/193,23.62%,PRKN;HACE1;SPSB4;RNF6;FBXO7;UBE2K;CUL3;HERPUD1;ANAPC7;FBXO45;CBL;USP33;TOLLIP;ANAPC2;PCYOX1L;MYLIP;DDB1;NDFIP1;NEDD8;BUB1B;NEDD4L;UBB;AREL1;RNF19A;RCHY1;CDC23;RNF111;FBXL4;ANAPC16;MIB1;RC3H1;RNF167;UBA1;FBXO22;MDM2;ELOC;PSMD9;TAF1;FBXO11;UBE2L3;CDC27;UBE2G1;RNF13;UBE2E1;PTTG1;ANAPC4;WDR81;RNF114;UBQLN4;TTC3;UBR3;ANAPC5;UBQLN1;SIAH1;UBQLN2;UBE3C;CDC16
prerank,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902230),0.2901535294562284,0.7333724981277984,0.8155737704918032,1.0,1.0,3/24,11.05%,BCL2;ACKR3;TAF9
prerank,regulation of ERAD pathway (GO:1904292),-0.29241572082365636,-0.7333350283109406,0.8109756097560976,0.9529729245575878,1.0,4/11,12.56%,USP19;RNF185;AQP11;TMEM259
prerank,ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway (GO:0043162),0.3024201296666007,0.7333186234404689,0.7870879120879121,1.0,1.0,5/22,15.09%,MVB12B;VPS37B;VPS36;MVB12A;PLAA
prerank,triglyceride metabolic process (GO:0006641),0.2663826992633446,0.7331946225700947,0.8506024096385543,1.0,1.0,7/48,17.71%,AGMO;LMF1;MOGAT3;PLAAT3;LIPC;GPAT3;GPAT4
prerank,regulation of protein transport (GO:0051223),0.28575454861733746,0.7331098126515492,0.820615796519411,0.99998745139245,1.0,9/27,22.49%,PTPN1;STXBP5;NDFIP1;SNX12;DNAJA1;ARFIP1;DISP1;LLGL1;P3H1
prerank,ncRNA 3'-end processing (GO:0043628),0.325141646086352,0.7328266812870736,0.7844827586206896,0.9999335824964736,1.0,4/14,17.36%,INTS6;INTS2;INTS8;SSB
prerank,negative regulation of programmed necrotic cell death (GO:0062099),-0.2948975469873863,-0.7322661147516396,0.8038674033149171,0.9531880173469979,1.0,3/11,9.08%,BIRC3;NUPR1;CASP8
prerank,regulation of protein secretion (GO:0050708),0.23953571962179215,0.7320714986551291,0.8970276008492569,1.0,1.0,15/119,12.69%,PRKCA;CACNA1E;FRMD4A;CACNA1A;TGFB1;SLC12A2;RFX3;PPP3CB;RAP1A;ENSA;PPID;TMED10;SLC2A2;STXBP5;DRD2
prerank,nucleus organization (GO:0006997),0.25936275478214504,0.7320595706814096,0.8557457212713936,1.0,1.0,10/47,19.67%,SPAG4;PITPNB;NUP155;BIN1;NUP205;NDC1;PDCD6IP;CHMP4C;ATXN7;CHMP1B
prerank,B cell receptor signaling pathway (GO:0050853),0.27743013719777926,0.7316582222773396,0.8079896907216495,1.0,1.0,9/32,26.09%,BCL2;TEC;VAV3;LAT2;MS4A1;CD38;PLEKHA1;NFAM1;SYK
prerank,telomere maintenance via telomere lengthening (GO:0010833),-0.21412222703759437,-0.7309337137741354,0.9078947368421053,0.9538063951820208,1.0,12/33,18.97%,TERF2;RFC1;DKC1;WRAP53;HSP90AA1;CDK2;TERT;PINX1;DCLRE1B;GAR1;HSP90AB1;TINF2
prerank,regulation of cytokine production involved in immune response (GO:0002718),0.29816835375980705,0.7304075530118087,0.810958904109589,1.0,1.0,2/22,5.52%,CCR2;WNT5A
prerank,regulation of TOR signaling (GO:0032006),0.2525357168929789,0.7303340955442763,0.8772935779816514,1.0,1.0,8/67,9.87%,MIOS;NPRL2;ARAF;DEPTOR;TSC1;LAMTOR2;TBCK;PIH1D1
prerank,intracellular protein transmembrane transport (GO:0065002),0.26722390835590665,0.7299249061314793,0.821831869510665,1.0,1.0,9/42,18.30%,ZFAND2B;C2CD5;TOMM20;SEC61G;SEC63;DNAJC19;PAM16;AIFM1;PEX1
prerank,RNA modification (GO:0009451),0.2562986579820496,0.72958558153321,0.8485915492957746,1.0,1.0,15/54,23.38%,DTWD1;NOP2;METTL3;NSUN5;DTWD2;ADARB1;PUS7;ELP5;MEPCE;SSB;TRIT1;NSUN2;LCMT2;ALKBH1;TRMT1
prerank,regulation of telomere maintenance via telomerase (GO:0032210),0.25947673807340144,0.7294597199118882,0.8505882352941176,1.0,1.0,16/51,25.05%,PRKCQ;CCT7;STN1;MAPK1;NEK7;MAP3K4;ATM;SMG6;HNRNPU;HNRNPC;CTC1;GNL3L;ACD;ATR;TCP1;PKIB
prerank,receptor catabolic process (GO:0032801),-0.2356686945238935,-0.7292949241180607,0.8726591760299626,0.954695165017093,1.0,6/24,16.17%,ZNRF3;BECN1;LGMN;UVRAG;RNF43;CLTA
prerank,response to exogenous dsRNA (GO:0043330),0.30846418239910095,0.7292592505025169,0.7988668555240793,1.0,1.0,4/18,15.21%,IRAK3;RALB;TICAM1;CGAS
prerank,exonucleolytic catabolism of deadenylated mRNA (GO:0043928),0.2852475053477232,0.7291330259452594,0.8368700265251989,1.0,1.0,6/29,15.90%,EXOSC8;DCP1B;EXOSC2;EDC4;LSM3;NT5C3B
prerank,telomere maintenance in response to DNA damage (GO:0043247),-0.2940560372489985,-0.7286593293408836,0.8210526315789474,0.9544254194877841,1.0,2/10,6.15%,RIF1;TERF2
prerank,organophosphate biosynthetic process (GO:0090407),0.27552539603911375,0.7285620793821442,0.83729662077597,1.0,1.0,6/37,17.75%,FGF2;PNPO;GPHN;AGPAT5;NFS1;PIP5K1A
prerank,ribonucleoprotein complex assembly (GO:0022618),0.23652404391128434,0.7283884700012063,0.9208333333333333,1.0,1.0,27/132,18.60%,CELF5;CPSF6;RPL23A;NOP2;BRIX1;LUC7L2;SHQ1;EIF6;TXNL4A;NCBP1;TGS1;CLNS1A;PRPF6;PRPF18;CELF6;SRSF6;YTHDC1;TRAF7;LUC7L;RPS27L;CDC73;SF1;GEMIN7;BOP1;SART1;DDX23;RPSA
prerank,negative regulation of microtubule polymerization or depolymerization (GO:0031111),0.2780838778767721,0.728132697348722,0.8284993694829761,1.0,1.0,9/32,18.72%,FGF13;CLASP1;FKBP4;APC2;KATNB1;SNCA;NAV3;ATXN7;CAMSAP1
prerank,hexose transmembrane transport (GO:0008645),0.2987944798067461,0.7280645426919875,0.8048780487804879,1.0,1.0,3/21,10.56%,SLC5A3;SLC50A1;SLC2A2
prerank,central nervous system neuron differentiation (GO:0021953),0.2819628459036352,0.7280100097171096,0.8230088495575221,0.9998577258854929,1.0,5/33,11.42%,NTRK2;GBA2;GRID2;MDGA2;OPHN1
prerank,apoptotic nuclear changes (GO:0030262),-0.23143551978664906,-0.7279558114866712,0.8769230769230769,0.9541958973069044,1.0,11/24,29.90%,ACIN1;DFFA;H1-0;DNASE2;DEDD2;GPER1;HMGB2;CASP3;FOXL2;DICER1;CECR2
prerank,positive regulation of glial cell differentiation (GO:0045687),0.3114190465586505,0.7279129914971108,0.7890173410404624,0.9995403413433542,1.0,5/17,17.76%,TGFB1;BIN1;SERPINE2;PTPRZ1;MDK
prerank,amide biosynthetic process (GO:0043604),0.2562451876873304,0.7277167216202303,0.8488095238095238,0.9993622433505757,1.0,9/47,21.04%,SLC25A2;CERS3;CERS6;SPTSSA;SLC25A15;SGMS2;AGK;CERS2;FURIN
prerank,synaptonemal complex organization (GO:0070193),0.3232182923176388,0.7270281607360173,0.779788838612368,0.9993985762320582,1.0,3/15,22.24%,TEX11;SYCE2;SYCP2
prerank,synaptonemal complex assembly (GO:0007130),0.3232182923176388,0.7270281607360173,0.779788838612368,0.9993985762320582,1.0,3/15,22.24%,TEX11;SYCE2;SYCP2
prerank,C4-dicarboxylate transport (GO:0015740),0.320241525956408,0.7266846313140328,0.7960426179604262,0.9993987918950739,1.0,6/14,28.85%,LRRC8D;SLC25A10;SLC25A11;SLC1A6;SLC1A2;SLC25A13
prerank,telomere maintenance via telomere trimming (GO:0090737),0.3513935331264333,0.7262425683586079,0.794435857805255,0.9986741161989607,1.0,4/10,25.08%,XRCC3;BLM;WRN;SLX4
prerank,formation of extrachromosomal circular DNA (GO:0001325),0.3513935331264333,0.7262425683586079,0.794435857805255,0.9986741161989607,1.0,4/10,25.08%,XRCC3;BLM;WRN;SLX4
prerank,t-circle formation (GO:0090656),0.3513935331264333,0.7262425683586079,0.794435857805255,0.9986741161989607,1.0,4/10,25.08%,XRCC3;BLM;WRN;SLX4
prerank,positive regulation of response to endoplasmic reticulum stress (GO:1905898),0.3095204096610998,0.7262214441492532,0.8016194331983806,0.9982726011271207,1.0,5/18,20.32%,RNFT1;PIK3R1;NCK1;BCL2L11;USP13
prerank,cardiac muscle cell membrane repolarization (GO:0099622),0.3393676080226273,0.726067635433903,0.7964071856287425,0.9980390858086354,1.0,3/11,16.10%,KCND3;KCNJ3;KCNH2
prerank,positive regulation of protein binding (GO:0032092),0.2526818866654015,0.7257709583670683,0.8711943793911007,0.9980132732277698,1.0,10/56,15.54%,PRKN;LRP1;PSEN1;RALB;MEN1;USP33;AKTIP;PKD1;DACT1;ABL1
prerank,nucleobase-containing small molecule interconversion (GO:0015949),0.28716172289656355,0.7256409756505245,0.8257978723404256,0.9977526374542197,1.0,9/27,23.17%,DTYMK;AK5;AK6;AK2;TXNRD1;CTPS2;AK8;GLRX;CMPK1
prerank,peptidyl-serine dephosphorylation (GO:0070262),0.32642229151916446,0.7255622786783178,0.7938461538461539,0.9974299045729761,1.0,4/14,13.99%,PPP3CA;PPP2R2A;PPP1CA;NCK1
prerank,protein sumoylation (GO:0016925),0.25879785139761957,0.7252313467920495,0.861904761904762,0.997407294524571,1.0,10/49,16.73%,RANBP2;UBA2;NUP155;PIAS2;NUP205;NDC1;NUP160;SUMO1;POM121;AAAS
prerank,positive regulation of lipid transport (GO:0032370),0.32968335482579075,0.7247457550074015,0.7784522003034902,0.9975943391676002,1.0,1/12,2.55%,LRP1
prerank,sulfation (GO:0051923),-0.29398962399542294,-0.7245132415489625,0.8091168091168092,0.9573186903693467,1.0,5/11,44.32%,UST;SULT4A1;CHST5;SULT2B1;SULT6B1
prerank,L-alpha-amino acid transmembrane transport (GO:1902475),0.2883531738679293,0.7243957841040405,0.828,0.997612757007543,1.0,5/27,12.94%,SLC1A3;SLC25A38;ARL6IP5;SLC7A8;PRAF2
prerank,cellular iron ion homeostasis (GO:0006879),0.2562914761679109,0.7243213744029467,0.8657407407407407,0.9972761223126642,1.0,3/55,5.56%,SCARA5;MYC;CYBRD1
prerank,DNA integrity checkpoint signaling (GO:0031570),-0.20435384470652365,-0.7243197625925691,0.9333333333333333,0.9564934455618274,1.0,18/36,32.86%,MAP3K20;CLOCK;DOT1L;HUS1;CLSPN;DONSON;ERCC6;DNA2;NBN;TIMELESS;E2F1;RAD9B;RAD9A;CDC45;CHEK2;CHEK1;PRPF19;ATRIP
prerank,peptidyl-tyrosine autophosphorylation (GO:0038083),0.3243127733645244,0.7242653844917766,0.7858197932053176,0.9969157309309317,1.0,2/15,4.19%,EGFR;TEC
prerank,negative regulation of GTPase activity (GO:0034260),0.2921979742163856,0.7239021098219045,0.8201634877384196,0.9969638392696595,1.0,5/22,19.14%,ARL2;TMED2;ARFGEF1;FICD;RDX
prerank,regulation of receptor internalization (GO:0002090),0.2725817488343081,0.723562409198206,0.8485639686684073,0.9970094209428139,1.0,9/35,22.42%,VEGFA;ATXN2;MKLN1;SFRP4;MAGI2;SCYL2;CD63;ARRB2;DLG4
prerank,translesion synthesis (GO:0019985),0.26575089753274544,0.7228359215260843,0.8555691554467564,0.9975236689816941,1.0,9/42,17.26%,POLN;POLE2;REV3L;RPA3;ZBTB1;RPA2;UBB;RCHY1;REV1
prerank,regulation of cellular amide metabolic process (GO:0034248),0.274275330842061,0.7226879838249712,0.8375634517766497,0.9972954012991994,1.0,7/32,14.94%,ATXN2;TSC1;TMED10;GRM5;DDX25;RBM4B;CYFIP1
prerank,regulation of hematopoietic stem cell differentiation (GO:1902036),0.2468929877913226,0.7226220649266395,0.8600682593856656,0.996953149255951,1.0,14/70,20.75%,CBFB;KMT2A;METTL3;PSMB7;GATA3;PUS7;PSMD2;PSMC1;RUNX1;ABL1;PSMB2;PSMD9;PSME4;PSMA8
prerank,cellular response to hydrogen peroxide (GO:0070301),0.2734340149562347,0.7225937350537702,0.8455696202531645,0.9965723197418582,1.0,10/33,20.81%,MAPK7;CYP1B1;NFE2L2;HDAC6;ABL1;PAX2;RIPK1;PARK7;OSER1;SIRPA
prerank,TRIF-dependent toll-like receptor signaling pathway (GO:0035666),0.27822349539439406,0.7225090124764783,0.8230668414154653,0.9962492708855306,1.0,7/29,18.16%,FADD;TBK1;TICAM1;UBB;RIPK1;CHUK;IRF3
prerank,positive regulation of voltage-gated potassium channel activity (GO:1903818),0.3319046331633699,0.7223128544795342,0.7923076923076923,0.9960558191112746,1.0,3/11,21.48%,AKAP6;NOS1AP;LRRC55
prerank,"protein localization to chromosome, telomeric region (GO:0070198)",-0.2657521783182201,-0.7222116983334383,0.8376811594202899,0.9579308723202393,1.0,5/14,18.97%,TERF2;BRCA2;TERT;PINX1;TINF2
prerank,ncRNA processing (GO:0034470),0.2285568983590712,0.7221560757144273,0.9393326592517695,0.9958348627139981,1.0,37/200,17.36%,WDR55;C1D;INTS11;WDR36;SENP3;RPL23A;METTL3;NOB1;XRN2;NOL8;INTS6;BMS1;TUT4;EXOSC8;MRTO4;DDX54;UTP6;HEATR1;FARS2;PIH1D1;EXOSC2;INTS4;RCL1;FBL;EBNA1BP2;INTS2;HELQ;INTS8;WDR46;TEX10;DDX10;DDX27;NOP56;NOC4L;POP1;RPP21;SSB
prerank,cellular response to amino acid starvation (GO:0034198),0.2466384519158657,0.7211630876501769,0.8891352549889135,0.996656856168126,1.0,26/71,27.43%,MIOS;NPRL2;EIF2AK3;ATP6V1B2;LAMTOR2;CASTOR2;ATF2;MAPK1;GCN1;ATP6V1C1;RPTOR;RRAGA;ATP6V0E2;DEPDC5;ATP6V0E1;CEBPB;MTOR;ATP6V1G2;SESN1;ITFG2;EIF2AK2;SLC38A9;ATP6V1H;CDKN1A;TCIRG1;ATP6V1D
prerank,posttranscriptional regulation of gene expression (GO:0010608),0.26122087375523767,0.7210576435553936,0.8462455303933254,0.9963561932603345,1.0,10/45,17.21%,ATXN2;TSC1;GRM5;DDX25;PER1;SPOUT1;RBM4B;YTHDC1;CYFIP1;RC3H1
prerank,myeloid cell activation involved in immune response (GO:0002275),0.3070637294616855,0.7209584660853962,0.8091922005571031,0.9960652738695941,1.0,1/18,1.40%,PYCARD
prerank,multivesicular body assembly (GO:0036258),-0.21255617927992282,-0.720859758842557,0.8914027149321267,0.9584208524531453,1.0,5/30,9.91%,CHMP3;TSG101;VPS37C;VPS4A;CHMP1A
prerank,response to amino acid starvation (GO:1990928),0.24572866678063437,0.7207242408696526,0.8807947019867549,0.9959621913685144,1.0,26/72,27.43%,MIOS;NPRL2;EIF2AK3;ATP6V1B2;LAMTOR2;CASTOR2;ATF2;MAPK1;GCN1;ATP6V1C1;RPTOR;RRAGA;ATP6V0E2;DEPDC5;ATP6V0E1;CEBPB;MTOR;ATP6V1G2;SESN1;ITFG2;EIF2AK2;SLC38A9;ATP6V1H;CDKN1A;TCIRG1;ATP6V1D
prerank,regulation of cell division (GO:0051302),0.24571236699829996,0.7207216687993755,0.8756936736958935,0.9955385783958576,1.0,11/72,17.40%,EFHC1;MYC;INSC;KLHL13;SETD2;MYO19;RAB11FIP3;CALM1;CALM2;BLM;NCOA3
prerank,cellular response to interleukin-6 (GO:0071354),0.2822274395610379,0.7204532137260456,0.8275401069518716,0.9954423995644744,1.0,8/26,21.17%,PTPRT;CBL;PTPN11;IL6ST;PID1;SELPLG;STAT3;NFKB1
prerank,regulation of B cell differentiation (GO:0045577),-0.2521886092035247,-0.7196923804803491,0.8807947019867549,0.9586487012597588,1.0,4/17,13.29%,ZFP36L1;ID2;NCKAP1L;INHBA
prerank,positive regulation of cytokine production involved in inflammatory response (GO:1900017),0.3196332454736393,0.7193443024092718,0.791907514450867,0.9964333344555821,1.0,4/15,19.76%,CARD9;HIF1A;TICAM1;STAT3
prerank,stress granule assembly (GO:0034063),0.29870725326403214,0.719299769710356,0.8146143437077131,0.9960676835405097,1.0,8/20,25.84%,BICD1;ATXN2;UBAP2L;CSDE1;DDX6;DYNC1H1;CIRBP;YTHDF3
prerank,negative regulation of phagocytosis (GO:0050765),-0.2534330140817639,-0.7192756271872951,0.8597014925373134,0.958016284775683,1.0,4/17,17.74%,PLSCR1;RACK1;CD300A;APPL1
prerank,phosphatidylcholine catabolic process (GO:0034638),0.34416755698091017,0.7188062143889833,0.789308176100629,0.9962523906798841,1.0,3/10,15.20%,PLA2G7;PNPLA8;LIPC
prerank,calcium ion transport (GO:0006816),0.23373687428632245,0.7173258482658672,0.912906610703043,0.9977059903383589,1.0,11/113,9.38%,CACNA1E;CACNA2D1;ANK2;CACNG7;ANO6;CACNA1A;CHRNA4;PSEN1;SLC8A2;FYN;SLC24A5
prerank,membrane raft organization (GO:0031579),-0.2538171768379558,-0.7169204066821729,0.8691275167785235,0.9596250553045133,1.0,8/15,31.82%,RFTN1;FLOT1;ABCA7;NAXE;S100A10;YJEFN3;PPT1;MYADM
prerank,DNA synthesis involved in DNA repair (GO:0000731),-0.19482376166252907,-0.7168221636089707,0.9175824175824175,0.9586885937224664,1.0,20/42,31.35%,POLD3;TRIM25;PRIMPOL;PARP10;RFC1;POLH;POLA1;PCNA;POLK;ISG15;FAAP20;RFC3;UBA52;USP43;POLD2;VCP;PCLAF;POLE;POLD4;POLD1
prerank,maturation of 5.8S rRNA (GO:0000460),-0.2525813532477254,-0.7166729522829018,0.8741007194244604,0.9578118153028118,1.0,5/17,15.66%,NSA2;URB1;MAK16;LAS1L;EXOSC10
prerank,determination of bilateral symmetry (GO:0009855),-0.22718316884492729,-0.7161749275585688,0.8971631205673759,0.9572822965611247,1.0,11/24,34.70%,KIF3B;TBX1;ZIC3;DNAH11;DNAH5;STIL;NPHP3;CFAP53;DLL1;ODAD2;ODAD3
prerank,histone methylation (GO:0016571),0.27942271460764245,0.7160873421103809,0.8333333333333334,0.9988714368704978,1.0,5/26,12.65%,SUV39H1;CARM1;FBL;PRMT1;TRMT112
prerank,positive regulation of isotype switching (GO:0045830),-0.2512343235184133,-0.7158242351909875,0.8459119496855346,0.9566218349223594,1.0,7/15,26.84%,RIF1;TFRC;PAXIP1;CD40;MAD2L2;CLCF1;TNFSF13
prerank,neuron projection organization (GO:0106027),0.31388873654746763,0.7157981654854019,0.8168389955686853,0.9988085986146944,1.0,2/15,4.80%,PSEN1;PRNP
prerank,sensory perception of taste (GO:0050909),-0.2934039622540469,-0.7157447400805297,0.8474114441416893,0.9556671304674517,1.0,8/10,50.77%,PKD2L1;PKD1L3;ASIC1;CD36;ASIC3;TAS1R1;TAS1R2;GNAT3
prerank,mitochondrion morphogenesis (GO:0070584),0.33052895924912934,0.7155092523812798,0.8030534351145038,0.9987458138382577,1.0,5/11,24.43%,PID1;WASF1;PNPT1;MTM1;SUPV3L1
prerank,peptidyl-methionine modification (GO:0018206),-0.2825910076331109,-0.7152981752918913,0.8409785932721713,0.9551014319854906,1.0,2/12,5.31%,NAA25;NAA30
prerank,positive regulation of cytokinesis (GO:0032467),0.2708314660816624,0.7151116452775987,0.8473091364205256,0.9988255358400044,1.0,8/32,20.27%,KIF20B;CUL3;CDC25B;DRD2;CDC14A;CENPV;PKN2;SVIL
prerank,nucleoside phosphate biosynthetic process (GO:1901293),-0.2646806270238125,-0.7151039871511817,0.8246153846153846,0.9542699696978822,1.0,6/14,22.04%,NMNAT2;ME1;NMNAT1;AK4;AK1;NME2
prerank,phospholipid biosynthetic process (GO:0008654),0.2705241735932097,0.7144434660546852,0.8431618569636136,0.9992334731636751,1.0,12/36,21.53%,IDI1;FAR1;AGPAT5;SGMS2;PIP5K1A;CPNE7;AGK;DPAGT1;CPNE1;DHDDS;CPNE3;FDPS
prerank,monocarboxylic acid biosynthetic process (GO:0072330),0.25064577181249353,0.7141450544404563,0.8763005780346821,0.9991894561254224,1.0,11/59,18.76%,ACACA;OXSM;CYP39A1;ACLY;CYP7B1;SRR;CYP27A1;LIPC;ALDH1A3;OSBPL1A;PARK7
prerank,positive regulation of p38MAPK cascade (GO:1900745),0.2898455390019058,0.7136971671712167,0.8432203389830508,0.999302508494428,1.0,8/22,23.34%,VEGFA;NCF1;PRMT1;MAP3K4;RELL2;EMC10;PJA2;BMP2
prerank,"DNA-templated transcription, termination (GO:0006353)",0.24902700908083844,0.7136775855539967,0.8919226393629124,0.9989048152436216,1.0,19/68,24.99%,CSTF3;GTF2H2;TAF1A;POLR2K;NCBP1;FIP1L1;POLR1B;PAPOLA;POLR1C;POLR1G;POLR2A;UBTF;MTERF2;SYMPK;POLR3K;POLR2F;CCNH;TBP;CPSF7
prerank,"transcription, DNA-templated (GO:0006351)",0.22424472541546236,0.7133177254260734,0.9459734964322121,0.99892162301736,1.0,62/207,24.87%,CBFB;NFX1;GTF2H2;SNAPC2;MBD1;RNGTT;TAF1A;HOXD3;POLR2B;TAF5L;DRAP1;IVNS1ABP;GTF2B;TFAM;TRIP11;SOX5;POLR2K;NCBP1;TAF9;TAF11;TAF2;EPC1;KLF13;POLRMT;POLR2G;TAF7;RNMT;ELL;GTF3C1;GTF2E2;GTF2E1;TAF4;TP53;TAF4B;CDC73;NFIX;RNPS1;POLR1C;TCEA2;MLF1;ELOC;TAF1;POLR2A;MLLT1;UBTF;POLR3G;FUBP3;SSRP1;NFKB1;THRA;ARRB2;BCL3;ELOB;CDK9;SNAPC3;PKNOX1;POLR3K;MEF2A;POLR2F;CCNT2;CCNH;TBP
prerank,termination of RNA polymerase I transcription (GO:0006363),0.2737453647582033,0.7131910857204559,0.8472400513478819,0.9986415410709644,1.0,11/30,26.50%,GTF2H2;TAF1A;POLR2K;POLR1B;POLR1C;POLR1G;UBTF;POLR2F;CCNH;TBP;TTF1
prerank,MyD88-independent toll-like receptor signaling pathway (GO:0002756),0.27383833361302906,0.7129776063877915,0.8436268068331143,0.9984947223468407,1.0,7/30,18.16%,FADD;TBK1;TICAM1;UBB;RIPK1;CHUK;IRF3
prerank,positive regulation of DNA metabolic process (GO:0051054),0.2511553199495934,0.7123893651339565,0.8714121699196326,0.9988066698047583,1.0,9/61,14.20%,FGF2;MYC;FGF10;EGFR;ATRX;BRCA1;SIRT6;SMOC2;RTEL1
prerank,cardiocyte differentiation (GO:0035051),0.3446068039929535,0.7121150538835117,0.8180404354587869,0.9987306561083961,1.0,2/10,7.41%,AKAP13;GATA6
prerank,negative regulation of release of cytochrome c from mitochondria (GO:0090201),-0.26399478260887504,-0.7119718334505567,0.8580246913580247,0.956662793425936,1.0,7/15,25.54%,IGF1;GPX1;FXN;HGF;CLU;AKT1;PPIF
prerank,microtubule polymerization or depolymerization (GO:0031109),0.2854833919179285,0.711162227532531,0.8437086092715231,0.9995021277368836,1.0,4/24,13.07%,FGF13;STMN4;KATNB1;CKAP5
prerank,"mRNA cis splicing, via spliceosome (GO:0045292)",0.3166474476483412,0.710989625472409,0.8403954802259888,0.9993045248453803,1.0,6/16,23.15%,PSIP1;PRPF39;SART1;DDX23;SNRNP200;WBP4
prerank,response to cAMP (GO:0051591),-0.20291786593698935,-0.7108979409757519,0.9211822660098522,0.9568241309160186,1.0,4/37,7.01%,RAP1B;IGFBP5;ZFP36L1;SLC5A5
prerank,nuclear envelope organization (GO:0006998),0.2901883368769818,0.7106470250435736,0.829700272479564,0.9992974239435359,1.0,3/20,11.39%,SPAG4;NUP155;EMD
prerank,positive regulation of ruffle assembly (GO:1900029),0.3195188333546498,0.7105288548124081,0.8170914542728636,0.9990274026049161,1.0,3/13,13.84%,NLGN1;EPS8L1;P2RY12
prerank,negative regulation of interferon-gamma production (GO:0032689),-0.22584364667895818,-0.7100182852228153,0.896551724137931,0.9567542276271689,1.0,7/23,25.64%,TLR4;INHBA;RARA;HAVCR2;LAPTM5;NR1H4;INHA
prerank,mitochondrion localization (GO:0051646),-0.24101511431500283,-0.7091868792359158,0.8954248366013072,0.9565837254203525,1.0,6/19,23.12%,MARK1;TRAK1;MARK2;ATCAY;MSTO1;MUL1
prerank,positive regulation of cyclin-dependent protein kinase activity (GO:1904031),0.29866053548637084,0.7089706487727919,0.8241758241758241,1.0,1.0,7/20,23.70%,EGFR;TTBK1;PKD1;CCND2;MAPRE3;PKD2;CCNY
prerank,positive regulation of superoxide anion generation (GO:0032930),-0.26942674878723627,-0.708818593344867,0.8647798742138365,0.9559394879181288,1.0,3/13,12.50%,PRKCD;SOD1;MAPT
prerank,"RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394)",-0.2602056300542745,-0.7083271395767762,0.8877887788778878,0.9554286779916693,1.0,7/15,29.86%,TSEN15;ERN1;ZBTB8OS;CPSF4;CLP1;TRPT1;TSEN54
prerank,regulation of presynapse assembly (GO:1905606),0.2925366772166698,0.7081747383860418,0.8314447592067988,1.0,1.0,6/18,21.79%,IL1RAPL1;EIF4G1;GPC4;SNCA;LRFN5;IL1RAPL2
prerank,regulation of presynapse organization (GO:0099174),0.2925366772166698,0.7081747383860418,0.8314447592067988,1.0,1.0,6/18,21.79%,IL1RAPL1;EIF4G1;GPC4;SNCA;LRFN5;IL1RAPL2
prerank,regulation of cellular protein metabolic process (GO:0032268),0.2536993899928649,0.7080169297217792,0.8619447779111644,1.0,1.0,9/47,14.94%,TGFB1;ATXN2;TSC1;GRM5;EIF4G1;DDX25;RBM4B;SSH1;CYFIP1
prerank,positive regulation of cardiocyte differentiation (GO:1905209),0.3342403135888512,0.7078304641385327,0.7996870109546166,1.0,1.0,2/11,16.91%,TGFB1;EFNB2
prerank,cellular response to topologically incorrect protein (GO:0035967),0.2737246284474967,0.7078258251996704,0.8543563068920677,0.9998542617242226,1.0,5/31,13.47%,PRKN;PACRG;PTPN1;HDAC6;TM7SF3
prerank,positive regulation of protein autophosphorylation (GO:0031954),-0.22726023744709462,-0.7073117079409035,0.8850574712643678,0.9555481336822897,1.0,1/22,0.09%,PDGFD
prerank,positive regulation of immunoglobulin production (GO:0002639),0.26653363559165205,0.7071717329146087,0.8512820512820513,1.0,1.0,2/31,3.65%,EPHB2;DNAJB9
prerank,regulation of mitotic spindle organization (GO:0060236),-0.20474263368808304,-0.7071234525315917,0.9175257731958762,0.9547077042039727,1.0,6/35,10.63%,CHMP3;DRG1;PARP3;CHMP1A;DCTN1;NUMA1
prerank,positive regulation of lamellipodium assembly (GO:0010592),0.28294750189299606,0.7068619257529528,0.8543046357615894,1.0,1.0,6/24,19.03%,AUTS2;BRK1;PIK3R1;CYFIP1;FSCN1;NCKAP1
prerank,histone H2B ubiquitination (GO:0033523),0.3398327791080585,0.7065919906867056,0.8076923076923077,1.0,1.0,4/10,25.75%,WAC;CDC73;UBE2E1;RNF20
prerank,regulation of receptor signaling pathway via STAT (GO:1904892),0.3191806215961602,0.7064748840797731,0.8132352941176471,0.9998165258897111,1.0,1/13,2.58%,PTPRT
prerank,hepaticobiliary system development (GO:0061008),0.2994634886962809,0.705483706085478,0.8254189944134078,1.0,1.0,5/20,15.00%,PRKCSH;NF1;COBL;CITED2;MET
prerank,positive regulation of neuron death (GO:1901216),0.2567796166865264,0.7053019383114326,0.8776978417266187,1.0,1.0,8/46,13.88%,PRNP;GRIN2B;NF1;WNT5A;FYN;CDK5R1;GRN;SNCA
prerank,positive regulation of peptidyl-lysine acetylation (GO:2000758),0.29289619926680455,0.7047773052360243,0.8399452804377565,1.0,1.0,6/20,21.94%,RPS6KA4;BRCA1;DIP2A;DIP2B;RUVBL2;PRKAA1
prerank,endoplasmic reticulum membrane organization (GO:0090158),-0.27935989247727433,-0.7045563970805553,0.8480662983425414,0.956352483074926,1.0,2/11,9.46%,ATL2;VAPB
prerank,negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315),0.3302786291658206,0.7043550309317324,0.8371040723981901,1.0,1.0,3/11,21.48%,CALM1;CALM2;PKD2
prerank,negative regulation of release of sequestered calcium ion into cytosol (GO:0051280),0.3302786291658206,0.7043550309317324,0.8371040723981901,1.0,1.0,3/11,21.48%,CALM1;CALM2;PKD2
prerank,mitotic sister chromatid segregation (GO:0000070),-0.1606384544249492,-0.7038633198466182,0.9859154929577465,0.9560617227197407,1.0,46/98,34.93%,CHMP3;BECN1;NUDC;VPS4A;CHMP1A;KIF18A;NCAPH2;PINX1;VPS4B;TENT4A;PIBF1;TUBG1;KIF23;CHMP7;CENPK;CSNK2B;BOD1;MCPH1;CHMP2B;NCAPD3;EML4;DCTN2;DSN1;NUSAP1;NIPBL;CENPE;EML3;KMT5A;NCAPD2;ZW10;KNSTRN;NCAPH;SPAG5;KIF18B;TTN;KIFC1;NUP62;NSL1;NDC80;REC8;KIF14;SPDL1;TUBG2;RAD21;CDCA8;CEP55
prerank,protein K63-linked deubiquitination (GO:0070536),0.2769816517661535,0.7036215055360883,0.8603491271820449,1.0,1.0,7/31,20.32%,USP50;OTUD7B;USP33;USP25;OTUD4;OTUD7A;USP13
prerank,multivesicular body organization (GO:0036257),-0.20571290280733245,-0.7026247781551364,0.9128440366972477,0.9563377863861899,1.0,5/31,9.91%,CHMP3;TSG101;VPS37C;VPS4A;CHMP1A
prerank,regulation of protein modification by small protein conjugation or removal (GO:1903320),0.2923637791662501,0.7018526113989902,0.8536585365853658,1.0,1.0,7/20,24.51%,PRKN;ZMIZ1;HIF1A;WASHC1;EGR1;UBQLN1;HSPA1A
prerank,negative regulation of amyloid-beta formation (GO:1902430),0.29672200106573154,0.7016377792014095,0.8409425625920471,1.0,1.0,4/17,14.55%,NTRK2;PRNP;BIN1;RTN4
prerank,negative regulation of receptor-mediated endocytosis (GO:0048261),0.27534018065067173,0.7009202551696556,0.8319327731092437,1.0,1.0,2/25,5.90%,PSEN1;ATXN2
prerank,positive regulation of macrophage derived foam cell differentiation (GO:0010744),-0.2593237410787825,-0.7006432748985516,0.8492307692307692,0.9573124071746223,1.0,2/15,7.87%,PRKCH;AGTR1
prerank,positive regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045737),0.30494266262802777,0.700604140162626,0.8394886363636364,1.0,1.0,6/17,23.70%,EGFR;PKD1;CCND2;MAPRE3;PKD2;CCNY
prerank,negative regulation by host of viral transcription (GO:0043922),0.3205637099950179,0.7002149344852334,0.8318452380952381,1.0,1.0,1/12,4.10%,CCL4
prerank,positive regulation of phosphatase activity (GO:0010922),0.287462890778236,0.6991187370884492,0.835635359116022,1.0,1.0,5/21,16.10%,PPP1R15A;MAGI2;CALM1;CALM2;GPLD1
prerank,fluid transport (GO:0042044),0.3175678628253732,0.697855549782301,0.8179012345679012,1.0,1.0,1/12,5.26%,AQP4
prerank,positive regulation of histone acetylation (GO:0035066),0.2845725051865095,0.6978225261107611,0.8317631224764468,1.0,1.0,3/23,9.87%,RPS6KA4;BRCA1;PIH1D1
prerank,regulation of mRNA 3'-end processing (GO:0031440),0.329030582074408,0.6969667051015999,0.8215962441314554,1.0,1.0,4/11,17.23%,NCBP1;AHCYL1;PAPOLA;CDC73
prerank,negative regulation of inflammatory response to antigenic stimulus (GO:0002862),0.22818288089347738,0.69691849699545,0.9295624332977588,1.0,1.0,11/116,12.74%,CRH;DPEP1;PTHLH;PRKAR1B;PTH2R;FYN;TSHR;SELENOS;MAPK14;PRKACA;GLP2R
prerank,eye photoreceptor cell differentiation (GO:0001754),0.31846461207033316,0.6965185269190403,0.8402457757296466,1.0,1.0,2/12,9.77%,VEGFA;DSCAM
prerank,glycerophospholipid metabolic process (GO:0006650),0.23639273773547403,0.6963135833393866,0.9172185430463576,1.0,1.0,17/75,19.94%,PRDX6;PLCB1;PLA2G7;PIGC;PIGP;FAR1;ENPP6;PIGN;PIGA;GPLD1;ABHD6;PIP5K1A;CPNE7;AGK;CPNE1;GDPD3;PLA2G4E
prerank,regulation of mitotic spindle assembly (GO:1901673),-0.22872898928748792,-0.6960741969624158,0.8956228956228957,0.9607731918562445,1.0,3/19,9.91%,CHMP3;DRG1;CHMP1A
prerank,regulation of complement activation (GO:0030449),0.25399151712273477,0.6957234589948309,0.8709677419354839,1.0,1.0,1/40,0.78%,C7
prerank,protein lipidation (GO:0006497),0.24072349495445383,0.6952907881468701,0.8834080717488789,1.0,1.0,23/59,28.06%,WIPI1;ATG5;ZDHHC8;PIGC;PIGP;HHAT;PIGN;PIGA;PIGU;GPLD1;DPM1;PIGO;ZDHHC21;PORCN;ZDHHC13;WDR45B;ATG12;ZDHHC15;ZDHHC17;ATG10;PIK3C3;ZDHHC5;PIGM
prerank,heme biosynthetic process (GO:0006783),0.28065330307457814,0.6949038594811494,0.8653333333333333,1.0,1.0,10/22,26.79%,SLC25A38;UROS;COX10;FECH;PGRMC1;TSPO;CPOX;ALAD;UROD;ABCB10
prerank,nucleoside salvage (GO:0043174),-0.2834657115212563,-0.6944215305947864,0.8535911602209945,0.9613014376966675,1.0,4/10,32.00%,TK2;DCK;CDA;TK1
prerank,positive regulation of organelle organization (GO:0010638),0.2650341320323368,0.6931591660105362,0.8706338939197931,1.0,1.0,13/32,27.57%,C2CD5;ATL3;RAB3GAP2;DOC2B;SURF4;RAB3GAP1;P2RX7;LMAN1;STX18;SORBS3;PFDN2;LIG4;FYCO1
prerank,negative regulation of neuron differentiation (GO:0045665),0.28294260760976386,0.6931400756082493,0.8548387096774194,1.0,1.0,2/22,11.41%,SOX9;BMP7
prerank,negative regulation of cellular senescence (GO:2000773),0.31482989941045175,0.693071476064616,0.8323442136498517,1.0,1.0,3/13,9.25%,MAP3K3;CDK6;AKT3
prerank,negative regulation of cellular catabolic process (GO:0031330),0.23845022653069942,0.6929229764817421,0.9003397508493771,1.0,1.0,14/63,19.79%,PTPN22;BCL2;MT3;BMF;TLK2;EIF4G1;ATRAID;WASHC1;MET;KLHL22;GPLD1;TAB3;STAT3;RRAGA
prerank,male meiosis I (GO:0007141),-0.24776400348479283,-0.6927141259127924,0.8344594594594594,0.9619340972014406,1.0,5/16,26.85%,ING2;MYBL1;FOXJ2;BRDT;HSF2BP
prerank,"DNA-templated transcription, elongation (GO:0006354)",0.23846656866466365,0.6925268491310357,0.8956714761376249,1.0,1.0,22/64,24.77%,GTF2H2;POLR2B;CDK13;POLR2K;NCBP1;SETD2;ELP2;ELP4;POLR2G;ELL;CDC73;PCID2;TCEA2;ELOC;POLR2A;MLLT1;SSRP1;ELOB;CDK9;POLR2F;CCNT2;CCNH
prerank,regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882),0.2886568906173772,0.6919156015244002,0.8439226519337016,1.0,1.0,5/20,17.45%,ANK2;PRKACA;CALM1;CALM2;SLC9A1
prerank,regulation of immune effector process (GO:0002697),0.2525725609371804,0.691915142126296,0.8790123456790123,1.0,1.0,1/41,0.78%,C7
prerank,positive regulation of myelination (GO:0031643),-0.2776792890598037,-0.6918129418350751,0.8831908831908832,0.9617650107181009,1.0,5/11,31.41%,PARD3;MYRF;TPPP;DICER1;TNFRSF1B
prerank,positive regulation of innate immune response (GO:0045089),0.26839429885360916,0.6917288083470645,0.8673602080624188,1.0,1.0,3/30,8.77%,FADD;WNT5A;UBE2K
prerank,chromatin assembly or disassembly (GO:0006333),0.3300253903997913,0.691444744013637,0.852760736196319,1.0,1.0,3/11,15.90%,MTA2;RBBP4;TP53
prerank,maintenance of protein location in nucleus (GO:0051457),-0.22717453194579193,-0.6904127774843195,0.9075342465753424,0.9620403335683192,1.0,4/20,17.78%,SP100;SUPT7L;PML;TAF3
prerank,tail-anchored membrane protein insertion into ER membrane (GO:0071816),0.2953223975557928,0.689726850423349,0.8467048710601719,1.0,1.0,8/17,23.28%,EMC10;EMC1;SGTA;EMC8;EMC3;CAMLG;EMC6;EMC2
prerank,positive regulation of protein import (GO:1904591),0.2660745321516367,0.6894037206911238,0.8767833981841764,1.0,1.0,4/30,10.37%,TGFB1;PSEN1;FLNA;PIK3R1
prerank,defense response to symbiont (GO:0140546),0.23106871439482507,0.6893559472211274,0.9341383095499451,1.0,1.0,9/92,10.48%,PYCARD;BCL2;FADD;NDUFAF4;RNASE6;BNIP3;FLNA;SETD2;AGBL4
prerank,maintenance of protein localization in endoplasmic reticulum (GO:0035437),-0.2690366797003633,-0.6893189553723376,0.8704819277108434,0.9620484453777917,1.0,5/12,24.31%,INSIG2;RER1;GPAA1;KDELR1;OS9
prerank,mesenchyme development (GO:0060485),0.3039144403547901,0.6888729613458261,0.8677325581395349,1.0,1.0,1/15,0.85%,MEOX1
prerank,mitochondrial RNA metabolic process (GO:0000959),-0.24437477081553283,-0.6887165692289163,0.8913043478260869,0.9615776188627545,1.0,8/14,29.34%,FASTKD1;SLC25A33;EARS2;MRPL12;TEFM;TFB2M;TWNK;FASTKD5
prerank,iron-sulfur cluster assembly (GO:0016226),-0.20966616349376935,-0.6885202979351814,0.9260700389105059,0.9607188732951512,1.0,10/24,26.33%,MMS19;ISCA1;LYRM4;FXN;CIAO3;ABCB7;NDOR1;CIAPIN1;GLRX5;NUBP1
prerank,mitochondrial membrane organization (GO:0007006),0.2666049112301585,0.6883527374762345,0.8809218950064021,1.0,1.0,6/32,18.00%,BCL2;APOOL;BNIP3;RCC1L;OPA1;HSPA9
prerank,positive regulation of regulated secretory pathway (GO:1903307),0.2979388124026117,0.6881233871238203,0.8441379310344828,1.0,1.0,5/17,17.34%,NLGN1;RAB3D;RAB3A;DOC2B;UNC13D
prerank,regulation of neural precursor cell proliferation (GO:2000177),0.2769858124570504,0.6876628958392466,0.8620236530880421,1.0,1.0,6/22,17.76%,TAFA1;SHCBP1;PTPRZ1;NES;FZD9;MDK
prerank,negative regulation of establishment of protein localization (GO:1904950),0.33278672527002007,0.6875814875299865,0.8278041074249605,1.0,1.0,3/10,18.00%,NDFIP1;SNX12;DNAJA1
prerank,cellular biogenic amine biosynthetic process (GO:0042401),0.3055551149784693,0.687561116741682,0.8421807747489239,1.0,1.0,2/15,10.02%,SMOX;PAOX
prerank,regulation of humoral immune response (GO:0002920),0.2464099148324485,0.6875369829878438,0.8992805755395683,1.0,1.0,3/44,12.85%,C7;GATA6;PROS1
prerank,alanine transport (GO:0032328),0.32836562892477644,0.6873467415914353,0.8441358024691358,1.0,1.0,1/10,5.20%,SLC36A2
prerank,oligosaccharide biosynthetic process (GO:0009312),0.2912991724857422,0.6868282771278441,0.8508064516129032,1.0,1.0,2/20,8.84%,ST3GAL4;ST6GALNAC6
prerank,regulation of G2/M transition of mitotic cell cycle (GO:0010389),0.22089134022695597,0.6866217536851403,0.9506302521008403,1.0,1.0,27/145,21.16%,DYNLL1;HAUS3;CNTRL;PCM1;NDE1;SDCCAG8;CEP57;PSMB7;CLASP1;CDC25B;PRKACA;CKAP5;CEP76;DYNC1I2;PSMD2;PSMC1;CSNK1E;PSMB2;CEP63;FBXO5;TUBA1A;PSMD9;PSME4;CEP78;SSNA1;PSMA8;PCNT
prerank,low-density lipoprotein particle remodeling (GO:0034374),0.31938335772559673,0.6865575232992375,0.8390461997019374,1.0,1.0,2/11,15.20%,PLA2G7;LIPC
prerank,response to glucagon (GO:0033762),-0.22859212152251537,-0.6859670751793303,0.9072164948453608,0.9620869775497491,1.0,7/19,25.13%,ADCY9;PRKAR1A;ADCY4;ADCY3;CYSLTR2;PRKAR2A;PRKACB
prerank,lipid biosynthetic process (GO:0008610),0.23482162495779346,0.6859267210786072,0.9196035242290749,1.0,1.0,11/77,17.75%,ACSS2;ACACA;OXSM;SCD5;ACLY;PRLR;AGPAT5;LIPC;ACSL6;GPAT4;PIP5K1A
prerank,positive regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0035774),0.30741347928566115,0.6858599611010837,0.8180428134556575,1.0,1.0,4/12,23.18%,PPP3CB;GPLD1;ADCY8;TRPM4
prerank,carbohydrate biosynthetic process (GO:0016051),0.28806556005475914,0.68584831628583,0.8521970705725699,1.0,1.0,2/21,8.84%,ST3GAL4;ST6GALNAC6
prerank,protein targeting to peroxisome (GO:0006625),0.26819323037241505,0.6849446806451707,0.8584415584415584,1.0,1.0,7/29,18.30%,ACBD5;PEX3;PXMP2;ZFAND6;GDAP1;ABCD2;PEX1
prerank,protein localization to nucleus (GO:0034504),0.22642542116825037,0.6849177439152998,0.9321851453175457,1.0,1.0,28/102,22.58%,NUP155;NOL8;FAM53B;XPA;ARL2;IPO9;BMP7;PRICKLE1;DVL1;KPNB1;IPO13;NXT1;COL1A1;LMNA;EIF4ENIF1;POM121;HNRNPU;WRN;MDM2;TNPO3;IPO5;CSE1L;TAF8;STAT3;PHB2;HEATR3;GBP2;BCL3
prerank,zinc ion homeostasis (GO:0055069),0.2687917201848585,0.6846582110692461,0.8663171690694627,1.0,1.0,2/28,4.84%,PRKN;MT3
prerank,regulation of T cell cytokine production (GO:0002724),-0.24725310026092506,-0.6844249953634575,0.8703703703703703,0.9624866727046838,1.0,3/15,11.63%,SMAD7;CD55;MAP3K7
prerank,negative regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045736),0.2832513795625937,0.6843405943406441,0.8654646324549237,1.0,1.0,2/20,7.62%,PTEN;MEN1
prerank,regulation of translational initiation (GO:0006446),0.23873983482253808,0.6838927872793841,0.9199110122358176,1.0,1.0,23/63,27.37%,EIF2AK3;EIF1B;EIF2B5;NCBP1;EIF4G1;POLR2G;NCK1;EIF1;EIF4A2;EIF2B2;CSDE1;EIF4G3;GLE1;PAIP2B;ALKBH1;CEBPB;NCK2;FMR1;RBM4;YTHDF3;KLHL25;DDX1;PAIP2
prerank,positive regulation of extrinsic apoptotic signaling pathway (GO:2001238),0.2672369774842923,0.6833245185656898,0.8496732026143791,1.0,1.0,2/29,2.66%,PYCARD;FADD
prerank,DNA-dependent DNA replication (GO:0006261),0.2180935880784609,0.6832124822817995,0.9483667017913593,1.0,1.0,29/128,20.98%,LRWD1;POLE2;BAZ1A;REV3L;RPA3;PSMB7;GINS2;POLE3;MCM4;RPA2;ORC1;TOPBP1;POLG2;PSMD2;UBB;PSMC1;BLM;POLG;PSMB2;WRN;ORC4;DDX23;PSMD9;DBF4;PSME4;WRNIP1;ORC2;PSMA8;SSBP1
prerank,activation of adenylate cyclase activity (GO:0007190),-0.19130926167754542,-0.6831979204490534,0.9502487562189055,0.9625228047373531,1.0,15/35,37.51%,ADCY9;LGR4;ADCY4;CAP1;ADCY3;ADCYAP1;ADRB2;CAP2;ADRB1;LHCGR;ADCY7;ACR;GIPR;CRHR1;GLP1R
prerank,negative regulation of growth (GO:0045926),0.2241987586264816,0.6831681388603874,0.9485294117647058,1.0,1.0,8/121,5.87%,DCBLD2;CRLF3;VGLL4;FRZB;JADE1;TGFB1;MT3;APBB2
prerank,establishment of epithelial cell polarity (GO:0090162),0.29170534741662546,0.6829678785627223,0.8514442916093535,1.0,1.0,5/19,15.75%,CLASP1;MYO9A;OPHN1;FBF1;CYTH3
prerank,positive regulation of immunoglobulin mediated immune response (GO:0002891),-0.2506656164959386,-0.6826796471033603,0.8955696202531646,0.9619720189044275,1.0,4/14,24.29%,RIF1;TFRC;PAXIP1;MAD2L2
prerank,regulation of vacuole organization (GO:0044088),0.27976234413813944,0.6825240460829491,0.8575498575498576,1.0,1.0,2/20,6.24%,NPRL2;LAPTM4B
prerank,ribosome biogenesis (GO:0042254),0.21680647572537223,0.682360525932146,0.9631901840490797,1.0,1.0,31/187,16.32%,WDR55;XPO1;C1D;WDR36;SENP3;RPL23A;NOB1;TSC1;XRN2;NOL8;BMS1;EXOSC8;MRTO4;DDX54;UTP6;EIF6;HEATR1;PIH1D1;EXOSC2;RCL1;FBL;EBNA1BP2;SDAD1;HELQ;WDR46;TEX10;DDX10;DDX27;NIP7;NOP56;NOC4L
prerank,oxoacid metabolic process (GO:0043436),0.26842002394019315,0.6821808096026623,0.8641160949868074,1.0,1.0,3/27,9.10%,DAO;BPNT1;BPNT2
prerank,regulation of ubiquitin-protein transferase activity (GO:0051438),0.2616250135809786,0.6820658410172714,0.8564102564102564,1.0,1.0,8/29,19.65%,FBXW7;LIMK1;BAG5;ABL1;FBXO5;PARK7;MAGEC2;UBE2L3
prerank,regulation of double-strand break repair via homologous recombination (GO:0010569),0.24891108777457874,0.6816668301260973,0.8784933171324423,1.0,1.0,10/42,17.91%,MRNIP;SETD2;FBH1;SIRT6;RPA2;RTEL1;CGAS;SPIDR;TERF2IP;FUS
prerank,RNA methylation (GO:0001510),0.23753453404457947,0.6814250823260795,0.920314253647587,1.0,1.0,11/60,15.73%,THUMPD3;NOP2;METTL3;TRMT12;NSUN5;THADA;TGS1;FBL;TRMT112;THUMPD2;MEPCE
prerank,pyrimidine nucleoside metabolic process (GO:0006213),0.30176180134599156,0.6810018398278316,0.8492537313432836,1.0,1.0,7/14,27.88%,UMPS;NT5C;DHODH;DPYD;NT5C3A;NT5E;CAD
prerank,positive regulation of protein modification by small protein conjugation or removal (GO:1903322),0.23143241506022874,0.6808817305495295,0.9217199558985667,1.0,1.0,15/76,16.40%,FBXW7;NSMCE3;UBA2;BRCA1;CUL3;HUWE1;PRICKLE1;MALT1;NDFIP1;SENP2;CRY1;UBB;RCHY1;XIAP;FANCI
prerank,aerobic electron transport chain (GO:0019646),0.2355942746116308,0.6800998862579367,0.9139297848244621,1.0,1.0,16/68,18.26%,UQCRQ;SDHC;NDUFS5;AFG1L;NDUFA4;NDUFB2;NDUFA8;NDUFS8;COX10;NDUFV3;NDUFS6;NDUFV2;NDUFA13;NDUFA6;NDUFA12;NDUFC1
prerank,interleukin-6-mediated signaling pathway (GO:0070102),0.2874070634691194,0.6799591633940194,0.8603988603988604,1.0,1.0,3/18,11.09%,CBL;PTPN11;IL6ST
prerank,positive regulation of lamellipodium organization (GO:1902745),0.26156593039257336,0.679868329333085,0.8961538461538462,1.0,1.0,7/32,19.03%,AUTS2;BRK1;PIK3R1;CORO1B;CYFIP1;FSCN1;NCKAP1
prerank,determination of heart left/right asymmetry (GO:0061371),0.25289433774274206,0.679859529511349,0.9058240396530359,1.0,1.0,5/42,10.98%,CCDC39;TGFBR2;BBS5;SMO;DAND5
prerank,regulation of cellular response to stress (GO:0080135),0.22088794723306243,0.6797555262008307,0.9416135881104034,1.0,1.0,21/115,16.73%,HSPH1;PRKN;RANBP2;MAPKAPK2;RPA3;NUP155;BAG5;CRYAB;EIF4G1;NUP205;FKBP4;NDC1;NUP160;MAPK1;DNAJB6;RPA2;ATM;ABL1;POM121;PNPT1;AAAS
prerank,high-density lipoprotein particle remodeling (GO:0034375),-0.24231818342007352,-0.6790325560149284,0.9082278481012658,0.9641814135543908,1.0,3/15,18.76%,PLTP;ABCG1;APOE
prerank,protein neddylation (GO:0045116),0.3041276623079951,0.6783543392483429,0.8355359765051396,1.0,1.0,3/13,13.90%,NAE1;UBA3;NEDD8
prerank,negative regulation of supramolecular fiber organization (GO:1902904),0.22988202547858408,0.6780491238651178,0.9195148842337376,1.0,1.0,16/72,19.38%,FGF13;KANK4;PRKN;SSH3;CRYAB;CLASP1;APC2;PLEKHH2;KATNB1;SNCA;SSH1;NAV3;ARFGEF1;ATXN7;CAMSAP1;KANK1
prerank,response to molecule of bacterial origin (GO:0002237),0.23284309356722874,0.6779984531437874,0.9038031319910514,1.0,1.0,9/69,13.88%,PTPN22;IRAK3;MAPKAPK3;MAPKAPK2;PELI1;ERBIN;PRDX3;SRR;SNCA
prerank,regulation of establishment of protein localization (GO:0070201),-0.26060407459305995,-0.6777870687309466,0.8980263157894737,0.964332978227148,1.0,7/13,36.01%,SCFD1;GAPVD1;CEP295;CORO2B;CTSD;TREM2;PTP4A3
prerank,autophagosome maturation (GO:0097352),0.25680861566310065,0.6772960668316428,0.8842239185750637,1.0,1.0,11/32,22.80%,VPS33A;LIX1;SNAP29;CALM1;GABARAPL2;STX17;SNX14;LAMP2;VMP1;VPS16;UBQLN1
prerank,positive regulation of transcription initiation from RNA polymerase II promoter (GO:0060261),0.2732344196945403,0.6769934858170913,0.8597222222222223,1.0,1.0,5/22,18.17%,MED13;ESR1;MED12;TP53;MED30
prerank,chromatin disassembly (GO:0031498),0.30203728521840256,0.6765378913372083,0.8689248895434463,1.0,1.0,4/14,20.23%,SMARCC2;SMARCC1;SMARCE1;SMARCA4
prerank,nucleosome disassembly (GO:0006337),0.30203728521840256,0.6765378913372083,0.8689248895434463,1.0,1.0,4/14,20.23%,SMARCC2;SMARCC1;SMARCE1;SMARCA4
prerank,aminoglycan metabolic process (GO:0006022),-0.2776737716042041,-0.6765373150698935,0.8555555555555555,0.9644617213949854,1.0,4/10,29.56%,B4GALT7;B3GAT1;B3GALT6;CHST9
prerank,adenylate cyclase-activating adrenergic receptor signaling pathway (GO:0071880),-0.24052920345359663,-0.6764764748793136,0.9056603773584906,0.9634806477845106,1.0,3/17,11.54%,ADCY9;ADRA1B;ADRA2A
prerank,regulation of type I interferon production (GO:0032479),0.22399715951941926,0.6764260285799478,0.9344978165938864,1.0,1.0,28/84,27.87%,PTPN22;DTX4;NLRX1;LRRFIP1;POLR2K;TAX1BP1;TBK1;XRCC6;DHX33;CGAS;POLR1C;IRF3;POLR3G;NFKB1;IRF8;STAT6;CYLD;PCBP2;POLR3K;MAVS;POLR2F;PRKDC;IRF5;POLR3F;IRAK1;PIN1;RELA;ACOD1
prerank,nuclear pore complex assembly (GO:0051292),0.3188154965695603,0.6763248152086379,0.8525641025641025,1.0,1.0,4/10,20.91%,NUP205;NDC1;RTN4;AHCTF1
prerank,negative regulation of catalytic activity (GO:0043086),0.27062517986591333,0.6763046105269329,0.8606224627875507,1.0,1.0,4/24,15.90%,MT3;HDAC6;NES;TP53
prerank,transcription elongation from RNA polymerase II promoter (GO:0006368),0.23316096104281922,0.6758957797823899,0.90625,1.0,1.0,21/62,24.77%,GTF2H2;POLR2B;CDK13;POLR2K;NCBP1;SETD2;ELP2;ELP4;POLR2G;ELL;CDC73;PCID2;ELOC;POLR2A;MLLT1;SSRP1;ELOB;CDK9;POLR2F;CCNT2;CCNH
prerank,cellular response to leucine starvation (GO:1990253),-0.28379482175513676,-0.675813505536343,0.8760330578512396,0.9629908518741169,1.0,5/10,31.38%,SESN2;LARS1;RRAGB;EIF2AK4;IMPACT
prerank,protein O-linked mannosylation (GO:0035269),0.2818660433269969,0.6756628828669804,0.8504273504273504,1.0,1.0,7/18,18.62%,TMTC2;POMGNT2;RXYLT1;TMTC3;DPM1;FKTN;FKRP
prerank,double-strand break repair via nonhomologous end joining (GO:0006303),0.23809524192717615,0.6752190359415153,0.9107551487414187,1.0,1.0,12/58,19.26%,ERCC4;SETMAR;ATP23;BRCA1;NHEJ1;NSD2;XRCC6;MDC1;SUMO1;ATM;CYREN;LIG3
prerank,negative regulation of amyloid precursor protein catabolic process (GO:1902992),0.27652312844482063,0.6748078252806332,0.8776671408250356,1.0,1.0,3/19,8.10%,NTRK2;PRNP;BIN1
prerank,negative regulation of viral transcription (GO:0032897),0.30096386701750866,0.6745087023788873,0.8778280542986425,1.0,1.0,5/13,24.41%,TRIM11;MID2;ZFP36;TRIM14;UBP1
prerank,regulation of interferon-gamma-mediated signaling pathway (GO:0060334),0.2711579857969397,0.6737423495912249,0.8753387533875339,1.0,1.0,2/23,5.68%,PTPN2;SOCS1
prerank,sensory perception of sound (GO:0007605),0.23069603784274795,0.6737389529960078,0.9285714285714286,1.0,1.0,12/88,16.12%,ROR1;LHFPL5;PCDH15;LHFPL3;LHFPL4;HOMER2;LRTOMT;PAX3;COL1A1;CCDC50;CDC14A;LRP2
prerank,regulation of carbohydrate catabolic process (GO:0043470),0.24493512019810781,0.6736764376445192,0.9023485784919654,1.0,1.0,9/41,16.73%,RANBP2;NUP155;EIF6;HIF1A;NUP205;NDC1;NUP160;POM121;AAAS
prerank,melanosome organization (GO:0032438),0.2643281039046364,0.6733515496388293,0.8887417218543047,1.0,1.0,6/26,23.23%,RAB38;AP1G1;TRAPPC6A;HPS1;KIF13A;BLOC1S6
prerank,mitotic cell cycle checkpoint signaling (GO:0007093),0.2671235174559513,0.6733380539755134,0.8768211920529801,1.0,1.0,4/23,15.22%,SETMAR;ZWINT;BUB1B;CHMP4C
prerank,positive regulation of ATP metabolic process (GO:1903580),0.25762283731932883,0.6732688291438698,0.8956406869220608,0.9996996351837683,1.0,10/32,22.02%,ZBTB20;PSEN1;MLXIPL;HIF1A;PID1;PFKFB1;P2RX7;PRKAA1;PRXL2C;SLC4A4
prerank,N-acetylglucosamine metabolic process (GO:0006044),0.2898729602621568,0.6722641546984236,0.8744460856720827,1.0,1.0,3/15,16.76%,NAGK;MGAT3;GNPDA1
prerank,regulation of lysosomal lumen pH (GO:0035751),0.30991304773003026,0.6722512691929867,0.8597285067873304,0.9999745473299905,1.0,2/12,12.11%,VPS33A;GRN
prerank,positive regulation of monooxygenase activity (GO:0032770),0.26364121941827523,0.6719807533589941,0.8691099476439791,0.9998387611211644,1.0,3/26,10.49%,POR;HIF1A;GDNF
prerank,mitotic chromosome condensation (GO:0007076),-0.2125573922074599,-0.6709673515643987,0.930327868852459,0.966010155761565,1.0,11/26,31.76%,CHMP1A;NCAPH2;TENT4A;CSNK2B;MCPH1;NCAPD3;NUSAP1;KMT5A;NCAPD2;NCAPH;TTN
prerank,negative regulation of tumor necrosis factor-mediated signaling pathway (GO:0010804),0.29625556873632064,0.6703104676061293,0.864406779661017,1.0,1.0,4/14,23.12%,PTPN2;PYDC1;TRAIP;CARD16
prerank,carbohydrate homeostasis (GO:0033500),0.23272027814970628,0.6700443654881224,0.9326599326599326,1.0,1.0,4/67,6.40%,PYGL;BACE2;PTPN2;MLXIPL
prerank,mitochondrial transport (GO:0006839),0.23914828260844648,0.6696460189480866,0.929510155316607,1.0,1.0,10/53,16.70%,BCL2;FBXO7;BNIP3;TOMM22;AIP;TOMM20;COX18;GDAP1;SLC25A24;DNAJC19
prerank,rRNA metabolic process (GO:0016072),0.21510444748141752,0.6695698571607027,0.9683673469387755,1.0,1.0,27/160,16.32%,WDR55;C1D;WDR36;SENP3;RPL23A;NOB1;XRN2;NOL8;BMS1;EXOSC8;MRTO4;DDX54;UTP6;HEATR1;PIH1D1;EXOSC2;RCL1;FBL;EBNA1BP2;HELQ;WDR46;TEX10;DDX10;DDX27;NIFK;NOP56;NOC4L
prerank,histone H2A monoubiquitination (GO:0035518),-0.23738250396147498,-0.6695430993352947,0.8821548821548821,0.9662367993349895,1.0,6/17,18.35%,PCGF3;PCGF2;PCGF5;BMI1;RING1;PCGF6
prerank,mitochondrial ATP synthesis coupled electron transport (GO:0042775),0.23147002395255964,0.6693418150944828,0.9289740698985344,1.0,1.0,16/69,18.26%,UQCRQ;SDHC;NDUFS5;AFG1L;NDUFA4;NDUFB2;NDUFA8;NDUFS8;COX10;NDUFV3;NDUFS6;NDUFV2;NDUFA13;NDUFA6;NDUFA12;NDUFC1
prerank,neuromuscular synaptic transmission (GO:0007274),-0.2291567434685984,-0.6689061467127689,0.928082191780822,0.9656961698167075,1.0,2/18,7.47%,FCHSD2;KIF1B
prerank,heterotypic cell-cell adhesion (GO:0034113),0.2630691467875043,0.6682978945427956,0.8778833107191316,1.0,1.0,6/25,17.05%,DSG2;CTNNA3;PKP2;ITGB1;JUP;ITGB7
prerank,glutathione biosynthetic process (GO:0006750),0.31910416024875077,0.6680045843761258,0.844311377245509,1.0,1.0,2/11,12.98%,GSS;GGCT
prerank,regulation of protein localization to cell periphery (GO:1904375),-0.2301453599664586,-0.6677374361237692,0.9106529209621993,0.9656214505246877,1.0,6/18,24.55%,VTI1B;ZDHHC7;VPS4A;APPL1;VAMP8;ZDHHC2
prerank,desensitization of G protein-coupled receptor signaling pathway (GO:0002029),0.31406294754954545,0.6673677266354231,0.8277439024390244,1.0,1.0,1/11,3.97%,GTF2H2
prerank,membrane lipid metabolic process (GO:0006643),0.27055445416664914,0.667298131483644,0.8758620689655172,1.0,1.0,3/22,8.13%,AGMO;CYP1B1;TEX2
prerank,negative regulation of endopeptidase activity (GO:0010951),0.23539541605621317,0.6672756455114817,0.9228886168910648,1.0,1.0,4/47,8.22%,RECK;MT3;BIN1;SERPINE2
prerank,double-strand break repair via break-induced replication (GO:0000727),0.3001253900079288,0.6670075149969776,0.8755760368663594,1.0,1.0,2/12,10.84%,GINS2;MCM4
prerank,pseudouridine synthesis (GO:0001522),0.30446112423805816,0.6669877477841317,0.8571428571428571,1.0,1.0,3/13,15.71%,PUSL1;PUS7;PUS1
prerank,ovarian follicle development (GO:0001541),0.3030860033183694,0.6667724746062138,0.8396825396825397,0.9998223362920442,1.0,5/13,23.26%,VEGFA;EIF2B5;EIF2B2;CEBPB;INHBB
prerank,cellular divalent inorganic cation homeostasis (GO:0072503),0.2159346611197172,0.6662770650004863,0.959830866807611,0.9999305135808502,1.0,12/107,12.92%,CCL11;ANK2;ATP2B3;MT3;CCR2;SLC8A2;SLC24A5;SLC10A7;HTR2C;EDN3;TPCN2;ATP2B1
prerank,regulation of purine nucleotide metabolic process (GO:1900542),0.2415378608864679,0.6655527945938329,0.9014778325123153,1.0,1.0,9/41,16.73%,RANBP2;NUP155;EIF6;HIF1A;NUP205;NDC1;NUP160;POM121;AAAS
prerank,retinoic acid receptor signaling pathway (GO:0048384),0.3148185072688501,0.6643617163814054,0.8465045592705167,1.0,1.0,2/10,8.79%,RARG;RARB
prerank,positive regulation of telomerase RNA localization to Cajal body (GO:1904874),0.2960841598815691,0.6643296859819302,0.8639652677279306,1.0,1.0,2/15,7.29%,CCT7;SHQ1
prerank,positive regulation of transcription regulatory region DNA binding (GO:2000679),0.27539426941727546,0.664198986464049,0.8699861687413555,1.0,1.0,4/20,18.76%,TGFB1;GTF2B;GATA3;PARK7
prerank,negative regulation of cyclin-dependent protein kinase activity (GO:1904030),0.2686793424594296,0.6639604663752918,0.871447902571042,1.0,1.0,2/22,7.62%,PTEN;MEN1
prerank,regulation of T-helper 17 cell differentiation (GO:2000319),-0.2713861966955332,-0.6638563105269788,0.8722826086956522,0.9676402393619156,1.0,1/10,2.50%,SMAD7
prerank,axonal transport of mitochondrion (GO:0019896),0.3121943620437418,0.6633382517413484,0.858877086494689,1.0,1.0,6/11,29.61%,HIF1A;OPA1;TRAK2;SYBU;SPAST;ACTR10
prerank,pre-replicative complex assembly (GO:0036388),-0.16838804231974655,-0.6629857851396609,0.9928571428571429,0.9673252750004552,1.0,26/64,34.32%,PSMD14;PSMB3;PSMD12;MCM6;PSMD6;PSMA1;ORC6;PSMD7;PSMA5;PSMC5;PSMC4;PSMB6;PSMA4;PSMB1;PSMB9;UBA52;PSMC6;MCM8;PSMD3;PSMD10;PSME3;MCM3;PSMA6;PSME2;MCM2;MCM5
prerank,cell surface receptor signaling pathway involved in heart development (GO:0061311),0.2841412375370892,0.6628519925338441,0.8890532544378699,1.0,1.0,7/17,23.34%,ACVR1;TGFB1;BMPR1A;HEYL;GALNT11;SNAI1;BMP2
prerank,beta-catenin destruction complex disassembly (GO:1904886),-0.22001278272430713,-0.6627041116699035,0.9230769230769231,0.9665124928809259,1.0,5/21,20.04%,CTNNB1;GSK3B;FZD1;CAV1;DVL2
prerank,lipid phosphorylation (GO:0046834),0.3186207881645228,0.6625434084280794,0.843042071197411,1.0,1.0,6/10,28.52%,DGKI;DGKA;DGKK;DGKD;DGKZ;DGKQ
prerank,regulation of phagocytosis (GO:0050764),0.23715722033786105,0.6624933167002813,0.9277251184834123,0.9999990026848656,1.0,2/53,1.52%,PYCARD;OLFM4
prerank,purine ribonucleoside monophosphate metabolic process (GO:0009167),0.277041194632472,0.6622573966357062,0.8899721448467967,0.9998218947799321,1.0,5/20,21.53%,ADSS1;NT5C2;AK3;ADSL;PFAS
prerank,negative regulation of DNA-binding transcription factor activity (GO:0043433),0.21404654297076886,0.661851032940255,0.9662802950474183,0.9998257982569978,1.0,23/136,17.79%,PTCH1;PYCARD;IRAK3;PRNP;UFL1;CYP1B1;OTULIN;MEN1;FLNA;ERBIN;HDAC2;SFRP4;ESR1;MTURN;BMP7;TAX1BP1;SUMO1;PKD1;PYDC1;FOXJ1;CHUK;HEYL;SUFU
prerank,rRNA processing (GO:0006364),0.21093794834269788,0.661209251141872,0.9613821138211383,1.0,1.0,29/172,16.52%,WDR55;C1D;WDR36;SENP3;RPL23A;NOP2;NOB1;XRN2;NOL8;BMS1;EXOSC8;MRTO4;DDX54;UTP6;EIF6;HEATR1;PIH1D1;EXOSC2;RCL1;FBL;EBNA1BP2;HELQ;WDR46;TEX10;DDX10;DDX27;NOP56;NOC4L;RRP15
prerank,rRNA 3'-end processing (GO:0031125),0.3095055726804546,0.6603948025947364,0.8682539682539683,1.0,1.0,2/10,10.32%,EXOSC8;EXOSC2
prerank,positive regulation of protein acetylation (GO:1901985),0.30522063980831576,0.6592860515498027,0.9016641452344932,1.0,1.0,5/12,23.27%,DIP2A;TERF2IP;DIP2B;PRKAA1;TAOK1
prerank,AMP metabolic process (GO:0046033),0.3012127659717005,0.6590653684060958,0.852017937219731,1.0,1.0,5/13,26.67%,ADSS1;AK3;ADSL;NUDT2;NT5E
prerank,response to ionizing radiation (GO:0010212),0.22683675805290393,0.6589364246434191,0.9362416107382551,1.0,1.0,13/70,15.98%,MYC;MRNIP;MEN1;BRCA1;NHEJ1;MAPK14;BRAT1;TOPBP1;AEN;ATM;BLM;TP53;SPIDR
prerank,filopodium assembly (GO:0046847),0.2820094838905238,0.6586885723107785,0.8714689265536724,1.0,1.0,4/16,19.08%,FGD4;SPATA13;ARHGEF4;S1PR2
prerank,negative regulation of stem cell differentiation (GO:2000737),0.30417937834631437,0.6583036706544312,0.8768996960486323,1.0,1.0,2/12,16.43%,ZFP36L2;HNRNPU
prerank,organonitrogen compound biosynthetic process (GO:1901566),0.2095222056257362,0.6582684107389432,0.9657320872274143,1.0,1.0,30/151,21.49%,SLC27A1;SLC25A2;CERS3;ST3GAL4;SLC44A2;CERS6;ELOVL6;ELOVL5;SPTSSA;VAPA;PCYT1B;CHPT1;GPHN;SLC25A15;NFS1;CHAT;CSNK1G2;SGMS2;GSTZ1;GPAT4;SLC44A1;GSTT1;CSNK2A2;LPCAT2;STARD7;HACD2;CERS2;LCMT2;FURIN;PRKD2
prerank,response to chemokine (GO:1990868),0.30086411319752526,0.658171602472135,0.8705701078582434,0.9997704869423615,1.0,2/13,9.18%,SLC12A2;STK39
prerank,peroxisomal membrane transport (GO:0015919),0.2607140088091407,0.6581316732970328,0.8916129032258064,0.9994094736522751,1.0,6/27,18.30%,ACBD5;PEX3;PXMP2;GDAP1;ABCD2;PEX1
prerank,mitochondrion organization (GO:0007005),0.2086903704138821,0.6580712509890807,0.9680082559339526,0.9990614735680129,1.0,42/165,22.67%,DNM1;PRKN;RAB38;FBXO7;ATP23;BNIP3;TFAM;TOMM22;AKT3;AIP;TOMM20;RHOT2;AFG1L;PID1;WASF1;PRDX3;YME1L1;POLRMT;POLG2;OPA1;GDAP1;PNPT1;DNAJC19;GABPB1;TRAK2;ADCK1;AIFM1;RHOT1;CLUH;PARK7;HK2;TSPO;PHB2;HSPD1;SSBP1;WDR81;AIFM2;MTFR1;BNIP3L;MIGA2;MGME1;IMMP2L
prerank,interleukin-1-mediated signaling pathway (GO:0070498),0.21713430919847113,0.6578242280007105,0.935659760087241,0.9988952956713333,1.0,33/94,29.38%,MAP3K3;IRAK3;RPS6KA4;PLCB1;PELI1;PSMB7;TOLLIP;PSMD2;UBB;PSMC1;IL1RAP;PSMB2;CHUK;PSMD9;TAB3;EGR1;PSME4;PSMA8;NFKB1;TNIP2;TAB2;IRAK2;CUL1;PELI2;PSMD8;PSMD13;IRAK1;RELA;TRAF6;TAB1;PSMD4;PSMD5;IRAK4
prerank,termination of RNA polymerase II transcription (GO:0006369),0.2545954138554102,0.6577621805785846,0.9066002490660025,0.9985520168860795,1.0,3/33,10.21%,CSTF3;NCBP1;FIP1L1
prerank,receptor signaling pathway via STAT (GO:0097696),-0.20864414909755163,-0.6572508395591073,0.9285714285714286,0.9697214010020998,1.0,7/25,21.10%,IL31RA;CTR9;STAT5B;NMI;STAT2;IFNAR1;IFNAR2
prerank,positive regulation of defense response (GO:0031349),0.21763923206319674,0.6562593918736214,0.9453551912568307,0.9996070579704871,1.0,15/89,20.09%,IL16;GPRC5B;CCR2;WNT5A;PLA2G7;IL18;GRN;SNCA;IL33;ABCC1;RIPK1;MDK;SETD4;PDCD4;POLR3G
prerank,regulation of lamellipodium morphogenesis (GO:2000392),-0.2655227452213846,-0.6561888616231201,0.8735955056179775,0.9694227970203654,1.0,3/11,17.46%,PDPN;ARPIN;RREB1
prerank,secondary palate development (GO:0062009),0.2933317425488862,0.6555694072841766,0.8673621460506706,0.9998423985627827,1.0,2/14,6.38%,WNT5A;TGFBR2
prerank,membrane repolarization during cardiac muscle cell action potential (GO:0086013),0.2892456653892288,0.6554274105291862,0.8820224719101124,0.9995672675844159,1.0,4/15,19.17%,KCND3;KCNJ3;KCNH2;KCNA5
prerank,"DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator (GO:0006978)",0.3204013867158921,0.6552871340657851,0.8541329011345219,0.9992950486540431,1.0,4/10,15.90%,FOXM1;ING4;RPS27L;TP53
prerank,regulation of signal transduction by p53 class mediator (GO:1901796),0.20908764698287519,0.6552127521553066,0.9680082559339526,0.9989684443866,1.0,53/148,27.00%,NOP2;MAPKAP1;MTA2;RPA3;PRKAB2;CHD3;PPP1R13L;BRCA1;HDAC2;PHF20;MAPK14;TAF9;TAF11;TAF2;CDK5R1;RBBP4;RPA2;TOPBP1;MDM4;TAF7;ATM;TAF4;BLM;TP53;TAF4B;SGK1;USP2;WRN;TP53RK;BOP1;MDM2;TAF1;CSNK2A2;RBBP7;TTC5;SSRP1;TOP3A;PRKAA1;RAD50;BARD1;MTOR;ATR;EHMT2;RHNO1;TBP;BRPF1;RBBP8;RFC2;PPP2R5C;CDK5RAP3;MAP2K6;HDAC1;PIN1
prerank,tyrosine metabolic process (GO:0006570),0.3090797005065039,0.6551216844379314,0.8635658914728682,0.9986620874830798,1.0,2/11,17.25%,IL4I1;GSTZ1
prerank,positive regulation of cilium assembly (GO:0045724),-0.22297913999416563,-0.6538314914911897,0.9436619718309859,0.9701665776738735,1.0,4/18,18.16%,ARHGAP35;CCP110;FUZ;CROCC
prerank,negative regulation of ATP metabolic process (GO:1903579),0.27961305670929354,0.6534350089468398,0.8847795163584637,0.9998229138565036,1.0,3/17,11.37%,MLXIPL;CBFA2T3;PID1
prerank,positive regulation of viral life cycle (GO:1903902),0.2662552013732862,0.6523925785913032,0.8685636856368564,1.0,1.0,6/22,18.99%,TRIM11;VPS37B;DDB1;KPNA6;CD74;AXL
prerank,positive regulation of myeloid leukocyte mediated immunity (GO:0002888),-0.262605684076502,-0.6523305699619009,0.8835820895522388,0.9702675795526735,1.0,5/11,30.01%,CAMK4;TYROBP;ITGB2;SPI1;ITGAM
prerank,cellular response to leucine (GO:0071233),0.3131555894377126,0.6517151955683803,0.8892355694227769,1.0,1.0,5/10,29.15%,KLHL22;RPTOR;MTOR;SESN1;UBR1
prerank,response to leucine (GO:0043201),0.3131555894377126,0.6517151955683803,0.8892355694227769,1.0,1.0,5/10,29.15%,KLHL22;RPTOR;MTOR;SESN1;UBR1
prerank,"negative regulation of translation, ncRNA-mediated (GO:0040033)",-0.2573968562890167,-0.651521936294986,0.8997050147492626,0.9688442094872827,1.0,6/11,30.18%,AGO1;NOTCH4;AGO3;TNRC6C;AGO2;AGO4
prerank,miRNA mediated inhibition of translation (GO:0035278),-0.2573968562890167,-0.651521936294986,0.8997050147492626,0.9688442094872827,1.0,6/11,30.18%,AGO1;NOTCH4;AGO3;TNRC6C;AGO2;AGO4
prerank,heart looping (GO:0001947),0.24557154625506494,0.6514203198778384,0.9158291457286433,1.0,1.0,4/39,8.63%,CCDC39;TGFBR2;BBS5;SMO
prerank,antigen processing and presentation of peptide antigen via MHC class I (GO:0002474),-0.20760905072150987,-0.6510876363766492,0.9461538461538461,0.968161539065426,1.0,8/24,23.42%,ERAP1;TAPBP;ACE;SAR1B;HFE;TAPBPL;FCER1G;CALR
prerank,regulation of exosomal secretion (GO:1903541),0.27590219840876273,0.6509597316101214,0.8972222222222223,1.0,1.0,4/19,18.12%,PRKN;SDC4;PDCD6IP;RAB7A
prerank,mitochondrial fusion (GO:0008053),-0.2238126093394388,-0.6509250811612863,0.9415384615384615,0.9672511692113133,1.0,3/18,11.42%,SPG7;STOML2;MFF
prerank,purine nucleoside monophosphate biosynthetic process (GO:0009127),0.2972278583093491,0.6505580079297894,0.8690476190476191,1.0,1.0,1/12,2.71%,ADSS1
prerank,negative regulation of hydrogen peroxide-induced cell death (GO:1903206),0.2935915011823496,0.6497963476625604,0.8646153846153846,1.0,1.0,4/13,18.76%,GPR37;NFE2L2;MET;PARK7
prerank,positive regulation of type I interferon production (GO:0032481),0.2211306836634632,0.6496739480770081,0.9477866061293984,1.0,1.0,23/73,26.58%,PTPN22;LRRFIP1;POLR2K;SETD2;PTPN11;TBK1;XRCC6;DHX33;CGAS;CHUK;POLR1C;IRF3;POLR3G;HSPD1;NFKB1;STAT6;POLR3K;MAVS;POLR2F;PRKDC;IRF5;POLR3F;IRAK1
prerank,regulation of stress-activated protein kinase signaling cascade (GO:0070302),-0.2676105602179013,-0.6496634211872191,0.8864265927977839,0.9671362584240373,1.0,5/10,27.98%,LYN;MAP2K1;MAP2K2;FAS;GREM1
prerank,cell differentiation in hindbrain (GO:0021533),0.3073654742339721,0.6492172127776273,0.8674698795180723,1.0,1.0,4/11,23.48%,GRID2;OPHN1;FAIM2;KNDC1
prerank,mitotic G2/M transition checkpoint (GO:0044818),0.23435245923250217,0.6489296185061496,0.9261904761904762,1.0,1.0,8/43,15.80%,MRNIP;NAE1;BRCA1;TAOK3;ORC1;TOPBP1;ATM;BLM
prerank,regulation of hematopoietic progenitor cell differentiation (GO:1901532),0.22053403958588355,0.6486832558795914,0.9457627118644067,0.9998435152118147,1.0,14/73,20.75%,CBFB;KMT2A;METTL3;PSMB7;GATA3;PUS7;PSMD2;PSMC1;RUNX1;ABL1;PSMB2;PSMD9;PSME4;PSMA8
prerank,establishment of melanosome localization (GO:0032401),0.27430310506771377,0.6485732247738278,0.8931082981715893,0.999543742976219,1.0,7/19,25.46%,BBS5;MREG;BBS7;MYO5A;BLOC1S6;BBS4;RAB27B
prerank,regulation of viral entry into host cell (GO:0046596),0.24809406781202037,0.6482472307706579,0.9077922077922078,0.99943494522294,1.0,4/30,12.73%,GSN;TRIM11;MID2;NECTIN2
prerank,positive regulation of G2/M transition of mitotic cell cycle (GO:0010971),-0.2210982190998404,-0.6480662680463308,0.9281045751633987,0.9672513974575074,1.0,5/18,19.71%,VPS4B;CDK4;CDC7;RAD51C;MECP2
prerank,negative regulation of protein ubiquitination (GO:0031397),0.22837696013557257,0.6475241782915919,0.9268867924528302,0.9996960940538734,1.0,19/50,26.17%,UFL1;LIMK1;IVNS1ABP;BAG5;SENP2;CRY1;ABL1;N4BP1;FBXO5;DNAJA1;PARK7;TAF1;ARRB2;CAMLG;PRKCG;GNL3L;HSPA1A;SOX4;PER2
prerank,negative regulation of T-helper cell differentiation (GO:0045623),0.30499977243453885,0.6468259857469723,0.8595679012345679,0.999917696786721,1.0,1/11,3.88%,SOCS5
prerank,lipoprotein biosynthetic process (GO:0042158),0.29723094338269446,0.6462102166845326,0.8696319018404908,1.0,1.0,5/11,27.78%,WIPI1;PORCN;WDR45B;ATG10;PIK3C3
prerank,ubiquitin-dependent protein catabolic process (GO:0006511),0.2007558107890871,0.6460530948934381,0.9899799599198397,0.9997795295773197,1.0,85/341,23.12%,ZFAND2B;RAD23B;PRKN;MVB12B;HACE1;FBXW7;SPSB4;RNF6;SPOP;FBXO7;OTUD7B;TRIM2;HECTD3;PELI1;UBE2K;PSMB7;UCHL1;CUL3;HERPUD1;HUWE1;VPS37B;ANAPC7;FBXO45;CBL;USP33;NFE2L2;TOLLIP;ANAPC2;MYLIP;MVB12A;DDB1;NDFIP1;NEDD8;BUB1B;NEDD4L;PSMD2;KLHL22;PLAA;AREL1;PSMC1;RNF19A;RCHY1;CDC23;RNF111;FBXL4;ZSWIM8;ANAPC16;PSMB2;MIB1;RC3H1;RNF167;UBA1;TRIM9;FBXO22;MDM2;ELOC;OTUD7A;RNF4;PSMD9;TAF1;PCNP;FBXO11;PSME4;UBE2L3;CDC27;UBE2G1;RNF13;UBE2E1;DCAF11;PSMA8;PTTG1;ANAPC4;WDR81;RNF114;UBE2D3;UBQLN4;ARRB2;TTC3;UBR3;ANAPC5;UBQLN1;SIAH1;RNF187;UBQLN2;COP1
prerank,telomere capping (GO:0016233),0.27979605437103333,0.6458015637943811,0.8827067669172932,0.9996204978682197,1.0,7/16,25.22%,STN1;TERF2IP;CTC1;RAD50;ACD;TFIP11;PRKDC
prerank,female gonad development (GO:0008585),0.2732742237928139,0.6457615511908914,0.8880813953488372,0.9992659682954763,1.0,7/19,23.54%,VEGFA;EIF2B5;EIF2B2;NR5A1;CEBPB;INHBB;NR2F2
prerank,protein targeting to lysosome (GO:0006622),0.2643544514527033,0.645543927389848,0.9164345403899722,0.9990626667599857,1.0,5/20,20.73%,GNPTAB;AP4M1;RAB7A;SNX16;LAMP2
prerank,arachidonate transport (GO:1903963),0.3063160629976753,0.6455362074453079,0.8954758190327613,0.9982802346779428,1.0,2/10,13.50%,DRD2;PNPLA8
prerank,arachidonic acid secretion (GO:0050482),0.3063160629976753,0.6455362074453079,0.8954758190327613,0.9982802346779428,1.0,2/10,13.50%,DRD2;PNPLA8
prerank,autophagosome assembly (GO:0000045),0.22659530799284874,0.6455012101451648,0.9443786982248521,0.9979134676492547,1.0,15/52,24.68%,PACS2;WIPI1;ATG5;RAB1A;ATG3;GABARAPL2;RAB7A;STX17;VMP1;TMEM41B;UBQLN1;UBQLN2;EMC6;WDR45B;ATG12
prerank,positive regulation of T cell receptor signaling pathway (GO:0050862),0.2877035906033688,0.6447873966480433,0.8871951219512195,0.9981311810596635,1.0,5/14,27.54%,NECTIN2;BCL10;PRKD2;CARD11;RELA
prerank,import into nucleus (GO:0051170),0.2196839213391546,0.6447517510972376,0.9477777777777778,0.9977708488064185,1.0,17/73,21.11%,NUP155;FAM53B;IPO9;PRICKLE1;KPNB1;IPO13;NXT1;EIF4ENIF1;POM121;HTATIP2;GEMIN7;TNPO3;IPO5;CSE1L;STAT3;PHB2;HEATR3
prerank,carbohydrate derivative biosynthetic process (GO:1901137),0.25392382140485453,0.6445710559525704,0.9040920716112532,0.9975412367742362,1.0,4/26,19.74%,ST3GAL4;SCCPDH;ALG8;ALG6
prerank,oligosaccharide metabolic process (GO:0009311),0.23582859418569022,0.6443776226513839,0.9290865384615384,0.9973239697988918,1.0,5/46,10.57%,ST3GAL4;NAGA;MAN2C1;ST6GALNAC6;ST8SIA1
prerank,"nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:0000288)",0.2279138179103444,0.6430694975070138,0.943127962085308,0.9980952051070512,1.0,14/52,23.06%,TUT4;EXOSC8;DCP1B;PNLDC1;EXOSC2;EDC4;LSM3;CNOT3;NT5C3B;RC3H1;ZFP36;CNOT6L;DDX6;EXOSC3
prerank,negative regulation of amyloid fibril formation (GO:1905907),-0.2463033997551488,-0.6429901900317494,0.9264705882352942,0.9697535954793968,1.0,6/12,30.02%,VBP1;APOE;CLU;PFDN5;PFDN6;LDLR
prerank,negative regulation of type I interferon production (GO:0032480),0.23887767165550722,0.6428350995979831,0.9232643118148599,0.9979063785063534,1.0,11/40,24.09%,PYCARD;NLRX1;PPM1B;TAX1BP1;TBK1;IRF3;PTPRS;SIRPA;CYLD;PCBP2;MAVS
prerank,establishment of vesicle localization (GO:0051650),0.27109137542809203,0.6419678807449617,0.8954802259887006,0.9982522931188965,1.0,6/18,21.99%,SPG11;SYT11;KIF5C;CCDC186;TESK1;LIMK2
prerank,protein maturation by iron-sulfur cluster transfer (GO:0097428),-0.24013581325330474,-0.641690422663241,0.8927444794952681,0.9696213799984099,1.0,2/13,7.09%,MMS19;ISCA1
prerank,protein targeting (GO:0006605),0.21002482976376544,0.6411655791101877,0.9590075512405609,0.9985599823817064,1.0,27/118,20.73%,ZFAND2B;NCF1;FBXO7;NLGN1;GOLGA7B;TOMM22;SPCS3;AIP;TOMM20;VPS37B;NACA;AKAP6;KATNB1;ATG3;ZDHHC24;ZFAND6;SEC61G;GDAP1;SEC63;DNAJC19;AP4M1;TRAK2;PEX1;CHM;TSPO;ZDHHC21;LAMP2
prerank,maturation of LSU-rRNA (GO:0000470),-0.2003257228894596,-0.6405306698838819,0.9555555555555556,0.9694026622119961,1.0,12/26,30.82%,NSA2;URB1;MAK16;LAS1L;RPL7A;PES1;SNU13;RPF2;RPF1;NHP2;DDX18;ZNHIT3
prerank,anaphase-promoting complex-dependent catabolic process (GO:0031145),0.21452976386214256,0.6404615919115296,0.9527472527472527,0.9987566496849439,1.0,23/84,23.62%,PSMB7;CUL3;ANAPC7;ANAPC2;BUB1B;PSMD2;UBB;PSMC1;CDC23;ANAPC16;PSMB2;FBXO5;FBXO31;PSMD9;PSME4;CDC27;UBE2E1;PSMA8;PTTG1;ANAPC4;ANAPC5;RB1;CDC16
prerank,regulation of superoxide anion generation (GO:0032928),-0.2344289522613185,-0.640255698293824,0.9238095238095239,0.9685775883031608,1.0,3/14,12.50%,PRKCD;SOD1;MAPT
prerank,positive regulation of wound healing (GO:0090303),0.23800206239550029,0.639997964572113,0.9292035398230089,0.9987377571177549,1.0,10/36,24.01%,ST3GAL4;CLDN1;SMOC2;ITGB1;ARFGEF1;HBEGF;KANK1;INSL3;MTOR;PRKCE
prerank,organic hydroxy compound biosynthetic process (GO:1901617),0.23761626993475096,0.6397662119877442,0.9326113116726835,0.9985463953695838,1.0,15/44,26.17%,SQLE;PSAT1;CYP39A1;PNPO;CYP7B1;CYP27A1;OSBPL1A;SC5D;PARK7;ACOT8;SCP2;HMGCR;HSD17B4;AMACR;PER2
prerank,regulation of multicellular organismal development (GO:2000026),0.25463327242563977,0.6392711657296057,0.8962765957446809,0.998578377735471,1.0,5/25,17.52%,RAB14;DUSP6;MYSM1;GATA3;SPAAR
prerank,cellular response to ionizing radiation (GO:0071479),0.22921837071457138,0.6384414844930401,0.9245508982035928,0.9988872291767844,1.0,20/47,30.08%,CRYAB;TLK2;MAPK14;XRCC6;ATM;BLM;TP53;SPIDR;WRN;MDM2;GRB2;ATR;RHNO1;TNKS1BP1;LIG4;CDKN1A;SIRT1;INTS7;NUCKS1;RAD1
prerank,regulation of mRNA catabolic process (GO:0061013),0.20690331424725586,0.63799374622736,0.9766702014846236,0.9988887615675222,1.0,24/121,20.75%,PRKCA;XPO1;PABPC1;MAPKAPK2;YWHAZ;EXOSC8;PSMB7;ZFP36L2;EIF4G1;EXOSC2;PCBP4;UPF1;PSMD2;KHSRP;UBB;PSMC1;PNPT1;PSMB2;RC3H1;PCID2;PSMD9;PSME4;ZFP36;PSMA8
prerank,fatty acid catabolic process (GO:0009062),0.2203993172969985,0.6372046060511803,0.9560315670800451,0.9991510731368384,1.0,19/67,24.82%,CEL;SLC27A4;ACBD5;HADHA;AIG1;ACOX1;MTLN;ABCD2;ILVBL;AUH;EHHADH;ACAA2;DECR1;ACOT8;ACADS;SCP2;ABHD3;HSD17B4;NUDT19
prerank,regulation of inflammatory response to antigenic stimulus (GO:0002861),0.20822006823340958,0.6368233497658743,0.971307120085016,0.9990813724617916,1.0,10/117,12.74%,CRH;DPEP1;PTHLH;PRKAR1B;PTH2R;FYN;TSHR;MAPK14;PRKACA;GLP2R
prerank,ventricular cardiac muscle tissue development (GO:0003229),0.2557802801563821,0.6363678608347044,0.9051490514905149,0.9990400909982301,1.0,2/23,4.54%,TGFB1;DSG2
prerank,"positive regulation of gene expression, epigenetic (GO:0045815)",0.22983249753241983,0.6363163406395711,0.9428223844282239,0.9986926243244233,1.0,9/48,17.82%,KAT2B;TAF1A;ZMIZ1;POLR2K;ASF1A;POLR1B;BAZ1B;POLR1C;POLR1G
prerank,proteasomal protein catabolic process (GO:0010498),0.19953367392583848,0.6362342309701736,0.9888551165146909,0.9983733942235826,1.0,46/201,23.12%,ZFAND2B;RAD23B;PRKN;HACE1;FBXW7;SPSB4;SPOP;TRIM2;HECTD3;PELI1;UBE2K;PSMB7;UCHL1;RCN3;CUL3;HUWE1;FBXO45;NFE2L2;DDB1;CCDC47;NEDD4L;PSMD2;KLHL22;PLAA;AREL1;PSMC1;ZSWIM8;PSMB2;CUL4B;TRIM9;MDM2;RNF4;PSMD9;PCNP;PSME4;UBE2G1;DCAF11;PSMA8;UBXN6;RHBDD1;UBE2D3;ARRB2;FBXO44;SIAH1;RNF187;COP1
prerank,regulation of JUN kinase activity (GO:0043506),0.24240487141264128,0.6349209822599056,0.9332460732984293,0.9990834061836343,1.0,10/33,24.03%,PTPN22;PAK1;TAOK3;MAP3K4;DNAJA1;MAP3K11;PDCD4;DVL3;AIDA;PPEF2
prerank,poly-N-acetyllactosamine biosynthetic process (GO:0030311),0.2938676854121507,0.6347987700186638,0.9040880503144654,0.998806186876751,1.0,1/12,6.45%,B3GNT9
prerank,lipoprotein catabolic process (GO:0042159),0.30223272492844633,0.6346534962270244,0.9037593984962407,0.9985393756856686,1.0,3/11,17.88%,LYPLA1;LYPLA2;ABHD10
prerank,positive regulation of cell development (GO:0010720),0.24031586083071663,0.6345775099731353,0.921994884910486,0.9982199500665869,1.0,3/31,6.19%,SOX11;NUMBL;RFX3
prerank,positive regulation of protein sumoylation (GO:0033235),0.30630524636818823,0.6342426340721402,0.8759571209800919,0.9981146237966713,1.0,1/10,5.36%,UBA2
prerank,protein homotetramerization (GO:0051289),0.22580539166232816,0.6339028160358208,0.9429928741092637,0.9979860050293922,1.0,10/49,21.48%,CTH;ACACA;AQP4;SOD2;ALDH1A3;GLS;RYR3;HCN1;SSBP1;PKD2
prerank,receptor signaling pathway via JAK-STAT (GO:0007259),-0.19518321459545268,-0.6332907228984417,0.9620853080568721,0.9721279661069303,1.0,7/29,21.10%,IL31RA;CTR9;STAT5B;NMI;STAT2;IFNAR1;IFNAR2
prerank,phosphatidylinositol dephosphorylation (GO:0046856),0.26063341763082254,0.6328873037357721,0.9040333796940194,0.9984201467846687,1.0,7/23,24.19%,PTEN;MTMR12;INPP5J;MTMR7;INPP5B;MTM1;MTMR1
prerank,positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900740),0.2535525365044073,0.630737358744409,0.9077134986225895,0.9993578328075869,1.0,4/23,15.90%,BCL2;YWHAZ;PPP3CC;TP53
prerank,regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900739),0.2535525365044073,0.630737358744409,0.9077134986225895,0.9993578328075869,1.0,4/23,15.90%,BCL2;YWHAZ;PPP3CC;TP53
prerank,regulation of amyloid-beta clearance (GO:1900221),0.2724833903247988,0.6303817842274914,0.9135618479880775,0.9992654429966844,1.0,1/16,2.55%,LRP1
prerank,dendritic cell chemotaxis (GO:0002407),0.2793808357790648,0.6300377751399511,0.9007299270072993,0.999167104781103,1.0,1/14,5.23%,CCR2
prerank,mitochondrion distribution (GO:0048311),-0.24383673164979988,-0.6295441718702356,0.9351032448377581,0.9733964097264112,1.0,5/12,20.06%,TRAK1;MAPT;ATCAY;DNM1L;MSTO1
prerank,regulation of chromosome segregation (GO:0051983),-0.223089839881073,-0.6286298483966951,0.9329073482428115,0.9729488481596412,1.0,9/16,43.90%,NUMA1;RAD18;RMI2;SMC6;MKI67;CDC6;BUB1;IHO1;KIF2C
prerank,glycosphingolipid metabolic process (GO:0006687),0.2327067992331554,0.628386641055083,0.9360675512665863,1.0,1.0,6/42,13.72%,GBA2;GM2A;ST6GALNAC6;GALC;ST8SIA1;SUMF1
prerank,"DNA damage response, signal transduction resulting in transcription (GO:0042772)",0.29727887650575807,0.6278612325127702,0.896551724137931,1.0,1.0,4/11,15.90%,FOXM1;ING4;RPS27L;TP53
prerank,regulation of telomere maintenance via telomere lengthening (GO:1904356),0.27519032103155733,0.6277680879174262,0.8895434462444771,0.9997847088320152,1.0,4/16,16.25%,ERCC4;RTEL1;ATM;SMG6
prerank,chaperone cofactor-dependent protein refolding (GO:0051085),0.25227601579814696,0.6277675999243992,0.9198931909212283,0.9993962874991507,1.0,6/25,24.51%,DNAJB4;GAK;SDF2;HSPA9;ERO1A;HSPA1A
prerank,regulation of immune response (GO:0050776),0.2027696575900719,0.62748626016651,0.9905857740585774,0.999241382295828,1.0,17/135,17.58%,PTPN22;CD34;FGL1;ELMOD2;CSK;COL3A1;IL4I1;COL1A2;NECTIN2;AHR;COL1A1;ITGB1;CD300LB;XIAP;N4BP1;ITGB7;CLEC2D
prerank,regulation of amyloid fibril formation (GO:1905906),0.2719688924865793,0.6274026721653735,0.9069767441860465,0.9989229233722291,1.0,2/15,8.98%,PSEN1;CRYAB
prerank,positive regulation of immune response (GO:0050778),0.21721356310273843,0.6264476739357911,0.9529276693455798,0.9993034343538663,1.0,2/64,2.66%,PYCARD;FADD
prerank,activation of protein kinase A activity (GO:0034199),0.2691152584438784,0.6261249204349435,0.9090909090909091,0.9991566231140631,1.0,3/16,12.48%,PRKAR1B;PRRC1;PRKACA
prerank,regulation of cytokinesis (GO:0032465),0.21101558456049221,0.6259415568900248,0.9627192982456141,0.9989109359619422,1.0,20/78,24.43%,KIF20B;KLHL13;CUL3;SETD2;MYO19;CDC25B;DRD2;RAB11FIP3;CALM1;CHMP4C;CDC14A;CALM2;CENPV;PKN2;SVIL;AHCTF1;KIF13A;PLK5;PRKCE;BBS4
prerank,phospholipid dephosphorylation (GO:0046839),0.2357460165927048,0.6252998925786122,0.9271604938271605,0.9990147685635555,1.0,13/37,26.72%,PTEN;MTMR12;PLPP4;PLPPR4;PLPPR2;INPP5J;PLPPR1;MTMR7;INPP5B;MTM1;MTMR1;EPHX2;SGPP1
prerank,activation of NF-kappaB-inducing kinase activity (GO:0007250),0.2822587294593874,0.624866656187839,0.9142419601837672,0.9989544146763711,1.0,2/14,13.22%,TNFRSF10B;MALT1
prerank,CENP-A containing chromatin organization (GO:0061641),0.24350606731940513,0.6243669616667031,0.918848167539267,0.9985594266264796,1.0,9/29,22.39%,HJURP;OIP5;RBBP4;ITGB3BP;NASP;CENPL;CENPC;RBBP7;CENPU
prerank,CENP-A containing nucleosome assembly (GO:0034080),0.24350606731940513,0.6243669616667031,0.918848167539267,0.9985594266264796,1.0,9/29,22.39%,HJURP;OIP5;RBBP4;ITGB3BP;NASP;CENPL;CENPC;RBBP7;CENPU
prerank,mucosal immune response (GO:0002385),0.27493797266035136,0.6238092949679463,0.895741556534508,0.9985666818229949,1.0,1/15,6.17%,OTUD7B
prerank,positive regulation of protein ubiquitination (GO:0031398),0.20884997978631414,0.6234644636096098,0.9695982627578719,0.9984673157285957,1.0,19/80,20.76%,FBXW7;SPSB4;NSMCE3;BRCA1;CUL3;HUWE1;PRICKLE1;MALT1;NDFIP1;SENP2;CRY1;UBB;RCHY1;XIAP;FANCI;MAGEC2;BCL10;UBE2L3;PEF1
prerank,defense response to Gram-negative bacterium (GO:0050829),0.2258744298590625,0.6230316408091889,0.9497549019607843,0.9983893415041004,1.0,2/42,3.93%,PYCARD;RNASE6
prerank,sterol metabolic process (GO:0016125),0.2227669987233963,0.6230129024673174,0.9538288288288288,0.9980187420500373,1.0,7/60,10.88%,SQLE;GBA2;CYP39A1;OSBPL5;CYP1B1;CYP7B1;ABCA5
prerank,cellular response to interleukin-12 (GO:0071349),0.22346447768975222,0.6221646134400802,0.9522673031026253,0.9982713133930289,1.0,14/48,26.12%,HNRNPDL;PLCB1;AIP;TYK2;SOD2;MTAP;HSPA9;PDCD4;TALDO1;SIRPA;BOLA2;TCP1;SNRPA1;HNRNPA2B1
prerank,MyD88-dependent toll-like receptor signaling pathway (GO:0002755),0.24686761846188304,0.6220930155515998,0.9122340425531915,0.997937277021439,1.0,12/27,30.56%,IRAK3;TLR1;UBB;TAB3;HSPD1;TAB2;IRAK2;IRAK1;TRAF6;TAB1;IRAK4;BTK
prerank,regulation of centrosome duplication (GO:0010824),-0.18770647388447076,-0.6220124813050286,0.9559471365638766,0.9758759235364243,1.0,13/29,32.46%,CHMP3;NPM1;CHMP1A;CENATAC;VPS4B;SPICE1;CEP295;CHMP2B;STIL;CCNF;GEN1;CEP131;PLK2
prerank,telomere maintenance (GO:0000723),0.22163253196191782,0.6216116377090887,0.9492325855962219,0.997914886736449,1.0,12/50,17.92%,ERCC4;STN1;RPA3;XRCC6;XRCC3;RPA2;RTEL1;ATM;BLM;TERF2IP;WRN;TPRKB
prerank,DNA recombination (GO:0006310),0.23504829827863905,0.6214400892487951,0.9318463444857497,0.9976525319574842,1.0,12/37,26.08%,FBH1;XRCC3;RTEL1;RAD52;BLM;WRN;RAD50;SUPV3L1;RECQL;RHNO1;LIG4;TSN
prerank,icosanoid biosynthetic process (GO:0046456),0.302935645716257,0.621086023949844,0.9210526315789473,0.9975142418442491,1.0,2/10,12.51%,LTA4H;ALOX5AP
prerank,purine-containing compound salvage (GO:0043101),0.2872275410835272,0.6200609236199659,0.9046875,0.9979000304149508,1.0,2/12,12.60%,ADK;DGUOK
prerank,T cell activation involved in immune response (GO:0002286),-0.24221928687956773,-0.6199204180552554,0.9125,0.9760361460211168,1.0,5/12,30.51%,ICAM1;FCER1G;LCP1;EIF2AK4;SLC11A1
prerank,polarized epithelial cell differentiation (GO:0030859),0.27926178997714457,0.6195760108314875,0.8869565217391304,0.9978814170056894,1.0,3/13,12.72%,MYO9A;OPHN1;SCRIB
prerank,regulation of mRNA stability (GO:0043488),0.19743133463108484,0.6194895166928436,0.9801670146137788,0.9975598570192391,1.0,33/145,22.19%,PRKCA;XPO1;PABPC1;MAPKAPK2;YWHAZ;METTL3;EXOSC8;PSMB7;ZFP36L2;EIF4G1;EXOSC2;GDNF;PCBP4;PSMD2;KHSRP;UBB;EIF4ENIF1;PSMC1;HNRNPU;PSMB2;RC3H1;PCID2;FUS;PSMD9;TENT5D;GIGYF2;PSME4;TENT5A;ZFP36;PSMA8;VIM;TENT5C;RIDA
prerank,adrenergic receptor signaling pathway (GO:0071875),0.2626297634711744,0.617720053906454,0.9267241379310345,0.9984767414697738,1.0,3/20,12.69%,AKAP13;PDE4D;DRD2
prerank,regulation of transcription by RNA polymerase III (GO:0006359),0.2615948958230844,0.617138143078386,0.898876404494382,0.9985067060262587,1.0,6/19,26.14%,ZC3H8;ELL;RPTOR;POLR3G;MTOR;POLR3F
prerank,regulation of biosynthetic process (GO:0009889),-0.251376164731173,-0.6154622115990231,0.918429003021148,0.9775928152378186,1.0,3/11,24.24%,SLC25A33;MID1IP1;SPHK2
prerank,peptide cross-linking (GO:0018149),0.2444132699435336,0.6150537288185148,0.9193548387096774,0.9996361692781162,1.0,2/25,9.11%,TGM1;COL3A1
prerank,high-density lipoprotein particle assembly (GO:0034380),0.28881428421335553,0.6148496133115404,0.896875,0.9993817735411987,1.0,2/10,12.48%,ZDHHC8;PRKACA
prerank,immune response-activating cell surface receptor signaling pathway (GO:0002429),-0.21472694112246,-0.6137983231643694,0.9525423728813559,0.9774571801958717,1.0,2/18,6.75%,LYN;BCAR1
prerank,"regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043516)",0.23775440895659614,0.6137322852338462,0.9389110225763613,0.9997951840710809,1.0,10/27,27.42%,SPRED2;SPRED1;SPRED3;ATM;CD74;MDM2;SNAI1;ATR;PTTG1IP;SIRT1
prerank,histone ubiquitination (GO:0016574),0.25241429430329543,0.6122221745473059,0.9269282814614344,1.0,1.0,4/21,20.33%,WAC;HUWE1;CDC73;UBE2E1
prerank,regulation of secretion by cell (GO:1903530),0.2152371660978449,0.6119379885638306,0.9616724738675958,1.0,1.0,14/54,22.49%,SYT1;RAB21;RAB3D;SYN1;MCTP1;RIMS1;STXBP5;RAB3A;RIMS2;RAB3B;ARFIP1;DISP1;LLGL1;P3H1
prerank,cardiac cell development (GO:0055006),0.2857244441721383,0.6105596397929761,0.8942598187311178,1.0,1.0,1/11,3.14%,VEGFA
prerank,gene expression (GO:0010467),0.189800973279454,0.6095788186703113,0.9969909729187563,1.0,1.0,78/348,22.58%,BICD1;DHX8;MRPS18A;THOC6;ELAVL4;RANBP2;TSPAN32;RPL23A;RNGTT;HOXD3;MRPL32;POLR2B;NUP155;XRN2;FARSB;SRBD1;DDX54;MCM3AP;SRSF11;LMF1;POLR2K;CASC3;APOBEC1;ALKBH5;NCBP1;ADARB2;MRPL35;FIP1L1;EIF4G1;DUSP11;NUP205;NDC1;TSPAN17;GSPT2;MRPL28;NUP160;UPF1;SNRNP40;DDX25;EPC1;ADARB1;NXT1;POLR2G;HARS1;NOVA1;SRSF6;YTHDC1;MRPL51;POM121;SMG6;HNRNPU;AAAS;ABCF1;NXF1;RNPS1;MLF1;RPSA;POLR2A;THOC7;SYNCRIP;SRRM1;HNRNPUL1;MRPS14;FUBP3;HSPD1;HNRNPL;MRPS6;HARS2;SRSF3;RBMS1;FYTTD1;MRPL52;RPS11;NUP42;MRPL18;GLE1;SYMPK;BCL3
prerank,response to peptide hormone (GO:0043434),0.22479096967625303,0.6089085858606836,0.9606205250596659,1.0,1.0,13/43,25.03%,SLC27A1;TSC1;EIF2B5;EIF6;GNAI1;CRY1;EIF2B2;STAT3;STAT5A;STAT6;ZBED3;TGFBR3;EPM2AIP1
prerank,regulation of cell aging (GO:0090342),0.28745390202472854,0.6085865845245151,0.8892307692307693,1.0,1.0,3/11,16.28%,FOXM1;LMNA;PNPT1
prerank,negative regulation of cell cycle (GO:0045786),0.20600654482996014,0.6085762314420563,0.9720044792833147,1.0,1.0,20/73,23.54%,PTEN;TGFB1;NUPR2;CDK6;MEN1;BMP7;SCRIB;GATA3;RPS6KA2;NPPC;RNF167;NUDT6;IPO5;PDCD4;TRIM35;DUSP1;HECA;RB1;BMP2;NR2F2
prerank,regulation of spindle assembly (GO:0090169),0.23984591719872134,0.6084990917987608,0.9205298013245033,1.0,1.0,9/25,24.51%,GPSM2;PDCD6IP;CHMP4C;HNRNPU;RNF4;CHMP1B;DYNC1H1;CEP97;HSPA1A
prerank,regulation of organelle organization (GO:0033043),0.2041281663684388,0.6079691565748908,0.9708846584546472,1.0,1.0,22/80,24.09%,PRKN;PARL;VPS11;SYT11;RHOT2;CAPN6;CLEC16A;TMEM33;MAPK1;USP6NL;ZEB2;SURF4;RBSN;CENPV;RHOT1;RDX;MYO5A;LMAN1;TAOK1;STX18;MTM1;MAVS
prerank,tRNA metabolic process (GO:0006399),0.25899110295488403,0.6073386783240052,0.918918918918919,1.0,1.0,7/17,24.16%,FARS2;POP1;RPP21;SSB;DTD1;RPP30;DARS2
prerank,mitochondrial transcription (GO:0006390),0.29229453853263876,0.6071267630024766,0.9088098918083463,1.0,1.0,3/10,21.10%,TFAM;POLRMT;MTERF2
prerank,poly-N-acetyllactosamine metabolic process (GO:0030309),0.27446723436898945,0.6064807775018319,0.9297971918876755,1.0,1.0,1/13,6.45%,B3GNT9
prerank,negative regulation of receptor internalization (GO:0002091),-0.23460840906785616,-0.6064631708797451,0.9318801089918256,0.9802850039704261,1.0,4/12,20.36%,RIN3;MTMR2;ANKRD13B;ANKRD13A
prerank,regulation of protein ubiquitination (GO:0031396),0.19834725154682667,0.6060325440737814,0.9775641025641025,1.0,1.0,36/108,26.60%,PRKN;FBXW7;NSMCE3;UFL1;IVNS1ABP;BAG5;BRCA1;CUL3;HUWE1;PRICKLE1;MALT1;NDFIP1;SENP2;CRY1;WASHC1;UBB;RCHY1;XIAP;FANCI;N4BP1;DNAJA1;PARK7;BCL10;UBE2L3;ARRB2;CAMLG;UBQLN1;PRKCG;GNL3L;HSPA1A;SOX4;MYCBP2;PER2;CENPX;PTTG1IP;CDK5RAP3
prerank,regulation of cell cycle phase transition (GO:1901987),0.19986655571650572,0.6059307610175384,0.9780941949616648,0.9997206387285136,1.0,33/91,29.29%,FBXW7;PSMB7;ANAPC7;ANAPC2;DDB1;BUB1B;PSMD2;PSMC1;TP53;CDC23;ANAPC16;PSMB2;FBXO5;PSMD9;TAF1;DBF4;PSME4;CDC27;UBE2E1;PSMA8;ANAPC4;ANAPC5;CDC16;CUL1;PSMD8;PSMD13;CDKN1A;TRIM39;PSMD4;UBE2S;ATP2B4;PSMD5;CDKN1B
prerank,negative regulation of cell cycle process (GO:0010948),0.20712022226470225,0.6044340337247174,0.969248291571754,1.0,1.0,18/61,27.21%,EED;APAF1;E2F6;BRCA1;AURKAIP1;BMP7;EPC1;RBBP4;CHMP4C;FBXO5;RBBP7;CBX5;RNF2;CBX3;EHMT2;RBBP8;EZH2;NME6
prerank,negative regulation of transposition (GO:0010529),0.2628397056078467,0.6043536116871698,0.924198250728863,0.9999998591115551,1.0,2/16,9.32%,TUT4;TEX15
prerank,cytoplasmic pattern recognition receptor signaling pathway (GO:0002753),0.2418799624894031,0.6035139133831912,0.9391534391534392,1.0,1.0,11/26,28.01%,ALPK1;UBB;TAB3;AAMP;TAB2;CYLD;IRAK2;IRAK1;MAP2K6;TRAF6;TAB1
prerank,negative regulation of response to biotic stimulus (GO:0002832),0.23625007287409844,0.6012699482451043,0.9402035623409669,1.0,1.0,2/26,8.38%,IRAK3;PPM1B
prerank,positive regulation of mitochondrial translation (GO:0070131),0.2681059645058007,0.6007326818850732,0.9300291545189504,1.0,1.0,2/14,12.06%,NGRN;RCC1L
prerank,positive regulation of tyrosine phosphorylation of STAT protein (GO:0042531),0.21547846557553235,0.6003596223093298,0.9563636363636364,1.0,1.0,5/49,11.09%,CRLF1;VEGFA;IL18;ERBB4;IL6ST
prerank,very-low-density lipoprotein particle assembly (GO:0034379),0.27236118198059517,0.5995458644922087,0.9161764705882353,1.0,1.0,2/12,15.26%,MTTP;ACSL3
prerank,renal water homeostasis (GO:0003091),0.24047182596763766,0.599003891106926,0.9246298788694481,1.0,1.0,3/23,12.48%,PRKAR1B;AQP4;PRKACA
prerank,interleukin-35-mediated signaling pathway (GO:0070757),0.28077333500721885,0.5987416719911876,0.9275590551181102,1.0,1.0,11/11,71.94%,IL6ST;STAT3;EBI3;IL12A;IL27RA;STAT1;STAT4;JAK1;IL12RB2;JAK2;CANX
prerank,negative regulation of insulin secretion (GO:0046676),0.25820311899676274,0.5983681281851243,0.9244755244755245,1.0,1.0,1/17,2.35%,PRKN
prerank,interleukin-12-mediated signaling pathway (GO:0035722),0.21510059767251508,0.5981790974908563,0.9539007092198581,1.0,1.0,13/46,26.12%,HNRNPDL;PLCB1;AIP;TYK2;SOD2;MTAP;HSPA9;PDCD4;TALDO1;BOLA2;TCP1;SNRPA1;HNRNPA2B1
prerank,ncRNA metabolic process (GO:0034660),0.22036833672750863,0.5980045915738367,0.9546568627450981,1.0,1.0,9/37,23.25%,FKBP6;TUT4;KHSRP;MEPCE;NIFK;DTD1;TDRKH;DDX4;XPO5
prerank,regulation of reactive oxygen species biosynthetic process (GO:1903426),0.2349940785910648,0.5956297578212661,0.9514066496163683,1.0,1.0,5/26,18.76%,SLC5A3;SNCA;ABCD2;TRAP1;PARK7
prerank,pancreas development (GO:0031016),0.275690529320386,0.5955871934818424,0.9107142857142857,1.0,1.0,1/12,2.93%,CCDC39
prerank,regulation of lipid catabolic process (GO:0050994),0.2439174928814321,0.5951606074175044,0.9484679665738162,1.0,1.0,4/19,21.94%,PDE3B;TYSND1;RARRES2;PRKAA1
prerank,regulation of acute inflammatory response (GO:0002673),0.2564095802005617,0.5949972878944284,0.943213296398892,1.0,1.0,2/18,17.78%,IL6ST;PTGES
prerank,"positive regulation of DNA-templated transcription, initiation (GO:2000144)",0.2429226473959852,0.5939794190274464,0.9316005471956225,1.0,1.0,6/21,22.78%,MED13;MED12;MED30;JUN;MITF;MED24
prerank,"tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388)",-0.220683927228277,-0.5923688104666471,0.9591194968553459,0.9860178906324434,1.0,8/14,37.99%,TSEN15;ZBTB8OS;CPSF4;CLP1;TRPT1;TSEN54;CSTF2;RTRAF
prerank,regulation of centrosome cycle (GO:0046605),-0.19657783576478888,-0.5923594442748118,0.9507042253521126,0.9850057568120802,1.0,3/21,9.91%,CHMP3;NPM1;CHMP1A
prerank,regulation of rhodopsin mediated signaling pathway (GO:0022400),0.23974281080006218,0.5913646117783078,0.9491758241758241,1.0,1.0,1/23,1.69%,RHO
prerank,cristae formation (GO:0042407),0.23295683983959078,0.5912562586875411,0.9541284403669725,1.0,1.0,10/27,27.65%,LETM1;APOOL;ATP5MG;DMAC2L;CHCHD6;ATP5MC2;ATP5PO;ATP5ME;ATP5PF;ATP5F1B
prerank,heart contraction (GO:0060047),0.21629748113370728,0.5905357137556553,0.960927960927961,1.0,1.0,3/41,5.87%,SGCD;SCN5A;SGCZ
prerank,autophagosome organization (GO:1905037),0.20811059019264588,0.5904716514853902,0.9702026221692491,1.0,1.0,14/50,24.68%,PACS2;WIPI1;ATG5;RAB1A;ATG3;GABARAPL2;RAB7A;VMP1;TMEM41B;UBQLN1;UBQLN2;EMC6;WDR45B;ATG12
prerank,regulation of cholesterol transport (GO:0032374),0.24398908685416157,0.5882929371137594,0.9457259158751696,1.0,1.0,4/20,21.17%,LRP1;ABCA5;TSPO;NFKB1
prerank,intrinsic apoptotic signaling pathway by p53 class mediator (GO:0072332),0.22452031282344326,0.5881870593362944,0.9628681177976952,1.0,1.0,9/32,24.96%,PYCARD;HINT1;AEN;RPS27L;TP53;BCL3;RRP8;FHIT;USP28
prerank,thyroid hormone generation (GO:0006590),0.2803550968946896,0.5864236484038072,0.9111791730474732,1.0,1.0,1/10,6.64%,CTSK
prerank,positive regulation of heart rate (GO:0010460),-0.19959377361801955,-0.5839580622435971,0.9589905362776026,0.9876982562861325,1.0,2/17,6.22%,ADRA1B;TPM1
prerank,SCF-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0031146),0.19270218229771874,0.5837605869891445,0.9890590809628009,1.0,1.0,18/88,20.75%,FBXW7;FBXO38;FBXL15;FBXL16;PSMB7;FBXO27;FBXO17;FBXL2;PSMD2;PSMC1;FBXL4;PSMB2;CUL4B;FBXO31;PSMD9;PSME4;FBXL12;PSMA8
prerank,protein catabolic process (GO:0030163),0.20623509572504573,0.5835946440069717,0.9713302752293578,1.0,1.0,17/59,23.95%,PRKN;FBXO27;UCHL3;FBXO17;DDB1;CUL4B;RIPK1;MAGEC2;UBE2G1;LAMP2;PSMA8;FBXO44;OGA;SIAH1;TPP1;CLN6;MTOR
prerank,mitotic recombination (GO:0006312),0.2572956987477864,0.5835772928506712,0.9286754002911208,1.0,1.0,4/15,22.69%,XRCC3;RAD52;TPRKB;RAD50
prerank,mitotic spindle assembly (GO:0090307),0.21404364845121898,0.5834313331107953,0.966824644549763,1.0,1.0,11/42,24.01%,ARHGEF10;STAG2;FLNA;CLASP1;KPNB1;AAAS;KIF2A;BCCIP;SMC1A;WRAP73;KIFC2
prerank,negative regulation of leukocyte apoptotic process (GO:2000107),0.2677798003891782,0.581998896267031,0.9300476947535771,1.0,1.0,11/11,73.24%,SELENOS;AXL;MERTK;CCR7;CXCL12;LILRB1;GAS6;IRF7;HCLS1;NOD2;CCL19
prerank,sno(s)RNA 3'-end processing (GO:0031126),0.26839322642716185,0.581985433398754,0.9355828220858896,1.0,1.0,2/11,11.12%,EXOSC2;FBL
prerank,positive regulation of cell division (GO:0051781),0.21489154166248906,0.5814139970213745,0.9694749694749695,1.0,1.0,8/38,20.27%,KIF20B;CUL3;CDC25B;DRD2;CDC14A;CENPV;PKN2;SVIL
prerank,cardiac left ventricle morphogenesis (GO:0003214),0.2598178790989449,0.5807444582652166,0.9273827534039334,1.0,1.0,1/13,6.38%,TGFBR2
prerank,ncRNA catabolic process (GO:0034661),0.22781336510104613,0.58048559098519,0.974025974025974,1.0,1.0,5/28,16.60%,TUT4;EXOSC8;EXOSC2;RBM7;POP1
prerank,"DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:0006977)",0.202788325732776,0.5799572705603132,0.972877358490566,1.0,1.0,10/54,18.13%,CARM1;PCBP4;PRMT1;CNOT3;MDM4;CASP2;CRADD;ATM;TP53;MDM2
prerank,protein deacylation (GO:0035601),0.23290989969655557,0.5798594161876887,0.938961038961039,1.0,1.0,5/23,17.88%,LYPLA1;HDAC6;SIRT6;LYPLA2;ABHD10
prerank,negative regulation of mitochondrion organization (GO:0010823),0.2233478421684903,0.5797252387769952,0.9588159588159588,1.0,1.0,8/33,18.81%,PRKN;BNIP3;HUWE1;OPA1;FZD9;MPV17L;ADCK1;ACAA2
prerank,negative regulation of mitotic metaphase/anaphase transition (GO:0045841),0.24087124878154337,0.5796882968619725,0.9333333333333333,1.0,1.0,5/21,17.86%,ZWINT;BUB1B;KLHL22;ATM;FBXO5
prerank,error-free translesion synthesis (GO:0070987),0.23938829888615043,0.5794419423654499,0.9630642954856361,1.0,1.0,5/22,17.26%,RPA3;RPA2;UBB;RCHY1;REV1
prerank,protein acylation (GO:0043543),0.21475198676998478,0.5784704249405159,0.9616306954436451,1.0,1.0,5/38,12.19%,KAT2B;GTF2B;ZDHHC8;ING4;HHAT
prerank,long-chain fatty acid biosynthetic process (GO:0042759),0.23661756429620184,0.5783391830106164,0.951856946354883,1.0,1.0,2/23,8.18%,LTA4H;ELOVL6
prerank,nonribosomal peptide biosynthetic process (GO:0019184),0.27090346718776254,0.5774851207372068,0.93519882179676,1.0,1.0,2/12,12.98%,GSS;GGCT
prerank,acylglycerol metabolic process (GO:0006639),0.21585561354965296,0.5771273786896339,0.9707317073170731,1.0,1.0,14/37,28.52%,LMF1;DGKI;PLAAT3;LYPLA2;ABHD6;DGAT2;DGKA;DGKK;PGS1;DGKD;GK;DGKZ;SEL1L;DGKQ
prerank,acute inflammatory response (GO:0002526),0.23974633132175058,0.5763763101375073,0.960328317373461,1.0,1.0,1/23,3.48%,ANO6
prerank,innate immune response (GO:0045087),0.1809856051162278,0.5760896661319101,0.9989806320081549,1.0,1.0,39/217,24.37%,CXCL10;KYNU;ALPK1;RNASE6;NCF1;ANKHD1;CARD9;OTULIN;TRIM11;FYN;NCF2;SETD2;MID2;STYK1;TBK1;MALT1;SNCA;CD300LB;CLPB;PYDC1;CD74;AKAP1;CHUK;LBP;MASP2;BCL10;PPARG;TRIM35;PHB2;YES1;RARRES2;CR2;PJA2;RNF187;CYLD;MAVS;TRIM14;HCK;RPL39
prerank,positive regulation of hormone secretion (GO:0046887),0.24976061188029414,0.5758483223705493,0.952112676056338,1.0,1.0,2/17,11.59%,SOX11;EDN3
prerank,establishment of protein localization to mitochondrion (GO:0072655),0.20444859804803014,0.5733603271161801,0.9735894357743097,1.0,1.0,18/46,29.24%,FBXO7;TOMM22;AIP;TOMM20;GDAP1;DNAJC19;PAM16;AIFM1;HK2;TSPO;HSPD1;HK1;CHCHD4;TIMM13;RALA;TOMM34;TIMM50;FIS1
prerank,glycine metabolic process (GO:0006544),0.2624162922216944,0.5722270467742118,0.9418960244648318,1.0,1.0,3/12,22.19%,GLYAT;AMT;RIDA
prerank,endosome transport via multivesicular body sorting pathway (GO:0032509),0.22592842423262752,0.5714616264518932,0.9442970822281167,1.0,1.0,7/25,21.01%,LAPTM4B;TMEM50B;MVB12A;CHMP4C;DENND10;CHMP1B;UBXN6
prerank,establishment of epithelial cell apical/basal polarity (GO:0045198),0.27353896818704926,0.5713603157617234,0.9293394777265745,1.0,1.0,2/10,11.42%,MYO9A;OPHN1
prerank,regulation of lipid kinase activity (GO:0043550),-0.2246334477560099,-0.5711712316045768,0.9589442815249267,0.9917597013240141,1.0,1/11,1.96%,PIK3R3
prerank,negative regulation of mitotic cell cycle (GO:0045930),0.20698561760594258,0.5710664934934918,0.9730392156862745,1.0,1.0,7/45,13.93%,TGFB1;AURKAIP1;ZFP36L2;BMP7;ZWINT;SCRIB;BUB1B
prerank,leukocyte tethering or rolling (GO:0050901),-0.19808066692802345,-0.570318673712119,0.9733333333333334,0.9910424421093034,1.0,1/17,1.73%,ROCK1
prerank,proteasomal ubiquitin-independent protein catabolic process (GO:0010499),0.22839221386415717,0.5695729133323876,0.9502018842530283,1.0,1.0,5/22,20.75%,PSMB7;NFE2L2;PSMB2;PSME4;PSMA8
prerank,modulation by host of symbiont process (GO:0051851),0.21736515949216692,0.569096172246012,0.9730077120822622,1.0,1.0,4/31,11.32%,CCL4;CARD9;SP1;TAF11
prerank,cholesterol efflux (GO:0033344),0.23840639083781612,0.5687169177992619,0.952513966480447,1.0,1.0,3/20,16.66%,NPC1;ABCA5;ABCG4
prerank,cellular response to lectin (GO:1990858),0.18525677834317938,0.5666341777295163,0.9924892703862661,1.0,1.0,28/104,26.09%,PAK1;CARD9;FYN;PSMB7;PRKACA;MALT1;PSMD2;MUC3B;MUC3A;PSMC1;PSMB2;CHUK;NRAS;KRAS;PSMD9;TAB3;PSME4;BCL10;PSMA8;NFKB1;CARD11;TAB2;CUL1;PAK3;RAF1;PSMD8;PSMD13;SYK
prerank,stimulatory C-type lectin receptor signaling pathway (GO:0002223),0.18525677834317938,0.5666341777295163,0.9924892703862661,1.0,1.0,28/104,26.09%,PAK1;CARD9;FYN;PSMB7;PRKACA;MALT1;PSMD2;MUC3B;MUC3A;PSMC1;PSMB2;CHUK;NRAS;KRAS;PSMD9;TAB3;PSME4;BCL10;PSMA8;NFKB1;CARD11;TAB2;CUL1;PAK3;RAF1;PSMD8;PSMD13;SYK
prerank,glutathione metabolic process (GO:0006749),0.21384063377553636,0.5664532310351367,0.9748427672955975,1.0,1.0,6/38,18.76%,DPEP1;GSS;GGCT;GSTZ1;GSTT1;PARK7
prerank,late endosome to vacuole transport via multivesicular body sorting pathway (GO:0032511),0.24453704821943317,0.5660267499639661,0.9558404558404558,1.0,1.0,3/16,15.22%,VPS36;TMEM50B;CHMP4C
prerank,regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083),-0.16473621243517023,-0.5654449597490085,0.9823008849557522,0.9918737550503107,1.0,12/32,32.17%,POLA1;TFDP2;ID2;PCNA;NPAT;ZPR1;E2F1;KLF11;CDC45;CDK14;CDK18;E2F7
prerank,negative regulation of biosynthetic process (GO:0009890),0.24391886165243057,0.5644978659957698,0.9514705882352941,1.0,1.0,4/16,18.76%,ASXL3;ABCD2;TRAP1;PARK7
prerank,innate immune response activating cell surface receptor signaling pathway (GO:0002220),0.18428576152354786,0.5630767339528656,0.9903329752953813,1.0,1.0,28/105,26.09%,PAK1;CARD9;FYN;PSMB7;PRKACA;MALT1;PSMD2;MUC3B;MUC3A;PSMC1;PSMB2;CHUK;NRAS;KRAS;PSMD9;TAB3;PSME4;BCL10;PSMA8;NFKB1;CARD11;TAB2;CUL1;PAK3;RAF1;PSMD8;PSMD13;SYK
prerank,response to prostaglandin E (GO:0034695),0.26776299271905596,0.5628859697084873,0.9477020602218701,1.0,1.0,10/10,73.24%,TGFBR3;ADCY6;GNG2;PTGER4;TNFSF4;CCR7;PTGER2;SFRP1;GNB1;CCL19
prerank,mitotic G2 DNA damage checkpoint signaling (GO:0007095),0.21443514566939542,0.562000085055067,0.9674185463659147,1.0,1.0,6/32,15.80%,MRNIP;BRCA1;TAOK3;TOPBP1;ATM;BLM
prerank,kinetochore organization (GO:0051383),0.2519769237457936,0.5613104054609469,0.9451219512195121,1.0,1.0,3/13,19.46%,POGZ;NUF2;CENPC
prerank,bile acid biosynthetic process (GO:0006699),0.2299851061866676,0.5597002001437469,0.9629139072847682,1.0,1.0,8/24,25.14%,CYP39A1;CYP7B1;CYP27A1;OSBPL1A;ACOT8;SCP2;HSD17B4;AMACR
prerank,positive regulation of DNA-dependent DNA replication (GO:2000105),0.2657766079818349,0.5596218223346657,0.9527027027027027,1.0,1.0,3/10,20.98%,ATRX;DBF4;SSBP1
prerank,positive regulation of cellular senescence (GO:2000774),0.2677898774690952,0.5583794907101127,0.9481132075471698,1.0,1.0,2/10,15.21%,YPEL3;CGAS
prerank,sensory perception of chemical stimulus (GO:0007606),0.24408542188869176,0.5583030990010588,0.9506172839506173,1.0,1.0,4/15,24.43%,DRD2;SLC24A4;UBR3;BBS4
prerank,negative regulation of defense response to virus (GO:0050687),0.2718319748011321,0.5581542647461939,0.9522342064714946,1.0,1.0,1/10,8.38%,PPM1B
prerank,gluconeogenesis (GO:0006094),0.2084592208049113,0.5579694610937016,0.9687108886107635,1.0,1.0,7/39,20.52%,PGM1;GOT2;SLC25A10;CRY1;SLC25A11;PCK2;PFKFB1
prerank,"DNA damage response, signal transduction by p53 class mediator (GO:0030330)",0.18923693999519112,0.5565480521017954,0.9886104783599089,1.0,1.0,15/72,18.77%,FOXM1;ATRX;CARM1;PCBP4;PRMT1;ING4;CNOT3;MDM4;CASP2;CRADD;ATM;RPS27L;TP53;MDM2;BATF
prerank,positive regulation of lipid storage (GO:0010884),0.22946787920967626,0.5546896178207822,0.9696551724137931,1.0,1.0,1/21,3.85%,PLIN3
prerank,negative regulation of osteoclast differentiation (GO:0045671),0.23635025851408492,0.5534718948409311,0.9579375848032564,1.0,1.0,1/18,3.89%,FBXW7
prerank,endoplasmic reticulum tubular network organization (GO:0071786),-0.19592390438597654,-0.5530925333347623,0.9770491803278688,0.9949783972696158,1.0,6/15,28.85%,ATL2;ZFYVE27;REEP1;RAB10;REEP2;REEP4
prerank,"synaptic transmission, GABAergic (GO:0051932)",0.26149492984614003,0.5529294728248394,0.933993399339934,1.0,1.0,5/10,26.55%,GABRG2;GABRA3;GABRA2;GABRG3;GABRA4
prerank,negative regulation of cyclase activity (GO:0031280),0.24843023843950518,0.5526038136937768,0.9552669552669553,1.0,1.0,2/14,12.69%,CCR2;DRD2
prerank,signal transduction by p53 class mediator (GO:0072331),0.21235201075470214,0.5523251969963857,0.9711664482306684,1.0,1.0,9/30,24.93%,PYCARD;ATRX;HINT1;MDM4;TP53;BATF;BCL3;RRP8;FHIT
prerank,macromolecule catabolic process (GO:0009057),0.21970477917732217,0.5517871734241304,0.9758713136729222,1.0,1.0,7/26,23.95%,TGFB1;UCHL3;MVB12A;SIAH1;TPP1;CLN6;MTOR
prerank,primary miRNA processing (GO:0031053),0.2623937563804344,0.5514181143353546,0.940625,1.0,1.0,1/10,6.20%,METTL3
prerank,negative regulation of adenylate cyclase activity (GO:0007194),0.25262589396165225,0.5506595463918555,0.9507246376811594,1.0,1.0,2/13,12.69%,CCR2;DRD2
prerank,inorganic ion transmembrane transport (GO:0098660),-0.21494036409290646,-0.5498987236768951,0.9528301886792453,0.9949217350879963,1.0,12/12,78.53%,ABCC9;KCNJ8;PKD2L1;ABCC8;P2RX3;KCNJ11;RHAG;ATP1B4;ASIC2;TRPM4;CACNA1H;PKD2
prerank,regulation of transcription regulatory region DNA binding (GO:2000677),0.22153997984191343,0.54981761558253,0.9651006711409396,1.0,1.0,2/25,4.44%,TGFB1;SOX11
prerank,positive regulation of syncytium formation by plasma membrane fusion (GO:0060143),-0.19924447308055734,-0.548351950633758,0.9782608695652174,0.9943688617292111,1.0,6/15,29.56%,CAMK1;FLOT1;CD53;RIPOR2;TYROBP;EHD1
prerank,negative regulation of inclusion body assembly (GO:0090084),0.26506402209389895,0.5481993201331646,0.9478827361563518,1.0,1.0,10/10,73.51%,DNAJB6;HSPA1A;DNAJB2;SACS;DNAJB8;DNAJA4;HSPA2;SORL1;HSPA1B;DNAJB1
prerank,positive regulation of exosomal secretion (GO:1903543),0.2425074933567556,0.5479891892130668,0.9573529411764706,1.0,1.0,3/15,18.12%,SDC4;PDCD6IP;RAB7A
prerank,negative regulation of response to DNA damage stimulus (GO:2001021),0.20748124034765403,0.5472215331140947,0.9819354838709677,1.0,1.0,12/30,30.42%,ACKR3;RTEL1;CD74;FBXO5;MDM2;SNAI1;THOC5;PTTG1IP;SIRT1;CDKN2D;BCL2L1;TMEM161A
prerank,phosphate ion transmembrane transport (GO:0035435),0.24669142640737135,0.5469432530788485,0.9479326186830015,0.9998709366607041,1.0,4/12,23.01%,SLC25A10;XPR1;SLC25A11;SLC20A1
prerank,regulation of myoblast fusion (GO:1901739),0.2520475348391653,0.5468259723319217,0.940625,0.9995432537670256,1.0,2/11,14.86%,MAPK14;EHD2
prerank,protein localization to microtubule organizing center (GO:1905508),0.2407341884741177,0.545858585338365,0.9555236728837877,0.9995570043692171,1.0,2/15,11.70%,PCM1;SNX10
prerank,nuclear pore organization (GO:0006999),0.23653492678884797,0.5455172735669745,0.9481481481481482,0.999317454966328,1.0,4/14,20.91%,NUP205;NDC1;RTN4;AHCTF1
prerank,cellular response to ketone (GO:1901655),0.20536911133978927,0.5446486664582507,0.9800498753117207,0.9992761275853919,1.0,6/35,20.07%,PTGFR;GNAI1;AHR;KLF9;PCK2;ADCY8
prerank,DNA unwinding involved in DNA replication (GO:0006268),0.2313861288436838,0.5442360716779152,0.9562043795620438,0.9990536857997537,1.0,5/16,24.62%,MCM4;BLM;WRN;SSBP1;RECQL
prerank,antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590),0.18586803141419714,0.544233208386582,0.9942396313364056,0.9986846857714281,1.0,13/70,20.95%,SNAP23;NCF1;PSMB7;NCF2;LNPEP;PSMD2;PSMC1;PSMB2;CHUK;PSMD9;PSME4;PSMA8;TAP1
prerank,protein autoprocessing (GO:0016540),-0.18294784340572548,-0.5438628986591375,0.9870967741935484,0.994658990352604,1.0,5/17,26.14%,CASP4;FXN;MYRF;HTRA2;OMA1
prerank,cAMP metabolic process (GO:0046058),0.24667053750252754,0.5428751527448292,0.9542682926829268,0.9988328774213522,1.0,2/13,12.05%,PTHLH;PDE4D
prerank,positive regulation of fatty acid metabolic process (GO:0045923),0.23611845361492273,0.5427009843682522,0.9608433734939759,0.998525739198468,1.0,2/15,9.43%,MLXIPL;ELOVL5
prerank,regulation of DNA metabolic process (GO:0051052),0.19522556426538185,0.5421553748552852,0.9820574162679426,0.9983593117720911,1.0,17/44,30.99%,MYC;UPF1;KPNA1;SMG6;TERF2IP;USP1;WRNIP1;CDK9;MPHOSPH8;KAT7;WDR18;SMG1;MPV17;NUCKS1;HNRNPD;UBE2V1;ALYREF
prerank,mitotic nuclear division (GO:0140014),0.18484114958292386,0.5402421708231236,0.9966703662597114,0.9987200715257428,1.0,13/71,20.15%,ARHGEF10;NDE1;STAG2;FLNA;CLASP1;SGO1;ZWINT;KPNB1;KLHL22;AAAS;SMC4;KIF2A;BCCIP
prerank,regulation of mitochondrial translation (GO:0070129),0.22472244869348623,0.5394804127659802,0.9681881051175657,0.9986254924136403,1.0,3/21,12.06%,NGRN;MTG1;RCC1L
prerank,TOR signaling (GO:0031929),0.2137738962942836,0.5393922986634271,0.967741935483871,0.9982878205922812,1.0,8/26,23.95%,MAPKAP1;GATA3;TIPRL;RPTOR;FNIP1;CCDC88A;CARD11;MTOR
prerank,DNA strand elongation involved in DNA replication (GO:0006271),0.22678509400512642,0.5386585928820294,0.9772727272727273,0.9981731259939081,1.0,3/18,10.84%,GINS2;POLE3;MCM4
prerank,regulation of transcription from RNA polymerase II promoter in response to stress (GO:0043618),0.18028953065152764,0.5385830494462778,0.9966442953020134,0.9978308758276847,1.0,16/86,20.98%,VEGFA;MAPK7;PSMB7;HIF1A;NFE2L2;PSMD2;UBB;PSMC1;GCN1;TP53;PSMB2;ELOC;PSMD9;PSME4;PSMA8;LIMD1
prerank,regulation of spindle organization (GO:0090224),0.2294157743157278,0.5385225245749368,0.9578059071729957,0.9974845985632036,1.0,4/18,22.86%,GPSM2;GNAI1;RNF4;DYNC1H1
prerank,negative regulation of glycolytic process (GO:0045820),-0.22353849106292778,-0.5380049756166151,0.9511494252873564,0.9942535150512642,1.0,3/10,18.17%,NUPR1;HDAC4;GIT1
prerank,negative regulation of purine nucleotide metabolic process (GO:1900543),-0.22353849106292778,-0.5380049756166151,0.9511494252873564,0.9942535150512642,1.0,3/10,18.17%,NUPR1;HDAC4;GIT1
prerank,regulation of membrane depolarization (GO:0003254),0.2292850877865793,0.5371391372211096,0.9716713881019831,0.997644863187752,1.0,2/18,14.26%,SCN5A;NEDD4L
prerank,negative regulation of calcium ion transmembrane transporter activity (GO:1901020),0.21225830306022916,0.536850573111752,0.9896774193548387,0.9973716175506222,1.0,7/26,25.00%,THADA;DRD2;CALM1;CALM2;PKD2;UBQLN1;FMR1
prerank,negative regulation of signal transduction by p53 class mediator (GO:1901797),0.22551904329196978,0.5363243807754499,0.9741007194244604,0.9971780232481728,1.0,1/17,2.35%,PRKN
prerank,regulation of DNA damage checkpoint (GO:2000001),0.260318400528419,0.5355594428225534,0.9496062992125984,0.9970625675263787,1.0,2/10,14.47%,RPA2;CRY1
prerank,tetrahydrofolate metabolic process (GO:0046653),0.2528071069648531,0.5344181025800615,0.9627906976744186,0.9970757178209328,1.0,1/10,11.94%,MTHFD2L
prerank,negative regulation of homotypic cell-cell adhesion (GO:0034111),0.2501731618161845,0.5331281950310723,0.9483037156704361,0.9971393936808698,1.0,3/10,19.14%,SERPINE2;CD9;RDX
prerank,cellular response to purine-containing compound (GO:0071415),0.25580865819481124,0.5326896354099636,0.9557926829268293,0.9969347863765159,1.0,2/10,19.09%,P2RY1;RYR3
prerank,rRNA transcription (GO:0009303),0.22698329541899515,0.5323502508547716,0.9600570613409415,0.9966880110857159,1.0,4/17,17.82%,SPIN1;GTF3C1;NIFK;POLR1G
prerank,spindle assembly checkpoint signaling (GO:0071173),0.222565527102215,0.5321970185082321,0.9681440443213296,0.9956358199508397,1.0,4/20,15.47%,ZWINT;BUB1B;KLHL22;ATM
prerank,mitotic spindle assembly checkpoint signaling (GO:0007094),0.222565527102215,0.5321970185082321,0.9681440443213296,0.9956358199508397,1.0,4/20,15.47%,ZWINT;BUB1B;KLHL22;ATM
prerank,mitotic spindle checkpoint signaling (GO:0071174),0.222565527102215,0.5321970185082321,0.9681440443213296,0.9956358199508397,1.0,4/20,15.47%,ZWINT;BUB1B;KLHL22;ATM
prerank,regulation of microtubule nucleation (GO:0010968),0.2595410746919298,0.5310731778707176,0.9634703196347032,0.9956338370563024,1.0,2/10,13.07%,PAK1;CKAP5
prerank,mRNA methylation (GO:0080009),-0.1923533655994807,-0.5304495842893826,0.9900990099009901,0.9952294763226379,1.0,2/15,6.61%,WTAP;METTL14
prerank,phosphate ion transport (GO:0006817),0.22563049020400144,0.529573542996679,0.9610778443113772,0.9957472195461027,1.0,3/16,16.03%,SLC25A10;XPR1;SLC25A11
prerank,regulation of response to stress (GO:0080134),-0.2158846330195619,-0.5294345735867361,0.976,0.9944847415237826,1.0,5/10,29.80%,OPRM1;SLC38A2;MLC1;STOX1;CORO2B
prerank,organelle fusion (GO:0048284),0.21763526972091676,0.5285853420974865,0.973314606741573,0.9956997782196562,1.0,7/22,29.24%,VPS11;OPA1;GDAP1;MIGA2;VPS18;EEA1;FIS1
prerank,response to UV-B (GO:0010224),-0.20308918105541843,-0.528277366603374,0.9761194029850746,0.9937482919242329,1.0,6/12,36.08%,MFAP4;STK11;HYAL2;MME;MSH2;HYAL3
prerank,nucleotide-binding oligomerization domain containing signaling pathway (GO:0070423),0.20692940146373406,0.527463519730221,0.9732262382864793,0.9956892610854936,1.0,12/28,28.01%,OTULIN;UBB;TAB3;AAMP;TAB2;CYLD;IRAK2;IRAK1;MAP2K6;RELA;TRAF6;TAB1
prerank,negative regulation of cellular protein metabolic process (GO:0032269),0.17344972525777252,0.5257983508239236,0.9989082969432315,0.9958358282738753,1.0,17/88,22.70%,EPRS1;EIF2AK3;CSTB;TSC1;CPEB3;SERPINE2;HDAC6;ATRAID;PUS7;EIF4ENIF1;GIGYF2;SYNCRIP;PLAT;NFKB1;DDX6;RIDA;PAIP2B
prerank,cardiac muscle contraction (GO:0060048),0.2008050681242404,0.5256805169782174,0.9870633893919794,0.9955080410808281,1.0,2/34,5.51%,GSN;SCN5A
prerank,detection of light stimulus involved in sensory perception (GO:0050962),0.2507532011046947,0.5248228839008516,0.9633173843700159,0.9950359475521692,1.0,10/10,74.94%,CACNA2D4;GRM6;RPE65;CACNA1F;GNAT2;REEP6;GNAT1;CNGB1;TULP1;CEP250
prerank,detection of light stimulus involved in visual perception (GO:0050908),0.2507532011046947,0.5248228839008516,0.9633173843700159,0.9950359475521692,1.0,10/10,74.94%,CACNA2D4;GRM6;RPE65;CACNA1F;GNAT2;REEP6;GNAT1;CNGB1;TULP1;CEP250
prerank,pyrimidine-containing compound catabolic process (GO:0072529),-0.18585960065302023,-0.524281155289557,0.9811320754716981,0.9936053767309114,1.0,16/16,81.44%,UPB1;NT5M;DPYSL5;NT5C1A;UPP1;DPYSL4;DPYS;CRMP1;DPYSL3;UPP2;DPYSL2;NT5E;TET2;NT5C3A;DPYD;NT5C
prerank,B cell homeostasis (GO:0001782),0.24498188887476632,0.524263761918571,0.9585987261146497,0.9948564552134359,1.0,1/10,6.74%,DOCK10
prerank,cell cycle checkpoint signaling (GO:0000075),0.23965735615137052,0.523131858688586,0.9649390243902439,0.994852641111227,1.0,2/12,13.93%,ZWINT;BUB1B
prerank,regulation of NIK/NF-kappaB signaling (GO:1901222),0.17709750008262337,0.5227114221630011,0.9966592427616926,0.9946238162805268,1.0,15/76,23.27%,PTPN22;EGFR;TRIM44;PPM1B;TRIP6;BMP7;RTKN2;RASSF2;TERF2IP;CPNE1;PDCD4;PHB2;PPM1A;BCL3;CYLD
prerank,response to purine-containing compound (GO:0014074),-0.1787206447019541,-0.520949416901274,0.9929824561403509,0.9933669940580684,1.0,4/17,25.43%,ABCC9;TRPC3;TRPM2;VGF
prerank,negative regulation of macroautophagy (GO:0016242),0.20420823779061453,0.519338211125071,0.9776021080368906,0.9952252113906616,1.0,12/26,29.23%,TSC1;CLEC16A;UBQLN4;NRBP2;MTOR;MTM1;CHMP4A;CHMP4B;SMG1;PIK3CA;TMEM39A;SEC22B
prerank,macrophage activation involved in immune response (GO:0002281),0.23301120974706307,0.5185886394758356,0.9803030303030303,0.995076316783702,1.0,3/13,18.61%,GRN;DYSF;LBP
prerank,dendritic cell migration (GO:0036336),0.22526783930288097,0.5184039327098552,0.9700854700854701,0.9947575428315066,1.0,1/16,5.23%,CCR2
prerank,regulation of peptidase activity (GO:0052547),0.21722894396924916,0.517047713667992,0.9703389830508474,0.9947749685257767,1.0,4/19,21.04%,CSTB;RCN3;NDUFA13;FURIN
prerank,"negative regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043518)",-0.19196717597525825,-0.5155046319370434,0.9944598337950139,0.9934824738062086,1.0,2/13,11.04%,KDM1A;YJU2
prerank,heterocycle biosynthetic process (GO:0018130),0.22818729445264543,0.5135979860998625,0.9798270893371758,0.995349295210484,1.0,2/14,14.15%,GPHN;NFS1
prerank,negative regulation of protein exit from endoplasmic reticulum (GO:0070862),0.2445093285016624,0.5103539933726107,0.9698412698412698,0.9958388303570169,1.0,1/10,9.30%,DERL2
prerank,peptidyl-amino acid modification (GO:0018193),0.23741904664187025,0.5074914341709483,0.9751166407465007,0.9962073193702803,1.0,3/10,23.10%,TTLL4;METAP1;METAP1D
prerank,protein kinase A signaling (GO:0010737),0.23098283065254227,0.5032216705792556,0.9646697388632872,0.9968813822544096,1.0,2/12,19.14%,PRKACA;RDX
prerank,pyrimidine nucleobase metabolic process (GO:0006206),0.22847416966357592,0.5028136849660405,0.961764705882353,0.9966215370639739,1.0,4/12,22.68%,UMPS;CTPS2;ALDH6A1;DPYD
prerank,regulation of actin filament depolymerization (GO:0030834),-0.19014429764895255,-0.4972247507674661,0.990990990990991,0.9958552655349955,1.0,2/12,13.74%,MTPN;LIMA1
prerank,negative regulation of phosphatase activity (GO:0010923),0.19570171217425814,0.493214075429598,0.982573726541555,0.9984201448576724,1.0,2/25,5.64%,PPP1R15A;URI1
prerank,chromosome condensation (GO:0030261),0.18484977277617487,0.4910126142250829,0.9924812030075187,0.9985263965541651,1.0,5/36,18.94%,BANF2;PHF8;SMC4;AIFM1;CSNK2A2
prerank,regulation of phosphate metabolic process (GO:0019220),0.2124929227934007,0.48957278718542985,0.9824817518248176,0.9984571524935701,1.0,1/16,4.32%,PSEN1
prerank,'de novo' posttranslational protein folding (GO:0051084),0.1885096757255691,0.4875841358706795,0.9910828025477707,0.9984935940198264,1.0,7/30,25.39%,DNAJB4;GAK;SDF2;HSPA9;ERO1A;HSPA1A;CHCHD4
prerank,positive regulation of actin filament depolymerization (GO:0030836),-0.19935975178908666,-0.4854687368735685,0.9862258953168044,0.9966845619178779,1.0,1/10,8.12%,ACTN2
prerank,non-motile cilium assembly (GO:1905515),0.18554782442052303,0.48544033360552846,0.9885786802030457,0.9985338808388666,1.0,4/30,15.64%,PCM1;DISC1;CEP89;IFT57
prerank,pyrimidine nucleoside biosynthetic process (GO:0046134),0.22578159285498045,0.4844198318489782,0.9775449101796407,0.9983521145381804,1.0,5/12,27.88%,UMPS;DHODH;UCK1;UCK2;CAD
prerank,homeostasis of number of cells (GO:0048872),0.21835542718821482,0.48363995972010315,0.9641791044776119,0.9981384731167283,1.0,1/12,6.84%,CARD9
prerank,triglyceride catabolic process (GO:0019433),0.20303962821076438,0.4835538879853031,0.9844413012729845,0.9977917295246531,1.0,19/19,79.72%,LIPC;FABP7;APOC3;FABP6;PNPLA5;PNLIPRP2;LIPI;PNPLA1;FABP2;CPS1;LIPG;FABP5;FABP12;FABP4;LIPH;FABP3;PNPLA3;LPL;PNPLA2
prerank,negative regulation of lipid catabolic process (GO:0050995),0.20448917230333968,0.4833363875129306,0.9824817518248176,0.9974698417780935,1.0,3/17,21.94%,PDE3B;GPLD1;PRKAA1
prerank,regulation of protein kinase A signaling (GO:0010738),0.19899627119744256,0.48281830526143066,0.9875,0.9972008905543636,1.0,2/20,10.70%,PRKAR1B;AKAP6
prerank,regulation of Golgi organization (GO:1903358),0.20501878098000353,0.48088547082020056,0.9885386819484241,0.9971604280245551,1.0,5/17,23.74%,MAPK1;USP6NL;RBSN;MYO5A;STX18
prerank,attachment of mitotic spindle microtubules to kinetochore (GO:0051315),0.21676082862523535,0.4793418948974542,0.988835725677831,0.9970754062282584,1.0,12/12,78.34%,NUF2;CENPC;MIS12;CDT1;CHAMP1;KIF2C;RMDN1;SEH1L;MAD1L1;NDC80;CENPE;BOD1
prerank,mRNA modification (GO:0016556),0.1965308889087096,0.47825773620125384,0.9878869448183042,0.9968977916402553,1.0,5/22,20.17%,METTL3;PUS7;PUS1;VIRMA;NSUN2
prerank,nucleoside catabolic process (GO:0009164),-0.19517038267091816,-0.4775676557395184,0.9943342776203966,0.9966493615083138,1.0,3/11,22.68%,UPB1;NT5M;NT5C1A
prerank,pyrimidine nucleoside catabolic process (GO:0046135),-0.19966182009828154,-0.47533070912562936,0.994535519125683,0.9958957507918867,1.0,3/10,22.68%,UPB1;NT5M;NT5C1A
prerank,regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090266),0.21237344316417994,0.47462765549163755,0.9955357142857143,0.997172534962179,1.0,4/13,22.48%,XRCC3;PCID2;DUSP1;CDK5RAP2
prerank,defense response to protozoan (GO:0042832),0.2165097300690521,0.4733240898863708,0.9909638554216867,0.9970318386508277,1.0,12/12,78.37%,BATF;GBP2;GBP4;LYST;GBP7;IRF4;GBP6;PF4;BATF2;SLC11A1;MYD88;CD40
prerank,ruffle organization (GO:0031529),0.2065443984898603,0.4687878575094012,0.9855491329479769,0.9973915251212259,1.0,4/16,23.92%,CORO1B;CYFIP1;PIP5K1A;PLEKHA1
prerank,regulation of double-strand break repair via nonhomologous end joining (GO:2001032),0.1797566793385389,0.4617562708904876,0.994572591587517,0.9980074832504215,1.0,9/28,26.92%,MRNIP;SETMAR;CYREN;TFIP11;PRKDC;SMCHD1;ACTR2;KMT5B;KMT5C
prerank,protein deneddylation (GO:0000338),0.21712854009611796,0.45709052435146996,0.9951768488745981,0.9982621568648213,1.0,5/10,31.90%,COPS6;COPS7A;COPS2;TOR1A;COPS4
prerank,sister chromatid segregation (GO:0000819),0.17230600157949683,0.4541930681907684,0.9974811083123426,0.9982588981577758,1.0,7/31,23.57%,SGO1;ZWINT;KLHL22;SMC4;RB1;SMC1A;WRAP73
prerank,positive regulation of ERBB signaling pathway (GO:1901186),0.17713929676894827,0.44669289698107734,0.9933422103861518,0.9987779513208038,1.0,5/25,20.44%,HIP1;CBL;RTN4;CCDC88A;BCAR3
prerank,defense response to Gram-positive bacterium (GO:0050830),0.16331703496287714,0.4448214325433963,0.9975062344139651,0.9986282303367631,1.0,10/40,26.37%,RNASE6;MR1;LBP;RARRES2;GBP2;RPL39;DROSHA;RNASE3;GBP4;RNASE7
prerank,"maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000463)",-0.16606954056104786,-0.4414471660679702,0.9968152866242038,0.9978769599768884,1.0,5/14,30.82%,URB1;PES1;RPF2;DDX18;ZNHIT3
prerank,regulation of transposition (GO:0010528),0.1965513265910055,0.4366861507073576,0.9910581222056631,0.9990729614321349,1.0,1/13,9.32%,TEX15
prerank,positive regulation of type 2 immune response (GO:0002830),0.19291291124714166,0.43388613273687526,1.0,0.9989634567351504,1.0,2/14,17.14%,IL18;CD74
prerank,C21-steroid hormone metabolic process (GO:0008207),0.18471297575681433,0.43275910058601275,0.9958620689655172,0.9986956778600354,1.0,20/20,81.55%,TSPOAP1;TSPO;STARD3;STARD3NL;FDX1;DHRS2;HSD3B1;CYP17A1;AKR1B1;CYP11A1;CYP11B1;AKR1D1;DHRS9;AKR1C1;HSD3B2;FDX2;CYP46A1;HSD17B10;STAR;FDXR
prerank,low-density lipoprotein particle receptor catabolic process (GO:0032802),0.2093686092579551,0.43117773979782364,0.9938271604938271,0.9981135443247182,1.0,1/10,12.50%,MYLIP
prerank,low-density lipoprotein receptor particle metabolic process (GO:0032799),0.2093686092579551,0.43117773979782364,0.9938271604938271,0.9981135443247182,1.0,1/10,12.50%,MYLIP
prerank,regulation of mast cell degranulation (GO:0043304),0.18422869953371313,0.4175989112101093,1.0,0.9987738037616564,1.0,3/14,20.82%,GAB2;UNC13D;CD84
prerank,organic cyclic compound biosynthetic process (GO:1901362),0.1603952769247569,0.4108093772783468,0.9974587039390089,0.9988391355409415,1.0,7/31,28.37%,PRLR;GPHN;NFS1;SCP2;MOCS3;CYP51A1;PYCR2
prerank,ATP transport (GO:0015867),0.19233089622295255,0.4008332534776128,1.0,0.9990049131675374,1.0,4/10,31.29%,SLC25A24;SLC17A9;SLC25A17;CD47
prerank,dendritic cell differentiation (GO:0097028),0.16052790423937557,0.3932829125778517,1.0,0.998992329967661,1.0,4/22,22.09%,TGFBR2;BATF;AXL;IRF8
prerank,natural killer cell activation (GO:0030101),0.15736845548188821,0.3904928583281562,0.9986263736263736,0.9987447440515687,1.0,4/23,23.67%,RABL3;AXL;PBX1;KAT7
